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There is considerable epidemiologic evidence that drinking alcoholic beverages is associated with an 
increased risk for certain cancers (i.e. cancers of the upper-aero digestive tract) though the evidence of 
an increased risk for colorectal and breast cancer is controversial. For other cancers (e.g. kidney, 
bladder, lung, ovarian) the evidence remains inconclusive. Considering the high prevalence of many 
of these cancers in Scotland, even a small increase in cancer risk is of great importance, therefore 
from a public health perspective it is important that the evidence linking alcohol to an increased risk 
of cancer is continuously evaluated. Questions still remain, however, concerning the robustness and 
consistency of the alcohol information collected across studies. Furthermore, the heterogeneity of 
drinking levels, drinking patterns, and definitions of standard drinks internationally make it 
problematic to generalise the findings of these studies.  
Aim: 
To further clarify the role of alcohol in the occurrence of cancer in a country marked by high levels of 
alcohol consumption and rising incidence of many of the cancers linked with alcohol consumption. 
The aim of this study, therefore, is to (1) investigate the association between alcohol consumption and 
the risk of fourteen cancers using routine Scottish data sources and (2) to test the hypothesis that 
alcohol consumption increases the risk of these cancers in a sample of the Scottish population.  
Methods: 
A systematic review of the published literature between 1999, the date of the last major review, and 
2009 on alcohol related cancers to determine the strength of evidence on the association between 
alcohol and cancer, and if it varies by amount drunk, by drinking pattern and drink type. Two cohort 
studies were formed; in the first a population based cohort study, based on a linkage between a 
representative general population sample and hospital, cancer registry and death records in Scotland, 
describes risk of cancer by amount of alcohol consumed per week and by drinking frequency and in a 
second study, based on a linkage between hospital and cancer and death records, the risk of cancer in 
a population that has been admitted to hospital (between 1981 and 2007) with an alcohol related 
diagnosis was investigated. 
Results: 
The present study provides weak evidence of a relationship, in a sample of the Scottish general 
population, between alcohol drinking frequency and amount consumed and cancers of the upper aero 
digestive tract. An increased risk (though non-significant) of colorectal cancer for daily drinkers was 
observed but no relationship was detected for amount consumed for this cancer. There was no 
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association observed between drinking frequency or amount consumed and risk of breast, lung and 
prostate cancer. People with an alcohol-related hospital admission, however, are at substantially 
higher relative risk of head and neck and upper gastrointestinal cancers compared to the general 
population, and relative risks increase with increasing levels of deprivation. It is likely that tobacco 
smoking also contributes to this excess risk.  
Conclusions: 
The generalisability of findings from the international literature to Scotland is problematic due to 
different measures of alcohol consumption. Although the present study provides evidence that people 
in Scotland who require in-hospital care for an alcohol related condition are at substantial subsequent 
relative risk of head and neck and upper gastrointestinal cancers and that the relative risk increases 
with increasing levels of deprivation, further prospective studies with longer-follow-up are required to 
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Chapter 1: Introduction 
 
This chapter aims to provide the historical and policy perspectives on alcohol and health and to 
review the historical evidence of the link between alcohol and cancer. Finally, it details the thesis 
hypotheses and describes the thesis objectives. 
 
1.1 A short history of alcohol  
An alcoholic beverage is a drink containing ethanol (or ethyl alcohol), commonly known as alcohol. 
Alcoholic beverages that have lower alcohol content (e.g. beer and wine) are produced by 
fermentation of sugar- or starch-containing plant material. Beverages of higher alcohol content (e.g. 
spirits) are produced by fermentation followed by distillation. The effects of alcohol (i.e., ethanol) on 
various tissues depend on its concentration in the blood (blood alcohol concentration [BAC]) over 
time. BAC is determined by how quickly alcohol is absorbed, distributed, metabolized, and excreted 
(Zakhari 2006). After alcohol is swallowed, it is absorbed primarily from the small intestine into the 
veins that collect blood from the stomach and bowels and from the portal vein, which leads to the 
liver. From there it is carried to the liver, where it is exposed to enzymes and metabolized. The major 
pathway for alcohol metabolism involves the enzyme alcohol dehydrogenase. This enzyme converts 
alcohol to acetaldehyde through a chemical process called oxidation. Acetaldehyde is highly toxic to 
the body, even in low concentrations. Normally, however, the enzyme aldehyde dehydrogenase 
rapidly oxidizes acetaldehyde to acetate (Maher 1997). Chronic alcohol consumption and alcohol 
metabolism are strongly linked to several pathological consequences and tissue damage (Zakhari 
2006). 
Alcoholic beverages have been used in human societies at least since the beginning of recorded 
history. Fermented beverages existed in early Egyptian civilization and there is evidence of an early 
alcoholic drink in China around 7000 B.C. In India, an alcoholic beverage called sura, distilled from 
rice, was in use between 3000 and 2000 B.C. The Babylonians worshiped a wine goddess as early as 
2700 B.C. In Greece, one of the first alcoholic beverages to gain popularity was mead, a fermented 
drink made from honey and water (Hanson 1995, Walton 2001). During the time of the Roman 
Republic and Empire, trade in wine and other alcoholic beverages grew enormously. In this period, 
the Romans were essentially responsible for the beginnings of the European wine industry planting 
vineyards across Europe including England, France, Germany, Italy, Hungary and other parts of 
southeastern Europe (Blocker et al 2003). With the collapse of the Roman Empire and decline of 
urban life, religious institutions, particularly monasteries, became the repositories of the brewing and 
winemaking techniques that had been earlier developed (Babor et al 1986). As the end of the middle 
ages approached, the popularity of beer spread to England, France and Scotland (Austin 1985). Beer 
18 
 
brewers were recognized officially as a guild in England (Monckton 1966) and the adulteration of 
beer or wine became punishable by death in Scotland (Hanson 1995). The most important 
development, in Europe, regarding alcohol throughout the Middle Ages was probably that of 
distillation (Walton 2001). The knowledge of this process, first used in India and China from around 
800BC, began to spread slowly among monks, physicians and alchemists, who were interested in 
distilled alcohol as a cure for ailments (Hanson 1995). Spirit drinking was still largely used for 
medicinal purposes throughout most of the 16th century. It has been said of distilled alcohol that, "the 
sixteenth century created it; the seventeenth century consolidated it; the eighteenth popularized it." 
(Braudel 1967, quoted in Hanson 1995).
 
The industrial revolution and subsequent European colonial 
expansion changed the cultural position of alcohol nearly everywhere (Hanson 1995, Room et al 
2005, Berridge 2006). New forms of alcoholic beverages were introduced especially around spirit 
based drinks e.g. gin. A product prepared within the household and community was gradually 
transformed into an industrial commodity, available at any time and virtually any place (Room et al 
2005). 
 
1.2 Alcohol and health: historical perspective 
Accompanying the near ubiquity of alcoholic beverages in human history, has been an appreciation, 
documented in ancient texts from Greece, Palestine, or China, of the social and health problems 
caused by drinking (Babor 1986, Room et al 2005). During the Roman period came the first 
complaints of widespread public drunkenness and of what we now commonly describe as "binge 
drinking", for example alcohol was frequently distributed free at charge at festivals, large public 
gatherings etc., and often led to large-scale disorder (Hanson 1995). On the other hand, alcohol was 
also prized for its medical properties. Classical medical opinion generally held that wine had curative 
properties, particularly for gastric and urological ailments (Blocker et al 2003). What was most 
notable about responses to intoxication or excessive use of alcohol, was that concerns revolved around 
moral attitudes and social behaviours regarded as ‘licentious’, ‘sinful’ or ‘criminal’, that were 
associated with excessive drinking (Thom 2001). From the Middle Ages, through at least the 
beginning of the eighteenth century, attitudes toward alcohol and drinking were also generally 
characterized by a continued recognition of the positive nature of moderate consumption and an 
increased concern over the negative effects of drunkenness (Hanson 1995, Walton 2001). 
Drunkenness itself became a civil offence in England in 1552, and in 1606 an act was passed in 
England to allow authorities “to repress the odious and loathsome sin of drunkenness” (Thom 2001). 
Similar legislation was passed in Scotland in 1617. There is little evidence, however, that this 
legislation was rigoursly enforced (Thom 2001) and one reason for this, as Porter (1985) observes, 
was that heavy drinking was still prized as a ‘manly and sociable custom’ in Georgian Britain. Heavy 
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drinking, which was generally viewed as arising out of the increased self-indulgence of the time, was 
seen as a threat to spiritual salvation and societal well being (Hanson 1995). An early example of this, 
in the United Kingdom, can be seen in the language used the Royal College of Physicians in a 
statement to the House of Commons in 1726, which demanded an increase in taxes on spirits to act as 
a disincentive to ‘this (gin drinking) great and growing evil’ (Royal College of Physicians 1987). A 
similar tone was adopted by the then government, which in passing the 1736 Gin Act to control the 
sale of gin, stated that action was necessary because of the prevalence of gin consumption “among the 
people of lower and inferior rank, which led to the destruction of their healths, rendering them unfit 
for useful labour and business, debauching their morals, and citing them to all manner of vices” 
(Nicholls 2009). 
While drunkenness was still an accepted part of life in the eighteenth century (Austin, 1985), the 
nineteenth century brought a change in attitudes as a result of increasing industrialization and the 
societal changes that followed (Porter 1990). From an early stage of the industrial revolution, alcohol 
was more available, stronger and cheaper than ever before. This led to sharp increases in the 
consumption of alcohol across Europe peaking in the 1870’s (Wilson, 1940, p335 in Berridge 2006). 
The most significant increases in consumption occurred among the working classes (Knapp 1998). 
Drunkenness became progressively more common, more public and more associated with poverty 
(Porter 1985, Barrows and Room 1991, Anderson and Blaumberg 2001). As Walton (2001) observed, 
the new work patterns the Victorian era ushered in required labourers, however, to be available and 
fully functioning for a clearly defined major portion of their waking hours. Therefore, in the context 
of an industrialising society which needed adaptable, time-aware workers, sobriety became a virtue 
(Porter, 1990 Berridge 2006). In most countries where Protestant Christianity was strong, substantial 
temperance movements in the 19th century at first sought individual pledges to abstain from drinking 
and eventually pressed for national prohibition (Room et al 2005). In Scotland, the temperance 
movement first became organised in the 1820s and by the 1830s temperance societies had sprung up 
all over Glasgow and elsewhere in Scotland (Glatt 1958). In England, Joseph Livesey and seven 
Preston working men signed a pledge in 1832 stating that they would never again drink alcohol. Other 
groups of working men followed the example of Livesey and his friends, and by 1835 the British 
Association for the Promotion of Temperance was formed (Blocker et al 2003). 
The issues of the health effects of alcohol in the late 19th and early 20th Century were, therefore, seen 
within the context of broader debates about the temperance movement and prohibition (Leon 2001). 
The most prominent leader of the temperance movement was Dr. Benjamin Rush. His ideas were the 
primary foundation of the temperance movement. Rush explained that alcohol consumption was 
detrimental to one’s health, both physical and psychological. In 1784, he described what we would 
now call alcohol dependence as an involuntary condition. Rush subsequently laid the foundation for 
what is now called the disease concept or model of addiction and alcoholism (Thom 2001, Berridge 
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2006). By the end of the Eighteenth century, prominent physicians were observing, that a ‘new and 
terrible source of mortality had been opened for the ‘poor’, and this marked a crucial transition in 
public assessment of what was problematic about drink. Alcohol as Edwards (2000) noted “had 
become, in the modern term, a public health issue”. These issues came to the fore in an era of rapidly 
changing social conditions, new philosophical and political perspectives and the emergence of new 
power elites (Thom 2001). Medical temperance supporters worked with public-order interests in 
moves to establish a state-funded treatment system for 'inebriates' (the alcoholics of the day) and to 
divert drunkards out of the criminal justice system and into treatment (Berridge 2006). In Scotland, 
the temperance campaigners achieved a notable triumph in 1913 with the Temperance (Scotland) Act 
allowing electors to vote locally on whether their district should allow the sale of alcohol.  
Although the outbreak of World War One meant implementation of the law was suspended until 
1919, excessive drinking and drunkenness, especially among serviceman and factory workers, 
remained a significant problem. The then British Prime Minister, Lloyd George even observed in a 
speech to factory workers in 1915 that, “…we are fighting Germany, Austria, and drink; and, as far as 
I can see, the greatest of these three deadly foes is drink” (Chalmers 1915). During the First World 
War controls were put in place, which were the equivalent of a national alcohol strategy (Berridge 
2006). The creation of the Central Control Board (Liquor Traffic) in 1915 initiated a more active 
governmental interest in alcohol policy. Existing restrictions on opening hours (i.e. the ‘afternoon 
gap’ and Sunday trading were tightened, excise duties on beer and spirits were increased significantly, 
and the strengths of both beer and spirits were reduced) (Berridge 2006, House of Commons 2009). 
The restriction on opening hours was enshrined in the 1921 Licensing Act. Once the war was over, 
many Scottish communities took advantage of the Temperance Act to ban the sale of alcohol. In 1922, 
Winston Churchill, then a Liberal MP for Dundee, even lost his seat in parliament to a prohibitionist 
candidate (Paton 1992). 
The effect of the temperance movement was to result in a steady decline in alcohol consumption 
between 1900 and 1945, as measured by alcohol sales derived from Customs and Excise figures 
(Department of Health 1995). The spate of legislation to control manufacturing, distribution and 
consumption of alcohol (e.g. the 1921 Licensing Act) along with major changes in social and 
economic circumstances had resulted in a fall in consumption and related problems and a wane in 
policy attention to alcohol issues in general (Thom 2001). By the 1930s, the influence of the 
temperance movement was on the decline. In Britain, attention had strayed from the disease concept 
of alcoholism towards social harms such as loss of productivity, accidents and crime and poverty 
associated with excessive alcohol consumption rather (Thom 2001). Thom argues that by the 1970’s, 
the disease concept of alcohol had been firmly supplanted by a concern for alcohol misuse and 
problem drinking (rather than ‘alcoholism’) and the extent of alcohol related harm in communities 
and populations as a whole. The term “preventive paradox” summed up the belief that a greater level 
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of harm accrued from drinking by the majority of the population, than from the minority of alcoholics 
or excessive drinkers (Rose 1981, Kreitmann 1986). The ‘new public health approach’ proposed that 
both change in individual lifestyles and public health measures were required to minimize the harms 
related to the use of alcohol (Thom 2001). 
The idea of ‘sensible’ drinking was introduced, in the early 1980s by the UK government’s Health 
Education Authority, in response to increasing concern about rising number of hospital admissions for 
alcoholism and alcoholic psychosis and death rates from cirrhosis of the liver, (Dight 1976, Donnan 
and Haskey 1977, Royal College of Psychiatrists 1979, Tuck 1980, Haskey et al 1983). In 1984, the 
Health Education Council (the predecessor of the Health Education Authority) published the first 
edition of its pamphlet “That’s the Limit” (Health Education Council 1984) . This drew on material 
from a similar pamphlet which had been developed by health educators and clinicians working in the 
field of addiction in the North East of England (House of Commons Science and Technology 
Committee 2012). This gave advice on sensible drinking - described as the amounts, well within the 
“safe limits”, to which people should limit their drinking. These were defined as 18 “standard drinks” 
(equivalent to units) a week for men and 9 for women. “Too much” was defined as 56 a week for men 
and 35 for women. Initial advice framed these guidelines in terms of ‘standard’ drinks, the common 
measure of alcohol consumption used in many North American studies (Room 1977); a ‘standard’ 
drink is a notional drink that contains a specified amount of pure alcohol (ethanol). One standard 
drink always contains the same amount of alcohol regardless of serving size or the type of alcoholic 
beverage. A ‘standard drink generally contains between 10-14 grams of pure ethanol although the 
measure varies among countries (ICAP 2010). Further guidance from the Governments’ Health 
Education Authority in 1987, replaced the ‘standard drink’ with the alcohol ‘unit’ (Cabinet Office 
2004); the ‘unit’ was a construct first developed by Dight (1976) in a survey of drinking habits in 
Scotland to overcome the problem that the predominant Scottish beverage, beer, was sold primarily in 
two different drink sizes, a half-pint and a pint (Room 2000). As Room (2000) observed, Dight chose 
the smaller size as the ``standard unit'', although an ordinary male drinker in Scotland would think of 
``a drink'' in terms of a pint (equivalent to two standard units). When British governments then moved 
to promoting ``sensible drinking guidelines”, the Dight unit took on a new role as the metric for 
stating these guidelines. Sensible drinking guidelines were set at a maximum of twenty one units 
weekly for men and fourteen units weekly for women in the 1987 edition of the pamphlet ‘That’s the 
Limit’ (Health Education Authority 1987). Three of the medical Royal Colleges issued reports on 
alcohol in 1986/7 (Royal College of Psychiatrists 1986, Royal College of General Practitioners 1986, 
Royal College of Physicians 1987) endorsing the 1987 Health Education Authority line on “sensible” 
drinking. The British Government officially adopted the 1987 advice of the Royal Colleges in the 
Lord President’s (1991) report “Action Against Alcohol Misuse” with national targets for reducing 
people drinking beyond these “sensible” levels being set in both England and Scotland (Tuck 1980, 
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Paton 1988, Department of Health 1995). These “safe and sensible” drinking guidelines were further 
developed following a review of the “sensible” drinking message partly in response to evidence that 
alcohol may be protective from coronary heart disease, but also in recognition that weekly 
consumption levels can have little relation to single drinking episodes and may mask short term 
episodes of heavy drinking which often correlate strongly with both medical and social harm 
(Department of Health 1995). Therefore, in addition to weekly “sensible” guidelines, guidelines were 
set for daily alcohol intake: no more than four units a day for men and three units for women. 
Over the last decade, governments in Scotland and England have responded to concerns about the 
health and social harm associated with excessive drinking with a number of strategies (Scottish 
Executive 2002, Cabinet Office 2004, Scottish Government 2007, Department of Health/Home Office 
2007) combining harm reduction approaches with law and order initiatives to address excessive 
drinking patterns, including 'binge drinking' and regular drinking above the daily and weekly 
guidelines. More recently, however, and in an innovative departure from traditional post war alcohol 
policy, the Scottish Government have proposed the introduction of minimum retail pricing for alcohol 
to prevent loss-leading and below-cost selling of alcohol which has “generated the conditions for 
increasing levels of drinking and alcohol-related problems” (Scottish Government 2009). Although 
minimum pricing remains relatively untested and has not yet been implemented in many places nor 
evaluated extensively, some evidence exists that price control can lead to reductions in alcohol 
problems; in Canada with minimum pricing of beer, and the implementation in some Australian 
localities of bans on the sale of the cheapest form of alcohol (which amounts to raising the minimum 
price) (Babor et al 1986, Stockwell et al 2011). Work quantifying the potential impact of policies 
targeting pricing and promotion of alcohol on alcohol related harm in England (ScHARR 2008) and 
Scotland (ScHARR 2009) has demonstrated significant potential health gains for harmful drinkers 
drinking above safe levels, (usually beyond those of hazardous drinking, with evidence of alcohol-
related problems), and also important health gains in hazardous (drinking over the recommended 
weekly guidelines) and moderate drinkers (Raistrick et al 2006). The potential health gains depend 
greatly on the level of minimum price. At a low threshold (e.g. 25 pence per unit) there is little impact 
at reducing harmful outcomes, however, as the minimum price threshold increases, alcohol-related 
hospital admissions and deaths are estimated to reduce: for example, in Scotland 3,600 admissions per 
annum (once the full effect on the risk of harm has been realised) for a 40p threshold compared to 
8,900 per annum for a 50p threshold (ScHARR 2009). Purshouse  et al (2010) reported on the 
estimated effect of a £0.50 minimum price on the yearly prevalence of illness in England 10 years 
after policy implementation; of an estimated 49,000 cases of illness prevented by £0.50 minimum 
price, approximately two-thirds (64%) occurred in diseases of the circulatory system (net of any 
23 
 
increased cases of ischaemic heart disease) 16.5% (8,150 cases) in ‘alcoholic disorders’
1
 and 2940 
(6.0%) in cases of epilepsy. There were also smaller reductions in the number of cases in diseases of 
the digestive system (1490), diabetes (1300) and cancer (1050).  
 
1.3 Alcohol and health: a developing science 
Leon (2001) asserts that alcohol is the epidemiological ‘risk factor’ with the longest history of 
systematic study. Early epidemiological studies, in the late nineteenth century and early twentieth 
century, started to link excessive alcohol consumption with increased mortality. In 1851, one of the 
first scientific papers on alcohol and its effect on mortality was published in the Journal of Statistical 
Society. This study, which followed up ‘intemperates’, observed a mortality rate three times higher 
among excessive drinkers, than that in ‘abstainers’ (Neison 1851 in Edwards 2000). The most 
systematic evidence of alcohol’s health effects occurred in 1904 when Moore (1904) published an 
analysis of mortality among over sixty thousand policy holders who had taken out life insurance with 
the United Kingdom Temperance and General Provident Institution over the period 1841-1901. 
Moore found the mortality rate among male non-abstainers was unexceptional by the standard used by 
the life-insurance industry at the time. However, mortality among abstainers was considerably lower, 
resulting in a 10% greater life expectancy from age 30 years, than among non-abstainers. Similar 
results were reported for women.  
Despite these earlier studies, it is generally considered that the scientific study of alcohol related 
mortality began in the 1920s with Pearl’s studies (1926) of alcohol and longevity (Leon 2001, Mann 
et al 2003). Pearl, in a study whose primary aim was to throw light on genetic factors in tuberculosis, 
also investigated death rates among various types of drinkers based on analyses of family history data 
collected in Baltimore in the early 1920s (Leon 2001). Pearl demonstrated that heavy drinkers had 
higher rates of overall mortality and of cirrhosis mortality than did lighter drinkers or abstainers. In 
the same study, it was also reported that abstainers had a slightly higher mortality rate than moderate 
drinkers, providing early evidence of a U-shaped associated between alcohol consumption and 
mortality. Over the next fifty years, from Pearl’s work in Baltimore, studies continued to observe 
higher liver cirrhosis death rates among heavy drinkers than the general population (Pearl 1962, 
Sundby 1967, Schmidt and de Lint 1969, Schmidt and de Lint 1972, Pell and D’Alonzo 1973, Bruun 
et al 1975). From the early 1980’s, a number of studies provided evidence that both non-drinkers 
(abstainers) and heavy drinkers of alcohol have higher total and cardiovascular mortality rates than 
light or moderate drinkers (Klatsky et al 1981, Marmot et al 1981). This U-shaped mortality curve has 
                                                          
1
 wholly alcohol-attributable conditions which include alcoholic psychoses, alcohol-dependence syndrome, 
alcoholic polyneuropathy, alcoholic cardiomyopathy, alcoholic gastritis, alcoholic liver cirrhosis, and ethanol 
toxicity, see Section 1.3 p25) 
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been interpreted as indicating that moderate alcohol intake may confer protection against 
cardiovascular disease in general, and against heart attacks in particular (Turner et al 1981, Marmot 
1984, Moore and Pearson 1986). A number of biologically plausible mechanisms have been invoked 
to support the hypothesis, including the effects of alcohol on high-density-lipoprotein cholesterol and 
apolipoproteins, on fibrinolysis and coagulation, on blood pressure, and on coronary artery reactivity 
(Castelli et al 1977, Moore and Pearson 1986, Criqui et al 1987, Criqui 1990). Although the evidence 
of a lower risk of coronary heart disease among moderate drinkers is substantial and consistent, 
controversy remains about whether the relationship is truly causal-that is, whether moderate alcohol 
consumption really prevents coronary heart disease Mukamal and Rimm (2001). One of the major 
criticisms levelled at many of the studies is that non-drinkers will include people who have given up 
drinking because they were unwell. Such people would be expected to have an increased rate of 
disease. The argument suggests that it is the inclusion of "sick quitters" with the non-drinkers that 
accounts for the high incidence of coronary heart disease in non-drinkers compared with moderate 
drinkers (Shaper et al 1988). 
By the end of the 1970s, the substantial increase in alcohol consumption in many European and North 
American countries after World War II, driven by a relative decrease in price and a relaxation of 
licensing laws had spurred a greater interest in the effects of alcohol consumption on health (BMJ 
1981). In Britain, the relaxation of local licensing laws following the Errol report for England and 
Wales and the Clayson report for Scotland, published in 1973, resulted in both the British Medical 
Journal and Lancet producing editorials attacking these proposals, which were condemned as contrary 
to the interests of health. A Royal College of Physicians (1979) report towards the end of the decade 
commented on the relaxation of local licensing that ‘the relationship between normal drinking patterns 
and the country’s experience of alcohol related problems was ‘accidentally, but unequivocally put into 
the arena of debate’. In America, the disease model of alcoholism had shifted to one where alcoholism 
was viewed as an illness and government reports began to talk about problem drinking as opposed to 
‘alcoholics’ (Hewitt 1995). The founding in 1970 of the National Institute on Alcohol Abuse and 
Alcoholism in America also coincided with a large increase in national government research funds, 
for studies of health problems resulting from heavy alcohol consumption (Voas and Fell 2010). 
Spanning several decades since then, the literature now contains many reports linking alcohol with a 
broad array of adverse health outcomes and some beneficial health outcomes associated with alcohol 
use in individuals (IARC 1988b, Longnecker 1995, English et al 1995, Gutjahr et al 2001, Ridolfo 
and Stevenson 2001, Corrao et al 2000, Rehm et al 2003, Room et al 2005). Recent research has 
contributed substantially to our understanding of the relation of drinking to specific disorders and has 
shown that the relationship between alcohol consumption and health outcomes is complex and 
multidimensional. Alcohol has been shown to be ‘causally’ related to more than 60 different medical 
conditions, in most, but not all cases detrimentally, and in the majority of cases there is a dose-
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response relation with the volume of alcohol consumption, with risk of disease increasing with higher 
volume (Corrao et al 1999, 2004, Rehm et al 2003, 2004). Alcohol consumption, above recommended 
daily drinking guidelines, significantly increases the risk of various diseases, and it has been 
suggested to be a significant contributory factor to a range of chronic conditions (WCRF/AICR 2007, 
BMA 2008). The disease conditions related to alcohol consumption fall into three categories that 
reflect the nature of the conditions and the nature of the aetiologic influence of alcohol on the 
conditions (Rehm et al 2003): wholly alcohol-attributable conditions which include alcoholic 
psychoses, alcohol-dependence syndrome, alcoholic polyneuropathy, alcoholic cardiomyopathy, 
alcoholic gastritis, alcoholic liver cirrhosis, and ethanol toxicity; chronic conditions where alcohol is 
deemed a contributory cause which include lip, oral, pharyngeal, oesophageal, liver, laryngeal, and 
breast cancer (see Figure 1.1), epilepsy, hypertension, cardiac arrhythmias, stroke, oesophageal 
varices, gastro-oesophageal haemorrhage, liver cirrhosis, acute and chronic pancreatitis, spontaneous 
abortion, low birth weight, and psoriasis; acute conditions where alcohol is a contributory cause, 
which include road injuries, injuries from falls, fires, drowning, occupational and machine injuries, 
other accidents, suicide, assault, and child abuse. 
 





1.4 Alcohol and cancer outcomes 
Alcohol has long been implicated as a risk factor for cancer (Blot 1992). Reports early in the last 
century described smoking and drinking as unusually common among cancer patients This link 
between alcohol and cancer was first observed over a hundred years ago in a study of 85000 persons 
insured with the United Kingdom Temperance and General Provident Institution between 1841 and 
1901 (Newsholme 1903). In this study, it was found that the cumulative death-rate from malignant 
disease was 0.95 among abstainers and 1.32 per 1,000 among non-abstainers. Cancer site analysis did 
not indicate any ‘special irritating effects’ of alcohol on the oesophagus or stomach. Newsholme 
(1903) observed of his findings that if alcohol was to influence cancer development, it must be an 
indirect effect and only one of a number of conditions favouring cancer. Newsholme, however, did 
not totally reject the notion that alcohol ‘cannot be elevated to the position of a primary cause, 
concluding that ‘this is at present unknown’. These sentiments would not be out of place in modern 
day epidemiological studies of the association between alcohol consumption and cancer. Pearce 
(1910) subsequently updated Newsholme’s analysis and showed a widening gap in mortality 
experience between abstainers and non-abstainers and delivered a prophetic message when 
concluding that “The influence of alcohol on the incidence of cancer is really important”. Several case 
series studies followed those by Newsholme and Pearce; in a French study, Lamu (1910) noticed an 
increased incidence of oesophageal cancer in absinth drinkers; Abbe (1913) described drinking (and 
smoking) as unusually common among oral cancer patients; Craver (1932) investigated a variety of 
factors in patients with cancer of the oesophagus and found alcohol to the second most important 
factor, after tobacco, in the development of oesophageal cancer. 
It was not until the late 1950s and early 1960s, however, that epidemiological studies began to depict 
the association in quantitative terms. Case-control studies in the United States (Wynder and Bross 
1957, Wynder et al 1961, Vogler et al 1962, Vincent and Marchetta 1963, Keller and Terris 1965) and 
France (Schwartz et al 1957) documented an elevated risk of oral cancer associated with alcohol 
consumption, as well as smoking, although adjustment for one factor by the other was generally not 
made in these early studies. Wynder and Bross (1957), in a detailed history of 36 patients, found that 
alcohol consumption, particularly whisky, was an important factor in the development of oral cancer; 
whereas this risk increased in moderate drinkers, it rose very sharply among heavy drinkers (i.e. those 
who drank 7 or more ounces of whiskey a day). Schwartz et al (1957) recorded the average daily 
alcohol consumption in a large range of cancer patients and calculated the average consumption for 
each type of cancer. The result was a scale showing that these averages were highest among patients 
with cancer of the mouth, tongue, pharynx, hypopharynx, larynx and oesophagus (upper aero 
digestive tract, see Figure 1.2). Vogler et al (1962) reported an excess of drinkers among male mouth 
cancer patients though acknowledged that the association with other factors was minor compared to 
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that with tobacco. Keller and Terris (1965), in an American case control study involving 600 cases 
and 600 controls, further observed that both heavy alcohol consumption and heavy smoking were 
independently and significantly related to cancer of the mouth and pharynx. 
Figure 1.2 Upper aero digestive tract 
 
 
In one of the first critical reviews of the association between alcohol and cancer (Lowenfels 1975), 
several mechanisms were hypothesised whereby heavy drinking might predispose to subsequent 
formation of cancer, including;  
 Alcohol itself might be carcinogenic, though Lowenfels observed that this was unlikely in 
view of the simple uncomplicated molecular structure of ethanol and experimental evidence 
which suggested that prolonged exposure of mice to 20% alcohol in their drinking water, did 
not induce tumours 
 Contamination of alcoholic beverages during or after production by carcinogens 
 Damage to mucus membranes from alcohol might increase susceptibility to another 
carcinogen 
 Alcohol might enhance the carcinogenic effect of smoking. Heavy drinkers are nearly always 
heavy smokers 
 An associated nutritional defect in the alcoholic might predispose to cancer  
 
Lowenfels acknowledged that the precise mechanism was not known, but concluded that the 
association between alcohol and risk of cancer seemed strongest where there is direct contact of 
tissues with alcohol (oral cavity, pharynx, larynx, and oesophagus) or where there is serious organ 
damage (liver). Lowenfels also observed that the current evidence available would suggest that 
‘alcoholism’ was not influential on the major forms of cancer in Westernized countries, namely 
cancer of the breast, colon, lung, or cervix. 
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Some fifteen years on from the Lowenfels’ review, a large group of experts met in Lyon, France, at 
the invitation of the International Agency for Research on Cancer (IARC), in order to review 
thoroughly the literature on the association between alcohol consumption and cancer and to make a 
judgement concerning the strength of evidence that alcohol is carcinogenic to humans. In making their 
judgement, the experts were guided by several criteria for causality first suggested by Hill (1965), 
which provided a background framework to assess the causal nature of an observed association in 
epidemiological studies (Lucas and McMichael 2005). These criteria lay particular emphasis upon the 
temporality of the relationship between exposure and outcome, its strength of association, the 
presence of a plausible biological mechanism, evidence of a dose-response relationship, the 
consistency of findings in diverse studies, and coherence with other disciplinary findings and 
biomedical theory (Table 1.1).  
 
Table 1.1 Criteria for judgment of causal associations in observational studies 
Source: IARC 1988a, Grimes and Schulz 2002  
 
The subsequent report of the IARC meeting (IARC 1988b), generally regarded as one of the most 
significant reviews of the alcohol cancer association undertaken (Blot 1992, Single et al 2000), 
assessed the epidemiological evidence for an association between alcohol consumption and twenty-
seven cancers. The review confirmed Lowenfels’ (1975) earlier hypothesis by concluding that the 
‘occurrence of malignant tumours of the oral cavity, pharynx, larynx and oesophagus and liver was 
Temporality: For a relationship to be causal, the cause must precede the effect. Considerations of 
temporality are especially noteworthy for diseases that take a long time to develop, such as 
cancer. 
Strength of association: Strong associations argue for causation. Whereas weak associations in 
observational studies can easily be due to bias, large amounts of bias would be necessary to 
produce strong associations. Some suggest that relative risks (a measure used in cohort studies 
that compares the risk of a disease or other event in a group of people exposed to a particular 
substance or condition to that in a comparison group (typically an unexposed group or one with a 
low level of exposure)) more than 3 in cohort studies, or odds ratios (a similar though not identical 
measure to the relative risk that is frequently used in case-control studies. It compares the odds of 
an event occurring in one group of people to the odds of it occurring in another group) greater than 
4 in case-control studies, provide strong support for causation (Sackett et al 1991, Grimes and 
Schulz 2002). 
Biological gradient (dose-response relation): The likelihood or intensity of a biological effect is 
greater in people or animals with greater exposures to an agent than in those with lesser 
exposures. The presence of a dose-response relationship tends to support causality 
Consistency: An association is more likely to be causal if it is observed by different researchers, in 
different places, circumstances, and times. 
Coherence with existing knowledge: Is the association consistent with available evidence? 
Biological plausibility: An association is more likely to be causal if it makes sense in terms of 
scientific understanding of the biology of the disease or health effect under investigation. 
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causally related to the consumption of alcoholic beverages’ (IARC 1988b). Of greater significance, 
however, and in contrast to Lowenfels’ earlier findings were the expert group’s conclusions on the 
association between alcohol consumption and breast, and colorectal cancer. Although the report 
observed that no ‘firm conclusions’ could be drawn about a causal relationship between alcohol and 
breast, and colorectal cancer, the expert group concluded that ‘the available epidemiological evidence 
indicated a positive association between alcohol consumption and breast cancer in women’ and for 
colorectal cancer concluded that the evidence of an increased risk of colorectal cancer was ‘suggestive 
but inconclusive’ (IARC 1988b). As the report noted, ‘the modest elevation in relative risk that has 
been observed is potentially important because of the high incidence of breast and colorectal cancer in 
many countries’ (IARC 1988b). For the remaining cancers under investigation, the expert group 
concluded there was ‘little evidence that alcohol had a causal role in lung, stomach and pancreatic 
cancer, or the evidence was too inconclusive or inconsistent to allow for a judgement of causality to 
be made for cancers of the urinary bladder, kidney, ovary, prostate, brain, skin and cervix. 
In the decade after the publication of the IARC (1988b) report, a substantial body of evidence has 
emerged from epidemiological studies reporting on the alcohol-cancer association. Epidemiologists 
also began to make use of meta-analysis and pooled analysis. Meta-analysis is a formal quantitative 
method for evaluating a potential health effect across a body of epidemiologic literature. In a meta-
analysis, researchers assess heterogeneity across studies, examine subgroups of studies to determine if 
selected subsets of the research data provide similar or different results, and calculate summary 
relative risk estimates. A meta-analysis provides a more statistically precise risk estimate, as well as a 
better understanding of the consistency of findings (or lack of) in the research literature. A meta-
analysis is distinct from a qualitative or narrative review in that a meta-analysis involves a systematic 
review of the literature, relevant data extraction, and quantitative analyses of data across multiple 
studies. A pooled analysis is similar to a traditional meta-analysis, except that exposure and outcome 
data are combined (or pooled) from multiple studies and are analysed as a single dataset (Egger et al 
1997a, Egger 1997b, Shapiro 1997). Systematic literature reviews, and meta- and pooled analyses of 
studies published up until the end of the last century further developed the findings of the 1988b 
IARC report. Evidence strengthened regarding an association between alcohol consumption, even at 
low to moderate levels of drinking and cancer of mouth, pharynx, larynx, oesophagus and liver 
(English et al 1995, WCRF/AICR 1997, Corrao et al 1999, Gutjahr et al 2001), reinforcing the causal 
relationship between alcohol and these cancers observed in the IARC report (1988b). One of the first 
meta-analyses of published non-experimental research was an evaluation of breast cancer risk in 
relation to alcohol consumption which provided further evidence of a small increased risk of breast 
cancer from alcohol consumption (Longnecker 1988). A meta-analysis of 34 cohort studies (Ellison et 
al 2001) and a pooled analysis of 53 cohort and case control studies (Collaborative Group on 
Hormonal Factors in Breast Cancer 2002) provided further evidence of a modest increase in risk of 
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breast cancer, even at moderate levels of consumption, with a dose response trend. A meta-analysis 
also observed an increased risk of colorectal cancer (Bagnardi et al 2001) though the evidence here of 
an association was less convincing leading cancer experts to conclude in a comprehensive systematic 
review that alcohol ‘probably’ increases the risk of colorectal cancer (WCRF/AICR 1997). Evidence 
of an association between alcohol consumption and lung, stomach, prostate, bladder, endometrial and 
ovarian cancer remained either inconsistent or inconclusive based on findings from systematic 
reviews ( WCRF/AICR 1997, Gutjahr et al 2001) and meta-analyses (Longnecker 1995, Bagnardi et 
al 2001). During the writing of this present thesis, IARC and WCRF/AICR published findings from 
an update of their earlier international reviews published in 1988 and 1997 respectively. The most 
significant changes from these earlier reviews were the conclusions that that there is now sufficient 
epidemiological evidence to regard alcohol as a causal factor in the development of breast, colon and 
rectal cancer (Baan et al 2007, WCRF/AICR 2007). 
Alcohol is one of the very few examples of a chemical which has never been shown to cause cancer in 
experimental animals, but which is nevertheless implicated in the causation of certain cancers in 
humans (Turyns 1990, Blot 1992). Alongside the increasing epidemiological evidence on associations 
between alcohol consumption and cancer, researchers, therefore developed and investigated 
hypotheses regarding possible mechanistic pathways through which alcohol drinking may cause 
cancer. Although the mechanisms by which alcoholic beverages exert their carcinogenic effect are 
still not fully understood and are likely to differ depending on anatomical site (Poschl and Seitz 2004), 
strong evidence has emerged of plausible mechanisms whereby alcohol may cause cancers of oral 
cavity, oropharynx, larynx, oesophagus and liver. In humans and experimental animals, ethanol (i.e. 
alcohol) metabolism generates acetaldehyde, a known animal carcinogen, predominantly in the liver, 
and low concentrations of acetaldehyde are found in the blood. Among heavy drinkers, the rate of 
ethanol oxidation is likely to be enhanced, resulting in increased levels of acetaldehyde in the liver 
and blood leading to DNA damage to tissues that come into direct contact with alcohol (IARC 1988b, 
Poschl and Seitz 2004, Bofetta and Hashibe 2006). An increase in sex hormone concentrations (i.e. 
oestrogen) is seen as the most important explanation of a biological mechanism of the alcohol and 
breast cancer association, and is supported by randomized controlled alcohol feeding trials (Terry et al 
2001, Lin et al 2005, Stolzenberg-Solomon et al 2006). The possible mechanisms of carcinogenicity 
of alcoholic drinks are concisely summarised in a recent IARC review (Boffetta and Hashibe 2006), 





Table 1.2 Possible mechanisms of carcinogenicity of alcoholic beverages. 
Mechanism Potential target organs 
STRONG EVIDENCE  
DNA damage by acetaldehyde Head & neck, oesophagus, and liver 
Increased oestrogen concentration Breast 
MODERATE EVIDENCE  
Solvent for other carcinogens Head & neck, and oesophagus 
Production of reactive-oxygen species and 
nitrogen species 
Liver, colon & rectum and others 
Changes in folate metabolism Colon & rectum, breast, gastric, kidney 
WEAK EVIDENCE  
Nutritional deficiencies (e.g., in vitamin A) Head & neck, breast prostate and 
others 
Reduced immune surveillance Liver, breast and others 
Carcinogenicity of constituents other than ethanol Head & neck, oesophagus, liver, and 
others 
DNA damage by ethanol Head & neck, oesophagus, and liver 
Adapted from Boffetta & Hashibe (2006) 
 
1.5 Research to policy: the burden of cancer attributable 
to alcohol consumption 
Epidemiology as a scientific method provides evidence that bears directly on the health of the 
population. As a consequence, epidemiological findings generally have immediate relevance to the 
debate on and the formation of policies affecting health (Samet 2000). The application of quantitative 
methods, such as the meta-analysis and pooled analyses of individual level data from multiple studies 
has allowed epidemiologists greater power to explore weak associations observed in epidemiological 
studies of alcohol consumption and breast, colorectal and other cancers (Longnecker 1988, Samet et 
al 1998). Such approaches are not without their critics (Charlton 1995, Feinstein 1995, Shapiro 1997), 
but nevertheless, results from meta and pooled analyses have increasingly been used to quantify the 
risk in the whole population and to produce population level estimates of alcohol-caused cancer 
mortality and morbidity to inform policy making and planning (Boniol and Autier 2010); in Australia 
(English et al 1995, Ridolfo and Stevenson 2001), Canada (Single at al 1999), the United States 
(Rothman 1980, Schultz 1990, Tseng et al 1999), Italy (Cipirani et al 1999, Corrao et al 2000), 
Denmark (Britton et al 2003), Germany (Nolte et al 2003, John & Hanke 2003), England and Wales 
(Britton & McPherson 2001, White et al 2004, Jones et al 2008) and Scotland (Grant et al 2009). In 
the majority of these studies, 40% to 50% of overall alcohol related cancer mortality is attributable to 
deaths from breast and colorectal cancer.  
The use of meta-analysis and pooled analysis to draw conclusions about the association between 
alcohol consumption and the risk of certain cancers e.g. breast and colorectal merits further 
consideration. In in any reasonably well conducted study, a weak association may be due to 
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confounding or bias, but it is unlikely that a strong association can be completely explained away by 
defects in study design (Shapiro 1997). That point is critical to the topic of meta-analysis: when 
associations are strong (as, say, with alcohol and oral cancer), there is no need to resort to it. It is 
when associations are weak (e.g. breast and colorectal) that meta-analysts are tempted to combine 
studies. Consideration of confounding and bias becomes of paramount importance, particularly when 
associations between individual risk factors or interventions and disease outcomes are not strong, e.g., 
those characterized by relative risks of less than 2.0 (Szklo 2001). The argument that in the meta-
analysis of a large number of reasonably well conducted studies, bias and confounding should, in the 
aggregate, tend to “cancel each other out” may hold true for randomised controlled trials, but for the 
argument to hold true in observational research ‘some very large and dubious assumptions must be 
made that the right studies, with the right weights, in the right directions, are present’ (Feinstein 1995, 
Charlton 1996, Shapiro 1997). If this is not the case, the “cancelling out” will not occur. Even if it is 
assumed that there is no bias, and that uncontrolled confounding is the only issue, there can be no 
reassurance that the “cancelling out” will occur, since the same confounder may be shared by more 
than one study (Shapiro 1997). 
Measurement bias in meta-analysis is inevitable since so many of the individual studies included in 
this approach are likely to vary in the definition of alcohol consumption, timing of intake and of the 
quantity consumed with multiple sources of confounding present in most studies. Dawson (2003) 
observed that, as the one important goal of alcohol epidemiology is to understand the association 
between alcohol consumption and alcohol-related problems, alcohol consumption first must be 
determined as accurately as possible. Yet many of the results for alcohol consumption and cancer 
outcomes are based on epidemiological work, which have numerous shortcomings with respect to the 
measurement of alcohol consumption (Rehm et al 1997, Room et al 2005, Turner and McLellan 
2009). For example, in cohort studies, measures of alcohol consumption are usually assessed only 
once, at the beginning of the observation interval. In relating such a measure to an endpoint, e.g. 
incident cancer, it is assumed that (a) individual alcohol consumption is stable between the beginning 
and the end of the study, or (b) changes in consumption are the same for all members of the cohort, or 
(c) at least rank order between people with regard to consumption is preserved or (d) any changes in 
consumption are irrelevant for the outcome (Room 1977). It may be argued that none of the 
assumptions hold true for most studies (Lemmens et al 1997). Moreover, measures of alcohol 
consumption are usually limited in scope, often failing to capture theoretically relevant aspects of the 
alcohol-cancer association such as drinking pattern, drinking frequency and lifetime exposure. Other 
relevant methodological limitations include definitions of drinkers and non-drinkers, choice of 
reference period, beverage strength and beverage specific serving size (WHO 2000, Greenfield and 




More recently concerns have arisen about the variation contributed by measurement of ethanol 
content of “drinks” which Greenfield and Kerr (2008) argue may be of equal importance to all the 
other influences discussed above from the perspective of accuracy of consumption and drinking 
pattern measurement. Most measures of alcohol consumption are phrased in terms of “drinks”, 
meaning standard drinks of the respective country or area surveyed. In some cases, these drinks are 
defined for the respondents in terms of millilitres or typical container sizes of beer, wine or spirits 
suggested to constitute a ‘standard drink’, but in many cases they are not (Greenfield and Kerr 2008). 
Regardless, it appears that respondents are likely to report in terms of the drink sizes they actually 
consume (Kaskutas and Graves 2000). These differences can therefore affect the precision and 
statistical significance of risk estimates, as a factor of the accuracy of the assumptions made about the 
ethanol content of self-reported drinks (Greenfield and Kerr 2008). The ‘standard’ drink concept also 
suggests that there is a serving size of alcohol that is typical of a particular country, however, the 
concept is complicated by different standards across countries (Miller 1991, ICAP 1998, WHO 2000, 
WCRF/AICR 2007). In practice, one standard will be taken by researchers to apply to all beverage 
types while in reality the typical serving sizes and ethanol contents tend to differ by beverage type, 
leading to non-equivalence (Greenfield and Kerr 2008). The end result can be difficulties in the 
interpretation of the epidemiological evidence and confusion about the clear “bottom line” messages 
to policy makers (Samet 2000). 
As Seabrook (2007) observed, this ‘confusion’ was perfectly illustrated in a BMJ editorial (Key 2007) 
discussing the recommendations of the WCRF/AICR (2007) report ‘Food, nutrition, physical activity, 
and the prevention of cancer: a global perspective’. In the WCRF/AICR report, the expert panel 
concluded that men drinking more than two ‘standard’ drinks per day and women drinking more than 
one ‘standard’ drink per day were at increased risk of cancer. The ‘standard’ drink in the 
WCRF/AICR report contains 10-15 grams of ethanol (the range reflecting the variation in standard 
drink size definition used in international studies). Key (2007), however, assumed that the standard 
drink in the WCRF/AICR report was equivalent to the UK ‘unit’ measure and observed that the “the 
report's recommendation that men should drink no more than two units of alcohol a day and women 
no more than one unit a day” were much lower than government advice on safe daily drinking limits 
in Britain (<3 units for men and <2 units for women) and would require “a substantial shift in 
drinking habits would be needed to achieve these goals” (Key 2007). This highlights a widespread 
confusion regarding units of alcohol and “standard” drinks - WCRF “standard drinks” contain 10-15 
grams of ethanol and British units contain 8 grams (Seabrook 2007). 
Although the need to measure alcohol consumption accurately and consistently is crucial to 
understanding the associations between alcohol consumption and cancer outcomes, the measurement 
bias inherent in many approaches to measuring alcohol consumption suggests the need for caution 
when interpreting such studies. It can be hypothesised that there will be differences in not only the 
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exposure prevalence in different countries, but also in drinking patterns which may affect the slope of 
alcohol related risk (Poikolainen 1998). Therefore, both quantitative measures (how many light, 
moderate and heavy drinkers in population) and qualitative measures (drinking patterns e.g. daily, 
‘binge’ drinking) of alcohol exposure present some methodological barriers to generalising the data 
derived from a single population. Given the importance of alcohol as a risk factor and the rising 
incidence of many cancers in Scotland attributable to alcohol consumption (ISD Scotland 2010a), it is 
important that measures of alcohol consumption are reliable and valid and that estimates of risk are 




The overall aim of this body of work is to test the following hypotheses: 
 
1. Alcohol consumption is a risk factor for a number of cancers 
2. Alcohol consumption is associated with an increased risk of cancer, in the Scottish general 
population 
3. People admitted to hospital in Scotland with an alcohol related condition are at more risk of 
developing an alcohol related cancer than the general population 
 
1.7 Objectives 
These hypotheses will be tested through the following objectives, each of which will comprise a 
chapter: 
1. To systematically review the literature on alcohol related cancers to determine the strength of 
evidence of an association between alcohol and each cancer type, and if it varies by drink type, 
amount drunk, and drinking pattern and frequency (Chapter 2). 
2. To describe the epidemiology of alcohol consumption in Scotland, reviewing sources of data on 
alcohol consumption in Scotland to determine trends in drinking over time, and variation by gender 
and age (Chapter 3). 
3. To review trends in the incidence of alcohol related cancers in Scotland (Chapter 4). 
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4. To investigate the cancer risk associated with alcohol consumption in a sample of the Scottish 
population using a record linkage between the Scottish Health Surveys, hospital discharge data, 
cancer and death registrations (Chapter 6). 
5. To explore whether people admitted to hospital in Scotland with an alcohol related diagnosis are at 
increased risk of an alcohol related cancer using a record linkage between hospital discharge data, 





Chapter 2 Systematic review of literature on alcohol consumption and 
cancer risk by cancer site 
 
In Chapter 1, the origins of epidemiological research into the association between alcohol 
consumption and cancer were traced. A summary of the current evidence, from international reviews 
(including meta-analyses) based on published research up to 1999, was provided. This evidence 
shows a strong association between alcohol consumption and an increased risk of oral and pharyngeal, 
laryngeal, oesophageal and liver cancer. An increased risk of breast and colorectal cancer has also 
been observed. The evidence of an association between alcohol consumption and other types of 
cancer e.g. stomach, pancreatic, lung prostate, endometrial, ovarian and bladder, remains 
inconclusive. Chapter 1 concluded with a summary of some issues related to collection of alcohol data 
in epidemiological studies. Since the above reviews, many further studies have been published which 
can be used, in some cases, to further refine estimates of risk and in others, to support (or refute) a 
significant association between alcohol consumption and specific cancer types. The inconsistency of 
findings in this area and the on-going publication of new research underline, from a public health 
perspective, the need to continuously evaluate the risk of alcohol as an exposure factor for cancer by 
updating and reviewing, systematically, the literature around alcohol and cancer risk. 
 
In this chapter, the published literature between 1999 and 2009 on the association between alcohol 
consumption and cancer will be systematically reviewed
2
. The cancers most commonly hypothesized 
to be associated with alcohol consumption are included in the review (i.e. oral, oesophageal, 
laryngeal, gastric (stomach), breast, liver, lung, colon, rectal, kidney, pancreatic, prostate, bladder, 
endometrial and ovarian). Specifically, the review will assess the strength of evidence provided by the 
epidemiological literature, between three dimensions of alcohol exposure and the risk of cancer;  
1. total alcohol consumption (‘recent’ and lifetime) 
2. drinking patterns (e.g. daily/weekly drinking, ‘binge’ drinking) 
3. alcohol beverage type (e.g. wine, beer, spirits) 
 
2.1 Methods 
To address the inherent biases (i.e. selection and information bias) in conducting systematic reviews 
and in accordance with recommended practice in systematic reviews of observational studies, a 
                                                          
2
 During the course of the present study, IARC (Baan et al 2007) and WCRF/AICR (2007) updated their earlier 
reviews of the association between alcohol consumption and cancer, published in 1988 and 1997 respectively. 
These updated reviews covered the published literature between 1966 and 2005. Although they could not be 
included in the systematic literature review, the recommendations from the IARC and WCRF/AICR reviews are 
discussed, in the context of the findings from the present study, in the concluding section of each cancer type. 
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review search protocol was developed (Blettner et al 1999, Stroup et al 2000, Dickersin 2002, Von 
Elm et al 2007). The protocol was based on the Cochrane Collaboration’s set of policies and guidance 
on how a systematic review of the literature should be conducted and reported (Higgins and Green 
2009). The protocol includes details on study inclusion and exclusion criteria, outcomes, the search 
identification strategy, quality criteria for assessing studies, data extraction and data synthesis, and 
data presentation: 
2.1.1 Study inclusion and exclusion 
 
The following inclusion criteria were applied (i.e. studies had to meet all these criteria): 
1. Human studies only: adult population aged 16 years and over 
2. Cohort, Case-control or cross sectional (prevalence) studies 
3. Studies published between January 1999 and 30 September 2009 in the English language in a peer 
reviewed journal 
4. Studies reporting a measure of association between the risk of cancer and alcohol consumption 
5. Data on any of the outcomes listed in section 2.1.2 
 
Studies were excluded for any of the following reasons: 
1. The paper did not deal with alcohol related health effects; it dealt, rather, with natural history, 
prognosis, treatment or complications of disease 
2. Sample size was too small (less than 50 people with the cancer of interest) 
4. Study design was one of the following, (non) randomized controlled trials, case reports, ecological 
(correlation) studies, literature review and meta-analyses (though relevant reviews and meta analyses 
were identified and retained for cross reference with bibliographies and findings) 
5. There was a duplication of the study - when the results of a study were published more than once, 
only the most recent and complete article was included in the review 
6. Study available in abstract form only or not available in English 
7. Findings were reported in letters, news items and editorials  
2.1.2 Outcomes 
 
 Oesophageal cancer 
 Pharyngeal cancer 
 Laryngeal cancer 
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 Gastric (stomach) cancer 
 Breast cancer 
 Hepato-cellular (liver) cancer 
 Lung cancer 
 Colon cancer 
 Rectal cancer 
 Kidney (renal cell) cancer 
 Pancreatic cancer 
 Prostate cancer 
 Bladder cancer 
 Endometrial cancer 
 Ovarian cancer 
2.1.3 Search strategy for identification of studies 
 
Electronic Searches 
A computerised literature search of peer reviewed papers was undertaken using the OVID platform 
(Ovid Technologies, 2000-2009 Inc. <http://www.ovid.com> Version: rel10.5.1) and the following 
databases: 
 Ovid MEDLINE (R) (1999 to 30 September 2009) 
 PSYCINFO (1989 to 30 September 2009) 
 EMBASE (1999 to 30 September 2009) 
 CINAHL (Cumulative Index to Nursing and Allied Health Literature) (1999 to 20063) 
  
In addition, the following online library databases were also searched: 




 Dissertation Abstracts Online 
 
The search strategy combined alcohol and cancer related MeSH headings and free text words as 
follows: 
 alcohol drinking, drinking behaviour, alcoholism, alcohol abuse, alcoholic beverages, alcohol 
consumption 
 neoplasms/cancer: pharyn$, laryn$, colonic, rectal, colorectal, colon$, colorec$, stomach, 
gastric, esophag$, oesophag$, liver, hepatic, mouth, oral, breast, pancreatic, pancreas, 
bladder, kidney, renal, prostrate, ovarian, ovary, endometrial, endometrium 
 carcinoma or cancer or tumour or tumour or malignan$. 
 
                                                          
3
 The CINAHL database was withdrawn from the OVID platform in 2006 and became a subscription service 
4
 ETOH is a database of historic alcohol-related research information. Produced by the National Institute on 
Alcohol Abuse and Alcoholism (NIAAA), ETOH contains over 130,000 records and covers the period from 
1972 to 2003. 
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Initially, a broad search strategy was compiled for each database searched, but revised appropriately 
for each database to take account of differences in controlled vocabulary and syntax rules (see 
Appendix A for search terms used in each bibliographic database). The results were then limited to 
human studies, published in the English language and in peer reviewed journals from January 1999 to 
September 2009. No attempt was made to contact study authors for additional information due to time 
constraints. 
All located records with available abstracts were downloaded to a Reference Manager (version 13: 
Researchsoft Thomson - ISI Reference Manager 2004) database and stored with the search strategies 
for each database. References retrieved from other sources (e.g. hand searching, reference lists) were 
also entered into a Reference Manager database. Duplicate records were then identified and deleted.  
 
Grey Literature  
Electronic searching of bibliographic databases, described above, can, however, only retrieve articles 
that are present in the database being searched (e.g. conference proceedings and non-indexed journals 
would not typically be included), and only if they are indexed under the ‘key words’ selected by the 
searcher (Dickersin 2002). The term ‘grey literature’ a commonly used term which refers to 
publications issued by government, academia, business, and industry, in both print and electronic 
formats, but not controlled by commercial publishing interests, and where publishing is not the 
primary business activity of the organization. Scientific grey literature comprises newsletters, reports, 
working papers, theses, government documents, bulletins, fact sheets, conference proceedings and 
other publications distributed free, available by subscription, or for sale (Alberani 1990, Luxembourg 
Convention 1997, Last 2001). A number of electronic databases and bibliographic sources were, 
therefore, searched for relevant research reports (completed and uncompleted), references and 
abstracts from scientific meetings, conferences, and theses and dissertations (Calabria et al 2008). 
These included the following: 
 World Health Organisation (WHO) www.who.int 
 International Agency for Research on Cancer (IARC): http://www.iarc.fr/ 
 World Cancer Research Fund International: http://www.wcrf.org/ 
 National Institute on Alcohol Abuse and Alcoholism database: (available at: 
http://etoh.niaaa.nih.gov/ncadidatabases.htm) 
 National Institutes of Health Research Portfolio Online Reporting Tools (RePORT): 
(available at: http://projectreporter.nih.gov/reporter.cfm ) 
 The National Research Register Archive (2000-2007): (available at 
http://www.nihr.ac.uk/Pages/NRRArchive.aspx) 
 ProQuest Dissertations & Theses database (available at: http://www.proquest.co.uk/en-
UK/catalogs/databases/detail/pqdt.shtml) 




Additional hand searching of the peer reviewed journals list below was also carried out. The table of 
contents was reviewed over a two year period for each journal and relevant papers were identified and 
matched against those retrieved from the electronic search: 
 Cancer Epidemiology Biomarkers and Prevention (1999-2000) 
 International Journal of Cancer (2001-2002) 
 Cancer Causes and Controls (2003-2004 
 British Journal of Cancer (2005-2006) 
 American Journal of Epidemiology (2007-2008) 
 
2.1.4 Study selection criteria and procedures 
All titles and abstracts identified by the computerised literature search were reviewed to identify 
potentially relevant papers. Publications not obviously addressing the relationship between alcohol 
consumption and the risk of cancer in humans were eliminated. Papers deemed relevant or of 
uncertain relevance were obtained and read in full. All selected papers were then reviewed against 
inclusion and exclusion criteria. Those deemed irrelevant were excluded and reasons for exclusion 
noted. Where there was an element of uncertainty, assistance was sought from academic supervisors 
and/or relevant experts in the area.  
 
Progress was quantified at all stages of study selection using a flow diagram (Figure 2.1) based on the 
































2.1.5 Assessment of methodological quality 
Quality assessment does not routinely occur in systematic reviews of observational studies (cohort, 
case-control, cross-sectional) and where it does occur, there is no clear consensus about the methods 
to be used (Mallen et al 2006). Assessment of quality of observational studies is often more difficult 
than assessment of quality for randomized controlled trials and other experimental studies because of 
inherent biases and differences in study design (Stroup et al 2000, IARC 2006). Careful consideration 
therefore is required of both the internal validity (e.g. study design, conduct and analyses) and the 
external validity (i.e. the extent to which the results observed in a study are applicable outside of the 
study) of individual studies included in a systematic review. Quality assessment methods for 
observational studies have not been adequately developed and, although several assessment scales and 
checklists have been proposed (Stroup et al 2000, Hayden et al 2006, von Elm et al 2007), none of 
them have been fully validated and there are no widely agreed quality criteria for assessing studies 
(Altman 2001). 
 
Potentially relevant studies identified for inclusion in review       (n=8,580) 
Total no. of studies identified after duplicates removed (n=2,662)             (n=6,118) 
Potentially relevant citations identified after title screening of electronic search (n=673) 
Meta analyses and 
reviews (n=43) 
Relevant studies included in systematic review 
(n=227) 
Studies excluded after full evaluation of text                (n=157) 
Reasons: not English language (20); letter/commentary (16); 
exposure (59); outcome (33); study design (19); studies 
reporting duplicate findings (5); review (n=2); duplicates (n=3) 
Potentially relevant citations identified for full text evaluation                         (n=371) 
Studies excluded based on title screening   (n=259) 
Reasons incl. language, design, duplicate, outcome & exposure 
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The Cochrane Non-Randomized Studies Methods Working Group currently recommends the use of 
the partly validated Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized 
studies in meta-analyses (Wells et al 2005, Higgins and Green 2009). The NOS allocates stars, with a 
maximum of nine stars available for studies appraised on three areas: the selection of the study 
groups; the comparability of the groups; and the ascertainment of either the exposure or outcome of 
interest for case-control or cohort studies respectively. Studies that score between 6-8 stars are 
generally considered to be of the highest quality, 4-5 of medium quality and 2-3 of low quality 
(Leonardi-Bee et al 2006, Ellen et al 2006, Henderson et al 2007a and 2007b, Park et al 2010). The 
face/content validity of the NOS has been established based on a critical review of the items by 
several experts in the field who evaluated its clarity and completeness for the specific task of 
assessing the quality of studies to be used in a meta-analysis. Also, the NOS has been refined based 
on experience of using it in several projects, in particular, a project assessing the association of CHD 
with hormone replacement therapy in postmenopausal women and a project assessing the association 
of connective tissue disease with silicone breast implants (Wells et al 2005). Deeks et al (2003) 
evaluated a range of quality assessment scales and NOS was found to be the most sensitive for 
observational studies compared to other scales for measuring the quality of observational studies. The 
NOS was, therefore, adapted for the purposes of this study and is reproduced in Appendix B. 
 
There are a number of issues related to collection of alcohol data in epidemiological studies including; 
quality of self-reported alcohol data (Feunekes et al 1999); difficulties in quantifying prior long term 
alcohol intake (Schottenfeld 1979); and measurement error which is likely to occur with 
summarization across different types of alcoholic beverages (Fraumeni 1979). The NOS only provides 
for the measurement of the ‘exposure’ in a single fashion and does not allow for consideration of the 
myriad of ways an exposure can be measured, and over what time period and by what frequency. All 
of these are important considerations when measuring the impact of alcohol consumption (i.e. the 
exposure) as a risk factor for an outcome. The consumption of alcohol takes place in a number of 
ways and depending on frequency, quantity consumed and time period during which consumption 
occurred, may affect the measurement of the association with cancer (Room 1979). To assess how 
these aspects of drinking were addressed in the papers included in the systematic review, several 
alcohol consumption indicators were included in the data extraction sheet (see section 2.6) and are 





Table 2.1 Alcohol consumption measurement indicators. 
A B C 
Assessment of alcohol 
consumption 
Alcohol analytical strategy Drinking dimensions 
reported 
Questionnaire type Measure (e.g. grams, drinks) Average intake per day, week 
Reference period Frequency (e.g. per day, week) Frequency (daily, weekly, 
monthly) 
Frequency (e.g. per week, day) Reference group ‘Binge’ drinking 
Beverage type No. of drinking categories Heavy/excessive consumption 
Alcohol content of drink 
measures 
Maximum intake level Duration of drinking (years) 
Gram equivalency of alcohol 
measure 
 Age started drinking 
 
2.1.6 Data Extraction  
A specifically designed data extraction spreadsheet was completed for each full-text evaluated report. 
This spreadsheet includes 40 variables distributed into five modules. Modules were designed to 
collect information on (i) the general characteristics of the study such as design, population, setting, 
size and response rate, (ii) the measurement of alcohol consumption (see Table 2.1 column A and C), 
(iii) the measurement of the cancer outcome e.g. case identification and verification, (iv) statistical 
methods used to obtain effect estimates and to adjust for confounding and (v) the presentation of the 
study findings (e.g. see Table 2.1 column B). 
 
2.1.7 Presentation and Synthesis of Extracted Data 
Data from each full text evaluated report were synthesised into summary tables, giving descriptive 
information for each study included. This was performed separately for each of the cancer outcomes 
[see section 2.1.2]. A meta-analysis was not carried out as part of the systematic review due to the 
heterogeneity of included studies. Separate tables were prepared providing: 
 
1. A summary of study characteristics and design (e.g. author, country, sample base and selection of 
study population, and study size), presented in the individual cancer chapters (chapter 2.3 to 2.16). 
2. Quality assessment scores for each full text evaluated report by individual items in the NOS. From 
this, summary tables of the scores by individual paper and cancer type were derived, and presented in 
the individual cancer chapters (chapter 2.3 to 2.16). 
3. Full descriptive information, for each evaluated paper, describing; study aims, study sample and 
characteristics (including population, exclusion criteria, observation time), and exposure measurement 
and main results (including questionnaire type, reference period, reference group and full study 
results). Descriptive tables by cancer type are provided in Appendix D. 
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4. A summary of alcohol measurement and reporting methods (based on indicators listed in Table 
2.1). 
 
2.2 Results  
Searches of Medline, Embase, Cinahl, PsychInfo, ETOH and DOI resulted in 8,580 papers being 
identified (see Fig 2.1). Exact duplicates were deleted on merging which left 6,118 papers. After 
screening of title and abstract (where available), 371 papers were identified as either relevant (187) or 
of uncertain relevance (184). Where an abstract was not available, the paper was included in the 
category of ‘uncertain’ relevance. Full text of these 371 papers were obtained and measured in full 
against the inclusion and exclusion criteria [see section 2.1.1]. After removing papers (n=157) 
because they were either (a) duplicate studies, (b) not published in the English language, (c) an 
inappropriate study design and (d) irrelevant exposure and/or outcome measure, 214 relevant papers 
remained for measurement against quality assessment criteria. Reasons why individual papers, were 
excluded at the full text evaluation stage, are shown in Appendix E. From the excluded list, 43 
reviews (including meta and pooled analyses} were identified and retained for cross reference with 
bibliographies and findings. A further 13 relevant papers, from bibliographies of reviews and from the 
grey literature, were identified and added to the list for quality assessment. This left 227 papers, from 
149 studies, for appraisal in the systematic review (Table 2.2). Bibliographic references and 
descriptive tables for these references are provided in Appendix C and D respectively.  
Table 2.2 Number of studies and papers for full text evaluation, by study type 
 Papers Studies 
Overall 227 149 
Cohort 93 46 
Case-control 129 95 
Cross-sectional 1 1 
Meta or Pooled analysis 4 - 
 
Multiple papers were provided by individual cohort and case control studies. One case control study 
carried out in Italy and Switzerland was the basis for nineteen papers (14.7% of all case control 
studies). Over a third of the papers (34.4%) describing cohort studies were based on five cohort 
studies; the European Prospective Investigation into Cancer and Nutrition (EPIC); the Swedish 
Mammography Cohort (SMC); the Copenhagen Centre for Prospective Population Studies; the 
Netherlands Cohort Study on diet and cancer (NCS); the Health Professionals Follow-up Study and 
Nurses’ Health Study. As all these cohort studies contributed papers on two or more cancer types, 
further details of these studies are provided in Box 2.1 to avoid repetition of study characteristics in 
each cancer section. There were two pooled cohort studies which were retained in the review as they 
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included unpublished data from cohort studies on the alcohol-cancer association. Two meta-analyses 
were also retained in the review despite this being an exclusion criterion; both studies reported on an 
aspect of the alcohol-cancer association (e.g. breast cancer by oestrogen status, lung cancer by drink 
type), where study findings are inconsistent and imprecise as a result of the small number of cases 
identified in individual studies. 
 
A breakdown of the cancers under investigation by individual studies is provided in Table 2.3. The 
most common cancers investigated for an association with alcohol consumption were breast (17.4%) 
oesophagus (10.9%), colorectal (10.4%) and prostate (9.5%). Only a small number of studies were 
identified that reported on the association between alcohol and cancer of the kidney (3.0%) and 
endometrium (3.5%). 
Table 2.3 Cancer type by individual studies 
 Cohort Case-control  Other Total
1
 
Bladder 3 5 - 8 
Breast 20 14 1 35 
Colorectal 13 7 1 21 
Endometrial 4 3 - 7 
Gastric (stomach) 6 7 - 13 
Kidney 3 3 - 6 
Laryngeal - 9 - 9 
Liver 1 8 - 9 
Lung 8 5 2 15 
Oesophagus 5 17 - 22 
Oral - 13 - 13 
Ovarian 6 7 - 13 
Pancreas 9 9 1 19 
Prostate 8 3 - 11 
1 
Totals do not match those in Table 2.2 since some papers reported on more than one cancer 
 
In the following sections, and for each cancer type a summary of the evidence from previous reviews 
covered the published literature up to approximately 2000 is provided at the start of each cancer 
section. For each cancer type a description of individual study characteristics and assessment of 
overall study quality is provided. Results are presented for the association between cancer and; total 
alcohol consumption, other drinking dimensions (e.g. drinking frequency, drinking duration, age at 
which first started drinking, drinking pattern); drink type (wine, beer, spirits) and effect modification 
by other risk factors. For the sections describing results by total alcohol consumption and by drink 
type, forest plots comparing the highest versus the lowest alcohol exposure category are presented. 
Measures of alcohol consumption are commonly expressed in terms of ‘grams’, ‘standard drinks’, 
‘units’ or millilitres. Standard "drinks" or "units" generally contain between 8 and 14 grams of pure 
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ethanol, although the measure varies among countries (Table 2.4). One gram is approximately 
equivalent to 1.25 millilitres (ICAP 2010). Each section then concludes with a discussion of the 
quality of the evidence, the strengths and weaknesses of the findings and an assessment of the strength 
of evidence for an association with alcohol consumption for each cancer type. 
Table 2.4 Grams of ethanol in standard drinks and alcohol units, by country 
Standard drink / unit size 
(grams of ethanol) 
Country 
8 United Kingdom 
9.9 Netherlands 
10 Australia, Austria, France, Ireland, New Zealand, Poland, 
Spain 
11 Finland 
12 Denmark, Italy, South Africa 
13.6 Canada 
14 Portugal, United States 




Box 2.1 Details of selected cohort studies that form basis of several papers 
Copenhagen Centre for Prospective Population Studies (CCPS): The Copenhagen Centre for 
Prospective Population Studies is based on three comprehensive Danish programmes of prospective 
population studies: the Copenhagen City Heart Study, the Copenhagen County Centre of Preventive 
Medicine (formerly, the Glostrup Population Studies) which includes six cohorts, and the Copenhagen 
Male Study. In the former two, initiated in 1976 and 1964, respectively, subjects were randomly 
selected within age strata in defined areas in greater Copenhagen. In the Copenhagen Male Study, 
initiated in 1970, employees of 14 large companies in Copenhagen were invited to participate. The 
mean participation rate in all studies was 80% (range 69-88%). 
Swedish Mammography Cohort (SMC): From 1987 to 1990 a population-based mammography 
screening program was introduced in two counties in central Sweden. In Västmanland County all 
women born between 1917 and 1948 received a mailed invitation to be screened by mammography 
between March 1987 and March 1989 (n=41,786) together with a 6-page questionnaire; 31,735 
women (76%) returned the completed questionnaires. In Uppsala County all women born between 
1914 and 1948 were invited to the screening and received the same questionnaire between January 
1988 and December 1990 (n=48,517); 34,916 women (72%) returned the completed questionnaires. 
Questionnaires completed before undergoing mammography were obtained from 66,651 women 
(74%) in the source population. At enrolment, women were 30-74 years old.(URL: 
http://www.imm.ki.se/smc/history/index.html) 
The Netherlands Cohort Study on diet and cancer, (NLCS): The NLCS is an ongoing cohort study 
that was initiated in 1986. The study consists of 58,279 men (48.2%) and 62,573 (51.8%) women who 
were 55-69 years old at the beginning of the study and were identified from 204 Dutch computerized 
municipal population registries. Studies reporting on the NLCS in this review all followed the case–
cohort approach in which data are processed and analyzed only for a random sample of the cohort 
and all incident cancer cases arising each year. Cases were identified for the entire cohort, whereas a 
random sample of the cohort, i.e., the sub-cohort, was used to estimate person years at risk 
accumulating in the cohort (from the date of entry into the cohort until the date of a cancer diagnosis, 
death from any cause. 
European Prospective Investigation into Cancer and Nutrition (EPIC): The EPIC study is a 
Europe-wide prospective cohort study of the relationships between diet and cancer, as well as other 
chronic diseases, such as cardiovascular disease. EPIC is coordinated by the International Agency 
for Research on Cancer (IARC), part of the World Health Organization.  Study population consists of 
521,457 healthy adults, mostly aged 35-70 years, who were enrolled in 23 centres in ten European 
countries: Denmark (11%), France (14%), Germany (10%), Greece (5%), Italy (9%), The Netherlands 
(8%), Norway (7%), Spain (8%), Sweden (10%) and the United Kingdom (17%). One UK centre 
(Oxford) recruited 27,000 vegetarians and vegans; this subgroup forms the largest study of this 
dietary group. Recruitment to the study took place between 1993 and 1999, and follow up is planned 
for at least ten years, with repeat interview/questionnaires every three to five years. (URL: 
http://epic.iarc.fr/ 
Health Professionals Follow-up Study and Nurses Health Study, (HPFS and NHS): The HPFS is 
an ongoing cohort study that was initiated in 1986 and consists of 51,529 male dentists, pharmacists, 
optometrists, osteopaths, podiatrists, and veterinarians aged 40-75 years at the beginning of the 
study. Fifty-eight percent of the men in the HPFS cohort are dentists, and the other professions 
include optometrists, osteopaths, podiatrists, pharmacists, and veterinarians. (URL: 
http://www.hsph.harvard.edu/hpfs/). 
The NHS is an ongoing cohort study of 121,700 U.S. female nurses who were residents in 11 large 
U.S. states and were 30-55 years old at enrolment in 1976. The nutritional component of the NHS 




2.3 Bladder cancer  
Bladder cancer: summary of evidence from previous reviews 
Earlier systematic reviews covering the published literature up to the early 1990s 
concluded that overall studies on cancer of the bladder showed no association with alcohol 
consumption (IARC 1988b, WCRF/AICR 1997). Bagnardi et al (2001), in a meta-analysis 
of four cohort and seven case-control studies published between 1966 to 2000, observed a 
small increase in risk at the highest alcohol intake level (100 g/d; RR 1.17, 95% CI 0.97-
1.41), compared to non-drinkers. Zeegers et al (1999, 2004) reviewed three cohort and 
thirteen case control studies, published between 1966 and 2003, and concluded, that 
although there was convincing evidence for a positive association between alcohol 
consumption and bladder cancer risk in men (but not in women), the risk was “small and 
not clinically relevant”.  
 
The literature search identified eight studies, published between 1 January 1999 and September 2009, 
which examined the relationship between alcohol consumption and bladder cancer. There were three 
prospective cohort studies and five case control studies. Tables for each paper, describing the study 
aims, population, alcohol measurement methods and main results are provided in Appendix D. 
2.3.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.3.1 below.  










Sample base  
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Cohort studies 

















































Pohlabeln 1999 Germany 300/209 M=65 4 state hospitals 
consecutive/selected 
sequentially 
Abb: n/s not specified; M=mean; Mdn= median  
 
One paper was based on an established prospective cohort study described in Chapter 2.2 Box 2.1; 
Netherlands Cohort Study on diet and cancer (Zeegers et al 2001). In the largest cohort study (Allen et 
al 2009), approximately 1.2 million women, attending breast cancer screening clinics in the UK, were 
recruited to the Million Women Study. The study reported on the association between moderate 
alcohol intake and risk of fourteen cancers and identified 928 incident cases of bladder cancer, over a 
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mean follow up period 7.2 years. Djoussé et al (2004) derived their cohort from the Framingham 
Study which began in 1948 and included 873 women, aged 28-62 years, in Framingham, 
Massachusetts, at the first examination. In 1971, examination was begun on many of the children of 
the original cohort and their spouses and 5,124 subjects aged 12-60 years joined the study. The 
combined cohort was followed up for 27.3 years. In the largest case control study, Jiang et al (2007) 
identified cases through the Los Angeles County Cancer Surveillance Program and controls from a 
random sample of a ‘neighbourhood’ population which was not defined in the paper. 
2.3.2 Study quality 
The quality scores assessed, according to the NOS (in which higher scores reflect higher quality, see 
table footnote), varied between studies with cohort studies generally of a higher quality than the case 
control studies (Table 2.3.2).  
Table 2.3.2 Bladder cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of 3) 
Total 
Cohort     
Allen 2009 4 2 3 9 
Djoussé 2004 4 2 2  8 
Zeegers 2001 4 2 3 9 
Case-control     
Benedetti 2009 3 2 1 6 
Demirel 2008 2 0 1 3 
Jiang 2007 3  2 2  7 
Pelucchi 2002 3 2 3 8 
Pohlabeln 1999 2  2  1  5 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment. 
1 
Outcome for cohort, exposure for case-
control studies 
 
Of the cohort studies, all three scored highly across all three items: sample selection, comparability 
and outcome measurement. Only the paper by Djoussé et al (2004) did not achieve maximum ratings 
by not reporting any loss to follow-up that may have occurred in their study. For comparability, 
smoking was robustly adjusted for in all three studies, using measures of amount, frequency and 
duration smoked based on self-reported data. To further address the bias that may be caused by the 
residual effects of smoking, Djoussé et al (2004) used a risk set method that matched each bladder 
cancer case to control subjects on current smoking status and age. Two studies controlled for the 
effects of socio-economic status by either using the using the median family income of the census 
tract of residence in two Canadian cities from which study cases and controls were recruited 
(Benedetti et al 2009) or by using quintiles of the Townsend deprivation index
5
 (Allen et al 2009) 
                                                          
5 Townsend deprivation index includes measures of unemployment, overcrowding, owner - occupier 
status, and car ownership for the postcode area of each participant, based on the 1991 United 
Kingdom National Census, (Townsend et al 1988) 
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To address misclassification bias caused by measurement error from changes in alcohol consumption 
from baseline measurement, Allen et al (2009) categorized women into five levels of alcohol intake, 
based on consumption reported at recruitment, but used the average intake of alcohol (expressed as 
grams per day) in each category reported in the follow-up survey three years later. Djoussé et al 
(2004) collected alcohol consumption data every 4 years over a 27 year follow-up period and used a 
weighted average of repeated measures of alcohol consumption over time. Zeegers et al (2001) did 
not collect follow up information though with a mean follow up period of only 6 years and a study 
population aged more than 55 years, it is unlikely that changes in drinking levels would have 
markedly influenced the positive associations reported in this study. There was considerable variation 
in the recall period over which the amount of alcohol consumed was measured, from within the last 
week (Allen et al 2009), the last month (Djoussé et al 2004) and within the last year (Zeegers et al 
2001).  
Case control study quality varied between a low rating of three stars out of possible nine (Demirel et 
al 2008), a moderate rating of five stars (Pohlabeln et al 1999) and a high rating of eight stars 
(Pelucchi et al 2002). For sample selection, all case control studies scored either two or three stars. Of 
those that only scored two, most were not awarded the third because of the use of controls recruited 
from a hospital setting. Only Pelucchi et al (2002) addressed concerns that use of hospital controls 
may under estimate the effect of alcohol on bladder cancer by excluding from their comparison group 
patients admitted for smoking and alcohol chronic conditions and alcohol related traumas. Two 
population case control studies failed to confirm that bladder cancer (or any other cancer that may be 
related to alcohol consumption) was absent in the control group at recruitment (Jiang et al 2007, 
Benedetti et al 2009). The study by Demirel et al (2008) was the only paper not to control for the 
effects of smoking (and age) and this may partly explain the increased risk of bladder cancer 
associated with lifetime alcohol daily consumption reported in this study. Residual confounding from 
smoking is still likely in the remaining studies, but will vary from study to study due to the range of 
smoking variables used in adjusting analyses.  
Case control studies did not perform well in exposure assessment - only one study managed three 
stars, failing on not specifying the blinding status of interviewers (Pelucchi et al 2002). Three studies 
did not report response rates for cases and controls ((Pohlabeln et al 1999, Demirel et al 2008, 
Benedetti et al 2009) or reported variation in response rates between cases (83%) and controls (69%) 
(Jiang et al 2007). The low response rate in controls reported in the Jiang paper may explain the 
inverse association between alcohol consumption and bladder cancer reported in this paper if non-




2.3.3 Results: total alcohol intake and risk of bladder cancer
6
 
Three studies reported on the association between bladder cancer and ‘recent’ alcohol intake defined 
as habitual alcohol consumption during the year before the study (Zeegers et al 2001), in the previous 
month (Djousse et al 2004) and within the last two years (Jiang et al 2007). Two studies reported on 
the association between bladder cancer with lifetime alcohol intake defined as any period when 
alcohol was drunk at least once a week or nearly every day (Benedetti et al 2009) and amount drunk 
10 to 15 years prior to prior to survey baseline (Pohlabeln et al 1999). The remaining three studies did 
not specify a reference period (Pelucchi et al 2002, Demirel et al 2008, Allen et al 2009). A summary 
of bladder cancer risk estimates, comparing the highest versus the lowest alcohol exposure category, 
is presented in Figure 2.3.1. Risk estimates reported by Demirel et al (2008) are not included in Figure 
2.3.1, as they only reported on current drinking status (yes/no) and risk of bladder cancer. 
Figure 2.3.1 Alcohol consumption and bladder cancer, highest versus lowest exposure category by 












OR/RR, highest vs lowest exposure category
 
Zeegers et al (2001), observed an increased risk of bladder cancer in men, but not women, across all 
categories of alcohol intake, compared to those drinking less than once a month, though the relative 
risk (RR) was only statistically significant at the highest intake level (>30 grams per day [g/d]) and 
there was no evidence of dose response relationship (p value for trend =0.13). Zeegers et al (2001) 
also observed, a weak inverse association (RR 0.75, 95% CI 0.41-1.37) with bladder cancer and 
women drinking at the highest alcohol exposure category (5 to <15 g/d). There was an insufficient 
number of female drinkers in this study to explore whether risk of bladder cancers increased with the 
amount drunk. Allen et al (2009), in a large prospective cohort study of approximately 1.2 million 
women in the UK, did not find any association with bladder cancer across all categories alcohol intake 
(15 drinks per week [d/w] RR 0.96, 95% CI 0.63-1.17, p value for trend =0.2). In the remaining 
cohort study, Djoussé et al (2004) observed a 50% reduction in the risk of bladder cancer for those 
                                                          
6
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
52 
 
drinking >48 g/d, compared to never drinkers, but this estimate was based on only eight cases. Risk 
estimates for all other categories of alcohol intake, in the Djoussé paper, were not associated with an 
increased risk of bladder cancer. 
In the largest case control study of alcohol and bladder cancer included in the present review, Jiang et 
al (2007), reported a weak statistically significant inverse association between alcohol and bladder 
cancer for those drinking >1 drink per day [d/d], with strong evidence of a dose response relationship 
(p value for trend =0.003) up to >4 d/d. Pelucchi et al (2002) also observed a small, but statistically 
non-significant, reduced risk (OR 0.77, 95% CI 0.58-1.22) of bladder cancer at the highest alcohol 
intake level (up to ≥6 d/d), but there was no evidence of a dose response relationship (p value for 
trend =0.52). Demirel et al (2008) reported an unadjusted odds ratio of 1.85 (95% CI 1.15-2.96) for 
‘drinkers’ (undefined in the paper), compared to never drinkers 
Two case control studies reported on the association between bladder cancer and measures of 
‘lifetime’ alcohol consumption. Benedetti et al (2009) found little evidence of an association in men 
regularly drinking >7 d/w (OR 1.10, 95% CI 0.77-1.56), compared to men who had not drank weekly 
over their lifetime. Pohlabeln et al (1999) observed an increased risk (OR 1.71, 95% CI 0.78-3.73) of 
bladder cancer for those reporting drinking, on average >41 g/d, over ten to fifteen years prior to entry 
into the study, compared to those who reported no daily alcohol intake. 
 
2.3.4 Results: drinking dimensions and risk of bladder cancer  
Two case control studies reported on the association between drinking duration (i.e. number of years) 
and bladder cancer. Pelucchi et al (2002) did not find any association between the length of time their 
study population had been drinking and bladder cancer. A statistically significant inverse association 
between bladder cancer and drinking alcohol for >41 years (OR 0.66, 95% CI 0.48-0.89) was reported 
by Jiang et al (2007), with strong evidence of a linear increase in risk with years of drinking (p value 
for trend =0.017). In addition, Jiang et al (2007) also reported a statistically significant inverse 
association with bladder cancer for those who first started drinking at aged 18 years and younger and 
this association increased with increasing age of first use (p value for trend =0.005). 
 
2.3.5 Results: drink type and risk of bladder cancer 
A summary of bladder cancer risk estimates by drink type, comparing the highest versus the lowest 
alcohol exposure category as described in the four studies that investigated the risk of bladder by 





Figure 2.3.2 Alcohol consumption and risk of bladder cancer, highest versus lowest exposure; by 
































Zeegers et al (2001) observed an increased risk of bladder cancer at the highest alcohol intake level 
(>30 g/d) for beer (p value for trend =0.12), wine (p value for trend =0.48) and spirit drinkers, but this 
increased risk only reached statistical significance for spirit drinkers (RR 1.94, 95% CI 1.17-3.22, p 
value for trend =0.03). Djousse et al (2004) also reported a statistically non-significant 60% increased 
risk of bladder cancer among spirit drinkers drinking ≥4 d/w (p value for trend =0.2) compared to 
non-drinkers. In same study, wine drinkers did not have an increased risk of bladder cancer, but low 
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levels of beer drinking (>4 d/w) was associated with a statistically significant reduced risk of bladder 
cancer, with weak evidence of a dose response relationship (p value for trend =0.03). 
 
Case control studies 
In a large American case control study, Jiang et al (2007) reported similar protective effects  of 
drinking beer, even for heavy beer drinkers (>4 d/d; OR 0.54, 95% CI 0.35-0.83) with strong evidence 
of a dose response trend (p value for trend =0.002) whereas spirit and wine consumption was not 
associated with bladder cancer. Pelucchi et al (2002) reported a small, but statistically significant, 
decreased risk of bladder cancer for ‘current’ beer drinkers compared to non-drinkers, though an 
insufficient number of beer drinkers in this study prevented further analysis of risk associated with 
specific drinking categories. 
 
2.3.6 Results: effect modification  
The effect modification of other risk factors for bladder cancer was reported in two studies Pelucchi et 
al (2002), in a hospital based case control study, reported that the association between alcohol 
consumption and bladder cancer did not differ within strata of smoking status; current smokers who 
drank ≥6 d/d had an OR of 0.81 (95% CI 0.46-1.44), compared to non-drinkers, and never smokers 
who drank ≥6 d/d (OR 0.99, 95% CI 0.42-2.33). In addition, odds ratios according to average drinks 
per day, in separate strata of age, gender, smoking habit, occupation at risk, coffee and tea, and green 
vegetable intake, were below unity in most subgroups though only statistically significant for coffee 
drinking. In the paper, it was stated that none of the interaction terms were statistically significant, but 
these terms were not presented in main text (Pelucchi et al 2002). Zeegers et al (2001) reported that 
the association between alcohol consumption and bladder cancer risk did not differ within strata of 
smoking status, amount, or duration; but no data were presented in the paper to demonstrate this.  
 
2.3.7 Summary and conclusions 
Eight studies, three cohort and five case-control, were appraised which considered the association 
between alcohol and bladder cancer. Study quality varied by design; cohort studies were generally of 
high quality, whilst case control studies were of low to moderate quality subject to considerable 
selection bias (Demirel et al 2008, Benedetti et al 2009) and, response bias (Pohlabeln et al 1999, 
Jiang et al 2007). Key confounders, in particular smoking, were controlled for, except in the study by 
Demirel et al (2008).  
Overall, the findings from these studies provide inconsistent evidence of an association between 
bladder cancer and total alcohol consumption. Only one cohort study (Zeegers et al 2001) reported a 
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small (RR<2) positive association at the highest alcohol exposure level, with little evidence of 
significant dose response relationship. Although a small inverse association between bladder cancer 
and alcohol consumption was reported in a large case control study (Jiang et al 2007), with a 
significant dose response relationship, results in this study may be subject to bias due to a high non-
response rate among controls (approximately 30%). Residual confounding from smoking is likely to 
explain all these small associations, but this will vary from study to study due to the range of smoking 
variables used in adjusting analyses. The findings of previous systematic reviews of the association 
between bladder cancer and alcohol consumption have also been inconsistent. Zeegers et al (2004) 
reviewed papers published between 1966 and 2003 and concluded, on the basis of a meta-analysis (of 
three cohort and thirteen case control studies (SOR
7
 1.3, 95% CI 0.9-2.0) carried out by the same 
authors (Zeegers et al 1999), that although there was convincing evidence for a positive association 
between alcohol consumption and bladder cancer risk in men (but not in women), the risk is small and 
not ‘clinically’ relevant. Bagnardi et al (2001), in a meta-analysis of four cohort and seven case-
control studies published between 1966 to 2000, observed a small increase in risk at the highest 
alcohol intake level (pooled RR for 100 g/d; 1.17, 95% CI 0.97-1.41, compared to non-drinkers) with 
no evidence of risk increasing with amount of alcohol drunk. Pelucchi and La Vecchia (2009) 
concluded that the existing epidemiological data, based on thirty four papers published between 1970 
and 2007, on alcohol drinking and bladder cancer suggests no association although the findings were 
not always consistent. Recent international reviews have also concluded that the evidence of an 
association between bladder cancer and alcohol consumption is inconclusive or limited (Baan et al 
2007, WCRF/AICR 2007).  
Interestingly, an association between bladder cancer and alcohol in the present review was more 
evident when examined by drink type, with a statistically significant protective effect from beer 
drinking reported in three (including one cohort study) of the four studies investigating the risk of 
bladder cancer by alcohol beverage type. Previous systematic reviews have not reported on this aspect 
of the alcohol-bladder cancer association. There are some plausible mechanisms that may explain the 
beer-mediated bladder cancer protection. Beer is consumed in greater volume than other types of 
alcoholic beverages and previous reports document the diuretic properties of alcohol in both 
experimental animals and humans, with acute alcohol consumption increasing urine flow, possibly by 
inhibiting anti-diuretic hormones (Jiang et al 2007). Increased fluid intake and frequency of urination 
may, therefore, play a role in the alcohol-mediated bladder cancer protection by decreasing the time 
the bladder is exposed to carcinogens in the urine (Oyasu & Hopp 1974, Melicow 1974). These 
hypothesised mechanisms, however, still remain controversial (Zeegers et al 2004). Residual 
confounding from smoking and limitations of sub-group analyses (e.g. small sample sizes in each of 
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the study’s alcohol intake categories) and recall bias could equally explain the inverse association 
reported for beer drinking and bladder cancer. 
In summary, the evidence from this review does not provide convincing evidence of an association 
between alcohol consumption and an increased risk of bladder cancer. However, given the small 
number of studies identified in the review, a lack of consistency in findings, the possible residual 
effect of smoking and the variation in approaches to the measurement of alcohol consumption, an 





2.4 Breast cancer  
Breast cancer: summary of evidence from previous reviews 
Earlier systematic reviews covering the published literature up to the early 1990s 
concluded that although the available data indicate a positive association between alcohol 
consumption and breast cancer in women, a firm conclusion about a causal relationship 
could not be made IARC 1988b, WCRF/ICR). Several pooled analyses, based on studies 
published up to and including 2000, have suggested a positive association between alcohol 
consumption and breast cancer with a modest dose-response relationship, such that 
consumption of 25-40 g/d is associated with a 30-40% increase in risk, (Longnecker 1994, 
Smith-Warner et al 1998, Ellison et al 2001, Collaborative Group 2002). These analyses 
have also suggested a linear effect of alcohol on breast cancer risk, whereby the risk of 
breast cancer increases by each daily amount of alcohol drunk: Ellison et al (2001), in a 
meta-analysis of 15 cohort and 27 case control studies, reported a 10% increase in breast 
cancer risk per 12 g/d of alcohol drank. Similar results were reported in a pooled analysis 
of six cohort studies (RR 1.9, 95% CI 4%-13%, Smith-Warner et al 1998) and a pooled 
analysis of 53 cohort and case control studies (RR 1.7, 95% CI 5%-8%, Collaborative 
Group 2002). 
 
This literature review identified 41 papers from 34 studies, published between 1999 and 2009, 
examining the association between alcohol consumption and breast cancer. Of the 41 papers, 26 
papers were based on 21 cohort studies and 15 were based on 13 case control studies. Tables for each 
paper, describing the study aims, population, alcohol measurement methods and main results are 
provided in Appendix D. 
2.4.1 Study characteristics 
Cohort studies 
Of the 21 cohort studies, 20 were prospective in design with the remaining study, a retrospective 
linkage cohort study (Kuper et al 2000). Four prospective cohort studies contributed two or more 
papers to the review and all were retained since each study reported on a different aspect of the 
association between alcohol consumption and breast cancer; by lifetime (Tjønneland et al 2003) and 
‘recent’ (Tjønneland et al 2004) alcohol consumption in the Netherlands Diet, Cancer and Health 
Cohort; in women of all ages (Thygesen et al 2008) and by post- (Nielsen et al 2008) and pre- (Petri et 
al 2004) menopausal status in the Copenhagen City Heart study; by post-menopausal (Chen et al 
2002) and pre-menopausal status (Garland et al 1999) in the US Nurses Health Study and by 
incidence and mortality in the US Cancer Society Cancer Prevention Study (CPS-II) Nutrition Cohort 
(Feigelson et al 2001, 2003). 
A summary of the general characteristics of the cohort studies is provided in Table 2.4.1 below. Nine 
papers were provided by five of the established prospective cohort studies described in more detail in 
Section 2.2, Box 2.1; CCPS (Petri et al 2004, Nielsen et al 2008, Thygesen et al 2008); NLCS 
(Tjønneland et al 2003, 2004), NHS (Garland et al 1999, Chen et al 2002), SMC (Suzuki et al 2005) 
and EPIC (Tjønneland et al 2007). The largest cohort study identified in the present review included 
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approximately 28,000 incident cases of breast cancer (Allen et al 2009) and has been previously 
described in section 2.3.1. Other large cohort studies by Tjønneland et al (2007) and Lew et al (2009) 
identified 4000 and 5500 breast cancer cases respectively. The majority of cohort studies were of 
reasonable size identifying over 1000 breast cancer cases. Three studies identified less than 250 cases 
(Jain et al 2000, Petri et al 2004, Lin et al 2005). 
Table 2.4.1 Alcohol and breast cancer: general characteristics of cohort studies  




Sample base  Sample 
selection  
Allen 2009 UK 28,380/1,251,916 >55 breast screening clinics volunteers 






1,722/119,978 30-55 Nurses’ Health Study 
registered nurses in 14 
states 
volunteers  
Garland 1999 445/116,226 25-42 
Chlebowski 2007 USA 3,236/144,680 
50-79 
(M=63) 
clinical centres volunteers 





1,422/240,588 >29 CPS-II Nutrition Cohort 
general population (50 
states) 
random 
selection Feigelson 2003 1,303/65,258 
40-87 
(M=63) 
Horn-Ross 2004 USA 1,742/101,718 <85 
active/retired female 
teachers/administrators 








Kuper 2000 Sweden 514/36,342 (M=42.7) all hospitals consecutive 
Lew 2009 USA 5,461/178,957 50-71 six US states volunteers  
Lin 2005 Japan 151/35,693 40-79 general population 
random 
selection 





(M=62) CCPS  
general population 
registry (see Section 2.2 
Box 2.1) 
random sample Petri 2004 76/12,998 20-91 
Thygesen 2008 476/8,842 
not 
specified 




Sellers 2002 USA 1,875/32,518 55-69 










Suzuki 2005 Sweden 1,284/50,563 
not 
specified 






Diet cancer health study 
regional population 
random 
selection  Tjønneland 2004 423/23,260 
Tjønneland 2007 Europe 4,285/270,403 35-75 general population 
random 
selection 
Zhang 1999 USA 287/4,761 28-62 city population volunteers 




Abb: n/s not specified; M=mean; Mdn= median 
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There were 15 case control papers from 13 case control studies reporting on the association between 
alcohol consumption and breast cancer (Table 2.4.2). Two case control studies contributed two papers 
each to the review. All papers were retained in the review because each paper reported on a different 
aspect of the relationship between alcohol and breast cancer; by drinking in ‘adolescence’ (Kinny et al 
2000) and by lifetime alcohol consumption (Marcus et al 2000) in the US Carolina Breast Cancer 
Study; and by the modifying effect of menopausal status (McDonald et al 2004) and hormone receptor 
status (Li et al 2006) in the US Women’s Contraceptive and Reproductive Experiences Study 
(CARE). 
A summary of the general characteristics of the case control studies is provided in Table 2.4.2 below. 
The majority of studies were based in the USA. The largest case control study identified 6,327 cases 
(Newcomb et al 2009). Five studies identified over 1000 breast cancer cases (Althuis et al 2003, 
McDonald et al 2004, Li et al 2006, Terry et al 2006, Berstad et al 2008). Only two case control 
studies included less than 500 cases (Wrensch et al 2004, Bessaoud et al 2008).  
Table 2.4.2 Alcohol and breast cancer: general characteristics of case control studies  
Authors  Year  Country Case/Control) Age range 
(M/Mdn) 
Sample base Sample selection 
Cases/Controls 
Althuis 2003 USA 1,750/1,557 20-54 




Berstad 2008 USA 1,728/435 
20-49, 
(M=43) 
regional population not specified 







Deandrea 2008 Italy 989/1,350 
23-74, 
(Mdn=55) 











Carolina Breast Cancer 
Study  
state cancer registry/ 




Kropp 2001 Germany 706/1,381 
<51 
(M=42) 
regional population  
consecutive/random 
sample 
Lenz 2002 Canada 556/577 50-75 city hospitals 
consecutive/non-
random selection 
Li 2003 USA 975/1,007 65-79 
state cancer registry 










selection McDonald 2004 4,575/4,682 
Newcomb 2009 USA 6,327/7,558 20-69 
cancer registries/ driver 
licence lists or medi-
care in 3 states 
consecutive/non-
random selection 
Terry 2006 USA 1,508/1,506 20-98 state population 
consecutive/random 
sample 
Wrensch 2003 USA 285/286 >18 state cancer registry/ 
consecutive/random 
selection 




2.4.2 Study quality 
The quality scores for cohort and case controls studies, according to the NOS, are presented in Tables 
2.4.3 and 2.4.4, respectively. Cohort studies were generally of high quality scoring an average 7.5 
stars on the NOS (Table 2.6.3) and case control studies of moderate quality scoring an average 6.7 
stars (Table 2.6.4). 
 
Table 2.4.3 Breast cancer: assessment of study quality in cohort studies  
 Selection* 
(out of 4) 
Comparability* 
(out of 2) 
Outcome* 
(out of  3) 
Total 
Cohort     
Allen 2008 4 2 3 9 
Baglietto 2005 4 2 3 9 
Chlebowski 4 2 3 9 
Chen 2002 3 2 2 7 
Dumeaux 2004 4 2 2 8 
Feigelson 2001 
4 2 2 8 
Feigelson 2003 
Garland 1999 3 2 2 7 
Horn-Ross 2004 3 2 2 7 
Jain 2000 3 2 2 7 
Kuper 2000 3 2 3 8 
Lew 2009 4 2 3 9 
Lin 2005 4 2 3 9 
Mattison 2004 4 2 3 9 
Nielsen 2008 
4 2 2 
 
Petri 2004 8 
Thygesen 2009  
Rohan 2000 4 2 3 9 
Sellers 2002 4 2 2 8 
Stolzenberg 2006 4 2 2 8 
Suzuki 2005 4 2 3 9 
Tjønneland 2003 
4 2 2 8 
Tjønneland 2004  
Tjønneland 2007 4 2 1 7 
Zhang 1999 4 2 2 8 
Zhang 2007 3 2 2 7 
*High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 





Table 2.4.4 Breast cancer: assessment of study quality in case control studies  
 Selection* 
(out of 4) 
Comparability* 
(out of 2) 
Exposure 
(out of  3) 
Total 
Case-control     
Althuis 2003 4 2 1 7 
Berstad 2008 4 2 1 7 
Bessaoud 2008 3 2 1 6 
Deandrea 2008  3 2 1 6 
Enger 1999 3 2 1 6 
Kinny 2000 
4 2 2 8 
Marcus 2000 
Kropp 2001 4 2 2 8 
Lenz 2002 3 2 3 8 
Li 2003 3 2 3 8 
Li 2006 
4 2 3 9 
McDonald 2004 
Newcomb 2009 3 2 3 8 
Terry 2006 2 2 1 5 
Wrensch 2003 3 2 1 6 
*High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment
 
 
On the basis of sample selection, cohort and case control studies scored highly on the NOS, with 
either three or four stars out of four. All studies that scored three failed on the selection of sub-groups 
of the general population in cohort studies (e.g. teachers, nurses, health professionals) or through the 
selection of hospital based controls in case-control studies. For outcome assessment in cohort studies, 
all studies scored either two or three stars. Of those that only scored two, most were not awarded the 
third because diagnosis of breast cancer was identified through self-reports via mailed questionnaires. 
However, in five of these studies, the majority of self-reported cases (>90%) were subsequently 
verified by a pathologist (Garland et al 1999, Zhang et al 1999, Chen et al 2002), or verified by 
reviewing medical records (Feigelson et al 2003, Stolzenberg and Solomon et al 2006). 
For exposure assessment in case control studies, there was more variation, with four papers scoring 
three stars, seven papers scoring two stars and seven papers scoring one star. Most papers scoring one 
failed because they did not specify the blinding status of the interviewers. Of more concern was the 
number of case control studies with low and contrasting response rates among cases and controls. 
Results could be biased if the women who were not interviewed differed from those who did 
participate, with regard to their use of alcohol. Kinny et al (2000) observed that some characteristics 
of their non-responders (i.e. older, less educated, black race) were associated with lower levels of 
alcohol consumption, suggesting that their results may underestimate the true association between 
alcohol consumption and breast cancer. Selection bias could, however, influence results in either 
direction and none of the case control studies were able to determine the net effect of non-responders 




In the ‘comparability’ category, one star was awarded if a study controlled for age and one star 
awarded if a study controlled for either one of the following; weight, hormone replacement therapy 
use, socio-economic status, reproductive factors, oral contraceptive use or diet and/or measures of 
‘energy intake’. All prospective cohort and case control studies achieved a maximum of two stars, but 
the studies ranged from adjusting for only two, to all of the afore-mentioned potential confounders. 
Weight (measured by body mass index) and reproductive factors (age at menarche, age at first full-
term pregnancy, parity) were the most common possible confounders controlled for; only one 
prospective cohort study (Stolzenberg and Solomon) and three case control studies did not control for 
the effects of weight in their analysis (Enger et al 1999, Kropp et al 2001, Wrensch et al 2003). 
Hormone replacement therapy (HRT) use was the next most common variable controlled for. This 
was more common in cohort studies than in case control studies; three of the 14 case control studies 
adjusted their analysis for HRT use (Lenz et al 2002, Li et al 2006, Newcomb et al 2009), whilst only 
three of the 21 cohort studies did not control for HRT use (Garland et al 1999, Jain et al 2000, Zhang 
et al 2007).  
Education was the most common measure of socio-economic status (SES) controlled for in studies 
included in present review and varied across studies, from type of education, length of education to 
number of qualifications. This was more common in case control studies where 9 of the 14 studies 
controlled for education, compared to 7 of the 21 cohort studies. Two additional SES measures were 
controlled for; by Enger et al (1999) based on  five categories derived from census tract of residence 
and by Wrensch et al (2003) for self assessed socio-economic status defined as ‘poor’, ‘lower’, 
‘middle’ and ‘upper class’. Allen et al (2009) controlled for the effects of socio-economic status by 
using quintiles of the UK Townsend deprivation index which includes measures of unemployment, 
overcrowding, owner-occupier status, and car ownership for the postcode area of each participant, 
based on the 1991 National Census. 
Smoking terms including smoking status, number of packs per day and length of time smoked, were 
included in the models of eight studies and six studies also controlled for oral contraceptive use. Other 
more controversial risk factors and possible confounders of the alcohol breast cancer association such 
as nutritional factors, particularly folate intake were only controlled for in a small number of studies 
(Baglietto et al 2006, Feigelson et al 2003, Mattison et al 2004, Suzuki et al 2005).  
 
2.4.3 Results: total alcohol intake and risk of breast cancer
8
 
Twelve, nine cohort and three case control, studies reported on the association between ‘recent’ total 
alcohol consumption (i.e. amount consumed in the previous year) and the risk of incident breast 
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cancer. A summary of breast cancer risk estimates, comparing the highest versus the lowest alcohol 
exposure category, is presented in Figure 2.4.1. 
Allen et al (2009), in a large UK prospective cohort study with over 28,000 incident cases of breast 
cancer, reported that women drinking >15 drinks per week [d/w] had a statistically significant 
increased risk (RR 1.29, 95% CI 1.23-1.35) of breast cancer, compared to women drinking <2 d/w, 
with strong evidence of a statistically significant dose response trend (p value for trend <0.001). Non-
drinkers, in the same study, were not at an increased risk of breast cancer (RR 1.00, 95% CI 0.97 to 
1.03).  
Three cohort studies, with approximately 1,500 incident cases of breast cancer, produced mixed 
results. Rohan et al (2000) and Zhang et al (2007) observed a statistically non-significant increased 
risk (ranging from 10% to 70%) of breast cancer across all alcohol intake categories (maximum of 
>30 grams per day [g/d]). Zhang et al (2007) provided stronger evidence then Rohan et al (2000) of 
the risk of breast cancer increasing with amount of alcohol drunk; p value for trend <0.001 and =0.35 
respectively. Dumeaux et al (2004) reported statistically significant estimates for all alcohol intake 
levels (up to >10 g/d, compared to 0 g/d, p value for trend <0.0001), compared to non-drinkers.  
Figure 2.4.1 Recent alcohol consumption and risk of breast cancer, highest versus lowest exposure 
category, by study type (relative risk/odds ratio and 95% confidence intervals) 




















The remaining cohort studies were small to moderate in size (≤750 cases) and reported mixed results 
on the association between alcohol consumption and breast cancer. Baglietto et al (2005) observed a 
non-significant 40% increase in risk (HR 1.41, 95% CI 0.90-2.23) of breast cancer among women 
drinking ≥40 g/d, compared to abstainers. In this study, women who drank between 1-19 g/d 
(representing 80% of all drinkers in the cohort) had a small, and statistically non-significant, increased 
risk of breast cancer (HR 1.12, 95% CI 0.93-1.36). In the Copenhagen City Heart Study, increased 
risks were observed for women with baseline alcohol intakes of 13-24 g/d (HR 1.36, 95% CI 1.01-
1.81) and >48 g/d (HR 4.64, 95% CI 1.67-12.9), compared to women drinking <1.71 g/d (Thygesen et 
al 2008), with strong evidence of a statistically significant dose response association (p value for trend 
<0.001), between alcohol intake and breast cancer. However, in the alcohol exposure category with 
the largest number of drinkers (1.71-12 g/d), there was no association (RR 1.00, 95% CI 0.80-1.24) 
with breast cancer. When the analysis was updated to take into account current drinking behaviour 
over the period of follow-up (27 years) in the study, there was no significant association (p value for 
trend =0.13) between breast cancer and alcohol consumption across all alcohol intake categories 
(Thygesen et al 2008). Two studies reported on the association between low level drinking only, and 
breast cancer. In a Japanese cohort study (Linn et al 2005), average alcohol intake of <15 g/d did not 
significantly increase the risk of breast cancer. However, risk was significantly increased for women 
who drank ≥15 g/d (RR 2.93, 95% CI 1.55-5.54), compared to non-drinkers. Zhang et al (1999) did 
not find any association at any level of drinking and increased risk of breast cancer. In this study 
women drinking >15 g/d, compared to non-drinkers had a 30% (RR 0.7, 95% CI 0.5-1.1) reduced risk 
of breast cancer.  
Of the case control studies, Newcomb et al (2009) observed a statistically significant increased risk of 
breast cancer at the highest alcohol exposure category (≥14 d/w). Drinking below this level was not, 
however, associated with an increased risk of breast cancer and the OR for an increment of 1 drink per 
day and risk of breast cancer was 1.01 (95% CI 1.00-1.02). McDonald et al (2004), based on reported 
alcohol intake within the previous two years, reported a weak, statistically significant, increased risk 
of breast cancer, but no obvious linear trend with amount drunk (up to >14 d/w). Bessaoud et al 
(2008), in a French case control study, found no association between breast cancer and drinking >20 







Figure 2.4.2 Lifetime alcohol consumption and risk of breast cancer, highest versus lowest exposure 








OR/RR, highest vs lowest exposure category
 
 
Four studies reported on the association between lifetime alcohol consumption and risk of breast 
cancer. A summary of breast cancer risk estimates comparing the highest versus the lowest alcohol 
exposure category are presented in Figure 2.4.2. Lifetime drinking of approximately 20-30 grams per 
week (g/w) was not associated with an increased risk of breast cancer in a prospective cohort study 
(Tjonneland et al 2007) and in two case control studies (Kinny et al 2000, Terry et al 2006). Li et al 
(2003) did, however, report raised point estimates across all levels of alcohol intake, based on 
consumption over the last twenty years, but only intake at the highest exposure level (≥30 g/d) was 
statistically significant (p value for trend =0.419). 
2.4.3.1 Results: total alcohol intake and risk of breast cancer by histological 
types  
Three studies reported on association between alcohol consumption and breast cancer, by histological 
type. In a large cohort study, Lew et al (2009) reported a strong, statistically significant, dose response 
association between alcohol consumption and increased risk of ductal tumours (>35 g/d, RR 1.46 
(95% CI 1.22-1.75, p value for trend >0.001), compared to non-drinkers, and slightly weaker 
evidence of an increased risk of lobular tumours (>35 g/d; RR 1.52 95% CI 0.95-2.44, p value for 
trend =0.04). In the same study, there was no increased risk of ductal-lobular tumours at any alcohol 
intake level, compared to non-drinkers.  
In a case control study, Li et al (2003) also reported a positive association for both ductal and lobular 
tumours across all alcohol exposure categories, compared to never drinkers. However, this increased 
risk only reached statistical significance for lobular tumours among women drinking >30 g/d (OR 3.3, 
95% CI 1.7-6.4, p value for trend =0.453). The corresponding figures for ductal tumours were OR 1.5 
(95% CI 0.9-2.6, p value for trend =0.638). Li et al (2006) reported a similar non-significant 
increased risk (range 10-90%) of ductal, lobular, medullary and ductal lobular tumours in women 
66 
 
drinking >7 d/w, compared to never drinkers. Less common tumours identified in the cohort, tubular, 
comedo and mucinous, were not associated with alcohol consumption (Li et al 2006). 
2.4.3.2 Results: total alcohol intake and risk of breast cancer mortality 
Two prospective cohort studies reported on the association between alcohol consumption and breast 
cancer mortality. In an American cohort study, Feigelson et al (2001) reported an increased risk of 
breast cancer mortality across all alcohol consumption categories, compared to non-drinkers, with 
weak evidence of a statistically significant dose response trend (>3 d/d; RR 1.2, 95% CI 1.0-1.5, p 
value for trend =0.08). Women drinking >20g, compared to non-drinkers were not at increased risk of 
death from breast cancer in a Canadian cohort study (Jain et al 2000). In the same study, the authors 
reported a ‘1% increase’ in risk of breast cancer mortality per 10 gram increase in alcohol intake (HR 
1.012, 95 CI 1.005-1.019). 
2.4.4 Results: drinking dimensions and risk of breast cancer 
Overall, six studies reported on the risk of breast cancer by a number of drinking dimensions, 
including drinking frequency, duration of drinking and age at which participants first started drinking. 
Two cohort and two case-control studies reported on the association between breast cancer and 
measures of drinking frequency. In a cohort of American teachers, post-menopausal women who were 
‘daily heavy’ drinkers (i.e. drinking a weekly average of >20 g/d and regularly drinking alcohol on ≥5 
days in a week) had a statistically significant increased risk of breast cancer (RR 1.34, 95% CI 1.07-
1.67), compared to non-drinkers (Horn-Ross et al 2004). ‘Daily heavy’ drinkers drinking <20 g/d on 
≥5 days per week (RR 1.07, 95% CI 0.86-1.32) and ‘sporadic’ drinkers (i.e. those drinking alcohol on 
<4 days in a week; RR 0.99, 95% CI 0.84-1.17) were not at an increased risk of breast cancer. In a 
Japanese cohort, the risk of breast cancer increased by 50% among both ‘daily’ and ‘weekly’ drinkers, 
compared to non-drinkers (Lin et al 2005). In a French case control study, frequent (>5 times per 
week, (OR 0.75, 95% CI 0.40-1.45) or sporadic drinkers (OR 1.03, 95% CI 0.62-1.71) were not an 
increased risk of breast cancer compared to never drinkers (Bessaoud et al 2008). Lenz et al (2002) 
observed a 50% (OR 1.5, 95% CI 1.0-2.2) increase in risk of breast cancer in current weekly and daily 
drinkers for post-menopausal women, compared to a 20% (OR 1.2, 95% CI 0.8-1.8) increase for 
infrequent drinkers, compared to never drinkers.  
 
Four studies investigated the association between age at when first alcoholic beverage was drunk and 
risk of breast cancer. Drinking before the ages of twenty (Marcus et al 2000), and thirty five years 
(Lin et al 2005) was not associated with an increased risk of breast cancer. Horn-Ross et al (2004) 
observed that among both pre- and post-menopausal women in a cohort of American teachers, 
drinking >20 g/d at ages 18-22 and at 30-35yrs was not significantly associated with an increased risk 
67 
 
of breast cancer. Wrensch et al (2003), in a population based case control study, reported a three -fold 
increase (OR 2.8, 95% CI 1.9-5.0) in the odds of developing breast cancer for women who starting 
drinking alcohol aged ≥21yrs, compared to those who first drank <21 yrs.  
Tjonneland et al (2004) reported no association between lifetime intake (based on aggregated reports 
of drinking by cohort members in their twenties, thirties and forties) and increased risk of breast 
cancer, compared to abstainers. 
2.4.5 Results: drink type and risk of breast cancer 
Eleven studies reported on the association between breast cancer and alcohol consumption, by type of 
alcohol beverage (e.g. wine, beer, and spirits). A summary of risk estimates, comparing the highest 
versus the lowest alcohol exposure category, are presented in Figure 2.4.3. In general, a positive 
association was observed between the highest alcohol exposure category in each study and an 
increased risk of breast cancer, from drinking wine, but not for drinking beer or spirits.  
In four studies reporting on the association between drink type and breast cancer in post-menopausal 
women only, intake of wine, but not beer or spirits, significantly increased the risk of breast cancer. 
Mattison et al (2004) observed a statistically significant two fold increase in breast cancer risk among 
post-menopausal women in a Swedish cohort, drinking >20 millilitres per day in the previous week. 
No association was observed at lower intake levels. In a study where wine was the preferred drink, 
Tjonneland et al (2003) also observed a twofold increase in breast cancer among post-menopausal 
wine drinkers, drinking >24g-≤60 g/day and >60 g/d in their Danish cohort, compared to those 
drinking between 0-6 g/d. In two case control studies, McDonald et al (2004) reported a small 
statistically significant increased risk of breast cancer among post-menopausal (but not pre-
menopausal) women drinking >7 d/w in the previous two years, compared to non-drinkers and Lenz 
et al (2002) found a two-fold increased risk of breast cancer in current regular drinkers of wine 
compared to abstainers. Berstad et al (2008) found no association between drink type and risk of 




Figure 2.4.3 Alcohol consumption and risk of incident breast cancer, highest versus lowest exposure 
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Spirit drinking, but not beer or wine, significantly increased the risk of breast cancer in an American 
study (Newcomb et al 2009), but only at the highest intake level (>14 d/w compared to non-drinkers). 
Three further studies reported a non-significant 50-80% increased risk of breast cancer from drinking 
of spirits (Kropp et al 1999, Kinny et al 2000, Tjonneland et al 2003). A statistically significant 
increased risk of breast cancer at the highest intake level only (>12 g/d) was also reported for beer 
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drinkers only in a German case control study (Kropp et al 1999). Mattison et al (2004) and Berstad et 
al (2008) also reported an 80% and two-fold increase in breast cancer risk from beer drinking, but 
neither estimate was of statistical significance.  
In three studies, wine, beer or spirit drinking was not associated with an increased risk of breast 
cancer among women of any ages; for very low levels of drinking (>3 g/d), compared to non-drinkers 
in the Framingham cohort (Zhang et al 1999); for consumption up to >20 g/d, compared to non-
drinkers in a nested case control study (Rohan et al 2000); for drinking up to >91 g/d in a population 
case control study, compared to abstainers (Kinny et al 2000).  
 
2.4.6 Results: effect modification 
Menopausal status 
Fifteen studies, reported on the dose response association between breast cancer and alcohol 
consumption by menopausal status. Of these, three studies reported on the association between breast 
cancer and alcohol in both pre- and post-menopausal women (Horn-Ross et al 2004, McDonald et al 
2004, Newcomb et al 2009). In the remaining studies, eight reported on the association between 
alcohol and breast cancer in post-menopausal women, and four studies in pre-menopausal women. A 
summary of findings comparing risk estimates for breast cancer between the highest and lowest 
alcohol exposure category, by menopausal status, are presented in Figures 2.4.4 and 2.4.5. 
In the three studies reporting on both post- and pre-menopausal women, there was no strong evidence 
that the association between breast cancer and alcohol consumption was modified by menopausal 
status. In a cohort of American teachers, Horn-Ross et al (2004) reported a 32% statistically 
significant increased risk of breast cancer for post-menopausal women, drinking ≥20 g/d, compared to 
non-drinkers. The corresponding increase of 21% in pre-menopausal women was not statistically 
significant, but did not differ significantly from that of pre-menopausal women (Pinteraction=0.54). 
McDonald et al (2004) reported a non-significant 10% and 30% increased risk of breast cancer in pre- 
and post-menopausal women respectively, drinking >168 g/w, compared to non-drinkers, but 
differences were not statistically significant (Pinteraction<0.16). Menopausal status did not significantly 
modify the association (Pinteraction=0.05) between alcohol and breast cancer risk in a cohort of 
American health professionals; Newcomb et al (2009), reported a statistically significant 37% 
increased risk of breast cancer in post-menopausal women drinking >168 g/w and a non-significant 
10% increased risk in pre-menopausal women compared to non-drinkers.  
Nine studies reported on risk of breast cancer from alcohol consumption in post-menopausal women 
(Figure 2.4.4). Overall, the majority of studies reported a statistically significant association between 
the highest alcohol exposure category and an increased risk of breast cancer. In one of the largest 
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cohort studies of the alcohol-breast cancer association, included in the present review, Lew et al 
(2009) observed a statistically significant dose response relationship (p value for trend >0.001) for 
alcohol intake up to >35 g/d in post-menopausal women, though point estimates were not statistically 
significant below <10 g/d. Suzuki et al (2005) observed positive associations with breast cancer, at all 
alcohol intake levels, based on drinking reports within the previous six months, with strong evidence 
of statistically significant dose response relationship (≥10 g/d; RR 1.43, 955 CI 1.16-1.76, p value for 
trend =0.0012).  
 
Figure 2.4.4 Alcohol consumption and breast cancer in post-menopausal women, highest versus 
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Four studies reported on risk of breast cancer from alcohol consumption among pre-menopausal 
women (Figure 2.4.5). In a Danish cohort, Petri et al (2004) observed a threefold increase in risk 
among pre-menopausal women drinking >27 d/w, though no increased risk was observed at lower 
intake levels. Garland et al (1999) reported non-positive associations between breast cancer and both 
current and lifetime alcohol consumption. Berstad et al (2008) did observe a weak statistically 
significant dose response relationship (p value for trend =0.04), but only consumption at the highest 
intake level (>14 d/w) reached statistical significance. Kropp et al (1999) in a German case control 
study, observed a statistically significant increased risk of breast cancer among women drinking at the 
highest intake levels of ≥31 g/d, though this estimate was based on less than 50 cases and controls. 
Conversely, at low levels of alcohol consumption (between 1-11 g/d) and where there were ten times 
as many cases and controls, a mild statistically significant inverse association (OR 0.67, 95% CI 0.50-




Figure 2.4.5 Alcohol consumption and breast cancer in pre-menopausal women, highest versus 
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Hormone receptor status 
Nine observational studies and one meta-analysis were identified that investigated alcohol intake and 
risk of breast cancer, defined by hormone receptor status; oestrogen (ER) and progesterone (PR) 
receptor status. Six of these studies were included in a meta-analysis (Suzuki et al 2008) which also 
included four studies not identified by the present review’s search strategy. The results, therefore, of 
the meta-analysis are presented here and compared with the three studies identified in this review, but 
not included in the meta-analysis. 
Suzuki et al (2008) reported that the dose response meta-analysis (based on 4 cohort and 16 case 
controls studies) showed that an increase in alcohol consumption of 10 g/d was statistically 
significantly associated with a 12% (95% CI 8%-15%; p heterogeneity among studies =0.24) 
increased risk of developing all ER+ (positive) tumours and a 7% (95% CI 0%-14%; p heterogeneity 
among studies =0.27) increased risk of all ER- (negative) tumours. Among joint ER/PR tumour 
subtypes, an increase in alcohol consumption of 10 g/d was associated with a 11% (95% CI 7%-14%) 
increase in risk of ER+/PR+ tumours, and a 15% (95% CI 2%-30%) increase in risk of ER+/PR- 
tumours. Alcohol consumption was not associated with an increased risk of ER-/PR+ tumours (RR 
1.04, 95% CI 0.76-1.43) or ER-/PR- tumours (RR 1.04, 95% CI 0.98-1.09). 
Of the three studies included in this review, but not in Suzuki’s meta-analysis, Chlebowski et al 
(2007) observed that women drinking >1 d/d (approximately 12 grams), compared to those drinking 
≤1 d/d, had a statistically significant increased risk of ER+ tumours (OR 1.17 95% CI 1.02-1.33) and 
a small, non-significant, increased risk of ER- tumours (OR 1.06 95% CI 0.75-1.49). Differences 
between risk estimates were, however, not statistically significant (Pinteraction=0.60). An Italian case 
control study, (Deandrea et al 2007), reported a statistically significant two-fold increased risk (OR 
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2.16, 95% CI 1.68-2.76) of ER+ tumours in women drinking ≥13.8 g/d, compared to never drinkers. 
The odds of ER-tumours increased by 36% in women drinking >13.8 g/d, but was not statistically 
significant (OR 1.36, 95% CI 0.93-2.01). In a large cohort study, Lew et al (2009), reported a 
statistically significant dose response relationship for ER+/PR+ tumours (>35 g/d; RR 1.46, 95% CI 
1.12-1.91, p value for trend =0.003), but not for ER+/PR- (>20g/d; RR 1.13, 95% CI 0.73-1.77, p 
value for trend =0.51) or ER-/PR- tumours (>20g/d; RR 1.21, 95% CI 0.79-1.84, p value for trend 
=0.25).  
Hormone Replacement Therapy 
Five cohort studies examined the interaction between alcohol and hormone replacement therapy 
(HRT) use on the risk of breast cancer.  
In one of the largest studies included in the present review of the alcohol and breast cancer 
association, Lew et al (2009) observed a statistically significant increased risk in breast cancer for 
both current and never users of HRT, who drank >35 g/d (RR 1.40, 95% CI 1.14-1.71, and RR 1.31 
95% CI 1.04-1.64, respectively, Pinteraction=0.10). In the same study, only current users of HRT for >10 
years, and who drank >35 g/d were at increased risk (RR 1.70, 95% CI 1.28-2.26) of breast cancer, 
though duration of HRT use overall did not significantly (Pinteraction=0.26) modify the association 
between alcohol and breast cancer. In a cohort of American nurses, compared with non-drinkers who 
never used HRT, current HRT users for ≥5 years and who drank >20 g/d had a RR for breast cancer of 
1.99 (95% CI 1.41-2.79). In contrast, the RR was 1.32 (95% CI 1.05-1.66) in women taking HRT for 
≥5 years and who were non-drinkers and 1.28 (95% CI 0.97-1.69) in never-users of HRT who drank 
>20 g/d (Chen et al 2002). The authors reported that, although the RRs suggested a modifying effect 
of HRT on the alcohol-breast cancer association, the test for interaction was not statistically 
significant, though no results were presented in the paper (Chen et al 2002). Similar findings were 
reported by Horn-Ross et al (2004) in a cohort of American teachers. 
Zhang et al (2007) reported that for an increment of 10 grams of alcohol per day, there was a 
statistically significant increased risk of breast cancer among women who were current (RR 1.15, 
95% CI 1.05-1.26) users of HRT, but not past (RR 0.91, 95% CI 0.72-1.16) or never (RR 0.99, 95% 
CI 0.86-1.15) users of HRT, although the test for interaction was not statistically significant 
(Pinteraction=0.07). The same results for current and never users (Pinteraction=0.11) of HRT among 
drinkers, were reported in a Danish cohort study (Neilsen and Gronbaek 2008). 
Body weight 
Four studies examined the interaction between alcohol and body weight (as measured by body mass 
index (BMI: kg/m
2
) on the risk of breast cancer. 
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In a large cohort study, women who weighed <25 kg/m
2 





), had an increased risk of breast cancer across all alcohol intake levels (up to a 
maximum of >35g/d) and there was no evidence of a statistically significant (Pinteraction=0.27) effect of 
weight on the alcohol and breast cancer association (Lew et al 2009). Zhang et al (2007) reported 







(Pinteraction=0.68). In a cohort of teachers, Horn-Ross et al (2004) observed an increased risk of 
breast cancer of similar magnitude in stratum of women weighing <27.3 kg/m
2
 or ≥27.3 kg/m
2
 and 
drinking either <20g/d or ≥20 g/d, compared to non-drinkers weighing <27.3 kg/m
2 
. 
In an American case control study, women with a BMI of <25 kg/m2and who drank 15-30 g/d over 
their lifetime, had a two-fold increased risk (OR 2.13, 95% CI 1.29-3.54) of breast cancer, compared 
to non-drinkers. In contrast, women with a BMI of ≥25 kg/m2and lifetime drinking of 15-30g/d, 
compared to non-drinkers, were not at increased risk (OR 0.95, 95% CI 0.58-1.54) of breast cancer 
(Terry et al 2006). No formal test for interaction was reported in the paper.  
Folate 
Five studies examined the possible interaction between alcohol and folate consumption on risk of 
breast cancer. Three studies found no evidence that the association between alcohol and breast cancer 
was significantly modified by total folate intake. Zhang et al (2007) reported positive associations 
across all folate intake levels (highest category of ≥600 µg/day) with an increment of 10 grams of 
alcohol per day, but no evidence of a statistically significant interaction (Pinteraction=0.96). In a further 
two cohort studies, Feigelson et al (2003) and Lew et al (2009) did not find an increased risk of breast 
cancer in any stratum of total folate and total alcohol intake. There was no evidence of a significant 
modifying effect of folate on the alcohol and breast cancer association in either study; Pinteraction=0.61 
and Pinteraction=0.13, respectively. 
Two studies, however, did provide some weak evidence of a significant interaction between folate 
intake and alcohol consumption on the risk of breast cancer. Baglietto et al (2005) reported a 
statistically significant two-fold increase in risk in women with a low folate intake (200 µg/day) and 
who drank >40 g/d, compared to abstainers (HR 2.00, 95% CI 1.14-3.49). Women with a daily intake 
of 330 µg/day or 400 µg/day and who drank >40 g/d, did not have an increased risk of breast cancer 
(Pinteraction=0.04). Stolzenberg-Solomon et al (2006) also observed that low levels of drinking (>7.62 
g/d) and a folate intake of ≤335.5 µg/day, increased the risk of breast cancer in women two-fold (RR 
2.10, 95% CI 1.08 4.07), compared to non-drinkers, but in women drinking >7.62 g/d and a folate 
intake of ≥335.5 µg/day, the RR was 1.23 (95% CI 0.93-1.62, Pinteraction=0.05). 
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Other effect modifiers 
Dumeaux et al (2004) observed a two fold increase in risk of breast cancer from women who were 
long term users (>10 years) of oral contraceptives (OC) and drinking >10 g/d, compared to non-
drinkers and non-users of OC. No significant interaction between alcohol consumption and duration 
of OC use was observed after stratification by menopausal status; pre-menopausal (Pinteraction=0.14) 
and post-menopausal women (Pinteraction=0.21). The results for the interaction of alcohol intake with 
history of breast cancer in first-degree relatives were not statistically significant in three studies that 
tested for this interaction, though in each study no data was presented in the paper (Horn-Ross et al 
2004, Suzuki et al 2005, Terry et al 2006). 
2.4.7 Summary and conclusions 
This review identified 41 papers from 34 studies, published between 1999 and 2009, which examined 
the relationship between alcohol consumption and the risk of breast cancer. Overall, the majority of 
the larger prospective studies included in the present review reported a statistically significant dose 
response association between ‘current’ alcohol consumption and an increased risk of breast cancer. 
These findings were consistent in studies of the association between breast cancer and alcohol 
consumption in post-menopausal and pre-menopausal women. Positive associations between ‘current’ 
alcohol consumption and an increased risk of breast cancer were in general only associated with 
alcohol consumption of approximately >15 g/d (i.e. approximately >1 ‘standard’ drink or >2 UK 
‘units per day). The evidence from the present review that current drinking of <15g/d increases the 
risk of breast cancer was less conclusive; results from the larger cohort studies in the present review 
were mixed ranging from no association, to small, statistically non-significant, positive associations. 
When analysed as a continuous variable, however, an increment of 10 grams of alcohol per day was 
consistently associated with a statistically significant 5-10% increased risk of breast cancer.  
The results for ‘current’ alcohol consumption are broadly consistent with those published previously. 
Several pooled analyses, based on studies published up to and including 2000, have suggested a 
positive association between alcohol consumption and breast cancer with a modest dose-response 
relationship, such that consumption of two to three drinks (between 25-40 g/d) is associated with a 30-
40% increase in risk, (Longnecker 1994, Smith-Warner et al 1998, Ellison et al 2001, Collaborative 
Group 2002, Key et al 2006). These analyses have also suggested a linear effect of alcohol on breast 
cancer risk, whereby the risk of breast cancer increases by each daily amount of alcohol drunk: 
Ellison et al (2001), in a meta-analysis of 15 cohort and 27 case control studies, reported a 10% 
increase in breast cancer risk per 12 g/d of alcohol drank. Similar results were reported in a pooled 
analysis of six cohort studies (RR 1.9, 95% CI 4%-13%, Smith-Warner et al 1998) and a pooled 
analysis of 53 cohort and case control studies (RR 1.7, 95% CI 5%-8%, Collaborative Group 2002). A 
recent international systematic review has concluded that the evidence is now convincing that alcohol 
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consumption is a cause of pre-menopausal and post-menopausal breast cancer and that there is a 
strong dose response pattern without a threshold effect (WCRF/AICR 2007). 
Lifetime alcohol consumption was not associated with an increased risk of breast cancer in the present 
review, though only four studies reported on this aspect of the alcohol-breast cancer association.  
Recall bias, leading to an underreporting of alcohol intake in the distant past, may, however, have 
resulted in attenuation of risk estimates for lifetime consumption. Four studies reported on the 
association between drinking frequency and increased risk of breast cancer. Measures of ‘daily’ 
drinking were consistently associated with a statistically significant increased risk of breast cancer. 
This is not an unexpected finding since ‘daily’ drinkers often account for the majority of total alcohol 
consumed in surveys of drinking habits. Of more interest is the finding by Horn-Ross et al (2004) that 
only ‘daily’ drinkers drinking >20 g/d, compared to non-drinkers, had a statistically significant 
increased risk of breast cancer. This suggests that a more valid and interesting comparison in relation 
to risk of breast cancer by drinking frequency, is one that takes into account both quantity and 
frequency. 
The results of analyses by drink type, in the present review, were inconsistent. There was some 
evidence that wine, but not beer or spirits, increased the risk of breast cancer in post-menopausal 
women, but in many of these studies it was moderate drinkers who consumed wine more often than 
beer or spirits. This pattern of increased risk may, therefore, implicate wine, when, in fact, risk may be 
associated with moderate consumption of any alcoholic beverage. Higher estimates for wine may also 
be due to residual confounding by social class, which strongly affects beverage preference; in a 
number of studies, women of high socio-economic status drank more wine, while drinking beer was 
associated with lower educational level (Tjonneland et al 2003, 2004, McDonald et al 2004). The 
previous literature has not consistently linked one beverage type to breast cancer risk (Smith-Warner 
et al 1998). A meta-analysis (Ellison et al 2001) and a pooled analysis (Smith-Warner et al 1998) 
concluded that their analyses did not support the hypothesis that alcoholic components of wine 
modify the alcohol-breast cancer relation.  
The evidence from the present review and that from large international reviews and meta-pooled 
analyses would therefore suggest that current alcohol consumption of approximately 12-16 grams per 
day is associated with an increased risk of breast cancer. Lifetime consumption, drinking patterns and 
drink type associations with breast cancer are less conclusive: some caution needs to be taken, 
however, regarding the association between alcohol intake and breast cancer observed in the present 
review. Risk estimates, when comparing the highest with the lowest alcohol exposure category and 
for an increment of 10 15 grams of alcohol per day, were modest in size in both cohort and case 
control studies, ranging from a 10% to 70% increased risk of breast cancer. Small associations could 
be explained by imprecise control for what Mattison et al (2004) termed the ‘web of confounding 
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factors’ of the alcohol-breast cancer association. Although many of the studies in this review 
controlled for some, but not all of the possible confounding factors e.g. body weight, HRT use, sexual 
reproductive factors, socio-economic status and smoking, too little detail was provided in most papers 
on measurement of these terms to rule out the effects of residual confounding. 
In the present review, the association between an increased risk of breast cancer and alcohol 
consumption did not vary by menopausal status. This is consistent with the evidence in the published 
literature; in a meta-analysis (Ellison et al 2001) and two large pooled analyses (Smith and Warner et 
al 1998, Colloborative Group 2002), no significant differences in the relation between alcohol intake 
and relative risk of breast cancer before and after menopause were observed. Hormone replacement 
therapy use and obesity were also not significant modifiers of the association between alcohol 
consumption and breast cancer in the five studies in the present review reporting on this aspect. Body 
weight was adjusted for in 30 of the 34 studies in the review, and adjustment for weight did not 
appreciably change the relation between alcohol intake and breast cancer risk. Although folate intake 
did not significantly modify the alcohol and breast cancer association in three studies, there was some 
evidence from two cohort studies that ‘heavy’ drinkers with low folate intake levels had a statistically 
significant greater risk of breast cancer than drinkers with a high folate intake. No firm conclusions 
can be made concerning the effect of folate since only a small number of studies, with small numbers 
in each stratum of alcohol and folate intake, reported on this aspect. Incomplete assessment of folate 
consumption from food frequency questionnaires may have led to measurement error contributing to 
the inconsistencies reported on the modifying effect of the alcohol consumption and breast cancer 
association.  
There was some evidence from the present review that alcohol use may selectively increase a 
woman’s risk of hormonally responsive breast cancers, i.e. hormonally related breast cancer risk 
factors are associated with ER/PR positive breast tumours, but not with ER+/PR- or ER-/PR- tumours. 
The finding that alcohol may be more strongly associated with ER+/PR+ risk of breast cancer lends 
support to the theory that hormone receptor status defines distinct diseases, rather than different stages 
of the same disease (Enger et al 1999). However, missing receptor status of study participants’ was a 
problem for all studies, leading to potential misclassification bias and possible attenuation of risk 
estimates. Low numbers of hormone receptor subtypes in all studies could reduce the statistical power 
to detect a true association and although a meta-analysis concluded that receptor status was a modifier 
of the alcohol-breast cancer relationship, no figures on the number of cases involved in the analysis 
were provided (Suzuki et al 2008). Epidemiological data from previous studies investigating the 
relationship between alcohol use and risk of breast tumours with different hormone receptor profiles 
has been inconsistent with some observing positive associations across all receptor subtypes (Li et al 
2003, Suzuki et al 2005). The fact that alcohol use is but a moderate risk factor for breast cancer may 
account for these inconsistencies, although additional investigation of these relationships is warranted. 
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Interestingly, a large prospective cohort study included in the present review, reported that the strong 
positive dose response relation between baseline alcohol intake and breast cancer observed in their 
study was markedly attenuated by inclusion of the most recent alcohol intake levels (Thygesen et al 
2008). When the authors examined this association by latency period, their findings suggested a 
pronounced increase of effect with latency. Effect estimates of updated alcohol intake on the risk for 
breast cancer increased almost monotonically; for an alcohol intake of 12-23 g/d, the risk estimates 
increased markedly from RR=1.18 for a 0-year time window to RR=2.48 for a 20 year window, while 
for alcohol intake of >48 g/d, the estimates increased from RR=1.05 for 0 years to RR=110.5 for a 20 
year window. There is some biological evidence indicating a long latency between alcohol intake and 
breast cancer, as alcohol influences an early stage of carcinogenesis (Poschl and Seitz 2004). One 
proposed mechanism is that alcohol increases the breast area occupied by mammographically dense 
tissue, which is associated with breast cancer. Another hypothesis is that cumulative lifetime exposure 
to oestrogens increases the risk for breast cancer, and studies of both pre- and post-menopausal 
women support the hypothesis that alcohol intake increases oestrogen concentrations. Singletary and 
Gapstur (2001) also concluded that the biological evidence for a longer latency between alcohol 
intake and breast cancer is stronger than that for a short latency. In a study of long-term lifestyle 
factors like alcohol intake, however, the time of exposure is often not clear (Rothman 1981), and the 
effect of latency may be difficult to separate from the effect of cumulative exposure (product of 
duration and intensity) and this information was not available in the Thygesen et al (2008) study.  
In summary, despite the overall consistency in the association between alcohol and an increased risk 
of breast cancer, several important questions remain concerning the nature of the dose response 
association including whether the association between alcohol intake and breast cancer risk is affected 
by the timing of alcohol exposure (e.g. current or lifetime), modified by other risk factors and 
potential confounders or effect modifiers of the relationship such as, reproductive factors, deprivation, 
folate intake, use of hormone replacement therapy or is more pronounced among women diagnosed 
with hormone receptor positive tumours or in certain histologic subtypes. Given that the magnitude of 
the association between alcohol consumption and breast cancer risk appears to be relatively modest, 
resolution of the nature of the dose-response relationship may require further pooling of data, 
particularly from prospective studies. This would also assist with clarification of whether the 
association between alcohol consumption and breast cancer risk is modified by other factors, and of 
whether there are beverage-specific effects. Furthermore, to better understand the biological 
mechanisms involved, more studies on alcohol intake and studies on interactions between alcohol 
intake and other lifestyle habits (such as use of hormone replacement therapy), nutritional factors 
(such as low folate intake) and or biological characteristics (such as tumor hormone receptor status) 




 2.5 Colorectal cancer  
Colorectal cancer: summary of evidence from previous reviews 
Systematic reviews of the literature published up until the early 1990s concluded that in 
view of the inconsistent findings from epidemiological studies and the probability of 
uncontrolled confounding by dietary factors, no conclusion could be drawn about the role 
of alcohol consumption of alcoholic beverages in the causation of colorectal cancer (IARC 
1988b, WCRF/AICR 1997, Doll 1999). A pooled analysis of 8 cohort studies, reported that 
the increased risk for colorectal cancer was limited to persons with an alcohol intake of ≥30 
g/d; compared with non-drinkers, the pooled multivariate relative risks for 30 to <45 g/d 
1.16 (95% CI 0.99-1.36) and ≥45 g/d 1.41 (95% CI 1.16-1.72) (Cho et al 2004).  
 
 
The literature search identified 22 studies, published between 1999 and 2009, which examined the 
association between alcohol consumption and colorectal cancer. Tables for each paper, describing the 
study aims, population, alcohol measurement methods and main results are provided in Appendix D. 
 
Of the 22 studies, 15 were cohort (14 prospective and 1 retrospective) studies and seven were case 
control studies. Five studies assessed the effect of alcohol on colorectal cancer as a single entity 
(Flood et al 2002, Ye et al 2002, Hong et al 2005, Thygesen et al 2008, Toriola et al 2008). A further 
nine studies reported on the association between alcohol consumption and colon and rectal cancer 
separately (Murata et al 1999, Ji et al 2002, Sharpe et al 2002, Otani et al 2003, Pedersen et al 2003, 
Shimizu et al 2003, Wei et al 2004, Akhter et al 2007). Murtaugh et al (2004) investigated the 
association between alcohol consumption and rectal cancer and Su and Arab (2004) the association 
between alcohol consumption and colon cancer. The remaining studies reported estimates for all of 
colorectal, colon and rectal cancer. 
 
2.5.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.5.1 below. Of the 
individual cohort studies, four papers were based on established prospective cohort studies described 
in section 2.4; Netherlands Cohort Study on diet and cancer (Bongaerts et al 2008); European 
Prospective Investigation into Cancer and Nutrition (Ferrari et al 2007); Health Professional follow up 
study (Thygesen et al 2008) and Copenhagen Centre for Prospective Population Studies (Pedersen et 
al 2003). In a Swedish record linkage cohort study, patients with a diagnosis of ‘alcoholism’ based on 
ICD-9 coding of hospital admissions outpatient data were identified and retrospectively followed up 





















307/24,972 40-64 regional population random sample 







Bongaerts 2008 Netherlands 2,323/118,677 55–69 general population random sample 
Chen 2005 China 242/64,363 ≥30 regional population volunteers 
Ferrari 2007 Europe 1,833/476,899 35-70 various random selection 






Otani 2003 Japan 716/89,288 40-59 regional population volunteers 
Pedersen 2003 Denmark 623/32,377 23-95 general population random sample 
Shimizu 2003 Japan 295/29,051 ≥35 regional population volunteers 
Su 2004 USA 111/10,418 25-74 general population 
representative 
sample 




Toriola 2008 Finland 59/2,623 (M=53) regional population 
representative 
sample 
Tsong 2007 Singapore 845/62,412 45-74 regional population non-random selection 
Wei 2004 USA 1,478/134,365 30-55 




Ye 2003 Sweden 929/178,469 (M=45) all hospitals consecutive 
                                                             Case control studies                                           cases/controls 
Ho 2004 Hong Kong 822/926 (M=66.8) 
3 hospitals serving 
30% of HK pop. 
consecutive/non-
random selection 
Hong 2005 S.Korea 209/209 (M=59) city hospital 
consecutive/random 
sample 
Ji 2002 China 1805/1552 30-74 regional population 
consecutive/random 
sample 






429/794 30-79 university hospital 
consecutive/non-
random selection 
Murtaugh 2004 USA 952/1205 30-79 regional population 
consecutive/random 
sample 





* included in meta-analysis by Moskai et al (2008). Abb: n/s not specified; M=mean; Mdn= median  
 
Cohort and cases control studies varied in size. The largest cohort study identified in the present 
review included approximately 6,300 incident cases of colorectal cancer in women (Allen et al 2009). 
Other large cohort studies by Bongaerts et al (2008), Ferrari et al (2007) and Wei et al (2004) 
identified 2,323, 1,833 and 1478 colorectal cancer cases respectively. A third of the cohort studies 
identified less than 500 incident cases. The smallest cohort study, recruited only 59 colorectal cancer 
cases from a cohort of middle-aged Finnish men (Toriola et al 2009). The largest case control study 
identified approximately 1800 cases and controls (Ji et al 2002). Two of the seven case control 
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studies, identified in the present review, recruited less than 250 cases and controls to their study 
population (Kim et al 2002, Hong et al 2005).  
 
2.5.2 Study quality 
The quality scores assessed according to the NOS are presented in Table 2.5.2. Overall cohort studies 
were of a high quality, scoring between 8-9 stars. Case control study quality was of a moderate to 
high quality scoring between 5-8 stars.  
Table 2.5.2 Colorectal cancer: assessment of study quality 
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Akhter 2007 4 2 3 9 
Allen 2009 4 2 3 9 
Bongaerts 2008 4 2 3 9 
Chen 2005 3 2 3 8 
Ferrari 2007 4 2 3 9 
Flood 2002 4 2 2 8 
Otani 2003 4 2 3 9 
Pedersen 2003 4 2 3 9 
Shimizu 2003 4 2 2 8 
Su 2004 4 2 3 9 
Thygesen 2008 3 2 2 7 
Toriola 2008 4 2 3 9 
Tsong 2007 4 2 3 9 
Wei 2004 4 2 1 7 
Ye 2003 4 0 3 7 
Case control     
Ho 2004 3 2 1 6 
Hong 2005 2 2 2 6 
Ji 2002 2 2 3 7 
Kim 2004 2 2 1 5 
Murata 1999 2 2 2 6 
Murtaugh 2004 3 2 3 8 
Sharpe 2002 3 2 2 7 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment; 
1 
Outcome for cohort, exposure for case-
control studies 
 
Only three of the cohort studies did not achieve maximum ratings in each of the criteria on the NOS. 
Flood et al (2002) only achieved two out of three stars for outcome measurement because 
identification of colorectal cancer cases in their study was based on self-reports. Eighty per cent of 
self-reported cases were, however, subsequently verified by pathology reports and on this basis the 
authors accepted the remaining 20% self-reports, without pathology confirmation, as colorectal cancer 
cases. Thygesen et al (2008) did not achieve four stars in sample selection, as the study population 
was selected from a sub-group of the general population i.e. health professionals and only two stars 
for outcome measurement because they did not provide information on completeness of follow-up in 
their study cohort. Ye et al (2003) did not control for any of the established confounding risk factors 
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of the alcohol and colorectal cancer association as this information was not available in their hospital 
based record linkage cohort study. 
For sample selection in case control studies, the majority of studies secured two stars out of four 
because either they used cases and controls from a hospital or clinical setting, or failed to confirm that 
cases of colorectal cancer were not present in their study controls. In general, case control studies 
performed poorly in exposure assessment. The extent of interviewer bias was not clear as the majority 
of case control studies did not specify blinding status. Among the hospital based case control studies, 
two reported high response rates (>90%) among cases and controls with two studies not reporting 
response rates in their paper (Murata et al 1999, Kim et al 2004). Of the population case control 
studies, response rates varied from over 90% (Ji et al 2002) to 73% and 69% amongst cases and 
controls respectively (Murtaugh et al 2004).  
In the ‘comparability’ category, one star was awarded if a study controlled for age and one star 
awarded if a study controlled for either one of the following; weight, smoking, diet and or nutritional 
status and physical activity. All prospective cohort and case control studies achieved a maximum of 
two stars, but the studies ranged from adjusting for only two to all of the afore-mentioned potential 
confounders of the alcohol and colorectal cancer association. Weight (measured by BMI) was the 
most often used measure across studies and smoking terms included amount and duration smoked. 
Diet and or nutritional terms used in studies varied considerably; energy from non-alcohol sources 
(Ferrari et al 2007), folate, methionine, processed meat and calcium intake (Pedersen et al 2003, 
Thygesen et al 2008), fruit and vegetable intake (Akhter et al 2007), total energy intake, intakes of fat, 
dietary fibre and calcium (Bongaerts et al 2008).  
 
2.5.3 Results: total alcohol intake and risk of colorectal cancer
9
 
Eight studies reported on the dose response association between alcohol consumption and colorectal 
cancer. Of these, five studies reported on the association between colorectal cancer and ‘recent’ 
alcohol consumption; defined as intake in the previous year (Flood et al 2002, Ferrari et al 2007, 
Bongaerts et al 2008, Thygesen et al 2008, Toriola et al 2008). One study reported on the association 
between colorectal cancer with lifetime alcohol intake (Kim et al 2004). Hong et al (2005) did not 
specify a reference period. In the remaining study Ye et al (2002) did not collect alcohol consumption 
data. A summary of colorectal cancer risk estimates, comparing the highest versus the lowest alcohol 
exposure category, is presented in Figure 2.5.1. 
  
                                                          
9
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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Figure 2.5.1 Alcohol consumption and colorectal cancer, highest versus lowest exposure category, by 
study type (relative risk/odds ratio and 95% confidence intervals) 
0.1 1 10 100










OR/RR, highest vs lowest exposure category
 
In general, individual cohort and cases control studies also consistently reported a statistically 
significant increased risk of colorectal cancer at the highest alcohol exposure category, compared to 
the lowest (Figure 2.5.1.) In a large Dutch cohort, drinking >30 grams per day [g/d], increased the risk 
(RR 1.32, 95% CI 1.06-1.65) of colorectal cancer, compared to abstainers (Bongaerts et al 2008). In 
the same study, drinking <30 g/d was, however, not associated with an increased risk of colorectal 
cancer. In a large multi-centre European cohort (Ferrari et al 2007), no association with colorectal 
cancer was reported for those drinking <30 g/d (e.g. 15-29g/d; OR 1.03, 95% CI 0.88-1.20), compared 
to those drinking <5 g/d. In contrast the risk of colorectal cancer increased by 26% (95% CI 6%-49%) 
and 64% (95% CI 29%-108%) in those drinking 30-59.9 g/d and >60 g/d, respectively. There was 
strong evidence of a statistically significant dose response association (p value for trend =0.001). 
Non-drinkers were not increased risk of colorectal cancer (RR 0.98, 95% CI 0.72-1.22). A similar 
pattern was observed for the association between average lifetime intake and risk of colorectal cancer 
(Bongaerts et al 2008). Thygesen et al (2008) reported that baseline, updated and cumulative average 
alcohol intakes were positively associated with colorectal cancer, with only minor differences among 
the approaches (baseline intake >45g/d; RR 1.75, 95% CI 1.21–2.52, p value for trend =0.0006). Point 
estimates for baseline and cumulative alcohol intake indicate a threshold effect, with a statistically 
significant increased risk only for alcohol intake of >30 g/d. The hazard ratio for baseline alcohol 
intake was 1.07 (95% CI 1.02-1.11) per 10 g/d increase (Thygesen et al 2008). Flood et al (20020 
observed a non-significant increase in risk among women who drank >2 drinks per day (RR 1.16), 
compared to non-drinkers. With only 11 cases in the top category of consumption, the confidence 
intervals were wide (95% CI 0.63-1.24) and the test for tend was not significant (p=0.84) 
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In a small Finnish cohort study, Toriola et al (2008) reported a 3.5-fold (95% CI 1.2-9.9 P value 0.02) 
increased risk among people who drank >115 grams per week [g/w] compared with the lowest 
quintile (<3.3 g/w) of alcohol consumption. Although men drinking ≤115 g/w also showed a two-fold 
increase in risk, none of the estimates were of statistical significance and confidence intervals were 
wide. Similar patterns of a statistically significant increased risk of colorectal cancer at the highest 
alcohol exposure category only, were reported in two hospital based case control studies; >30 g/d 
compared to <5 g/d (Kim et al 2004) and >80 g/w, compared to ≤ 80 g/w (Hong et al 2005). Ye et al 
(2002), in a study based on record linkage to inpatient registers in Sweden, reported that the incidence 
rate (SIR 1.00, 95% CI 0.93-1.06) of colorectal cancer cases in a cohort of people admitted to hospital 
with a diagnosis of ‘alcoholism,’ was comparable to that found in the general population in Sweden.  
 
2.5.3.1 Results: total alcohol intake and risk of colon and rectal cancer 
Fourteen studies reported on the dose response association between alcohol consumption and colon 
and rectal cancer. Of these three studies reported on the association between colon and/or rectal 
cancer with lifetime alcohol intake; Murtagh et al (2004) defined lifetime intake as average weekly 
alcohol consumption 10 and 20 years ago; Ji et al (2002) defined lifetime drinkers as those with at 
least one drink per week for 6 months and Kim et al (2004) did not specify did not specify a measure 
for their ‘lifetime’ drinkers. Three studies did not specify a reference period (Murata et al 1999, 
Akhter et al 2007, Tsong et al 2007). The remaining studies reported on the association between colon 
and/or rectal cancer and ‘recent’ alcohol consumption defined as intake in the previous year with the 
exception of the study by Ho et al (2004) who reported ‘drinking habits immediately prior to 
diagnosis.A summary of colon and rectal cancer estimates, comparing the highest versus the lowest 
alcohol exposure category, are presented in Figure 2.5.2 and Figure 2.5.3, respectively.  
Overall, individual prospective cohort studies were also consistent in reporting an increased risk of 
colon and rectal cancer in the highest alcohol exposure category. In three cohort studies, however, an 
increased risk of colon or rectal cancer was only reported in those drinking >30g/d, compared to non-
drinkers (Akhter et al 2007, Bongaerts et al 2008) or those drinking between 0.1-<5 g/d (Ferrari et al 




Figure 2.5.2 Alcohol consumption and colon cancer, highest versus lowest exposure category by 
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Figure 2.5.3 Alcohol consumption and rectal cancer, highest versus lowest exposure category by 
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increment of 10 grams of alcohol per day significantly increased the risk of both colon (RR 1.07, 95% 
CI 1.02-1.12, P value =0.004), and rectal (RR 1.11, 95% CI 1.05-1.17, P value <0.001) cancer. Allen 
et al (2009), in a large UK prospective cohort study with over 6,000 incident cases of colon cancer 
and 2000 cases of rectal cancer, reported that women drinking >15 drinks (approximately 150 grams) 
per week [d/w] did not have an increased risk (RR 1.00, 95% FCI 0.87-1.15, p value for trend =0.8) 
of colon cancer, compared to women drinking <2 d/w. Non-drinkers, in the same study, were also not 
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at an increased risk of colon cancer (RR 1.00, 95% CI 0.94-1.07). In contrast, there was a statistically 
significant increased risk of rectal cancer in women drinking >15 d/w (RR 1.25, 95% FCI 1.06-1.49, p 
value for trend =0.02), though drinking <15 d/w was not associated with an increased risk of rectal 
cancer (Allen et al 2009). 
Ji et al (2002) observed an increased risk of colon cancer only in men drinking ≥560 g/w, (OR 1.5, 
95% CI 1.1-2.2, p value for trend =0.16) and in women drinking ≥262.5 g/w (OR 1.4, 95% CI 0.4-4.6, 
p value for trend =0.60). Murtaugh et al (2004) found little evidence that alcohol consumption 
significantly increased risk of rectal cancer in men (>114 g/w; OR 1.0, 95% CI 0.78-1.38) and women 
(>114 g/w; OR 1.07, 95% CI 0.76-1.50). Four hospital based case control studies observed 
statistically significant associations between an increased risk of colon cancer, and positive 
associations for an increased risk of rectal cancer, at the highest alcohol intake level (Ho et al 2004, 
≥40 g/w compared to <40 g/w; Kim et al 2004, >30 g/d compared to <3.5 g/d; Murata et al 1999, 
56ml
10
 of alcohol per day compared to non-drinkers).  
 
2.5.3.2 Results: total alcohol intake and risk of colon cancer by tumour site 
Four studies, three cohort and one case control, analysed the effect of alcohol intake on increased risk 
of distal and proximal colon cancer. In all four studies, alcohol consumption was more closely 
associated with an increased risk of distal colon cancer. Of the three cohort studies, Ferrari et al 
(2007) observed that for both measures of average lifetime drinking and baseline drinking, heavy 
drinkers only (>60 g/d; baseline p value for trend =0.018, average lifetime p value for trend =0.025) 
had a statistically significant increased risk of distal, but not proximal colon cancer (baseline p value 
for trend =0.442; average lifetime p value for trend=0.708). Bongaerts et al (2008) reported that daily 
alcohol consumption of >30 g/d, compared to abstainers, was associated with an increased risk of 
distal (RR 1.32, 95% CI 0.95-1.83), but not proximal (RR 1.05, 95% CI 0.75-1.46) colon cancer. In a 
Japanese cohort, Akhter et al (2007) reported that the volume of alcohol drunk per day among current 
drinkers only showed a strong dose-dependent significant linear association for distal (p value for 
trend= 0.0002) colon cancer and not proximal (p value for trend =0.04) colon current alcohol drinkers 
though only ‘moderate’ (22.8-45.5 g/d) and ‘heavy’ drinkers (≥45.6 g/d) had a statistically significant 
increased risk of distal colon cancer.  
 
2.5.4 Results: drinking dimensions and risk of colorectal cancer 
Four studies reported on other aspects of drinking behaviour and the association with colorectal 
cancer. Chen et al (2005), in a Chinese prospective cohort study, reported no significant association 
                                                          
10
 one gram = approximately 1.25 milliliters (ml) 
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between alcohol consumption and the risk of colorectal in men taking alcohol occasionally (RR 0.99 
95% CI 0.61-1.63) and daily (RR 1.03 95% CI 0.65–1.64). Among daily female drinkers, the risk of 
colon cancer increased 2.7-fold compared to non-drinking females (RR ¼ 2.70, 95% CI, 0.80–9.14), 
but this association was no significant. In a Canadian case control study, ‘daily’ drinkers and ‘weekly’ 
drinkers were at higher risk of distal and rectal cancer, compared to those who did not drink weekly, 
but there was no increase in the risk of proximal cancer (Sharpe et al 2002). Among ‘daily drinkers’, 
however, only those drinking >5 drinks per day [d/d] had a statistically significant increased risk of 
distal (OR 3.0, 95% CI 1.6-5.6) and rectal (OR 2.0, 95% CI 1.1-3.6) cancer. ‘Daily’ drinkers drinking 
>5 d/d were also at an increased risk of proximal colon cancer (OR 1.6, 95% CI 0.9-2.9).  
Two case control studies reported conflicting results on the association between duration of drinking 
habit and risk of colorectal cancer. Ho et al (2004) reported that among current drinkers, drinking 
duration was not associated with an increased risk of colorectal cancer (>39 years; OR 0.75 95% CI 
(0.38–1.49 p value for trend =0.52, compared to <20 years). On the other hand, Ji et al (2002) 
observed that among current drinkers, increased risks of colon and rectal were associated with long-
term alcohol consumption. The ORs for colon cancer among men were 1.3 (95% CI 0.9-1.8) and 1.4 
(95% CI 0.9-2.2) for current drinkers of 30-44 years and ≥45 years, respectively, compared to non-
drinkers (p value for trend =0.10). Similar patterns were reported for the association between drinking 
duration and rectal cancer (p value for trend =0.10).  
 
2.5.5 Results: drink type and risk of colorectal cancer  
Five studies examined whether risk of colorectal cancer (including separate studies on colon and 
rectal cancer) varied by type of alcoholic beverage. A summary of risk estimates, comparing the 
highest versus the lowest alcohol exposure category, is presented in Figure 2.5.4. 
In a large European cohort study, moderately higher colon cancer hazard ratios were observed for 
baseline beer intake (>40 g/d; 1.62, 95% CI 1.21-2.17 vs. 0.1-2.9 g/d), than wine (>40 g/d, 1.19, 95% 
CI 0.90-1.57 vs. 0.1-2.9 g/d) or spirits (>5 g/d 1.07 95% CI 0.89-1.29 vs. 0.1-1.9 g/day) (Ferrari et al 
2007). The authors reported that these associations were not significantly different by cancer subtypes 
or alcoholic beverages, but results were not reported in the paper. In a Danish cohort study, Pedersen 
et al (2003) reported that beer and spirits were associated with a non-significant increased risk of 
colon and rectal cancer at the highest alcohol exposure category. Drinking wine on the other hand, 
was associated with a decreased risk of colon (>14 d/w; RR 0.5, 95% CI 0.2-1.0, p value for trend 
=0.07) and rectal cancer (>14 d/w; RR 0.9, 95% CI 0.4-2.1, p value for trend= 0.87). Bongaerts et al 
(2008), in a large Dutch cohort study, reported that wine, beer and spirit drinkers, compared to non-
drinkers, did not have an increased risk of colorectal cancer overall and by sub-site (colon, including 
proximal and distal, and rectal cancer),  
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Figure 2.5.4 Alcohol consumption and risk of colorectal cancer, highest versus lowest exposure 
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Of the case control studies, Murtaugh et al (2004) reported that the risk of rectal cancer increased non-
significantly among men drinking >2.7 ‘servings’ of beer per week (OR 1.20, 95% CI 0.89-1.61), but 
not among men drinking red or white wine or spirits. Among women, the risk of rectal cancer 
increased non-significantly among those drinking >3.4 ‘servings of white wine per week (OR 1.26, 
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95% CI 0.85-1.86), but there was no association with red wine, beer or spirits. Sharpe et al (2002) 
reported that ‘daily’ drinkers of ≥5 ‘drinks’ of beer or spirits per day, compared to non-weekly 
drinkers, had an increased risk of distal and proximal, and rectal cancer. Wine was not associated with 
increased risks at any sub-site.  
 
2.5.6 Effect modification 
Four studies assessed the joint effect on the alcohol and colorectal cancer association from one or 
more of the following risk factors for colorectal cancer; smoking, folate intake and weight (measured 
by Body Mass Index (BMI)). 
Two studies assessed the joint effect of alcohol consumption and folate intake on colorectal cancer 
risk. Ferrari et al (2007), from the EPIC study, reported that the association between an increment of 
15 grams of alcohol per day and an increased risk of colorectal cancer was stronger in individuals 
with ‘low’ folate intake (RR 1.13, 95% CI 1.06-1.20) than in those with ‘high’ folate intake (RR1.03, 
95% CI 0.98-1.09 with a borderline significant interaction (Pinteraction=0.06). No definition of low and 
high folate categories was provided in the paper. In a small American cohort study, Flood et al (2002) 
reported that for women who drank >1 d/d, with a low level of folate intake (<167 µg/1000 Kcal per 
day), did not have a significantly increased risk (OR 1.10 95% CI 0.67-1.80) of colorectal cancer 
compared to non-drinkers with a high folate intake (>232 µg/1000 Kcal per day of folate). In a similar 
analysis examining total folate, no combination of folate and alcohol consumption showed any 
significant increase in risk compared to the reference category. For both dietary and total folate, there 
was no greater risk among women in the low folate vs. high folate category, within the highest alcohol 
category. 
All four studies assessed the joint effect of alcohol consumption and smoking on colorectal cancer 
risk. Ferrari et al (2007) reported that alcohol consumption was more strongly associated to colorectal 
cancer in current smokers (RR 1.23, 95% CI 1.12-1.36 for 15 g/d increase) than never smokers (RR 
1.15, 95%CI 1.03-1.28) or former smokers (RR 1.11, 95% CI 0.97-1.28), but overall interaction was 
not statistically significant (Pinteraction=0.41). Flood et al (2002) reported that the excess risk of 
colorectal cancers associated with alcohol was present only among non-smokers: the RR comparing 
women who drank >2d/d to non-drinkers was 1.78 95% CI 0.66-4.83. Among smokers (former and 
current) there was no association between alcohol consumption and colorectal cancer (>2d/d; 
RR=0.89 95% CI 0.41-1.93). 
In a Japanese cohort study, colorectal cancer risk for drinkers of >300 g/w who smoked was estimated 
at RR 3.0 (95% CI, 1.8-5.1), compared with non-drinkers who never smoked (Otani et al 2003). 
Among those drinking >300 g/d and who had never smoked, the RR was 2.3 (0.7-7.1). The 
association did not differ between colon and rectum. Otani et al (2003) reported no significant 
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interaction between alcohol consumption and smoking status (Pinteraction=0.88 in colorectal, and 0.75 in 
colon, and 0.44 in rectum). Tsong et al (2007) reported that the risk of colorectal cancer, at each level 
of cigarette smoking, increased with increasing alcohol intake. Similarly, at each level of alcohol 
intake, risk of rectal cancer increased with increasing level of smoking; compared with non-smokers 
and non-drinkers, heavy smokers who consumed seven or more drinks of alcoholic beverages per 
week had a HR of 2.03 (95% CI 1.03-3.97) for colorectal cancer. The interaction effects between 
alcohol and smoking on colorectal cancer risk (Pinteraction=0.30), were not statistically significant. 
 
2.5.7 Summary and conclusions 
This literature review identified 22 studies and one meta-analysis, published between 1999 and 2009, 
which examined the association between alcohol consumption and risk of colorectal, colon or rectal 
cancer. Cohort studies were of a high quality and adjustment for most of the main confounders of the 
alcohol and colorectal cancer association took place in both cohort and case control studies. Overall, 
studies were consistent in only reporting a statistically significant increased risk of colorectal cancer 
associated with drinking ≥30 g/d. Drinking <30 g/d was not associated with an increased risk of 
colorectal cancer in many of the larger cohort and case controls studies though some smaller studies 
did observe a small, non-significant increased risk of colorectal cancer. These patterns were repeated 
in studies of the association between alcohol consumption and both colon and rectal cancer. Residual 
confounding, however, from imprecise measures of diet (e.g. fibre, folate, and methionine) is likely in 
many of the studies though the effect of this on the reported alcohol-colorectal association is difficult 
to determine. It is possible that the effect of alcohol consumption on the risk of colorectal cancer is 
modified by other factors and by intake level. High doses of alcohol combined with a low methionine, 
low folate diet have been shown in some studies to increase the risk of colon cancer in men (Pedersen 
et al 2003), but not in women (Flood et al 2002). In contrast, alcohol in combination with a high 
intake of vitamin B6 among women has been shown to decrease the risk of colorectal cancer (Larsson 
et al 2005). Increasingly, studies are suggesting removing the concern from simple alcohol 
consumption to the interaction of folate and vitamin use, and enzyme genetic polymorphisms (Chen et 
al 2005, Larsson et al 2005). 
The finding of the present review of a possible threshold effect of alcohol consumption on colorectal 
cancer risk, where only those drinking ≥30 g/d had a statistically significant increased risk, is 
consistent with previous published findings. Earlier systematic reviews covering the published 
literature between 1966 and 1999, have reported a possible direct relationship between alcohol 
drinking and risk of colorectal cancer, but that the relationship is quantitatively moderate with most 
studies reporting less than a twofold increase in risk, even at high levels of drinking (IARC 1988, Doll 
et al 1999). A pooled analysis of 8 cohort studies reported that the increased risk for colorectal cancer 
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was limited to persons with an alcohol intake of ≥30 g/d; compared with non-drinkers, the pooled 
multivariate relative risks for 30 to <45 g/d 1.16 (95% CI 0.99-1.36) and 1.41 (95% CI 1.16-1.72), for 
those who consumed ≥45 g/d (Cho et al 2004). A recent systematic review recently concluded that 
there was ‘convincing evidence’ that drinking >30 g/d is a cause of colorectal cancer in men and 
‘probably’ in women’. The evidence of an effect at lower levels of drinking on colorectal cancer risk 
is currently inconclusive (WCRF/AICR 2007). In a meta-analysis of prospective cohort studies 
published between 1990 and June 2005 by Moskal et al (2008), the highest alcohol intake level, 
compared to the lowest, was positively, but not significantly associated with colorectal cancer (RR 
1.34, 95% CI 0.92, 1.96). The results were heterogeneous across cohorts (p test for Heterogeneity (p 
Het) =0.002). High alcohol intake was significantly associated with colorectal cancer in men (RR 
1.73, 95% CI 1.00-2.98, p Het=0.02), but not in women (RR 0.88, 95% CI 0.61-1.27, p Het=0.44). 
The paper did not define the amount drank at the highest level, however, in further dose response 
analysis, Moskal et al (2008) did observe a 21% increase, (95% CI 2%-43%) increase of colorectal 
cancer associated with an increment of 100g of alcohol per week, but not for women (RR 1.05, 95% 
CI 0.92-1.20). In the Moskal meta-analysis, results were combined from studies that varied in study 
populations, methods of assessment of alcohol intake, levels and type of alcohol consumed and 
adjustment for potential confounders varied across studies.  
The evidence, from the present review, on the association between drink type and an increased risk of 
colorectal cancer, was inconclusive. Only five studies were identified that reported on this aspect of 
the alcohol and colorectal cancer association. Beer and spirits were consistently associated with an 
increased risk of colorectal cancer, whilst the evidence for wine included both inverse and positive 
associations with colorectal cancer. Many of the studies, however, had small numbers of drinkers of 
specific alcohol drink types and risk estimates lacked precision and prevented formal significance 
testing of interactions between wine, beer and spirits. The positive associations between beer and 
spirits and an increased risk of colorectal cancer correlated with these drink types being the most 
commonly consumed beverage in the studies’ population, conversely the majority of inverse 
associations reported for wine drinking were reported by studies where wine was the least preferred 
beverage type. There has been, little consensus in the literature that there is an appreciable and 
consistent difference in risk of colorectal cancer among different types of alcoholic beverage (Doll et 
al 1999). In a pooled analysis of eight cohort studies (Cho et al 2004), beer or wine was significantly 
associated with an increased risk of colorectal cancer and spirits with a non-significant positive 
association of colorectal cancer, but the risk did not differ significantly by type of alcohol drink (for 
intake of ≥30 g/d, P Het >0.2).  
It has been hypothesised that because of differences between men and women in alcohol metabolism 
and gut physiology, the risk of colorectal cancer from alcohol drinking may vary by gender, as a result 
of slower metabolism of alcohol in women than in men (Gapstur et al 1994, Corrao et al 1999). Few 
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studies in the present review reported on the association between alcohol consumption and colorectal 
cancer by gender. A statistically significant increased risk of colorectal cancer in both men and 
women drinking ≥30 g/d was reported in a meta-analysis of sixteen cohort studies (Moskal et al 2008) 
with higher risk estimates reported for men. Although there is was some evidence, in the meta-
analysis, that gender differences were close to statistical significance (P Het =0.07), the authors 
reported that the relationship was ‘attenuated’ after the inclusion of alcohol level intake in their 
statistical model. Previous pooled and meta-analysis studies have not found a gender variation in risk 
of colorectal cancer. Bagnardi et al (2001) in a meta-analysis of 6 cohort studies and 16 case control 
studies, reported no significant effect of gender on modifying the effect of alcohol on the risk of 
colorectal cancer. Cho et al (2004) also found no significant heterogeneity by gender: for alcohol 
consumption of >45g, (P Het >0.2).  
There was little evidence in the present review to suggest that the risk of colorectal cancer varied by 
tumour site. Previous meta- and pooled analyses have found no evidence of a significant difference in 
heterogeneity in estimates of the risk of colon and rectal cancer from alcohol consumption (Corrao et 
al 1999, Cho et al 2004, Wei et al 2004). To date, experimental research has not distinguished 
between colon and rectal cancer as most research has been performed on human colon cancer cells 
and can therefore offer no explanation as to potential differences, if any, in risk by sub-site (Pedersen 
et al 2002). A small number of studies from Europe and Asia in the present review did, however, 
report a consistently higher, and statistically significant, increased risk of distal colon, but not for 
proximal colon cancer from alcohol consumption. A recent review concluded that accumulating 
evidence suggests that the risk of colon cancer conferred by various environmental and genetic factors 
is different for proximal and distal tumours (Iacopetta 2002). The mechanisms for this relationship, 
however, are unclear. Administration of alcohol to experimental animals has been reported to 
influence carcinogenesis in the colon in different fashions depending on dose; lower doses have no 
effect on the proximal colon, but enhance carcinogenesis in the distal colon, while higher doses inhibit 
carcinogenesis in the proximal colon and have little effect on the distal colon (Seitz et al 1992). 
Evidence from this review, however, suggests that an increased risk of colorectal cancer and by 
tumour type (distal colon and rectal) from alcohol consumption was only apparent at higher doses of 
alcohol (≥30 g/d). The small number of studies reporting on the association between colon cancer and 
alcohol consumption by tumour type and the imprecision of risk estimates due to small sample sizes 
in many of the studies prevents any firm conclusions concerning the effect of alcohol on distal and 
proximal colon cancer. The existence of two broadly different groups of cancer, defined by site of 
origin in the colon (i.e. distal and proximal), should therefore be considered in the design of future 
epidemiologic studies on the association between alcohol consumption and colorectal cancer. 
In summary, there is strong evidence of a threshold effect of alcohol consumption on colorectal 
cancer risk whereby approximately ≥30 g/d significantly increases the risk of colorectal cancer. The 
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positive association between total alcohol and colorectal cancer would appear to be attributable to 
ethanol itself rather than a specific beverage. There is little evidence to suggest a modifying effect of 
gender or by tumour type (colon and rectal) on the association between alcohol consumption and 
colorectal cancer risk. The association between alcohol consumption and distal colon cancer is worthy 
of further investigation. Future studies on the alcohol and colorectal cancer association should include 
well designed food frequency questionnaires to enable more accurate measurement of diet and 
nutritional status. 
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2.6 Endometrial cancer 
Endometrial cancer: summary of evidence from previous reviews 
Earlier systematic reviews covering the published literature between 1966 and 2001 
concluded that studies did not offer much support for a positive association between 
alcohol intake and endometrial cancer, with results generally indicating no association or 
suggesting an inverse relationship with endometrial cancer (IARC 1988, Bandera et al 
2003). 
 
The literature search found nine studies, published between 1 January 1999 and 30 September 2009, 
which examined the relationship between alcohol consumption and endometrial cancer. There were 
six cohort studies (five prospective and one retrospective) and three case control studies. Tables for 
each paper, describing the study aims, population, alcohol measurement methods and main results are 
provided in Appendix D.  
2.6.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.6.1 below.  











Sample base  
 
Sample selection  
Cohort studies 
Friberg 2009 Sweden 687/60,539 40-76 regional population n/s 




Loerbroks 2007 Netherlands 280/1,619 55-69 general population random sample 




Terry 1999 Sweden 133/11,526 >18 population register census 




of hospital patients 
non-random selection 
                                                Case control studies                     cases/controls 




city cancer hospital 
consecutive/random 
selection 



















Abb: n/s not specified; M=mean; Mdn= median  
 
Two papers were based on established prospective cohort studies described in box 2 section 2.4; the 
Netherlands Cohort Study on diet and cancer (Loerbroks et al 2007) and the Swedish Mammography 
Cohort (Friberg et al 2007). In the remaining cohort studies, Terry et al (1999) recruited their cohort 
from the Swedish Twin Registry and consisted of women from same-sexed twins born in Sweden 
over a forty year period around 1900. In a paper by Setiawan et al (2008), potential participants were 
identified through US state driver's license files, voter registration lists and Health Care Financing 
Administration data files and entered into the ‘Multi Ethnic Cohort (MEC)’ study. This cohort 
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consisted of over 200,000 men and women and comprised mainly five of self-reported racial/ethnic 
populations: African Americans, Japanese Americans, Latinos, Native Hawaiians and Whites. 
Eligible post-menopausal women (n= 41,574; 15.7% African Americans, 31.5% Japanese Americans, 
21.5% Latinas, 6.7% Native Hawaiians, and 24.5% Whites) from the MEC study were then followed 
up for an average of 8.3 years. Post-menopausal status was not defined in the paper though the mean 
age of the post-menopausal cohort was approximately 60 years. Jain et al (2000) conducted their 
study as a case-cohort study within a cohort of approximately 57,000 women: the Canadian National 
Breast Screening Study, a randomized controlled trial primarily designed to assess mammographic 
screening for breast cancer in volunteer women aged 40-59 years. The sub-cohort was constructed by 
selecting a stratified (by recruitment centre) random sample of 5,681 women. In a record linkage 
cohort study, women who were hospitalised in any Swedish hospital, between 1965 and 1994 with a 
diagnosis of ‘alcoholism’ were identified and retrospectively followed up for an average of 10 years 
(Weiderpass et al 2001).  
2.6.2 Study quality 
The quality scores assessed, according to the NOS, are presented in Table 2.6.2. Overall, cohort and 
case control studies were of a moderate to high quality, scoring between 6-7 stars.  
Table 2.6.2 Endometrial cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Friberg 2009 3 2 2 7 
Jain 2000 2 2 3 7 
Loerbroks 2007 4 2 3 9 
Setiawan 2008 4 2 3 9 
Terry 1999 2 2 3 7 
Weiderpass 2001 2 2 3 7 
Case Control     
Hosono 2008 2 2 3 7 
McCann 2000 3 2 2 7 
Weiderpass 2001 3 0 2 5 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment; 
1 
Outcome for cohort, exposure for case-
control studies 
 
The prospective cohort studies were generally of a high quality. The nearly complete end-point 
ascertainment across all cohort studies reduced the potential for bias from differential follow-up. The 
weakest area was in sample selection where only two studies by obtained a maximum rating 
(Loerbroks et al 2007, Setiawan et al 2008). Terry et al (1999), Jain et al (200) and Friberg et al 
(2009) failed to specify if endometrial cancer was absent from their study participants at baseline 
entry. In a cohort of people admitted to Swedish hospitals with ‘alcoholism’, it was not clear from the 
paper how ‘alcoholic’ patients were identified (Weiderpass et al 2001). Measurement error was an 
issue in one paper (Terry et al 1999) where over a long follow up period of approximately 20 years, 
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information on alcohol consumption was only collected at baseline. This may have lead to 
misclassification error since drinking habits, as well other lifestyle factors associated with endometrial 
cancer risk among the study population, will have changed over that period. What effect this would 
have on the point estimates is unclear though if we assume that drinking decreases with age, then risk 
estimates will be biased towards null. 
For the case controls studies, non-response bias was a significant problem. Response rates for cases 
and controls were below 80% in the study by Weiderpass and Baron (2001) and only reached 50% for 
both cases and controls in a US population control study (McCann et al 2000). In both the afore-
mentioned studies, physician and participant’s refusal to take part in the study accounted for the 
majority of non-responders. Furthermore, in the study by McCann et al (2000), information on alcohol 
consumption was based in the first instance on usual intake over a 2 year period then for periods, 10 
years, and 20 years before the interview and at age 16, increasing the potential for misclassification of 
alcohol drinking data as a result of recall bias. 
The known risk factors for the endometrial cancer, which include oestrogen replacement therapy, 
obesity in middle age, diabetes mellitus and low parity, were controlled for in eight of the nine 
studies. In the record linkage cohort study by Weiderpass et al (2001), no adjustment for these risk 
factors took place since no lifestyle information was collected. The possibility of residual 
confounding may therefore account for the weak statistically significant inverse association observed 
in this study. 
2.6.3 Results: total alcohol intake and endometrial cancer
11
  
Seven of the eight studies reported on the association between endometrial cancer and ‘recent’ alcohol 
consumption; defined as intake in the previous year in four studies (Loerbroks et al 2007, Hosono et 
al 2008, Setiawan et al 2008, Weiderpass and Baron 2001), by McCann et al (2001) as usual 
consumption in the previous two years, with the remaining three studies not specifying a reference 
period. A summary of endometrial cancer risk estimates, comparing the highest versus the lowest 
alcohol exposure category is presented in Figure 2.6.1. 
Setiawan et al (2008) reported a statistically significant increased risk (RR 2.01, 95% CI 1.30-3.11) of 
endometrial cancer in women drinking more than >24 grams per day [g/d], compared to non-drinkers. 
Women drinking <24 g/d did not have an increased risk of endometrial cancer and little evidence of a 
dose response relationship (p value for trend =0.19). Similar findings were reported by Loerbroks et al 
(2007) with a statistically non-significant, increased risk (RR 1.78, 95% CI 0.88-3.60) of endometrial 
cancer for women drinking >30 g/d, compared those drinking less than once a month. There was no 
                                                          
11
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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association with endometrial cancer below 30 g/d and no evidence of a dose response association (p 
value for trend =0.62). 
Figure 2.6.1 Alcohol consumption and endometrial cancer: highest versus lowest exposure category, 













OR/RR, highest vs lowest exposure category
 
 
Friberg et al (2009) observed a small (12%), statistically non-significant, increased risk of endometrial 
cancer only in women drinking ≥10 g/d. There was no evidence of a dose response relationship and no 
significance test for trend was reported in the paper. Terry et al (1999) reported similar risk estimates 
for women drinking in the highest alcohol category (>7 g/d), but very few women (n=40) drank in this 
study and confidence intervals were large. Jain et al (2000) did not find an increased risk of 
endometrial cancer in women drinking across all quartiles (not defined in the paper) of alcohol 
consumption compared to non-drinkers. In the remaining cohort study, Weiderpass et al (2001) 
observed a statistically significant, lower risk of endometrial cancer in people admitted to hospitals in 
Sweden with a diagnosis of ‘alcoholism’, compared to that in the Swedish general population. 
Two population based case control studies did not find an association between alcohol consumption 
and endometrial cancer at all intake levels, up to and including >4 g/d (Weiderpass & Baron 2001) 
and >9 grams per month (McCann et al 2000) compared to non-drinkers and those drinking less than 
monthly, respectively. In a hospital based case control study (Hosono et al 2008), consumption of 
>175 grams per week (approximately 2 ‘standard’ drinks per day), compared to non-drinkers, was 
associated with a 50% reduced risk of endometrial cancer with convincing evidence of an increased 




2.6.4 Results: drinking dimensions and risk of endometrial cancer 
Drinking frequency, and in particular daily drinking (5 times a week; OR 0.37, 0.17-0.82), was 
associated with an inverse association with endometrial cancer in a Japanese case control study 
(Hosono et al 2008), with strong evidence of a statistically significant dose response relationship (p 
value for trend =0.009). Weiderpass et al (2001), observed no substantial difference in endometrial 
cancer risk in their cohort of ‘alcoholic’ patients, according to duration of follow-up, calendar year at 
cohort enrolment or presence or absence of a hospital discharge diagnosis of obesity or liver cirrhosis 
compared to that expected in the general population in Sweden. 
2.6.5 Results: drink type and risk of endometrial cancer  
Two studies reported on the association between drink type and endometrial cancer (Table 2.6.3). No 
statistically significant association was observed for wine and current drinkers of beer and spirits in a 
Dutch cohort study- highest alcohol exposure category of >15 g/d (Loerbroks et al 2001). Similar 
finding were reported in a Swedish population based case control study for current drinks of wine, 
fortified wine, light and strong beer, and spirits (Weiderpass & Baron 2001).  
Table 2.6.3 Alcohol intake and risk of endometrial cancer by drink type  
Study Ref. 
Group 
Beer Wine Spirits 
Loerbroks <1 per 
month 
Yes              1.30 (0.82-2.07) 0.1–4g/d 1.16 (0.84-1.59) 
5–14        1.07 (0.68-1.67) 
≥15          1.11 (0.64-1.93)  





Light beer    0.94 (0.76-1.17) 
Strong beer 0.80 (0.49-1.28) 
Wine        0.96 (0.79-1.18) 
Fortified  1.10 (0.86-1.41) 
Yes  1.06 (0.84-1.34) 
 
2.6.6 Results: effect modification 
No studies were identified. 
2.6.7 Summary and conclusions 
The present review identified nine papers, published between 1999 and 2009, which examined the 
association between alcohol consumption and endometrial cancer. Overall, the evidence provided by 
the majority of studies was not supportive of an association between alcohol consumption and 
endometrial cancer. Certain methodological limitations, such as small sample size, limited range of 
alcohol intake, and confounding may explain this finding. Bandera et al (2003), in a review of two 
cohort and thirteen case control studies published before 2001, also concluded that studies did not 
offer much support for a positive association between alcohol intake and endometrial cancer, with 
results generally indicating no association or suggesting an inverse relationship with endometrial 
cancer.  
An effect of alcohol consumption on the risk of endometrial cancer, cannot, however, be ruled out. 
Many studies included in the present review, and that carried out by Bandera et al (2003), because of 
the limited range of alcohol intake in these studies, were effectively only measuring the association 
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between low level drinking (approximately ≤1 d/d) and endometrial cancer. It was, therefore, 
interesting to observe that in two prospective cohort studies in the present review (Loerbroks et al 
2007, Setiawan et al 2008), both reported an approximate two-fold increased risk of endometrial 
cancer in women drinking ≥2 d/d (≥24 g/d). In both studies however, there was neither an association 
between endometrial cancer and women drinking <2 drinks per week or evidence of a dose response 
relationship. Two small case control studies identified in the Bandera et al (2003) review also reported 
an increased risk of endometrial cancer in women drinking ≥ 2 d/d. An effect of moderate alcohol 
consumption is biologically plausible. Alcohol has been shown to increase the levels of oestrogen, 
which in turn, have been shown to increase endometrial cancer risk by stimulating the proliferation of 
endometrial cells (Hill and Austin 1996, Purdie 2003). A recent study found significantly elevated 
blood oestrone levels in post-menopausal women who consumed >25 g/d, compared to non-drinkers 
(Rinaldi et al 2006). 
Although a marked increase in oestrone concentrations, and ultimately in endometrial cancer risk, 
may be plausible in women who consume more than moderate amounts of alcohol, there are some 
unexplored aspects of the possible effect of moderate alcohol consumption on endometrial cancer risk 
such as the possible interaction with use of exogenous estrogens, that need clarification (Bandera et al 
2003). Although many studies included in this review controlled for other known risk factors for 
endometrial cancer; weight, oral contraceptive use, cigarette smoking history and to a lesser degree 
hormone replacement therapy (HRT), residual confounding or an effect modification of these other 
risk factors cannot be ruled out. Even if alcohol is unrelated or weakly inversely related to 
endometrial cancer in all groups combined, it may be associated with increased risk in selected 
subgroups, such as women using HRT or those with low intake of folate. 
Due to the small number of studies in this review, small sample sizes and inconsistent findings, the 
association of alcohol intake on the risk of endometrial cancer remains unclear. More studies are 
required that can report on the association between moderate and heavy alcohol consumption. 
Possible effect modification by menopausal status, weight, HRT, oral contraceptive use, and smoking 
status needs further evaluation. Moreover, information should be collected on frequency, quantity, 
and duration of use of wine, beer, and spirits, to ensure a better estimate of total alcohol intake as well 




2.7 Gastric (stomach) cancer 
 
Gastric cancer: summary of evidence from previous reviews 
Earlier systematic reviews concluded that in view of the overall lack of excess risk for 
stomach cancer in cohort studies, the inconsistent results of the case-control studies, and the 
inadequate control for dietary and socioeconomic factors, there was little in the aggregate data 
to suggest a causal role for alcohol consumption in stomach cancer (IARC 1988b, 
WCRF/AICR 1997). A meta-analysis of two cohort and fourteen case control studies, 
published between 1996 and 2000 (Bagnardi et al 2001), reported a positive (and statistically 
significant) association with gastric cancer; (25 g/d: RR 1.07, 95% CI 1.04-1.10; 50 g/d: RR 
1.15, 95% CI 1.09-1.22; 100g/d: RR 1.32, 95% CI 1.18-1.49). Forman et al (2006), however, 
in a meta-analysis of five cohort and thirteen case control studies (published between 1980 
and 2000) reported no significant linear increase in risk of gastric cancer with amount drunk; 
the RR from the cohort studies was 0.99 (95% CI 0.97-1.02) per 10 g/day and the PRR from 
the case-control studies was 1.02 (95% CI 1.00-1.04) per 10 g/day. 
 
The literature search identified 21 studies, 10 cohort and 11 control studies, published between 1999 
and 2009, which examined the association between alcohol consumption and the risk of gastric 
cancer. Tables for each paper, describing the study aims, population, alcohol measurement methods 
and main results are provided in Appendix D.  
 
2.7.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Tables 2.7.1 (cohort studies) 
and Table 2.7.2 (case control studies). Two papers were based on established prospective cohort 
studies described in Box 2.1, Chapter 2.2; the Copenhagen City Heart Study (Barstad et al 2005) and 
the Swedish Mammography Cohort (Larsson et al 2006). The paper by Allen et al (2009) has been 
previously described in Chapter 2.3.1. 
The largest cohort study included in the present review of the association between alcohol 
consumption and gastric cancer identified approximately 3500 cases of gastric cancer (Sung et al 
2000). A further two cohort studies, identified approximately 800-1000 cases (Tran et al 2005, Allen 



































Freedman 2007 USA 375/474,231 
>50 
(Mdn=62.5) 
members of American 






















293/19,364 40-59 general population n/s 
Sjödahl 2006 Norway 251/69,751 >20 regional population volunteers 
Sung 2007 Korea 3,452/666,182 M=44 
govt. employees, 





Tran 2005 China 1,152/28,432 
40-69 
(M=52) 
regional population volunteers 
 
Of the larger case control studies, Lindblad et al (2005) conducted a case-control study nested in the 
General Practitioner Research Database (GPRD) which contains more than 35 million patient-years of 
British primary care data and contains prospectively recorded information routinely recorded by GPs 
during their standard medical care; cases were all patients on the database with a diagnosis code 
indicating gastric cancer and controls, free of cancer, were randomly selected from the same database. 
Wu et al (2001) used a US state cancer registry to select cases and controls were randomly sampled 
from the local population by use of a systematic algorithm based on the address on the case patient 
and Kikuchi et al (2002) selected cases from one of nine hospitals in the Tokyo Metropolitan Area 
and controls were recruited from several health check programs in a hospital in the same area. The 








































Kikuchi 2002 Japan, 718/883 20-69 1 hospital in Tokyo  
consecutive/ non-
random selection 


















Rao 2002 India 170/2,184 30-75 city cancer hospital n/s 
Suw’gruang 2008 Thailand 101/202 M=53 
hospitals in two 
regions 
consecutive/ n/s 
Wu 2001 USA 770/1,356 30-74 




Ye 1999 Sweden 292/485 40-79 general population 
consecutive/ 
random sample 
Zaridze 2000 Russia 448/610 20-74 
two main cancer-





2.7.2 Study quality 
The quality scores assessed according to the NOS are presented in Table 2.7.3. Overall, cohort studies 
were of a moderate to high quality, scoring over seven stars. The quality of case control studies 
ranged from those of low quality (Suwanrungruang et al 2008) to those of high quality with eight out 
of nine stars (Lagergren et al 2000, Zaridze et al 2000). 
On the basis of sample selection, cohort studies scored highly with either three or four stars out of 
four. Of the three studies that scored three stars, they either failed on not showing that the outcome of 
interest was absent at baseline (Barstad et al 2005) or their study population was a selected from a 
sub-group of the general population (Huang et al 2000, Sung et al 2007). For outcome assessment, 
most studies scored either two or three stars. Of those that only scored one or two stars, Sjödahl et al 
(2006) and Freedman et al (2007) provided no details of any loss to follow-up in their cohort. Tran et 












Table 2.7.3 Gastric cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Alllen 2009 4 2 3 9 
Barstad 2005 3 2 3 8 
Freedman 2008 4 2 1 7 
Huang 2000 3 1 3 7 
Kasum 2002 4 1 3 8 
Larsson 2006 4 2 3 9 
Sasazuki 2002 4 2 3 9 
Sjödahl 2006 4 2 2 8 
Sung 2007 3 2 3 8 
Tran et al 2005 4 1 2 7 
Case Control     
Benedetti 2009 3 2 1 6 
Chow 1999 2 2 2 6 
Kikuchi 2002 2 2 2 6 
Lagergren 2000 3 2 3 8 
Lindblad 2005 3 2 2 7 
Munoz 2001 3 2 1 6 
Rao 2002 3 1 2 6 
Suwanrungruang 2008 2 1 1 4 
Wu 2001 3 2 2 7 
Ye 1999 3 2 2 7 
Zaridze 2000 3 2 3 8 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for selection, two 
stars for comparability and three stars for assessment: 
1 
Outcome for cohort, exposure for case-control studies 
 
Case control studies scored between two and three stars for sample selection. Of those that scored 
two, most failed because they used controls from a hospital setting and failed to demonstrate that 
gastric cancer was absent from their control group at recruitment. Of those studies who excluded 
those with a previous history of cancer cases from their control group, only Rao et al (2002) excluded 
patient controls admitted to hospital for alcohol or tobacco related diseases. For exposure assessment, 
the majority of case control studies scored either two or three stars. Of those that only scored two, 
most were not awarded the third because they did specify how they addressed possible interviewer 
bias or failed to provide details of response rates among cases and controls. In addition, the paper by 
Lindblad et al (2005) also failed because alcohol consumption data was based on information from 
medical records for which information on drinking levels was incomplete for 60% of cases and 40% 
of controls. 
There was considerable variety across studies when controlling for the main risk factors for gastric 
cancer i.e., helicobacter pylori (H pylori) infection, diet and smoking. Four studies did not collect any 
information on the afore-mentioned risk factors and results were adjusted for age only (Huang et al 
2000, Rao et al 2002, Tran et al 2005, Suwanrungruang et al 2008). Smoking terms, including 
cigarettes smoked per day, pack years of smoking and smoking status (current vs. never), were 
included in the models of the remaining studies and each study was awarded a star on the grounds that 
smoking is considered a moderate risk factor for gastric cancer. Measures of diet were controlled for 
in five studies; whole and refined grains intake and orange and yellow vegetables (Kasum et al 2002), 
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fruit, green or yellow vegetables, salted cod roe or fish (Sasazuki et al 2002) and for intake of fresh 
fruit and vegetables only (Lagergren et al 2000, Larsson et al 2006, Freedman et al 2008). Only two 
studies controlled for H pylori infection status (Ye et al 1999, Kikuchi et al 2002). Eight studies also 
controlled for varying measures of socio-economic status (SES). In two studies, SES was not defined 
(Munoz et al 2001, Kikuchi et al 2002). Ye et al (1999) used lifetime occupational experience as their 
measure of SES. The remaining studies controlled for education; levels/type of education (Freedman 
et al 2008), years of education (Larsson 2006 et al, Sjödahl et al 2007) or an undefined term of 
‘education’ (Chow et al 1999, Lagergren et al 2000). 
 
2.7.3 Results: total alcohol intake and risk of gastric cancer12 
Fourteen studies reported on the association between total alcohol consumption and gastric cancer. 
OF these, five studies reported on the association between gastric  cancer and ‘recent’ alcohol 
consumption; defined as intake in the previous year (Munoz et al 2001, Barstad et al 2005, Larsson et 
al 2007, Sung et al 2007), or alcohol intake in the previous two years (Chow et al 1999). Two studies 
reported on the association between gastric cancer with lifetime alcohol intake; Benedetti et al 2009 
defined lifetime intake as any period when alcohol was drunk at least once a week or nearly every day 
and Kikuchi et al (2002) and (Suwanrungruang et al 2008) did not specify a measure for their 
‘lifetime’ drinkers. The remaining six studies did not specify a reference period (Huang et al 2000, 
Kasum et al 2002, Sasazuki et al 2002, Lindblad et al 2005 Rao et al 2002, Allen et al 2009). A 
summary of gastric cancer risk estimates, comparing the highest versus the lowest alcohol exposure 
category, is presented in Figure 2.7.1. Two studies reported only on the association between drinking 
status and gastric cancer and are not included in Figure 2.7.1; Rao et al (2002) found no association 
(OR 0.8, 95% CI 0.4-1.3, p value =0.2) between ‘alcohol’ drinkers and gastric cancer compared to 
non-drinkers and Suwanrungruang et al (2008) reported a statistically non-significant increase risk 





                                                          
12
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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Figure 2.7.1 Alcohol consumption and gastric cancer, highest versus lowest exposure (odds 
















OR/RR, highest vs lowest exposure category
 
The majority of cohort studies were consistent in reporting a non-significant 20-40% increased risk of 
gastric cancer, at the highest alcohol exposure level (range 25-40 grams per day [g/d], Figure 2.9.1). 
Of the two largest cohort studies, Sung et al (2007) reported a small (20%) statistically significant 
increase of gastric cancer for Korean men drinking (≥25 g/d), compared to non-drinkers with strong 
evidence of a dose response relationship (ptrend 0.0001). Allen et al (2009), however, did not find any 
association between alcohol consumption and gastric cancer in women, at any level of drinking, 
compared to women drinking <2 drinks per week [d/w]. In contrast, non-drinkers in this study did 
have a statistically significant increased risk (RR 1.27, 95% CI 1.12-1.44) of gastric cancer. Evidence 
of a dose response relationship in this study was very weak (p value for trend =0.2). Although women 
in a Swedish cohort drinking >40 grams per week (g/w), compared to non-drinkers, had a small and 
non-significant increased risk of gastric cancer, there was little evidence (p value for trend =0.14) of a 
dose response relationship (Larsson et al 2006). Similar findings were reported by Sasazuki et al 
(2002) in a cohort of Japanese men drinking >325 g/w (p value for trend =0.66). Kasum et al (2002) 
also reported an increased risk of gastric cancer for women drinking >2 drinks per day [d/d], 
compared to non-drinkers. Although confidence intervals were not provided in the paper, there were 
only eight women in the highest alcohol exposure category  
In line with the findings of the cohort studies, four of the seven case control studies also reported a 
20-40%, non-significant, increased risk of gastric cancer at the highest alcohol exposure category; two 
studies for consumption in the previous year (Chow et al 1999, Suwanrungruang et al 2008) and two 
for measures of ’lifetime’ drinking (Kikuchi et al 2001, Benedetti et al 2009), compared to a range of 
reference groups. No formal tests for the significance of the dose response trend were undertaken in 
these studies. Drinking ≥34 units per week [u/w] in the previous two years, compared to up to 2 units 
per day, was associated with a non-significant decreased risk of gastric cancer in a UK nested case 
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control study (Lindblad et al 2005). The study by Lindblad et al was also characterised by a large 
number of drinkers (50%) in their study population whose consumption details were unknown. 
Analysis of gastric cancer risk in this group of drinkers found no evidence of an association with 
gastric cancer (>34 u/w; OR 0.99, 95% CI 0.80-1.24). 
 
2.7 3.1 Results: total alcohol intake and risk of gastric cancer by tumour 
site 
Nine studies specified the risk of gastric cancer from alcohol consumption by tumour site (gastric 
cardia and gastric non-cardia). Two studies reported on the association between drinking status and 
gastric cancer by tumour site. In a Chinese prospective cohort study a small decreased risk of both 
cardia (RR 0.84, 95% CI 0.72-0.97) and non cardia (RR 0.79, 95% CI 0.61-1.02) gastric cancer was 
reported for those reporting any drinking in the last 12 months, compared to those not drinking in last 
12 months (Tran et al 2005). Zaridze et al (2000), in a hospital based case control study, reported a 
non-significant two-three fold increased risk of gastric cardia and non-cardia cancer for men who had 
drank alcohol in their lifetime compared to abstainers. There was no association in this study for 
either tumour site in female drinkers. The remaining studies investigated the dose response 
association between alcohol consumption and gastric cancer tumour site. A summary of risk 
estimates, comparing the highest versus the lowest alcohol exposure category, is presented in Figure 
2.7.2. 
In a large prospective cohort study, Sung et al (2007) reported a 30% increased risk in both tumour 
sites for men drinking >25 g/d, compared to non-drinkers, though this was only statistically 
significant for non cardia gastric tumours. There was no association at lower levels of drinking. There 
was strong evidence of a statistically significant dose response trend (p value for trend =0.0002) 
between alcohol consumption and non-cardia tumours, but not for cardia tumours (p value for trend 
=0.5914). In a further two prospective cohort studies, Sasazuki et al (2002) and Freedman et al (2008) 
observed a statistically non-significant three fold (p value for trend =0.66) and thirty per cent (p value 
for trend =0.12) increased risk of gastric cardia tumours respectively, in those drinking approximately 
>3 d/d, compared to non-drinkers (Freedman et al) and those drinking 0-3 times per month (Sasazuki 
et al). Freedman et al (2008) also observed a 40% decreased risk of non-cardia tumours in those 
drinking >3 d/d. Although drinking at lower levels was associated with a positive association with this 
tumour type, there was no evidence of a dose response relationship (p value for trend =0.15). No 





Figure 2.7.2 Alcohol consumption and gastric cancer, highest versus lowest exposure category; by 
tumour site: (odds ratio/relative risk and 95% confidence intervals) 
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Of the case control studies, Wu et al (2001) observed a non-significant 35% increased risk in both 
tumour sites for those drinking >36 d/w, but not at lower levels of consumption and no evidence of a 
dose response association (cardia; p value for trend =0.42; non-cardia; p value for trend =0.29). In a 
nested case control study, alcohol consumption of up to >34 u/w was not associated with gastric 
cardia cancer, but did significantly reduce the risk of non-cardia gastric cancer (Lindblad et al 2005). 
In the remaining case control studies, Ye et al (1999) and Lagergren et al (2000) did not find any 
association between an increased risk of gastric cardia and non-cardia tumours, and lifetime alcohol 
consumption.  
 
2.7.4 Results: drinking dimensions and risk of gastric cancer 
One study reported on the association between drinking frequency and gastric cancer. Sjödahl et al 
(2007) observed positive associations between all measures of drinking frequency in those drinking in 
the 14 days prior to baseline (drinking occasionally: HR 1.24, 95% CI 0.80-1.91; 1-4 times a week: 
HR 1.30 95% CI 0.78-2.16; or ≥ 5 times a week: HR 1.49, 95% CI 0.78-2.83) and gastric cancer, 




2.7.5 Results: drink type and risk of gastric cancer  
Three prospective cohort and four case control studies, investigated the association between alcohol 
drink type and gastric cancer. A summary of risk estimates, comparing the highest versus the lowest 
alcohol exposure category, is presented in Figure 2.7.3. Overall, wine intake was associated with a 
decreased risk of gastric cancer in the majority of studies. The evidence of a positive association 
between gastric cancer and beer and spirit drinking was more mixed. 
Wine 
In a Danish prospective cohort study, the risk, adjusted for age and smoking only, of gastric cancer, 
decreased with increasing wine intake (>13 glasses per week; RR 0.16, 95% CI 0.02-1.18, p value for 
trend =0.02) with trend analysis showing a statistically significant 40% decreased risk of gastric 
cancer for each glass of wine per day compared to non-wine drinkers (Barstad et al 2005). All three 
case control studies also reported an inverse association between wine drinking in the highest alcohol 
exposure category and gastric cancer. In studies by Ye et al (1999) and Wu et al (2001), wine drinking 
was inversely and dose-dependently associated with risk for cardia cancer (p value for trend =0.03 
and 0.05, respectively), and to a lesser extent for non-cardia gastric cancer (p value for trend =0.08 
and 0.04, respectively). 
Beer 
The majority of studies reported a positive association between beer intake and gastric cancer. Only 
two studies reported evidence of a possible dose response association. Medium and strong beer 
consumption, compared to non-drinkers was associated with a statistically significant two-fold 
increased risk (p value for trend =0.02) of gastric cardia cancer in Swedish women (Larsson et al 
2006). In the same study, women drinking ‘light’ beer were not at increased risk of gastric cardia 
cancer. In an American population based case control study, drinking >15 d/w (OR 1.67, 95% CI 
1.10-2.60, p value for trend =0.09) was associated with a statistically significant increased risk of 
gastric cardia cancer, but no association was found between beer drinking and non cardia gastric 
cancer. 
Spirits 
Four studies reported a positive association between spirit drinking and gastric cancer at the highest 
exposure category. Freedman et al (2008) reported that men drinking >3 ‘spirit’ drinks p/d, compared 
to those drinking between >0-1 ‘spirit’ drinks p/d had a statistically significantly two-fold increased 
risk of gastric cardia cancer with some weak evidence of a dose response trend (p value for trend 
=0.023). A similar increase in risk of cardia gastric cancer ,with amount drunk, was reported by 
Zaridze et al (2000) for men drinking >10.4 litres of vodka per year (OR 3.9, 95% CI 1.2-12.3, p 
value for trend =0.03), compared to non-drinkers. Wu et al (2001), on the other hand, found no 
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association between gastric cardia cancer and spirit drinking, but did observe a 30% decreased risk of 
non-cardia gastric cancer in the highest exposure category (>15 d/w, p value for trend =0.02). 
Figure 2.7.3 Alcohol consumption and risk of gastric cancer, highest versus lowest exposure 
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2.7.7 Effect modification 
The effect modification of other factors on the alcohol-gastric cancer association was reported in two 
cohort and one case control study. In a large Korean cohort study, Sung et al (2007) reported that 
smoking >20 cigarettes p/d combined with alcohol consumption of >25 g/d, was associated with a 
nearly five-fold increased risk of cardia gastric cancer (HR 4.5, 95% CI 1.7-11.9), and a two-fold 
increased risk of non cardia gastric cancer compared to nonusers. The interaction between smoking 
and alcohol drinking was not statistically significant for total gastric cancer (Pinteraction=0.48), cardia 
(Pinteraction=0.68) or non-cardia cancer (Pinteraction=0.89). Sjödahl et al (2008) reported similar findings in 
a Norwegian cohort study; smoking of >20 cigarettes p/d combined with drinking >5 ‘times’ within 
the past fourteen days was associated with a 4-fold increased risk of gastric cancer compared to 
nonusers. The interaction between tobacco smoking and alcohol drinking was not statistically 
significant regarding total gastric cancer (Pinteraction=0.32), non-cardia gastric cancer (Pinteraction=0.44) or 
cardia cancer (Pinteraction=0.89). In a hospital based case control study, Zaridze et al (2000) reported no 
significant interaction (Pinteraction=0.51) between helicobacter pylori status and vodka drinking. 
2.7.8 Summary and conclusions 
The present review identified 21 papers, published between 1999 and 2009, which examined the 
association between alcohol consumption and gastric cancer. Overall, the majority of cohort studies 
were consistent in reporting a non-significant 20-40% increased risk of gastric cancer, at the highest 
alcohol exposure level (range 25-40 g/d, approximately 2.5-3.5 ‘standard’ drinks). Drinking below 
this level was rarely associated with an increased risk of gastric cancer. Only one study (Sung et al 
2007) reported a statistically significant dose response relationship. A meta-analysis of two cohort and 
fourteen case control studies, published between 1996 and 2000 (Bagnardi et al 2001), reported 
pooled relative risks (PRR) for selected alcohol intake levels all of which showed a positive (and 
statistically significant) association with gastric cancer; (25 g/d: PRR 1.07, 95% CI 1.04-1.10; 50 g/d: 
PRR 1.15, 95% CI 1.09-1.22; 100g/d: PRR 1.32, 95% CI 1.18-1.49). Forman et al (2006), however, in 
a meta-analysis of five cohort and thirteen case control studies (published between 1980 and 2000) 
reported no significant linear increase in risk of gastric cancer with amount drunk; the PRR from the 
cohort studies was 0.99 (95% CI 0.97-1.02) per 10 g/day (P Het =0.7) and the PRR from the case-
control studies was 1.02 (95% CI 1.00-1.04) per 10 g/day (P Het =0.04).  
The lack of adjustment for H pylori status and diet in all the papers included in the present review 
(including the meta-analyses above) is a significant limitation. H pylori infection and diet are the main 
known causative agents of gastric cancer and are potential confounders of the association between 
alcohol and gastric cancer (WCRF/AICR 2007). Some studies have suggested that moderate and 
lifetime drinkers have a lower risk of H pylori infection than people who do not drink alcohol, though 
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the evidence remains inconclusive (Daroch et al 2001, Zhang et al 2010). A diet high in salt, 
carbohydrate and foods rich in nitrate or nitrite and their derivatives has been associated with an 
increase in risk. Conversely, a decrease in risk with higher intake of fresh fruits and vegetables has 
been consistently observed in epidemiological studies of gastric cancer (WCRF/AICR 2007). Studies 
examining diet quality of individuals who drink any kind of alcoholic beverage, have found that 
people who drink the largest quantities of alcohol, even infrequently, have the poorest quality diets. 
Conversely, people who drink the least amount of alcohol, regardless of drinking frequency, have the 
best quality diets (Cerhan et al 2004, Grosbeak et al 2004, Breslow et al 2006). It is, therefore, likely 
that confounding from H pylori status and diet will account for the positive associations between 
alcohol consumption and gastric cancer reported in the present review. 
The evidence of an association between tumour sites (cardia and non-cardia) and alcohol consumption 
was inconsistent. Risk estimates for cardia and non-cardia gastric cancer tumours generally followed 
those reported for the association between total gastric cancer and alcohol consumption in each study 
reporting on this aspect. Small numbers in each stratum for most studies and the strong possibility of 
misclassification of these tumour sites (Sasazuki et al 2002) prevent any firm conclusions being 
drawn concerning these tumour sites and their association with alcohol consumption. 
Evidence from the present review was consistent in reporting an inverse association between wine 
drinking and gastric cancer. Three of the six studies reporting on this aspect, observed a statistically 
significant dose response relationship. In two of these studies, both took into account the strong 
inverse social class gradient for gastric cancer by controlling for SES. In contrast, results were 
inconsistent for beer and spirit drinking and positive association observed for these drink types tended 
to reflect the association with gastric cancer observed for all alcohol consumption in each individual 
study. In addition, reverse causality is often a problem in observational studies; the level of alcohol 
exposure may diminish as an individual ages or becomes ill, which can lead to an underestimation of 
the disease risk (Lewis and Smith 2005). Only the case control studies in the present review reported 
an inverse association between wine and gastric cancer and alcohol consumption was assessed 
relatively close to the cancer diagnosis and cases may have altered their alcohol intake or their report 
of it (Freedman et al 2011). The possible protective effect of wine observed in the present review, is 
also not consistent with the findings of earlier reviews (Barstad et al 2005, Forman et al 2006). These 
reviews concluded that the evidence from cohort studies (n=2) did not support an association between 
type of alcohol beverage and gastric cancer whilst the evidence from case control studies (n=7) was 
mixed and inconsistent. There are, also some plausible biological mechanisms whereby wine may 
hypothetically prevent gastric cancer; studies have shown anti-carcinogenic properties of resveratrol 
and several other factors present in wine, but not in beer and spirits (Jang et al 1997, Sgambato et al 
2001, Soleas et al 2002); and growth of H pylori infection has been suggested by some to be inhibited 
by wine intake (Murray et al 2002, Gao et al 2010). The absence of any adjustment or measure of 
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effect modification for H pylori infection, in papers included in the present review is, therefore, a 
major limitation in assessing a possible inverse association between wine and gastric cancer.  
In conclusion, the positive associations between total alcohol consumption and gastric cancer and the 
protective effect of wine observed in the present review are likely to be explained by confounding 
from H pylori and diet. Further large prospective cohort studies which control for the effects of diet 





2.8 Kidney cancer  
Kidney cancer: summary of evidence from previous reviews 
Overall, studies on cancers of the kidney show no association with alcohol consumption 
(IARC 1988b, WCRF/AICR). Bagnardi et al (2001) in a meta-analysis of two case control 
studies  observed an inverse association between alcohol consumption and kidney cancer 
(25g/d; RR 0.88, 95% CI 0.77-1.02 and 100 g/d; RR 0.62, 95% CI 0.36-1.06). 
 
This literature review identified ten papers, published between 1999 and 2009, which examined the 
association between alcohol consumption and risk of kidney (renal cell) cancer. There were five 
cohort and five case control studies available for appraisal. Tables for each paper, describing the study 
aims, population, alcohol measurement methods and main results are provided in Appendix D. 
 
2.8.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.8.1 below. Two papers 
were based on established prospective cohort studies described in Box 2 Chapter 2.2; the Health 
Professionals Follow-up Study and Nurses Health Study (Lee et al 2006) and the Swedish 
Mammography Cohort (Rashidkhani et al 2005). The paper by Allen et al (2009) has been previously 
described in Chapter 2.3.1. In the paper by Mahabir et al (2005), the study population consisted of a 
sample of male smokers living in south-western Finland, who had been recruited to a randomised 
control trial  
 
Of the five case control studies, three were population based and two hospital based. In an American 
population case control study, cases were selected from regional cancer registries and controls either 
randomly sampled from the states driver’s license records (Parker et al 2002) regional (Hu et al 2008) 
or national populations (Gerving et al 2007). An Italian case control study drew both cases and 
controls from a network of general hospitals and university clinics in the areas under surveillance 
(Pelucchi et al 2002). In the remaining study (Hsu et al 2007) no details were provided of case 
recruitment and controls were recruited from hospitals across four countries (Russia, Romania, Poland 








Table 2.8.1 Alcohol and kidney cancer: general characteristics of studies reviewed 
Authors  
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2.8.2 Study quality 
The quality scores, assessed according to the NOS, are presented in Table 2.8.2. Overall studies were 
of a moderate to high quality, scoring between 6-7 stars.  
Table 2.8.2 Kidney cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Allen 2009 4 2 3 9 
Lee 2006 3 2 3 8 
Mahabir 2005 3 2 2 7 
Nicodemus 2004 4 1 3 8 
Rashidkhani 2005 4 2 3 9 
Case Control     
Greving 2007 4 2 2 8 
Hsu 2007 2 2 2 6 
Hu 2008 3 2 1 6 
Parker 2002 4 2 3 9 
Pelucchi 2008 3 2 1 6 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment; 
1 
Outcome for cohort, exposure for case-
control studies 
 
On the basis of sample selection, cohort and cases control studies scored highly with either three or 
four stars out of four. A number of studies failed in this item because of the potential selection bias 
introduced by their choice of study populations i.e. groups of nurses and health professionals (Lee et 
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al 2006), hospital controls (Hsu et al 2007, Pelucchi et al 2008) and ‘current’ smokers (Mahabir et al 
2005). Greving et al (2008) failed to specify if controls had been excluded for a prior history of 
kidney cancer. In addition, two case control studies attempted to minimize further selection bias 
amongst controls by excluding patients with chronic conditions (particularly those associated with 
smoking and alcohol drinking), digestive tract diseases and alcohol-related traumas (Pelucchi et al 
2008, Hsu et al 2008).  
All the cohort studies scored maximum stars for outcome assessment. Exposure assessment in the 
case control studies, however, varied in quality. Interviewer bias could not be ruled out in three 
studies since the blinding status of the interviewers was not specified (Hsu et al 2007, Hu et al 2008, 
Pelucchi et al 2008). Non-response bias may affect results in the studies by Greving et al (2008) and 
Hu et al (2008) due to differential response rates among cases and controls: approximately 65% 
response rate for cases and controls. Response rates were not provided in one study (Pelucchi et al 
2008). 
Established risk factors for kidney cancer and possible confounders of the alcohol and kidney cancer 
association e.g. age and smoking, were generally well controlled for across all studies. Smoking 
terms, including cigarettes smoked per day, pack years of smoking and smoking status, were included 
in the models of eight of the nine studies. Rashidkhani et al (2005), however, only controlled for 
smoking in a sub-cohort analyses involving 41 cases, the results of which were not reported in their 
paper. Obesity, measured by body mass index (BMI ≥30 kg/m
2
, was not controlled for in one study 
(Nicodemus et al 2003). A further four studies also controlled for a history of hypertension (Mahabir 
et al 2005, Rashidkhani et al 2005, Lee et al 2006, Hsu et al 2007). 
 
2.8.3 Results: total alcohol intake and kidney cancer13 
Seven studies reported on the association between kidney cancer and ‘recent’ alcohol intake defined 
as alcohol consumption in the preceding year in four studies (Nicodemus et al 2003 Mahabir et al 
2005, Lee et al 2006, Pelucchi et al 2008), consumption in the previous two years (Hu et al2008), or 
five years (Greving et al 2007) and during the last 6 months (Rashidkhani et al 2005). Two studies 
reported on the association between kidney cancer with lifetime alcohol intake defined as drinking 
over all adult years (Parker et al 2002) and usual weekly consumption during different periods of 
adult life (i.e., ages ≤25, 26–40, 41–50, 51-60, and >60 years) (Hsu et al 2007). Allen et al (2009) did 
not specify a reference period. A summary of kidney cancer risk estimates, comparing the highest 
alcohol versus the lowest alcohol exposure category, is presented in Figure 2.8.1. Cohort and case 
control studies were consistent in reporting an inverse association between kidney cancer at the 
highest alcohol exposure category (range >3 grams to >20 grams per day [g/d]). 
                                                          
13
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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Figure 2.8.1 Alcohol consumption and kidney cancer, highest versus lowest exposure category, by 
















OR/RR, highest vs lowest exposure category
 
In the largest cohort study, Allen et al (2009) reported a statistically significant 30% decreased risk of 
kidney cancer in women drinking >15 drinks per week [d/w] compared to women drinking <2 d/w. 
All other intake categories were inversely associated with kidney cancer and there was some evidence 
of a dose response relationship (p value for trend=0.03). In the same study, non-drinkers had a small 
increased risk, of borderline statistical significance, in gastric cancer (RR 1.12, 95% CI 1.00-1.26). 
Lee et al (2006) observed a weak, statistically significant, protective effect against kidney cancer, in a 
cohort of American health professionals, for those drinking >15 g/d, compared to non-drinkers with 
weak evidence of a dose response relationship (p value for trend=0.07). In a Finnish study, male 
smokers drinking a median of 39 g/d, compared to men drinking <2.5 g/d (including never and ex-
drinkers) had a statistically significant reduced risk of kidney cancer (RR 0.53, 95% CI 0.34-0.83). 
Lower levels of drinking were also inversely associated with kidney cancer and there was statistically 
significant dose response relationship (Mahabir et al 2005). In the two remaining cohort studies, very 
low levels of drinking in women (3 to 4 g/d) were also inversely associated with kidney cancer, 
compared to those drinking <2.5 g/d (Rashidkhani et al 2005) and non-weekly drinkers (Nicodemus et 
al 2004). 
 In an American population based case control study (Parker et al 2002), women drinking at any level 
had a reduced risk of kidney cancer (>35 grams per week [g/w], OR 0.4, 95% CI 0.2-0.9, p value for 
trend=0.04), compared with never drinkers. The study did not support an inverse association between 
men drinking at similar levels and risk of kidney cancer. In a Canadian population based case control 
study (Hu et al 2008), men and women drinking at any level, had a reduced risk (p value for trend= 
0.04 and 0.008, respectively) of kidney cancer, compared to non-drinkers. Pelucchi et al (2008), in 
their Italian hospital based case control study, reported a significant dose response relationship (p 
value for trend =0.01) with consumption of >4 drinks per day [d/d] associated with a statistically 
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significant protective effect. Greving et al (2007) also observed a dose response relationship (p value 
for trend =0.03), but this protective effect was only statistically significant at the highest alcohol 
intake level (>620 grams per month) compared to non-users of alcohol.  
2.8.4 Results: drinking dimensions and risk of kidney cancer 
One paper, Pelucchi et al (2008), considered other aspects of drinking behaviour and risk of kidney 
cancer. There was no trend in risk of kidney cancer with duration of drinking (>45 yrs; OR 0.97, 95% 
CI 0.76-1.24, p value for trend=0.94) compared to non-drinkers and age at which participants started 
drinking alcohol (≥23 years of age, OR 1.02, 95% CI 0.75-1.39, p value for trend=0.81) compared to 
those aged ≤16 years. 
2.8.5 Results: drink type and risk of kidney cancer 
Three cohort studies and four case control studies reported on the association between drink type and 
kidney cancer. A summary of risk estimates, comparing the highest exposure versus the lowest 
alcohol exposure category, are presented in Figure 2.8.2. Overall results by drink individual type in 















Figure 2.8.2 Alcohol consumption and risk of renal cell cancer, highest versus lowest exposure 
category; by drink type (relative risk/odds ratio and 95% confidence intervals) 
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OR/RR, highest vs lowest exposure category
 
2.8.6 Results: effect modification 
The effect modification of other factors on the alcohol-kidney cancer association was reported in two 
cohort studies and two case control studies. Lee et al (2006) reported that the association between 
total alcohol consumption and kidney cancer were not modified by body mass index [BMI] 
(Pinteraction=0.71), a history of hypertension (Pinteraction=0.42) or smoking status (current vs. never, 
Pinteraction=0.63). In the study by Mahabir et al (2005), no evidence was found for any significant 
interactions between total alcohol intake, in male smokers, within strata defined by age 
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(Pinteraction=0.73), BMI (Pinteraction=0.30) or cigarettes smoked per day (Pinteraction=0.14) and kidney 
cancer.  
In the two case control studies, Pelucchi et al (2008) found no significant heterogeneity for total 
alcohol consumption across strata of age (Pinteraction= 0.92), BMI (Pinteraction=0.40) and smoking 
(Pinteraction=0.51). Hu et al (2008) reported a significant inverse association between total alcohol intake 
and kidney cancer in men and women among never smokers (OR 0.6, 95% CI 0.4-0.9) for the group 
with the highest alcohol intake (>22.9 g/d), compared to non-drinkers. The inverse association also 
appeared in never smokers, but the difference was not statistically different (OR 0.6, 95% CI 0.3-1.2). 
Hu et al. also reported inverse associations with kidney cancer related to total alcohol consumption in 
men and women with who had a BMI >25 or <25 kg/m
2
.  
2.8.7 Summary and conclusions 
This review identified five prospective cohort and five case control studies, published between 1999 
and 2009, which examined the association between alcohol consumption and risk of kidney cancer. 
Study quality was generally of a moderate to high level and smoking and obesity, possible 
confounders of the association between alcohol and kidney cancer were controlled for in all studies. 
Overall, the evidence presented suggests a weak protective effect of moderate alcohol consumption 
(approximately 12-24 g/d), irrespective of drink type, for both men and women, against the 
development of kidney cancer. Evidence of an inverse association between alcohol consumption and 
kidney cancer is consistent with the findings of previous, meta and pooled-analyses and international 
reviews. Bagnardi et al (2001) in a meta-analysis of two case control studies (n=921 cases) observed 
an inverse association between alcohol consumption and kidney cancer (25g/d; pooled RR (PRR) 
0.88, 95% CI 0.77-1.02 and 100 g/d; PRR 0.62, 95% CI 0.36-1.06). In a recent pooled analysis of 
twelve prospective studies (including four cohort studies identified in this review and data from four 
previously unpublished studies) on alcohol intake and kidney cancer, drinking ≥15 g/d reduced the 
risk of kidney cancer by approximately thirty per cent (PRR 0.72, 95% CI 0.60-0.86, p value for trend 
<0.01, P heterogeneity among studies =0.99) (Lee et al 2007b). The WCRF/AICR (2007) systematic 
review also observed that many of the study’s estimates in their review were in the direction of a 
protective effect, but concluded that a substantial effect of alcohol on kidney cancer was still 
unproven since the biological mechanisms whereby alcohol would mediate a protective effect against 
kidney cancer were unknown (WCRF/AICR 2007). 
 
Residual confounding from smoking and obesity could explain the inverse associations observed 
between alcohol consumption and kidney cancer. Lee et al (2007b) in their pooled analysis of twelve 
cohort studies, however, did not find any evidence that weight and smoking status modified the 
association between alcohol consumption and kidney cancer. Smoking was the strongest confounder 
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for the association between alcohol intake and kidney cancer among the potential risk factors (weight, 
history of hypertension, folate intake, oral contraceptive use) controlled for in the pooled analysis and 
adjustment for smoking strengthened the inverse association reported in the paper. With more 
thorough control for smoking, the true inverse relationship may, therefore, have been stronger. There 
was no evidence of a statistically significant interaction, in the present review, between alcohol 
consumption and obesity, and alcohol consumption and smoking. However, small numbers in each 
stratum in all the studies reporting on the interaction between alcohol and smoking, and obesity mean 
that a modifying effect of either smoking or obesity on the alcohol-kidney cancer association still 
cannot be completely ruled out.  
Bias as a result of measurement error, from under-reporting of alcohol consumption especially among 
heavy drinkers, may account for the inverse associations observed in the present review. All studies 
used food frequency questionnaires to collect information on alcohol consumption and this method, 
compared to other approaches, has been shown to underestimate true levels of alcohol consumption 
(Feunekes et al 1999, McCann et al 1999). Whether levels of under-reporting of alcohol consumption 
are of a sufficient amount to account for the inverse associations between alcohol and kidney cancer 
has yet to be demonstrated.  
In summary the findings of this review are suggestive of a possible inverse association between 
alcohol consumption and kidney cancer for both men and women. There is little evidence, however, 
of biological mechanisms that would mediate a protective effect of alcohol against RCC. Alcohol 
consumption has been associated with decreased risk of type 2 diabetes mellitus possibly through a 
mechanism involving decreased insulin resistance and diabetes mellitus is positively related to RCC 
(Rashidkhani et al 2005). It is also possible that alcohol consumption, which can contribute to lower 
blood pressure levels when drunk moderately, might prevent or limit renal fibrosis and chronic renal 
failure via improved vascular function (Mahabir et al 2005). Furthermore, based on alcohol 
metabolism and the production of reactive oxygen species, alcohol would be expected to increase the 
risk of RCC. Alcohol may also interfere with folate absorption, transport, and metabolism, potentially 
limiting folate stores in tissues. This could contribute to RCC via abnormal DNA methylation 
(Mahabir et al 2005).However, the small number of studies, heterogeneous study populations, the 
small number of kidney cancer cases identified in each study and possible under-reporting of alcohol 
consumption prevent any definitive conclusions being drawn about the relationship between alcohol 
consumption and kidney cancer. There is, therefore, a need for additional studies to solidify alcohol’s 
role as a consistent and believable protective factor in the development of kidney cancer and which 
include a sufficient range of drinkers to investigate an association between heavy alcohol 
consumption and risk of kidney cancer.   
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2.9 Laryngeal Cancer  
Laryngeal cancer: summary of evidence from previous reviews 
Epidemiological studies clearly indicate that alcohol consumption is causally related to 
laryngeal cancer. There is no indication that the effect is dependent on type of beverage 
(Lowenfels 1975, IARC1988B, WCRF/AICR). 
 
The literature search identified 13 papers from 10 studies, published between 1 January 1999 and 30 
September 2009, which examined the association between alcohol consumption and laryngeal cancer. 
Four papers were based on one hospital case control study carried out in Italy and Switzerland. All 
four have been included in this review since they looked at different aspects of the association 
between alcohol intake and risk of laryngeal cancer; from total alcohol intake (Garavello et al 2006); 
in women (Gallus et al 2003); in a population of non-smokers (Bosetti et al 2002); and on the joint 
effect of alcohol and smoking on risk of laryngeal cancer Talamini et al (2002). Tables for each paper, 
describing the study aims, population, alcohol measurement methods and main results are provided in 
Appendix D. 
2.9.1 Study characteristics. 
A summary of the general characteristics of the papers are provided in Table 2.9.1 below.  
In the only cohort study identified in the present review, Allen et al (2009) recruited their study 
population from women attending breast screening clinics in the United Kingdom (see section 2.3.1 
for further details of this study) identifying 138 cases of laryngeal cancer over a mean follow up 
period of 7.2 years. Of the nine case-control studies that examined the association between laryngeal 
cancer and alcohol consumption, eight studies were hospital based. In these studies, cases were 
selected from hospitals study area and non-random samples of controls were recruited from the same 
network of hospitals as the cases. In the remaining study, Ramroth et al (2004) recruited cases from 
treatment clinics and controls from a random sample of the local population from population registries 
registry Study size varied considerably from 51 cases (Pacella-Norman et al 2002, Gallus et al 2003) 









Table 2.9.1 Alcohol and laryngeal cancer: general characteristics of studies reviewed 

















Case control studies 







De Stefani 2004 
Uruguay 
(men) 









See Bosetti 2002 
Garavello 2006 Italy/Switz. 672/3,454 
30-80 
(M=61/58) 
See Bosetti 2002 










51/2,900 18-74 two city hospitals consecutive/ n/s 





Sapkota 2007 India 511/718 >18 hospital 
consecutive// non-
random selection 




Talamini 2002 Italy/Switz. 527/1,297 
30-79 
(Mdn=61) 
See Bosetti 2002 
Zvrko 2008 Montenegro 108/108 38-85 (60) hospital 
all/ non-random 
selection 
*Romania, Hungary, Poland, Russia, Slovakia. Abb: n/s not specified; M=mean; Mdn= median  
 
2.9.2 Study quality 
The quality scores assessed according to the NOS are presented in Table 2.9.2. Overall, studies on 
laryngeal cancer were of moderate to high quality scoring 7-8 stars out of a possible nine stars. 
Table 2.9.2 Laryngeal cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of 3) 
Total 
Allen 2009 4 2 3 9 
Bosetti 2002, Talamini 




3 2 2 
 
7 
De Stefani 2004 3  2 3 8 
Hashibe 2007 2  2 1  5 
Menvielle 2004  2  2 3 7 
Pacella 2002 3  2 2  7 
Ramroth 2004 3  2 1  6 
Sapkota 2007 3  2 1  6 
Schlecht 2001 3  2 3 8 
Zvrko 2008 3  2 2 7 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment 
1 
Outcome for cohort, exposure for case-
control studies 
2 




All case control studies tried to minimize selection bias by frequency matching cases and controls on 
age, residence and gender. In addition to excluding people admitted to hospital with neoplastic 
conditions from their control group, two studies further sought to minimize selection bias by selecting 
controls admitted to hospital for diseases not related to smoking and alcohol use (Bosetti et al 2002 
etc, De Stefani et al 2004). Schlecht et al (2001) excluded people with mental disorders (including 
alcoholism) though included people who were admitted for digestive system diseases without 
specifying if those with alcoholic liver disease were excluded. Menvielle et al (2004) and Pacella-
Norman et al (2002) chose cancer patients as their control group though patients with alcohol related 
cancers (defined as bladder, liver or pancreas cancer) were excluded since these neoplasms were 
considered to be associated with alcohol consumption. Ramroth et al (2004) did not specify any 
exclusion criteria for their control group. The majority of case control studies reported response rates 
for cases and controls exceeding 90%. In a population based case control study, there was a low-
response rate (38%) among controls (Ramroth et al 2004) and Menvielle et al (2004) reported 
response rate of 80% and 86% among cases and controls respectively. Studies performed poorly on 
exposure assessment with only one study stating that interviewers were blinded to case status 
(Schlecht et al 2001) Outcome measurement was clearly defined in all studies with the exception of 
Menvielle et al (2004) paper which did not specify how the outcome was defined and measured. 
All studies received maximum stars for comparability. Age and smoking were controlled for in all 
studies. Adjustment for smoking was detailed across all studies and included measures of amount 
smoked per day, duration and status of smoking. Adjustment for other known, and possible, 
confounders of the alcohol-laryngeal cancer association varied across studies. A number of measures 
were used as proxies for socio-economic status (SES). Allen et al (2009) used the Townsend index; a 
UK area based measure (including unemployment, overcrowding, owner-occupier status, and car 
ownership) of deprivation. Four studies used education as a measure of SES (Bosetti et al 2000 etc, 
Pacella-Norman et al 2002, Ramroth et al 2004, Hashibe et al 2007). Pacella-Norman et al (2002) 
further controlled for occupation status. Saptoka et al (2007) did not define their measure of SES. 
Only one study controlled for fruit and vegetable intake (Hashibe et al 2007).  
 
2.9.3 Results: total alcohol intake and risk of laryngeal cancer14 
Eight studies, providing ten papers, reported on the association between total alcohol consumption 
and laryngeal cancer. Of these, two studies providing four papers reported on the association between 
laryngeal cancer and ‘recent’ alcohol consumption; defined as intake in the previous year (Bosetti et 
al 2002, Gallus et al 2003, Garavello et al 2006, Hashibe et al 2007). Two studies reported on the 
association between larnygeal cancer with lifetime alcohol intake; Ramroth et al (2004) defined as 
                                                          
14
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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alcohol consumption 10 years before survey interview and De Stefani et al (2004) did not specify a 
measure for their ‘lifetime’ drinkers. The remaining four studies did not specify a reference period 
(Pacella-Norman et al 2002, Menvielle et al 2004, Zvrko et al 2008, Allen et al 2009). A summary of 
laryngeal cancer risk estimates, comparing the highest versus the lowest alcohol exposure category, is 
presented in Figure 2.9.1. In a case control study, not included in Figure 2.9.1, Zvrko et al (2008) 
reported that, based on multiple logistic regression analyses, drinking >2 drinks per day [d/d] was 
independently related to laryngeal cancer (OR 4.96, 95% CI 2.04-12.04, p-value =0.000), but drinking 
>4 d/d or drinking for >40 years was not. 
Figure 2.9.1 Alcohol consumption and laryngeal cancer, highest versus lowest exposure category, by 
study type (odds ratio/relative risk, 95% confidence intervals)  
0.1 1 10 100
Bosetti 2002 (non-smokers)
Pacella-Norman 2002 (men) 
Gallus 2003 (women) 







OR/RR, highest vs lowest exposure category
 
In a large UK prospective cohort study (Allen et al 2009), women drinking >15 drinks per week 
[d/w], compared to those drinking <2 d/w had a two-fold statistically significant increased risk of 
laryngeal cancer. Positive, but not statistically significant, associations were observed at all other 
alcohol intake levels and among non-drinkers, with no strong evidence of a statistically significant 
dose response relationship (p value for trend =0.08). Non-significant positive associations were also 
reported by Gallus et al (2003) for women drinking >5 d/d (p value for trend =0.062) compared to 
those drinking <3d/d. From the same study however, Garavello et al (2006), in mixed population of 
men and women, observed a statistically significant association at all alcohol intake levels with the 
highest intake category showing an approximate 500% increase in risk for >12 d/d, compared to those 
drinking <2 d/d, with a strong statistically significant dose response relationship (p value for trend 
<0.0001). 
 
Two further case control studies observed positive and statistically significant associations between 
alcohol consumption and laryngeal cancer across all alcohol intake levels, compared to those drinking 
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≤2 d/d (Ramroth et al 2004) and ‘occasional’ drinkers (Menvielle et al 2006). Both studies reported 
increases of between 300% and 500% at the highest alcohol exposure category (>150 grams per day 
[g/d] and >12 d/d, respectively). In the remaining study, Hashibe et al (2007a) reported moderately 
raised risks at all intake levels (maximum of >420 grams per week) in a multi-centre hospital based 
case control study, with weak evidence of a dose-response relationship (p value for trend =0.08). 
 
2.9.3.1 Results: total alcohol intake and risk of laryngeal cancer by tumour 
site 
Five case controls studies reported on the association between alcohol consumption and risk of 
laryngeal cancer by tumour site; the glottis (the central part of the larynx), the supra glottis (the area 
above the glottis), or more rarely in the sub glottis. Three of the five studies also reported on the 
association between alcohol consumption and, the very rare, hypopharyngeal cancer (the hypopharynx 
is the part of the throat that lies beside and behind the larynx). 
De Stefani et al (2004) observed a stronger effect of alcohol consumption on the odds of developing 
hypopharyngeal cancer compared to laryngeal cancer; compared to never drinkers, the odds ratio 
(OR) for hypopharyngeal cancer in those drinking 1-48 g/d was 2.3 (95% CI 0.7-8.1) and >192 g/d; 
12.8, (95% CI 4.0-41.2, p value for trend <0.0001). On the other hand, cancers of the larynx displayed 
less impressive effects; 1-48 g/d; OR 0.8 95% CI 0.4-1.5 and >192 g/d; OR 2.5, 95% CI 1.4-4.5, p 
value for trend <0.0001. Differences between sites were of statistical significance (p-value for 
heterogeneity=0.03). Di Stefani et al (2004) also noted that whereas the effect of alcohol drinking was 
much higher in patients with hypopharyngeal lesions, tobacco smoking displayed higher effect in 
laryngeal cancer. These differences by site were statistically significant (p-value for 
heterogeneity=0.04 for tobacco and 0.02 for alcohol drinking).  
In a French case control study, Menvielle et al (2004) observed statistically significant increased odds 
ratios at all alcohol intake levels (highest exposure level, >13 g/d) for cancers of the hypopharynx, 
glottis and the supraglottis. Odds ratios were of a greater magnitude for cancers of the hypopharynx 
(<13 g/d; OR 11.7, 95% CI 5.1-27.2) than those reported for the glottis (OR 2.9, 95% CI 1.1-7.1) and 
supraglottis (OR 4.1, 95% CI 1.4-11.5) though no test for heterogeneity between cancer sites was 
reported. In an Indian population based case control study, Sapkota et al (2007) reported no difference 
in the odds ratios for alcohol consumption and cancers of the supraglottis (OR 3.76, 95% CI 1.25-
11.30) and hypopharynx (OR 2.22, 95% CI 1.11-4.45). 
In a German study, increased risks were observed in the highest category (>150 g/d) of alcohol 
consumption, more than twice as high for supraglottic than for glottic and subglottic tumours 
(Ramroth et al 2004). This effect was not found in a study in central and eastern Europe where risk 
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estimates for frequency, duration, and cumulative alcohol consumption categories were moderate for 
both glottic and supraglottic cancers (Hashibe et al 2007).  
 
2.9.4 Results: drinking dimensions and risk of laryngeal cancer 
De Stefani et al (2004) and Hashibe et al (2007a) observed a possible dose response relationship for 
duration of drinking (p value for trend = 0.06), however, most point estimates were not of statistical 
significance and in only men drinking between 40-49 years in De Stefani’s study was it of statistical 
significance. Talamini et al (2002) reported a two-fold increased risk for those drinking less than 
35years, but for those drinking >35 years, compared to non-drinkers. 
 
2.9.5 Results: drink type and risk of laryngeal cancer 
The association between alcohol beverage type and risk of laryngeal cancer was investigated in six 
studies. A summary of laryngeal cancer risk estimates, comparing the highest versus the lowest 
alcohol exposure category, by drink type is presented in Figure 2.9.2. 
Garavello et al (2006) reported that in an Italian population characterized by frequent wine 
consumption, wine was the beverage most strongly related to the risk of laryngeal cancer. Significant 
trends in risk were found wine drinkers, with odds ratios (ORs) of 1.12 95% CI 0.83-1.50 for drinkers 
of 3-4 d/d, and 5.91 95% CI 3.18-7.33 (p value for trend <0.0001) for >12 d/d, compared to abstainers 
or light drinkers. After allowance was made for wine intake, the ORs for beer drinkers were 1.65 
(95% CI 1.31-2.10) for 1-2 d/d, and 1.36 (95% CI 0.86-2.15) for >3 d/d, as compared to non-beer 
drinkers; corresponding values for spirits drinkers were 0.88 (95% CI 0.70-1.11) and 1.15 (95% CI 
0.67-1.96). Di Stefani et al (2004) reported similar results from a Uruguayan case control study with 
lifetime drinking of wine, the preferred alcoholic beverage in Uruguay having the strongest 
association with laryngeal cancer compared to either beer or spirits. In a French study, Menvielle et al 
(2004) also noted a statistically significant association among ‘current’ wine drinkers only, but not 
amongst ‘current’ drinkers of beer or spirits, when compared to non-drinkers.  
In a study from Brazil, Schlecht et al (2001) observed an increased risk of laryngeal cancer from wine, 
beer and spirits, but none of the point estimates were statistically significant (Schlecht et al 2001). In 
this study, only cachaca, the predominant choice of alcoholic beverage in southern Brazil, displayed a 
strong dose response relationship in risk increase of laryngeal cancer with cumulative consumption. 
Zvrko et al (2007) reported statistically significant increased risks among spirit drinkers though no 




Figure 2.9.2 Alcohol consumption and laryngeal cancer, by drink type (odds ratio/relative risk and 
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2.9.6 Results: effect modification 
The joint effect of cigarette smoking and alcohol drinking on the risk of laryngeal cancer was 
examined by four studies. Talamini et al (2002) reported that, compared to never smokers and 
abstainers or light drinkers, the risk of laryngeal cancer increased with increasing alcohol 
consumption in each stratum of smoking habit. The same held true for smoking within strata of 
alcohol intake. The OR for highest levels of alcohol drinking and current smoking was 177.2 (95% CI 
65.0-438.3), compared to non-smokers drinking less then <14 d/w. De Stefani et al (2004) also 
observed that both smoking and alcohol have an independent effect on laryngeal cancer risk with 
results following a multiplicative model, with an OR for >25 cigarettes a day and >121ml p/d, of 42.2 
(95% CI 18.9-94.6), compared to those smoking  <14 cigarettes per day and drinking < 60ml p/d. 
Ramroth et al (2004) observed that compared to never smokers and light drinkers, the risk of 
laryngeal cancer increased with increasing alcohol consumption in each stratum of smoking habit. 
The same held true for smoking within strata of alcohol intake. The OR for highest level of tobacco 
and alcohol consumption was 52.6 (95% CI: 17.9, 154.6, Pinteraction=0.75). In a small Italian case 
control study (Gallus et al 2003), the OR for women who smoked ≥15 cigarettes p/d and drank ≥3 d/d 
was 318 (95% CI: 71–1434), compared to never and ex-smokers drinking <3 d/d. Never and ex-
smokers drinking ≥3 d/d had an OR of 1.3 (0.2–10.9). Gallus et al (2003) reported that smoking and 
alcohol consumption appear to have a multiplicative effect on laryngeal cancer risk (Pinteraction=0.45 on 
the additive scale). 
 
2.9.7 Summary and conclusions 
The literature search identified 13 papers from 10 studies, which examined the association between 
alcohol consumption and risk of laryngeal cancer. The studies were generally of good quality and all 
controlled for smoking, one of the major risk factors for laryngeal cancer. Although alcohol is also 
considered to be an important risk factor for laryngeal cancer (IARC 1988, WCRF/AICR 2007), the 
evidence presented in this review is inconsistent when considering the exact nature of the dose 
response relationship between alcohol and laryngeal cancer. Although dose response relationships 
were evident in a number of studies, point estimates were only statistically significant at >5 d/d. This 
does not rule out an effect of low to moderate levels of drinking since many of studies included 
current light drinkers in their reference group. This prevented investigation of low levels of drinking 
on increased laryngeal cancer risk and more than likely contributed to underestimating risk at 
moderate and heavy levels of alcohol consumption. In a meta-analysis of twenty case control studies, 
Bagnardi et al (2001) reported a statistically significant increase  in risk of laryngeal cancer associated 
with drinking 25 g/d (pooled RRR 1.38, 95% CI 1.32-1.45, P test for heterogeneity <0.05) and an 
approximate 400% increase in risk of laryngeal cancer associated with drinking on average 100 g/d.  
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The majority of studies investigating the association between laryngeal cancer and drink type reported 
a dose response effect for wine, but not beer or spirits, suggesting a possible carcinogenic effect of 
wine intake. However, in each of these studies, wine happened to be the most common alcoholic 
beverage in each of the populations studied. Previous studies have also shown increased risks of 
laryngeal cancer risk for beer drinkers. This different pattern of risk from studies in different 
populations according to type of alcoholic beverages could be due to the different level of 
consumption of each alcoholic beverage in these populations. The apparent discrepancy between 
studies can also be explained in terms of different characteristics of heavy drinkers in various 
populations. Thus, where wine is the most common alcoholic beverage, wine drinkers are at highest 
risk. Schlecht et al (2001) in their study set in southern Brazil found that the strongest statistical 
association was with cachaca, the most popular consumed beverage in that area. It is, therefore, likely 
to be ethanol per se that has an effect on laryngeal cancer rather than components of alcoholic 
beverages. 
In a recent pooled analysis, results demonstrated that the larynx was the organ within the head and 
neck that was most susceptible to the effects of cigarette smoking (Hashibe et al 2007). The higher 
risk estimates for hypopharyngeal cancer, compared to laryngeal cancer, reported in three studies 
identified in the present review, may therefore suggest that the two tumour sites are distinct 
epidemiological entities. Since hypopharyngeal mucosa is in direct contact with alcohol, whilst on the 
other hand, laryngeal mucosa is most strongly exposed to inhaled tobacco, this mechanism could fit 
with the hypothesis that alcohol drinking may influence laryngeal cancer risk, by enhancing the 
effects of tobacco or other environmental carcinogens (Altieri et al 2005). However, some caution 
needs to be taken when interpreting the results of these studies. Notwithstanding the selection bias 
present in these hospital case control studies which could attenuate the risk estimates, other design 
weaknesses present in the studies could alter the risk estimates i.e. odds ratio based on small number 
of cases with hypopharyngeal cancers (De Stefani et al 2004) or high non response rates among both 
cases and controls (Menvielle et al 2004). This said, the effect would be the same for estimates for 
laryngeal cancer, therefore, hypopharyngeal cancer would still continue to show a significantly 
stronger association with alcohol consumption compared to laryngeal cancer. Cancers of the 
hypopharynx and larynx have often been analysed as a single entity in several studies in the past and 
this was also the case for a number of studies reviewed here, where either the risk estimates for 
laryngeal cancer also included hypopharyngeal cases or the outcome itself was not clearly defined by 
explicitly excluding hypopharyngeal cancers. The findings here would suggest that the two sites, 
laryngeal and hypopharyngeal, should not be analysed as a single cancer in the future.  
Overall, despite weakness in study design, the small size of many of the studies and the potential for 
residual confounding from socio-economic status and diet, studies consistently observed a strong 
association between alcohol consumption and risk of laryngeal cancer. Effects of drink type were 
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inconclusive though the weight of evidence would suggest that alcohol itself and not the type of drink 
is the most important factor in determining risk of laryngeal cancer. Further studies are required to 





2.10 Liver cancer 
Liver cancer: summary of evidence from previous reviews 
IARC 1988b concluded in their international literature review that although potential 
confounding due to hepatitis B virus, tobacco smoking and aflatoxin was not explored in 
all the studies; whenever it was, it did not alter the findings qualitatively. The available 
results, taken together, therefore indicated that alcohol consumption is causally related to 
liver cancer. (IARC 1988b). A meta-analysis of studies (3 cohort and 17 case control 
studies published between 1966 and 1999) on liver cancer and alcohol consumption only 
observed a small, and weak, statistically significant risk of liver cancer at low (25 g/d; RR 
1.17, 95% CI 1.11-1.23) to moderate (50 g/d; RR 1.36, 95% CI 1.23-1.51) levels of 
consumption, compared to non-drinkers and even heavy levels of alcohol intake (100 g/d) 
only had a RR of 1.86 (95% 1.53-2.27) (Bagnardi et al 2001). 
 
This literature review identified 11 papers from 10 studies, published between 1999 and 2009, that 
examined the association between alcohol consumption and the risk of liver cancer (hepatocellular 
carcinoma). There were two cohort studies and eight case control studies. Tables for each paper, 
describing the study aims, population, alcohol measurement methods and main results are provided in 
Appendix D. 
2.10.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.10.1 below.  
Table 2.10.1 Alcohol and liver cancer: general characteristics of studies reviewed 
Authors  
 






















                                         Case control studies              cases controls  
Donato 2002 Italy 464/824 
40-75 
(M=64) 
2 regional hospitals 
consecutive/non-
random selection 
Hassan 2008 USA 319/1,061 (M=60/62) state hospital 
consecutive/non-
random selection 
Kuper 2000 Greece 333/360 >18 city hospital not specified 
Marerro 2005 USA 210/420 (M=56/55) city hospital 
consecutive/non-
random selection 






Ohishi 2008 Japan 224/644 (M=67) general population random sample 
Sakamoto 2006 Japan 209/381 
40-79 
(Mdn=69/61) 
2 regional hospitals 
consecutive/non-
random selection 
Takeshita 2000 Japan 102/125 (M=62/60) 20 regional hospitals 
consecutive/non-
random selection 
Abb: n/s not specified; M=mean; Mdn= median 
 
For the majority of studies in the review, the number of liver cancer cases identified did not exceed 
500; the largest case control studies in this review recruited approximately 500 cases and 800 controls 
(Donato et al 2002, Hassan et al 2008) and the smallest case control study recruited only 78 cases and 
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138 controls (Munaka et al 2003). Of the case control studies, Ohishi et al (2008) nested their study 
within a cohort of atomic bomb survivors in Japan, identified through Japanese cancer registries. 
Controls were randomly selected from the same cohort, from those who matched cases on age, 
gender, radiation exposure. Two studies recruited two control groups; hospital patients and patients 
with chronic liver disease, but without liver cancer (Sakamoto et al 2006) and patients with cirrhosis 
and patients with no liver disease (Marerro et al 2005).  
 
2.10.2 Study quality 
The quality scores assessed according to the NOS are presented in Table 2.10.2. Overall, studies were 
of a moderate to high quality, scoring between 6-7 stars.  
Table 2.10.2 Liver cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Allen 2009 4 2 3 9 
Mori 2000 4 2 2 8 
Case Control     
Donato 2002 3 2 3 8 
Hassan 2008 3 2 2 7 
Kuper 2000 3 2 2 7 
Munaka 2003 2 1 1 4 
Marerro 2005 2 1 3 6 
Ohishi 2008 3 2 2 7 
Sakamoto 2006 2 2 2 6 
Takeshita 2000 3 1 3 7 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment; 
1 
Outcome for cohort, exposure for case-
control studies 
 
Although the cohort study Mori et al (2000) scored highly on the NOS, the study lacked statistical 
power because of the small number of cases (n=50) identified over a follow up period of four years. 
Attempts to address selection bias varied across the case control studies. Kuper et al (2000) excluded 
patients with conditions related to smoking and alcohol consumption, only including among their 
controls, patients hospitalised for injuries or for eye, ear, nose or throat (excluding laryngeal cancer) 
conditions. Donato et al (2002), however, excluded patients admitted to hospital with injuries because 
of the relation between such conditions and alcohol abuse and patients with malignant neoplasms and 
those admitted with liver disease. A further two studies also excluded patients with prior history of 
liver disease from their control group (Sakamoto et al 2006, Takeshita et al 2000). In three studies, no 
exclusion criteria were specified (Munaka et al 2003, Marerro et al 2005, Ohishi et al 2008). 
Response rates among both cases and controls in the majority of studies exceeded 85% with the 
exception of Sakamoto et al (2006) which had a 73% response rate among controls and 98% among 
cases). In three remaining case control studies, no information was provided on response rates among 
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cases and controls (Marerro et al 2005, Munaka et al 2003, Takeshita et al 2000). Interviewer bias was 
also a potential issue for all the case control studies, since blinding status was not specified in any of 
the studies. 
Measurement error for alcohol intake was also a potential source of bias across studies. In the cohort 
studies information on alcohol consumption was only collected at baseline although given the short 
period of follow up in both studies (<7 years), it is possible that such error would have a minimal 
effect. Seven of the eight cases control studies sought to measure either lifetime intake or intake at 
specified periods throughout a participant’s drinking history. In each of these studies, questions on 
these aspects of an individual’s drinking history were not based on validated drinking history 
measurement tools, but on questions designed specifically for the study. Only the case control study 
by Kuper et al (2000) looked at risk of liver cancer based on a consumption levels within a year of 
being interviewed for the study. Although this approach is less prone to measurement error noted in 
the other case control studies, it does not take into account the latency period for liver cancer which 
will be considerably longer than an individual’s level of alcohol consumption over a one year period. 
The three most common risk factors controlled for in studies investigating association between 
alcohol consumption and liver cancer were age (in all studies), the hepatitis C (and hepatitis B) virus 
(Mori et al 2000, Kuper et al 2001 Donato et al 2002, Sakamoto et al 2006, Ohishi et al 2008, Hassan 
et al 2008) and smoking (Marerro et al 2005, Sakamoto et al 2006, Takeshita et al 2000). Marerro et 
al (2005) further adjusted for obesity (defined as BMI> 30kg/m
2
) and in one study, only age and 
gender were controlled for (Munaka et al 2003). 
 
2.10.3 Results; total alcohol intake and risk of liver cancer15 
All 10 studies reported on the dose response association between total alcohol consumption and liver 
cancer. Nine studies reported on the association between ‘lifetime’ drinking and liver cancer and one 
study on the association between ‘recent’ drinking and liver cancer (Allen et al 2009). A summary of 
liver cancer risk estimates, comparing the highest versus the lowest alcohol exposure category, is 
presented in Figure 2.10.1.  
 
‘Recent’ drinking 
Allen et al (2009) observed a statistically significant increased risk of liver cancer at the highest 
alcohol exposure category (>15 drinks per week [d/w]; RR 1.70, 95% CI 1.12- 2.56, p value for trend 
=0.03), compared to those drinking <2 d/w. In the same study, however, drinking below <3-<6 d/w 
was not associated with an increased risk of liver cancer (RR 0.94, 95% CI 0.72-1.21) whilst ‘never-
                                                          
15
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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drinkers had a 40% (RR 1.41 95% CI 1.16-1.72) increased risk of liver cancer compared to the 
reference group (Allen et al 2009). 
Figure 2.10.1 Recent and lifetime alcohol consumption and liver cancer: highest versus lowest 
exposure category, by study type (odds ratio/relative risk, 95% confidence intervals)  



















In a Japanese prospective cohort study, a history of ‘habitual’ alcohol consumption (those drinking at 
>1 d/w for ≥20 years) was associated with a non-significant 14% increased risk of liver cancer (Mori 
et al 2000). In the largest case control study of the alcohol-liver cancer association in the present 
review, Donato et al (2002) reported a statistically significant increased risk for Italian men and 
women drinking more than >80 grams per day [g/d] during ‘peak’ (i.e. intake during their decade of 
which consumption was the highest) exposures in their lifetime. Although there was evidence of a 
dose response relationship (though no p value for trend was reported), intake of less than ≤80 g/d was 
not associated with a statistically significant increased risk of liver cancer in either men or women. 
Donato et al. also found no strong evidence for substantial differences between men and women in the 
liver cancer risk curves by alcohol intake though no test for heterogeneity was undertaken. In a similar 
sized study in the USA, Hassan et al (2008) observed a statistically significant increase of liver cancer 
for lifetime heavy drinking (>60 millilitres per day [ml/d] (approximately >48 g/d
16
), compared to 
never drinkers. Marrero et al (2005) also reported an increased risk for liver cancer at the highest 
exposure level only (≥1500 gram-years
17
) compared to patient controls with no history of liver disease 
and also for controls with cirrhotic disease, The odds ratios among the former were four times higher 
than those for the latter. In a nested case controls study, Ohishi et al (2008) observed a modest 
                                                          
16
 one gram = approximately 1.25 milliliters  
17




statistically significant increased risk of liver cancer for those drinking only >40 g/d during their 
lifetime with strong evidence of a statistically significant dose response relationship (p value for trend 
=0.008). 
In three Japanese hospital case control studies, statistically significant positive associations were only 
evident at the highest alcohol exposure levels in each study, compared to the lowest intake group. 
Sakamoto et al (2006) observed a statistically significant increase in patients drinking >72 g/d in the 
previous two years, compared to non-drinkers. Sakamoto et al. also compared liver cancer cases to a 
second control group with chronic liver disease (CLD) and observed the same statistical significance 
at higher exposure levels as reported for hospital controls. The odds ratio for the control group of 
CLD patients (OR 5.0, 95% CI 1.3–19.2) was considerably lower than for the hospital controls (OR 
10.2, 95% CI 1.7–60.5), but confidence intervals were wide and overlapping. Similar patterns and 
point estimates were also observed when the authors described history of alcohol consumption 10 
years before interview and risk of liver cancer (Sakamoto et al 2006). Takeshita et al (2000) reported 
that higher cumulative amounts of alcohol consumption (>40 ‘drink-years’ (drinks per day times years 
of drinking) over the last 30 years) showed a statistically significant association with liver cancer, 
compared to 0-20 ‘drink-years’ over the last 30 years. Compared to non-drinkers, Munaka et al (2003) 
reported an increased risk of liver cancer for those drinking >600,000 ml (cumulative amount) during 
their lifetime, but no association was found at lower intake levels. 
2.10.4 Results: drinking dimensions and risk of liver cancer 
There were no studies investigating the associations between drinking dimensions (e.g. duration, 
frequency, pattern) and risk of liver cancer identified in this review. 
2.10.5 Results: drink type and risk of liver cancer  
There were no studies investigating the associations between drink type and risk of liver cancer 
identified in this review. 
2.10.6 Results: effect modification 
Two studies looked at interaction between hepatitis B surface antigen (HBsAg) and hepatitis C virus 
antibody (HCVAb). In a prospective cohort analysis based on 52 incident liver cancer cases, Mori et 
al (2000) reported that there was no significant interaction on both the additive or multiplicative scale, 
between HBsAg and HCVAb status and a history of habitual alcohol consumption. Donato et al 
(2002), reported higher odds-ratio values for cases with hepatitis C virus infection, followed by those 
with hepatitis B virus infection and finally by those without hepatitis virus infection; the OR for 
drinking >60 g/d was 7.0 (95% CI 4.5-11.1) for cases negative for both infections, whereas the ORs 
for drinking >60 g/d were, 109.0 (95% CI 50.9-233.0) for cases positive for HCVAb and 48.6 (95% 
CI 24.1-98.0) for cases positive for HbsAg, compared to drinkers of 0-60 g/d who were negative for 
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both infections. There was no significant interaction on the additive scale (Pinteraction >0.1), suggesting 
a multiplicative effect of hepatitis virus infection.  
Kuper et al (2000) reported that heavy smoking (≥2 packs p/d) and heavy drinking (≥400 grams per 
week [g/w]) increased the odds (OR 9.6, 95% CI 3.4-27.5) of liver cancer occurring, compared to 
never smokers drinking <400 g/w. Heavy smokers drinking <400 g/w had an OR of 1.5 (95% CI 0.6-
3.9). There was strong evidence of a statistically significant (Pinteraction=0.0001) interaction on the 
multiplicative scale. Marerro et al (2005) evaluated the interactions of alcohol consumption, tobacco 
smoking, and obesity on the risk of liver, by comparing liver cancer patients with cirrhotic controls. 
They found that when compared to patients with lifetime exposure to tobacco (OR 2.5, 95% CI 1.7-
15) or alcohol (OR 1.4, 95% CI 1.1-4.0) only, the risk of liver cancer was higher when both risk 
factors were present (OR 7.2, 95% CI 2.2-14.1). An increase in risk of liver cancer was also observed 
when exposure to alcohol was present with obesity (>100 drinks in lifetime and BMI > 30kg/m
2
, OR 
5.5, 95% CI 1.8-20). To assess whether the interactions between the alcohol, tobacco and obesity 
were additive or synergistic, Marrero et al calculated a Synergism index, and its 95% CI, based on the 
estimated odds ratio of the risk factors. A value greater than the reference unit (1.0) suggests that the 
effect of the joint exposures of two risk factors, is greater than the sum of the separate effects. 
Marrero et al (2005) reported that the synergistic indices for the interaction between alcohol and 
tobacco, tobacco and obesity, and alcohol and obesity were 3.3 (95% CI 1.8-5.7), 2.9 (95% CI 1.8-3.5) 
and 2.5 (95% CI 1.6-4.9), respectively. When all three variables were analysed together, the 
synergistic index was 1.6 (95% CI 1.1-4.3), indicating a possible synergism between the effects of 
alcohol, tobacco and obesity on the risk of liver cancer in their study population. 
 
2.10.7 Summary and conclusions 
This literature review identified two prospective cohort and eight case control studies, published 
between 1999 and 2009, examining the association between alcohol consumption and liver cancer.  
The majority of studies reported on the association between ‘lifetime drinking’ and liver cancer. 
Despite considerable variation in measures of lifetime drinking, the majority of studies were 
consistent in observing a statistically significant increased risk of liver cancer at the highest levels of 
alcohol exposure (approximately >40 g/d), consistent with the findings of earlier studies (La Vecchia 
et al 1988, Tanaka et al 1992; 1995, Adami et al 1992). The evidence of an association between 
drinking <40 g/d and an increased risk of liver cancer was less convincing, with only a few studies 
reporting small, non-significant, positive associations with liver cancer. This could imply a threshold 
effect of alcohol drinking on the risk of liver cancer, however, a stronger effect of low to moderate 
levels of alcohol intake on the risk of liver cancer cannot by fully ruled out due to the range of 
reference groups used across the studies, recall bias in measuring lifetime drinking and small study 
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sizes. A previous meta-analysis of studies (3 cohort and 17 case control studies published between 
1966 and 1999) on liver cancer and alcohol consumption only observed a small, and weak, 
statistically significant risk of liver cancer at low (25 g/d; RR 1.17, 95% CI 1.11-1.23) to moderate 
(50 g/d; RR 1.36, 95% CI 1.23-1.51) levels of consumption, compared to non-drinkers and even 
heavy levels of alcohol intake (100 g/d) only had a RR of 1.86 (95% 1.53-2.27) (Bagnardi et al 2001). 
A recent meta-analysis, of six cohort studies, reported a summary effect estimate of 1.10 (95% CI 
1.02-1.17) per 10 g/d with no heterogeneity, though no p values were provided (WCRF/AICR 2007). 
It has been hypothesised that the relationship between alcohol and liver cancer could differ for men 
and women; for women, a higher susceptibility to liver damage due to alcohol has been suspected on 
the basis of metabolic differences (Frezza et al 1990). A meta-analysis of the association between 
alcohol consumption and the risk of liver cancer based on ten studies for men and three for women, 
reported the effects of gender in modifying the effect of alcohol intake reaching statistical 
significance, with higher risks in women (Bagnardi et al 2001). Two studies in this review reported 
analyses of the association between alcohol consumption and liver cancer by gender with mixed 
results. Donato et al (2002) found no strong evidence, despite higher risk estimates among men, for 
substantial differences between men and women in the liver cancer risk curves by alcohol intake. 
However, because of the small number of women who drank a medium-high amount of alcohol in this 
study, these results should be considered cautiously. In contrast, Hassan et al (2008) reported higher 
odds ratios from women compared to men, but again estimates for women were based on less than 
twenty drinkers among cases and controls and accordingly confidence intervals were wider and 
overlapped those for men. No definite conclusion, therefore, on gender differences in the strength of 
the association between alcohol consumption and risk of liver cancer can be drawn at present and 
larger studies or further meta-analyses are necessary to explore this further. 
It has also been hypothesized that heavy alcohol consumption may lead to liver cancer only through 
the production of liver cirrhosis as an intermediate step (Adami et al 1992). Alcohol may further 
promote the development of liver cancer by increasing tumour growth in people with cirrhosis or 
other chronic liver diseases (Mukaiya et al 1998). This hypothesis was not supported by the two 
studies in this review which looked at the effects of alcohol consumption on risk of liver cancer in two 
control groups of chronic liver disease and non-chronic liver disease patients, both of which found 
higher risks among their control groups of non chronic liver disease patients. This review does 
support, however, previous observations (Donato et al 1997, Tagger et al 1999), that alcohol drinking 
has a “pure” effect in increasing the risk of liver cancer and that its effect can be modified by hepatitis 
B or hepatitis C virus infection. An interactive effect of heavy smoking and heavy drinking in the 
development of liver cancer was found in two studies. This interaction is biologically plausible 
because tobacco smoke contains several mutagenic initiating agents as well as potential promoting 
agents, and heavy alcohol drinking is likely to have a promoting or growth-enhancing effect via the 
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process of cirrhosis. Thus, smoking and alcohol could act together along the same pathway resulting 
in liver cancer. In one study, no interaction between smoking, alcohol consumption and obesity was 
reported. Obesity, particularly central obesity, is however, associated with non-alcoholic fatty liver 
disease which increases the risk of cirrhosis and liver cancer. An interaction between obesity and 
alcohol intake has been identified in studies with chronic liver disease as the outcome (Liu et al 2010, 
Hart et al 2010) and it is likely that tobacco exposure further increases the risk. Indeed a similar 
synergistic effect between alcohol, tobacco and obesity has been observed in patients with 
oesophageal and stomach cancer (Marerro et al 2005). A limitation to these observations concerns the 
small samples inherent in subgroup analysis which restricts the precision of the risk estimates. 
Nevertheless these findings are consistent in suggesting an interactive effect of various lifestyle 
factors and an increased risk of liver cancer and underline the difficulty in unravelling the precise 
dose response relationship between alcohol consumption and increased risk of liver cancer. 
 
Although the major risk for liver cancer development has been attributed to the hepatitis B and 
hepatitis C virus evidence other risk factors including history of cigarette smoking, heavy alcohol 
consumption and obesity may also contribute to the development of liver cancer. Research 
investigating the interactions of hepatitis B or C virus with lifestyle factors may provide further 
insight into the multi-factorial aetiology of liver cancer. In sum, the evidence in this review confirms 
established evidence of an increased risk of liver cancer from heavy/excessive alcohol consumption. 
Given that the development of liver cancer is a multistage, multi-factorial process the relative role of 
alcohol is likely to vary between countries depending on the prevalence of the other risk factors, 




2.11 Lung cancer  
Lung cancer: summary of evidence from previous reviews 
Earlier systematic reviews concluded that In view of the lack of excess risk in case-control 
studies and the inconsistent results of cohort studies, there is no indication that alcohol 
consumption has a causal role in lung cancer (IARC1988b, WCRF/AICR 1997, Bandera et 
al 2001). In a meta-analysis of twelve cohort and thirteen case control studies published 
before 1999 reported that the evidence for a smoking-adjusted association between alcohol 
and lung cancer risk was limited to very high consumption groups (>60 g/d) in cohort and 
hospital-based case-control studies (Korte et al 2002). 
 
The literature search identified 15 papers from 13 studies, published between 1 January 1999 and 30 
September 2009, which examined the relationship between alcohol consumption and lung cancer. Of 
the 15 papers, eight were prospective cohort studies and five were case control studies with one case 
control study contributing two papers to the present review. Both papers were retained as they 
reported on different aspects of the alcohol and lung cancer association: ‘recent’ (Benedetti et al 2006) 
and lifetime alcohol consumption (Benedetti et al 2009). The literature search also identified one 
pooled analysis which was retained in the review; in the pooled analysis by Freudenheim et al (2005), 
six of the seven prospective cohort studies included had not previously published findings on the 
alcohol and lung cancer association during the search period covered by the present review.  
 
2.11.1 Study Characteristics 
A summary of the general characteristics of the studies is provided in Table 2.11.1 below. Tables for 
each study describing the study aims, population, alcohol measurement methods and main results are 
provided in Appendix D. Two papers were based on the established prospective cohort studies 
described in Box 2.1 Chapter 2.2; the Copenhagen City Heart study (Prescott et al 1999); and the 
European Prospective Investigation into Cancer and Nutrition (Rohrmann et al 2006).  
A pooled analysis by Freudenheim et al (2005) was based on the ‘Methods for the Pooling Project of 
Prospective Studies of Diet and Cancer’ and included approximately 3,300 lung cancer cases. 
Inclusion criteria for cohort studies in the pooled analyses were >50 incident cases of lung cancer, an 
assessment of usual diet, a validation study of the diet instrument or of a closely related instrument, 
and assessment of smoking status at baseline. Seven cohort studies were included: the Canadian 
National Breast Screening Study, the Iowa Women’s Health Study, the Netherlands Cohort Study, the 
New York State Cohort, the Tocopherol Carotene Cancer Prevention Study (see Woodson et al 1999), 
the Nurses’ Health Study (see Section 2.4) and Health Professionals Follow-up Study (see Section 
2.4).  
The largest cohort study identified in the present review included approximately 5,000 incident cases 
of breast cancer (Allen et al 2009) and has been previously described in section 2.3.1. Two cohort 
139 
 
studies (Woodson et al 1999, Rohrmann et al 2006) and one case control study (Benedetti et al 2006) 
were of reasonable size, identifying over 1000 lung cancer cases  
Table 2.11.1 Alcohol and lung cancer: general characteristics of studies reviewed 


















Djoussé 2002 USA 269/9,016 28-62 town random selection 
Freudenheim 2005 Various 3,317/396,630 >15 various various 
Prescott 1999 Denmark 674/27,486  >20 local population random selection 


























Case control studies 









De Stefani 2002 Uruguay 160/520 30-89 city hospitals 
consecutive/random 
selection 















2004 Spain 132/187 M=64/62 city hospital 
consecutive/random 
selection 
 Abb.: n/s= not specified; M=mean; Mdn= median  
 
2.11.2 Study Quality 
The quality scores assessed according to the NOS are presented Table 2.11.2. Cohort studies were of a 
high quality scoring 7-9 stars whilst case-control studies varied in quality with star ratings ranging 
from 4-7.  
 
Selection bias, as measured by the NOS, was generally avoided in the cohort studies, with only two 
studies failing to achieve maximum stars because either their study population was a specific 
population subgroup i.e. teachers (Chao et al 2008) or they did not specify the exclusion of previous 
cases of lung cancer from their study population (Prescott et al 1999). For outcome assessment, Chao 
et al (2008) only had a follow-up period of four years (300,516 person-years) thereby reducing the 
study’s power to detect a true association between lung cancer and alcohol consumption. Four cohort 
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studies failed to specify whether there was any loss to follow-up in their studies and in one European 
wide study different methods of outcome measurement were used depending on the country, with 
lung cancer diagnoses being based on population registries or by active follow-up through information 
obtained from study subjects, next of kin, health insurance records, and cancer and pathology 
registries (Rohrmann et al 2006).  
Table 2.11.2 Lung cancer: assessment of study quality 
 Selection* 
(out of 4) 
Comparability* 




(out of 3) 
Total 
Cohort     
Allen 2009 4 2 3 9 
Chao 2008 3 2 3 8 
Djoussé 2002 4 2 2 8 
Prescott 1999 3  2 3 8 
Rohrmann 2006 4 2 1 7 
Shimizu 2008 4 2 2 8 
Toriola 2009 4 2 2 8 
Woodson 1999 4 2 3 9 
Case-control     
Benedetti 2006 3  2 2  7 
De Stefani 2002 1 2 1 4 
Freudenheim 2003 3  2 1  6 
Kubik 2004 2  2 2 6 
Ruano-Ravina 2004 3 2 2  7 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for selection, 
two stars for comparability and three stars for assessment. 
1 
Outcome for cohort, exposure for case-control studies 
 
Smoking and age were controlled for in all studies. The majority of studies controlled for ‘current’ 
smoking status (current, never, and former, which included the number of years since quitting), 
current smoking (cigarettes smoked per day) and duration of smoking (which was either measured by 
length of time smoked in years or in ‘pack-years’ calculated by multiplying amount smoked by 
smoking duration). Two studies controlled for ‘current’ smoking status and for cigarettes smoked per 
day (De Stefani et al 2002) or duration of smoking (Shimizu et al 2008). Two studies reported only 
controlling for length of time smoked (Kubik et al 2004, Ruano-Ravina et al 2004). In addition, two 
studies controlled for the effects of passive smoking; Freudenheim et al (2003) controlled for lifetime 
smoke exposure at home, at work and ‘in other settings’ and Shimizu et al (2008) controlled for 
passive smoking in the workplace (exposure of between 1-3 days/month, 1-4 days/week, and almost 
every day). 
One study attempted to fully control for the effects of socio-economic status on the alcohol-lung 
cancer association; a summary index was developed that combined measures of income, education, 
occupation, occupational ‘prestige’, material standard of living and housing conditions (Toriola et al 
2009). Two studies controlled for both years of schooling and household family income (Benedetti et 
al 2006, Chao et al 2008). Education was controlled for in eight studies though this varied from level 
of education (high school, university, no education) to years of schooling; and type of occupation in 
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one study (Ruano-Ravina et al 2004). Two studies did not control for any SES measures (Woodson et 
al 1999, Shimizu et al 2008). 
2.11.3 Results: total alcohol intake and risk of lung cancer18 
One pooled analysis, six cohort and two case-control studies, reported on the association between 
lung cancer and total ‘recent’ alcohol consumption. A summary of lung cancer risk estimates, 
comparing the highest alcohol exposure category versus the lowest alcohol exposure category, is 
presented in Figure 2.11.1. The highest alcohol exposure categories  reported ranged from low (12 
grams per day [g/d]; Benedetti et al 2006) and moderate levels of drinking (20-25 g/d; Djoussé et al 
2002, Allen et al 2009) to >60 g/d (Rohrmann et al 2006, Shimizu et al 2008). In the remaining 
studies, the highest alcohol intake group reported was approximately 30-40 g/d. Two papers used a 
reference group comprising of non-drinkers, including former drinkers (Djoussé et al 2002, 
Freudenheim et al 2005) with the remaining papers using a reference group of occasional and low 
level drinkers (>0 to 10 g/d). 
Figure 2.11.1 Alcohol consumption and lung cancer, highest versus lowest exposure category, by 
















OR/RR, highest vs lowest exposure category
  
                                                          
18
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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In the pooled analysis by Freudenheim et al (2005), an increased risk of lung cancer was observed at 
the highest alcohol exposure category (>30 g/d) in both men (RR 1.21, 95% CI 0.91-1.61) and women 
(RR 1.16, 95% CI 0.94-1.43), though confidence intervals were wide and crossed the null value, with 
weak evidence of a dose response trend (p value for trend =0.03). In two prospective cohort studies of 
similar size, Prescott et al (1999) and Shimizu et al (2008) reported an increased risk of lung cancer in 
men, drinking at the highest alcohol intake level, of similar magnitude to that reported by 
Freudenheim et al (2005). There was convincing evidence of an increased risk of lung cancer with 
increasing amount of alcohol consumed in the study by Prescott et al. (p value for trend =0.002), but 
not in the study by Shimizu et al. (p value for trend =0.07). In a cohort of male smokers, however, 
drinking at any level up to a median of 42 g/d (RR 1.0, 95% CI 0.8-1.2, p value for trend =0.89), was 
not associated with an increased risk of lung cancer (Woodson et al 1999). Benedetti et al (2006) also 
observed no association between low levels of alcohol consumption (<1 d/d) and risk of lung cancer 
in men in their population based case control study.  
The small increased risk of lung cancer for women at the highest alcohol intake level, reported above 
by Freudenheim et al (2005), was not repeated in two prospective cohort studies; Allen et al (2009) in 
the largest study identified in the present review of alcohol intake and lung cancer risk in women, did 
not find an increased risk of lung cancer reported for women drinking approximately >20 g/d (p value 
for trend =0.20) and lung cancer and Prescott et al (1999) for women drinking >30 g/d (p value for 
trend =0.94). Allen et al (2009) did observe, however, an inverse association between three and six 
drinks per week (d/w) (RR 0.91, CI 95% 0.85-0.97) and risk of lung cancer in women. A possible 
protective effect (RR 0.78, 95% CI 0.65-0.94) of low level (>0-<5g/d) and moderate levels (5-<15g/d; 
RR 0.84, 95% CI 0.69-1.03) of drinking was also reported in the pooled analysis paper (Freudenheim 
et al 2005). Similar findings for women drinking between 1-6 d/w were reported by Prescott et al 
(1999) and Rohrmann et al (2006). In a Canadian case control study (Benedetti et al 2006), women 
drinking ≥7 d/w had a reduced risk of lung cancer (OR 0.7, 95% CI 0.5-1.1) with this protective effect 
stronger for women drinking 1-6 d/w (OR 0.4, 95% CI 0.2-0.5), compared to non-drinkers. 
Three studies reported on the association between ‘lifetime’ alcohol consumption and lung cancer. In 
a large prospective cohort study (Rohrmann et al 2006), mean lifelong ethanol intake of >60 g/d was 
related to a non-statistically-significantly higher risk (RR 1.29, 95% CI 0.93-1.74) of lung cancer 
compared to ‘low level’ drinkers (0.1-4.9 g/d) whilst lifelong non-drinkers did not have an elevated 
risk of lung cancer. Similar odds ratios were reported in two case control studies for weekly drinking 





2.11.3.1 Results: alcohol and risk of lung cancer by histological subtype 
Five papers reported on the association between alcohol consumption and lung cancer by histological 
subtype (adenocarcinoma, small cell and squamous cell). Overall, across the majority of studies, when 
comparing the highest alcohol exposure to the lowest exposure category, the effect of alcohol 
consumption was stronger and more consistent across studies for adenocarcinoma of the lung, 
compared to squamous cell (SCC) of the lung and small cell carcinoma. However, point estimates for 
all tumour types were rarely of statistical significance and with wide confidence intervals. A summary 
of lung cancer risk estimates, comparing the highest versus the lowest alcohol category by histological 
subtype, is presented in Figure 2.11.2 
The pooled analysis of seven prospective cohort studies by Freudenheim et al (2005) contained the 
largest number of lung cancer cases for each histological subtype (approximately 600 cases). In this 
analysis, there was some evidence that alcohol consumption at the highest alcohol exposure (>30 g/d), 
compared to non-drinkers, was more strongly associated with the risk of adenocarcinoma in both men 
(RR 1.44, 95% CI 1.10-2.06 p value for trend =0.10) and women (RR 1.40, 95% CI 0.98-1.98 p value 
for trend <0.01), and with the risk of small cell tumours in men (RR 1.65, 95% CI 1.19-2.29, p value 
for trend <0.01). However, intake at lower levels was not associated with an increase in risk of any 
tumour type and the difference in the RRs was not significant; for men and women drinking >30 g/d 
category (Freudenheim et al 2005). 
Figure 2.11.2 Alcohol consumption and lung cancer, highest versus lowest exposure category, by 









































OR/RR, highest vs lowest exposure category
 
 
2.11.4 Results: drinking dimensions and risk of lung cancer  
One study, from Finland, reported on the association between ‘binge’ drinking, defined as drinking 
>70 grams
19
 in one drinking session, in men and risk of lung cancer (Toriola et al 2009). The RR of 
lung cancer among binge drinkers in the whole cohort was 1.89 (95% CI 1.10-3.20) compared to non-
binge drinkers in men. In an analysis restricted to smokers alone, the RR of lung cancer among binge 
drinking smokers, compared with non-binge drinking smokers, was 1.79 (95% CI 1.03-3.12). 
2.11.5 Results: drink type and risk of lung cancer 
Nine studies reported on the risk of lung cancer by type of alcoholic drink (beer, wine and spirits). A 
summary of lung cancer risk estimates from all the studies comparing the highest versus the lowest 
alcohol category is presented in Figure 2.11.3. 
 
                                                          
19 equivalent to the consumption of (i) six or more bottles of beer; (ii) one or more big bottle (75 cl) of mild 
wine;(iii) three-fourth or more of one big bottle (75 cl) of strong wine and (iv) >5 portions of hard liquor 
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Figure 2.11.3 Alcohol consumption and lung cancer, highest versus lowest exposure by drink type 
(odds ratio/relative risk and 95% confidence intervals) 
wine


























































In a cohort study, comprising of male teachers, Chao et al (2008) did not find any clear association 
between risk of lung cancer and beer, white wine, and spirit drinking. The RR estimates for 
consuming ≥1 d/d of beer, white wine, and liquor were 0.78 (95% CI 0.45-1.35), 0.87 (95% CI 0.31-
2.40), and 0.93 (95% CI 0.54-1.58). An inverse association for red wine intake, however, was 
suggested by a linear model in which level of red wine intake was modelled as a continuous variable 
(RR 0.98; 95% CI 0.97-1.00; p value for trend =0.06). 
 
2.11.6 Results: effect modification  
Four studies examined the interaction between alcohol and smoking on the risk of lung cancer. In a 
pooled analysis, Freudenheim et al (2005) reported a statistically significant increased risk of lung 
cancer in  men who had never smoked and who drank  ≥15 g/d (RR 6.38, 95% CI 2.74-14.9; p value 
for trend <0.001), compared to non-smokers and non-drinkers. No association was observed with lung 
cancer for men who were current smokers and who drank up to and including ≥15 g/d. For women 
who were non-smokers, and drinking ≥15 g/d, the increase was more modest and the confidence 
interval included the null (RR 1.35, 95% CI 0.64-2.87; p value for trend =0.98), but the estimate was 
based on only 8 cases. There was no association with lung cancer among women who were current 
smokers and drinking up to and including ≥15 g/d. 
Rohrmann et al (2006), however, in a European prospective cohort study, reported no association 
between lung cancer and never smokers who were non-drinkers, and or who drank between 5-60 g/d, 
compared to those drinking 0.1-4.9 g/d. Former and current smokers who were non-drinkers had a 
modest non-significant increased risk of lung cancer (45% and 27% respectively), but no association 
was reported at any alcohol intake level up to ≥60 g/d for former and current smokers. In a Japanese 
cohort (Shimizu et al 2008), the relative risk for male non-smokers who drank >450 g/w compared 
with occasional drinkers was 0.58 (95% CI 0.26-1.30, p value for trend =0.49). Among current 
smokers (defined by length of time an individual smoke), the RR of lung cancer for men who drank 
>450 g/w, compared with occasional drinkers, was 1.69 (95% CI 1.05–2.72, p value for trend =0.02).  
In a Canadian case-control study, Benedetti et al (2006) observed no strong evidence of any effect 
modification by cigarette smoking in men or in women drinking >7 d/w, compared to those who 
never drank weekly. This lack of relationship was consistent across all categories of smoking; light, 
moderate and heavy smoking (Pinteraction=0.52 and 0.54 in men and women, respectively). 
 
2.11.7 Summary and conclusions 
This review identified 14 papers (seven prospective cohort studies, five case control studies, one 
pooled analysis and one meta-analysis), published between 1999 and 2009, that examined the 
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association between alcohol consumption and lung cancer. Studies were of moderate to high quality. 
Overall, there was inconsistent evidence of an association between alcohol consumption and lung 
cancer perhaps as a result of the strong effect of smoking on lung cancer risk, the likely weak effect of 
alcohol, the heterogeneity of reference groups and the different size of the studies. The large 
prospective cohort studies in the present review (including the pooled analysis) provided weak 
evidence for an association between alcohol consumption and lung cancer risk. Evidence of a dose 
response trend in risk was weak and confidence intervals for the risk estimates in the highest alcohol 
consumption category (>30 g/d) included the null. Although the evidence of a weak positive 
association was more consistently observed in men, too few studies reported women drinking at 
comparable levels to men and evidence of a gender differences in lung cancer risk associated with 
alcohol consumption in the pooled analysis was inconclusive. A weak association between high levels 
of alcohol consumption and lung cancer risk reported in the present study is consistent with the 
findings of other reviews (Bandera et al 2001, WCRF/AICR 2007) and that reported in a meta-
analysis of twelve cohort and thirteen case control studies published before 1999 which reported that 
the evidence for a smoking-adjusted association between alcohol and lung cancer risk was limited to 
very high consumption groups (>60 g/d) in cohort and hospital-based case-control studies (Korte et al 
2002). 
In three prospective cohort studies, low levels of drinking were reported to be protective, against lung 
cancer in women, but not in men though in each study different reference groups were used; 0 grams 
per day (Freudenheim et al 2005), <1 d/w (Prescott et al 1999) and not drinking weekly (Benedetti et 
al 2006). In each study, former drinkers were also included in the reference. Boffetta (2005) observed 
that whilst it might be possible to provide a mechanistic interpretation for these findings e.g., by 
postulating a stronger reduction in C-reactive protein concentrations among female than male 
drinkers, as suggested in a few studies (Stewart et al 2002, Albert et al 2003), the suggestion of a 
protective effect should be treated with caution until replicated in other large cohort studies. 
It has been previously reported that the effect by alcoholic beverage type on the risk of lung cancer is 
not clear, but studies seem to indicate that beer and spirits may increase risk, whereas moderate wine 
consumption may be protective (Bandera et al 2001). The findings of this review, based primarily on 
a meta-analysis of studies reporting on the association between drink type and lung cancer (Chao 
2007), support the hypothesis of a protective effect of wine compared to an increased risk observed 
from spirit and beer drinking. Chao (2007) in a meta-analysis of cohort and case control studies  
published before February 2007, observed an inverse association for wine drinking and lung cancer risk 
when all studies (case control and cohort studies) were combined and in all subgroup analyses. The 
inverse association was suggested for both the average drinking level of <1 d/d (for all studies: RR 
0.77, 95% CI 0.59-1.00, p test for Heterogeneity <0.01) and for ≥1 d/d (for all studies: RR 0.78, 95% 
CI, 0.60-1.02, p test for Heterogeneity =0.03). The meta-analysis showed a positive association (RR 
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1.25; 95% CI 1.06-1.48, P value for test of heterogeneity 0.11) between average beer drinking of ≥1 
d/d and lung cancer risk. For average beer drinking of <1 d/d, an inverse association was suggested 
(RR 0.78; 95% CI 0.64-0.95, p test for Heterogeneity=0.01). This J-like pattern for the dose-specific 
risk estimates was found in both case-control and cohort studies. Average liquor consumption of ≥1 
d/d was also found to be significantly associated with increased lung cancer risk (RR 1.25, 95% CI 
1.04-1.51, p test for Heterogeneity= 0.02). 
A protective effect from wine drinking may also support the inverse association observed for low 
levels of drinking and lung cancer in women who are more likely to be wine drinkers than men, 
though this could be mediated by the association of both wine drinking and smoking with social class 
Furthermore, what is not clear, is whether drinking heavy amounts of wine increase the risk of lung 
cancer since estimates by Chao (2007) are for low to moderate levels of drinking (>1 d/d). Studies 
included in this review were unable to report on this aspect since so few drinkers in their study 
population drank large amounts of wine. 
Previously the relationship with alcohol by lung cancer cell type has been questioned due to 
inconsistent findings based on very small numbers with reported differences being attributed to 
chance (Bandera et al 2001). Overall, in this review a stronger effect for adenocarcinoma of the lung 
from drinking alcohol was reported, compared to SCC and small cell tumours although estimates 
again were based on small numbers. This effect was observed across all five prospective cohort 
studies reporting on this aspect of the alcohol-lung cancer association. Chance findings due to 
measurement bias, misclassification of tumour type or residual confounding from smoking or other 
risk factors may well explain the increased risk of adenocarcinoma of the lung, but the fact that this 
association with alcohol consumption was observed consistently across cohort studies merits further 
investigation.  
Selection and measurement bias may contribute to some of the associations reported for overall 
alcohol intake, drink type and histological sub-type, but the main concern in the interpretation of these 
associations is residual confounding by some other factors. Boffetta (2005) observed that residual 
confounding by tobacco smoking is one of the main concerns in the interpretation of the increased 
risk among heavy drinkers. Heavy drinkers may also be more than likely to be heavy smokers and 
misclassification of smoking exposure at these high levels may well explain some of the associations 
reported (Korte et al 2002). Although all of the studies included in this review considered cigarette 
smoking as a confounder of this association, it was controlled for in different ways, undoubtedly 
resulting in varying degrees of residual confounding by smoking. Measurement error in measured 
aspects of smoking (i.e., smoking status, duration of smoking, and amount smoked) and variations in 
other unmeasured aspects (i.e., depth of inhalation and length of time that smoke is held in the lungs) 
may have an effect on the estimation of the risk of lung cancer from other factors correlated with 
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smoking, such as alcohol (Bandera et al 2001, Zang et al 2001, Freudenheim et al 2005). Recent 
simulations have also suggested that even a moderate misclassification of smoking status might 
explain most of the results reported in the literature (Korte et al 2002, Fewell et al 2007). Residual 
confounding from smoking may, however, only be part of the answer. Very few studies in this review 
fully controlled for socio-economic status (SES) despite the well established links between SES and 
lung cancer incidence and mortality (van Loon et al 1995a; 1995b, Brown et al 1997, Singh et al 
2002). Residual confounding from SES could well explain some of the associations, positive and 
negative, reported between lung cancer and specific drink types. Furthermore, the effects of diet were 
poorly addressed in all studies included in this review and some weak evidence exists of a possible 
effect modification by dietary factors such as Vitamin A or vegetable intake (Bandera et al 2001).  
In conclusion, there is some weak evidence of an association between alcohol consumption and risk 
of lung cancer though this is only apparent for consumption of more than thirty grams per day. Drink 
type, especially wine, may modify the effect of alcohol on the risk of lung cancer. Residual 





2.12 Oesophageal cancer  
Oesophageal cancer: summary of evidence from previous reviews 
Epidemiological studies clearly indicate that alcohol consumption is causally related to 
cancer of the oesophagus. There is no indication that the effect is dependent on type of 
beverage (IARC 1988b, WCRF/AICR 1997). 
 
The literature search identified 26 papers from twenty three studies, published between 1999 and 
2009, which examined the relationship between alcohol consumption and oesophageal cancer. There 
were six prospective cohort studies and 20 case control studies. Three papers, derived from two 
pooled case control studies carried out in Italy and Switzerland, were retained in the review because 
each paper reported on a different aspect of the relationship between alcohol and oesophageal cancer; 
risk among men (Zambon et al 2000), among women (Gallus et al 2001) and by drink type (Bosetti et 
al 2000a). A UK case control study contributed two papers reporting on the association between 
alcohol consumption and oesophageal cancer by tumour type; squamous cell carcinoma (Sharp et al 
2001) and adenocarcinoma (Cheng et al 2001). Tables for each study describing the study aims, 
population, alcohol measurement methods and main results are provided in Appendix D. 
 
2.12.1 Study characteristics 
A summary of the general characteristics of the studies by study type is provided in Tables 2.12.1 
(cohort studies) and 2.12.2 (case control studies).  























101/18,143 45-64 city population 
representative 
random sample 





























Abb: n/s not specified; M=mean; Mdn= median  
 
Five cohort studies looked at incident cases of oesophageal cancer as an outcome and Sakata et al 
(2005) at the association between oesophageal cancer mortality and alcohol consumption. The largest 
cohort study, based in China, identified approximately 2000 incident cases of oesophageal cancer 
(Tran et al 2005). Two cohort studies reported on the association between alcohol consumption and 
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oesophageal cancer in women only (Kasum et al 2002, Allen et al 2009) and one study in men only 
(Fan et al 2008). 
Table 2.12.2 Alcohol and oesophageal cancer: general characteristics of case control studies  
Authors  Year  Country Case/control Age 
range 
(M/Mdn) 
Sample base  Sample selection  
Boony’at 2002 Thailand 202/261 (M=64) hospital 
consecutive/ non-
random selection 

















830/1,779 (M=64/63) hospital 
consecutive/ non-
random selection 


































Lagergren 2000 Sweden 356/820 n/s general population 
consecutive/random 
selection 














51/1,370 18-74 hospital n/s 




346/11,936 40-79 hospital 
consecutive/ non-
random selection 



















Zambon 2000 Italy 275/593 
39-77 
(M=60) 
See Bosetti 2000 
Znaor 2003 India 566/3,638 >25 hospital 
not specified/non-
random selection 
1 Argentina, Brazil, Paraguay and Uruguay; 2 Romania, Poland, Russia and the Czech Republic. Abb: n/s not specified; 
M=mean; Mdn= median  
 
Study size was modest for the majority of case-control studies (Table 2.12.2). Of the seventeen case 
control studies, six studies identified more than 500 cases and controls. The largest case control study 
identified in this review involved 1181 cases and 1650 controls, pooled from three case control 
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studies across South America (Ibiebele et al 2008). Two studies identified less than 100 incident cases 
of oesophageal cancer (Cheng et al 2001, Pacella-Norman et al 2002). 
 
2.12.2 Study Quality 
The quality scores assessed according to the NOS are presented in Table 2.12.3. Overall, cohort 
studies were of a moderate to high quality with two studies achieving maximum stars (Kasum et al 
2002, Fan et al 2008). Case control studies were of more mixed quality ranging from five stars 
(Castellsagué et al 1999, Wang et al 2008) to eight stars (Lagergren et al 2000, Vioque et al 2008).  
All the cohort studies scored a maximum of four stars for sample selection. For outcome assessment, 
Freedman et al (2009) and Sakata et al (2005) only achieved two stars because no statement was 
provided on losses during follow-up in each study and Tran et al (2005) because they did not secure 
independent confirmation of outcome diagnosis relying instead on self-reports from the study 
population. 
Table 2.12.3 Oesophageal cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Allen 2009 4 2 3 9 
Freedman 2007 4 2 2  8 
Fan 2008 4 2 3 9 
Kasum 2002 4 2 3 9 
Sakata 2005 4 1 2 7 
Tran 2005 4 1 2 7 
Case-control     
Boonyaphiphat 2002 3 2 1 6 
Bosetti 2000a, Gallus 
2001, Zambon 2000 
3 2 1 6 
Brown 2001  3 2 2 7 
Cast'gue 1999 1 2 2 5 
Cheng 2000, Sharp 
2001 
3 2 2 7 
Engel 2003 3 2 2 7 
Hashibe 2007 3 2 2 7 
Ibiebele 2008 3 2 1 6 
Lagergren 2000 3 2 3 8 
Lee 2005 2 2 1 6 
Lindblad 2005 3 2 2 7 
Pacella 2002 3 2 2 7 
Takezaki 2000 2 2 3 7 
Vioque 2008 3 2 3 8 
Wang 2007 3 1 1 5 
Wu 2001 3 2 2 7 
Znaor 2003 3 2 1 6 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for selection, 
two stars for comparability and three stars for assessment: 
1 




For sample selection in the case control studies, the majority of studies secured three stars out of four 
because either they used cases and controls from a hospital or clinical setting or failed to confirm that 
cases of oesophageal cancer were not present in their study population. Further selection bias in 
recruitment of controls was addressed in four case control of studies by excluding, from their control 
sample, subjects admitted to hospital for alcohol or tobacco related diseases in order to avoid 
overrepresentation of smokers and drinkers compared to the source populations (Boonyaphipat et al 
2002, Bosetti et al 2000a etc, Castellsague et al 1999, Zambon et al 2000). 
Non-response bias did not appear to be a problem for the hospital based case control studies as in the 
four studies that reported on this aspect, all had response rates over 90% for both cases and controls. 
For the majority of remaining population based studies, response rates ranged from between 62%-
72% for cases and 65%-75% for controls. Six case control studies, four hospital and two population 
based, did not report response rates. The extent of interviewer bias was not clear as the majority of 
case control studies did not specify blinding status in the study. In two studies that did reported on 
this, interviewers were not blinded to case or control status, but they were unaware of the study 
hypothesis (Lagergren et al 2000, Wu et al 2001). Outcome measurement was clearly defined in the 
majority of studies. This was done through histological confirmation of oesophageal cancer in the 
majority of studies. In one study, however, outcome measurement was based on a review of medical 
records held in a general practice database without histological confirmation (Lindblad et al 2005).  
Adjustment for smoking took place in the majority of studies reporting on the association between 
alcohol consumption and oesophageal cancer with the exception of two prospective cohort studies 
(Sakata et al 2005, Tran et al 2005). There was considerable variation in how smoking was controlled 
for in the studies reviewed. The most common approach taken in seven studies was simply to control 
for smoking status (i.e. never, ever, current and former smoker). The remaining studies controlling for 
smoking, either adjusted for number of years smoked (Sharp et al 2000), or pack years smoked 
(Kasum et al 2002, Lee et al 2005, Takezaki et al 2000) or the amount of cigarettes smoked per day 
(Castellsagué et al 1999, Gallus et al 2001, Zambon et al 2000) or packs of cigarettes (Brown et al 
2001) smoked per day. The majority of Asian based studies, with the exception of Sakata et al (2005) 
and Takezaki et al (2000) also controlled for betel quid chewing, a practice common in southern Asia 
and linked to an increased risk of oesophageal cancer. The possible protective effects of raw fruit and 
vegetable consumption against oesophageal cancer was controlled for in only five studies (the 
majority of these based in Europe), with one American cohort study (Kasum et al 2002) further 
adjusting for whole or refined grain intake also linked with a protective effect against oesophageal 
cancer. The most common proxy indicator used for socio-economic status was education, usually 
levels or years of schooling, and this was controlled for in eight studies. Other SES related variables 




Obesity is regarded as a major risk factor for oesophageal adenocarcinoma and was controlled for in 
two of the four studies investigating association between this tumour type and alcohol consumption 
either directly in terms of body mass index measurement (Lagergren et al 2001) or indirectly through 
slimming practices (Cheng et al 2000). Gastroesophageal reflux was also controlled for by Lagergren 
et al (2001) and Lindblad et al (2005). Three of the four studies adjusted for smoking status with the 
exception of Cheng et al (2000). 
 
2.12.3 Results: total alcohol intake and risk of oesophageal cancer20 
Twenty studies, providing 23 papers, reported on total alcohol consumption and risk of oesophageal 
cancer either as a single entity (see below) or by tumour type: squamous cell carcinoma (see section 
2.12.3.1) or adenocarcinoma (see section 2.12.3.2). Nine studies, providing 11 papers reported on the 
association between oesophageal cancer (including tumour type); and ‘recent’ alcohol intake defined 
as alcohol consumption in the preceding year in eight studies (Bosetti et al 2000*, Zambon et al 
2000*, Gallus et al 2001*, Takezaki et al 2000, Engel et al 2003, Lee et al 2005, Tran et al 2005, 
Freedman et al 2008, Ibiebele et al 2008, Vioque et al 2008) and in the previous six months by Sakata 
et al (2005). Three studies providing four papers reported by lifetime consumption; defined as alcohol 
consumption 20 years before survey interview by Lagergren et al (2000) and drinking in a typical 
week during specific age periods (at ages 25, 40, 50 and 60) by Hashibe et al (2007). In two studies, 
providing three papers, the lifetime measure of alcohol consumption was not defined (Castellsague et 
al 1999, Cheng et al 2000** Sharp et al 2001**). In the remaining seven studies, the reference period 
was not specified (Brown et al 2001, Wu et al 2001, Boonyaphiphat et al 2002, Kasum et al 2002, 
Znaor et al 2003, Lindblad et al 2005, Fan et al 2008). 
Six studies reported on association between alcohol consumption and oesophageal cancer only. A 
summary of oesophageal cancer risk estimates, comparing the highest versus the lowest alcohol 
exposure category, is presented in Figure 2.12.1. 
Irrespective of study design, all studies reported a statistically significant increased risk of 
oesophageal cancer across a range of alcohol intake levels. In an American cohort study, women, 
drinking >2 drinks per day [d/d], compared to 0 d/d, had a two-fold increased risk of oesophageal 
cancer though no confidence intervals were reported (Kasum et al 2002). Fan et al (2008), reported 
that men drinking >20 grams p/d [g/d], compared to non-drinkers, were also at increased risk of 
oesophageal cancer, with risk increasing with amount drunk, up to the highest exposure category (≥80 
g/d, p value for trend <0.001). A statistically significant dose response relationship between daily 
alcohol intake and increased risk of death from oesophageal cancer was observed in a Japanese 
                                                          
20
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
*all from the same case control study carried out in Italy (see Table 2.12.1) 
** from the same UK case control study (see Table 2.12.1) 
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prospective cohort among daily drinkers drinking ≥3 units per day (p value for trend =0.028), 
compared to never drinkers (Sakata et al 2005). Three hospital based case control studies also 
identified a statistically significant increased risk of oesophageal cancer. Compared to never drinkers, 
Znaor et al (2003) and Takezaki et al (2000) reported positive associations between cancer of the 
oesophagus among those drinking >50 millilitres per day [ml/d]
21
 and in men drinking >5 d/d, 
respectively. The largest risk estimate (OR 12.35, 95% CI 8.37-18.21) was reported in an Italian 
hospital based case control study for those drinking ≥12 d/d compared to those <3 d/d. In the same 
study, even those drinking 3-4 d/d had a twofold, statistically significant, increased risk of 
oesophageal cancer (Bosetti et al 2000a). 
Figure 2.12.1 Alcohol consumption and oesophageal cancer: highest versus lowest exposure 














                                                          
21
 1 gram = 1.25 millilitres 
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2.12.3.1 Alcohol consumption and risk of squamous cell carcinoma of the 
oesophagus 
Fifteen papers from 14 studies reported on the association between total alcohol consumption and 
oesophageal squamous cell carcinoma (SCC). Of these, 13 studies reported on the dose response 
association between alcohol consumption and oesophageal SCC. A summary of SCC risk estimates, 
comparing the highest versus the lowest alcohol exposure category, is presented in Figure 2.12.2. In 
the remaining study, not included in Figure 2.12.2, Tran et al (2002), observed no association between 
current drinking status and SCC (RR 1.03, 95% CI 0.82-0.92), compared to never and former 
drinkers. 
In a large UK prospective cohort study (Allen et al 2009), women drinking at the highest alcohol 
exposure category (>15 drinks per week [d/w]), compared to those drinking <2 d/w had a two-fold 
statistically significant increased risk of oesophageal SCC. Positive, but non-statistically significant, 
associations were observed at all other alcohol intake levels with a statistically significant dose 
response relationship (p value for trend =0.02). In the same study, never-drinkers had a 60% (RR 
1.56, 95% CI 1.29-1.89) increased risk of oesophageal SCC, compared to the reference group (Allen 
et al 2009). Freedman et al (2008), in a US prospective cohort study also reported statistically 
significant positive associations for those drinking <1-3 and >3 d/d, compared to those drinking >0-1 
d/d with strong evidence of a statistically significant dose response trend (p value for trend <0.0001). 
Non-drinkers had a two-fold increased risk (RR 2.06, 95% CI 1.16.368) of oesophageal SCC. 
In the case control studies using low to moderate drinkers as a reference group, there was also clear 
evidence of an increased risk of SCC, from moderate to heavy alcohol consumption, with statistically 
significant dose response relationships. Zambon et al (2005) reported the risk of oesophageal cancer 
steeply rising with increasing level of alcohol consumption (>84 d/w p value for trend <0.001) 
compared to light drinkers (1-20 d/w). Gallus et al (2001) found a statistically significant dose 
response relationship (p value for trend <0.001) between average weekly lifetime alcohol 
consumption and increased SCC risk for women drinking ≥3 d/d, compared to <1 d/d. In a UK based 
nested case control study, Lindblad et al (2005) only reported a statistically significant association for 
those drinking >34 units p/w [u/w], compared to those drinking 0-2 u/w, but not for those drinking 3-







Figure 2.12.2 Alcohol consumption and SCC of the oesophagus: highest versus lowest exposure 
category, by study type (odds ratio/relative risk and 95% confidence intervals)  

















OR/RR, highest vs lowest exposure category
 
In those studies using ‘abstainers’ as a reference group the reported associations with SCC were less 
consistent. In four hospital based case control studies (Castellsagué et al 1999, Boonyaphiphat et al 
2002, Lee et al 2005; p value for trend <0.0001, Hashibe et al 2007b; p value for trend =0.01), alcohol 
consumption at all levels was associated with an increased risk of SCC of the oesophagus. Viogue et 
al (2008), in a Spanish based hospital case control study reported a strong statistically significant dose 
response for their study population (≥75 g/d; OR 7.65, 95% CI 3.16-18.49 p value for trend 
<0.00001). In the same study drinking 1-24 g/d was associated with a small and statistically non-
significant increased risk of SCC (OR 1.16, 95% CI 0.54-2.49). Similar findings were reported in two 
population based case control studies; Lagergren et al (2001) although observing a threefold increase 
in risk of SCC, for those drinking >70 u/w (OR 3.1, 95% CI 1.4-6.7) compared to abstainers, found no 
association for those drinking <70 u/w. Engel et al (2003) only observed a statistically significant 
increased risk of SCC for those drinking ≥5 d/w, compared to never drinkers. In a small nested case 
control study in the UK, involving less than a hundred cases and controls, Sharp et al (2001) observed 
a positive association between average weekly lifetime alcohol and an increased risk of  SCC in 
women drinking ≥14 u/w; (OR 1.23 95% CI 0.44-3.37), compared to non-drinkers, but no association 
with SCC in women drinking <2 u/w (OR 0.80, 95% CI 0.47-1.37 or ≥2->14 u/w OR 0.75, 95% CI 




2.12.3.2 Alcohol consumption and risk of oesophageal adenocarcinoma 
Two cohort and five case control studies reported on the association between alcohol consumption 
and oesophageal adenocarcinoma. A summary of oesophageal adenocarcinoma risk estimates, 
comparing the highest versus the lowest alcohol exposure category, is presented in Figure 2.12.3 
Figure 2.12.3 Alcohol consumption and oesophageal adenocarcinoma: highest versus lowest 
exposure category by study type (odds ratio/relative risk and 95% confidence intervals)  










OR/RR, highest vs lowest exposure category
 
 
In two prospective cohort studies, alcohol consumption at any level including the highest exposure 
category (>3d/d), compared to moderate drinkers, was not associated with an increased risk of 
oesophageal adenocarcinoma with no evidence of a dose response relationship; p value for trend =0.2 
(Allen et al 2009) and p value for trend =0.68 (Freedman et al 2008). Allen et al., however, observed 
a small statistically significant increased risk of oesophageal adenocarcinoma in never-drinkers (RR 
1.28, 95% CI 1.01-1.63). 
Two case control studies reported increased risks of oesophageal adenocarcinoma associated with 
alcohol consumption. Hashibe et al (2007b) observed a non-significant increased risk of oesophageal 
adenocarcinoma risk for all intake levels (maximum >420 g/w) though there were only approximately 
10 cases in each intake category Lindblad et al (2005) observed a positive association between >34 
u/w and an increased risk of adenocarcinoma (OR 1.25, 95% CI 0.61–2.55) though there were only 
nine drinkers in this category. There was no association (OR 1.06, 95% CI 0.76–1.49) with 
oesophageal adenocarcinoma in the category with the largest number of drinkers (3-15 u/w, n=59).  
In two population based case control studies, ‘lifetime’ drinking was inversely associated with 
oesophageal adenocarcinoma. Cheng et al (2001) reported similar odds ratios for all alcohol intake 
levels (average >14 u/w over lifetime; OR 0.66, 95% CI 0.08-4.96, p value for trend =0.074), 
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compared to non-drinkers. Lagergren et al (2002) reported similar findings for those reporting 
drinking >70 u/w (OR 0.6, 95% CI 0.3-1.1) twenty years prior to the study, compared to never 
drinkers. 
2.12.4 Results: drinking dimensions and risk of oesophageal cancer  
In two studies drinking frequency was associated with an increased risk of cancer of the oesophagus. 
Wang et al (2007) observed an increased risk of SCC of the oesophagus in both daily (OR 2.32, 95% 
CI 1.53-3.53) and occasional drinkers (OR 1.99, 95% CI 1.21-3.27), compared to never drinkers. In a 
South African case control study, compared to non-drinkers, frequent drinking (OR 1.8, 95% CI 1.2-
2.8), but not weekly (OR 0.7, 95% CI 0.4-1.3) or occasional drinking (OR 0.7, 95% CI 0.3-1.5) 
increased the risk of oesophageal cancer. 
The association between drinking duration and risk of oesophageal cancer was investigated by five 
studies with mixed results. A Taiwanese hospital control study (Lee et al 2005) observed a 
statistically significant dose response relationship (p value for trend =0.0001) between duration of 
drinking and increased risk of SCC, compared to never drinkers. After further adjusting for the 
amount of alcohol consumed or length of time alcohol was consumed, it was found that the amount of 
alcohol consumed had a stronger effect (OR 2.29, 95% CI 1.69–3.08) on the development of SCC 
than the length of time over which it had been consumed (OR 1.84, 95% CI 1.55–2.18). Hashibe et al 
(2007b) and Fan (2008) both observed a statistically significant increased risk of SCC in those 
drinking >20 years, but no association with SCC for those drinking <20 years. Castellsagué et al 
(1999) and Vioque et al (2008) reported a statistically significant odds ratio for each exposure level of 
drinking duration among men, compared to never drinkers, though no dose response relationship was 
evident. There was no clear pattern among women for years of alcohol drinking and risk of 
oesophageal cancer. Zambon et al (2000) reported no association between duration of drinking and 
oesophageal cancer in men compared to those drinking less than 45 years.  
2.12.5 Results: drink type and risk of oesophageal cancer 
Eleven studies identified in the present review, investigated the relationship between alcohol drink 
type and oesophageal cancer. Six studies reported on the dose response association between drink 
type and oesophageal cancer and a summary of risk estimates, comparing the highest versus the 
lowest alcohol exposure category is presented in Figure 2.12.4. The remaining five studies reported on 
the association between drink type and oesophageal cancer, by drinking status. Four studies reported 
statistically significant associations between ‘current’ drinkers of wine, beer and spirits, compared to 
non-drinkers. The highest odds ratios were often reported for the most commonly consumed beverage 
in the study; arrack (Znaor et al 2003), sake and sochu (Sakata et al 2005), wine and spirits 
(Castellsagué et al 1999, Lee et al 2005). Hashibe et al (2007b) reported a non-significant inverse 
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association between current drinkers or either beer, wine or spirits, compared to a reference group 
comprising of drinkers of all three drink types. 
Figure 2.12.4 Alcohol consumption and oesophageal cancer, by drink type (odds ratio/relative risk 
and 95% confidence intervals) 
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In four of the six studies reporting on the dose response association (Figure 2.12.4), a statistically 
significant increased risk of oesophageal cancer was only reported in the most frequently consumed 
drink type in each study irrespective of the reference group in each study; Zambon et al (2000) 
reported a clear trend in risk (p value for trend <0.001) for wine drinkers compared to abstainers; 
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Lagergren et al (2002) for spirit drinkers (ptrend <0.0001) compared to never drinkers; Freedman et al 
(2007) for beer (p value for trend =0.0002) and spirit drinkers (p value for trend <0.0001) compared 
to those drinking <1 d/d and Bosetti et al (2000a) for wine drinkers at all exposure levels, with a clear 
trend in risk up to an including more than 12 drinks p/d compared to those drinking 1-2 d/d. In the 
remaining study, Ibiebele et al (2008) observed that beer consumption of >1 d/d, compared to never 
drinkers, had a statistically significant increased risk of oesophageal cancer, but not for those drinking 
<1 d/d (p value for trend =0.05).  
Four studies reported on drink type and risk of oesophageal adenocarcinoma (Table 2.12.4). Hashibe 
et al (2007b) and Ibiebele et al (2008) reported no association between adenocarcinoma of the 
oesophagus and drink type among current drinkers. In two studies, the most commonly drunk 
beverage type was reported to have a statistically significant inverse association with adenocarcinoma 
of the oesophagus. Wu et al (2001) observed a dose response protective effect of beer drinking (p 
value for trend =0.001) and Lagergren et al (2000) for spirit drinkers consuming >30 g/w. compared 
to those who never drank spirits. 
Table 2.12.4 Risk of oesophageal adenocarcinoma by drink type 
Author Measure/Ref. group Drink type 
Hashibe 2007b Current drinkers/ Beer 
+ Wine + Spirits 
            Beer                          Liquor 
        0.88 0.16–4.91      0.74 0.17–3.29 
Ibiebele 2008 Times per day/ Never 
drinkers of beer 
                       Beer 
Low                1.10 (0.70–1.71) 
Moderate       0.68 (0.45–1.02) 
High               0.74 (0.47–1.16)  
Lagergen 2000 Grams per week/Never 
drinker of specified 
drink type 
               Strong beer                 Wine                   Spirits 
1–5           1.3 (0.7–2.3)         0.8 (0.5–1.5)           0.6 (0.3–1.2) 
6–25         1.0 (0.6–1.9)         0.9 (0.5–1.7)           1.1 (0.5–2.2) 
>25           1.2 (0.6–2.3)         1.2 (0.7–2.1)           2.3 (1.1–4.7) 
Wu 2001 never drank/ 
Drinks per week 
 
d/w               Beer                    Wine               Spirits 
<7      0.44 (0.3–0.7)    0.86 (0.6-1.3)   0.93  (0.6-1.4) 
7-14   0.30 (0.2-0.5)     0.72 (0.4-1.3)   1.35  (0.8-2.3) 
15+    0.57 (0.3-1.0)     1.27 (0.6-2.8)   1.34  (0.8-2.3) 
ptrend         0.001                   0.40                  0.17 
 
2.12.6 Results: effect modification 
Four studies reported on the combined effect of alcohol and smoking on the risk of oesophageal 
cancer.  
Castellsagué et al (1999) observed a strong and highly significant dose response (p value for trend 
<0.000001) relationship between an increased risk of oesophageal cancer and average number of 
cigarettes smoked per day and average amount of alcohol consumed per day among male patients. In 
this study, point estimates for even low to moderate consumers of both alcohol and cigarettes were 
above one though no confidence intervals were provided in data tables to determine the significance 
of these estimates. In a Swedish population case control study (Lagergren et al 2000), combined 
intake at the highest exposure level (long term smokers of >35 years and heavy alcohol users drinking 
162 
 
>70g/w) significantly increased the risk, compared to never users, of squamous cell oesophageal 
carcinoma (OR 23.1, 95% CI 9.6-56.0), but not of oesophageal adenocarcinoma (OR 2.3, 95% CI 0.9-
5.7). In an Italian hospital based study, compared with never-smokers/non or light drinkers, the risk of 
oesophageal cancer also increased with increasing alcohol consumption in each stratum of smoking 
habit (Zambon et al 2000). The authors also noted that the risk increase for the highest joint level of 
alcohol drinking (>60 d/w) and current smoking was compatible with a multiplicative model 
(Pinteraction=0.27). From the same case control study, Gallus et al (2001) also observed that the 
combined effect of low alcohol intake and smoking status increased the risk of squamous cell 
oesophageal cancer among women; Female patients who were current smokers and drank ≥3 d/w had 
an OR of 12.75 (95% CI 5.09-31.96), compared to non current smokers who were drinking <1 d/w.  
 
2.12.7 Summary and conclusions 
This review identified 26 papers from 23 studies that examined the risk of oesophageal cancer and 
alcohol consumption. Overall the majority of studies were consistent in reporting a statistically 
significant dose response relationship between alcohol consumption and risk of squamous cell 
carcinoma (SCC) of the oesophagus, in line with the already substantial body of evidence establishing 
alcohol as major risk for oesophageal SCC (IARC 1988, Corrao et al 1999, 2004, Baan et al 2007, 
WCRF/AICR 2007). Studies ranged in quality, but whilst issues of selection bias through poor 
response rates among cases and controls or recall bias may affect the size of the risk estimates they 
will not alter the underlying positive association between alcohol consumption and SCC of the 
oesophagus. In studies reporting by gender, risk estimates for men tended to be higher than those for 
women, but then men tend to drink more and in greater numbers than women and it is unlikely that 
male drinkers are necessarily at any greater relative risk of SCC than female drinkers. Specific 
alcoholic beverages were also shown to increase the risk of SCC though in each study this was the 
most obvious for the most consumed type drink in the study’s country/region of origin e.g. wine in 
Italy (Bosetti et al 2000), arrack in India (Znaor et al 2003), sake in Japan (Sakata et al 2005) and 
spirits in Sweden (Lagergren et al 2001). These findings support the conclusion that ethanol is the 
main component of alcoholic beverages that determines the risk of oesophageal cancer, and that the 
most frequently consumed beverage in each area tends to be the one with the highest estimated and 
statistically significant relative risk (Boffetta and Hashibe 2006).  
Six studies were identified in this review that reported on risk of oesophageal adenocarcinoma from 
alcohol consumption. In all these studies, no association was found between this tumour type and 
alcohol consumption which is consistent with the findings in previous case-control studies (Boffetta 
and Hashibe 2006). This is of particular relevance in western countries, especially in the US and UK, 
163 
 
where incidence rates of SCC are decreasing and those of adenocarcinoma are increasing rapidly 
(Takezaki et al 2005).  
Average daily alcohol intake (usually within the year prior to the study commencing) and not drinking 
frequency or drinking duration appeared to be the relevant exposure with respect to drinking and 
increased risk of SCC (Lee at el 2005, Zambon et al 2000). It is not clear, however, despite consistent 
statistically significant dose response relationships in the majority of studies reviewed, whether low 
levels of drinking increased the risk of SCC. The majority of studies in this review reporting 
statistically significant associations at each alcohol intake level with increased risk of SCC had low 
level drinkers as the reference group or included in low level drinkers with never drinkers in the 
reference group (primarily due to the low number of abstainers/never drinkers in each of study 
populations). When lifelong abstainers were used as a reference group, the evidence was inconsistent 
on the risk of SCC from low levels of drinking (i.e. approximately 1 to 2 d/d). This may be attributed 
to poor study power in detecting a true association at these levels because of the small number of SCC 
cases identified (in those studies with never drinkers as a reference group, cases numbered between 
200 and 300). Since non-response bias was an issue for many case control studies in this review this 
also could explain some of statistically non-significant association observed for low levels of 
drinking. However, this could affect risk estimates either way and heavy or excessive drinkers are 
more likely to be non-responders in these types of studies.   
Although smoking was controlled for in nearly all studies, the measure used varied from smoking 
status, duration of smoking or amount smoked per day to pack years. Residual confounding is, 
therefore, likely to contribute to some of the excess risks observed in many of the studies though not 
sufficient to alter the overall association observed at moderate to heavy levels of consumption. It may, 
however, further, weaken the link between low levels of alcohol drinking and increased risk of SCC 
of the oesophagus. Equally, diet especially intake of fresh fruit and vegetables has increasingly been 
linked with a protective effect against both SCC and oesophageal adenocarcinoma and whilst it was 
adjusted for in the all studies investigating the latter tumour type, only five of the fifteen studies 
reporting on the association between SCC and alcohol consumption adjusted for diet. 
The interaction between smoking and alcohol observed in this review is also consistent with the 
numerous case control and cohort studies have shown that both tobacco and alcohol increase the risk 
of oesophageal cancer and that their joint effect is multiplicative (Boffetta and Hashibe 2006). The 
small sample sizes in the analysis as well as different smoking and drinking categories used across the 
studies may preclude any firm conclusions being drawn about the precise size of the risk nevertheless 
it was evident that even at low and moderate levels, the interaction between combined smoking and 
drinking increased the risk of SCC.  
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In conclusion, the evidence from this review supports the previous findings of a statistically 
significant dose response relationship between alcohol consumption and increased risk of SCC of the 
oesophagus. The evidence is convincing for moderate to heavy levels of alcohol consumption, but at 
lower levels of alcohol consumption due to heterogeneous reference groups and inherent bias in cases 
control studies, the evidence is less convincing.  There was no convincing evidence of an association 




 2.13 Oral cancer  
Oral cancer: summary of evidence from previous reviews 
Epidemiological studies clearly indicate that alcohol consumption is causally related to 
cancers of the oral cavity and pharynx (excluding the nasopharynx). There is no indication 
that the effect is dependent on type of beverage (Lowenfels 1975, IARC 1988b, 
WCRF/AICR 1997).  
 
 
The literature search identified 22 papers from 17 studies, published between 1999 and 2009, which 
examined the association between alcohol consumption and oral cancer. There was one prospective 
cohort study and sixteen case control studies. 
Six papers were derived from the same pooled analysis of two case control studies carried out in 
northern Italy and Switzerland. All six were retained in this review because each paper reported on a 
different aspect of the relationship between alcohol and oral cancer; risk by total alcohol consumed 
and by drink type (Altieri et al 2004); risk among women (Bosetti et al 2000); among never-smokers 
(Fioretti et al 1999); in those aged under 46years (Rodriguez et al 2004); differences in risk when 
drinking with and without a meal (Maso et al 2002) and on the interaction between smoking and 
alcohol and risk of oral cancer (Franceschi et al 1999). Two population based case control studies 
came from the same Puerto Rican study population, with one examining oral cancer risk by total 
alcohol consumed (Hayes et al 1999) and by drink type (Huang et al 2003). Tables for each study 
describing the study aims, population, alcohol measurement methods and main results are provided in 
Appendix D. 
 
2.13.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.13.1(cohort) and 12.3.2 
(case control) below.  
Table 2.13.1 Alcohol and oral cancer: general characteristics of cohort study reviewed 
Authors  
 






Sample selection  
Allen 2009 UK (women) 758/1,279,538 >55 breast screening clinics random selection 
Abb: n/s not specified; M=mean; Mdn= median  
 
The largest study was provided by Allen et al (2009) who identified approximately 800 incident cases 
of oral cancer in a cohort of UK women attending breast screening clinics over a mean follow up 
period 7.2 years. Two case control studies identified more than 500 cases (Hayes 1999, Altieri et al 
2004), four studies between 300-500 (Schwartz et al 2001, Sanchez et al 2003, Castellsague et al 
2004, Subapriya et al 2007). The majority of the case control studies were, however, small in size, 
identifying approximately 100 oral cancer cases or less. 
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Table 2.13.2 Alcohol and oral cancer: general characteristics of case control studies reviewed 
Authors  
 







Sample selection  


























See Altieri 2004 






Fioretti 1999 Italy 52/864 
22-76, 
(M=62) 
See Altieri 2004 
Franceschi 1999 Italy/Swiss 274/1,254 
23-74, 
(M=57/55) 
See Altieri 2004 
















Huang 2003 Puerto Rico 286/417 21-79 See Hayes 1999 


























Maso 2002 Italy/Swiss 324/1,545 <80 See Altieri 2004 





Rodriguez 2004 Italy/Swiss 137/298 
<46, 
(42/40) 
See Altieri 2004 
Schwartz 2001 USA 407/615 18-65 




Subapriya 2007 India 467/525 30 to 75 hospital 
all/ relatives and 
friends 
Vlajinac 2006 Serbia 100/100 
37-79, 
(M=59) 
cancer clinical centre 
all/ non-random 
selection 













2.13.2 Study quality 
The quality scores assessed according to the NOS are presented in Table 2.13.3. Overall, studies on 
the association between alcohol consumption and oral cancer were of moderate to high quality scoring 
6-7 stars out of a possible nine.  
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Table 2.13.3 Oral cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Allen 2009 3 2 2 7 
Altieri 2004, Bosetti 2000b, Fioretti 
1999, Franceschi 1999, Maso 
2002, Rodriguez 2004 
3 2 2 7 
Anaya-Saavedra 2008 3 0 2 5 
Balarm 2000 2 2 2 6 
Castellsague 2004  2 2 2 6 
Garrote 1999 3 2 2 7 
Hayes 1999, Huang 2003 3 2 3 8 
Llewellyn 2004b 2 1 2 5 
Llewellyn 2004a 3 2 2 7 
Lissowska 2003 3 2 2 7 
Moreno-Lopez 2000 3 1 2 6 
Schwartz 2001 3 2 2 7 
Subapriya 2007 3 2 2 7 
Vlajinac 2006 3 2 2 7 
Zavras 2001 3 2 2 7 
Znaor 2003 3 2 1 6 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment 
1 
Outcome for cohort, exposure for case-
control studies 
 
On the basis of sample selection, three studies achieved only two stars in the selection of their sample, 
because either their study populations were recruited from clinical or hospital services (Balarm et al 
2003), or failed to report the absence of the outcome in their control group (Bosetti et al 2002b, and 
did not provide an adequate case definition (Llewellyn et al 2004b). The majority of studies, however, 
scored three stars out of four, most of them failing on the selection of controls from hospital or clinic 
settings. A further four studies only achieved three stars because they did not specify the absence of 
oral cancer in their control population (Hayes et al 1999, Huang et al 2003, Llewellyn et al 2004a, 
Vlajinac et al 2006). Given the established associations between alcohol consumption, smoking and 
oral cancer, further selection bias in choice of controls was also dealt with in seven studies who 
excluded from their control population those who had been admitted to hospital with smoking and 
alcohol related chronic conditions (all case control studies from Italy Switzerland study, Lissowska et 
al 2003, Subapriya et al 2007). 
Smoking and age were controlled for in the majority of studies. The most common approach taken 
was simply to control for smoking status (i.e. never, ever, current and former smoker though some 
studies controlling for smoking, by number or pack years smoked (Schwartz et al 2001, Zavras et al 
2001) or the amount of cigarettes smoked per day (Altieri et al 2004, Bosetti et al 2000, Castellsagué 
et al 2004, Garrote et al 2001) or by “light”, medium” or “heavy” smoking status (Hayes et al 1999, 
Huang et al 2003). A further eleven studies also controlled for education status though only three 
specified that this was measured by years of education (Garrote et al 1999, Sanchez et al 2000, 
Castellsagué et al 2004). Three studies also further adjusted for the intake of vegetables and fruit 
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(Franceschi et al 1999, Hayes et al 1999, Huang et al 2003). In two studies, no adjustment was made 
for age (Moreno-Lopez et al 2000, Llewellyn et al 2004a). 
For exposure assessment, two studies scored maximum rating (Hayes et al 1999, Llewellyn 2004b), 
whilst the majority of studies scored two stars. Of those that only scored two, most were not awarded 
the third because they failed to specify if interviewers were blinded to case status. A further four 
studies failed because response rates were substantially different between cases (59%) and controls 
(>95%) and no reasons were provided for non-response (Llewellyn et al 2004a), or no response rates 
were specified in the paper (Castellsagué et al 2004, Rodriguez et al 2004 Vlajinac et al 2006). 
Participation rates across the majority of hospital based studies were very high (i.e. >90% for both 
cases and controls. This was not the case for the population based case control studies; response rates 
among cases and controls, varied from 54% and 63% respectively (Schwartz et al 2001), 60% for both 
cases and controls in paper by Llewellyn et al (2004b) and in two Puerto Rican studies, participation 
rates for cases and controls were 70% and 83% respectively (Hayes et al 1999, Huang et al 2003). 
 
2.13.3 Results: total alcohol intake and risk of oral22 
Sixteen studies, providing 19 papers, reported on the association between total alcohol consumption 
and laryngeal cancer. Of these, one study providing four papers reported on the association between 
oral cancer and ‘recent’ alcohol consumption; defined as intake in the previous year (Fioretti et al 
1999, Bosetti et al 2000, Altieri et al 2004, Rodriguez et al 2004). Nine studies reported on the 
association between oral cancer and lifetime alcohol consumption (Hayes et al 1999, Balarm et al 
2000 Moreno-Lopez et al 2000, Sanchez et al 2003, Znaor et al 2003, Castellsague et al 2004, 
Lissowska et al 2003, Vjajiinac et al 2006, Anaya-Saavedra et al 2008). The remaining six studies did 
not specify a reference period (Garrote et al 1999, Schwartz et al 2001, Zavras et al 2001, Llewellyn 
et al 2004a, Llewellyn et al 2004b, Allen et al 2009). A summary of oral cancer risk estimates, 
comparing the highest versus the lowest alcohol exposure category, is presented in Figure 2.13.1. One 
study reported only on the association between drinking status and oral cancer and is not included in 
Figure 2.13.1; Znaor et al (2003) reported a statistically significant association (OR 1.70, 95% CI 
1.36–2.13) between ‘ever’ drinkers and oral cancer compared to never drinkers 
 
  
                                                          
22
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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Figure 2.13.1 Alcohol consumption and oral cancer: highest versus lowest exposure category, by 
study type (odds ratio/relative risk and 95% confidence intervals) 
























OR/RR, highest vs lowest exposure category
 
 
In a large UK prospective cohort study (Allen et al 2009), women drinking at the highest alcohol 
exposure category (>15 drinks per week [d/w]), compared to those drinking <2 d/w had a two-fold 
statistically significant increased risk of oral cancer. Positive, but non-statistically significant, 
associations were observed at all other alcohol intake levels, with strong evidence of statistically 
significant dose response relationship (p value for trend <.001). In the same study, never-drinkers had 
a 20% (RR 1.18, 95% CI 1.02 to 1.36) increased risk of oesophageal SCC, compared to the reference 
group (Allen et al 2009). In the only other study, case-control in design, reporting on the association 
between oral cancer and alcohol consumption in women, Bosetti et al (2000b) observed a near three-
fold, statistically significant, increased risk of oral cancer in women drinking >2 drinks per day [d/d] 
compared to non-drinkers (p value for trend <0.0001). 
Of the larger case control studies reporting on the association between alcohol consumption and oral 
cancer, all provided evidence of a statistically significant dose dependent association; Altieri et al 
(2004), in an Italian study and Castellsague et al (2004) in a Spanish study, observed a strong 
statistically significant dose response relationship with oral cancer (p value for trend 0.0001), 
including people who drank >11 d/d, compared to a reference group of abstainers, or light drinkers or 
non-drinkers. Consumption at all levels including drinking as little as 1 d/d had a small positive, 
statistically significant, association with oral cancer in both studies. In an American population case 
control study (Schwartz et al 2001), people drinking >43 d/w had an odds ratio of developing cancer 
of 4.7 (95% CI 2.4-9.4), compared to those drinking <1 d p/w to be at risk of oral cancer. Although 
there was evidence of increasing risk with amount consumed, there was no association with oral 
cancer for those drinking <7 d/d (OR 1.0, 95% CI 0.6-1.5). No formal test for trend was reported in 
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the paper. In an Indian case control study, Subapriya et al (2007) reported a statistically significant 
two fold increased risk or oral cancer for those drinking >7 d/w, compared to non-drinkers, with a 
statistically significant dose dependant association (p value for trend <0.0001). Lifetime alcohol 
consumption of >22 d/w (p value for trend <0.0001), compared to non-drinkers, was also associated 
with an increased risk of oral cancer in a population of Puerto Rican men (Hayes et al 1999), though 
drinking <7 d/w was did not significantly increase the risk of oral cancer (OR 0.8, 95% CI 0.3-2.1). 
Smaller studies, based on less than 200 cases and controls, reported statistically significant increased 
risks of oral cancer at the highest alcohol exposure category ranging from >2 d/d (Balarm et al 2000, 
Moreno-Lopez et al 2000) to >6 d/d (Garotte et al 1999, Zavras et al 2001), compared to reference 
groups of lifelong abstainers (Garotte et al 1999, Lissowska et al 2003, Vlajinac et al 2006), non-
weekly drinkers (Zavras et al 2001), and non-drinkers (Moreno-Lopez et al 2000). The dose response 
relationship was statistically significant in all these studies, though lower intake levels all showed a 
positive, but non-significant association with oral cancer. 
In a Spanish study with a young adult population (<46 years), drinking >10 d/d was associated with a 
statistically significant increased risk (OR 4.94, 95% CI 1.62-15.10) of oral cancer, compared with 
non-drinkers (Rodriguez et al 2004). In the same study, although, a strong statistically significant dose 
response relationship ( p value for trend <0.0001) was evident, drinking <6 d/d was not associated 
with an increased risk of oral cancer. In a UK case control study, a statistically significant increased 
risk of oral cancer was observed in men and women aged ≤45 years drinking above recommended 
weekly drinking guidelines (21 units for men and 14 units for women) compared to those drinking 
below the weekly guidelines (Llewellyn et al 2004a, 2004b). Among non-smokers, drinkers of <3 d/d 
had a statistically significant increased risk (OR 3.4, 95% CI 1.1-10.1) of oral cancer, but not for those 
drinking ≥3 d/d (OR 2.6, 95% CI 0.7-9.3), compared to non-drinkers (Fioretti et al 1999).  
 
2.13.4 Results: drinking dimensions and risk of oral cancer 
Seven studies reported on other dimensions of drinking behaviour and the association with oral 
cancer, including duration of drinking, age first started drinking, and drinking before and after meals. 
Castellsagué et al (2004) reported that the odds of oral cancer risk increased steadily and markedly 
with longer duration of alcohol consumption with increased odds that were statistically significant 
after 20 years, and >51 years of alcohol consumption (p value for trend =0.0001), compared to 
abstainers. An increased risk of oral cancer still remained for ex-drinkers who had been drinking for 
>40 years (OR 4.53, 95% CI 2.00-10.27), whilst ex-drinkers of between 1-40 years were at 
considerably less risk of oral cancer (OR 1.58, 95% CI 0.82-3.07). In an Indian study, point estimates 
were all raised for drinking duration (up to >40 years of alcohol consumption compared to abstainers), 
but not for <10 years of alcohol consumption (OR 0.86) though no confidence intervals were provided 
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in paper to gauge precision of the estimates (Subriya et al 2007). Two studies reported no association 
for duration of drinking (up to >40yrs), compared to a reference group of those drinking for <20 years 
(Lissowska et al 2003, Vlajinac et al 2006). Age at which drinking was first started was also not 
associated with an increased risk of oral cancer in two studies (Balarm et al 2003, Lissowska et al 
2003). 
In an Italian case control study (Maso et al 2002), those who drank >56 d/w only at meals (vs. <20 
d/w) showed an OR=10.3 (95% CI 5.3–20.1) for oral cancer and 7.1 (95% CI 3.7-13.8) for pharyngeal 
cancer, compared to those drinking 1-20 d/w. This pattern was also observed for those who drank 
between meals (>56 d/w; OR 27.6, 95% CI 7.3-103.7) and 11.3 (95% CI 4.5-28.4). However, in any 
alcohol-intake level, subjects also drinking between meals showed a higher risk of developing an oral 
and pharyngeal cancer than subjects drinking only at meals. Castellsagué et al (2004) in a Spanish 
study, reported that compared to abstainers, those drinking with meals only, had an OR of 2.22 (95% 
CI 1.18-4.15) and those drinking between meals only, an OR of 3.58 (95% CI 1.84-6.98). Drinking 
both with meals and in-between meals, had an OR 3.71 (95% CI 1.94-7.08), compared to never-
drinkers. 
 
2.13.5 Results: drink type and risk of oral cancer 
Eight studies reported on the association between alcohol drink type and risk of oral cancer. A 
summary of oral cancer risk estimates, comparing the highest versus the lowest alcohol exposure 
category, is presented in Figure 2.13.2. 
Five studies reported ORs for spirits that were consistently higher and stronger than those reported for 
wine and beer. In a Puerto Rican study (Huang et al 2003), the risk of oral cancer was most strongly 
related to heavy spirit consumption (≥43 d/w), irrespective of the quantity of beer/wine consumed, 
while the elevated risks associated with heavy beer/wine consumption were pronounced only among 
subjects who also consumed moderate to heavy quantities of spirits (≥8 d/w). Castellsagué et al 
(2004) reported that, drinkers of spirits (p value for trend <0.0001) had a consistent increase in cancer 
risk in each stratum of amount and duration of alcohol consumption, compared to wine and/or beer 
drinkers. Furthermore, although statistically significant associations were found with amount and 
duration within each one of the three groups of type of drink, the ORs for spirits were consistently 
higher and stronger than those for the other types of drinks. Zavras et al (2001) reported that drinking 
ouzo (or tsipouro), a local clear spirit of a high (40%) ethanol concentration, was more strongly 
associated with an increased risk of oral cancer than comparable amounts of wine or beer, e.g., 
drinking 1-13 drinks of ouzo per week, compared with 1-13 drinks of other types of alcohol, was 
associated with a 17.4-fold increased risk (95% CI 1.9-162.5), compared to a two-fold increase in risk 
for those drinking comparable amounts of wine, or beer.  
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Figure 2.13.2 Alcohol consumption and risk of oral cancer, by drink type (relative risk and 95% 
confidence intervals) 
wine









Relative risk, highest vs lowest exposure category
 
beer









Relative risk, highest vs lowest exposure category
 
Spirits









Relative risk, highest vs lowest exposure category
 
 
In a Brazilian study, Schlecht et al (2001) observed increasing risk effects of oral cancer, for wine, 
beer, hard ‘liquor’ and cachaca (spirit based drink and predominant choice of alcoholic beverage in 
southern Brazil) drinkers, though odds ratios were higher for drinkers of cachaca compared to other 
drink types. Similar findings were also observed for spirit drinkers, compared to wine or beer 
drinkers, in a small Cuban case control study (Garrote et al 1999). 
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In contrast, Altieri et al (2004) reported a strong statistically significant positive association for wine 
drinkers drinking >3 d/w up to >12 drinks p/w, compared to non-wine drinkers. Beer and spirit 
drinkers of more than >3 d/w also had a statistically significant increased risk (OR 2.3, 95% CI 1.4-
3.7) of oral cancer, compared to non-beer and spirit drinkers respectively. The trends in risk with the 
dose were significant for wine (p value for trend <0.0001) and beer (p value for trend =0.02), but not 
for spirits (p value for trend =0.29). Lissowska et al (2003) observed a fourfold, non-significant 
increase in risk for wine drinkers, but only at the highest level of consumption (>5 d/w, OR 3.9, 95% 
CI 0.94-16.39). No associations were observed between beer and spirit consumption and increased 
risk of oral cancer. In an Italian population of non-smokers, where wine was the most popular drink 
type consumed, wine and not beer or spirits was associated with an increased risk of oral cancer, 
compared to abstainers (Fioretti et al 1999). 
 
2.13.6 Results: effect modification 
Three small case control studies examined the interaction between alcohol and smoking on the risk of 
oral cancer.  
Castellsagué et al (2004) found that simultaneous exposure to both smoking and drinking at the 
highest exposure levels (>6 d/d and ≥21 cigarettes p/d) increased oral cancer risk by almost 50-fold 
(OR 50.65, 95% CI 19.11-134.24), compared to never drinkers and never smokers. Drinking 1-2 d/d 
combined with smoking ≥21 cigarettes p/d had a OR of 8.20 (95% CI 2.93-22.94), and never drinkers 
who smoked >21 cigarettes p/d had a OR of 1.85 (95% CI 0.31-11.13). Castellsagué et al (2004) 
concluded that the combined effects of smoking and drinking amounts were compatible with a 
synergistic model of borderline statistical significance (Pinteraction=0.1), but did not state if an additive 
or multiplicative model was used. 
Hayes et al (1999) also reported an increased risk of oral cancer in men at all joint exposure levels, 
compared to non-smokers and non-drinkers, but risk estimates only reached statistical significance in 
men smoking >10 cigarettes p/d and who drank >21 d/w. Male non-smokers who drank ≥42 d/w had a 
OR of 6.4 (95% CI 1.3-31.9), whilst men who did not drink and who smoked >40 cigarettes p/d had a 
OR of 2.4 (95% CI 0.2-27.2). Heavy drinkers (≥42 d/w) and heavy smokers (>40 p/d), however, had a 
OR of 38.7 (95% CI 13.6-110.0). Garrotte et al (2001) reported a similar pattern in their Cuban case 
control study; OR of 111 (95% CI 22.7-543.7), at the highest levels of both exposures (>30 cigarettes 
p/d and >21 d/w), compared to non-drinkers and non-smokers. Both Hayes (1999) and Garotte (2001) 
concluded that the joint exposure to alcohol and tobacco resulted in risks ‘consistent with independent 




2.13.7 Summary and conclusions 
This review appraised 24 papers from 18 studies (17 case-control and one prospective cohort) that 
examined the association between alcohol and oral cancer. The majority of studies were consistent in 
reporting a statistically significant dose response relationship between total alcohol consumption and 
increased risk of oral cancer irrespective of study size or study design The findings from this review 
are in line with the already substantial body of evidence establishing total alcohol consumption as a 
major risk factor for oral cancer (IARC 1988, Corrao et al 2004, WCRF/AICR 2007). There are, 
however, persisting uncertainties concerning the risk of oral cancer and variation in risk by drink type, 
duration of use, age and gender, and in relation to the interaction between smoking and alcohol on risk 
of oral cancer.  
Study quality was of a moderate to high standard. The majority of studies recruited cases and controls 
from hospital settings and were subject to selection bias though in itself unlikely to alter the consistent 
positive association with oral cancer at the highest alcohol intake levels reported across these studies 
Smoking and age were controlled for across the majority of studies though residual confounding from 
smoking is still likely due to imprecise measurements of smoking. The well-established link between 
socio-economic status (SES) and risk of oral cancer (IARC 2004, Conway et al 2006) was 
insufficiently dealt with in all studies; although, levels of education were controlled for in eleven of 
the studies, this is an imprecise measure of SES and further residual confounding from SES is 
therefore likely though it would only alter the size of the effect and not the direction of the 
relationship between alcohol intake and risk of oral cancer risk. 
To date, little has been published on the effect of drinking on the risk of oral cancer in women though 
it has been hypothesised that women may be more susceptible than men to alcohol carcinogens as a 
result of alcohol exposure due to the potential differences in alcohol metabolism (Blume 1986, Corrao 
et al, 1999; 2000). Two large well designed studies, included in this review both observed an 
increased risk of oral cancer in women drinking more than two drinks per day (Bosetti et al 2000, 
Allen et al 2009). The use of low-drinkers as a reference group in a UK study (Allen et al 2009) may 
have also underestimated the risk of oral cancer in women by using a reference group of light 
drinkers. Effect sizes in these studies were broadly comparable to those reported for men and for 
combined populations suggesting very little difference in oral cancer risk by gender. A meta-analysis 
recently reported no statistically significant effects of gender in modifying the effect of alcohol intake 
(up to and including more than 100 grams per day) on oral cancer risk (Bagnardi et al 2001). 
The association between drink type and risk of oral cancer was investigated by eight studies with 
inconsistent findings. The ORs for spirits were consistently higher and stronger than those for the 
other types of drinks in four studies, and wine higher than other drink types in two studies, but these 
analyses were based on small subgroups of drinkers and estimates lacked precision with wide 
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confidence intervals. Huang et al (2003) hypothesised that the stronger effect of spirits observed in 
their study suggested that, alcohol concentration per se is an important risk factor for oral cancer 
independent of the total quantity of alcohol consumed. However, the differences between drink types 
in this study were only observed at the highest exposure category where there were three to four times 
more spirit drinkers than beer or wine drinkers. This pattern was repeated across the majority of 
studies where the most popular drink type consumed tended to have the highest ORs: spirits (Garrote 
et al 1999, Castellsagué et al 2004), ouzo (Zavras et al 2003), cachaca (Schlecht et al 2001), and wine 
(Altieri et al 2004). This would suggest the effects of alcohol per se are perhaps more important than 
drink type in determining the risk of oral cancer risk.  
A number of recent studies have observed the rising incidence of oral cancer cases in younger ages 
particularly in the UK (Conway et al 2007). Three studies in this review reported on risk of oral 
cancer in young adults; heavy levels of alcohol consumption associated with non-significant six fold 
increase in risk in two UK studies and one Spanish study. Studies, however, were small 
(approximately 100 cases) and estimates lacked precision and in the case of the UK studies, low 
response rates among cases and controls) make any conclusion about an increased risk in younger 
people difficult. 
The interaction between smoking and alcohol observed in this review is consistent with the numerous 
case control and cohort studies that have shown that both tobacco and alcohol increase the risk of oral 
cancer and that their joint effect is multiplicative. The small sample sizes in the analysis as well as 
different smoking and drinking categories used across the studies may preclude any firm conclusions 
being drawn about the precise nature of the interaction between smoking and oropharyngeal cancer 
risk. Previous studies on the interaction between alcohol consumption and smoking and risk of upper 
aero-digestive tract cancers (UADT) have indicated that in the absence of tobacco use, the association 
between alcohol consumption and the risk of head and neck cancer is weak and is apparent only at 
high doses and only for pharyngeal and laryngeal cancers (Hashibe et al 2007). Allen et al’s UK study 
also reported that moderate alcohol intake, compared to those drinking less than 2 drinks per day was 
only associated with an increased risk of UADT cancers among current smokers. However, in 
common with all studies included in this review Allen et al (2009) did not report on the risk separately 
for oral and pharyngeal cancer. Furthermore the inclusion of people drinking at low levels and 
moderate levels of consumption in a studies reference group ignores the increased risk of oral cancer 
posed by even low levels of alcohol consumption and this will be particularly marked in light drinkers 
who smoke low to moderate amounts per day. 
Overall, despite weakness inherent in study design, the small size of many of the studies included in 
the review and the potential for residual confounding from insufficient control for smoking habit and 
socio-economic status, studies consistently observed a strong association between alcohol 
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consumption and risk of oral cancer. Effects of drink type were inconclusive though the weight of 
evidence would suggest that alcohol itself and not the type of drink is the most important factor in 




2.14 Ovarian cancer  
 
Ovarian cancer: summary of evidence from previous reviews 
Overall, studies on cancers of ovary show no association with consumption of alcoholic 
beverages (IARC1988b, WCRF/AICR 1997). Webb et al (2004) in a meta-analysis of seven 
population based case control studies, published between 1966 and 2003 observed an inverse 
association between ovarian cancer and the highest compared to the lowest alcohol exposure 
category (OR 0.72 95% CI 0.54-0.97).  
 
This literature review identified 14 studies, published between 1999 and 2009, that examined the 
association between alcohol consumption and ovarian cancer. There were seven prospective cohort 
studies and seven case control studies. Tables for each study describing the study aims, population, 
alcohol measurement methods and main results are provided in Appendix D. 
 
2.14.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.14.1 below. 
Table 2.14.1 Alcohol and ovarian cancer: general characteristics of studies reviewed 
Authors  
 








Sample selection  
Cohort studies 











Keleman 2004 USA 147/27,008 55-69 
Iowa driver’s license 
registry 
random sample 




Larsson 2004 Sweden 266/61,084 39-76 regional population random-selection 
Schouten 2004 Netherlands 214/2,412 55-69 general population random sample 




Case control studies 
Fujita 2008 Japan 141/2,016 >30 hospital consecutive/ 
Goodman 2003 USA 558/607 n/s regional population 
consecutive /random 
sample 











Riman 2004 Sweden 655/3,899 50-74 regional population 
consecutive/random 
sample 
Tavani 2001 Italy 1,031/2,411 
18-79 
(M=56) 
hospital not specified 





Abb: n/s not specified; M=mean; Mdn= median  
 
The largest prospective cohort study was carried out by Allen et al (2009) with seven times as many 
incident ovarian cancer cases as the next largest study (Tworoger et al 2008). The remaining cohort 
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studies identified approximately 200 ovarian cancer cases. The majority of case control studies were 
also moderate in size ranging between 650-750 cases. The largest case control study identified in this 
review was carried out by Tavani et al (2001), recruiting approximately 1031 cases and 2411 controls 
to their study population 
 
2.14.2 Study quality 
The quality scores assessed according to the NOS are presented in Table 2.14.2. Overall, studies were 
of a moderate to high quality, scoring between 5-8 stars.  
Table 2.14.2 Ovarian cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Allen 2009 3 2 2 7 
Chang 2008 3 2 3 8 
Kelemen 2004 4 2 1 7 
Larsson 2004 4 1 2 7 
Lagiou 2001 3 0 2 5 
Schouten 2004 4 1 3 8 
Tworoger 2008 3 1 3 7 
Case control     
Fujita 2008 3 1 2 6 
Goodman 2003 4 1 2 7 
Modugno 2003 3 1 1 5 
Petersen 2006 3 1 2 6 
Riman 2004 4 1 2 7 
Tavani 2001 3 1 3 7 
Webb 2004 4 1 2 7 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment; 
1 
Outcome for cohort, exposure for case-
control studies. 
 
On the basis of sample selection, cohort studies scored highly with either three or four stars out of 
four. A number of studies failed in this item because of the potential selection bias introduced by their 
choice of study populations i.e. groups of nurses and health professionals (Tworoger et al 2008), and 
teachers (Chang et al 2008).  
Attempts to address selection bias varied across the case control studies. The majority of studies were 
consistent in excluding subjects reporting a history of ovarian cancer or previous bilateral 
oophorectomy. Only one study excluded patients admitted to the hospital for chronic conditions or 
digestive tract diseases related to alcohol intake (Tavani et al 2001). In one study, no exclusion 
criteria were specified (Modungo et al 2003). For many of the studies there was, therefore, the 
possibility that conditions related to known or potential risk factors for ovarian cancer or alcohol 
consumption were included in the study populations. The extent of interviewer bias among the case 
control studies was unclear. Only one study specified the interviewers were blinded to case and 
control subject status (Peterson et al 2006). Non response bias was generally not a problem for the 
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majority of case control studies with four reporting participation rates for cases and controls of 
approximately 75%-85%. However, in one American case control study response rates were only 60% 
and 65% for cases and controls, respectively (Goodman and Tung et al 2003). A lack of detail in the 
study on reasons for non-participation makes it difficult to determine what effect these low rates may 
have on the risk estimates. In one study response rates were not specified (Tavani et al 2001). The 
potential for recall bias and measurement error varied across the case control studies. Consumption in 
the last month was used as the reference period by Riman et al (2004) and in the preceding year by 
Webb et al (2004). In contrast, Goodman and Tung (2003) examined lifetime history of alcohol use 
and Peterson et al (2006) defined their reference period as intake in early adulthood (20-30 years of 
age) and 1 or 5 years before study commenced. 
Many of the established risk factors for ovarian cancer and possible confounders of the alcohol-
ovarian cancer association such as parity, oral contraceptive use and hormone replacement therapy 
(HRT), were controlled for in all the studies. For comparability purposes, therefore, studies were only 
awarded an extra star if they controlled for HRT. All studies controlled for age and a further two for 
HRT (Keleman et al 2004, Chang et al 2008). The remaining studies all received one star though in 
the majority of these adjustment was made for other risk factors associated with ovarian cancer (and 
alcohol consumption), but where the evidence was less consistent e.g. measures of BMI (controlled 
for in eight studies), or diet and in particular folate intake (Larsson et al 2004). Petersen et al (2004) 
did not adjust their estimates for the established ovarian cancer risk factors and only controlled for 
age. In the record linkage cohort study by Terry et al (2001), no adjustment for the aforementioned 
risk factors since no lifestyle information was collected as part of their study. 
 
2.14.3 Results: alcohol intake and risk of ovarian cancer23 
Thirteen of the 14 studies reported on the dose response association between alcohol consumption and 
ovarian cancer. Six studies reported on the association between ovarian cancer and ‘recent’ alcohol 
intake defined as  alcohol consumption in the preceding year in five studies (Kelemen et al 2004, 
Schouten et al 2004, Chang et al 2007, Fujita et al 2008, Tworoger et al 2008) and in the previous 
month (Riman et al 2004). Goodman and Tung (2003) examined lifetime history of alcohol use 
defined as drinking any type of alcoholic beverage at least once a week for 6 months or more and 
Peterson et al (2006) defined their reference period as intake in early adulthood (20-30 years of age) 
and 1 or 5 years before study commenced. In the remaining five studies, the reference period was not 
specified (Tavani et al 2001 Modugno et al 2003, Larsson and Wolk 2004, Webb et al 2004, Allen et 
al 2009). A summary of ovarian cancer risk estimates, comparing the highest versus the lowest 
alcohol exposure category, is presented in Figure 2.14.2. In the remaining study, Fujita et al (2008) 
                                                          
23
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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reported a statistically significant inverse association (OR 0.58, 95% CI 0.35-0.96) between ‘current’ 
drinkers and ovarian cancer, compared to abstainers. 
Figure 2.14.1 Alcohol consumption and ovarian cancer, highest versus lowest exposure category, by 
















OR/RR, highest vs lowest exposure category
 
 
In an Australian case control study, increasing of alcohol consumption of ≥2 drinks per day [d/d] was 
associated with a 50% decreased risk of ovarian cancer (p value for trend =0.003), compared to non-
drinkers (Webb et al 2004). Goodman and Tung et al (2003) also reported an inverse association for 
women drinking <7 d/w and ≥14 d/w, compared to non-drinkers, but women drinking 7-<14 d/w had 
an increased risk (OR 1.14 95% CI 0.76-1.72, p value for trend =0.70) of ovarian cancer. Two case 
control studies, however, found no association between ovarian cancer and alcohol consumption. In a 
Swedish study, women drinking ≥5 g/d had an OR of 0.99 (95% CI 0.75-1.29, p value for trend 
=0.80), compared to non-drinkers (Riman et al 2004). Tavani et al (2001), in an Italian hospital based 
case control study, observed no association between alcohol and ovarian cancer for women drinking 
36 g/d, compared to lifelong abstainers. 
 
2.14.3.1 Results: total alcohol intake and risk of ovarian cancer by 
histological type 
Four studies investigated risk of ovarian cancer associated with alcohol consumption based on 
histological subtype. Three studies, one cohort (Riman et al 2004) and two case control studies 
(Goodman and Tung 2003, Petersen et al 2006) found no association between mucinous ovarian 
tumours and alcohol consumption. In contrast, Modugno et al (2003) reported a significant increase in 
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risk for mucinous tumours among current drinkers (but not former drinkers), drinking >24 grams per 
week [g/w] (OR 1.93, 95% CI 1.02-3.65), compared to never drinkers. 
Goodman and Tung (2003) reported a significant inverse association between current drinkers and 
risk of non-mucinous (i.e. serous, endometrioid, or clear cell tumours) ovarian cancer (OR 0.69, 95% 
CI 0.48-0.98). Riman et al (2004), however, observed no association for endometrioid, serous, and 
clear cell tumours among women drinking >5 g/d compared to non-drinkers. Petersen et al (2006) 
found that for serous tumours, risk was significantly elevated in women consuming >1d/d aged 
between 20-30 years (OR 1.72, 95% CI 1.16-2.56), compared to non-drinkers, though a more modest 
and non-significant association was obtained for recent consumption (OR 1.19, 95% CI 0.82-1.73). 
 
2.14.4 Results: drinking dimensions and risk of ovarian cancer 
Chang et al (2008) found no association between drinking at ages 18-22 years and 30-35 years and 
risk of ovarian cancer in a cohort of American teachers. Further, in an American population case 
control study (Peterson et al 2006), compared to non-drinkers, ever drinking at ages 20-30 (OR 1.27, 
95% CI 0.96-1.68, p value for trend =0.11) or drinking >1 d/d in the recent past was not associated 
with an altered risk of ovarian cancer (OR 0.89, 95% CI 0.70-1.20, p value for trend =0.77).  
 
2.14.5 Results: drink type and risk of ovarian cancer 
Eight studies examined whether risk of ovarian cancer varied by type of alcoholic beverage. A 
summary of risk estimates, comparing the highest versus the lowest alcohol exposure category, is 
presented in Figure 2.14.2. 
Three prospective cohort studies reported no association between wine, spirits or beer, and risk of 
ovarian cancer (Keleman et al 2004, Schouten et al 2004, Tworoger et al 2008). In the remaining 
cohort study, Chang et al (2008) observed a statistically significant increased risk of ovarian cancer 




Figure 2.14.2 Alcohol consumption and risk of ovarian cancer, highest versus lowest exposure, by 





































OR/RR, highest vs lowest exposure category
 
 
Of the four case control studies to look at the risk of ovarian cancer by drink type, Goodman and 
Tung (2003) found a modest reduction in risk, but not statistically significant, associated with wine 
and beer drinking, but no association with spirits drinking. Webb et al (2004) also reported that wine 
drinkers had a lower risk of ovarian cancer than both self-reported non-drinkers and women who 
reported drinking only beer or spirits. There was also a statistically significant trend toward lower risk 
with increasing wine consumption (p value for trend =0.01 excluding non-drinkers). In both these 
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studies, wine was the most consumed alcoholic beverage among cases and controls. In the hospital 
case control study by Tavani et al (2001), consumption of wine, which accounted for 95% of the total 
alcohol consumption in their study population, closely resembled the total alcohol drinking pattern, 
with a slight increase in risk of ovarian cancer from wine drinking, but no trend in risk with dose. In 
the remaining study, no association was found between wine or beer consumption and risk of ovarian 
cancer, compared to never drinkers (Peterson et al 2004). 
 
2.14.6 Results: effect modification 
Three studies, two prospective and one case control, reported on the interaction between alcohol and 
other risk factors in increasing or decreasing the risk of ovarian cancer.  
Keleman et al (2004) examined whether the relation of folate with ovarian cancer would depend on 
the level of alcohol intake in a population of post-menopausal women. They reported that women 
drinking ≥4 g/d with a total folate intake of ≥331 µg/day had a non-significant decreased risk (RR 
0.46, 95% CI 0.16–1.32) of ovarian cancer compared to those drinking with a folate intake of <331 
µg/day. On the other hand, women drinking <4g/d with a folate intake of ≥331 µg/day, had a small, 
non-significant, increased risk of ovarian cancer (RR 1.19, 95% CI 0.76–1.88). The test for interaction 
between total folate and alcohol consumption and ovarian cancer risk was statistically significant 
(Pinteraction=0.04). 
Schouten et al (2004) examined the effect modification on the association between alcohol 
consumption and ovarian cancer by use of oral contraceptives, parity and body mass index (BMI) and 
found little evidence of a statistically significant interaction with any of the risk factors. Among 
women who had never used oral contraceptives, there was no association between ovarian cancer and 
alcohol consumption (RR 0.99, 95% CI 0.69-1.42), while the risk among ever users of oral 
contraceptives was only slightly and non-significantly increased (RR 1.22, 95% CI 0.51-2.91). The 
interaction with BMI, however, appeared to show a trend; in women of normal weight (BMI < 25 
kg/m
2
) alcohol consumption was associated with a non-significantly increased relative risk of 1.33 
(95% CI 0.82- 2.14). In overweight (BMI 25-<30 kg/m
2
) and obese (BMI ≥30 kg/m
2
) women, alcohol 
consumption was associated with non-significantly decreased relative risks of 0.95 (95% CI 0.54-
1.67) and 0.52 (95% CI 0.20-1.34), respectively, but there was no evidence of a statistically 
significant interaction (Pinteraction=0.21). There was no also statistically significant interaction between 
parity (Pinteraction=0.22) and energy intake (Pinteraction=0.23) on the relationship between alcohol 
consumption and ovarian cancer (Schouten et al 2004). It was not clear from this paper whether the 
additive or multiplicative model had been used to test for interaction. 
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In an Italian case control study, there was no significant consistent heterogeneity with ovarian cancer 
risk for alcohol intake in any subgroup of age at diagnosis, education, parity, oral contraceptive use, 
family history of ovarian/breast cancer, body mass index, and calorie intake (Tavani et al 2001). 
 
2.14.7 Summary and conclusion 
This review identified 14 studies which examined the association between alcohol consumption and 
risk of ovarian cancer. In summary, the findings of this review furnish an inconsistent picture 
regarding an association between total alcohol consumption and ovarian cancer. Cohort studies 
reported both positive and inverse associations between drinking alcohol and ovarian cancer and the 
two largest cohort studies in the present review found no association between alcohol consumption 
and ovarian cancer. Evidence from previous reviews is also inconsistent. Webb et al (2004) in a meta-
analysis of seven population based case control studies observed an inverse association between 
ovarian cancer and the highest compared to the lowest alcohol exposure category (pooled OR 0.72 
95% CI 0.54-0.97, p heterogeneity among studies =0.09). In the same paper, a meta-analysis of seven 
hospital based case control studies reported an OR of 1.10 (95% CI 0.83-.44, p heterogeneity among 
studies =0.20) for the highest intake versus the lowest alcohol intake level (Webb et al 2004). In a 
pooled analysis of 10 prospective cohort studies (published between 1997 and 2004), which included 
2001 ovarian cancer cases, alcohol consumption was not associated with ovarian cancer risk (pooled 
RR (PRR) 1.12, 95% CI 0.86-1.44, p value for trend =0.72, p heterogeneity among studies =0.50) 
comparing >30g/d to 0 g/d (Genkinger et al 2006). 
In the present review an association between drink type and ovarian cancer was observed for wine 
drinkers, but not beer or spirit drinkers, compared to never drinkers. The findings reported for wine 
drinkers were, however, contradictory. One study reported an inverse association between 
approximately one glass of wine a day and ovarian cancer (Webb et al 2004) whilst two studies 
reported an increased risk of ovarian cancer at similar levels of drinking (Tavani et al 2001, Chang et 
al 2008). Socio-economic status was not controlled for in these studies and this may explain the 
associations observed between wine drinkers and ovarian cancer in the present review. In addition, 
many of the studies suffered from small numbers of cases within strata and subsequently results of 
variations in ovarian cancer risk, by drink type should interpreted cautiously. Genkinger et al (2006) 
in pooled analyses that simultaneously adjusted for intakes of alcohol from wine, beer, and spirits as 
continuous variables (increment 15 g/d) reported no association of alcohol from wine (pooled 
multivariate RR (PRR) 1.07, 95% CI 0.95-1.21), beer (PRR 1.02, 95% CI 0.84-1.24) and spirits (PRR 
1.03, 95% CI 0.93-1.14) with ovarian cancer risk (P-value for the test of difference=0.83).  
There was little evidence, in the present review, of a modifying effect of other risk factors on the 
association between alcohol consumption and ovarian cancer. Only a small number of studies 
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reported on this aspect and no evidence was provided of a significant interaction of parity, oral 
contraceptive use, folate intake or weight on the association between alcohol consumption and 
ovarian cancer. Genkinger et al (2006), in their pooled analysis of 10 cohort studies, also reported that 
the association between total alcohol intake (15 g/d increment) and ovarian cancer risk was not 
significantly modified by a range of hormonal, environmental and nutritional factors including folate 
intake (Pinteraction=0.18), BMI (Pinteraction=0.74), parity (Pinteraction>0.99) and oral contraceptive use 
(Pinteraction=0.41). 
Overall a strong association between alcohol consumption and ovarian cancer seems unlikely. 
However, only observations can be made about low to moderate levels of consumption since most 
studies contained few heavy drinkers. Further studies looking at this aspect of drinking are therefore 
required. Additional studies of risk factor for epithelial ovarian cancer by histological type are also 




2.15 Pancreatic Cancer  
 
Pancreatic cancer: summary of evidence from previous reviews 
Earlier systematic reviews have concluded that alcohol consumption is unlikely to be causally 
related to cancer of the pancreas. IARC1988b, WCRF/AICR 1997). A meta-analysis of 17 
studies (including 4 cohort and 13 case control studies published between 1966-1999) 
reported no increased risk of pancreatic cancer in those drinking 25 g/d (RR) 0.98, 95% CI 
0.90-1.05) and a small non-significant, increased risk in those drinking 50 g/d (RR 1.05, 95% 
CI 093-1.18) and 100 g/d (RR 1.18 95% CI 0.94-1.49, P Het <0.05) (Bagnardi et al 2001).  
 
This literature review identified 12 studies, published between 1999 and 2009, which examined the 
association between alcohol consumption and pancreatic cancer. There were eight cohort studies and 
four case control studies, including one nested case control study. Tables for each study, describing 
the study aims, population, alcohol measurement methods and main results, are provided in Appendix 
D. 
 
2.15.1 Study characteristics 
Ten studies reported on the association between alcohol drinking and incident pancreatic cancer and 
the remaining two (prospective cohort) studies investigated the association between alcohol 
consumption and pancreatic cancer mortality (Coughlin et al 2000, Lin et al 2002). Three papers were 
based on established prospective cohort studies described in described in section 2.4; Netherlands 
Cohort Study on diet and cancer (Heinen et al 2009); the European Prospective Investigation into 
Cancer and Nutrition (Rohrmann et al 2009) and the US Nurses’ Health Study and Health 
Professional follow up study (Michaud et al 2001). A summary of the general characteristics of the 
studies is provided in Table 2.15.1 below. 
The largest study included in the present review, a US prospective mortality study, identified 
approximately 3,500 pancreatic cancer deaths (Coughlin et al 2000). A further two cohort studies, 
investigating the association between incident pancreatic cancer and alcohol consumption, identified 
over 1,000 cases; the UK Million Women Study (Steven et al 2009, see Allen et al in section 2.3.1.) 
and the US National Institutes of Health (NIH)-AARP Diet and Health Study (Jiao et al 2009). In 
general, however, the majority of studies were of a small to moderate size, with the number of 











Country Sample size Age range 
(M/Mdn) 




 2000 USA 3,751/1.2m 
≥30 
(Mdn=57) 
general population volunteers  
Heinen 2009 Netherlands 447/120,405 55–69 general population random sample 




regional pop. in 6 






 2002 Japan 225/110,567 
40–79 
(M=57.3) 
general population random selection 
Michaud 2001 US 288/136,305 30-75 














Ye 2002 Sweden 305/178,383 (M=44) 




                                                    Case control studies                   cases/controls 
Hassan 2007 US 808/808 (M=61/62) hospital 
consecutive/ 
random selection 
De Martel 2008 US 104/262 (M=49/52) general population random sample 





Villeneuve 2000 Canada 583/4,813 (M=61.5/58) 





Abb: n/s not specified; M=mean; Mdn= median 
1 
Outcome is pancreatic cancer mortality 
 
Eleven of the 12 cohort studies were prospective in design. In the remaining study, women 
hospitalised in any Swedish hospital between 1965 and 1994, with a diagnosis of ‘alcoholism’ based 
on ICD-9 classification, were identified and retrospectively followed up for an average of 10 years 
(Ye et al 2002). De Martel et al (2008) conducted a nested case control study among 128,992 adult 
subscribers to a Medical Care Program; cases were randomly selected from newly diagnosed cases of 
pancreatic cancer and matched to controls from the same source as the cases. In an Italian hospital 
based case control study, Talamini et al (1999) created two groups from their pancreatic cancer cases 
– patients with pancreatic cancer without a history of chronic pancreatitis and those without a history 
of chronic pancreatitis. Of the chronic pancreatitis cases, 80% were estimated to have alcohol-induced 
chronic pancreatitis. 
 
2.15.2 Study quality 
The quality scores assessed according to NOS are presented in Table 2.15.2. Overall, cohort studies 
were of a high quality, scoring between 7-9 stars. Case control study quality was of a moderate to 
high quality scoring between 5-8 stars.  
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Six cohort studies achieved maximum rating on the NOS. One prospective study achieved three stars 
failing because of possible selection choice of study population i.e. health professionals (Heinen et al 
2008), whilst Ye et al (2002) in their retrospective hospital based record linkage study did not control 
for any of the established confounding risk factors of the alcohol and pancreatic cancer association. 
On the basis of sample selection, two case-control studies scored highly four stars out of four. Hassan 
et al (2008) failed because their control group was selected from a small group of relatives and friends 
attending the same hospital as cases. Villeneuve et al (2000) did not demonstrate that cancer was 
absent from their control group. Hassan et al (2008) also excluded from their control group, people 
with tobacco-related cancers from their control group, but no case-control study specified the 
exclusion of alcohol related cancers or diseases from their control group.  
Table 2.15.2 Pancreas cancer: assessment of study quality 
 Selection* 
(out of 4) 
Comparability* 




(out of 3) 
Total 
Cohort     
Coughlin 4 2 3 9 
Heinen 4 2 3 9 
Jiao 4 2 2 9 
Lin 4 2 3 9 
Michaud 3 2 2 7 
Rohrmann 4 2 3 9 
Stevens 4 2 2 8 
Ye 3 0 3 6 
Case control     
De Martel 4 0 2 6 
Hassan 3 2 3 8 
Talamini 4 1 2 7 
Villeneuve 3 2 2 7 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment; 
1 
Outcome for cohort, exposure for case-
control studies 
 
Two studies failed to achieve any stars for comparability, since unadjusted estimates were presented 
in their paper (Ye et al 2002, De Martel et al 2008). Age and smoking were controlled for in the 
remaining studies. Smoking terms generally consisted of current smoking status, amount (per day) 
and duration smoked (pack-years). Villeneuve et al (2000) did not control for weight (BMI). Five 
studies controlled for a ‘history’ of diabetes (Coughlin et al 2001, Michaud et al 2001, Lin et al 2002, 
Hassan et al 2007, Jiao et al 2009). Diet and nutritional status was controlled for in a number of ways 
from measures of ‘energy intake’ (Michaud et al 2001, Rohrmann et al 2009) to measures of total 
energy intake, energy-adjusted saturated fat, red meat, and total folate intake (Jiao et al 2009). 
Talamini, et al (1999) stratified their analysis by pancreatic cancer patients, with and without a history 




2.15.3 Results: total alcohol intake and risk of incident pancreatic cancer 
24 
Nine studies, six cohort and three case-control studies, investigated the association between incident 
pancreatic cancer and ‘recent’ alcohol consumption. A summary of pancreatic cancer risk estimates, 
comparing the highest versus the lowest alcohol exposure category, is presented in Figure 2.15.1. 
Figure 2.15.1 Alcohol consumption and incident pancreatic cancer, highest versus lowest exposure 
category, by study type (odds ratio/relative risk and 95% confidence intervals) 
 
 
In one of the larger cohort studies, Jiao et al (2009) observed an increased risk of pancreatic cancer in 
only those drinking ≥3 drinks per day [d/d] compared with light drinkers; those who drank ≥3 d/d 
(approximately 39-42 grams per day [g/d]) had a relative risk of 1.45 (95% CI 1.17-1.80, p value for 
trend =0.002). Men (RR 1.50, 95% CI 1.18-1.90, p value for trend =0.001) were at higher risk of 
pancreatic cancer than women (RR 1.24, 95% CI 0.72, 2.13, p value for trend =0.75) though the 
differences were not statistically significant (Pinteraction=0.50). Male and female non-drinkers had a non-
significant 12% and 21%, respectively, increased risk of pancreatic cancer, compared to ‘light 
drinkers’ (Jiao et al 2009). Heinen et al (2009) observed a modest borderline statistically significant 
70% increased risk of pancreatic cancer, in their Dutch cohort, for those drinking >30 g/day, 
compared to abstainers, but not at lower levels of intake and there was no evidence of a dose response 
relationship (p value for trend =0.12). Michaud et al (2001) also observed a non-significant 20-40% 
increased risk (p value for trend =0.55) of pancreatic cancer in male health professionals across all 
alcohol intake levels (highest intake level of (≥30 g/d) compared to non-drinkers, but no association 
between alcohol and pancreatic cancer in female nurses (≥30 g/d; RR 0.78, 95% CI 0.36-1.68, p value 
for trend =0.49). In a Swedish retrospective cohort study, a modest and unadjusted, statistically 
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OR/RR, highest vs lowest exposure category
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significant, excess risk in pancreatic cancer of 30% and 60% was also observed among men and 
women, respectively, who had been admitted to hospital with a diagnosis of ‘alcoholism’, compared 
to the Swedish general population (Ye et al 2002). 
In contrast, in a multi-centre European based cohort study, drinking 30 to 59.9 g/d (RR 1.03, 95% CI 
0.88-1.21) and ≥60 g/d (RR 0.88, 95% CI 0.72-1.08), compared to those drinking 0.1 to 4.9 g/d, was 
not associated with an increased risk of pancreatic cancer. Non-drinkers were also not at an increased 
risk (RR 0.95, 95% CI 0.81-1.12) of pancreatic cancer, compared to light drinkers (Rohrmann et al 
2008). Stevens et al (2009), in a large cohort study, reported that the risk of incident pancreatic cancer 
did not vary significantly for women across categories of alcohol consumption (≥14 units per week 
[u/w]; RR 1.08, 95% CI 0.11, p value for trend =0.2), compared to women drinking 1-2 u/w. Non-
drinkers had a similar risk of pancreatic cancer as drinkers in highest alcohol exposure category (RR 
1.07, 95% CI 0.06). 
Villeneuve et al (2000) reported a modest and non-significant increased risk of pancreatic cancer in 
men drinking >7 drinks per week, compared to non-drinkers. There was no increased risk of 
pancreatic cancer in women drinking at similar levels. In a nested case control study reporting only 
unadjusted odds ratios, drinking ≥2 d/d did not increase the odds of pancreatic cancer occurring, 
compared to non-drinkers (De Martel et al 2008). In an Italian hospital based case control study, 
Talamini et al (1999) reported a six-fold increase in the odds of pancreatic cancer in men with chronic 
pancreatitis, drinking >80 g/d (OR 6.7, 95% CI 1.2-36), compared to those drinking 0-40 g/d. In 
contrast, they reported a weak statistically significant inverse association in men without a history of 
chronic pancreatitis who drank >80 g/d (OR 0.4, 95% CI 0.2-1.0), compared to non-drinkers without a 
history of chronic pancreatitis. Male cases with chronic pancreatitis and without cancer, had a two-
fold, statistically significant, increased risk of pancreatic cancer (OR 2.2, 95% CI 1.5-3.3), compared 
to men drinking >40 g/d. 
Two studies reported on the association between lifetime drinking and increased risk of pancreatic 
cancer; Hassan et al (2007), in a US hospital case control study, reported that for average lifetime 
alcohol consumption of >60millilitres (ml) per day compared to those drinking <60 ml/d (approx. <40 
g/d) there was no increased risk of pancreatic cancer. Rohrmann et al 2009 also observed that an 
average lifetime intake of ≥30 g/d did not significantly increase risk of pancreatic cancer. 
 
Three prospective cohort studies reported on the association between pancreatic cancer mortality and 
alcohol consumption (see Figure 2.15.2). In a large American cohort study, alcohol consumption was 
not associated with an increased risk of pancreatic cancer mortality in men and women who drank >1 
d/d (Coughlin et al 2002) and for women drinking up to and including >14 u/w in a UK study 
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(Stevens et al 2009). In a Japanese cohort, heavy alcohol consumption (>60 g/d for men and >30 g/d 
for women) was also not associated with an increased risk of fatal pancreatic cancer (Lin et al 2002). 
Figure 2.15.2 Alcohol consumption and pancreatic cancer mortality, highest versus lowest exposure 








Relative risk, highest vs lowest exposure category
 
 
2.15.4 Results: drinking dimensions and risk of pancreatic cancer 
There were no studies identified in this review investigating the associations between drinking 
dimensions (e.g. duration, frequency and pattern) and risk of pancreatic cancer. 
 
2.15.5 Results: drink type and risk of pancreatic cancer  
Four studies examined whether risk of pancreatic cancer varied by type of alcoholic beverage. A 
summary of risk estimates, comparing the highest versus the lowest alcohol exposure category, is 







Figure 2.15.3 Alcohol consumption and risk of pancreatic cancer, highest versus lowest exposure 



































OR/RR, highest vs lowest exposure category
 
 
In two prospective cohort studies, which reported on low levels of drinking only (approximately one 
drink per day), beer, wine or spirit consumption was not associated with either an increased risk of 
pancreatic cancer among current drinkers i.e. those drinking in the previous year (Heinen et al 2009) 
or among current and lifetime drinkers (Rohrmann et al 2009). Jiao et al (2009) observed an increased 
risk, of statistical significance, in their cohort of Dutch spirit drinkers, drinking >3 d/d. Similar 
193 
 
findings were reported by Villeneuve et al (2000) for men drinking >1 spirit d/d, but not in women. 
Neither beer nor wine was associated with an increased risk of pancreatic cancer in these studies. 
 
2.15.6 Results: effect modification 
Three studies assessed the interaction between smoking and alcohol consumption on the risk of 
pancreatic cancer. Jiao et al (2009), in a large US cohort study reported, that there were no statistically 
significant interactions of alcohol use on risk of pancreatic cancer, by lifelong smoking status 
(Pinteraction=0.25), the number of years since quit smoking (Pinteraction=0.61), or folate intake 
(Pinteraction=0.50). The authors further evaluated the risk of pancreatic cancer among participants with 
self-reported diabetes based on 161 cases and found that heavy total alcohol use (> 6 d/d) was not 
associated with risk. The association of alcohol use with risk did not vary by diabetes status 
(Pinteraction==0.30). 
Heinen et al (2009) reported that current smokers drinking >30 g/d had a two-fold (RR 2.40, 95% CI 
1.06-1.41) statistically significant increased risk of pancreatic cancer, compared to never-smokers and 
abstainers. Non-smokers drinking >30 g/d had a non-significant increased risk of pancreatic cancer 
(RR1.77, 95% CI 0.58-5.33). There was no evidence of significant interaction (Pinteraction=0.97) of 
alcohol consumption and smoking on the risk of pancreatic cancer. 
In a cohort of nurses and health professionals, Michaud et al (2001) reported that male current 
smokers, who drank >5 g/d had an increased risk of pancreatic cancer, but these associations were 
statistically non-significant (compared with <5 g/d, the RRs, for male current smokers drinking 
between 5-14.9 g/d and ≥15 g/d, were 3.98, 95% CI 0.8-18.9 and 2.14, 95% CI 0.4-10.5 respectively). 
The alcohol intake and pancreatic cancer associations were similar for never-smokers and past 
smokers with both not associated with an increased risk of pancreatic cancer.  Michaud et al (2001) 
also assessed the interaction between weight (measured by BMI) and alcohol consumption on the risk 
of pancreatic cancer; those with a BMI ≥25 kg/m
2
 did not have an increased risk of pancreatic cancer 
at any alcohol intake level (>15 g/d, RR 0.97, 95% CI 0.54-1.76), compared to non-drinkers with a 
BMI ≥25 kg/m
2. 
In contrast, a BMI of <25kg/m
2
 and drinking >15g/d was associated with a non-
significant increased risk of pancreatic cancer compared to non-drinkers with a BMI of <25kg/m
2
. 
Michaud et al (2001) reported that these differences were not statistically significant, and that no trend 
was apparent for the increased risk among those in the low BMI stratum, but no data was provided in 
the paper to demonstrate this. 
 
2.15.7 Summary and conclusions 
Twelve studies, eight cohort and four case-control, published between 1999 and 2009, were appraised 
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and which considered the association between alcohol consumption and pancreatic cancer. Drinking 
≥30 g/d was associated with an increased risk of pancreatic cancer in most, but not all, of the cohort 
studies. Risk estimates were generally higher for men than for women, but differences were not 
statistically significant. There was no convincing evidence that drinking <30 g/d was associated with 
an increased risk of pancreatic cancer. The association between drink type and risk of pancreatic 
cancer was inconsistent across studies and these analyses were limited by very small sample sizes and 
risk estimates lacked precision. Alcohol consumption was not associated with an increased risk of 
pancreatic cancer mortality. 
Studies in the present review were generally of a moderate to high quality. In general, studies adjusted 
for the main confounders of the alcohol and pancreatic cancer association including age, smoking and 
weight (BMI). Some studies controlled for history of diabetes mellitus thought the nature of the 
association between alcohol consumption and diabetes is still uncertain. Residual confounding from 
smoking may explain some of the inconsistent results reported for the association between low to 
moderate levels of alcohol consumption, and pancreatic cancer risk. Diabetes mellitus and chronic 
pancreatitis, however, may have a modifying effect on the association between alcohol consumption 
and increased risk of pancreatic cancer. The potential effect of chronic pancreatitis was demonstrated 
in the paper by Talamini et al (1999) where a small number of pancreatic cancer cases (n=69) without 
a history of chronic pancreatitis, drinking >40 g/d, had a 50% reduced risk of pancreatic cancer 
compared to a two-fold increased risk for chronic pancreatitis cases without cancer, the vast majority 
of which were alcohol related. Heavy alcohol consumption has also been known to be a risk factor for 
type 2 diabetes mellitus, which is also linked to pancreatic cancer (Go et al 2005). The various 
metabolic effects of alcohol through heavy consumption can also lead to or interact with other risk 
factors (genetic, dietary, environmental, and lifestyle factors) that result in acute and chronic 
pancreatitis and diabetes mellitus and, ultimately, affect the multi-step process of carcinogenesis 
toward the development of pancreatic cancer (Go et al 2005). 
The findings of the present review are consistent with those in the published literature. The recent 
WCRF/AICR (2007) review concluded that low to moderate levels of drinking were unlikely to have 
an effect of the risk of pancreatic cancer, but the effects of heavy (approximately 30-40 g/d) drinking 
on the risk of pancreatic cancer could not be excluded. A meta-analysis of 17 studies (including 4 
cohort and 13 case control studies published between 1966-1999) reported no increased risk of 
pancreatic cancer in those drinking 25 g/d (pooled relative risk (PRR) 0.98, 95% CI 0.90-1.05) and a 
small non-significant, increased risk in those drinking 50 g/d (pooled PRR 1.05, 95% CI 093-1.18) 
and 100 g/d (pooled PRR 1.18 95% CI 0.94-1.49, P Het <0.05) (Bagnardi et al 2001). In a recent 
pooled analysis of 14 cohort studies (including data from the Michaud et al (2001) paper identified in 
the present review), only drinking ≥30 g/d, compared to drinking 0 g/d, was associated with a modest 
increase in the risk of pancreatic cancer (PRR 1.36, 95% CI 1.15-1.60, p value for trend =0.05, P Het 
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=0.80) (Genkinger et al 2009). The PRRs were consistently higher for women than for men, but 
differences were not statistically different (P Het =0.19).  
Overall the evidence for an association between low and moderate alcohol consumption and increased 
pancreatic cancer is weak. Heavy alcohol consumption may increase the risk of pancreatic cancer 
either directly or by causing chronic pancreatitis. Further studies are required, to clarify the possibility 
of an increased risk of pancreatic cancer at heavy levels of alcohol consumption and which take into 





2.16 Prostate Cancer 
Prostate cancer: summary of evidence from previous reviews 
Overall, studies on cancers of the prostate show no association with consumption of 
alcoholic beverages. IARC1988b, WCRF/AICR 1997). The lack of association between total 
(current) alcohol consumption and prostate cancer risk was also reported in a review of 
studies conducted between 1971 and 1996 (Breslow and Weed 1998) and a meta-analysis 
(Dennis and Hayes 2001). 
 
 
The literature search identified 18 papers from 17 studies, published between 1999 and 2009, which 
examined the relationship between alcohol consumption and prostate cancer. There were nine cohort 
studies and eight case control studies. Two cohort studies reported on the same cohort of male health 
professionals in America and both have been retained in the review as they report on different aspects 
of the relationship between alcohol and prostate cancer; from baseline and average lifetime alcohol 
intake (Sutcliffe et al 2007), and by drinking frequency and prostate tumour type (Platz et al 2004). Of 
the cohort studies, eight were prospective and one was retrospective in design (Putnam et al 2000). 
Tables for each study, describing the study aims, population, alcohol measurement methods and main 
results, are provided in Appendix D. 
 
2.16.1 Study characteristics 
A summary of the general characteristics of the studies is provided in Table 2.16.1 below.  
Five papers were based on four established prospective cohort studies described in Box 2, section 2.2 
(p28); Netherlands Cohort Study on Diet and Cancer (Schuurman et al (1999); European Prospective 
Investigation into Cancer and Nutrition Rohrmann et al (2008); the Health Professional follow up 
study (Platz et al 2004, Sutcliffe et al 2007) and the Copenhagen Centre for Prospective Population 
Studies (Albertsen et al 2001). In a small retrospective cohort study, the study population consisted of 
cancer-free controls who participated in a population-based case-control study conducted between 
1986 and 1989 (Putnam et al 2000). Controls were randomly selected from a regional population 
identified through driver’s license records and health insurance plans. 
Cohort and cases control studies varied in size. The largest cohort study identified in the present 
review included approximately 3,348 prostate cancer cases (Sutcliffe et al 2007). Other large cohort 
studies by Rohrmann et al (2008) and Platz et al (2004) identified 2655 and 2,479 prostate cancer 
cases, respectively. The length of follow up in the majority of cohort studies ranged from between ten 
to twenty years though in three studies the duration of follow up was between five and six years 
(Schuurman et al 1999, Putnam et al 2000, Sesso et al 2001), whilst Rohrmann et al (2008) reported 
an average follow up of 8.7 years.  
197 
 
Three case control studies identified approximately 1500 cases and controls (Villeneuve et al 1999, 
Crispo et al 2004, Chang et al 2005). One case control study recruited less than 100 cases and controls 
to their study population (Barba et al 2004).  
Table 2.16.1 Alcohol and prostate cancer: general characteristics of studies reviewed 
Authors  Year  Country Sample size Age 
range 
(M/Mdn) 
Sample base  Sample selection  
Cohort studies 
Albertsen 2001 Denmark 233/26,496 (M=52) city population  random sample 
Breslow 1999 USA 386/5,766 25 -75 general population 
representative 
sample 
















Sutcliffe* 2007 3,348/45,433 
Putnam 2001 USA 101/1,577 (M=69.4) state population random sample 
Rohrmann 2008 Europe 
2,655/ 
142,607 
40-65 various random selection 
Schuurman 1999 Holland 680/58,279, 55-69 general population random sample 




                                            Case control studies                   cases/controls 





Chang 2005 Sweden 1,499/1,130 45-79 regional population 
consecutive/non-
random selection 
Crispo 2004 Italy 1,294/1,451 (M=66) hospital 
consecutive/non-
random selection 
Hodge 2004 Australia 858/905 <70 regional population random sample 
Hsieh 1999 Greece 372/308 >60 hospital 
consecutive/non-
random selection 









Villeneuve 1999 Canada 1623/1623 50-74 regional population 
consecutive/random 
sample 
* papers from the same study. Abb: n/s not specified; M=mean; Mdn= median  
 
2.16.2 Study quality 
The quality scores assessed according to the NOS are presented in Table 2.16.2. Overall, studies were 
of a moderate to high quality, scoring between 6-8 stars.  
On the basis of sample selection, cohort and case control studies scored highly with either three or 
four stars out of four. Seven studies scored four stars, and all the other studies that scored three failed 
either because their study cohort could not be considered truly representative of the general 
population (Schuurman et al 1999, Sesso et al 2001, Sutcliffe et al 2007), for not specifying that the 
outcome was absent prior to baseline entry into cohort (Albertsen et al 2002) or from the study control 
group (Schoonen et al 2005, Chang et al 2005). All studies scored either two or three stars for 
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exposure assessment in cases control studies and for outcome assessment in cohort studies. Of those 
that only scored two, most were not awarded the third because of the potential response bias in their 
study due to low and contrasting response rates among cases and controls (Barba et al 2004, Hodge et 
al 2004 Chang et al 2005) or for failing to provide a statement of the completeness of follow-up in 
cohort studies (Breslow et al 1999, Ellison et al 2000, Llund-Nilsen et al 2000, Albertsen et al 2002, 
Rohrmann et al 2008). 
Table 2.16.2 Prostate cancer: assessment of study quality  
 Selection* 
(out of 4) 
Comparability* 




(out of  3) 
Total 
Cohort     
Albertsen 2002 3 2 2 7 
Breslow 1999 4 1 2 7 
Ellison 2000 4 1 2 7 
Llund-Nilsen  2000 4 1 2 7 
Platz 2004 
3 1 3 7 
Sutcliffe 2007 
Putnam 2000 3 1 3 7 
Rohrmann 2008 4 1 2 7 
Schuurman 1999 3 2 3 8 
Sesso 2001 3 1 2 6 
Case-control     
Barba 2004 3 2 2 7 
Chang  2005 3 1 2 6 
Crispo 2004 3 2 2 7 
Hodge 2004 4 2 2 8 
Hsieh 1999 1 1 2 4 
Schoonen 2005 3 1 2 6 
Sharpe 2001 4 2 3 9 
Villeneuve 1999  4 2 3 9 
* High quality characteristics within each of these items were awarded a star, up to a maximum of four stars for 
selection, two stars for comparability and three stars for assessment; 
1 
Outcome for cohort, exposure for case-
control studies 
 
Since the aetiology of prostate cancer is poorly understood, adjusting for confounding factors in 
studies on alcohol consumption and prostate cancer is problematic which explains the variation in 
comparability scores. Only six studies scored two stars and the remaining studies only one star 
principally because they controlled for age. Of the six studies with two stars, the second star was 
awarded because each study attempted to control for the possible confounding effects of socio-
economic status (SES) on the association between alcohol consumption and prostate cancer. Measures 
of SES used, however, varied across studies from years of education (Albertsen et al 2002, Barba et al 
2004), to levels of family incomes (Villeneuve et al 1999, Sharpe et al 2001). A further two studies 
did not define their measure of SES (Schuurman et al 1999, Hodge et al 2004). 
 
2.16.3 Results: total alcohol intake and risk of prostate cancer25 
Eight cohort and five case-control studies, reported on the association between total ‘recent’ alcohol 
                                                          
25
 Multivariate relative risks/odds ratios are presented unless otherwise stated 
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consumption and prostate cancer. A summary of prostate cancer risk estimates, comparing the highest 
versus the lowest alcohol exposure category, is presented in Figure 2.16.1. 
Figure 2.16.1 Alcohol consumption and prostate cancer, highest versus lowest exposure category, by 

















OR/RR, highest vs lowest exposure category
 
 
Of the larger cohort studies, Rohrmann et al (2008) did not find an association between alcohol 
consumption and an increased risk of prostate cancer (≥60 grams per day [g/d]; RR 0.88, 95% CI 
0.72-1.08, compared to 0.1-4.9 g/d). For each additional 10 g/d of alcohol the relative risk was 1.00 
(95% CI, 0.98-1.02). Non-drinkers were not at an increased risk of prostate cancer. 0.95 (95% CI 
0.81-1.12). Sutcliffe et al (2007) reported a modest, non-significant, increased risk of prostate cancer 
across all alcohol intake categories, with strong evidence of a statistically significant dose response 
relationship (≥16.5 g/d; RR 1.14, 95% CI 0.96-1.34, p value for trend =0.0034).  
Schuurman et al (1999) observed a small increased risk of prostate cancer associated with alcohol 
consumption, but none of the point estimates were statistically significant and there was no evidence 
of a dose response association (≥30 g/d; RR 1.1, 95% CI 0.8 95% CI 0.8-1.6, p value for trend =0.74, 
compared to non-drinkers). Sesso et al (2001) reported similar findings in a cohort of American 
university alumni (>36 g/d; RR, 1.33 95% CI 0.86-2.05, p value for trend =0.40, compared to ‘almost 
never’ drinkers). 
In a small retrospective cohort study, Putnam et al (2000), reported a threefold increased risk of 
prostate cancer in men drinking >13 g/d (RR 3.1, 95% CI 1.5-6.3), compared to non-drinkers, with 
strong evidence of a statistically significant dose response relationship (p value for trend =0.001). 
Breslow et al (1999) reported a 40% non-significant increased risk of prostate cancer in men drinking 
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≥22 drinks per/week [d/w], but drinking <22 d/w was not associated with an increased risk of prostate 
cancer, compared to non-drinkers. In a Danish cohort study (Albertsen and Grønbaek 2004), men 
drinking >70 g/d, compared to those drinking <1.5 g/d (including non-drinkers), had a relative risk of 
0.68 (95% CI 0.31-1.52). There was no association between prostate cancer and men drinking <30 g/d 
and no strong evidence of statistically significant dose response relationship (p value for trend =0.48). 
Of the larger case control studies, Chang et al (2005) observed a weak statistically significant dose 
response relationship (>22 g/d OR 1.2, 95% CI 1.0-1.7, p value for trend =0.06, compared to non-
drinkers) between ‘recent’ alcohol consumption and prostate cancer. In the remaining case control 
studies there was no evidence of an association between alcohol consumption and an increased risk of 
prostate cancer (Villeneuve et al 1999, Crispo et al 2004, Hodge et al 2004, Schoonen et al 2005). 
Three studies reported on the association between lifetime drinking and an increased risk of prostate 
cancer. In a large European cohort study Rohrmann et al (2008) did not find an association between 
lifetime alcohol consumption and prostate cancer (≥60 g/d; RR 1.09, 95% CI 0.86-1.39). Cumulative 
drinking levels over a person’s lifetime also did not increase the risk of prostate cancer in an 
American population based control study (≥24,000 grams; OR 1.29, 95% CI 0.84–1.97, p value for 
trend =0.33, compared to non-drinkers) (Schoonen et al 2005) or in an Italian case control study 
(>11048 ounces; OR 0.83, 95% CI 0.43-1.6, compared to drinking<2647 ounces) (Barba et al 2004). 
 
2.16.3.1 Results: total alcohol intake and risk of prostate cancer by tumour 
type 
Five studies investigated the association between alcohol consumption and risk of prostate cancer, by 
tumour type. In three prospective cohort studies, there was no association between advanced or 
localised tumours and alcohol consumption, and risk estimates were similar for both tumour types 
across all alcohol intake levels in each study (Schuurman et al 1999, Platz et al 2004, Rohrmann et al 
2008). In a large Swedish case control study, Chang et al (2005) reported an increased risk of 
localised tumours across all alcohol intake levels (>22 g/d; OR 1.4, 95% CI 1.0-2.0, p value for trend 
=0.34), compared to non-drinkers, but not of advanced tumours (>22 g/d; OR 0.9 0.7-1.2, p value for 
trend =0.50). Differences between tumour types were, however, not statistically significant (p value 
for test of heterogeneity =0.78).  
 
2.16.4 Results: drinking dimensions and risk of prostate cancer 
Six studies investigated the association between prostate cancer and other aspects of drinking 
behaviour including drinking frequency, patterns and duration of drinking. Daily drinking was not 
associated with an increased risk of prostate cancer in Norwegian cohort study (Llund-Nilsen et al 
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2000) and in a cohort of American health professionals (Platz et al 2004). However, a moderate, 
statistically significant, increased risk of prostate cancer was observed in a Canadian case control 
study, for both weekly (OR 1.6, 95% CI 1.1-2.4) and daily (OR 1.6, 95% CI 1.1-2.3) drinkers 
compared to those reported ‘never drinking weekly’ (Sharpe and Siemiatycki 2001).  
Duration of drinking was also not associated with prostate cancer in three case control studies (Barba 
et al 2004; Crispo et al 2004; Schoonen et al 2005) though Sharpe and Siemiatycki (2001) reported, as 
they did with drinking frequency, that men drinking for more than 39 years were four times more 
likely to get prostate cancer than non-drinkers. Men who started drinking between the ages of 17-19 
years had a small, but statistically significant increased risk of cancer of the prostate (OR 1.36, 95% 
CI 1.05-1.75) compared to those who started drinking at 16 years and under. This increase in risk was 
not evident for those who started drinking between ages 20-22 years and >23 years (Crispo et al 
2004). 
 
2.16.5 Results: drink type and risk of prostate cancer  
Eleven studies reported on the association between alcoholic beverage type and risk of prostate 
cancer. A summary of risk estimates, comparing the highest versus the lowest alcohol exposure 
category, is presented in Figure 2.16.2. 
Five cohort studies reported on the association between drink type and prostate cancer. In a large 
European prospective cohort study, wine (red or white), beer and spirits were not associated with an 
increased risk of prostate cancer (Sutcliffe et al 2007). Similar findings were reported by Albersten 
and Grønbaek (2002). Putnam et al (1999) reported non positive associations, in their retrospective 
cohort study, between prostate cancer and drinking of wine, beer or spirits, compared to non-drinkers. 




Figure 2.16.2 Current and lifetime alcohol consumption and risk of prostate cancer, highest versus 

















































OR/RR, highest vs lowest exposure category
 
 
In contrast to findings reported in their paper on the association between total alcohol consumption 
and prostate cancer, Schuurman et al (1999) observed a twofold increase in risk (RR 2.3, 1.0-5.3, p 
value for trend =0.67) of prostate cancer among men drinking ≥30 g/d of wine. Men drinking 
equivalent amounts of beer, however, had a reduced risk of prostate cancer (RR 0.5, 95% CI 0.2-1.3, p 
value for trend =0.48), compared to non-drinkers, but no association with prostate cancer was 
reported at lower intake levels. There was no association between spirits and prostate cancer. Sesso et 
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al (2001), in a cohort of university alumni, also reported an inverse association between prostate 
cancer and men drinking >3 ‘units’ p/d of beer, but no association between wine or spirit drinkers and 
prostate cancer.  
Of the large case control studies, Crispo et al (2004) reported that wine beer and spirits were not 
associated with an increased risk of prostate cancer. In the paper by Chang et al (2005), results for 
drink type were similar across all intake levels and were comparable to those reported for total alcohol 
consumption and risk of prostate cancer. Villeneuve et al (1999), however, observed a reduced risk of 
prostate cancer among men drinking >1/d/d of beer (OR 0.5, 95% CI 0.2-1.0), compared to non-beer 
drinkers. In contrast spirit intake of ≥4 d/d was associated with a non-significant 80% (OR 1.8, 95% 
CI 0.9-3.8, p value for trend =0.52) increased risk of prostate cancer. No association was reported 
between wine and prostate cancer. 
Two case control studies reported on the association between lifetime drinking and prostate cancer by 
drink type. Barba et al (2004) observed a non-significant 10-40% decreased risk of prostate cancer at 
the highest alcohol lifetime exposure category, compared to abstainers, for all three drink types. A 
similar decrease in the odds of getting prostate cancer, was observed by Schoonen et al (2005), for 
lifetime wine drinkers; ≥15 d/w, OR 0.63, 95% CI 0.31-1.27, p value for trend =0.41, compared to 
non-drinkers. Beer and spirit drinkers however, drinking at comparable amounts, had ORs of 1.16 
(95% CI 0.71-1.91) and 1.42 (95% CI 0.83–2.43), respectively. 
 
2.16.6 Results: effect modification 
Two studies reported on the effect modification of other risk factors on the association between 
alcohol consumption and prostate cancer. In both papers, details of these interactions where only 
provided in the main text with no supporting data tables.  
Rohrmann et al (2008) reported that the associations between baseline or average lifetime alcohol 
consumption and prostate cancer risk were not modified by age at baseline (Pinteraction =0.34 and 0.82, 
respectively) or body mass index (Pinteraction =0.92 and 0.87, respectively). Platz et al (2004) reported 
that the association between alcohol intake and prostate cancer did not vary by age at diagnosis or by 
intake of folic acid, vitamin E, or tomato sauce. However, the association of alcohol with advanced 
and metastatic/fatal disease was stronger in men who were younger (<60 years old) at diagnosis 
(Pinteraction=0.03 and 0.07, respectively). Risk of prostate cancer associated with alcohol consumption 
was greater among men with type 2 diabetes mellitus (Pinteraction= 0.08). Among men with diabetes, in 
comparison with non-drinkers, the hazard ratios were 1.09 for 0.1-4.9 g/d, 1.27 for 5.0-14.9 g/d, 1.92 
for 15.0-29.9 g/d, 1.37 for 30-49.9 g/d, and 2.48 for ≥50 g/d (p-trend = 0.05). For men without 




2.16.7 Summary and conclusion 
This review identified 18 papers from 17 studies that examined the association between prostate 
cancer and alcohol consumption. Overall the majority of cohort and case control studies observed an 
increased risk of prostate cancer at the highest alcohol exposure category (range 16-30g/d), compared 
to reference groups mainly consisting of non-drinkers, but rarely reported a statistically significant 
dose response relationship. Residual confounding from socio-economic status or unknown or less well 
established risk factors may explain the observed increased risk. Weiss et al (2003) for example have 
argued that the screening history for prostate cancer may affect disease incidence and act as 
confounder. Schoonen et al (2005) in their case control study did observe a strong association 
between screening history and disease and found that screening history differed across levels of 
alcohol intake among controls. The lack of association between total (current) alcohol consumption 
and prostate cancer risk has been reported elsewhere: in a comprehensive review of studies conducted 
between 1971 and 1996 (Breslow and Weed 1998) and a meta-analysis (Dennis and Hayes 2001). 
There was no convincing evidence that drink type modified the association between alcohol 
consumption and prostate cancer. The larger and better designed studies, both cohort (Sutcliffe et al 
2002, Sutcliffe et al 2007) and case-control (Crispo et al 2004 and Chang et al 2005) reported no 
variation in the association for prostate cancer by beer, wine or spirits. Overall, the reported 
associations between drink type and prostate cancer were similar to those reported for total alcohol 
consumption and risk of prostate cancer. The inconsistency of results of the association between 
prostate cancer and wine or beer drinking could be explained by the different reference groups used 
across studies varied which consisted in some studies of ‘abstainers’ and in others of ‘non-drinkers of 
specific drink types’.  
Five studies examined this aspect of the relationship between alcohol consumption and prostate 
cancer. In each of the studies alcohol intake showed stronger associations with localized prostate 
tumours than with advanced prostate tumours or distant and familial tumours though these were of 
borderline statistical significance and were often based on less than 100 cases. It may be that these are 
chance findings because of small sample sizes and inconsistencies in defining tumour type outcomes, 
however, the consistent reporting of an increased association between alcohol consumption and risk 
of localised prostate tumours cannot be ignored.  
Other aspects of drinking behaviour may have a role in the aetiology of prostate cancer. Whereas 
traditionally alcohol and prostate cancer risk studies have assessed usual alcohol consumption over 
the previous year (as is the case in the studies reviewed here), clinical and epidemiological evidence 
suggests that prostate carcinogenesis may span decades (Issacs 1994). Drinking duration or distant 
past alcohol intake may, therefore, be more relevant to prostate cancer risk and/or very different from 
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recent intake. Evidence from this review would suggest however that this type of drinking behaviour, 
as with current drinking, has no relationship with the development of prostate. Five of the studies in 
this review explored this aspect of the alcohol and prostate cancer relationship and in each study 
drinking duration showed no association with prostate cancer including a large high quality cohort 
study (Rohrmann et al 2008). Furthermore in Schoonen et al's (2005) study, a rigorous approach to 
measuring this aspect of drinking behaviour was taken whereby men were allowed to change their 
drinking pattern over time without standardized consumption periods, enabling short periods of heavy 
drinking to be recorded in addition to the typical adult drinking habits. In this study duration of 
drinking years, lifetime total intake and average lifetime intake per week were not associated with 
increased risk of prostate cancer. Interestingly two studies, both population based case-control studies, 
did observe a statistically significant dose response relationship for those who had first started 
drinking alcohol aged <16 years when they were sixteen years or younger was reported (Sharpe & 
Siemiatycki 2001, Crispo et al 2004) though it was not clear if those in this age-group continued to 
drink throughout their adult life and for how long. Distant past exposures are also problematic to 
ascertain because they depend on participants’ memory of exposure history leaving considerable room 
for misclassification error. 
In conclusion, although alcohol consumption is unlikely to increase the risk of prostate cancer, a 
positive effect of high intakes of alcohol cannot be excluded, since the majority of studies reviewed 
here were only able to look at effects of low to moderate drinking. The positive associations between 
age related exposure and drinking frequency are interesting, but due to the small number of studies 
looking at this aspect, inconclusive. The long latency period of prostate carcinogenesis certainly 
requires past alcohol consumption to be considered as much an important dimension to prostate 
cancer risk as total alcohol consumption and future cohort and case control studies should look at 
these previously ignored areas of drinking behaviour and risk of prostate cancer. The inconclusive 
nature of prostate cancer risk by drink type needs further research and in particular studies would look 
to recruit sufficient numbers of people drinking each drink type to fully explore the range of alcohol 
intake levels. Further studies are also needed to explore alcohol consumption and risk of localized or 







2.17.1 Summary of evidence 
The aim of the current systematic literature review was to provide a summary of the evidence relating 
to the relationship between alcohol consumption and cancer for 
 
1. total alcohol consumption (‘recent’ and lifetime) 
2. drinking patterns (e.g. daily/weekly drinking, ‘binge’ drinking) 
3. alcohol beverage type (e.g. wine, beer, spirits) 
 
2.17.1.1 Total alcohol consumption 
Table 2.17.1 summarises the current state of evidence for the association between alcohol 
consumption and risk of cancer at specific sites, based on the data presented in sections 2.3 to 2.16. 
Table 2.17.1 Summary of evidence for a link between alcohol and cancer 
 Cancer site Evidence base: relationship between alcohol and cancer 
Bladder No relationship 
Breast Increased risk, irrespective of menopausal status, at moderate to heavy 
consumption, cannot rule out residual confounding 
Colon Increased risk with heavy consumption  
Endometrium No relationship  
Gastric (stomach) No association with low to moderate consumption, possible increased risk 
with heavy consumption and variation by tumour type (cardia and non-cardia) 
Kidney (renal cell) Evidence of decreased risk 
Larynx Increased risk, even with moderate consumption,  
Liver Increased risk at heavy consumption, possible threshold effect 
Lung Possibly increased risk at heavy levels of alcohol consumption, heavily 
confounded by smoking 
Rectum Increased risk with heavy consumption 
Oesophagus Increased risk, even with moderate consumption for SCC, but not 
adenocarcinoma 
Oral Increased risk, even with moderate consumption 
Ovary Conflicting and inconsistent evidence  
Pancreas Increased risk with heavy consumption 
Prostate No relationship with low-moderate consumption, cannot rule out effect of 
heavy alcohol consumption or lifetime consumption 
NOTE: Moderate consumption is defined as up to 2 alcoholic drinks per day (24-30 grams per day), Heavy 
consumption > 30 grams per day (WCRF/AICR 2007)  
 
There is convincing evidence that alcohol consumption increases the risk of upper aero-digestive tract 
cancers (oral, pharynx, larynx and oesophagus). Strong evidence exists that alcohol consumption 
increases the risk of oesophageal squamous cell carcinoma, but not oesophageal adenocarcinoma. The 
evidence would also suggest that the association between alcohol consumption and laryngeal cancer 
risk may differ by tumour type (larynx and hypopharynx). For these cancer sites, there is a dose-
207 
 
response relationship with alcohol consumption that persists after adjustment for potential 
confounders such as age tobacco smoking and diet. These results appear to hold for both men and 
women, though many studies suffered from limited numbers of women drinkers, compared to men, 
especially those drinking heavily to totally rule out a gender effect. 
There is sufficient evidence that moderate to heavy alcohol consumption (≥30g/d) is associated with 
an increased risk of liver and colorectal cancer. For liver cancer there is evidence of a threshold effect 
whereby drinking ≥40 g/d increases the risk of liver cancer. Positive associations between ‘current’ 
alcohol consumption and an increased risk of breast cancer were in general only associated with 
alcohol consumption of approximately >15 g/d (i.e. approximately >1 ‘standard’ drink or >2 UK 
‘units per day). For cancers of the breast and colorectal cancer, there is insufficient evidence of an 
effect at low levels of alcohol consumption due to residual confounding, particularly from diet and 
folate intake (Klatsky 2001). Alcohol is known to modestly suppress blood folate levels (Barak 1993, 
Chiuve 2005) and in some, but not all, studies of alcohol and breast cancer the elevated risk attributed 
to alcohol is attenuated among women with high dietary folate intake (Zhang 1999, Baglietto 2005, 
Beasely 2010). 
Low to moderate levels of drinking are unlikely to have an effect of the risk of pancreatic and prostate 
cancer, but the effects of heavy alcohol consumption (approximately 30-40 g/d) drinking on the risk 
of these cancers cannot be ruled out. The latency period of prostate carcinogenesis almost certainly 
requires past alcohol consumption to be considered as much an important dimension to prostate 
cancer risk as total recent alcohol consumption and too few studies in this review reported on this 
aspect to completely rule out an effect of lifetime alcohol consumption increasing the risk of prostate 
cancer.  
The evidence is inconsistent or insufficient for cancers of the lung, bladder, ovary, kidney, 
endometrium, and bladder. The association between alcohol and lung cancer is heavily confounded by 
tobacco smoking, to the extent that it is difficult to reliably determine the independent effect of 
alcohol consumption. Evidence of a decreased risk for kidney cancer was evident in the review, but 
the association is based on too few studies to be convincing.  
Overall, studies published since 2009 support the findings of the present systematic literature review. 
Tramacere et al (2010a), in a recent meta-analysis of alcohol consumption and risk of oral and 
pharyngeal cancers (45 studies including 17,085 cases), reported that “light alcohol drinking” (≤1 
drink per day ), compared to non-drinkers, was associated with a statistically significant 20% (RR 
1.21, 95% CI 1.10-1.33, p value for heterogeneity (P) =0.01), increase in risk of oral and pharyngeal 
cancer. The corresponding estimate for heavy alcohol drinking (≥4 drinks per day (approximately 7.5 
units), compared to non-drinkers, was 5.24 (95% CI 4.36-6.30, P =0.01). Further evidence of 
alcohol’s weak association with adenocarcinoma of the oesophagus is provided by Freedman et al 
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(2011). In a pooled analysis of two cohort and nine case control studies, including 1821 cases of 
oesophageal adenocarcinoma (OA), drinking >98 grams per day (approx. 12 units), compared to non-
drinkers, was not associated with an increased risk of OA (OR 0.97, 95% CI 0.68-1.36, p trend 0.21). 
The authors also reported that ‘moderate’ alcohol intake (7->14 grams per day or 1-2 units) was 
associated with a decreased risk of OA (OR 0.63, 95% CI 0.41-0.99). Seitz et al (2012) reported that a 
significant increase of the order of 4% in the risk of breast cancer associated with up to on drink per 
day. Heavy alcohol consumption, defined as three drinks or more a day was associated with an 
increased risk by 40-50%. In the most recent published meta-analysis of 23 cohort and 34 case control 
studies, Fedriko et al (2011) reported a 7% increase (95% CI 4-10%) in risk of colorectal cancer per 
10 grams of alcohol consumed per day and a 38% (95% CI 28-50%) increase in risk per 50 grams per 
day. In categorical analysis, “light drinkers” (<12.5 grams per day), were, however, not at increased 
risk of colorectal cancer; RR 1.01 0.97-1.05, compared to non- and occasional drinkers. On the other 
hand, moderate (≥12.6 to 49.9 g/day) and heavy drinkers (≥50g/day) had a 20% (95% CI 20-30%) and 
42% (95% CI 13-80%) statistically significant increased risk of colorectal cancer. 
Fillmore et al (2009) performed a meta-analysis (21 cohort and 14 case control studies) finding 
evidence to suggest that prostate incidence is positively linearly associated with heavier alcohol use. 
This finding was largely due to the contribution of population case-control studies and those 
measuring men recruited before age 60. Thus, for population case-control studies, “heavier” drinking 
among younger samples at recruitment increased the likelihood of prostate cancer incidence. The 
point at which statistical significance was reached was around 2 ‘standard drinks’ per day (approx. 4 
units ) for the younger population case-control samples No relationship between alcohol consumption 
and prostate cancer was found for cohort and hospital case-control studies. Fillmore et al. also carried 
out analyses of study design effects and found that population case-control studies were probably 
better suited to identify potential alcohol-prostate cancer relationships due to the close temporal 
proximity of the measurement of level of alcohol consumption to diagnosis. It is also possible that 
other variables not measured in the meta-analyses and in many individual cohort and case control 
studies may have an important role to play. One such variable might be the degree to which the 
populations sampled by the various studies were exposed to prostate cancer screening. In a meta-
analysis of seven prospective cohort studies, including 6086 endometrial cancer cases (Friberg et al 
2010), compared with non-drinkers, women drinking less than 1 ‘drink’ of alcohol (=13g) per day had 
a lower risk for endometrial cancer; this risk was lower by 4% (95% CI: 0.93-1.00) for consumption 
up to 0.5 drink per day and by 7% (95% CI: 0.85-1.02) for consumption up to 1 drink. However, there 
was no evidence of a statistically significant increased risk for endometrial cancer for drinking ≥2 
drinks per day: compared with non-drinkers, the risk was higher by 14% (95% CI: 0.95-1.36) for 2-
2.5 drinks per day and by 25% (95% CI: 0.98-1.58) for >2.5 drinks per day. In a pooled analyses (of 
12 prospective cohort studies and one case control study) with 1530 pancreatic cancer cases (Michaud 
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et al 2010), there was no significant overall association between total alcohol intake and pancreatic 
cancer (OR=1.38, 95% CI 0.86-2.23.for ≥60 grams per day compared to those drinking <5 grams per 
day). A statistically significant increase in risk was reported, however, for men drinking ≥45 grams of 
alcohol from spirits per day (OR 2.23 95% CI 1.02-4.87). In a recent meta-analysis of 24, 557 gastric 
cancer cases from 15 cohort and 44 case control studies, Tramacere et al (2011) reported there was no 
dose response association observed for those drinking an increment of 10 grams (RR 0.95,95% CI 
0.91-0.99) and 25 grams (RR 1.01 95% CI 0.96-1.06) per day of alcohol but those drinking an 
increment of 50 grams per day had a statistically significant increased risk of gastric cancer (RR 
1.14,95% CI 1.08-1.21).  
2.17.1.2 Drinking frequency, patterns 
Evidence that other dimensions of drinking behaviour such as ‘age first started drinking’ and duration 
of drinking increase cancer risk was mixed and largely came from case control studies and therefore 
subject to selection bias and recall bias. Where reported, evidence suggested a stronger effect for daily 
drinking compared to infrequent or occasional drinking though estimates were broadly similar to 
those reported for total alcohol intake. A few studies concluded that average daily alcohol intake, 
usually within the year prior to the study commencing and not drinking frequency appeared to be the 
relevant exposure index with respect to drinking and increased risk of cancer (Lee at el 2005, Zambon 
et al 2000). Less than 10% of papers in this review, however, reported on the risk of cancer by 
drinking frequency and many of the estimates were based on small numbers, different definitions of 
what constituted ‘daily’ ‘weekly’ and ‘occasional’ drinkers and therefore an association between 
drinking frequency and an increased risk of cancer cannot be ruled out. 
The finding of a different effect on the alcohol-breast cancer association, depending on whether 
alcohol is drunk with meals or between meals reported by Dal Maso et al (2002), is intriguing. 
Unfortunately this was the only study to investigate this aspect of the relationship between alcohol 
consumption and cancer. This may be of significance in understanding risk estimates provided in 
studies depending on the study’s country of origin and each country’s drinking patterns. Sieri et al 
(2002) observed that, across countries in Europe, the distribution of alcohol consumption varied 
during the week and whether or not it was consumed mainly at mealtimes; in Italy, most alcohol is 
consumed with meals, whereas in most other countries more alcohol was drunk outside main meals, 
especially in Germany and the Netherlands. The consumption pattern was not very different in the 
majority of countries when weekdays and weekends were considered separately. However, in Spain, 
and in Norway the proportion of alcohol consumed outside mealtimes increased during the weekend; 
while among women in the UK the proportion of alcohol drunk outside mealtimes decreased during 
the weekend (Sieri et al 2002). The study by Sieri et al suggests large variation in drinking patterns 
among European countries, especially if alcohol was drunk with meals or outside mealtimes. There 
are, however a number of limitations in their study design (Riboli and Kaaks 1997); Alcohol 
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consumption is measured by a 2-hour recall interview which provides an incomplete estimated of 
regular consumption and cannot distinguish, occasional drinkers, non and former drinkers. The 
selected study cohorts were also from restricted regions in each individual country included in the 
study; for example in the UK, the cohort was drawn from a sample of GP practices in Oxford and 
Cambridge. The overall figures for alcohol consumption may therefore not accurately reflect 
consumption at the country level. These limitations aside the findings by Sieri et al form a useful basis 
for future prospective studies on association between alcohol consumption and cancer.  
It is reasonable to assume that the effects of a given volume are more pronounced in heavy episodic 
drinkers than in persons who do not drink large amounts per occasion (Rehm et al 2003). However, 
demonstration of such interaction requires a large sample size. For example, a study with a 1000 
participants is probably too small. Once the sample is stratified by, for example, gender, age and 
binge drinking, the individual cells become too small for meaningful analyses of interactions. The 
misclassification of alcohol intake would obscure further the underlying associations (Bobak 2005). 
Some time ago, Peto (1982) suggested that most clinical trials are too small to be useful. The same 
may apply to alcohol-related research: there is now a need for large studies and good measurements to 
disentangle the effects of drinking volume and patterns and their interaction in relation to cancer 
outcomes. 
2.17.1.3 Types of alcoholic drink 
Analysis of cancer risk by type of alcoholic beverage has not provided consistent results. Some of the 
evidence reviewed in chapters 2.3 to 2.16 does appear to show that some types of drink seem to have 
different effects. A few studies have shown a more protective effect from wine and a more harmful 
effect from beer and spirit For example, for cancers of the mouth, pharynx, and larynx, the evidence 
that alcohol causes cancer, is stronger for consumption of beer and spirits than for wine. Here is the 
possibility of residual confounding: wine drinkers in many countries tend to have healthier ways of 
life than beer or spirit drinkers. Apparent discrepancies in the strength of evidence may also be due 
partly to variation in the amounts of different types of alcoholic drinks consumed. Equally the 
presence of resveratrol, a polyphenol specifically present in red wine, may contribute to the cancer 
preventive effects. Resveratrol in fact inhibits the metabolic activation of carcinogens, has antioxidant 
and anti-inflammatory properties, decreases cell proliferation and induces apoptosis. Data on the 
availability of resveratrol in vivo are however still lacking. Bianchini and Vainio (2003) argue that in 
order to establish a causal relationship between consumption of wine or resveratrol and prevention of 
disease, a beneficial effect should be demonstrated in intervention studies, in which known doses of 
wine and/ or resveratrol are given for a precise duration. 
One difficulty in determining an independent effect of a particular alcohol type is that people who 
drink alcohol tend to drink a variety of alcohol-containing beverages. It is widely accepted that, in 
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general, the beverage associated with the greatest risk of cancer is the most frequently consumed type 
of alcoholic beverage in each population (Bagnardi 2001, Burger et al 2004, Altieri et al 2005, 
Garavello et al 2006), suggesting that no meaningful difference exists for different types of alcoholic 
beverages. This finding could potentially be the result of inadequate power to assess uncommon 
drinks, under-reporting, or misclassification of consumption (Brennan & Boffetta 2004). In general, 
the evidence to date suggests that alcoholic drinks are or may be associated with increased risk of 
various cancers, irrespective of the type of alcoholic drink, though an effect of drink type cannot be 
completely ruled out.  
2.17.2 Limitations of current research base 
The evidence considered in this review exhibited methodological limitations which are summarised 
below. These limitations can be divided into two categories: limitations of the research included in the 
review and limitations of the review process. 
2.17.3.1 Limitations of research 
The quality of studies included in this review was assessed using the NOS developed by Wells et al 
(2005) for assessing the quality (i.e. internal validity) of non-randomized trials in met-analyses. 
Overall the cohort studies included in this review were of a moderate to high quality scoring an 
average of 7.7/9 stars and case control studies of a moderate quality scoring an average of 6.6/9 stars 
though there was variation in the average scores awarded to each study design by cancer type (Table 
2.17.2). 
           Table 2.17.2 NOS scores by cancer and study type 
 COHORT CASE CONTROL  
 No of studies Average score No of studies Average score  
Bladder 3 8.7 5 5.2 6.1 
Breast 24 7.7 17 7.1 7.4 
Colorectal 7 8.3 7 6.4 7.4 
Larynx  0 - 12 6.8 6.8 
Liver 1 8.0 8 6.5 6.7 
Gastric 9 7.6 10 6.5 6.3 
Endometrial 4 7.5 3 6.3 7.0 
Pancreas 8 8.1 4 7.0 7.8 
Prostate 10 6.9 9 7.0 6.9 
Oral 0 - 22 6.4 6.4 
Oesophagus 5 7.8 20 6.3 6.6 
Ovary 6 7.0 7 6.4 6.7 
Renal 4 8.0 5 7.0 7.4 
Lung 7 8.3 5 5.2 6.1 




Case control studies were characterised by susceptibility to selection bias and recall bias. Recall bias 
would be expected to result in over-estimation of the true level of association between the specific 
risk factor and risk of cancer. Some of the case control studies were more likely to suffer from 
selection bias than others due to variation in the methods of control selection. The magnitude and 
direction of this source of bias is more difficult to estimate. Cohort studies were also susceptible to 
bias, including selection bias (due to low participation and follow-up rates) and information bias (due 
to misclassification of exposure or outcome). Misclassification of exposure is most likely to be non-
differential, thus diluting the level of association with cancer.  
Although the NOS has been considered easy to use and suitable for systematic reviews (Deeks et al 
2003), it still remains un-validated and there are a number of serious limitations both for the items 
selected as a measure of internal validity and the gaps in bias measurement not covered by the scale. 
The NOS assigns a higher score to cohort studies with community representativeness of the exposed 
cohort. Established prospective cohort studies providing multiple papers in this review, such as the 
Nurses Health Study, the Health Professionals Follow-Up Study, received a lower quality score as 
their cohorts are not representative of the general population. However as Stang et al (2010) observe, 
‘representative’ cohort studies frequently suffer from low baseline response resulting in questionable 
generalisibility of the study findings whilst unrepresentative cohorts may have the advantage of  
higher baseline response, better exposure assessment and better follow-up response that may result in 
higher internal validity of the study. The NOS gives a higher score to case-control studies that had 
blinded exposure assessment, but blinding is sometimes impossible as the case control status can be 
easily discerned due to visual or acoustic signs of the disease which is particularly true for many of 
the cancers included in this review (Stang et al 2010). The NOS also gives a higher score to case-
control studies with comparable non-response rates among cases and controls than case control 
studies with different response proportions, but does not take into account different non-response rates 
with exposed and non-exposed controls. Identical response proportions, of the case control group, are 
therefore no safeguard against selection bias.  
Another weakness of the NOS in relation to alcohol consumption and cancer outcomes concerns its 
approach to managing data on risk factors that may confound the alcohol-cancer association. A higher 
score is awarded on the NOS which control for the most ‘important factor’ by design (matching) or by 
analysis (adjustment) and an even higher score if adjustment for a second ‘important’ factor takes 
place. However, matching in case-control studies is undertaken in the vast majority of studies 
included in this review and in the general epidemiological literature (Miettinen 1985). Therefore, the 
quality items on NOS have little discriminatory effect on the vast majority of case-control studies. 
Furthermore, the meaning of important factor is undefined and therefore arbitrary. Confounding is 
specific to individual research questions and the importance of confounding (e.g. change in estimate, 
multiple confounding risk factors) of the NOS remains undefined. In this review, the vast majority of 
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studies received the maximum stars in this category as they controlled for age and one of the main 
risk factors that confound the alcohol-cancer association e.g., smoking diet, weight. A more robust 
system would award for complete confounding of all possible important risk factors. For example, 
many of the studies in this review that reported on the alcohol-gastric cancer association controlled for 
dietary factors, but only a few for H pylori infection and dietary factors yet the absence of control for 
H pylori infection could result in a substantial influence on the estimated level of association. Overall, 
the NOS provides at best a quality score that has unknown validity or that includes quality items that 
may be even invalid for both cohort and case-control studies. 
A further issue concerning the quality of the studies in this review concerns the measurement of 
alcohol consumption itself. The NOS does not look this in any detail with only one item regarding 
whether questionnaire used was self-completed or administered by a structured interview. Yet the 
construction of questions on alcohol consumption and how are they are reported may have a 
significant impact on the risk estimates produced in epidemiological studies. There are longstanding 
concerns about the measurement and reporting of alcohol consumption in cohort and case control 
studies regarding the type of questions used to elicit drinking information, the use of reference and 
recall periods, the choice of reference groups and the variation contributed by different measures of 
ethanol content used in studies to estimate volume consumed (Turner 1990, Correa et al 1994, White 
et al 1994, Greenfield and Kerr 2008) These issues will now be briefly discussed with reference to the 
studies included in the present review. 
 
Survey questionnaires 
Many epidemiological studies, particularly those focused on alcohol-related health outcomes, have 
relied on the type of food frequency questionnaires (FFQ) commonly used in nutrition and other 
medical research. In many cases all alcohol, or beer, wine and spirits separately, would be assessed in 
the course of obtaining rates of consuming other beverages such as milk, soda and coffee. These 
questions typically include several frequency categories for less than daily drinking and quantity 
levels for daily drinkers. This discrepancy highlights the main problem with this type of measure, 
which is that it is not suited for populations that typically drink on a weekly or monthly basis and 
often have more than one drink per occasion (Rehm and Gmel 2000, Greenfield and Kerr 2008). Use 
of FFQ measures in epidemiological research may therefore underestimate true levels of alcohol 
consumption in study populations In survey research, new instruments have been developed such as 
the quantity frequency and graduated frequency approach to better identify different patterns of 
drinking (these are discussed in more detail in chapter 3) and have been shown to more sensitive than 




Overall, it was difficult to ascertain the exact method of alcohol data collection used by studies due to 
poor reporting of this aspect in many of the papers included in this review with 42% not specifying 
their method or simply stating they used a structured questionnaire. Over one in ten (14%) reported 
devising a questionnaire specific to the study, but did not provide details of any validation of these 
questionnaires. Food frequency questionnaire were used in over a third of studies (38.7%) compared 
to 4.1% using the quantity frequency method. It is difficult not to conclude that alcohol consumption 
is under-reported in many studies and therefore the true association with cancer outcomes may be 
underestimated.  
Another issue relevant to exposure assessment is change in exposure status during the follow-up 
period in cohort studies. In general, unless the exposure status is not subject to modification, it should 
be reassessed periodically to account for any changes. As far as possible, each exposure should be 
characterized as to when it began, when it ended (if at all), and how it was distributed during the 
intervening period (was it periodic or continuous? did the dose vary over time?). Similar details 
should also be obtained for any behaviour that may protect against the exposure. There is thought to 
be a restricted period, the critical time window, during which the exposure could have caused cancer. 
Unfortunately, the beginning and end of this critical time window are not known, and its length is 
likely to vary between individuals (Dos Santos Silva 1999). Collecting data on the timing of exposure 
allows the possible extent of this window to be estimated. The frequency of reassessment will depend 
to some extent on the likelihood of change and the costs of reassessment. Exposure to alcohol is 
measured typically among participants at baseline and health outcomes are tracked during the follow-
up period (which may be several decades). 
The majority of studies (38/46) in the present literature review have used single measurements of 
alcohol use and hence have not assessed the importance of updating alcohol intake or the effect of 
changes in consumption over time. despite evidence from descriptive alcohol studies that 
consumption levels change throughout the life course (Fillmore et al 1987, Midanik et al 1990, 
Mulder et al 1998, Britton et al 2009). This could be a limitation if people vary their alcohol intake 
substantially during follow-up (Willet et al 1987, Emberson et al 2005) because random measurement 
error of long-term intake based on one measure may bias the association toward the null (Willet et al 
1987). Also, repeated measures of exposure are useful for studying latency (time from exposure to 
cancer) (Thomas 1988). Of the eight studies (providing 27 papers) identified in the present review that 
did collect follow up alcohol exposure information, the majority used a weighted average of alcohol 
consumption from the baseline examination until the examination preceding the occurrence of cancer. 
Previous prospective studies of use of baseline and updated information on risk factors for 
cardiovascular disease showed that the strongest risk estimates were for updated information 
(Emberson et al 2003; 2005). This has been ascribed to increasing non-differential misclassification of 
baseline information on risk factors with longer follow-up (MacMahon et al 1990). Willett and 
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Stampfer (1997) proposed that the association for example between alcohol intake and breast cancer 
might be underestimated by at least 50% when based on a single assessment of alcohol intake. In two 
papers from the Copenhagen Heart Study, however, it was reported that results for baseline, updated, 
and cumulative average alcohol intake in relation to breast (Thygesen et al 2008a) and colorectal 
(Thygesen et al 2008b) cancer were relatively consistent which the authors argued implied that the 
timing of alcohol exposure during follow-up was not important because of a pronounced effect of 
latency; Thygesen et al (2008b) reported that for higher alcohol intake and risk of colorectal cancer, 
the suggestive lower consistency may reflect the influence of timing - a possibility that was supported 
by the weak attenuation of risk estimates for longer latency times, especially for alcohol intake above 
30 g/d. The consistency for alcohol intake <20 g/d could also be because alcohol intake was rather 
stable during follow-up for persons with low and moderate intake. Recent studies support this 
supposition; adult abstainers and moderate drinkers had more stable alcohol intake over time than 
heavy drinkers (Kerr et al 2002, Britton et al 2009). For higher alcohol intake, the suggestive lower 
consistency may therefore be explained by higher intra-individual intake variation during follow-up; 
thus, repeated measures of alcohol intake may be important for persons with high alcohol intake.  
Previous studies have suggested that updated exposure information is more precise and therefore 
superior to baseline information however one conclusion of papers from the Copenhagen Heart Study 
is that this may not apply in cancer epidemiology, because of a pronounced effect of latency. If the 
latency is long, variations in alcohol intake during follow-up may equate to non-differential 
misclassification. The effect will be strong if the variation in exposure during follow-up is large and 
independent of previous exposure. Despite these considerations, the overall conclusion of minor 
differences between the approaches indicates that other studies based on only one measurement well 
characterize alcohol intake for at least 16 years of follow-up (Thygesen et al 2008a), a finding that 
may have impact on the planning on future prospective cohort studies. 
 
Reference period 
It is crucial to provide a reference period - the period over which the respondent is instructed to 
provide summary information - such as 12 months or 30 days. When reference period is not explicit 
(e.g., “how often do you usually drink alcohol” rather than “During the last 12 months, how often...”), 
it has been shown that respondents assume periods ranging from a week to several years when 
describing their recent drinking (Greenfield 2000, Midanik and Greenfield 2003). Monthly or weekly 
thirty day measures can easily omit both infrequent light and intermittently heavy drinkers, which is 




Approximately a third of studies (32.8%) included in this review specified a reference period of 
drinking within the previous year and a further 5% used a reference period of drinking within the last 
2 years. Only a small number of studies (5.9%) looked at drinking in the prior month or week. 
Approximately, one in five (17.7%) of studies investigated consumption over a respondent’s lifetime, 
with a further 5% of studies using other to be less reliable than assessments of current drinking 
patterns, because they are subject to recall bias (Schottenfield 1979, Greenfield and Kerr 2008). 
Generally the farther in the past that the behaviour occurred the stronger this effect will be. There is 
also some evidence that the respondent’s current drinking behaviour will influence their retrospective 
reports (Lemmens et al 1997). This generally means a downward bias because drinking often 
decreases with age. Lifetime measures were used by approximately one in five of studies and there 
was no consistency in the approach used, resulting in between-study differences in drinking 
distributions making results non comparable. Only three studies specified using established 
techniques to assist recall such as calendar of life events (Li et al 2003, Berstad et al 2008) or the 
Skinner Alcohol Use Inventory (Marrero et al 2005). 
The reference period used in studies also, implicitly defines current drinkers; and by implication this 
also establishes the study's definition of non-current drinker or abstainers (Midanik and Greenfield 
2003). Therefore the lack of detail in the majority of the studies on this aspect is reflected by the 
variation in reference groups used across studies in this review. The majority of studies (52.9%) in the 
review specified a reference group of ‘non-drinkers), but did not define this group, over one in ten 
(13.7%) used a reference group of lifelong abstainers (excluding ex-drinkers) whilst one in four 
(25.5%) included in their reference group light drinkers (and even moderate drinkers in some studies). 
There is a potential source of bias if light, infrequent, or ex-drinkers are classified as non-drinkers, 
and the risk associated with alcohol consumption is estimated relative to this group (odds 
ratio/relative risk 1.0). The inclusion of former drinkers within the ‘non-drinker’ reference category is 
subject to misclassification bias. If ex-drinkers are grouped into the reference category with never 
drinkers then the risk for current drinkers will be underestimated (Wakai et al 2007). Fillmore et al 
(2006) observed that this approach will inevitably include more individuals with some pre-existing 
illness i.e. the "sick quitter" hypothesis, as proposed by Shaper et al (1988) in the United Kingdom; 
this states that the pool of abstainers includes many former drinkers who quit drinking because of 
illness or because alcohol interacts with prescription drugs they are taking. Obviously, comparisons of 
healthy drinkers with abstainers who take prescription drugs or who have underlying illnesses that 
raise one's risk for heart disease will produce a biased result in favour of the alcohol-consuming 
subjects. Prospective cohort studies in which alcohol intake is assessed at different times (rather than 
having “changes” based only on recall at one point in time) usually indicate that subjects who 
decrease their intake are more likely to subsequently develop adverse health outcomes, especially 
related to cardiovascular disease, than those who continue moderate drinking (Liang and Chikritzhs 
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2010). Future prospective cohort studies should consider multiple repeated measures to establish the 
heterogeneity of the ‘non-drinking’ group. 
 
Units of measurement: the ethanol content of drinks 
It has recently become apparent that the variation contributed by this source of measurement may of 
equal importance to all the other influences discussed above from the perspective of accuracy of 
consumption and drinking pattern measurement (WCRF/AICR 2007, Greenfield and Kerr 2008, 
Turner et al 2009).  
Studies included in these reviews frequently analyzed the effect of alcohol as quantified by a 
‘standard drink.’ The standard drink concept suggests that there is a serving size of alcohol that is 
typical of a particular country. However the use of the standard drink concept is complicated by 
different standards across countries and even within countries (WHO 2000). This was evident across 
studies included in this review. In the U.S., Canada, and Denmark for example, both 12 grams and 14 
grams and in Italy both 13 grams and 15 grams were commonly cited as standard drink amounts. 
Some countries use a smaller standard such as 8-10 grams in the UK, 8-13 grams in the Netherlands 
or 10 grams in Australia and Greece, while others use a larger standard, the highest being reported to 
between 23-29 grams in Japan. 
In practice, one standard will be taken by researchers to apply to all beverage types while in reality the 
typical serving sizes and ethanol contents tend to differ by beverage type, leading to non-equivalence. 
A number of factors are potentially associated with variation in drink ethanol content including 
beverage type and brand, glass size and shape, cultural and historical factors, the context in which 
drinking takes place, the specific drink recipe used (in the case of mixed drinks), the percentage 
alcohol content of the beverage/s used, and the type of measuring device or other pouring method 
involved. Variation in strength of beers commonly consumed complicates this further. In recent years, 
the strength and serving size of some alcoholic drinks have also increased. For example, in the UK, 
wine is commonly served in 250 ml glasses as opposed to the standard 125 or 175 ml glass. Studies 
that measure consumption in terms of number of drinks may therefore be referring to very different 
amounts of alcohol therefore making the syntheses of the alcohol-cancer association from 
international studies more challenging. 
 
Reporting of alcohol consumption as a categorical variable 
Due to the way that questionnaires ask about alcohol consumption, studies that relate the risk of 
cancer to levels of alcohol consumption summarize alcohol consumption within discrete categories, 
whereas the distribution between individuals is, in fact, continuous. Categorizing the alcohol intake 
has several disadvantages: high and low risk individuals could be merged (e.g., for highest alcohol 
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consumption group), and thereby dilute the estimated influence; and the number and placement of 
category boundaries may affect the estimates and thereby the level of alcohol consumption with the 
lowest risk of ill-health (Greenland 1995, Weinberg 1995, Polesel et al 2004)  
 
2.17.3.2 Limitations of review 
There are also limitations in the review process used. The review has been limited by restriction to 
English language articles and to articles that were published over restricted time period (1999-2009). 
Both of these factors may have resulted in bias. Publication bias may also have resulted from 
restriction to the published literature. Published literature is more likely to have identified an 
association with the outcome of interest though there was an extensive search of the grey literature, 
the results of which did not differ from those in the published literature. There was no double 
selection of relevant research and double extraction of data was not used. This increases the chance of 
missing relevant literature and incorrectly extracting data. 
Considering the size of the topic, a limited timeframe was available to conduct the review. This meant 
that the search strategy had to be restricted to a specified number of cancers that have been linked 
with alcohol consumption in the literature prior to 1999. There were, therefore, a number of cancers 
(e.g. nasopharynx, cervix, gallbladder, small intestine, thyroid and non-Hodgkin’s lymphoma) not 
included in this review, but which potentially may be associated with alcohol consumption. 
It should also be noted that the review did not include the role of various genetic polymorphisms and 
their effect on the alcohol-cancer association. Individuals differ in their ability to metabolize alcohol 
through genetic differences in alcohol dehydrogenase (ADH), the enzyme that catalyzes the oxidation 
of approximately 80% of ethanol to acetaldehyde, a known carcinogen (Lachenmeier et al 2009). 
There is a growing body of evidence that suggests that for many of the alcohol related cancers, the 
relationship is potentially modified by genotype. A recent review concluded that there is evidence for 
a role of the ADH1B and ALDH2 polymorphisms on risk of cancer of the upper aero-digestive tract 
(Druesne-Pecolla et al 2009). Terry et al (2006) demonstrated in US based study and Stürmer et al 
(2002) in a German study, that fast metabolisers of alcohol as measured by the ADH3
1-1
 genotype have 
a higher risk of breast cancer risk, from alcohol intake than slow metabolisers. Hong et al (2005) also 
demonstrated that polymorphisms in the XRCC1 genes may contribute to colorectal cancer 
susceptibility in their Korean study population with evidence of a genetic modification for the 
relationship between alcohol intake and colorectal cancer. It is therefore possible that the overall small 
increased risk in association seen between alcohol and breast, colorectal and even gastric cancer in 




The present review also did not consider the role of ethnicity and the relationship with alcohol 
consumption on cancers. Striking variations by ethnic group and incidence of cancer have been 
reported in the US (Miller et al 1993, Zahm and Fraumeni 1995) and a recent report by Cancer 
Research UK/National Cancer Intelligence Network (2009) observed that males and females in the 
Asian, Chinese and Mixed ethnic groups in England all had significantly lower risk of getting cancer 
than whites when the all malignancies combined group was examined. Across both age groups and for 
all ages, people from these three ethnic groups were between 20% and 60% less likely to get cancer 
than those from the White ethnic group. Overall the report concluded that generally, people from the 
Black and Minority Ethnic groups examined were at a significantly lower risk of getting cancer than 
the White ethnic group and there was no evidence for an overall inequality in cancer incidence. The 
report did observe, however, that for certain alcohol related cancers, e.g. liver and oral, Asian ethnic 
group had significantly higher rates for three specific sites of cancer in comparison with the White 
ethnic group (Cancer Research UK/National Cancer Intelligence Network (2009). The contribution of 
alcohol consumption to these disparities is unclear. Studies have shown that the prevalence of certain 
variations of genes for the alcohol-metabolizing enzymes alcohol dehydrogenase (ADH) and aldehyde 
dehydrogenase (ALDH) can vary across Asian ethnic groups and may cause some groups to have 
higher rates of alcohol dependence than others. For example, relatively high rates of alcohol 
dependence have been determined among Koreans and Korean Americans, whereas relatively low 
rates have been found in Chinese and Chinese Americans (Eng et al 2007). Tramacere et al (2011) 
also found that the effect of heavy drinking was stronger and of statistical significance in non-Asian 
countries explained by higher presence of ADH and ALDH in Asian populations, subjects with these 
mutant alleles cannot be heavy drinkers and which reduces prevalence of heavy drinking in Asia. 
Moles et al (2010) observed in a UK study that the positive trend in oral and pharyngeal cancer risks 
with socioeconomic status in non-South Asians in their study was consistent with the socioeconomic 
differences in the consumption of tobacco, but not alcohol, reported by the 1999 English Health 
Survey. Similarly, the ethnic differences in risk in females in our study do not parallel differences in 
their alcohol consumption but are, to a certain extent, consistent with their higher prevalence of 
tobacco chewing, particularly among Bangladeshi women. This would accord with tobacco chewing 
being associated with higher risks of oral than pharyngeal cancers (Dikshit and Kanhere, 2000), the 
former effect being stronger in females (Balaram et al 2002). More descriptive and analytic and 
comparative studies are needed to identify and explain variations in cancer risk associated with 
alcohol consumption among population subgroups. Especially important are studies to clarify the role 





2.17.3 Research gaps and scope for further research 
Based on the current review of alcohol consumption and cancer risk, a number of research gaps have 
been identified that warrant further investigation so that a clearer understanding can be gained of the 
link between alcohol intake and risk of specific cancers, and the mechanisms underlying such risks. 
The following areas warrant further investigation: 
 Alcohol consumption and risk of cancers of the bladder lung, pancreas, ovary, and kidney 
(Note that the evidence base for these cancers is currently inconsistent and often insufficient) 
 Role of folate and other effect modifiers in breast and other cancers (such as colorectal and 
gastric cancer) 
 Cancer risks associated with lifetime alcohol consumption versus consumption during specific 
periods 
 The combined effect of latency and alcohol exposure on the association between alcohol and 
cancer 
 Patterns of drinking on risk of cancer e.g., drinking with meals versus between meals, heavy 
irregular (binge) drinking 
 Role of age at starting and stopping drinking (and starting and stopping smoking for those 
cancers confounded by tobacco) 
 Risk in different sub-sites of the upper aero-digestive tract (oral vs. pharynx, larynx vs. 
hypopharynx 




The evidence that alcoholic drinks are a cause of cancers of the oral cavity, pharynx, and larynx, SCC 
of the oesophagus, and are a probable cause of colorectal, breast and liver cancer is convincing. There 
is insufficient evidence for an effect on cancers of the ovary, bladder, lung and endometrium. There is 
little evidence to suggest that alcohol is a risk factor for pancreatic and prostate cancer though an 
effect of heavy alcohol consumption cannot be ruled out. There is some evidence, based on a small 
number of studies, that alcohol is protective against cancer of the kidney. Confounding for risk factors 
especially socio-economic status, diet and folate intake may affect these estimates. 
Associations between alcohol and cancer are however based on imprecise measurements that vary by 
type of assessment method used as well as the different alcohol content and strength of alcohol drinks 
in individual countries which makes it difficult to generalise the findings from the international 
literature to specific countries. Country specific research is therefore required to support or dispute 
these associations particularly in countries such as Scotland which are associated with high levels of 
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both alcohol consumption and incidence of alcohol related cancers. In the next two chapters the 





Chapter 3 Trends in alcohol consumption in Scotland 
 
This chapter will describe trends in population and individual levels of drinking in Scotland, using the 
two common approaches to measuring alcohol consumption (Midanik & Room 1992); 
1. analyzing production and distribution statistics for alcoholic beverages as market 
commodities (aggregate population alcohol consumption) and  
2. asking samples of the population questions about their drinking behaviour 
 
Specifically, the chapter will describe trends in the weekly and daily alcohol consumption reported by 
national population surveys in Scotland and trends in the production and sales of alcohol at national 
level in Scotland. Variation by gender, age, deprivation and internationally will be examined. The 
strengths and limitations of these approaches to measuring alcohol consumption will be assessed.  
 
3.1 Aggregate alcohol consumption 
The oldest and most widely available measures of drinking behaviour in the United Kingdom (UK) 
are social statistics on the production and sales of alcohol drinks. These are commonly described as 
‘per capita’ consumption figures. Series of such statistics are available in the United Kingdom, back 
to the beginning of the twentieth century. Her Majesty’s Customs and Excise (HMCE) publish annual 
estimates, based on excise duty return, of the amount of pure ethanol in litres of total alcohol, and 
separately, beer, wine and spirits released for sale per adult (capita) in the country during a calendar 
year. The primary motivation behind the collection of such statistics was of course not a concern with 
alcohol problems, but rather the fiscal interest of the state in alcohol as a vehicle for taxation (Room 
1979, Midanik and Room 1992). 
Aggregate ‘per capita alcohol consumption’ statistics tell us something about levels of drinking at a 
societal level. Trends in per capita consumption are available over a longer period of time than trends 
obtained from series of population surveys. Due to the nature of reporting on excise duty returns, per 
capita alcohol consumption estimates have been traditionally published for the UK as a whole, with 
no disaggregation of the data to the constituent areas of the UK, Scotland England and Wales and 
Northern Ireland, and these data do not indicate whether alcohol consumption levels differ across the 
UK. It is only recently that separate per capita alcohol consumption data for Scotland and 
England/Wales have been reported (Robinson et al 2010). These data are not directly comparable with 
HMCE figures; they are based upon industry sales data derived from a sample of on-trade outlets 
(which allow the consumption of alcohol on the premises e.g. pubs, restaurants) and off-trade outlets 
(where alcohol must be removed from the vendor's premises and drunk elsewhere e.g. supermarkets) 
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across the United Kingdom, as opposed to HMCE figures which are based on alcohol production 
statistics (Robinson et al 2010). 
From the WHO Global Information System on Alcohol and Health (GISAH), it is also possible to 
compare international trends in ‘per capita alcohol consumption’ over a forty year period (Gliksman 
and Rylett 2009). GISAH provides estimates of pure ethanol in litres of total alcohol, and separately, 
for beer, wine and spirits consumed per adult (15 years and older
26
) in each country during a calendar 
year, as calculated from official statistics on production, sales, import and export. In order to make the 
conversion into litres of pure alcohol, the alcohol content of beer, wine, and spirits is considered to be 
5%, 12% and 40% respectively. Specific conversion factors are used for other, less common types of 
alcoholic beverages (WHO 2004). GISAH estimates are based on either FAO (Food and Agriculture 
Organization of the United Nations) or alcohol industry (e.g. World Drink Trends) data, except for a 
few countries in Europe where the data come directly from governments (e.g. United Kingdom). 
 
3.1.1 Trends in ‘per capita alcohol consumption’ 
Since the middle of the last century, ‘per capita alcohol consumption’ i.e. alcohol released for sale in 
the UK market, has been rising; from 7.14 litres per capita in 1961 to 11.39 litres per capita in 2006 
(Figure 3.1). Most of this increase has been due to growing consumption of wine, which increased 
eight-fold from 0.28 litres per head in 1961 to 3.48 in 2000. Spirit consumption doubled over the 
same period (from 1.04 litres per capita in 1961 to 2.35 litres per capita in 2000) whilst beer 
consumption has been in decline since the early 1980s (Figure 3.1). These figures will also be an 
underestimate of actual aggregate consumption since the data do not account for unrecorded alcohol 
consumption, resulting from home-made production and cross-border shopping and smuggling. 
Unrecorded per capita alcohol consumption is estimated to equate to approximately 2 litres per person 
per annum for the years after 1995 (Leifman 2001), though the peak of cross-border shopping and 
smuggling in the UK occurred between 1997 and 2000 (IAS 2010). 
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WHO uses adult (people 15 years and older) per capita to measure alcohol consumption, instead of per capita 
for the whole population. This is to balance the fact that population distributions in developing countries are 
quite different from developed countries, i.e. they have a much larger proportion of children and young people. 
Using per capita would mean that countries with many young people will underestimate the consumption among 




Figure 3.1 Pure alcohol consumption, litres per capita aged 15 plus, United Kingdom, 1961 to 2006 by 




Using a methodology based on alcohol sales data
27
 (as opposed to HMCE alcohol production 
statistics), Robinson et al (2010) have estimated per capita alcohol consumption levels in Scotland 
and, England and Wales, from 2005-2009 (Figure 3.2). The volume of pure alcohol sold per person 
(aged 16 and over), in Scotland, has remained broadly stable over the past five years (2005 = 12.0 
litres; 2009 = 11.9 litres). In contrast, the volume of pure alcohol sold per person (aged 16 and over) 
in England and Wales has decreased slightly every year between 2005 and 2009 (2005 = 10.2 litres; 
2009 = 9.6 litres). The gap between Scotland and the rest of Great Britain has, therefore, widened 
(2005 = 1.8 litres; 2009 = 2.3 litres). Differences in per capita consumption are accounted for by the 
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Data obtained from The Nielsen Company based on their continuous retail measurement system, which 
captures actual sales from scanned readings at Electronic Points of Sale. Weekly data are obtained from (a) all 
large multiple retailers which provide data from all of their stores, and (b) a stratified random sample of 

















































































Figure 3.2 Sales of pure alcohol per person (aged 16+) in Scotland and England & Wales, 2005-2009 
































SCOTLAND ENGLAND & WALES UK*
 
* GISAH UK per capita consumption data only available up to 2006 
 
‘Per capita alcohol consumption’ data allow a direct comparison to be made between UK or Scotland 
with countries (i.e. USA, Japan, Sweden, Denmark, and Italy) in which the majority of studies on the 
association of alcohol consumption and cancer (described in Chapter 2) were conducted. In the early 
1960s, per capita alcohol consumption in the UK was roughly equivalent to that found in Sweden, 
Denmark, the US and Japan (Figure 3.3), though per capita alcohol consumption in Italy was 
approximately three times higher than that in the UK. By 2006, UK per capita alcohol consumption 
data was the highest among the selected countries at 11.4 litres per head having steadily increased 
from 7.1 litres per head in 1961. Consumption in Denmark was at comparable levels (10.8 litres per 
head) to the UK in 2006 and has been at this level since the late 1980s. Japanese per capita 
consumption has increased the most in relative terms, rising from 4 litres per head in 1991 to 7.3 litres 
per head in 2007. On the other hand per capita alcohol consumption in Italy has fallen dramatically, 
from a high of 19.7 litres per head in 1970 to 8.0 litre per head in 2006. In Sweden and the US, per 
capita consumption changed very little between 1961 and 2007 (approximately 6 litres and 8 litres per 
head, respectively). Analysis of alcohol sales data for Scotland shows a widening gap with alcohol 
sales data in England and Wales (Figure 3.2), and they demonstrate that the population of Scotland is 
continuing to drink more alcohol than most of those countries where much of the epidemiological 





Figure 3.3 Pure alcohol consumption, litres per capita aged 15 plus, Trends in selected countries, 
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3.1.2 Limitations of per capita alcohol consumption 
‘Per capita alcohol consumption’ data have, however, some limitations. Alcohol production statistics 
collected at the wholesale level, or sales data collected at the retail level, do not take account of the 
fact that goods may not actually be consumed in the year in which they are recorded as having been 
shipped or sold. Taxes collected at the producer or wholesale level may also introduce a variable time 
lag into the data, since they do not reflect actual retail sales. Alcohol sales data also assume that all 
alcohol sold is consumed, but this is not necessarily the case (WHO 2000). Generally sales data from 
the alcohol industry at a retail level are considered more accurate than statistics on alcohol production 
or taxes raised at a wholesale level provided that sales of alcoholic beverages are separated from the 
sales of other items sold at the location and that sales data are beverage specific (WHO 2000, Gmel 
and Rehm 2004). In reality, however, differences between the various methods are marginal; recent 
figures for alcohol ‘sales’ data in Scotland and England, were 11.9 and 10.1 litres per head 
respectively(Robinson et al 2010) compared to HMCE statistics on alcohol produced and released for 
sale, of 11.4 litres per head (WHO GISAH 2010). 
‘Per capita alcohol consumption’ data also do not take into account or adjust for tourist consumption. 
Hospitality and tourism is one of the largest industries in Scotland, employing over 200,000 people, or 
about 9% of the total number of people employed in Scotland and contributing between £2-4 billion 
to the economy (5% of Gross Domestic Product). Consequently tourism is a significant factor in high 
alcohol sales and consumption in Scotland (British Hospitality Association 2008, Scottish Beer and 
Pub Association 2008, Scottish Parliament 2008) and may make a larger contribution to sales data 
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than in other countries. There is also some uncertainty as to whether changes in per capita 
consumption are necessarily correlated with changes in individual drinking levels. A longitudinal 
survey of Finnish drinkers found no increase in individual levels of self-reported alcohol consumption 
among respondents between 1999 and 2002, despite an increase in ‘per capita alcohol consumption’ 
as a result of excise duty reductions (Makela et al 2007, Mustonen et al 2007).  
In principle, although per capita alcohol consumption statistics reflect the total volume of 
consumption by the population of a particular geographic area, by their nature, they offer few clues as 
to the structure of drinking within the geographically defined populations they are derived from 
(Room 1979, Midanik & Room 1992, Stimson 2006). In theory, a per capita consumption of 52 litres 
a year could represent a population where everyone is drinking 1 litre a year, or, on the other hand, a 
population where 90% are abstainers and the other 10% are each consuming 10 litres a year. Survey 
data certainly support the common sense observation that there is considerable variation between 
different populations in the proportion of abstainers and in the frequency of drinking (Room 1979). 
Lemmens (2001) observes that even though individual alcohol consumption is the result of a complex 
combination of personal, social or environmental factors resulting in considerable variability in 
individual drinking, it is remarkable that per capita consumption in societies in general is relatively 
stable (which has been the case in the United Kingdom in recent years). Research has shown that not 
only is per capita consumption relatively stable, but so also is the way consumption is distributed 
among drinkers. Many researchers, following the lead of Ledermann (1964), have observed an 
empirical regularity in the distribution of alcohol consumption among drinkers in a variety of cultures 
(Room 1979, Skög 1985, Lemmens et al 1990, Skög1995). It is generally acknowledged that the 
population distribution is skewed with a mean higher than the median which again is higher than the 
mode (Lemmens 2001). This implies that the heaviest drinkers account for a disproportionately large 
part of the total alcohol consumption in a population. Since it is estimated that one-tenth of the adult 
population is responsible for between 30-60% of the alcohol consumed, it is argued that trends in per 
capita alcohol consumption can generally be regarded as an indicator of trends in very heavy drinking 
(Room 1970, Room 1979, Midanik and Room 1992, Lemmens 2001). 
Lemmens (2001) argues that although undoubtedly one can speak of a certain regularity in the way 
alcohol consumption is distributed in a population, what is seen at the aggregate level should be 
regarded with caution. A stable distribution does not imply stable consumption patterns of individuals. 
What Lemmens describes, as ‘chronicity of heavy drinking’, has been found to vary across (sub) 
populations and over time. Similarly, a particular consumption level can be attained in different ways. 
Lederman’s theory on the regularity of alcohol consumption has been further developed by Skög’s 
(1995) social interaction model where people’s drinking is seen as interrelated through various social 
networks in such a way that any (independent) change in individual consumption will have an equi-
directional impact on the consumption of all others. Lemmens (2001) argues, however, that this is still 
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a disputed model. Earlier work by Tuck (1980) in the United Kingdom, found that the increase in total 
consumption from 1974 to 1979 was caused by an increase in the number of drinkers at moderate 
frequencies, but not in the number of (heavier) drinkers. Based on similar evidence, covering 
subsequent years, Duffy (1991) concluded that the changes in average consumption were due to 
changes in the frequency pattern of lower-frequency drinkers and thus not consistently along the 
entire consumption scale as would be predicted by the social interaction model. Other research has 
found similar findings (Lemmens 1995, Fillmore et al 1997). These examples highlight that although 
overall per capita alcohol consumption data is an important indicator of heavy drinking in a society, it 
cannot be relied on as a sole indicator. 
Per capita alcohol consumption measures are a convenient way of collecting relevant data and can be 
useful proxy indicators of levels of drinking patterns in populations and in particular heavy drinking 
in the absence of individual population level survey data (Edwards et al 1994, WHO 2000). However, 
they do not capture the myriad ways in which individuals drink. To attain a better understanding of 
drinking among individuals and groups, the harms and benefits that may accompany their drinking, 
and interventions likely to minimize harm, it is necessary to understand patterns of drinking in more 
detail. 
 
3.2 Alcohol consumption and population surveys 
The richest source of information on drinking patterns is sample surveys of the general population, 
enquiring about individual drinking patterns. In North America, and in particular the US, the first 
nationwide survey covering detailed patterns of drinking within a sample frame was performed in 
1946 (Room 1979). The measure of individual drinking patterns in the general population in Scotland 
is, however, a relatively new development. The methods of survey research were first applied in 
Scotland in a detailed study of drinking practices by Dight (1976). Dight’s study of a nationally 
representative sample of approximately 2500 adults aged eighteen years and over in 1972, revealed a 
significant gender gap in both the volume and frequency of drinking: 74% of men were identified as 
‘regular’ drinkers compared to 46% of women, whilst mean weekly consumption among men was 
20.5 units, compared to 4.8 units among women. Dight also estimated that 30% of all alcohol drunk in 
a typical week in Scotland was consumed by only 3% of the total population (Dight 1976).  
Dight’s study was notable in two respects. Firstly, it highlighted the differences between European 
and North American traditions of asking about drinking behaviour in surveys. In European studies of 
the time, it was particularly common to list all drinking occasions in a specified period of time 
usually, as in the case of Dight’s study, within the last week (Gmel and Rehm 2004). This approach 
had been criticised as resulting in considerable under-estimation and misclassification of amount of 
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alcohol drunk, particularly for less frequent drinkers, unless information was collected over several 
drinking occasions other than in the last week (Room 2000). The ‘North American approach’, on the 
other hand, asked for the respondent's summary of his or her customary drinking behaviour, the so 
called Quantity Frequency (QF) measure which dates back to the work of Straus and Bacon (1953) 
from which the measure takes its name (Rehm 1998, Room 2000, Gmel and Rehm 2004).  
QF methods, of which there are many variants, inquire about “average” or “typical” consumption 
patterns, usually over a specific time period such as within the last year. These methods, also known 
as estimation formulas (Sobell and Sobell 2003), require respondents to report an average pattern of 
consumption (e.g., “How many days on average - in a specific time interval - did you drink beer, and 
when you drank beer, on average how many beers did you drink?”). Most QF methods repeat these 
questions for each major alcoholic beverage type (i.e., beer, wine and spirits) and then sum across 
beverage types (see Box 3.1 for example of QF in its most basic form). Drinking parameters (e.g., 
total amount consumed, mean number of drinks per day) are calculated based on the aggregate 
questions (e.g., “How many days on average- in a specified time interval - did you drink beer, and 
when you drank beer, on average how many beers did you drink?”). 
 
Dight’s study of drinking practices was also particularly notable because it introduced the concept of 
the alcohol ‘unit’ which was Dight’s construction to deal with the problem that the predominant 
Scottish drink, beer, was sold primarily in two different drink sizes, a half-pint and a pint. Dight chose 
the smaller size as the ``standard unit,'' although an ordinary male drinker in Scotland would think of 
`a drink' in terms of a pint which is equal to two standard units (Room 2000). This alcohol ‘unit’ 
(approximately equivalent to 8 grams of alcohol) was subsequently used to define government 
guidelines, in the mid-1980s, on safe and sensible drinking levels as described in Chapter 1. It would 
also eventually become the standard measure of alcohol drinking in national surveys, when from the 
late 1980s the measurement of alcohol consumption in the general population in Scotland became 
routine, with a number of nationally representative population surveys established and repeated over 
time. These surveys provide a range of information on drinking frequency and patterns among adults 
in Scotland over the last twenty years. 
3.2.1 Drinking in Scotland 1988-2009, a comparison of three surveys 
Between 1988 and 1995, three types of repeated national surveys were established with samples of the 
Box 3.1 Quantity Frequency questions 
Frequency: Thinking about the last year, how often do you have an alcoholic drink?  
Almost every day, five or six days a week, three or more days a week, once or twice a week, once 
or twice a month, once every couple of months, once or twice a year, less than once a year, never 
drunk or ex-drinker. 
Quantity: On a day that you drank, how many drinks would you usually have? 20 or more, 11-19, 
7-10, 5-6, 3-4, 1-2, less than 1. 
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Scottish adult population and which included questions on alcohol consumption; the General Lifestyle 
Survey (GLS), the Scottish Health Survey (SHeS) and the Health Education Population Survey 
(HEPS) which ran between 1996 and 2006. A description of each of the surveys is provided in Table 
3.1.  









Monitors health-related knowledge, attitudes, behaviours and motivations to change among 
the adult population in Scotland and had been carried out continuously since 1996, though 
survey was suspended in 1999 before restarting in 2000. Questions on drinking behaviour 
have been asked since 1996. HEPS has a sample size of approximately 1800 adults aged 
16-74 years. Fieldwork was undertaken in two waves each year, usually March and 
September. The survey was discontinued from 2007 with elements from HEPS incorporated, 




 (survey years: 
1988-1996, 2000-
2008) 
Formerly known as the General Household Survey (GHS), this is a multi-purpose continuous 
survey collecting information on a range of topics from people aged 16 years and above, 
living in private households in Great Britain. GLS started in 1971 and has been carried out 
continuously since then, except for breaks to review it in 1997/1998 and to re-develop it in 
1999/2000. Questions about drinking alcohol have been included in the GLS since 1978. 
Prior to 1988, the questions were only asked of those aged 18 years and over. Since 1988 
respondents aged 16 and 17 years have answered these questions using a self-completion 
questionnaire. GLS has included a Scottish sample since 1988 with an approximate sample 
size of 1500. 
Scottish Health 
Survey (SHeS) 
 (survey years 
1995, 1998, 2003, 
2008, 2009) 
Provides a detailed picture of the health of the Scottish population in private households 
collecting in-depth information on a range of health and behavioural topics, socio-
demographic information and physiological measurements taken by nurses. SHeS began 
running continuously in 2008 with a contract let for the four years from 2008 – 2011, 
following recommendations of a comprehensive review of the survey carried out by the then 
Scottish Executive (Corbett et al 2009). SHeS has the largest sample size of the three 
national surveys; approximately 8000 adults aged 16-64 years in 1995, and aged 16-74 
years in 1998; and approximately 6500 -7000 adults aged 16 years and over in 2003. 
Surveys in 2008 and 2009 have slightly smaller sample sizes of approximately 4500 (Corbett 




All three surveys use a quantity-frequency measure to elicit details of alcohol consumption, with 
SHeS and HEPS adopting the GLS alcohol module first used in 1988 with some slight refinements. 
An example of the approach used in SHeS is provided in Box 3.2. The main measure of drinking 
behaviour until 1998 was average weekly alcohol consumption expressed in terms of units per week. 
Following UK government recommendations in 1995 on safe daily drinking levels (Department of 
Health 1995), new questions about consumption on the heaviest day during the previous week were 





More recently, significant changes have taken place in the methods used to calculate levels of alcohol 
consumption in both the SHES and GLS. When drinking surveys were first carried out in the 1970s, 
the assumption that one unit was found in a half pint of beer, a glass of table wine, a small glass of 
fortified wine, and a single measure of spirits was reasonable. Since then, and particularly in recent 
years, the average strength by volume of some alcohol products (especially wine) has been increasing 
(Goddard 2007, Catto and Gibbs 2008). To take account of this, the Office for National Statistics 
undertook a review of the existing methodology for converting volumes into units in the GLS and the 
Health Survey for England. This work resulted in the publication of new unit conversion factors based 
on average strengths of alcohol in 2006 (Goddard 2007); for example under the original conversion 
factors one glass of wine = 1 unit and a half pint of strong beer = 1.5 units, compared to 2 units (for 
both) under the revised conversion factors (Appendix F outlines how the volumes of alcohol reported 
in the 2003 SHeS were originally converted into units and how the new conversion factors have 
changed this). These factors have been applied retrospectively to the estimates from the 2006 GLS 
and updated figures have been published. These factors have also been adopted for use in the Scottish 
Health Survey from 2008 onwards. The SHeS data from the 2003 survey, published in 2005, was also 
reanalysed using the new conversion factors (Bromley et al 2008). HEPS data is based on the original 
conversion factors. 
The impact of the revised conversion factors has been to produce more accurate (and increased) 
estimates of daily and weekly alcohol units consumed in the Scottish population. On the other hand, it 
means that any assessment of trends over time in alcohol consumption data from SHeS and GLS is 
problematic. Nevertheless, the standard approach to measuring alcohol consumption (i.e. average 
weekly consumption, exceeding weekly and daily recommended safe drinking guidelines) across the 
three surveys has ensured consistency in the way survey analysis has been aggregated and 
summarised allowing for some comparison of trends in alcohol consumption by gender, age and 
deprivation over approximately a twenty year period, in Scotland. 
Box 3.2 Quantity-Frequency questions in Scottish Health Survey 
To estimate weekly consumption, informants aged 16 years and over, after preliminary questions 
on whether they drank alcohol at all, were asked how often during the past 12 months they had 
drunk each of six different types of alcoholic drink (normal/strong beer, lager, cider and shandy; 
sherry and martini, spirits and liqueurs, wine, alcoholic soft drinks ("alcopops"). 
From this question, the average number of days a week the informant had drunk each type of 
drink was estimated.  
A follow-up question asked how much of each drink type they had usually drunk on each occasion. 
This data is converted into units of alcohol and multiplied by the amount they said they usually 




3.2.1.1 Trends in alcohol consumption in Scotland by gender 
 
3.2.1.1.1 Average weekly consumption (units per week) 
The mean unit consumption per week for men has declined over time (Figure 3.4). Over a ten year 
period, HEPS reported that mean weekly consumption in men fell from 16 units per week (u/w) in 
1996 to 15 u/w in 2006. Between 2001 and 2008, GLS reported a decrease from 16.1 u/w to 14.3 u/w, 
and SHeS also reported a decrease from 20.1 u/w in 1995 to 17.5 u/w in 2009. Data from SHeS and 
GLS would suggest that the decline in average weekly consumption has been constant since the turn 
of the century, even taking into account the revised consumption estimates in 2003 (SHeS) and 2006 
(GLS). 
There was greater variability between surveys in trends among women’s weekly mean consumption 
of alcohol (Figure 3.4). SHeS reported that mean weekly consumption in women increased from 6.3 
u/w in 1995, to 7.8 u/w in 2009. Whether this is a real increase is difficult to say as survey estimates 
of alcohol consumption are increased from 2003 onwards, based on revised unit conversion factors. 
GLS reported a decrease in weekly consumption in women from 2001 to 2005 until they updated their 
estimates in 2006 with the new alcohol unit conversion factors. The decrease in weekly mean 
consumption resumed in the 2008 GLS. In HEPS, mean weekly consumption in women increased to a 











Figure 3.4 Mean number of units consumed per week by gender; trends across three surveys (SHeS, 























SHeS (men) SHeS (wom.) HePS (men)
HEPS (wom.) GLS (men) GLS (wom,)
 
*Revised conversion factors (RCU) used in SHeS data from 2003 and **GLS from 2006 
 
3.2.1.1. 2 Exceeding recommended weekly limits 
Both SHeS and HEPS have consistently reported on the proportion of people exceeding recommended 
weekly limits in men (>21 u/w) and women (>14 u/w) whilst the GLS only used this measure 
between 1988 and 1994, switching to daily measures of alcohol consumption from 1998 onwards.  
The percentage of men exceeding recommended weekly limits has been on the decrease since early 
2000 (Figure 3.5). Even taking into account the updated consumption estimates in 2003, SHeS 
reported the percentage of men exceeding weekly limits falling from 34% in 1998 to 27% in 2009. 
The proportion of men exceeding weekly limits, reported by HEPS, peaked at 27% in 2001 falling to 
21% by 2007. 
For women, the proportion exceeding weekly limits reported by HEPS, has remained relatively 
constant from 2001 to 2007 at approximately 7-8% (Figure 3.5). SHeS reported an increase in women 
exceeding weekly limits from 1995-2003 (13% of women (aged 16-64yrs) in 1995 to 23% in 2003 
(aged 16 and over), but has fallen to 19% in 2009. Between 1995 and 2009, the gap between women 
and men in the proportion exceeding recommended weekly drinking levels has narrowed 
considerably: based on SHES, in 1995 men were 2.5 times (33% and 13%) more likely than women to 
exceed recommended weekly safe limits, in 2009 27% of men and 19% of men reported exceeding 




Figure 3.5 Percentage exceeding weekly limits by gender; trends across three surveys (SHeS, GHS, 
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* RCU used in SHeS data from 2003 and **GLS from 2006 
 
3.3.1.3 Exceeding recommended daily limits 
Both SHeS and GLS report on the percentage of their survey population exceeding recommended safe 
daily drinking limits
28
. The proportion of men drinking >4 units per day (u/d) has remained relatively 
constant since 1998 in both surveys at approximately 40% of weekly drinkers (Figure 3.6). The GLS 
has however reported a small decrease from 2001 onwards and although this trend was reversed in 
2006 following the introduction of revised conversion factors, in 2009 the lowest ever figure, for men 
exceeding daily limits (31%) was reported by the GLS. SHeS reported a small decrease in the 
proportion of women drinking >3 u/d from 37% in 2003 to 34% in 2009 (Figure 3.6). A similar 
downward trend was also reported by GLS from 1998 to 2005, though following introduction of 
revised unit conversion factors in 2006, the proportion of women exceeding daily limits has remained 
fairly constant (at approximately 30%). 
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The 1998 and 2003 SHES defined daily drinking above recommended limits as ≥3 units for women and ≥4 for 
men. These thresholds have now been adjusted to use the following thresholds to enable comparability with 
surveys of alcohol consumption across Britain; of: drinking above 'safe' daily drinking limits - women: >3 units; 
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* RCU used in GLS from 2006 
 
3.3.1.4 ‘Binge’ drinking  
Patterns of excessive drinking are also reported in each of the three surveys and are defined by various 
measures of what is considered unsafe daily drinking. This is commonly termed ‘binge drinking’ 
though the term ‘risky single occasion drinking’ is probably more accurate (Murgraff et al 1999, 
Gmel et al 2011). SHeS use a definition of ‘binge drinking’ as ‘double the recommended daily safe 
drinking limits (>8 units for men and >6 units for women) on the respondents’ heaviest drinking day 
in the past week. GLS ask how often respondents have drunk >8 and >6 units for men and women 
respectively, on at least one day in the past week. HEPS uses a measure based on amount drunk on a 
single drinking occasion in the past month, defined as drinking sixteen units for men and ten units for 
women.  
Trends in each of the survey measures for men and women are presented in Figures 3.7 and 3.9 
respectively. SHeS data have shown very little change, between 1998 and 2009, in the proportions of 
men and women who reported ‘binge’ drinking on their heaviest drinking day, with men twice as 
likely as women to drink double the recommended safe daily drinking limits. The GLS data shows a 
steady decline in the proportion of men reporting ‘binge’ drinking, from 30% in 2001 to 19% in 2008. 
In contrast, the proportion of women reporting binge drinking has increased from 12% in 2001 to 16% 
in 2008. The gender gap in excessive daily drinking reported by GLS in 1998 (30% of men and 12% 
of women drinking double recommended daily limits) had all but disappeared in 2009 (19% of men 
and 16% of women). In HEPS, the proportion of men ‘binge’ has shown very little change over time; 
from 18% in 1996 to 17% in 2007. In contrast, the proportion of women binge drinking has doubled 
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from 4% in 1996 to 8% in 2007. 






















































       * RCU used in SHeS data from 2003 and **GLS from 2006 
 
Direct comparisons between the surveys are, however, problematic because of the differences in 
‘binge’ drinking measures used each survey. In addition, SHeS and GLS data from 2006 onwards are 
based on the new alcohol unit conversion factors and, therefore, not directly comparable with 
previous surveys. The impact of the new conversion factors may, however, conceal a continuing 
downward trend in SHeS and GLS reports in men reporting ‘binge drinking’ that had been apparent 




3.2.1.2 Alcohol consumption in Scotland by age-group 
This section uses data from SHeS (Corbett et al 2010), to describe average weekly consumption and 
binge drinking
29
 reports in six age groups (16-24, 25-34, 35-44, 45-54, 55-64, 65-74, >75 years), by 
gender, across three surveys (2003, n=8027; 2008, n=6375; 2009 n=7498).  
 
Average weekly consumption by age group 
Average weekly consumption has decreased in men, aged 25-44 and 55-64 years, in each of three 
SHeS surveys (Figure 3.9). As a result, in 2009, young men aged 16-24 years had the highest average 
weekly consumption levels (22.7 u/w) of all age-groups and were the only age-group to exceed the 
recommended weekly safe drinking limits, for men, of >21 units. Average weekly consumption in 
women by age-group broadly follows a similar pattern to that observed for men (Figure 3.10). Young 
women aged 16-24yrs have the highest average weekly alcohol consumption levels (12.1 u/w) though, 
unlike men, still below the recommended safe weekly drinking levels for women (>14 units).  

































                                                          
29




























Excessive daily drinking, by age group 
In 2009, approximately one in three men aged between 16-44 years, drank >8 units on their heaviest 
drinking day (Figure 3.11) and one in four women aged between 16-34 years drank >6 units on their 
heaviest drinking day (Figure 3.12). The proportion of men aged 16-34 years reporting excessive 
daily drinking has fallen in each of three SHES surveys. Trends are less consistent among women, 
however, women aged 16-64 years are less likely to report excessive daily drinking in 2009 than they 
were in 2003.  
Figure 3.11 Drinking double the daily recommended daily limits on the heaviest drinking day, men, by 

































Figure 3.12 Drinking double the daily recommended daily limits on the heaviest drinking day, women 




























Overall, men and women aged between 16-24 years tend to drink more on average per week than 
other age groups and men and women aged 16-34 years are more likely to report excessive daily 
drinking than those >34years. Trend data from SHeS suggests a decrease in weekly and excessive 
drinking, in both men and women, in nearly all age groups with the exception of average weekly 
intake in 16-24 year old males and among women aged 25-54 years. Interpreting trends in SHeS age-
group consumption levels may, however, be unreliable due to small sample sizes in each age group 
(e.g. approximately 500 men and 500 women aged 16-24 years, 650 men aged 45-54 years, 300 men 
and women aged >75 years)
30
 and therefore represent chance findings. 
 
3.2.1.3 Alcohol consumption and deprivation 
Alcohol consumption and association with socio-economic deprivation is reported by SHeS using the 
Scottish Index of Multiple Deprivation
31
 (SIMD) quintiles which enables comparisons to be drawn 
between the most and least deprived 20% of areas in Scotland (and the intermediate three quintiles). 
Data from the 2009 SHeS are used below to describe the variation in weekly and daily alcohol 
consumption by area deprivation (Corbett et al 2010). 
The relationship between drinking behaviour and SIMD varies depending on the measure of alcohol 
consumption and by gender. For men, mean weekly consumption was significantly higher in the most 
deprived quintile (20.6 units per week) compared to the least deprived quintile (16.6 units per week) 
                                                          
30
These are base weighted averages (Corbett el 2010). See Appendix G for weighted and unweighted sample 
bases. 
31
SIMD is the Scottish Government's official measure of area based multiple deprivation. It is based on 37 
indicators across 7 individual domains of current income, employment, housing, health, education, skills and 




though there was no consistent trend of increased risk with increasing levels of deprivation (Figure 
3.13). Conversely, mean consumption reported by women in the least deprived quintile was slightly 
higher (9.5 units per week) than that reported in other quintiles (Figure 3.13). 
Figure 3.13 Mean weekly consumption by gender and SIMD quintile (SHeS 2009) 
 
 
In men, the proportions drinking over the recommended safe weekly drinking limits (>21 units) and 
recommended daily drinking limits (>4 units) were broadly similar across the different deprivation 
quintiles (Figure 3.14). The proportion of men reporting drinking >8 units per day on the heaviest 
drinking day, however, was higher in the most deprived quintile (1
st
) compared to the least deprived 
quintile (5
th
), (29% and 25% respectively).  




Women living in the least deprived quintile were more likely to report drinking over both the safe 
weekly limits (>14 units) and safe daily limits (>3 units) than women living in the most deprived 
quintile (weekly 26% and 16% respectively, daily 43% and 31% respectively), (Figure 3.15). The 
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proportion of women from the least deprived quintile reporting drinking >6 u/d, on the heaviest 
drinking day, was also slightly higher than that reported in other quintiles (20% vs. range 16-18%). 




Overall, data from the 2009 SHeS suggest that men in more deprived quintiles drink more, on 
average, per week, and are more likely to be ‘binge drinkers’, than those living in the least deprived 
areas. There were no differences between SIMD quintiles in men reporting exceeding both weekly 
and daily safe drinking limits. In contrast, women from least deprived quintiles were more far likely 
than women living in the remaining quintiles, to exceed both weekly and daily safe recommended 
drinking levels. Although differences here were of a greater magnitude (>10%), than those for men, 
sample size and confounding from age, geography or factors related to the composition of the female 
sample in SHeS will account for a large part if not all of the observed differences. There was no 
obvious evidence of linear relationship between area deprivation and weekly and ‘binge drinking’ 
measures of alcohol consumption though no formal test for trend was undertaken. 
 
3.2.2 Limitations of alcohol consumption survey data 
The validity of self-reported alcohol consumption from surveys, especially in terms of underreporting, 
is a longstanding methodological concern of alcohol researchers (Midanik 1982, Dawson 1998, Room 
1990; 2000). There are several lines of reasoning that have been put forward to account for 
underreporting, discussed below, including individual response patterns, selective non-response error 
and measurement error (Room 1977, Alanko 1984, Groves 1989, Gmel and Rehm 2004).  
Measurement error can arise from inaccurate recording by interviewers, inaccurate reporting by 
respondents and weaknesses in the questionnaire wording, or errors due to mode of data collection 
and mode of data administration (Poikolainen 1985, Groves 1989). One aspect of measurement error 
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concerns the possible bias introduced by the type of questionnaire used, to elicit details on alcohol 
consumption. The beverage specific quantity frequency (QF) measure is a common feature of 
population surveys on alcohol drinking in Scotland and it has been consistently found that greater 
detail included in this type of approach yields higher volumes of drinking (Dawson 1998, Knibbe and 
Bloomfield 2001). However, QF measures are also widely criticised for providing lower estimates of 
drinking when compared to other measures based on recent drinking occasions and, in particular, the 
graduated frequency (GF) approach
32
 which seem to yield comparable results as well as consistently 
higher estimates of the prevalence of high risk drinking and harm (Room 1990, Midanik 1988, 
Midanik and Room 1992, Rehm et al 1999). Theoretically, the GF should result in more valid 
estimates because special drinking situations are covered, yet its superiority over the QF approach in 
practical research is far from being conclusive (Dawson 2003, Gmel and Rehm 2004, Graham et al 
2004, Greenfield and Kerr 2008) and has been argued by some to overestimate actual alcohol 
consumption (Poikolainen et al 2002, Gmel et al 2006). In contrast to the QF approach, the GF 
approach provides a standard set of drinking pattern measures that is, the quantities of drinks for 
which frequencies are reported are the same for all respondents. This standardization can be achieved 
only if respondents are required to report their consumption in terms of standard drinks rather than 
actual drink sizes. This requirement may introduce a source of error, however, because past research 
has shown that not all respondents attempt to convert their actual drinks to standard drinks and that 
some are incapable of doing so because they cannot accurately estimate their actual drink sizes 
(Kaskutas and Graves 2000). These findings suggest that the standardization of data across 
respondents, which is part of the appeal of the GF approach, may be more apparent than real (Dawson 
2003). The difference in consumption estimates that may arise between the GF and QF approach are 
only thought to explain the gap between survey and per capita alcohol consumption data to a minor 
extent (Gmel and Rehm 2004). 
Selective non-response is another source of survey error which can occur either as sample selection 
bias or as self-selection bias. Sample selection bias is systematic error due to a non-random sample of 
a population, causing some members of the population to be less likely to be included in the sample 
than others. National population surveys of alcohol drinking in Scotland (SHeS, GLF, HEPS) are, 
however, based on a stratified, clustered random probability sample of individuals living in private 
households across the whole of mainland Scotland (plus the larger inhabited islands which are 
included in the SHeS sample). Weighting has been applied in each survey to take account of 
disproportionate sampling within regions, differing probabilities of selection within households of 
different sizes and within multi-occupied addresses, and differential response (Malam et al 2004, Gray 
et al 2009, ONS 2011). Selective non-response error is, therefore, unlikely to explain the consistent 
                                                          
32 the GF measure is a series of questions on the frequency of consuming specific numbers of drinks which 
ranges from the most ever consumed in the last year to 1–2 drinks per occasion. 
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differences in estimates of alcohol consumption reported by each survey described in section 
3.2.1.Sample selection effects in these surveys are still possible since people who have no fixed abode 
or who are living in an institution are not included in the sampling frame. On balance, these people 
are suspected of containing a higher proportion of heavy drinkers than individuals living in 
households (McAuliffe et al 1998, Goddard 2001). Due to the skewed distribution of alcohol 
consumption, even small subgroups with high consumption that are not included in the survey, may 
be a significant omission from population-based estimates. In survey samples, it is often the case that 
the highest drinker category can account for the majority of alcohol drunk (Gmel and Rehm 2004). 
Surveys will also suffer from self-selection bias, where certain groups e.g. abstainers, heavy drinkers, 
though included in sampling frame, are reluctant to participate or respond truthfully to questions on 
their drinking (Lahaut et al 2001, Gmel and Rehm 2004). Several studies have reported significant 
differences in the health status, health related behaviour, socio-economic background and mortality of 
survey respondents and non-respondents; Aromaa et al (2003) reported that non-participation seemed 
to be selective: in the younger age-groups with addictive behaviours or problematic life situations, in 
the middle-aged persons with higher disease risk and in the elderly with chronic diseases and/or 
disabilities. Several studies have reported that survey non-respondents have poorer health (Knudsen et 
al 2010) and higher mortality rates than survey respondents (Jousilahti et al 2005). There is some 
indication that abstention (i.e. teetotallers) is also more likely than heavy drinking to be related to 
non-response. Lahaut et al (2002) found that non-drinkers were overrepresented among non-
respondents, whereas only weak evidence was found for overrepresentation of frequent heavy 
drinkers among non-respondents. Other studies have also found that non-respondents had had lower 
mean consumption and a lower proportion of high consumers, than respondents (Caspar 1992, 
Romelsjὂ et al 1995, Hill et al 1997). Gmel and Rehm (2004), however, argue that non-response 
effects are generally small and not likely to explain the differences between per capita and survey 
estimates of drinking: non-response correction would usually increase mean consumption estimates 
for the respondents by around 3%-6% only (Makela 1971, McAuliffe et al 1998, Gmel 2000).  
One other source of survey error is individual response patterns which may be involuntary, such as 
memory deficits or involuntary such as denial and concealment of alcohol consumption (Gmel and 
Rehm 2004). It has been argued that people tend to underestimate the amount they drink in response 
to existing social values around alcohol drinking. (Goddard 2001). There is some evidence of 
differential reporting of diet by socioeconomic status (Hebert et al 2002). Bobak (2005) argues that it 
is conceivable that similar bias occurs with alcohol and that it also relates to characteristics other than 
social status, possibly including alcohol-related health outcomes. In QF measures of alcohol 
consumption, there also seems to be a tendency of respondents to interpret usual or customary 
drinking as the modal value although researchers actually interpret these as means (Duffy and Alanko 
1992, Kühlhorn and Leifman 1993). Therefore, the modal quantity would generally underestimate the 
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‘true’ mean quantity because the individual’s quantity distribution (i.e. the distribution of quantities 
over separate drinking occasions) is usually highly right skewed.  
Recall of drink sizes and amounts consumed are seen to represent a major contributor to individual’s 
underestimating their alcohol consumption (Dawson 1998). Standard drinks or standard serving sizes 
in surveys are usually based on sizes as served in restaurants and bars and these may be considerable 
underestimation of what is poured into glasses in people’s homes. Kaskutas and Grove (2000) in a 
study of 321 heavy-drinking pregnant women found that women consumed drink sizes that were 
much larger (up to four times that of a standard drink) and similarly they underestimated amount 
poured. In a Dutch study, the use of standard drinks for both home and outside home consumption 
resulted in an underestimation of total volume of drinking of 7.3% (11.9% for women and 5.8% for 
men) compared with the use of self-reported servings for at home drinking (Lemmens 1994). 
McAskill et al (2008), in a study of Scottish drinkers, found that, on average, home based vodka 
measures were twice normal pub measures and that for all drinks, a poured drink ranged from one to 
four units. Population surveys have also been criticised for underestimating the typical size of home-
based measures of spirits and wine (Goddard 2007, Catto and Gibbs 2008). Gill and Donaghy (2004) 
investigated size of home based measures using a 175ml glass (surveys have traditionally used 125ml 
glass measure), but many participants reported that this was much smaller than the glass that they 
would use at home, suggesting that 160ml represents a conservative estimate of the size of a typical 
home-poured glass of wine. Until recently, national population surveys in Scotland (and the UK) have 
also undercounted the number of units in a typical serving of beer/lager/cider and wine by failing to 
take into account the increased strength of beverage alcohol in the UK (Catto and Gibbs 2008); half of 
the most popular brands of lager now contain at least 3 units per pint. To date, Scotland’s surveys 
have used a conversion factor of 2 units for normal strength beers. The strength of the most popular 
brands of wine ranges from 11.5% to 14.5% ABV (alcohol by volume), but surveys have counted one 
glass of wine as 1 unit, which assumes an ABV of only 8%. Assuming that the average glass of wine, 
consumed either at home or in a licensed setting, is 175ml in size, a typical serving will contain 
between 2 and 2.5 units, more than double that estimated in surveys to date (Catto and Gibbs 2008). 
When issues of validity of survey results were raised in the mid-1970s the response was to view the 
proportion of alcohol sold (or released for sale, i.e. per capita consumption) which could be accounted 
for in a survey as the ‘gold standard for the validity of drinking measures. Volume of drinking, 
expressed as units of ethanol per member of the drinking-age population, derived from population 
survey, was seen as the most direct equivalent of the alcohol sales figures (Pernanen 1974, Rehm 
1998, Room 2000). Following this, a number of American studies observed that coverage of national 
alcohol consumption in national surveys was quite low with only a third (35%) to a half (50%) 
generally accounted for by respondent’s drinking in the past 12 months (Pernanen 1974, Kasukatas 
2000, WHO 2002). Goddard (2001) estimated that surveys in United Kingdom only accounted for 55-
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60% of actual alcohol consumed compared with UK sales data, whilst Catto and Gibbs (2008) 
recently estimated survey underestimation of alcohol intake in Scotland may be as great as 50%. From 
2003 and 2006, SHeS and GLF respectively, have used updated unit conversion factors for beers, 
lagers, ciders and wine and included in their survey questions on wine consumption in terms of small 
(125ml), plus new measures of medium (175ml) or large glasses (250ml), to more accurately reflect 
the amount people drink. Estimates based on the new alcohol conversion factors have resulted in 
significant increases across most measures of alcohol consumption; for example, in the 2003 SHeS, 
mean consumption among men and women, aged 16 years and over, using original conversion factors, 
was 17.2 and 6.5 units p/w respectively; the figures using the revised conversions factors were 20.1 
units p/w for men and 9.1 units p/w for women (Bromley et al 2008). These revisions reduced the 
estimates of SHeS survey under-reporting, compared to per capita alcohol consumption, from about 
around 50% reported by Catto and Gibbs (2008) to approximately 35%. According to Rehm (1998), 
this is as reasonable a coverage that one can expect from a population survey: coverage rates 
shouldn’t expect to be higher than 70% since based on the approximately log normal distribution of 
alcohol consumption a small minority of the population are expected to drink a large proportion of 
alcohol.  
One final aspect to consider in assessing the accuracy of population survey estimates concerns the 
actual summarizing and aggregating measures of alcohol consumption used in surveys. In one form or 
another, researchers have tended toward a measure of overall volume of drinking, that is, of the 
cumulative total amount of alcohol consumed per year or other unit of time. Though, as Room (1979) 
observes, the reasoning has often been left implicit, this dimension was perhaps seen as fairly 
representing the importance of alcohol in the respondent's life and as probably the most directly 
related to the risk of long-term physiological complications such as cirrhosis. An overall volume 
measure also has the virtue for analytical purposes of being an interval scale easily used in regression 
and other statistical analysis (Room 1979, Greenfield and Kerr 2003). Volume measures are 
commonly used in epidemiological studies especially those with cancer as an outcome. Yet volume of 
drinking remains essentially a crude summary measure of drinking behaviour, ignoring the fact that 
there might be different categories of drinkers within the population, with normal distribution and 
with quite complex drinking patterns and of amounts drunk, within each group(Tuck 1980, Midanik 





This chapter has presented an analysis of trends and patterns of alcohol consumption in Scotland 
based on estimates from national population surveys (i.e. self-reported alcohol consumption) and 
statistics on alcohol ‘sales’ (i.e. per capita alcohol consumption estimates).  
Of the three surveys, SHeS, consistently report higher estimates of mean consumption per week and 
in the proportion of men and women exceeding weekly and daily limits, than those reported by GLF 
or HEPS. Alcohol consumption estimates from GLF and HEPS, (both with sample sizes of 
approximately 1500 adults aged 16 years and over), are similar to each other across drinking 
measures. SHeS, simply because of its size (approximately four times larger than that of GLF and 
HEPS) offers greater precision than the GLF and HEPS. Differences in alcohol consumption 
estimates between surveys may be explained by differences in the age, gender and geographical 
sample sources of each of the surveys. 
Despite some variation in the estimate ranges of various drinking measures, alcohol consumption 
survey trends in Scotland are broadly in agreement and suggest a decrease in men exceeding weekly 
recommended limits, in excessive daily drinking and in their mean consumption per week albeit from 
very high levels in the first place. For women, the opposite is true, with weekly and daily 
consumption either remaining constant or slightly increasing, which may be indicative of a 
convergence in both the volume drunk and drinking patterns between men and women in Scotland 
over the last twenty years. Similar patterns have been observed in England and Wales (BMA 2008). 
Levels of drinking vary greatly by age with younger drinkers (16-34 years) more likely to exceed 
daily limits and ‘binge’ drink and middle age drinkers (35-54 years) more likely to drink more per 
week than other age groups. The strong socio-economic patterning in alcohol-related mortality and 
morbidity in Scotland has been well documented (Leyland 2007, SHAAP 2009, ISD 2010b). The 
evidence for an association between alcohol consumption and socio-economic deprivation is, 
however, inconsistent and varies by both gender and the measure of drinking behaviour and there was 
no obvious evidence of linear relationship between area deprivation and weekly and ‘binge drinking’ 
measures of alcohol consumption. 
Taken together, recent per capita alcohol consumption data and population survey data would seem to 
suggest that levels of drinking in the Scottish population may be falling or, at least, stabilising 
although it is too early to conclude that this is a long term trend. Nevertheless, approximately one in 
four of adults in Scotland still exceed the recommended safe weekly drinking guidelines and over one 
in three of adult weekly drinkers exceed the recommended safe daily drinking limits (Corbett et al 
2010). It is also very likely, as discussed in Section 3.2.2, that consumption data from population 
surveys will underestimate the true levels of drinking in the population by approximately 30%. 
Furthermore, levels of population drinking in Scotland, based on per capita alcohol consumption data, 
compare unfavourably to many other countries (Robinson et al 2010, WHO 2010) and are 
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considerably higher than consumption levels in the countries supplying the majority of 
epidemiological studies reporting on the association between alcohol consumption and cancer 
(described in Chapter 2). At the same time, Scotland’s experience of trends in cancer incidence, 
particularly those linked with alcohol consumption, e.g. oral, oesophageal, breast and colorectal 
cancer, also compare unfavourably with many other countries in the European Union (Botha et al 
2003, La Vecchia et al 2003). The potential contribution of alcohol consumption levels, past and 
present, to these cancer trends in Scotland cannot be underestimated; cancers of the upper aero-
digestive tract (oral, pharyngeal, laryngeal and oesophageal cancer) rank among the top ten most 
common sites in Scottish men and women, and lung, colorectal and breast cancer are ranked as the top 
three most common cancer sites in Scotland. Other common cancers include prostate, kidney and 
ovarian cancer (ISD 2010a). Surveillance of trends in incidence rates for alcohol-related cancers is, 
therefore, of interest to determine if they are correlated with levels of the drinking in the Scottish 
population. In the next chapter trends in incidence rates for those cancers commonly linked to alcohol 
consumption are summarised and the contribution of alcohol consumption and other prevalent risk 




Chapter 4 Trends in alcohol related cancers in Scotland  
 
This chapter presents data, from the Scottish Cancer Registry, on trends in cancers commonly linked 
with alcohol consumption.  
The Scottish Cancer Registry (SCR) is responsible for the collection of information on all new cases 
of primary malignant neoplasms, carcinoma in situ, neoplasms of uncertain behaviour and benign 
brain and spinal cord tumours arising in residents of Scotland. Data quality is monitored using routine 
indicators, computer validation and ad hoc studies of data accuracy and completeness of 
ascertainment (see Chapter 5.1.3 for further details of the SCR). SCR data is published on the ISD 
website and available to download at http://www.isdscotland.org/Health-Topics/Cancer/Cancer-
Statistics/. Cancer sites are classified according to the International Classification of Diseases (ICD) 
9th version from 1985 and from 1996 the 10th version, (see Chapter 7.1.1, Table 7.2 for a list of 
relevant ICD codes). 
Using published data (1985–2008) from the SCR, European age-standardised incidence rates 
(EASRs) per 100 000 person years at risk (pys)
33
, are presented for the following cancers; cancers of 
the UADT (oral, pharyngeal, laryngeal and oesophageal cancer), gastrointestinal cancers (liver, 
pancreatic gastric colon and rectal cancer), urological cancers (prostate, bladder, and kidney cancer) 
and lung, breast and ovarian cancer. Consistency in the temporal trends in incidence rates between 
men and women and, variation by deprivation are also examined. The chapter concludes with an 
assessment of the contribution of alcohol consumption and other prevalent risk factors in Scotland, to 
these trends. 
 
4.1 Trends in cancers of the upper aero digestive tract 
European age-standardised incidence rates (EASRs) for cancers of the upper aero digestive tract in 




                                                          
33
 Person time at risk is the time in years between entry into an analysis and exit from an analysis. This is the 
time during which a subject is at risk of having an event (whether second cancer, death, etc.) as defined by the 
analysis. Total person time at risk for a given subcategory is calculated by adding the person time at risk 
counted in that subcategory for each subject in the analysis (Breslow and Day 1987). Further details of the 
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EASRs for oral cancers in men increased, between 1985 and 2008, from 6.1 to 8.7 per 100,000 pys 
and almost doubled in women (2.2 to 4.0 per 100 pys). Although cancers of the pharynx are rare, 
there has been an approximate threefold increase in incidence of this cancer in men (1.1 per 100 000 
pys in 1985 to 3.0 in 2007) and a two-fold increase in women (from 0.4 to 0.9 per 100 000 pys). 
Laryngeal cancer EASRs reached a high in men in the mid-1990s at approximately 10 per 100 000 
pys, but have fallen subsequently over time to 7.3 per 100 000 pys in 2008. EASRs for laryngeal 
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cancer in women have remained constant, between 1985 and 2008, at approximately 1.5 per 100 000 
pys.  
Between 1985 and 2008, the EASR for oesophageal cancer has increased in men (from 12.9 to 17.5 
per 100 000 pys), but has not changed in women (from 6.1 to 6.4 per 100 00 pys). Much of the 
increase in the incidence of oesophageal cancer in men occurred between 1985 and 1996 (18.5 per 
100 000 pys), but the EASR since then has remained around this level. The EASR for oesophageal 
cancer in women also increased from 1985 to 1993 (6.1 to 9.1 per 100 000 pys), but since then the 
EASR has returned to levels close to those reported in the 1980s. The gender ratio for UADT cancers 
in Scotland has not changed since 1985 (See Appendix H, Table H1). 
The risk of developing UADT cancer increases with age. In Scotland, the majority of oral and 
pharyngeal cancer cases occur in people aged 50 or over and for laryngeal and oesophageal cancers, 
in people aged 60 years and over (Cancer Research UK 2010). The incidence of oral and pharyngeal 
cancer continues to rise across the UK in all age groups with significant increases observed in people 
aged less than 45 years (Conway et al 2006, Conway et al 2007). 
Figure 4.3 highlights that cancers of the UADT are most common in areas of high deprivation (Figure 
4.3). This reflects the strong gradient in smoking prevalence across deprivation quintiles in Scotland, 
where the most deprived communities have smoking prevalence rates similar to those seen nationally 
in the 1970s (McKinney et al 1995, Taulbut et al 2008). EASRs for cancers of the oral cavity and 
larynx are over three times and four times, respectively, higher in the 20% most deprived areas, 
compared to the 20% least deprived areas of Scotland. There was a similar pattern for cancers of the 
oesophagus, but not as marked a difference as that found in cancers of the oral cavity and larynx. 
There was a significant increase in incidence rate of cancers of the UADT with increasing severity (p 









































1 (Least deprived) 2 3 4 5 (Most deprived)
 
* p test for trend <0.001. 
1
 Rates are calculated using the populations in 2006 
4.1.1 Discussion 
In summary, oral and pharyngeal cancer rates have steadily increased in men and women over the last 
30 years. Over the same time period, laryngeal cancer rates have fallen in men and remained fairly 
constant on women. Smoking, a major risk factor for these cancers, is on the decline in the Scotland; 
the proportion of adults who smoke has reduced by about half (from 47% in 1972 to 24% in 2008) 
since the early 1970s (Taulbut, et al 2008, Robinson and Bugler 2010). In a recent pooled analysis, 
results demonstrated that the larynx was the organ within the head and neck that was most susceptible 
to the effects of cigarette smoking (Hashibe et al 2007). Trends in laryngeal cancer in Scotland are, 
therefore, most likely to be closely correlated with the trends in smoking prevalence in men and 
women in Scotland. Numerous studies have described the increase, over the last thirty years, in the 
incidence of oral and pharyngeal cancer in Scotland, largely attributing these trends to increasing 
levels of drinking in the Scottish population at a time when overall smoking prevalence was declining 
(MacFarlane et al 1992, Llewellyn and Mitchell 1994, MacFarlane et al 1996, Leon et al 2003, La 
Vecchia et al 2004, Conway et al 2006). Similar patterns in incidence rates in Scotland have been 
observed for cancers of the oesophagus, especially in men (MacFarlane and Boyle 1994, Swerdlow et 
al 1998, Corley and Buffler 2001, Botterweck et al 2001). The relationship between UADT cancer 
risk and socio-economic factors is also well established both in Scotland (McKinney et al 1995, 
MacFarlane et al 1996, Edwards and Jones 1999, Conway et al 2007) and across western 
industrialised countries (IARC 1997) and as the incidence of oral cancer has increased in Scotland, so 
has the gap in oral cancer incidence between affluent and deprived socio-economic groups (Conway 
et al 2007). 
It is interesting to compare the trends in oesophageal cancer with those for oral and pharyngeal 
cancers, for which alcohol and tobacco are major aetiological factors. The very large increase in 
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incidence of oral and pharyngeal cancers in young men in recent years is not matched by a similar 
scale of increase in cancer of the oesophagus. The secular trends in oesophageal cancer are also very 
different from those for lung cancer, suggesting that smoking is not the dominant reason for the 
trends. However, trends in the incidence of oesophageal cancer are difficult to interpret due to 
variations in trends in the two main histological types of oesophageal cancer; squamous cell 
carcinoma (SCC) and oesophageal adenocarcinoma. Until the 1970s, SCC accounted for the vast 
majority of oesophageal cancer diagnosed in Scotland. Whilst incidence rate of SCC of the 
oesophagus has increased since the 1970s, there has been a more striking increase in incidence rates 
of oesophageal adenocarcinoma (Botterweck et al 2000, Vizcaino et al 2002). Brewster et al (2000) 
reported that among Scottish males the estimated percentage changes in incidence rates of 
oesophageal adenocarcinoma and SCC of the oesophagus, between 1977 and 1996, were +139.5% (p-
value <0.0001) and +42.7% (p-value <0.001) respectively. Corresponding estimates for females were 
+124.6% (p-value <0.0001) and +57.3% (p-value =0.0001). In the early 1990s, oesophageal 
adenocarcinoma became the dominant histological type of oesophageal cancer in men in Scotland and 
incidence rates have continued to increase in men and women since then. Incidence rates of SCC of 
the oesophagus have remained relatively stable over the same time period (Park and Brewster 2002, 
Bosetti et al 2008). The evidence presented in Chapter 2.1.2 would suggest, however, that alcohol 
consumption is an unlikely risk factor for the rise he incidence of oesophageal adenocarcinoma. A 
more likely explanation lies in the high levels of obesity in the Scottish population, with obesity being 
positively associated with an increased risk of oesophageal adenocarcinoma, but not SCC of the 
oesophagus (Renehan et al 2008, Steffen et al 2009). 
 
4.2 Trends in alcohol-related gastrointestinal cancers  
European age-standardised rates (EASRs) for alcohol-related gastrointestinal (liver, pancreas, gastric 
and colorectal) cancers in Scotland between 1985 and 2008 are presented in Figures 4.4 (men) and 4.5 
(women). 
EASRs for liver cancer in Scotland have approximately doubled between 1985 and 2008 from 3.8 to 
7.3 per 100,000 pys in men and from (1.5 to 2.8 per 100 000 pys) in women. In contrast, EASRS for 
gastric cancer have almost halved in the same time period, in both men (33.1 to 16 per 100 000 pys) 
and women (14.8 to 6.4 per 100 000 pys). Pancreatic EASRs in men and women have remained 
relatively constant over the last 30 years. EASRs for colon and rectal cancer have increased in men 
(from 33.4 to 41.5 per 100 000 pys and 19.5 to 24.6 per 100 000 pys) though EASR rates for colon 
and rectal cancer in men have been fairly stable since the mid-1990s. For women, there has been little 
change in the EASR rate for colon cancer (28.8 to 29.8 per 100 000 pys) and rectal cancer (11.1 to 
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12.8 per 100 000 pys) between 1985 and 2008. The gender ratio for these alcohol related 
gastrointestinal cancers in Scotland has not changed since 1985 (See Appendix H, Table H2). 
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Incidence rates for gastrointestinal cancers increase steeply with age and the highest rates occur in the 
oldest age groups (Cancer Research UK 2010, ISD Scotland 2010a). Around three-quarters (75%) of 
liver and pancreatic cancer cases occur in people aged 65 years or over. Gastric (stomach) cancer 
occurs mainly in older people with less than 8% of cases diagnosed before the age of 55 years and the 
incidence rates increase steeply from age 60 years. The occurrence of colon and rectal cancer is also 
strongly related to age, with 84% of cases arising in people who are 60 years or older. Until 50 years 
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of age, men and women have similar incidence rates for colon and rectal cancer, but in later life 
incidence is higher among men than women. 
Incidence rates for most gastrointestinal cancers are strongly related to social class and measures of 
deprivation, with higher rates in socially and economically deprived groups (Figure 4.6). Incidence 
rates for cancer of the liver, pancreas and gastric cancer significantly increase (p value for trend 
<0.0001) with increasing levels of deprivation. EASRs for rectal cancer also increase across each 
deprivation quintile though less strongly (p value for trend =0.001) than that noted for gastric, liver 
and pancreatic cancer. There was no association between measures of deprivation and colon cancer (p 
value for trend =0.3571). 
Figure 4.6 EASRs
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* Test for trend p <0.0001; ** Test for trend p=0.3571; *** Test for trend p=0.001.
1
 Rates are calculated using the 
populations in 2006 
 
4.2.1 Discussion 
Significantly higher incidence rates of colorectal cancer have been reported in Scotland, compared to 
many other European countries (Janout and Kollarova 2001, Karim-Kosa et al 2008). Swerdlow et al 
(1998) observed that the reasons for the changes in incidence in Scotland are unclear with a large 
range of factors having been suggested as potentially affecting colorectal cancer risk - aspects of diet 
(including saturated fats, and dietary fibre), alcohol consumption, patterns of cholecystectomy, sex 
hormones and non-steroidal anti-inflammatory drugs. It is probable that dietary factors play a large 
role and changes in diet are at least partly responsible for the trend (Swerdlow et al 1998 Karim-Kosa 
et al 2008).  
Most cases of liver cancer occur in patients with cirrhosis of the liver (El-Serag 2007). In addition to 
excessive alcohol consumption, chronic viral hepatitis and non-alcoholic fatty liver disease (which is 
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associated with obesity) are other significant aetiological factors for cirrhosis of the liver (Bhala et al 
2009). Scotland has one of the fastest growing mortality rates of chronic liver disease (which includes 
cirrhosis mortality) in the world at a time when rates in most of Western Europe are falling (Whyte 
2006).  
In contrast to many other types of cancer, gastric cancer has a falling incidence in Scotland and in 
Europe (Karim-Kosa et al 2008), but is still one of the more common cancers reported, in men and 
women, in Scotland. There are established links between the development of gastric cancer and 
deprivation (Brewster et al 2000, Quinn 2005), particularly deprivation in childhood. The majority of 
gastric cancers in Scotland are adenocarcinoma (as opposed to lymphomas; Thompson 2001) and 
smoking and alcohol do not appear to be important predisposing factors for gastric cancer (IARC 
1988, WCRF/AICR 2007). The decrease in gastric cancer may also relate to better social and sanitary 
conditions in early life, and changes over time in the prevalence of infection with Helicobacter pylori 
(Swerdlow et al 1998).  
Pancreatic cancer trends in Scotland match those of several other countries in that there has been a 
slow decline in the incidence rates for pancreatic cancer in both men and women (Garden 2001, 
Karim-Kosa et al 2008). Smoking is the most important known risk factor for pancreatic cancer, with 
an attributable risk of between 20-40% for men and 10-20% for women (Fryzek et al 1997, Working 
Group on Diet and Cancer 1998). 
 
4.3 Trends in bladder, kidney and prostate cancer 
European age-standardised rates (EASRs) for selected urological cancers (prostate [men only], 
bladder and kidney) in Scotland between 1985 and 2008 are presented in Figures 4.7 (men) and 4.8 
(women). 
 
EASRs for prostate cancer in men have almost more than doubled since 1985 (from 46.0 in 1985 to 
84.3 per 100 000 pys in 2008). Incidence rates of bladder cancer in men and women, remained fairly 
constant at approximately 35 per 100 000 pys and 10 per 100 000 pys, respectively, from 1985 to 
1997, thereafter incidence rates have fallen significantly in both men and women: EASRs for bladder 
cancer in men and women in 2008 were 18.8 and 5.7 per 100 000 pys, respectively. Between 1985 
and 2008 the EASRs for kidney cancer have risen gradually in both men (from 9.9 to 15 per 100 000 
pys) and women (from 5.1 to 8.7 per 100 000 pys) from 1985 to 2008. Men are three times more 
likely to develop cancer of the bladder and twice as likely to develop kidney cancer as women. The 
gender ratio for incidence of bladder and kidney cancers in Scotland has not changed since 1985 
(Appendix H, Table H3).  
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The incidence of bladder, kidney and prostate cancer increases steeply with age (ISD Scotland 
2010c). There are very few cases of these cancers, in Scotland in early adulthood, but from age 40 for 
cancers of the kidney and from 50 years of age for cancers of the prostate and bladder, the rates begin 
to rise steeply with age to reach a peak in the oldest age-groups. 
Incidence rates for bladder cancer significantly increase (p value for trend <0.0001) with increasing 
levels of deprivation (Figure 4.9). Conversely, incidence rates for prostate cancer significantly 
increase (p value for trend <0.0001) with decreasing levels of deprivation. There was a weak 






 for cancers of the prostate, kidney and bladder, by SIMD 2006 deprivation quintile 
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* Test for trend p <0.0001, ** Test for trend p <0.0001, *** Test for trend p =0.0027. 
1
 Rates are calculated using 




Incidence rates for prostate cancer have been increasing for many years in Scotland. Although there is 
some evidence of a genuine increase in risk in prostate cancer, much of the observed increase in 
incidence has probably been due to increased detection of small, non-lethal cancers following 
transurethral resection for benign prostatic hyperplasia, and more recently through the introduction 
and increasing use of the prostate-specific antigen (PSA) test for screening (Brewster et al 2000a). 
The incidence of prostate cancer is higher among men from areas of less socioeconomic deprivation, 
but it is not clear whether this is due to genuine differences in risk or simply differences in detection 
through use of the PSA test (Brewster et al 2000a).  
Even though kidney cancer is relatively rare, there have been reports of increasing incidence and 
mortality across Europe (Karim-Kosa et al 2008). Some, but not all, of this increase is believed to be 
due to the wider application of diagnostic imaging techniques resulting in more kidney tumours being 
found incidentally (ISD Scotland 2010c).  
The decline in bladder cancer incidence since 1998 is an artefact due to a change in coding practice 
across cancer registries in the UK. Around a quarter of bladder tumors are no longer coded as invasive 
bladder cancers. This decrease is large enough to have an impact on the incidence figures for all 





4.4 Trends in lung, breast and ovarian cancer 
European age-standardised rates (EASRs) for lung, breast (women only) and ovarian cancers (women 
only) in Scotland, between 1985 and 2008, are presented in Figure 4.10.  
EASRs for lung cancer have declined from 1985 to 2008 in men (133 and 77.2 per 100 000 pys), 
respectively. In women, however, incidence rates rose quite markedly between 1985 (44.8 per 100 
000 pys) and 1996 (56.2 per 100 000 pys), thereafter continuing to increase up to 2008 (57.5 per 100 
000 pys). EASRs for breast cancer in women have increased from 84.6 per 100 000 pys in 1985 to 
122.8 per 100 000 pys in 2008. There has been very little change in the EASRs for ovarian cancer 
between 1985 (16.5 per 100 000 pys) and 2008 (17.2 per 100 000 pys). 
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Lung cancer is uncommon below the age of 40 years, but thereafter, incidence increases quite steeply 
with age peaking in people aged 75-84 years. Most cases (86%) occur in people over the age of 60 
years (Cancer Research UK 2010, ISD Scotland 2010a). Ovarian and breast cancer is predominantly a 
disease of older, post-menopausal women with over 80% of cases being diagnosed in women over 50 
years (ISD Scotland 2010a). There is a steep increase in incidence of both breast and ovarian cancer 
after the usual age of the menopause. The highest incidence rates are for women aged 65 years and 
over. 
For lung cancer, incidence rates in the most deprived areas are approximately three times as high 
(118.2 per 100 000 pys) as those in the least deprived areas (38.7 per 100 000 pys) with incidence 
rates rising with increasing levels of deprivation (p value for trend <0.0001) (Figure 4.11). In contrast, 
women from less deprived areas have a higher incidence of breast cancer than women from more 
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deprived areas (125.2 and 113.4 per 100 000 pys, respectively), with a clear trend of decreasing rates 
from least to most deprived groups (p value for trend <0.0001). EASRs for ovarian cancer are also the 
highest in the least deprived SIMD quintile, but they are not significantly different from EASRs in 
other quintiles and there was no evidence of a linear association (p value for trend =0.027). 
Figure 4.11 EASRs
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* Test for trend p <0.0001; ** Test for trend p 0.0207. 
1
 Rates are calculated using the populations in 2006 
 
4.4.1 Discussion 
In Scotland lung cancer is the second most frequently diagnosed cancer in men and women. The 
incidence of lung cancer has been falling in men since the late 1970's but has been increasing in 
women for several decades to reach a more recent plateau. Tobacco use, predominantly cigarette 
smoking, is the main cause of lung cancer (IARC, 1986), accounting for at least 90% of cases in high 
incidence populations. Variations in risk of lung cancer between males and females, between 
countries, and over time, are due to historical smoking patterns (Peto et al 2000, Alberg et al 2007, 
Jemal et al 2008). The prevalence of smoking in Scotland has declined in both men and women since 
surveys began in 1975 (Taulbut et al 2008). However, there is a latency period between exposure and 
outcome, and although incidence rates have declined in men, incidence rates are expected to continue 
to increase in women at least until the middle of the next decade (Stockton et al 2004).  
Cancer of the ovary is the fifth most frequent cancer experienced by women in Scotland and incidence 
and mortality rates in Scotland, and across Europe, have remained fairly stable in recent years (Karim-
Kosa et al 2008, ISD Scotland 2010c). The epidemiology of cancer of the ovary is complicated by the 
existence of several main histological types, and the aetiology of these may vary. Despite the 
identification of numerous risk factors (including those of hormonal or genetic origin), the aetiology 
of ovarian cancer remains unclear (Elmasry and Gayther 2006). Trends in ovarian cancer incidence 
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(other than to the extent they are artefacts of diagnosis or registration) are likely to reflect mainly 
changes in key risk factors including parity, age at menarche and in recent cohorts, oral contraceptive 
use (Swerdlow et al 1998).  
Breast cancer is the most common female cancer in Scotland, in common with many Western 
countries, with the incidence rate continuing to rise (Swerdlow 1998, Ferlay et al 2007). Over the last 
decade, the incidence rate has increased by 8%. This is partly due to increased detection by the 
Scottish Breast Screening Programme, which has seen a rise in attendance over the same time period, 
and an extension in the age range invited for screening to include women up to the age of 70 years, 
phased in over the 3-year period beginning 1st April 2003 (Ferlay et al 2007, Brown 2010, ISD 
2010c). However, increases in the incidence of breast cancer might also be anticipated with higher 
prevalence of known risk factors among the female population, such as increases in the mother’s age 
at the birth of her first child. The association between deprivation and socio-economic status and risk 
of breast cancer is well established, with women in the least deprived areas and higher socio-
economic groupings being at higher risk (Bray et al 2004, Brown et al 2007, Shack et al 2008). Breast 
cancer incidence rates in Scottish women are rising in parallel across all socio-economic categories 
and the incidence gap between deprived and affluent still remains. Trends in late age at first 
pregnancy, prevalence of obesity and screening uptake do not fully explain the observed trends 
(Brown et al 2007). 
 
4.5. Summary 
Overall, there is considerable variation in many alcohol related cancer trends and it is difficult to 
assess the impact of trends in the levels of alcohol drinking on cancer trends, independently of the 
impact of trends in tobacco use. The one exception to this, possibly, is the rise in the incidence of oral 
and pharyngeal cancer. Interpreting trends in alcohol related cancers is also complicated by 
confounding with trends with other cancer risk factors. Lag times for impacts of changes in alcohol 
use on cancer rates are uncertain, further complicating any assessment of the impact of increases in 
alcohol consumption and prevalence of heavy or excessive drinking (Polednak 2005). Yet the 
incidence of many of the cancers associated with alcohol consumption is increasing in Scotland and is 
expected to continue to do so well into the next decade (Stockton 2004). To further clarify the 
association between alcohol consumption and cancer risk in the Scottish population, the following 
chapters present an analysis and discussion of two Scottish population cohort studies investigating the 




Chapter 5 Alcohol consumption and risk of cancer in two Scottish 
prospective cohort studies 
 
In the previous chapter it was shown that those cancers with the strongest association with alcohol 
consumption have incidence rates which have either been increasing (colorectal, breast and liver 
cancer), or have remained constant (cancers of the oral cavity, pharynx larynx and squamous cell 
carcinoma of the oesophagus) over the last 10 years (ISD 2010a). Smoking, a major risk factor for 
many of these cancers, is on the decline in the Scotland; the percentage of adults who smoke has 
reduced by about half since the early 1970s (Taulbut et al 2008). One explanation for the increasing 
incidence of some cancers may be their association with changing levels of alcohol consumption in 
Scotland (as presented in Chapter 3), although other changes in other lifestyle risk factors such as diet 
and nutrition, physical activity levles and obesity may also be relevant. Despite an extensive body of 
research on the relationship between alcohol consumption and cancer (described in Chapter 2), there 
have been few studies that have explored the association between alcohol consumption and cancer 
risk in Scotland (or in the United Kingdom (UK)).  
Two papers from a UK wide case control study, investigating the association between alcohol 
consumption and oesophageal adenocarcinoma (Cheng et al 2000) and squamous cell carcinoma of 
the oesophagus (Sharp et al 2001) in women, included a small number of cases (n=73) and controls 
(n=73) from five NHS health board areas in Scotland. Other UK-wide studies published between 1999 
and 2009 have not disaggregated their study population by region of the UK. These have included a 
study by Allen et al (2009) on moderate alcohol intake and incidence of twenty-one cancers, in a 
cohort of 1,280,296 middle-aged women recruited from breast cancer screening clinics in the United 
Kingdom, and a nested case control study within the UK General Practitioners Research Database 
reporting on alcohol consumption and risk of oesophageal, and gastric cancer among men and women 
(Lindblad et al 2005).  
In order to address the limited research base in the UK, this study took advantage of a recent ability to 
link data on national lifestyle behaviours and hospitalization, cancer registration and mortality data 
across Scotland to investigate the association between alcohol consumption and the risk of the 
fourteen cancers included in the systematic review. Two approaches using different definitions of 
alcohol drinkers are employed to quantify this risk relationship. Firstly a population based cohort 
study, based on a linkage between a representative general population sample and hospital, cancer 
registry and death records in Scotland describes risk of cancer by amount of alcohol consumed per 
week and by drinking frequency. There are, however, some inherent weaknesses of general 
population surveys which lead to an under-representation of excessive and/or problem drinkers in the 
survey population (Goddard 2001). Survey samples of people living in private households by 
definition exclude those living in institutions and people who have no fixed address – groups which 
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probably contain a higher than average proportion of excessive drinkers and/or problem drinkers 
(Goddard 2001). Excessive and/or problem drinkers may also be more likely than others to be 
difficult to contact (Pernanen 1974, Chick 1982) e.g. young single people are generally under-
represented in survey samples and their alcohol consumption is substantially higher than average 
(Goddard 2001), or if reached, more likely to refuse to participate in a survey than light and moderate 
drinkers (Wild et al 2001). Another consideration common to most epidemiological studies is the 
likelihood that surveys contain a small number of heavy drinkers. In order to adequately investigate 
how heavy or excessive levels of alcohol intake affect cancer risk, and in line with previous record 
linkage studies of ‘alcoholics’ (Adami et al 1992, Kuper et al 2000) a second cohort study describes 
the risk of cancer in the Scottish population that has been admitted to hospital with an alcohol related 
diagnosis.  
Analyses and results from these two studies are presented in Chapters 6 and 7. The remainder of this 
chapter describes the data sources used in these analyses.  
5.1 Data Sources 
5.1.1 The Scottish Morbidity Record (SMR01) 
The Scottish Morbidity Record (SMR01) is an episode-based database, held by the Information and 
Services Division (ISD)
34
, of NHS National Services Scotland relating to all inpatients and day cases 
discharged from non-psychiatric, non-obstetric wards in Scottish hospitals (acute hospital 
admissions). General acute admissions are categorised as follows (ISD 2010d); 
 Inpatients - are patients who occupy a staffed bed in a hospital and: either remain overnight 
whatever the original intention at admission, or are expected to remain overnight, but are 
discharged earlier. Discharges include transfers-out and deaths. 
 Day cases - are patients’ who make a planned attendance to a specialty for clinical care, see a 
doctor or dentist or nurse and require the use of a bed or trolley in lieu of a bed. A day case 
patient is not expected to, and does not, remain overnight. 
 
The Scottish Morbidity Record (SMR) is a routine hospital activity monitoring scheme dating back to 
1961.  Initially, data collected related to all inpatient discharges (except obstetric and psychiatric 
patients) from NHS Hospitals using a paper form called SMR01 (National Services Scotland 2012). 
SMR01 records have, however, been computerised since 1968 (ScotPHO 2010). A record is formed 
when a patient is discharged from hospital, changes consultant or is transferred to another hospital or 
hospital department. Data from patient case records are used to code up to six, one principal and five 
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 ISD is Scotland's national organisation for health information, statistics and IT services. ISD is part of NHS 




secondary, diagnoses at the time of discharge according to the World Health Organization 
Classification of Diseases (“discharge” includes both live discharges and deaths). Discharge 
diagnoses use the International Classification of Diseases (ICD) Ninth Revision for discharges from 
1981 to 1995, and Tenth Revision for discharges since 1996, with data to 2007 used for this analysis. 
Approximately 1 million records are created annually. The episode based database includes 
information on demographic factors (e.g. age, gender, postcode of residence, ethnicity), diagnoses, 
clinical procedures and means of discharge.  
The SMR01 has been subjected to a number of reviews relating to its quality and ability to link 
hospital episodes (Kendrick and Clarke, 1993, Harley and Jones 1996). ISD monitors the accuracy 
levels of SMR01 coding by undertaking routine quality assurance assessments. The most recent 
assessment involving 5430 SMR01 records (1.75% sample of 3 months’ data) across 38 NHS acute 
hospitals for inpatient and day case discharges during time period 2004 to 2006, reported an overall 
accuracy for Main Condition coding of 88% and 93% for Main Operation coding (ISD 2007). SMR01 
accuracy rates have remained fairly static at these levels over the last fifteen years (ISD 2007).  
5.1.2 The Scottish Morbidity Record (SMR04) 
The Scottish Morbidity Record (SMR04) records information on all inpatient admissions and 
discharges from NHS mental health (psychiatric) hospitals in Scotland. Data are collected on all 
patients at the time of admission to hospital and at the time of discharge from hospital. Admissions 
are classified into three main types (ISD 2010e): 
 First admissions - Patients who have not previously received psychiatric inpatient care 
 Re-admissions - Patients who are re-admitted following a break from psychiatric inpatient 
care 
 Transfers - Direct transfer from another psychiatric hospital or from one consultant to another 
within the same hospital 
 
Current national data (2009/2010) completeness for psychiatric hospital activity is estimated to be 
97% (ISD 2010f). 
5.1.3 The Scottish Cancer Registry 
The Scottish Cancer Registry (SCR) has been collecting information on cancer diagnoses since 1958. 
The registry is responsible for the collection of information on all new cases of primary malignant 
neoplasms, carcinoma in situ, neoplasms of uncertain behaviour and (since 1 January 2000) benign 
brain and spinal cord tumours arising in residents of Scotland. Cancer information is stored on 
SOCRATES (Scottish Open Cancer Registration And Tumour Enumeration System) which receives 
notification of cancer from hospital systems, including discharges (SMR01 records), radiotherapy, 
oncology, haematology and pathology records, prospective audit datasets, deaths from the National 
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Records of Scotland (NRS, formerly the General Register Office for Scotland) and paper records from 
private hospitals. There are approximately 800,000 source records processed annually by the 
SOCRATES system using a complex set of rules and linkage routines to create provisional records. 
Data quality is monitored using routine indicators, computer validation and ad hoc studies of data 
accuracy and completeness of cancer ascertainment. Overall, the quality of recent cancer registration 
data in Scotland appears to be high with in-house studies, compared with clinical trial databases, 
reporting  discrepancies occurring in approximately 2-3% of cases ; Brewster et al 1994, Counsell et 
al 1997, Brewster et al 2002, Brewster and Stockton 2008). This compares favourably to that reported 
by other cancer registries; estimated ascertainment by the Trent Cancer Registry in England of 
cancers diagnosed in 1997 was only 88% (Stotter et al 2000).  Information on cancer incidence data in 
Scotland was available for these analyses to the end of 2007. 
5.1.4 Scottish Death Registrations 
Statutory registration of death began in Scotland in 1855, when civil registration replaced the old 
system of registration by parishes of the Established Church (Church of Scotland). All deaths in 
Scotland are now reported to the NRS which produces a database containing identifying information 
and the underlying and contributing causes of death. Mortality data is routinely provided to ISD for 
data linkage and this study uses this linked data rather than data provided directly from NRS. 
5.1.5 Record Linkage  
The ISD linked database contains information on Scotland's SMR01 records for acute specialty day 
case and inpatient discharges from hospital since January 1981, cancer registrations (SOCRATES) for 
patients diagnosed since January 1980, NRS death registrations from January 1980, and mental health 
(SMR04) admissions from January 1981. Using patient identifying information, these records are 
routinely linked, resulting in a linked database of all such patient records covering the period 1981 to 
the present day. This database only contains records from Scottish sources e.g. hospital admissions to 
Scottish hospitals, deaths registered in Scotland. Record linkage is done by probability matching
35
 
using the following information (Kendrick and Clarke 1993, Kendrick 2004): 
 Surname (and its phonetic code to overcome differences in spelling)  
 First initial (also full forename and second initial when available)  
 Gender  
 Year, month and day of birth  
 Postcode  
 Date of death, if available  
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 A computer matching algorithm calculates a score for each pair of records that are compared; the odds that 
they belong to the same person. The overall score is the sum of scores derived from the comparison of each item 
of identifying information, weighted according to the rarity of the information (e.g. the initial Z has a high weight). 
Similar negative weightings are applied to levels of disagreement between items (Kendrick and Clarke 1993).  
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 Patient identifiers: Hospital Case Reference Number, Community Health Index/ Unique 
Patient Identifier  and NHS Number, where available 
 
It is estimated that for each of the core items of identifying information used to link the records 
(surname, initial, year, month and day of birth), there may be a discrepancy rate of up to 3% in pairs 
of records belonging to the same person.  Thus exact matching using these items could miss up to 15 
% of true links (Kendrick 1997). To allow for the imperfections of the data, the system uses methods 
of probability matching which have been developed and refined in Canada, England and Scotland 
(Baldwin et al (eds.) 1968, Heasman 1968, Newcomb 1988). Murray et al (2000) estimated that the 
method of probability matching is estimated to be 13-14% more accurate than ‘exact matching’. From 
an independent check of the quality of linkages carried out by the Scottish record linkage team there 
was a false positive (incorrect links) rate of 3.7% and a false negative (missed links) rate of 1.9% 
between two incidence databases (3077 subjects). In that analysis, the rates were higher for non-post 
coded data (4.2% false positive and 2.4% false negative). The independent analysis was based on 
'clinical' events and would be lower if transfers and additional treatments were included (ScotPHO 
2010). 
5.1.6 Carstairs Index of Deprivation 
To control for the effects of deprivation, this study utilises the area based Carstairs index of 
deprivation available on the ISD linked database and on the Scottish Health Survey. The Carstairs 
index was originally developed in the 1980s using 1981 census data (Carstairs and Morris 1989). It is 
composed of four indicators at postcode sector level that were judged to represent material 
disadvantage in the population; overcrowding (the proportion of all persons living in private 
households with a density of more than one person per room), male unemployment (the proportion of 
economically active males seeking or waiting to start work), households without a car (the proportion 
of all persons in private households which do not own a car), and low social class (the proportion of 
all persons in private households with an economically active head with head of household in the 
Registrar General’s social class IV or V) The index has also been calculated based on 1991 and 2001 
census data (McLoone 1994, McLoone 2004). The scores are not a measure of the extent of individual 
material wellbeing or relative disadvantage, but are rather a summary measure applied to populations 
contained within small geographic localities (McLoone 2004). 
The Scottish Index of Multiple Deprivation (SIMD) published by the Scottish Government (2011a), 
also identifies small area concentrations of multiple deprivation across all of Scotland. The SIMD is 
calculated using data such as current income, employment, health, education, skills and training, 
telecommunications, and housing at the level of data zones. ‘Data zones’ are intended to be effective 
in identifying small areas with particular social characteristics, and are therefore more internally 
homogeneous than postcode sectors (Macintyre et al 2005). The first SIMD published in 2004 
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covered the years 2001 to 2002, 2003, and updates in 2006 and 2009 covered the years 2004 to 2006 
and 2007 to 2009 respectively (Scottish Government 2011b). 
The Carstairs index was chosen for use in this study because it covered a greater period of the 
observation time of the two prospective cohort studies (1987 to 2007) described in Chapter 6 and 
Chapter 7 respectively. The Carstairs index published in 1981 and updated using the 1991 and 2001 
census (McLoone 1994, McLoone 2004), covers at least fourteen years of this study’s observation 
time. The SIMD available from 2001 onwards, although it has also been assessed as suitable for 
analysis from 1997 onwards (ISD 2004), covers between six to ten years of observation time.  
5.1.7 Scottish Health Survey 
The Scottish Health Survey (SHeS) is a cross sectional survey that draws a nationally representative 
sample of the general population living in Scottish private households. SHeS was established to 
provide detailed information on a range of behavioural, biological, psychological and social 
characteristics. The survey is based on a stratified, clustered random sample of individuals living in 
private households across the whole of mainland Scotland plus the larger inhabited islands, with one 
in three postcode sectors (average population of 5000) in Scotland selected at each wave (Gray et al 
2010). Previous Scottish Health Surveys were undertaken in 1995, 1998, and 2003 (Dong & Erins 
1997, Shaw et al 2000, Bromley et al 2005). The continuous Scottish Health Survey began in January 
2008 and is running continuously from 2008-2011. An annual report is published for each year of the 
survey (Corbett et al 2009; 2010). The survey will continue for a further four years from 2012-2015.  
Over time, the range of ages included in the surveys has widened. The survey in 1995 only included 
adults up to the age of 65 years; in 1998, children over 2 years of age and adults up to the age of 75 
years were sampled, and, in 2003, 2008 and 2009, the full age range was surveyed. Weighting has 
been applied to take account of disproportionate sampling within health regions, differing 
probabilities of selection within households of different sizes and within multi-occupied addresses, 
and differential response (Gray et al 2010). SHeS interview response has varied from 81% in 1995 
and 76% in 1998 to 60% in 2003, 61% in 2008 and 64% in 2009.  
Survey data are gathered in two stages: a face-to-face interview, followed by a nurse visit for the 
collection of biological material. In each survey, interviews are carried out using Computer Assisted 
Personal Interviewing (CAPI). Each survey consists of information on somatic and psychological 
health with dedicated modules on specific conditions and risk factors, such as asthma, dental health, 
physical activity, eating habits, smoking and drinking.8 Additionally, anthropometric and, for a 
subsample, biological measurements such as blood pressure and blood and saliva specimens have 




Table 5.1 Baseline SHeS variables included in data linkage to Scottish linked dataset (Gray et al 2010) 
Health measures Health-related behaviours Biological measurements 
CVD Alcohol consumption Anthropometryc 
Diabetes Cigarette smoking Respiratory function 
Respiratory health Dietary characteristics Blood pressure 
Accidents Physical activity Blood analytesd 





Self-assessed general health Immunizationsa Biochemical measurement of 
smoking 








Psychiatric morbidity Individual socio-demographic 
characteristics 
Composition 
Health-related quality of life
a Economic activity status Relationships of householdersa 
Dental health Parental social classa Tenure 
Use of health services Occupational social class Car ownership 













prescribed drugs, contraceptive pills, vitamin supplements and nicotine replacement therapy; 
c
height (length, 
demispan), weight, waist, hip and mid-upper arm circumference (1998 and 2003); 
d
total cholesterol, high-density lipid 
cholesterol, C-reactive protein (1998 and 2003), g-glutamyl transferase (1995 only), fibrinogen, glycated haemoglobin, 
blood lead (1995 only) (for adults) and ferritin, total and house dust mite-specific immunoglobulin E (1998 and 2003) and 
haemoglobin (for children 11–15 years); 
e
sodium, potassium and creatinine (for 2003 adults). 
 
5.1.8 Scottish Health Survey and Record Linkage 
A prospective element of the surveys is provided by linkage to data on hospitalisations (Scottish 
Morbidity Records), cancer registrations and deaths in Scotland. As part of the Scottish health survey 
interview, participants are asked for their consent to their name, address and date of birth being sent to 
the ISD for confidential linkage to their health records. Approximately 92% of respondents in each 
survey consented to their records being linked to NHS administrative data (Gray et al 2010). For those 
who gave such permission, their health survey information was linked to the SMR data by standard 
probability matching (see section 5.1.5) based on name, postcode and date of birth (Figure 5.1). This 
included adults aged 16-64 from the 1995 survey, adults aged 16-74 in 1998 and all ages in 2003. 
Since 2004, they have been followed up with regular mortality and hospital discharge data linkage 
from 1981 to December 2008, and cancer registrations (also from 1981) to December 2007; on-going 
linkage is planned for the surveys being conducted from 2008 to 2011. Retrospective data from 1981, 
until conduct of survey interview, provides information on hospital diagnoses of any pre-existing 






























For each of the three surveys, data on consenting respondents are available in two distinct formats: the 
‘minimum’ datasets and the ‘full’ datasets (Gray et al 2010). The minimum datasets contain a set of 
summary variables derived from the linked SMR data (e.g. causes of death, incidence of acute 
myocardial infarction, stroke and cancer along with the complete health survey record. The full 
datasets contain fields from individual, anonymised patient SMR records. The minimum datasets are 
freely available to the wider research community by request from the Medical Record Linkage Team 
at ISD Scotland.  
The SHeS data have been linked to the Community Health Index (CHI), a population register, which 
is used in Scotland for health care purposes (the CHI number uniquely identifies a person on the 
index), to determine whether respondents have been registered with a Scottish General Practice at the 
end of the SMR follow-up period. This allows identification of a small number (approximately 5%) of 
emigrants for whom follow-up morbidity records in the linked datasets may be incomplete (Lawder et 
al 2007, Gray et al 2010). 
The linkage of pooled data from these three large surveys with follow-up for hospitalisations and 
mortality has generated a large prospective cohort study that facilitates the examination of the role of 
a range of social, psychological, lifestyle and biological factors in the development of a range of 
Scottish Health Survey (SHeS) 
SHeS Survey data + encrypted 
serial number 
SHeS Names, postcodes, Date of 
Births + encrypted serial number 
SMR01 data Names, postcodes, 
Date of Births + encrypted serial 
number 
linked by probability 
matching 
SHS Survey data + SMR01 data 
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important chronic diseases. The linkage for the most recent (2003) survey only took place in 2007 and 
there has only been one paper related to alcohol; based on a linkage of the 1995, 1998 and 2003 SHeS 
data, McDonald et al (2009) reported that moderate and higher levels of usual alcohol consumption 
and binge drinking were highly significant risk factors for an alcohol-related hospitalisation. 
In the following chapters, analysis and results from two prospective cohort studies, based on the 
ISD/SHeS linked database, are presented. Chapter 6 describes the risk of cancer associated with 
alcohol consumption in a representative sample of the Scottish population and in Chapter 7 the risk of 





Chapter 6 Self-reported alcohol consumption and subsequent cancer 
risk in a sample of the Scottish population (1995-2007) 
 
6.1 Methods 
An analysis of the linked SHeS/hospital admission/cancer registry/death record database (as described 
in Chapter 5), was performed. 
 
6.1.1 Study population 
The study population included adults aged 16 years and over participating in three Scottish Health 
Surveys in 1995, 1998 and 2003, who consented to their survey records being linked to health care 
records (n =7,365, 8,305, 7,710, for the three respective survey years)
36
. Overall, 91-93% of adult 
survey participants in 1995-2003 consented to their records being linked (Gray et al 2010). The initial 
study population therefore consisted of 23,380 adults (10,401 men and 12,979 women) aged 16 years 
and over at the interview date for each of three surveys, (March 1995 to March 1996, April 1998 to 
March 1999 and June 2003 to December 2004) with follow up until 31 December 2007. 
For the present analysis, 191 (0.8%), records with missing data for gender and/or age, and 280 (1.5%) 
records with incomplete information on drinking frequency and estimated weekly alcohol 
consumption were excluded. By linkage to the Scottish Cancer Registry, all those with a previous 
cancer diagnosis other than non-melanoma skin cancer (n =978) were identified and excluded from 
the cohort. Thus, the final study cohort comprised 21,931 men and women, aged 16 years and over, 
who had no history of cancer, had consented to linkage and had linked data available, at the start of 
follow-up.  
 
6.1.2 Exposure measurement 
 
Alcohol consumption 
The quantity-frequency (Q-F) measure has been used by the Scottish Health Survey, since the series 
began in 1995, to elicit information on levels of alcohol consumption. Respondents aged 16 and over, 
after preliminary questions on whether they drank alcohol at all, are asked how often (i.e. Almost 
every day/Every day; Five or six days a week; Three or four days a week; Once or twice a week; Once 
or twice a month; Once every couple of months; Once or twice; Not at all in the last 12 months), they 
had drunk six different types of alcoholic drink (beer, spirits, wine, fortified wine and shandy and 
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) during the past twelve months. From this question, the average number of days a week 
the informant had drunk each type of drink was estimated. A follow-up question asks how much of 
each drink type the respondent usually drank on any one day (Corbett et al 2010). The amount given 
to the latter question are converted into units of alcohol, with a unit equal to half a pint of normal 
strength beer/lager/cider/alcoholic soft drink, a single measure of spirits, one glass of wine, or one 
small glass of fortified wine. A half pint of strong beer/lager/cider is equal to 1.5 units
38
. The number 
of units are multiplied by the frequency to give an estimate of weekly consumption of each type of 
drink. The frequency multipliers used are listed in Table 6.1. The separate consumption figures for 
each type of drink are rounded to two decimal places and then added together to give an overall 
weekly (unit) consumption figure. Unit measures were then converted into gram equivalencies 
assuming 1 unit is equivalent to 8 grams of ethanol (Goddard et al 2007, Corbett et al 2010). The 
conversion to a gram measure was undertaken to be consistent with results published in the 
international literature which are predominantly presented in gram measures (WCRF/AICR 2007).  
Table 6.1 Drinking frequency multiplying factor 
Drinking frequency Multiplier 
Almost every day  7 
5 or 6 days a week 5.5 
3 or 4 days a week 3.5 
Once or twice a week  1.5 
Once or twice a month 0.375 (1.5 ÷ 4) 
Once every couple of months  0.115 (6 ÷ 52) 
Once or twice a year 0.029 (1.5 ÷ 52) 
Source; Bromley et al (2005) 
 
The association between alcohol consumption and cancer was evaluated through categorical 
indicators for tertiles of alcohol intake (grams per week), among the study population who drank. 
Categories included; >0-24, >24-104, >104 grams per week, and non-drinkers. Gender-specific 
tertiles were then created from the study population to allow for the risk of prostate cancer (men only) 
and breast cancer (women only) to be modelled and for further analysis by gender, where numbers 
allowed. Categories for men included; >0-60, >60-168 and >168 grams per week and categories for 
women included; 0-16, >16-60, and >60 grams per week. Non-drinkers were defined as those 
                                                          
37 The module of drinking questions in 1998 differed in a number of ways from the 1995 Health Survey questions. 
One change was the distinction made in 1998 between normal (alcoholic strength less than 6%) and strong (6% 
or more) beer, lager and cider. The separate question on shandy asked in 1995 was dropped, and shandy was 
included with normal strength beer. A question on alcoholic soft drinks (or 'alcopops') was also included in 1998 
(Bromley et al 2005). 
2 
In 2008, the Scottish Government published updated alcohol consumption estimates, from the 2003 SHeS 
(Bromley et al 2008), using new updated unit conversion factors published by the Office for National Statistics 
(Goddard 2007) which take in to account the changing strength of alcohol. The impact of these changes is 
discussed in Chapter 3, and the unit factors (old and new) are provided in Appendix F. At time of linkage of 




drinking less than once a year which means that the category of non-drinkers included both total 
abstainers and subjects with a very low alcohol intake, as well as former drinkers. 
The frequency question of the QF measure in SHeS asks respondents to report their usual frequency 
of alcohol intake in nine possible response categories (Table 6.2). For pattern of drinking in relation to 
drinking frequency during the last year, the following categories of decreasing frequency were applied 
(Room 1977, Tolstrup et al 2006, Paradis et al 2009): (1) almost daily drinkers: current drinkers who 
reported consuming alcoholic beverages on five to seven days in the week; (2) weekly nondaily 
drinkers: current drinkers who reported drinking between one and four days per week; (3) monthly or 
less drinkers: current drinkers who reported drinking once or twice a month or every couple of 
months; (4) non-drinkers: those reporting not drinking in the last 12 months including abstainers and 
former drinkers or those reporting drinking on less than one occasion in the past year (Table 6.2). 
Table 6.2 Drinking frequency dimensions in order of decreasing frequency 
Frequency question: response categories Aggregated groupings  
Almost every day   almost daily drinkers 
Five or six days a week   
Three or four days a week  weekly non-daily drinkers 
Once or twice a week   
Once or twice a month   monthly or less drinkers 
Once every couple of months,   
Once or twice a year,   
Less than once a year non-drinkers  




All three surveys included a physical activity module to collect information on the frequency, usual 
duration and usual intensity of physical activity over the four-week period immediately prior to 
interview. The SHeS 2003 physical activity module is directly comparable to the SHeS 1998, but the 
1995 module collected different information on types and frequency of physical activity (Bromley et 
al 2005) therefore it was not possible to create an aggregate variable for the whole cohort. Information 
on usual intake of a wide range of foods, including protein, starch, fat and fibre has been collected in 
each SHeS by a modified version of the Dietary Instrument of Nutrition Education (DINE) 
questionnaire developed by the Imperial Cancer Research Fund’s General Practice Research Group 
(Roe et al 1994). The DINE module use in 1995 is directly comparable with the module used in the 
2003 SHeS. However, a revised DINE module was used in 1998 which meant it was not possible to 
create an aggregate variable for the whole cohort. Information on smoking, weight, and deprivation 






Smoking prevalence is measured in two ways in SHeS. Informants are asked directly whether they 
“smoke cigarettes, pipes or cigars nowadays”, and cotinine levels in saliva are measured for those 
providing a saliva sample at the nurse interview. 
The measurement of cotinine levels in SHeS series provides an objective cross-check on self-reports 
of smoking behaviour, which are known not always to be accurate. Cotinine is a metabolite of 
nicotine. It is one of several biological markers that are indicators of smoking (others include carbon 
monoxide and thiocyanate), and is generally considered the most useful. It can be measured in, among 
other things, saliva or serum. A saliva cotinine level of 15 ng/ml and over is taken as defining that the 
informant currently smokes (those who use other nicotine products are excluded). Cotinine has a half-
life in the body of between 16 and 20 hours, which means that the level of 15 ng/ml in saliva will 
detect regular smoking (even if the person has not smoked that day), but will not detect occasional 
smoking if the last occasion was more than a day ago. A level of 15 ng/ml is also sufficiently high to 
avoid misclassifying people who are exposed to others' smoke as current smokers. Non-smokers who 
are exposed to heavy passive smoking would not be mis-classified as smokers using 15 ng/ml and 
over as the definition of a smoker (Corbett et al 210). 
SHeS use the following classifications of smoking status (Corbett et al 2010): 
 Current smoking status: current smokers (within the last year), ex-regular smokers, ex-
occasional smokers, never smoked at all. 
 Number of cigarettes smoked by current smokers: ‘Light’ (under 10 cigarettes per day), 




Height and weight measurements were collected by the nurse at physical examination.  Informants 
who were pregnant, chair bound, or unsteady on their feet were not weighed. Body Mass Index (BMI; 
weight (kg) divided by height squared (m
2
)) was calculated for all those informants for whom a valid 









The deprivation measure was based on the Carstairs index ( as described in Chapter 5.1.5), which 
combines four census indicators (overcrowding, unemployment, social class, and car ownership), 
judged to represent material disadvantage in the population (Carstairs and Morris 1991). Carstairs 
deprivation scores (coded as quintiles) were available for each linked record; deprivation score was 
determined from postcode sector of residence and was based on 2001 census variables (McLoone 
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1994). The highest number quintile (i.e. quintile 5) corresponds to the 20% most deprived localities in 
Scotland. 
 
6.1.3 Identification of alcohol-related cancer cases and follow-up of the 
cohort 
Survey respondents (n=21,931) who developed an alcohol related cancer during follow up, were 
identified through record linkage between survey dataset and the Scottish Cancer Registry. All 
cancers reviewed in chapter 2 were included and were defined according to the 9
th 
(1981 to 1995) and 
10
th
 (from 1996) revision of the International Classification of Diseases (WHO 1979; 1992). Table 6.3 
lists the cancers defined as ‘alcohol related’ and their respective ICD-9 and ICD-10 codes. Data on 
vital status were available up to 31 December 2007. The observation period for each survey 
respondent was from entry into the study until time of death, date of diagnosis of alcohol related 
cancer or 31 December 2007, whichever came first. 
Table 6.3 Alcohol related cancers– ICD-9 and ICD-10 classifications 
NEOPLASM ICD-9 ICD-10 
Lip, Oral cavity (incl. tongue) 140,141, 143-145 C00, C01-C06 
Pharynx/tonsil 146 C09 & C10 
Hypopharynx 148 C13 
Oesophagus 150 C15 
Larynx 161 C32 
Colorectal 153, 154.0-154.1 C18-C20 
Liver 155 C22 
Pancreas 157 C25 
Lung 162, C33-C34 
Breast 174, 233.0 C50, D05 
Ovarian 183.0, 236.2 C56 
Prostate 185 C61 
Bladder 188 C67 
Kidney 189.0-189.1 C64 C65 
Source: Percy 1995 
 
During follow-up, 853 alcohol related cancers in total were observed. Of the fourteen cancer sites 
under investigation, more than 50 cases were observed in four cancer sites: breast, lung, colorectal 
and prostate (Table 6.4). Of the breast cancer cases, three were identified in men. These cases were 
excluded from analysis, restricting observation to breast cancer cases occurring in women only 
(n=200). Cancers of the oral cavity (including lip) oropharynx, hypopharynx, larynx and oesophagus 
were grouped, in line with established practice, as upper aero-digestive tract (UADT) cancers for 
further analysis (Dobrossy 2005, Lagiou et al 2009). The low number of cases identified for cancer of 
the bladder (n=46), ovary (n=31), stomach (n=30), kidney (n=27) and liver (n=9) restricted any 
further meaningful analysis. No further analyses were conducted with these outcomes to determine 
the risk associated with levels of alcohol intake and drinking frequency. Cancers of the UADT, breast 
(women only in both the numerator and denominator), lung, colorectum and prostate were further 
investigated for an association with alcohol consumption. 
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6.1.4 Statistical analysis 
From the minimum linked SHeS dataset supplied by the ISD Medical Record Linkage team (as 
described in Chapter 5.1.8), person-years were accumulated up to death, cancer diagnosis or the end 
of 2007, whichever occurred first. Cox proportional hazards models were used to analyze the 
association between alcohol intake and cancer incidence for both sexes combined and for gender 
specific strata. Hazard ratios (HRs), including 95% confidence intervals (CIs), were calculated for 
weekly alcohol consumption and drinking frequency, and risk of breast, colorectal, lung, prostate and 
UADT cancers. These models take account of survival time until the event as well as whether or not a 
participant has the event, and are also able to adjust for other variables which may be confounders 
(Andersen et al 1993). 
In a first series of models, age-adjusted HRs were estimated for cancers of the colorectum, lung and 
upper aero-digestive tract with weekly alcohol consumption entered into the model in four categories 
(1.non-drinkers, 2.>0-24, 3.>24-104 and 4.>104 grams per week). For cancers of the breast (women) 
and prostate (men), gender-specific intake categories were used in the model; 1.non-drinkers, 2.0-60, 
3.>60-168, and 4.>168 grams per week for men and non-drinkers, 1.non-drinkers, 2.>0-16, 3,>16-60, 
and 4.>60 grams per week for women. HRs were estimated using the second category as the reference 
category since this was category with the largest number of cases. For each cancer, other potential 
confounders i.e. gender, smoking status (five levels) body mass index (three levels) and deprivation 
(quintiles) were then entered into the models singly and only those that were statistically independent 
risk factors, and that changed the estimates in the model by 5% were included in the final model for 
that cancer. All of the afore-mentioned variables were found to be confounders for some but not all 
cancers using these criteria and these are reported with the results. In the final model, multivariate 
adjusted HRs were produced for each cancer. A second series of models was constructed, including 
the same covariates as above, but using drinking frequency instead of total intake. Drinking frequency 
was entered into the model in four categories (almost daily, weekly not daily, monthly or less and 
non-drinkers) with weekly not daily drinkers, as the reference group because this represented the 
group containing the largest number of people. 
For the trend tests, median values for each exposure category of a categorized variable were included 
in the model (Rothman and Greenland 1998). Variables were also analyzed in continuous form when 
the results from the categorized analyses were compatible with the assumption that the effects are 
linear. The interaction between sex and alcohol intake for selected cancers was investigated by 
entering the factor and its interaction term in the model using the STATA ‘logit’ command (Mitchell 
and Chen 2005). All analyses were repeated after excluding the first two years of follow up in order to 
eliminate or reduce the possible impact of selection bias due to the presence of an alcohol related 
cancer at the baseline assessments. Scaled Schoenfeld residuals were used to check the validity of the 
proportional hazards assumption of the models (Schoenfeld 1982). P values less than 0·05 were 
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regarded as statistically significant. According to these tests, the proportional hazards assumption was 
not violated in the models. Intercooled Stata version 11 (STATA statistical software, release 11; Stata 
Corporation, College Station, TX) was used for all analyses. 
 
6.2 Results 
During a total of 199,037 person years of follow-up, 853 (3.9%) alcohol related cancers occurred 
(Table 6.4). Mean follow up was 9.1 years for the whole study population. The three most common 
cancers observed among the cohort in men (lung, prostate colorectal) and in women (breast, lung, 
colorectal) are the also the three most common cancers in Scottish men and women respectively (see 
page 287 for further detail (ISD 2010a), and which suggests that the study includes a representative 
sample of the whole population. 
 
Lung, breast colorectal and prostate cancers formed over two-thirds (71.5%) of the alcohol-related 
cancers identified during follow-up (Table 6.4). Mean follow up varied by cancer type, ranging from 
4.8 years for cancer of oral cavity (including lip) and stomach to 6.8 years for cancers of the 
oropharynx, 6.9 years for ovarian cancer and 7.2 years for cancer of the kidney. Oral (mean 52.5 
years, SD 11.3), breast (53.0 years, SD 12.6) and ovarian (54.0 years, SD 13.4) cancer cases identified 
during follow-up tended to be younger on entry into cohort compared to cases of cancer of the liver 
(mean 64.8 years, SD 7.0), pancreas (63.0 years, SD 8.9), lung (62.7 years, SD 9.7) and prostate (62.5 
years, SD 9.3). 





Mean age at 
cohort entry (SD) 
Mean follow up (yrs) 
to cancer diagnosis  
Oral cavity (incl. lip) 7/7 14 52.5 (11.3) 4.8 
Oropharynx 5/2 7 59.7 (10.0) 6.8 
Larynx 9/4 13 56.1 (11.8) 5.5 
Oesophagus 28/13 41 60.1 (9.7) 6.1 
Upper Aero-Digestive Tract
1
 49/26 75 58.1 (10.6) 5.8 
Gastric 15/15 30 61.9 (11.7) 4.8 
Liver 3/6 9 64.8 (7.0) 5.9 
Pancreas 10/15 25 63.0 (8.9) 5.6 
Colorectal 68/66 134 59.2 (10.7) 5.5 
Breast 3/200 200
2
 53.0 (12.6) 5.7 
Prostate 76/0 76 62.5 (9.3) 5.7 
Ovarian 0/31 31 54.0 (13.4) 6.9 
Lung 107/90 197 62.7 (9.7) 5.7 
Bladder 33/13 46 58.0 (11.8) 6.2 
Kidney 18/9 27 58.1 (10.7) 7.2 
1 








In this cohort, over half of the study population were women (55.6%). The mean age at entry to the 
cohort was 44.7 (SD 15.9) years (Table 6.5). Median alcohol consumption in the study population was 
48 grams per week (equivalent to 6 units per week) though median levels of consumption among men 
and women varied considerably (98 grams and 24.3 grams, respectively). Approximately half (48.7%) 
of the study population drank on a weekly, but not daily basis (i.e. 4-7 days per week). Men were 
more than twice as likely as women (31.2% versus 13.6% respectively) to exceed gender specific 
weekly drinking guidelines
39
. Over a third (39.6%) of the cohort were current smokers of whom 
13.3% reported smoking >20 cigarettes per day.  
Table 6.5 Characteristics of study population by survey year 
 1995 1998 2003 Total 
Survey participants 7204 7846 6881 21931 
Women (n) 3953 4392 3850 12195 
Men (n) 3251  3454  3031  9736  
Total person years of follow up 90,110 76,238 32,689 199,037 
Mean age at entry into cohort (SD) years 40.1(13.2) 44.8(15.7) 49.3(17.4) 44.7(15.9) 
Amount drunk     
grams per week (median) 49.0 48.0 44.9 48.0 
males median grams per week 111.5 104.41 84 98 
females median grams per week 24.9 24.5 24.0 24.3 
% above weekly limits- males 33.7 32.2 27.5 31.2 
% above weekly limits- females 13.0 13.6 14.3 13.6 
Drinking frequency     
% almost daily drinkers 10.1 12.7 15.7 12.8 
% weekly not daily drinkers 52.3 48.6 45.1 48.7 
% monthly or less drinkers 29.5 28.5 28.8 28.9 
% non-drinkers 8.2 10.2 10.4 9.6 
Weight (Body Mass Index )     
% overweight (BMI≥25 kg/m2) 35.0 37.6 39.8 37.4 
% obese (BMI≥30 kg/m
2
) 17.3 21.9 25.5 21.4 
Deprivation     
% living in most deprived Carstairs quintile 22.5 19.5 17.2 19.8 
% living in least deprived Carstairs quintile  18.0 17.8 18.9 18.2 
Smoking     
% never smoked 33.4 41.4 44.2 34.3 
% former smoker 26.8 23.7 28.0 26,1 
% current smoker 39.8 34.9 27.8 39.6 
% of which heavy smoker,≥20 p/day 33.4 41.4 44.2 13.3 
Alcohol related cancers     
number of cancers observed 306 375 172 853 
mean age at cohort entry 52. 5 60.2 66.9  
  
                                                          
39
 >21 units per week for men and >14 units per week for women 
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Across the three surveys, the mean age increased in each respective year e.g. those participating in the 
2003 survey were over a decade older, on average, than those entering in 1995 due to the changing 
eligibility criteria (Table 6.5). Over a fifth (22.5%) of the study population in the 1995 survey were 
living in the twenty per cent most deprived areas of Scotland, in contrast to 17.2% of those 
participating in the 2003 survey. The proportion of ‘almost daily’ and ‘non-drinkers’ significantly 
(p<0.001) increased across the three surveys. Although the proportion of those classified as current 
smokers reduced from 39.8% in 1995 to 27.8% in 2003 (p<0.001), the proportion of current smokers 
who were classified as heavy smokers (i.e. ≥20 cigarettes per day) increased from 33.4% in 1995 to 
44.2% (p<0.001). The proportion of people classified as obese (BMI ≥30 kg/m2), also increased 
significantly (p<0.001) from 17.3% in 1995 to 25.5% in 2003.  
‘Daily’ drinkers were more likely to be men, and women were more likely to be monthly (or less) 
drinkers or non-drinkers (Table 6.6). Daily drinkers had a median mean weekly alcohol intake (183 
grams per week) more than double that of weekly (not daily) drinkers (84 grams per week). Monthly 
(or less) drinkers drank on average 6 grams per week. Levels of weekly drinking were twice as high in 
men, than those in women, irrespective of drinking frequency status (with the obvious exception of 
non-drinkers). Drinking frequency did not vary by current smoking status, however, non-drinkers and 
monthly drinkers were more likely than ‘daily’ drinkers to be non-smokers. Approximately a quarter 
of non-drinkers (26%) and monthly drinkers (22%) were living in the most deprived Carstairs 
quintiles, compared to 14% of daily drinkers and 19% of weekly drinkers. Conversely 27% of daily 
drinkers were more likely to be living in the least deprived Carstairs quintiles, compared to 14% of 

















Number  2804 10680 6341 2106 
Men (%) 62.2 50.2 30.7 32.5 
Mean age at entry 50.6 (14.8) 42.4 (14.6) 44.01 (16.5) 50.9 (17.8) 
Amount drunk     
grams per week (median) 183.0 84.0 6.0 0 
males median grams per week 248.0 124.6 8.3 0 
females median grams per week 121.0 60.0 4.6 0 
% above weekly limits- males 70.3 33.8 0.2 n/a 
% above weekly limits- females 59.6 19.3 0.1 n/a 
Weight (BMI)     
% overweight (including obese) (BMI≥25) 61.2 57.6 59.5 57.7 
Smoking      
% current smoker 32.7 35.1 34.4 31.6 
% never smoked 32.7 39.1 41.7 45.2 
% heavy smoker, 20 plus per day 15.5 12.8 12.9 13.3 
Deprivation     
% living in most deprived Carstairs quintile 14 19 22 26 
% living in least deprived Carstairs quintile  27 19 14 13 
Alcohol related cancers     
Number of cancers observed  153  343  265  92  
 
6.2.1 Hazard ratios for selected alcohol related cancers by weekly intake. 
The hazard ratios for categories for alcohol intake and risk of cancer of the upper aero-digestive tract 
(UADT) are presented in Table 6.7. A threefold increased risk of UADT cancer was observed in age-
adjusted HRs (3.71, 95% CI 1.92-7.15), for survey respondents drinking >104 grams a week of 
alcohol, compared to those drinking between >0-24 grams per week. This statistically significant 
increased risk of UADT cancer remained, but was considerably reduced after further adjustment for 
gender, amount smoked, deprivation quintiles and BMI category (HR 2.54, 95% CI 1.25-5.14) (Table 
6.7), Both non-drinkers and those drinking between 24 grams and 104 grams per week had a non-
statistically, significant increased risk (24% and 62% respectively) of cancer of the UADT in both age 
and multivariate adjusted models compared to those drinking 0-24 grams per day. The test for linear 
trend in risk of UADT by increasing levels of alcohol consumption was statistically significant (p 
value for trend=0.005). Due to small number of UADT cases identified in the cohort, it was not 




Table 6.7 Hazard ratios for cancer of the UADT by weekly alcohol intake 
Tertiles of alcohol 
intake  
grams per week 
Cases HR
1








non-drinkers 7 1.30 0.51-3.32 0.58 1.24 0.49-3.17 0.65  
>0-24  12 1.00*   1.00*    
>24-104  20 1.72 0.84-3.52 0.14 1.62 0.78-3.33 0.19  
>104  36 3.71 1.92-7.15 <0.001 2.54 1.25-5.14 0.01 p=0.005 
1
 adjusted for age 
2
models adjusted for age, gender, smoking, deprivation (quintiles) and BMI. *referent group 
 
There was no statistically significant association between colorectal cancer and alcohol consumption 
at any level of alcohol consumption in either the age or multivariate models (Table 6.8). A small, but 
not statistically significant, increased risk of colorectal cancer (HR1.18, 95% CI 0.75-1.79, p value for 
trend =0.47) was reported among survey respondents drinking >104 grams per week, compared to 
those drinking 0-24 grams per week.  
Table 6.8 Hazard ratios for colorectal cancer by weekly alcohol intake 
Tertiles of alcohol 
intake  
grams per week 
Cases HR
1










non-drinkers 17 0.88 0.50-1.55 0.66 0.92 0.53-1.62 0.78  
>0-24  43 1.00*   1.00*    
>24-104  34 0.82 0.52-1.29 0.40 0.82 0.52-1.29 0.38  
>104  40 1.16 0.75-1.79 0.51 1.18 0.78-1.85 0.47 p=0.283 
1
 adjusted for age 
2
 adjusted for age smoking and BMI. *referent group 
 
Hazard ratios for weekly alcohol intake (gender specific categories) and risk of colorectal cancer, 
adjusted for age smoking and BMI, and stratified by gender are presented in Table 6.9. Men drinking 
more than 60 grams per week, compared to men drinking >0-60 grams per week, were not at an 
increased risk of colorectal cancer. Male non-drinkers had a non-statistically significant reduced risk 
of colorectal cancer (HR 0.53, 95% CI 0.18-1.52, p value for trend =0.26) though this estimate was 
based on only four cases. In women, there was a positive, non-significant, association between 
drinking ≥60 grams per week, compared to those drinking >0-16 grams per week and risk of 
colorectal cancer (HR 1.30 95% CI0.69-2.45, p value for trend =0.41). A formal test of interaction 
between alcohol intake and gender in relation to colorectal cancer risk was not statistically significant 






























 95% CI p- 
value
 
non-drinkers 4 0.55 0.19-1.56 0.26 non-drinkers 13 1.25 0.63-2.48 0.52 
>0-60  26 1.00*   >0-16  23 1.00*   
>60-168  16 0.67 0.36-1.25 0.21 >16-60 12 0.73 0.36-1.48 0.38 
>168  22 1.02 0.57-1.81 0.95 >60  18 1.30 0.69-2.45 0.41 
1
 model adjusted for age smoking and BMI. *referent group 
 
In age adjusted HRs, survey respondents drinking >104 grams per week, had a statistically non-
significant, increased risk of lung cancer (HR 1.33 95% CI 0.94-1.90, p value for trend =0.11) (Table 
6.10). After further adjustment for amount smoked, weight and by deprivation quintile, alcohol intake 
at this level was not associated with an increased risk of lung cancer (HR 1.05, 95% CI 0.73-1.50, p 
value for trend =0.81).  
Table 6.10 Hazard ratios for lung cancer by weekly alcohol intake 
Tertiles of alcohol 
intake  
grams per week 
Cases HR
1





 95% CI p- 
value
 
Test for trend 
non-drinkers 26 0.84 0.53-1.32 0.44 0.79 0.50-1.25 0.32  
>0-24  67 1.00*   1.00*    
>24-104  56 0.80 0.55-1.18 0.26 0.77 0.53-1.13 0.19  
>104  49 1.33 0.94-1.90 0.11 1.05 0.73-1.50 0.81 p=0.178 
1
 adjusted for age, 
2
 adjusted for age, smoking deprivation and BMI. *referent group 
 
Hazard ratios for weekly alcohol intake and risk of lung cancer were further stratified by gender 
(Table 6.11). There was no association between lung cancer at any alcohol intake category in both 
men, compared to those drinking 0-≤24 grams per week, and women, compared to those drinking >0-
16 grams per week. A formal test of interaction between alcohol intake and gender in relation to lung 
cancer risk was not statistically significant (P interaction =0.19). 












  95% CI p- 
value 
Tertiles of 





 95% CI p- 
value 
non-drinkers 10 0.93 0.45-1.88 0.83 non-drinkers 16 0.85 0.47-1.55 0.60 
>0-60  33 1.00*   >0-16  34 1.00*   
>60-168  32 0.99 0.61-1.61 0.97 >16-60 23 1.02 0.60-1.74 0.93 
>168  32 1.07 0.65-1.75 0.79 >60  17 0.95 0.52-1.72 0.86 
1




Alcohol intake, up to and including >60 grams per week was not associated with an increased risk of 
breast cancer among women in either age adjusted or multivariate models (Table 6.12). However, 
non-drinkers, compared to very low level drinkers (>0-16 grams per week), had a borderline, 
statistically significant, protection against breast cancer (multivariate HR 0.58, 95% CI 0.35-0.96, p 
value for trend =0.41). 
 Table 6.12 Hazard ratios for breast cancer in women, by weekly alcohol intake 
Tertiles of alcohol 
intake  
Grams per week 
Cases HR
1









non-drinkers 19 0.57 0.34-0.94 0.03 0.58 0.35-0.96 0.04  
>0-16  77 1.00*   1.00*      
>16-60 56 0.96 0.68-1.35 0.81 0.94 0.66-1.33 0.73  
>60  48 0.84 0.58-1.21 0.35 0.81 0.56-1.17 0.26 p=0.363 
1
 adjusted for age 
2
 adjusted for age and BMI. *referent group 
 
Although, men drinking >60 grams per week had an increased hazard (15-16% higher) of prostate 
cancer compared to more moderate drinkers (≥0 to ≤60grams per week) there were no statistically 
significant relationships with any category of intake (Table 6.13). 
Table 6.13 Hazard ratios for prostate cancer by weekly alcohol intake 
Tertiles of 
alcohol intake  
Grams per week 
Cases HR
1








non-drinkers 7 1.01 0.43-2.36 0.98 1.05 0.45-2.44 0.92  
>0-60  23 1.00*   1.00*    
>60-168  24 1.14 0.64-2.03 0.65 1.15 0.65-2.03 0.64  
>168  22 1.17 0.65-2.11 0.59 1.16 0.65-2.10 0.61 p=0.613 
1
 adjusted for age 
2
 adjusted for age and BMI. *referent group 
 
6.2.3 Hazard ratios for selected alcohol related cancers by drinking 
frequency 
‘Daily’ drinking, compared to weekly (not daily) drinking, was associated with a statistically 
significant increased risk of UADT cancers (multivariate HR 1.96, 95% CI 1.15-3.34) (Table 6.14). 
An inverse association between those reporting drinking monthly (or less), compared to weekly (not 
daily drinkers) and risk of UADT cancer was observed. Non-drinkers also had a, small, reduced risk 
of UADT cancer, but the HR was not statistically significant.  
‘Daily’ drinking, compared to weekly (not daily) drinking, was also associated with a, small 
statistically significant elevated increased risk of colorectal cancer (multivariate HR 1.68, 95% CI 
1.06-2.67, p value=0.03). Neither ‘monthly’ nor non-drinkers were at increased risk of colorectal 




Daily and monthly drinkers had, respectively, a 37% and 53%, increased risk of prostate cancer, 
compared to weekly (not daily) drinkers, but neither point estimate was statistically significant. There 
was no evidence of an association between drinking frequency and risk of lung cancer (Table 6.14). 
Non-drinkers (including ex-drinkers) were approximately 40% less likely than weekly not daily 
drinkers to develop breast cancer. Monthly drinkers had a small, but not statistically significant, 
increased risk of breast cancer (HR1.19, 95% CI 0.87-1.63, p value =0.26). Daily drinking was not 
associated with an increased risk of breast cancer (Table 6.14).  















         
non drinkers 7 1.16 0.51-2.62 0.72 0.69 0.30-1.57 0.37 
monthly or less 10 0.51 0.25-1.04 0.06 0.46 0.23-0.93 0.03 
weekly not daily 34 1.00*    1.00*   
almost daily 24 3.07 1.82-5.19 <0.05 1.96 1.15-3.34 0.01 
Colorectal
2
        
non drinkers 17 2.02 1.16-3.51 0.01 1.21 0.69-2.12 0.52 
monthly or less 40 1.48 0.97-2.25 0.07 1.30 0.85-1.99 0.22 
weekly not daily 47 1.00*    1.00*   
almost daily 30 2.73 1.73-4.32 <0.05 1.68 1.06-2.67 0.03 
Breast
3
        
non drinkers 19 0.84 0.50-1.41 0.51 0.62 0.36-1.06 0.08 
monthly or less 82 1.23 0.91-1.67 0.18 1.19 0.87-1.63 0.26 
weekly not daily 83 1.00*    1.00*   
almost daily 19 1.34 0.81-2.20 0.25 0.96 0.58-1.59 0.88 
Lung
1
        
non drinkers 24 1.66 1.05-2.62 0.03 0.80 0.51-1.27 0.35 
monthly or less 57 1.21 0.87-1.70 0.26 1.02 0.73-1.44 0.89 
weekly not daily 82 1.00*     1.00**   
almost daily 34 1.83 1.22-2.72 <0.05 0.96 0.64-1.45 0.86 
Prostate
3
        
non drinkers 6 1.74 0.73-4.19 0.21 1.02 0.42-2.46 0.96 
monthly or less 18 1.70 0.95-3.04 0.07 1.53 0.86-2.74 0.15 
weekly not daily 31 1.00*    1.00*   
almost daily 21 2.36 1.35-4.11 <0.05 1.37 0.78-2.40 0.27 
1
 adjusted for age, gender, smoking, deprivation, BMI, 
2
 adjusted for age, BMI and smoking, 
3
 adjusted for age, 
BMI. * Reference group 
 
6.3 Discussion 
In the literature review, only two case control studies were identified that reported the risk of 
(oesophageal) cancer from alcohol consumption in a Scottish population (Cheng et al 2001, Sharp et 
al 2001). This study, therefore, represents the first published retrospective cohort study of self-
reported alcohol intake and subsequent cancer in Scotland. Findings from the present study support an 
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overall association between alcohol consumption and risk of UADT cancer for those drinking at the 
highest alcohol exposure category compared to those drinking low amounts of alcohol. Drinking 
‘daily’ was also associated with an increased risk of UADT cancer compared to weekly drinkers. No 
statistically significant association was observed between alcohol consumption and drinking 
frequency, and risk of prostate, lung, and (in women) breast cancer.  
 
6.3.1 Alcohol and cancers of the upper-aero digestive tract 
In the present study, there was more than a two-fold increased risk of UADT cancer in those drinking 
>104 grams per week (approximately 13 units per week) and among ‘daily’ drinkers, with a dose 
response effect apparent. These estimates are consistent with other studies that have reported the 
effects of moderate drinking on risk of UADT cancer (Kasum et al 2002, Weikert et al 2009). The 
data add to consistent epidemiological evidence from around the world that clearly document that 
alcohol consumption increases the risk of UADT cancer (IARC 1988, WCRF/AICR 2007). 
As a result of the small number of UADT cancer cases (n=75) identified in the present study, it was 
not possible to explore the association between alcohol consumption and risk of UADT cancer by 
individual site. Head and neck (which include the oral cavity and pharynx) and oesophageal cancers 
are, respectively, the fourth and fifth most frequently occurring among men in Scotland, though in 
women they are far less common (ISD Scotland 2010a). The majority of the present study’s 
population were women (55.6%) which could potentially reduce the study’s power to detect UADT 
cancers. Another contributory factor to the small number of observed UADT cancers is the relatively 
young age, compared to other similar studies, of the overall study population (mean age at cohort 
entry 44.7 years) combined with an average follow up of less than ten years. 
Cancers of the UADT as an aggregate grouping may have limited value as such a grouping assumes a 
constant risk across cancer sub-sites. Although the effect sizes by UADT sub-site reported in the 
epidemiological literature, can vary considerably (see Chapter 2), this could be a result of many 
factors e.g. study size, study length, levels of drinking in study population. There has, however, been 
little formal testing of whether the associations of alcohol intake with UADT sub-site significantly 
differ and what evidence does exist is far from conclusive. In a meta-analysis of fourteen studies, 
published between 1966 and 2001, Zeka et al (2003) found that alcohol consumption appeared to have 
a much stronger effect on the oropharynx than on any of the other upper aero-digestive sites. Weikert 
et al (2009), based on a large European prospective cohort study, reported no significant differences 
between cancers of the oesophagus and the oral cavity or pharynx and between laryngeal and oral 
cavity/pharyngeal cancer. The multivariable adjusted relative risk per 10 grams per day (g/d) increase 




Although the present study controlled for the effects of smoking it is not possible to rule out the 
effects of residual confounding from smoking. Furthermore, risk of UADT cancer is further 
aggravated by diets deficient in fruits and vegetables (WCRF/AICR 2007) and it was not possible to 
control for the effect of diet in the present study. The effect of this may be to reduce the effect size 
reported in the study, if heavy drinkers were to eat less fruit and vegetables. 
 
6.3.2 Alcohol and colorectal cancer 
In the present study, alcohol consumption was not associated with a statistically significant increased 
risk of colorectal cancer in men and women. This finding is consistent with results from the published 
literature, discussed in Chapter 2.5, which suggests that a, statistically significant, increased risk of 
colorectal cancer is only found in those drinking ≥30 g/d, and a pooled analysis of eight cohort studies 
which observed that the increased risk of colorectal cancer was restricted to those drinking >210 
grams per week (g/w); pooled multivariate relative risks were 1.16 (95% CI 0.99-1.36) for persons 
who drank >210-<295 g/w and 1.41 (95% CI 1.16-1.72) for those who drank ≥295 g/w, compared to 
non-drinkers (Cho et al 2004). The highest alcohol exposure category in the present study was >104 
g/w therefore an increased risk of colorectal cancer in the present population cannot be ruled out as 
too few of the study population drank >210 g/w to allow an analysis of the risk of colorectal cancer at 
this level of drinking.  
‘Daily’ drinkers in the present study, compared to ‘weekly’ drinkers, did, however, have a statistically 
significant increased risk of colorectal cancer after adjustment for age, gender, body weight and 
smoking. No other studies have reported on drinking frequency and risk of colorectal cancer. The 
positive association between daily drinkers and increased risk of colorectal cancer can be attributed to 
daily drinkers drinking considerably more than the overall study population (median weekly intake of 
183 and 48 grams respectively). Daily drinkers in the present study population are also twice as likely 
as weekly (not daily) drinkers, to exceed the recommended weekly safe limits in the UK (of 21 units 
for men and 14 units for women) suggesting that this group are more likely than the overall study 
population to be drinking at levels (i.e. >30 grams per day) which are similar to the drinking levels 
consistently linked in the international literature with an increased risk of colorectal cancer 
(WCRF/AICR 2007). Due to the small number of colorectal cancer cases (n=30) who were ‘daily’ 
drinkers in the present study, it was not possible to investigate further, the relationship between ‘daily’ 
drinking and risk of colorectal cancer by different alcohol intake levels.  
The positive associations between ‘daily’ drinking and increased risk of colorectal cancer may, 
however, be explained by the lack of complete control for potential confounders of the alcohol-
colorectal cancer association. Several other risk factors for colorectal cancer have been identified 
through epidemiological studies (WCRF/AICR 2007); diet and micronutrients, including high intake 
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of fat, meat, protein, low intake of fibre, low intake of folate and calcium, low physical activity, large 
body size, and smoking. There is a possibility of confounding from lack of adjustment for dietary 
factors in this study as this information was not available and may explain the increased risk observed 
among daily drinkers especially if daily drinkers had a poor diet with low intake of fibre and folate. 
Overall, the results from the present study are consistent with those reported in the international 
literature which provides no strong evidence of an association between low to moderate levels of 
alcohol consumption and an increased risk of colorectal cancer.  
 
6.3.3 Alcohol and breast cancer 
In the present study, non-drinkers, compared to women drinking between >0-≤16 grams per week, 
had a weak statistically significant inverse association with breast cancer. Women drinking 16-60 g/w, 
did not have an increased risk of breast cancer, compared to light drinkers. Levels of reported alcohol 
consumption in the present study cohort were low among women. One reason for this is that the 
present record linkage between the Scottish Health Survey was based on old alcohol unit conversion 
factors which do not take into account the increasing strength of beverage alcohol in the UK (see 
Chapter 3, Section 3.2.2). Catto and Gibbs (2008) for example have shown that, for example, a typical 
serving of one glass of wine will contain between 2 and 2.5 units, more than double that estimated in 
surveys to date. In the present study, the highest alcohol intake category of >60 g/w is equivalent to 
approximately 8 UK alcohol units, which is considerably lower than current recommended weekly 
UK drinking guidelines for women. Very few studies, cohort or case control, have observed a 
statistically significant association with cancer at the intake levels reported in this study’s cohort. In a 
UK prospective cohort study, women drinking between 3-6 drinks per week, similar to the highest 
alcohol exposure category in the present study, had a small, but statistically significant, increased risk 
of breast cancer (RR 1.08, 95% FCI
40
 1.05-1.10) compared to women drinking ≤2 drinks per week 
(Allen et al 2009). Results of the present study and those by Allen et al (2009), however, are not 
directly comparable because in the present study one unit was equivalent to eight grams of alcohol 
and in the Allen et al study, one unit was equivalent to ten grams of alcohol. Across the majority of 
studies on the alcohol and the alcohol breast cancer association described in Chapter 2.4, however, an 
increased risk of breast cancer, either significant or non-significant, was often only associated with 
alcohol consumption of approximately 15 grams a day or more, which is more than twice the levels of 
the highest alcohol intake category in the present study. In this regard, the findings of the present 
study reflect existing evidence (WCRF/AICR 2007) of no association between very low levels of 
alcohol consumption and breast cancer. 
                                                          
40
 floating confidence interval (FCI) 
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No significant association was observed between drinking frequency and breast cancer risk. This 
finding is consistent with some studies that have reported on the association between drinking 
frequency and risk of breast cancer (Lenz et al 2002, Tjonneland et al 2003, Lin et al 2005). It is 
highly likely, however, that that the drinking frequencies used in the present study are not sufficiently 
precise to detect an association with breast cancer. Horn- Ross et al (2004) demonstrated this by 
combining frequency with amount drunk and found that breast cancer risk was significantly increased 
among ‘daily’ heavy drinkers (i.e., women consuming a weekly average of >20 grams per day of 
alcohol, but not in those drinking <20 grams per day. It was not possible to investigate this aspect due 
to the small number of breast cancers cases observed, and the low levels of alcohol intake overall, 
among women in the study cohort. 
It was not possible to investigate whether risk varied by menopausal status because of the small 
number of female drinkers. Reports are inconsistent on the alcohol-related risk of breast cancer before 
and after the menopause. While not statistically different in some past studies, the effects of alcohol 
consumption were more consistent and somewhat greater in post-menopausal women than in pre-
menopausal women in more recent studies (Smith-Warner et al 1998, Ellison et al 2001, Hanajima et 
al 2001). If menopausal status of women modifies the relationship between alcohol and breast cancer, 
the young age of female cohort members (44.8 SD16.0 years) in this study and follow up period of 
approximately ten years would make it more difficult to detect an association between alcohol and 
breast cancer.  
Although the present study controlled for the effects of deprivation with the Carstairs Index, there is a 
still a risk of residual confounding from socio-economic status. Studies have shown women with 
higher levels of education are more at risk of breast cancer than those with lower levels of education 
(Heck and Pamuk 1997, Lichtenstein 2000). The Carstairs index, however, does not include an area 
measure of educational status Thus, even when models are adjusted for deprivation a residual effect 
might remain. The present study was also not able to control for the effects of diet and nutrition as this 
information was not available across all three Scottish Health Surveys. There has been a lot of 
research into the effects of dietary factors on breast cancer risk, but findings are generally inconsistent 
and inconclusive. Although a meta-analysis of 45 studies (Boyd et al 2003) reported that higher total 
fat intake increased breast cancer risk by 13%, the recent WRCF/AICR review (2007) concluded that 
there is limited evidence suggesting that high total dietary fat is a cause of breast cancer. Poor diet, 
however, may play some part by contributing to increased body weight which is considered a 
convincing risk factor for breast cancer. In the present study, body weight was controlled for in the 
models.  
Overall, results from the present study are consistent with existing evidence of no association between 
breast cancer and low levels (approximately <1 drink per day) of alcohol consumption. Further studies 
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with longer follow-up are required to explore the effects of moderate and heavy drinking and risk of 
breast cancer in a Scottish general population. 
 
6.3.4 Alcohol and lung cancer 
In the present study, lung cancer was not associated with drinking frequency or weekly alcohol intake. 
Further stratification by gender did not show an increased risk of lung cancer in men drinking >168 
g/w (equivalent to approximately more than 21 units per week) or in women drinking >60 g/w 
(approximately 7-8 units per week). These findings are consistent with those reported the international 
literature and discussed in Chapter 2.11. A recent pooled analysis of seven prospective cohort studies 
did provide some weak evidence of a positive association between alcohol consumption and lung 
cancer risk, but only in those drinking ≥30 g/d, compared to non-drinkers (Freudenheim et al 2005). It 
was not possible to replicate this finding due to the small number of the present study’s population 
drinking >30 g/d. The role of alcohol consumption in lung cancer aetiology may been suggested in 
some studies (as described in Chapter 2.11), but this possible relationship has been often regarded 
with scepticism, with any indication of an association being attributed to confounding by cigarette 
smoking (Bofetta et al 2005).  
 
6.3.5 Alcohol and prostate cancer 
The present study found no statistically significant association between drinking frequency or weekly 
alcohol intake and an increased risk of prostate cancer. Epidemiological evidence suggests that 
prostate carcinogenesis may span decades and to fully explore the relationship between alcohol 
prostate cancer, it is necessary to look at the association with prostate cancer over longer period of 
time (Issacs 1994). The average length of the follow-up in the present study combined with the young 
age of the study population may, therefore, have limited the study’s ability to detect a true association 
between alcohol intake and risk of prostate cancer. 
 
Furthermore, since the aetiology of prostate cancer is poorly understood, adjusting for confounding 
factors in studies on of alcohol consumption and prostate cancer is problematic. Age was the only 
established risk factor controlled for in the present study. Previous studies have shown that although 
family history of prostate cancer is related to disease in the study population, it is not a confounder of 
an alcohol-prostate cancer association (Albersten and Gronbaek 2002, Schoonen et al 2005). 
Screening history has also been suggested as a possible confounder of the alcohol and prostate cancer 
association (Weiss 2003, Schoonen et al 2005). Although, there is currently no national screening 
programme for prostate cancer in Scotland, much of the increase in incidence of prostate cancer in 
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Scotland (described in Chapter 4) can be attributed to the use of prostate specific antigen (PSA)
41
 
testing. Since information on PSA testing status was not available for the present study’s population, 
it was not possible to investigate the effect screening history on the alcohol and prostate cancer 
association.  
The lack of association between measures of alcohol exposure and prostate cancer risk reported in the 
present study is supported by the literature review described in Chapter 2.16 and consistent with the 
findings of a comprehensive review of studies conducted between 1971 and 1996 (Breslow and Weed 
1998) and a meta-analysis (Dennis and Hayes 2001), which found no association between alcohol 
consumption and an increased risk of prostate cancer although an association with heavy alcohol 
consumption still cannot be ruled out. 
 
6.3.6 Advantages of present study 
The advantages of the present study include the fact that it was based on a large sample size randomly 
sampled from the Scottish general population and, results may, therefore, be readily transferable to 
that population. Loss to follow-up, as a result of incomplete linkage records due to emigration, was 
approximately 5%. The impact of this, on the results in the present study, was not included in the 
modelling strategies used in the analysis. Previous studies, however, examining the relationship 
between alcohol and health outcomes from the SHeS and SMR linked dataset, have reported no 
significant differences between models including and excluding incomplete records due to emigration 
(Lawder et al 2007, MacDonald et al 2009). This suggests that whether emigrants are included or 
excluded from the modelling will have minimal impact on the results. The elimination of subjects 
with a history of cancer at baseline, meant that previous cancers were not allowed to influence the 
association between alcohol and cancer. Bias resulting from undetected presence of sub-clinical 
disease at baseline is also unlikely, because an analysis excluding all cases with less than one year of 
follow-up did not change the results significantly; hazard ratios were not significantly different from 
those reported for complete follow-up. There was close to complete ascertainment of cases (cases 
having been ascertained through the Scottish Cancer Registry). The three most common cancers 
observed among the cohort in men (lung 28%, prostate 19.9%, colorectal 17.8%) and in women 
(breast 42.5%, lung 19.1%, colorectal 14.1%) are the also the three most common cancers in Scottish 
men (prostate 19.1%, lung 18.7%, colorectal 14.8%) and women (breast 28.2%, lung 15.5%, 
colorectal 14.1%) (ISD 2010a), and which suggests that the study includes a representative sample of 
the whole population. 
                                                          
41
 The PSA test is a blood test that measures the level of PSA (prostate specific antigen) in blood. PSA is made 
by the prostate gland, and some of it will leak into the bloodstream depending on the age and the health of the 
prostate. A raised PSA level may indicate presence of  prostate cancer. 
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A further advantage of the present study, is that because the information on alcohol consumption was 
collected at baseline, the possibility of bias due to differential recall is virtually non-existent. The 
present study has a modest length of follow-up period (mean 9.1yrs) which is shorter than follow-up 
in most other prospective cohort studies reporting on association between alcohol consumption and 
risk of alcohol related cancers. Therefore the information on alcohol intake given by participants at 
baseline is more likely to apply to their behaviour during follow-up than studies with longer follow-
up. Studies of the stability of drinking over time have found aspects of both stability and change. Kerr 
et al (2002) observed high correlations between measurements for adult sample 5 years apart or less 
(from baseline measurement of drinking), but low for longer follow-up. Baseline measures of drinking 
groups were especially unreliable for younger samples and heavier drinkers (mean weekly 
consumption among men and women in the sample was 12 and 6 units respectively, almost half the 
recommended sensible weekly drinking guidelines in the UK). 
The present study also reported on the association between cancer and drinking frequency. The effect 
of drinking frequency on the risk of alcohol related cancers has generally not been addressed partly 
because questions on drinking patterns have not been commonly included in epidemiological surveys 
(Arria and Gossop 1998). Only seven of the papers chosen for inclusion in the systematic review 
(chapter 2) reported drinking frequency in relation to risk of cancer. The present study was able to 
derive frequency groups that approximated to daily, weekly (not daily), monthly drinkers and non-
drinkers (comprising of former and never drinkers), based on the quantity/ frequency measure used in 
the Scottish Health Survey. Overall, results for drinking frequency were broadly similar to those 
reported for weekly alcohol intake. These results, however, need to be treated with some caution. 
Simply using broad frequency categories, as in the present study, will hide the significant variation in 
amount consumed within these groups; some ‘daily drinkers’ may drink as much or as little as weekly 
‘not daily’ drinkers. Aetiologically, the most interesting and valid comparison in relation to cancer 
risk would have involved taking into account both frequency and quantity, but estimation of risk using 
this approach was not possible due to the small number of cases in each group. Previous studies have 
highlighted that it is more often the amount of alcohol consumed as opposed to the number of days on 
which it was consumed that was important in determining risk (Tjonneland et al 2003, Horn-Ross et al 
2004). 
 
6.3.7 Limitations of present study 
The present study also had limitations. The relatively low incidence of many of the cancers under 
investigation, the long latency periods for many of the cancers, the size of the study’s cohort and the 
modest length of follow-up (mean 9.1yrs), may reduce the power of the study particularly its power to 
examine associations in sub-groups. 
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Random or non-differential misclassification of alcohol consumption is likely for several reasons. 
Firstly it is estimated that self reported alcohol use in the Scottish health survey accounts for only 50-
60% of alcohol sales, suggesting that under-reporting of actual consumption is a significant issue in 
this cohort. The changing strength of alcohol of many drinks in recent years,
42
 in particular wine and 
beer, and change in serving sizes in licensed premises (especially glasses of wine) contributes to 
survey under-estimation of levels of alcohol consumption (Catto and Gibb 2008). Secondly, it is also 
widely recognised that individuals who are very heavy drinkers are unlikely to participate in surveys 
(Goddard 2007). Thirdly, quantity/frequency measures used to elicit details of alcohol consumption in 
general population surveys (including the Scottish Health Survey) are also widely criticised for 
providing lower estimates of drinking when compared to other measures based on recent drinking 
occasions and the graduated frequency approach
43
 which seem to yield comparable results to one 
another, as well as consistently higher estimates of the prevalence of high risk drinking and harm 
(Midanik 1988, Room 1991, Midanik and Room 1992, Rehm et al 1999). Furthermore, in 
quantity/frequency measures of alcohol consumption, there also seems to be a tendency for survey 
respondents to interpret usual or customary drinking as modal value i.e. capturing the typical amount 
of alcohol consumed in a given period of time, although researchers actually interpret these as means 
(Duffy and Alanko 1992, Kühlhorn and Leifman 1993). Therefore the modal quantity would generally 
underestimate the ‘true’ mean quantity because the individual’s quantity distribution (i.e. the 
distribution of quantities over separate drinking occasions) is usually highly right-skewed. This type 
of misclassification could have resulted in an underestimation of the true effects of alcohol 
consumption on cancer risk if heavier drinkers underreported to a greater extent than light or moderate 
drinkers. 
Alcohol intake in the present study population was limited to a rather narrow range i.e. within weekly 
limits with small numbers drinking at high levels of alcohol consumption and based on baseline 
consumption only. The lack of a sufficient number of heavy drinkers in the sample limited the power 
of the study’s analyses to detect an association between alcohol consumption and the cancers under 
investigation in the present study. Furthermore abstainers and ex-drinkers were not separated in the 
study, but were included in the reference category. Ex-drinkers many differ in cancer risk from 
abstainers; therefore the estimated risk for each of the cancers may be biased in either direction. 
A further limitation is possible false positive results resulting from multiple comparisons. The more 
statistical tests one conducts, the greater the likelihood that a “statistically significant” result will 
emerge purely by chance (Scheffe 1953, Miller 1983). If we test two independent true null 
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 To take into account changing strengths and serving sizes of alcohol drinks, new alcohol unit conversion 
factors for use in population surveys were published by ONS in 2007. These were used to recalculate drinking 
levels from the 2003 Scottish Health Survey and published in 2009 (see Appendix F). 
43
 the graduated frequency measure is a series of questions on the frequency of consuming specific numbers of 
drinks which ranges from the most ever consumed in the last year to 1–2 drinks per occasion 
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hypotheses, when statistical significance is set at the P < 0.05 level, the probability that neither test 
will be significant is 0.95x0.95=0.90. If we test 20 such hypotheses the probability that none will be 
significant is 0.9520=0.36. This gives a probability of 1–0.36=0.64 of getting at least one significant 
result - we are more likely to get one than not. The expected number of spurious significant results is 
20x0.05=1 (Bland and Altman 1995). Numerous methods (e.g. the Bonferroni correction, the Holm’s 
test) have been proposed for dealing with this problem, but no one solution will be acceptable for all 
situations (Schaffer 1995). 
Comparison of the results of this cohort study with the international literature is problematic due to 
differences in the measurement of alcohol intake. A standard unit of alcohol is defined in Scotland as 
containing 8g (10ml) of pure alcohol. In contrast, the international literature uses a typical alcohol 
content of between 10g and 15g of ethanol for a ‘standard drink’; In a review of 27 studies, the 
standard drink used on average, in the epidemiological literature, provided 12 grams of alcohol 
(Turner 1990). This in turn complicates the transferability of many of the results of the observational 
studies included in the present review, to Scotland.  
 
6.4 Summary 
The study was the first of its type to investigate an association between alcohol consumption and risk 
of cancer in a sample of the Scottish population. In summary, the present study provides some 
evidence of a statistically significant relationship between alcohol drinking frequency, and weekly 
intake and cancers of the upper aero digestive tract. A small increased risk (though non-significant) of 
colorectal cancer for daily drinkers was observed, but no relationship was detected for amount 
consumed for this cancer. There was no statistically significant association observed between drinking 
frequency or amount consumed and risk of breast, lung and prostate cancer. Further studies with a 
larger sample and a longer-follow-up are required to further explore associations between alcohol and 
related cancers particularly the effect of heavy drinking and variation by gender, ideally with repeated 





Chapter 7 Cancer risk in a Scottish alcohol related hospital cohort 
 
In this chapter, the risk of cancer in a population admitted to hospitals in Scotland with an alcohol 
related diagnosis is investigated using linked data from national hospital/ cancer/death records dataset, 
described in Chapter 5. 
 
7.1 Methods 
The design was a cohort study based on a record linkage between the Scottish Morbidity Record and 
the Scottish Cancer Registry, and analysis of first-occurring alcohol related cancer among a cohort of 
patients admitted to hospital with an alcohol related condition during 1981–2007 (see chapter 5 for 
description of Scottish Morbidity Record and the Scottish Cancer Registry, and the record linkage 
process). 
 
7.1.1 Study Exposure/Study Population and Outcome 
All records from the SMR01 episode database with an alcohol related hospital diagnosis, in any 
diagnostic position in the hospital discharge record, among patients aged 15 or over, and hospitalised 
between 1 January 1981 and 31 December 2007 were considered. An alcohol related hospital 
diagnosis was defined using the WHO International Classification of Diseases (ICD)-9 codes 291, 
303 and 305a (WHO 1979) and ICD-10 codes F10.0 to F10.9 (WH0 1992) (Table 7.1)
44
. This list of 
codes is similar to that used in record linkage studies of alcohol related cancers in people with 
previous history of alcohol related hospital discharge (Adami et al 1992, Boffetta et al 2001, Ye et al 
2003). In these studies, cohorts were based on WHO ICD versions seven to nine and labelled as 
alcoholism or ‘alcoholic’ cohorts reflecting ICD terminology of the time. For previous record linkage 
cohort studies, their emphasis was on those drinkers identified by the ICD ‘alcoholic’ categorisation 
which included only people with chronic alcohol related conditions. Subsequent revisions to the ICD 
(9th and 10th) have provided more detailed guidance on coding of alcohol problems and include not 
only those dependent on alcohol, but also those admitted for drunkenness or acute intoxication (see 
Table 7.1). Since a hospital admission for drunkenness does not necessarily imply alcohol dependence 
or ‘alcoholism’, the study cohort defined using the above codes will be referred to as an alcohol 
related hospital admission cohort.  
 
                                                          
44
 The International Statistical Classification of Diseases and Related Health Problems (ICD) is a comprehensive 
classification of causes of morbidity and mortality, and is published by the World Health Organisation. The 
previous 9th revision (ICD-9) was published in 1975 and came into use in UK hospital information systems in 
1979. It was superseded in Scotland by the 10th revision (ICD-10) from April 1996 (ISD 2000).  
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Table 7.1 ICD classification and mapping
1





 ‘Psychosis’ ‘Alcoholism’ Alcohol ‘Abuse’ 
ICD-7  307 (Alcoholic psychosis) 322 (Alcoholism)  
ICD-8 291 (Alcoholic psychosis) 303 (Alcoholism)  








ICD-10 F10.3-F10.9 (Withdrawal state (incl. 
with Delirium), Psychotic disorder, 
Amnesic syndrome, Residual and 
late-onset psychotic disorder, 




F10.0 (Acute intoxication)  
F10.1 (Harmful use) 
1
 Chikritzhs et al 2002 
 
Between 1 January 1981 and 31 December 2007, 241,355 people, aged 15 years and over, admitted to 
hospitals in Scotland with an alcohol-related diagnosis, recorded in any diagnostic position, were 
identified. Patients who died (n=5,401) during their hospitalisation were identified and excluded from 
the cohort. The remaining episodes (n=236,154) were then linked to the Scottish Cancer Registry, 
with the aim of identifying cases of cancer that occurred among patients in the cohort after the first 
hospital discharge with an alcohol-related diagnosis. All cancers reviewed in chapter 2 were included 
and were defined according to ICD-9
 
(1981 to 1995) and ICD-10 (from 1996). Table 7.2 lists the 
cancers defined as ‘alcohol-related’ and their respective ICD-9 and ICD-10 codes (WHO 1976, 1992). 
Cancers of the oesophagus were further identified by histological code of the International 
Classification of Diseases for Oncology, Third Edition (ICD-O)
45
 and grouped by histological types as 
oesophageal squamous cell carcinomas or oesophageal adenocarcinoma (Botterweck et al 2000). 
 
Patients with a previous history of cancer (n= 6,995) diagnosed before the first alcohol related 
hospital admission were excluded. A further 435 patients were excluded at various steps of the 
linkage process because of inconsistencies of recording of gender, date of birth or death etc. in 
different sources of data. In addition, 8,807 patients were excluded because no information on area of 
residence of the patient was available on their hospital record to assign a deprivation score. The first 
year of observation, following the first alcohol related hospital discharge, was also excluded in order 
to reduce selection and detection bias which could occur if alcoholic patients with a yet undetected 
subclinical cancer are more likely to be hospitalised than other ‘alcoholic’ patients (Adami et al 1992, 
Boffetta et al 2001). This resulted in the exclusion of a further 18,987 patients who developed a 
cancer or died, within 1 year of the first alcohol hospital discharge. Of these, 9,186 (49.2%) died 
                                                          
45 International Classification of Diseases for Oncology (ICD-O) is used principally in tumour or cancer registries 





(including 1,137 cancer deaths) and 1,303 (7.0%) developed a cancer within a year of date of 
discharge. 
Table 7.2 Cancers linked to alcohol consumption – ICD 9, ICD-10 and ICD-O classifications 
NEOPLASM ICD-9 ICD-10 
Lip 140 C00 
Oral cavity (incl. tongue) 141, 143-145 C01-C06 
Oropharynx/tonsil 146 C09-C10 
Hypopharynx 148.0, 148.2-148.9  C13 
Oesophagus 150 C15 
     Squamous Cell Carcinoma* ICD-O M-8050-8078, 8083-8084 
     Adenocarcinoma* ICD-O M-8140-8141, 8143-8145, 8190-8231, 8260-
8263, 8310, 8401, 8480-8490, 8550-8551, 8570-
8574, 8576* 
Colon 153 C18 
Rectum (and rectosigmoid) 154.0-154.1 C19-C20 
Liver 155 C22 
Pancreas 157 C25 
Larynx 161 C32 
Lung 162, C33-C34 
Breast 174, 233.0 C50, D05 
Ovarian 183.0 236.2, C56 
Prostate 185 C61 
Bladder 188 C67 
Kidney 189.0-189.1 C64-C65 
Source: ISD (2010); * ICD-O classification 
 
7.1.2 Statistical Analysis  
Person-years at risk were calculated from the date of discharge of the index admission to hospital with 
an alcohol related diagnosis, to either occurrence of cancer, the date of death or 31 December 2007, 
whichever occurred first. Person-years at risk were calculated by summing the time each person in the 
cohort remained at risk of developing cancer during study period, taking into account each subject 
moving through age-groups until cancer, death or the end of the study. A further adjustment to these 
person years at risk was made by allocating a time effect to take into account the changes in cancer 
incidence over time. The expected number of cancers were calculated by multiplying the observed 
person-time (i.e. person years at risk) by cancer incidence rates specific for age (in 5-year groups), 
gender, and calendar year. The expected rates were derived from the entire Scottish population and 
aggregated into approximately 5-year intervals (1981-1986, 1987-1991, 1992-1996, 1997-2001 and 
2002-2007) to ensure a sufficient number of observations in each cell. The standardized incidence 
ratio (SIR), estimated as the ratio of the observed to the expected number of cancers, was used to 
estimate relative risk. 
In a second piece of analysis controlling for the effects of deprivation, this study utilises the area 
based Carstairs index of deprivation available on the ISD linked database and on the Scottish Health 
Survey (see Chapter 5.1.6 for more detailed information on the Carstairs Index). Cancer incidence 
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data by gender, age (eighteen five year age bands) and Carstairs quintiles
46
 (from quintile one (least 
deprived) through to quintile 5 (most deprived)) was obtained from the Scottish Cancer registry for 
each of the cancers under investigation. Expected rates were obtained by multiplying gender, 5-year 
age group 5 year aggregated cancer incidence and Carstairs quintiles by the observed number of 
person years within each stratum of the cohort.  
Confidence intervals for SIRs were calculated with the assumption that the observed number of events 
followed a Poisson distribution (Breslow and Day 1987). As incidence rates of the cancers studied 
were for the most part substantially different among men and women and there is still a lack of 
sufficient evidence of whether the risk of cancer from alcohol consumption varies by gender (see 
Chapter 2), all analyses were stratified by gender. Analyses were performed using Intercooled Stata 
version 11 (STATA statistical software, release 11; Stata Corporation, College Station, TX) and SPSS 
for Windows version 17 (SPSS, 2009). 
 
7.2 Results  
The alcohol related hospital cohort comprised 200,730 individuals, of whom 144,192 (71.8%) were 
men and 56,974 (27.9%) were women (Table 7.3). The mean age at index hospitalisation among the 
alcohol related hospital cohort was 43.6 years among men and 42.6 years among women. The patients 
in the cohort provided a total of 1,999,555 person-years at risk (men 1,423,645, women 569,910) for 
an average of 9.9 years of follow up (9.9 years for men and 10.1 years for women). Approximately, a 
quarter of men (29.1%) and a third of women (34.0%) had an alcohol related hospital condition 
recorded in the primary diagnostic position (see Section 5.1.1). Approximately, one in ten of men and 
women in the cohort lived in the least deprived quintile, compared to approximately a third or men 
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 The Carstairs index scores for the whole of Scotland are ranked in order and can be divided into either five 
(quintiles) or ten (deciles) equal sized groups for comparison (McLoone 2004). 
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Table 7.3 Characteristics of the alcohol related hospital cohort followed up during 1–20 years through 
2007 
 Alcohol related hospital 
discharge 
Alcohol related hospital 
discharge as primary 
diagnosis 
Characteristics Males Females Males Females 
No. of patients 144,192 56,538 42,026 19,204 
Mean age at entry (years) 43.6 42.6 42.1 41.3 
Years of follow-up, mean 9.9 10.1 11.7 11.3 
Person-years at risk 1,423,645 569,910 490,652 217,709 
Number of alcohol related cancers  10,464 3588 3460 1427 
Mean age at cancer diagnosis 
after first year of follow-up 
65.0 62.6 63.0 62.0 
     
Cohort subgroups (%)     
Alcohol abuse 67.6 67.6 34.5 42.1 
Alcohol dependence 24.3 25.6 48.3 45.1 
Alcohol psychosis 8.1 6.9 17.4 12.8 
     
% with alcohol related condition as 
primary diagnosis 
29.1 34.0 n/a n/a 
     
Socio-demographic* (%)     
% in least deprived quintile 9.3 10.7 9.6 11.0 
% in most deprived quintile 36.0 32.7 33.6 31.4 
* Based on quintiles derived from the 2001 Carstairs Index 
 
Approximately two thirds (67.6%) of the alcohol related hospital cohort were admitted to hospital 
with a diagnosis of ‘alcohol abuse’ with the remaining third admitted to hospital for alcohol 
dependence or alcohol-related psychosis (Table 7.3). Those cohort members with a diagnosis of 
alcohol abuse were younger at index hospitalisation, compared to those with a diagnosis of alcohol 
dependence or alcohol psychosis (Table 7.4). There were gender differences in the mean age of index 
hospitalisation by alcohol diagnosis grouping. Women admitted for alcohol abuse were significantly 
younger than men. In contrast, women admitted for alcohol related psychosis were significantly older 
than men. There was no difference in age of index hospitalisation for alcohol dependence between 
men and women. Some caution is required in interpreting differences across the alcohol diagnosis 
categories. The introduction of ICD-10 in 1996 (in Scotland), to replace ICD-9, resulted in a number 
of additional alcohol diagnostic groupings providing increased specificity and accuracy of coding for 
alcohol related diagnoses from 1996 onwards (see Table 7.1). Although the changes in diagnostic 
categories introduced by ICD-10 have been shown to have a minimal effect on overall numbers, 
evidence exists of movements across categories particularly between diagnoses of ‘alcohol abuse’ and 
‘alcohol dependence’ (Baker and Rooney 2003). The changes in diagnostic groupings, therefore, 
preclude any attempt to stratify cancer risk by alcohol abuse, alcohol dependence and alcohol 





Table 7.4 Characteristics of the alcohol related hospital cohort by alcohol diagnosis category 
 Alcohol abuse Alcohol dependence Alcohol psychosis 
Characteristics Men Women Men Women Men Women 
Number 97,501 38,217 35,042 14,446 11,649 3,875 














Average length of follow-up 
(years) 
9.3 9.7 11.8 11.7 8.5 8.4 
Person-years 911,090 369,112 413,736 168,386 98,819 32,413 
Mean age at diagnosis of alcohol 















7.2.1 Primary cancer incidence in the alcohol related hospital cohort 
Overall, 14,052 (7.0%) individuals with an alcohol-related hospital discharge, developed cancer 
during the study cohort period. Men accounted for 10,464 (7.3% of men in the cohort) of these 
cancers and women accounted for 3,588 cases (6.3% of women in the cohort).  
Lung (32.8%), prostate (11.4%) and oral (8.1%) cancers accounted for over half of cancers diagnosed 
in men in the cohort (Table 7.5). Compared to the distribution of alcohol-related cancers among men 
in the Scottish general population aged 35-64 years in 1999 (the median year of an alcohol-related 
hospital discharge in the cohort), there were disproportionately more cases of oral cancer (8.1% vs. 
4.9%), hypopharyngeal cancer (1.1% vs. 0.4%), liver cancer (4.2% vs. 1.7%) and lung cancer (32.8% 
vs. 26.3%) observed among men in the alcohol related hospital cohort (Table 7.5). Conversely, there 
were disproportionately fewer cases of kidney cancer (2.2% vs. 6.1%), colon cancer (7.4% vs. 10.4%) 
and rectal cancer (5.1% vs. 9.1%) among men in the cohort compared to the distribution among men 
aged 35-64 years in the general population.  
Among women in the alcohol-related hospital cohort, lung (30.9%) and breast cancer (25.3%) 
accounted for over half of all cancers diagnosed. Other commonly diagnosed cancers in women 
included colon cancer (6.8%) and oral cancer (6.1%). There were considerably fewer cases of breast 
cancer observed in the alcohol-related hospital cohort, compared to the distribution in women aged 
35-64 years in the general population (25.3% vs. 57.3%), whilst there were approximately twice as 
many lung cancer cases in women in the cohort, compared to the distribution in women in the general 
population (30.9% vs. 13.0%). Head and neck, oesophageal and liver cancers were also 
disproportionately more common in women in the cohort, compared to the distribution in the general 







Table 7.5 Primary cancer incidence in the alcohol related hospital cohort 
 Men Women 
Cancer Observed 
cases 
% of all 
cancers 
in cohort 







% of all 
cancers 
in cohort 





Lip 25 0.2 0.6 3 0.1 0.1 
Oral 849 8.1 4.9 220 6.1 1.4 
Pharynx 219 2.1 1.5 80 2.2 0.4 
Hypopharynx 110 1.1 0.4 27 0.8 0.1 
Larynx 602 5.8 5.1 102 2.8 0.8 
Oesophagus 669 6.4 6.1 178 5.0 1.9 
Gastric 465 4.4 5.7 83 2.3 2.1 
Colon 775 7.4 10.4 244 6.8 7.3 
Rectal 538 5.1 9.1 114 3.2 3.4 
Liver 438 4.2 1.7 70 2.0 0.6 
Pancreas 327 3.1 3.2 117 3.3 1.9 
Breast - - - 907 25.3 57.3 
Prostate 1196 11.4 14.2 - - - 
Lung 3430 32.8 26.3 1108 30.9 13.0 
Ovary - - - 165 4.6 6.8 
Bladder 589 5.6 4.6 115 3.2 1.3 
Kidney 232 2.2 6.1 55 1.5 1.6 
Total 10,464 100 100 (n=2,689) 3,588 100 100 (n=3,599) 
*Based on median year of alcohol related hospital discharge in cohort. 
1 
Scottish Cancer Registry, ISD (2010) 
 
 
Of the two main types of oesophageal cancer, oesophageal squamous cell carcinoma and oesophageal 
adenocarcinoma, there were disproportionately fewer cases of oesophageal adenocarcinoma identified 
in men and women from the alcohol-related hospital cohort, compared to the expected distribution in 
the general population (Table 7.6). Over one in ten of oesophageal cancer cases could not be assigned 
to either histological sub-type. 
 
Table 7.6 Oesophageal cancer incidence in the alcohol related hospital cohort by histological -type 
  Men Women 
Cancer Observed 
cases 
























358 55.4 33.5 122 68.5 77.8 
Adenocarcinoma 202 31.3 63.2 50 28.1 19.0 
Unknown 86 13.3 3.2 29 16.3 3.2 
 
 
Overall, women in the alcohol related hospital cohort were younger than men at entry into cohort 
(mean age difference 2.77 years, 95% CI 2.34-3.20, p<0.001) and at age of diagnosis (mean age 




Among men and women, however, the mean age at index hospitalisation by cancer site varied 
considerably; in men, the mean age ranged from 50.9 years for cancer of the pharynx to 61.7 years for 
prostate cancer and in women from 52.7 years for ovarian cancer to 61.5 years for cancer of the colon 
(Table 7.7). Overall, men developing cancers of the head and neck (oral, pharyngeal, laryngeal and 
hypopharyngeal cancer) tended to be younger at discharge with an alcohol-related diagnosis than 
other alcohol related cancers. Women in the alcohol-related hospital cohort diagnosed with head and 
neck cancers and cancers of the breast and ovary were also younger at hospital discharge than other 
alcohol-related cancers (Table 7.7). 
Table 7.7 Study characteristics by gender and cancer type 






Mean age (SD) 
at diagnosis of 






Mean age (SD) 
at diagnosis of 
primary cancer  
Lip 155.4 54.6 (15.1) 60.3 (14.9) 14.2 70.6 (19.0) 75.0 (18.7) 
Oral 7,045.0 51.6 (11.4) 59.7 (9.9) 1,950.7 51.1 (11.0) 59.6 (10.0) 
Pharynx 1,876.7 50.9 (10.4) 59.3 (9.3) 713.5 52.9 (12.1) 61.6 (10.2) 
Larynx 5,261.5 53.1 (11.2) 61.5 (9.6) 9,25.4 54.0 (12.1) 62.8 (10.8) 
Hypopharynx  867.0 52.4 (10.5) 59.7 (9.1) 218.9 53.7 (13.8) 61.6 (11.2) 
Oesophagus 5,256.4 56.9 (12.1) 64.6 (10.2) 1,589.8 56.5 (12.7) 65.2 (10.5) 
Gastric  3,512.9 58.9 (12.6) 66.4 (11.3) 642.3 58.3 (14.1) 65.9 (12.8) 
Pancreas  2,690.2 57.4 (12.6) 65.4 (11.0) 1,061.7 56.1 (12.9) 65.1 (11.0) 
Liver  3,444.3 57.4 (11.7) 65.1 (10.4) 544.0 56.9 (11.7) 64.6 (10.6) 
Colon  6,432.8 59.3 (12.5) 67. 3 (11.1) 2,034.1 58.8(14.9) 66.8 (13.0) 
Rectal  4,384.4 58.5 (12.0) 66.5 (10.6) 924.8 58.3 (14.6) 66.2 (13.3) 
Lung 27,119.8 58.4 (11.3) 66.1 (9.7) 9,817.8 56.9 (11.7) 65.5 (10.0) 
Breast  - - - 7,603.5 51.3 (13.3) 59.5 (12.4) 
Ovary  - - - 1,425.3 50.4 (14.1) 58.8 (13.0) 
Prostate  9,982.2 61.7 (11.5) 69.8 (8.9) - - - 
Bladder 4,520.3 60.6 (12.2) 67.9 910.4) 952.7 58.1 (12.9) 66.2 (11.6) 
Kidney 1,971.3 54.2 (11.8) 62.8 (10.3) 485.3 54.3 (11.5) 62.8 (10.5) 
TOTAL 84,520.2 57.3(12.8) 65.0 (11.3) 29,978.6 54.5 (14.0) 62.6 (12.9) 
SD- standard deviation 
 
For men and women, the mean age of primary diagnosis of cancer was 65.0 (SD 11.3) years and 62.3 
(SD 12.9) years old respectively (Table 7.7). The mean age of primary cancer diagnosis in the hospital 
varied by cancer type; men and women in the cohort diagnosed with head and neck cancers (i.e. 
cancers of the oral cavity, pharynx, larynx) and cancers of the breast and ovary (women only) were 
diagnosed at younger age (range 59-60 years old) compared to those diagnosed (range 65-68 years 
old) with gastrointestinal cancers (e.g. gastric, colon rectal, pancreas, liver) or urological cancers (e.g. 
bladder and kidney). The large standard differences in mean age, however, suggests some caution 




7.2.2 SIRs for cancers identified in the alcohol related hospital cohort  
The age and age and deprivation standardised incidence ratios for cancer of the oral cavity, pharynx 
hypopharynx and larynx were significantly elevated for both men (Table 7.8) and women (Table 7.9) 
in the alcohol related hospital cohort, compared to the general Scottish population. For men, the 
incidence rates of cancer of oesophagus and liver were elevated with an age and deprivation 
standardised incidence ratio of 1.80 (95% CI 1.67-1.94) and 3.24 (95% CI 2.94-3.55), respectively. 
Among women, the incidence of cancer of oesophagus and liver were also significantly elevated with 
age and deprivation standardised incidence ratios of 3.30 (95% CI 2.84-3.83) for oesophagus and 3.99 
(95% CI 3.11-5.05) for liver.  
Although the age standardised incidence ratio (ASIR) for gastric cancer in men was significantly 
elevated (Table 7.8), further standardisation by deprivation quintile did not show an association 
between gastric cancer and alcohol related hospital discharge (SIR 1.04, 95% CI 0.95-1.14). For 
women, the incidence of gastric cancer was non-significantly elevated (age and deprivation 
standardised incidence ratio of 1.19, 95% CI 0.95-1.48) (Table 7.9). In this cohort, the incidence of 
colon cancer was not significantly increased in men with an alcohol related hospital discharge 
compared to the Scottish general population. The ASIR for rectal cancer in men was significantly 
elevated, but this association disappeared after further standardisation by deprivation (SIR 1.04, 95% 
CI 0.95-1.13). In women, ASIRs for colon and rectal cancer were not significantly elevated, but after 
further standardisation by deprivation, the risk of colon and rectal cancer was significantly increased, 
by 24% and 36% respectively, in women with an alcohol related hospital discharge, compared to the 
general population. For both men and women in the alcohol related hospital cohort, cancers of the 
pancreas and lung were significantly more frequent, compared to expected numbers in the general 
Scottish population. 
The age, and age and deprivation standardised incidence ratios for bladder cancer were significantly 
elevated for both men (Table 7.8) and women (Table 7.9). The incidence rate of cancer of the kidney 
in women was not significantly higher than expected whilst, among men with an alcohol related 
discharge, kidney cancer was significantly less frequent, compared to that expected in the general 
population (SIR 0.85, 95% CI 0.74-0.96). The incidence rate of prostate cancer was significantly 
lower in men in the cohort with an alcohol related discharge, than in the general population. For 







Table 7.8 Standardised incidence ratio (SIR) with 95% confidence interval (CI) of developing alcohol 
related cancers among male patients with an alcohol related hospital discharge during 1-20 years of 
follow-up  
Cancer Type Obs.  Exp.  SIR
1
 95% CI SIR
2
 95% CI 
Head and neck       
Oral 849 173.7 4.89 4.57-5.23* 4.37 4.08-4.67*  
Pharynx 219 37.5 5.83 5.09-6.66* 4.10 3.58-4.68*  
Hypopharynx 110 13.3 8.29 6.81-9.99* 7.28 5.98-8.78*  
Larynx 602 185.4 3.25 2.99-3.52* 2.94 2.71-3.18*  
Digestive organs        
Oesophagus 669 344.6 1.94 1.80-2.09* 1.80 1.67-1.94*  
Gastric 465 402.5 1.16 1.05-1.27* 1.04 0.95-1.14
 p=0.021
  
Liver 438 120.9 3.62 3.29-3.98* 3.24 2.94-3.55*  
Pancreas 327 214.1 1.53 1.37-1.70* 1.40 1.25-1.56*  





Rectal 538 484.3 1.11 1.02-1.21** 1.04 0.95-1.13
 p=0.217
 
Respiratory system        
Lung 3430 1976.4 1.74 1.68-1.79* 1.54 1.49-1.60*  
Male genital organs       
Prostate 1196 1458.0 0.82 0.77-0.87* 0.80 0.75-0.84*  
Urinary system       
Kidney 232 260.8 0.89 0.78-1.01
 p=0.076
 0.85 0.74-0.96**  




age and deprivation standardised. *P<0.05, ** P<0.001. Abbreviations: Obs= observed 
cases, Exp= expected cases 
 
Table 7.9 SIR with 95% confidence interval (CI) of developing alcohol related cancers among female 
patients with an alcohol related hospital discharge during 1-20 years of follow-up 
Cancer Type Obs. Exp SIR
1
 95% CI SIR
2
 95% CI 
Head and neck       
Oral 220 29.8 7.38 6.43- 8.42* 7.89 6.88-9.01* 
Pharynx 80 5.6 14.17 11.23-17.64* 13.75 10.90-17.12* 
Hypopharynx 27 2.4 11.33 7.46-16.51*  12.15 8.00-17.70*  
Larynx 102 15.4 6.64 5.41- 8.06*  6.63 5.40-8.05*  
Digestive organs        
Oesophagus 178 59.5 2.99 2.57-3.46* 3.30 2.84-3.83*  
Gastric 83 72.5 1.14 0.91-1.42
p=0.242
  1.19 0.95-1.48
p=0.024
 
Liver 70 19.4 3.61 2.81-4.56* 3.99 3.11-5.05* 
Pancreas 117 64.7 1.81 1.50-2.17* 2.00 1.65-2.40* 
Colon 244 228.2 1.07 0.94-1.21
p=0.311
  1.24 1.09-1.41**  
Rectal 114 98.1 1.16 0.96-1.40
p=0.125
 1.36 1.12-1.63**  
Breast 907 944.3 0.96 0.90-1.03
p=0.231
  0.98 0.91-1.04
p=0.256
  
Respiratory system        
Lung 1108 426.4 2.60 2.45-2.76*  2.82 2.66-2.99  
Female genital organs       
Ovarian 165 116.7 1.41 1.21-1.65*  1.24 1.06-1.44**  
Urinary system       
Kidney 55 53.4 1.03 0.78-1.34
p=0.860
  1.14 0.86-1.49
p=0.262
  




age and deprivation standardised. *P<0.05, ** P<0.001. Abbreviations: Obs= observed 




expected (SIR 0.98, 95% CI 0.91-1.04). There was, however, an elevated incidence of ovarian cancer 
with a SIR of 1.24 (95% CI 1.06-1.44 
Table 7.10 provides ASIRs
47
 for oesophageal cancer among men and women with an alcohol related 
hospital discharge, by the main histological types. The incidence of squamous cell carcinomas (SCC) 
of the oesophagus was three times higher in men, and four times higher in women with an alcohol 
related hospital discharge, compared to the general population in Scotland. Incidence ratios of 
oesophageal adenocarcinoma for men and women were smaller than those observed for SCC; 
compared to Scottish general population, men with an alcohol related hospital discharge had a small 
and non-significant increased risk (ASIR 1.14, 95 % CI 0.99-1.31) of oesophageal adenocarcinoma, 
whereas women with an alcohol related hospital discharge were not increased risk (ASIR 0.98, 95% 
CI 0.73-1.30). 
Table 7.10 Age standardised incidence ratios, with 95% confidence intervals (CI) of oesophageal 
cancer among patients with an alcohol related diagnosis, by histological type 
 Men Women 
 Obs SIR 95% CI Obs SIR 95% CI 
Squamous cell 
carcinoma 
358 3.17 2.85-3.52 
p<0.001
 122 4.08 3.39-4.87
 p<0.001
 
Adenocarcinoma 202 1.14 0.99-1.31
 p=0.064
 50 0.98 0.73-1.30
 p=0.974
 
Missing 86   29   
 
7.2.3 Variation in cancer risk by gender and Carstairs deprivation 
quintile 
Age standardised incidence ratios (with 95% confidence intervals), for each cancer type, by gender 
and Carstairs (2001) deprivation quintiles are presented in Figures 7.1 to 7.16 (See Appendix I, for 
full data tables). 
Overall, there was a statistically significant increased risk for head and neck cancers (i.e. cancer of the 
oral cavity pharynx, hypopharynx and larynx) across the majority of Carstairs quintiles (Figure 7.1 to 
7.4) in both men and women with an alcohol related hospital discharge, compared to the Scottish 
general population. The highest ASIR for each of the afore-mentioned cancers was consistently 
observed in men and women with an alcohol related hospital discharge living in the most deprived 
quintile in Scotland. The risk ratio for oral and pharyngeal cancer in men increased with increasing 
levels of deprivation (Figures 7.1 and 7.2). 
 
  
                                                          
47
 Deprivation information was not available for histological types of oesophageal cancer 
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Figure 7.1 Age standardised incidence ratios, with 95% confidence intervals, for oral cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
































Figure 7.2 Age standardised incidence ratios, with 95% confidence intervals, for pharyngeal cancer, 
by gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 


































































Figure 7.3 Age standardised incidence ratios, with 95% confidence intervals, for hypopharyngeal 
cancer, by gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
 































































































Figure 7.4 Age standardised incidence ratios, with 95% confidence intervals, for laryngeal cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
 
































Overall, cancers of oesophagus (Figure 7.5) and liver (Figure 7.6) were significantly more frequent in 
men and women with an alcohol related hospital discharge, in each deprivation quintile, compared to 
the Scottish general population. The highest ASIR for oesophageal and liver cancers were observed 
for both men (ASIR 2.74, 95% CI 2.41-3.11, and ASIR 4.40, 95% CI 3.74-5.14, respectively) and 
women (ASIR 5.15, 95% CI 3.96-6.58 and ASIR 5.18, 95% CI 3.24-7.85, respectively) with an 
alcohol related hospital discharge and living in the most deprived quintile in Scotland. The risk ratio 
for oesophageal cancer in men, and for liver cancer in women, increased with increasing levels of 
deprivation (Figure 7.5 and 7.6). 
 
Figure 7.5 Age standardised incidence ratios, with 95% confidence intervals, for oesophageal cancer, 
by gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
 






























































































Figure 7.6 Age standardised incidence ratios, with confidence intervals, for liver cancer, by gender 
and Carstairs (2001) deprivation quintiles (y axis in log scale) 































For both men and women in the alcohol related hospital cohort, living in Carstairs quintiles four and 
five, cases of pancreatic cancer were significantly more frequent, compared to expected numbers in 
the general Scottish population living in similarly deprived areas (Figure 7.7). The observed gastric 
cancer rates for men and women in the least deprived quintile were lower than expected, compared to 
the general population, but the differences were not statistically different (Figure 7.8). The incidence 
ratio for gastric cancer was only significantly elevated for men and women with an alcohol related 
hospital discharge, living in the most deprived quintiles of Scotland. 
 
Figure 7.7 Age standardised incidence ratios, with 95% confidence intervals, for pancreatic cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 

































































































Figure 7.8 Age standardised incidence ratios, with 95% confidence intervals, for gastric cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
































Men from the alcohol related hospital cohort had a statistically significant elevated risk of colon 
(ASIR 1.54, 95% CI 1.37-1.74) and rectal (ASIR 1.65, 95% CI 1.42-1.91) cancer, only if they were 
living in the most deprived Carstairs quintile (Figures 7.9 and 7.10 respectively). Conversely, men 
living in the least deprived quintile with an alcohol related hospital admission, were less likely to be at 
risk of developing colon (ASIR 0.56, 95% CI 0.45-0.69) or rectal (ASIR 0.55, 95% CI 0.41-0.72) 
cancer, compared to men in the general population from the same Carstairs quintile. A similar 
reduced, but non-significant, risk of colon cancer, but not rectal cancer, was also observed in women 
with an alcohol related discharge living in the least deprived quintile compared to women from the 
same quintile in the general population (Figures 7.9 and 7.10 respectively). For colon and rectal 
cancers in women, the risk ratio increased with increasing levels of deprivation, compared to that 
expected among women in the general population. 
 
Figure 7.9 Age standardised incidence ratios, with 95% confidence intervals, for colon cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
 
































































































Figure 7.10 Age standardised incidence ratios, with 95% confidence intervals, for rectal cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 































The relative risk of lung cancer among men and women with an alcohol related diagnosis was the 
highest for those living in the most deprived quintile (ASIR 2.37, 95% CI 2.25-2.49 and 3.81, 95% CI 
3.46-4.20, respectively) and the relative risk increased with increasing levels of deprivation (Figure 
7.11). There was no evidence of a significant association with risk of lung cancer (ASIR 1.08, 95% CI 
0.95-1.23) for men from the alcohol hospital cohort living in the least deprived Carstairs quintile, 
compared to the Scottish general population.  
 
Figure 7.11 Age standardised incidence ratios, with 95% confidence intervals, for lung cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
 






























The standardised incidence ratio of alcohol related urological cancers increased with increasing levels 
of deprivation (Figures 7.12 and 7.13), however, compared to the Scottish general population only 
men and women living in the most deprived quintiles had a significantly elevated risk of cancer of the 
bladder (ASIR 2.02, 95% CI 1.77 2.30 and 3.66, 95% CI 2.69-4.85, respectively) and cancer of the 
kidney (ASIR 1.54, 95% CI 1.23-1.91 and 2.23, 95% CI 1.39-3.37, respectively). For women with an 
alcohol related hospital discharge living in the least deprived quintile, the incidence ratio for kidney 
cancer was lower and for bladder cancer, higher, than that among women in the general population, 































































but neither of these associations were statistically significant (p value= 0.555 and 0.125, respectively). 
In men, there was a statistically significantly reduced risk of developing kidney (SIR 0.44, 95% CI 
0.23-0.75) cancer and bladder (SIR 0.72, 95% CI 0.54-0.94) cancer compared to men in the least 
deprived quintile in the general population.  
 
Figure 7.12 Age standardised incidence ratios, with 95% confidence intervals, for kidney cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
































Figure 7.13 Age standardised incidence ratios, with 95% confidence intervals, for bladder cancer, by 
gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 
 































The incidence ratios for prostate cancer in men, with an alcohol related hospital discharge living in 
Carstairs quintiles one to four were significantly lower than those expected in the general population 
(Figure 7.14). Only among men living in the most deprived quintile was there a statistically 



































































Figure 7.14 Age standardised incidence ratios with 95% confidence intervals for prostate cancer, in 
men by Carstairs (2001) deprivation quintiles (y axis in log scale) 































The relative risk of breast cancer in women with an alcohol related hospital discharge increased with 
increasing levels of deprivation (Figure 7.15), however, compared to the Scottish general population, 
only women living in the most deprived quintiles had a significantly elevated risk of breast cancer 
(SIR 1.21, 95% CI 1.06-1.38 and SIR 1.64, 95% CI 1.46-1.84, in quintiles four and five respectively). 
There were significantly fewer cases of breast cancer observed in the present study among women 
with an alcohol related hospital discharge, living in the least deprived quintiles compared to that 
expected in the general population. Relative risk of ovarian cancer was at its highest for women in 
living in quintile five (SIR 2.15, 95% CI, 1.63-2.80), compared to women living in the most deprived 
quintile in the general population, with no evidence of a significant association in the remaining 
quintiles (Figure 7.16). 
 
Figure 7.15 Age standardised incidence ratios, with 95% confidence intervals, for breast cancer 
(women), by gender and Carstairs (2001) deprivation quintiles(y axis in log scale) 




































Figure 7.16 Age standardised incidence ratios, with 95% confidence intervals, for ovarian cancer 
(women), by gender and Carstairs (2001) deprivation quintiles (y axis in log scale) 

































This study is the largest of its type to estimate cancer risk in a population admitted to hospital with an 
alcohol related diagnosis (Adami et al 1992, Boffetta et al 2001, Kuper et al 2000, 2001, Ye et al 
2002) or with a diagnosis of alcoholism (Sigvardsson et al 1996, Ye et al 2003, Thygesen et al 2009). 
After controlling for the effects of age and deprivation, the incidence rates for cancers of the 
oesophagus, pancreas, bladder and lung were significantly increased in men and women with an 
alcohol-related hospital discharge, compared to the Scottish general population. An elevated incidence 
rate was found for colon and rectal cancer in women, but not in men. There was no significantly 
increased incidence of gastric, breast and kidney cancer in the alcohol related hospital cohort, 
compared to the general population. Ovarian cancer incidence rates were significantly higher, and 
prostate cancer cases significantly lower than expected among women and men respectively in the 
general population. In the present study, deprivation would appear to modify the association between 
an alcohol related hospital discharge and cancer incidence. For many of the cancers under 
investigation, the relative risk associated with a previous alcohol admission increased with increasing 
levels of deprivation.  
A key innovation of this study is that, compared to other record linkage cohort studies (Adami 1992 et 
al, Boffetta et al 2001, Ye et al 2003, Thygesen et al 2009), it is the first to investigate the effects of 
deprivation both as a potential confounder and effect modifier of the association between a previous 
alcohol related hospital admission and subsequent cancer incidence. Although the relationship 
between alcohol consumption and area deprivation is complex with associations with amount drunk, 
either weekly or daily varying by gender and by age, there is a clear positive association between the 
number of people admitted to general hospitals in Scotland for an alcohol related diagnosis and 
increasing levels of deprivation. In 2007/08, people living in the most deprived areas of Scotland were 
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almost six times more likely to be admitted to a general hospital with an alcohol related diagnosis than 
those in the least deprived area; 7% (2,991 discharges) of all general hospital discharges in Scotland 
came from people living in the least deprived fifth of areas, compared to 42% (17,775 discharges) 
from those living in the most deprived fifth of areas (ISD Scotland 2009a). There is also a clear 
association between area deprivation and the incidence of most cancers. In England, between 2000 
and 2004, there were 21% more diagnoses of cancer in men who live in the most deprived areas than 
in the least deprived (National Cancer Intelligence Unit 2010). The most deprived areas in Scotland 
have higher incidence and mortality rates for all cancers combined, but the effect of deprivation varies 
by cancer site. The incidence of head and neck cancers, for example, in Scotland and across Europe 
are strongly associated with increasing levels of deprivation (Conway et al 2007, Conway et al 2010), 
though previous studies have only found such an association for men and not for women (Conway et 
al 2010). On the other hand, women in the least deprived socioeconomic groups have higher breast 
cancer incidence rates (Brown et al 2007, Shack et al 2008, ISD Scotland 2009b). As a consequence, 
it is likely that deprivation could confound the association between alcohol related hospital 
admissions and cancer incidence and thus influence the interpretation of studies where its effect was 
not considered. 
In the present study, there was a marked increase in relative risk of many of the cancers with 
increasing levels of deprivation among male and female patients in the alcohol related hospital cohort, 
compared to that expected in the Scottish general population. Consistently, men and women living in 
the most deprived quintile of Scotland had the highest incidence rates of each of the cancers under 
investigation compared to the Scottish general population living in the most deprived quintile. The 
link between an alcohol admission and relative risk of cancer with increasing levels of deprivation 
suggests that alcohol is contributing in some way to continuing inequalities in the incidence of many 
of the cancers under investigation in the present study in men and women with and alcohol related 
diagnosis compared to the Scottish general population. Another innovation of the study was to report 
the excess risk of the cancers under investigation by gender and to evaluate the excess risk of 
oesophageal cancer in patients with an alcohol related discharge, by histological subtype. 
This study design also offers a number of strengths, including avoiding the risk of recall bias and 
virtually complete follow-up (>99%). Further, the high quality of Scottish national registers and the 
consistent use of the unique identifier numbers assigned to each person ensure correct linkage, thereby 
precluding selective loss to follow-up. Selection and information bias is therefore unlikely, especially 
since the first year of follow-up was excluded.  
Despite these advantages, the study suffers from certain limitations. One potential concern is the 
possibility of biased ascertainment or detection of the cancer outcome. A lower diagnostic coverage 
among patients with an alcohol related diagnosis, than in the population at large, would entail 
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underestimation of the true relative risk (Ye et al 2003). However, the Scottish health-care system, 
with no patient fees and relatively equal access to hospital care for everyone, helps minimise this 
effect, although it is likely that people with alcohol related problems are less likely to participate in 
cancer screening programmes than those with no such problems.  It is possible that this effect could 
be more marked in more than less deprived populations. A further limitation of the present study is 
the young age of the cohort, with a mean age at admission in men and women of 43.6 and 42.6 years 
respectively, which reduces the study’s power to detect associations between alcohol related hospital 
admissions and cancer, particularly less common cancers.  
Another concern is the lack of information about amount and type of alcohol intake, duration of 
alcohol abuse before index hospitalisation, and treatment, since it precludes a meaningful assessment 
of dose–response relationship. Using the diagnostic groupings (alcohol abuse, alcohol dependence and 
alcohol psychosis), which comprised the alcohol related hospital cohort as a proxy for increasing 
severity was considered, but rejected due to the broad and overlapping definitions within ICD for each 
of these groupings. This would introduce considerable measurement bias further accentuated by the 
change in ICD classifications in the 1990s which resulted in broader definitions and a shift in the 
trend within each of the groupings when the revised classification was introduced (Anderson and 
Robenberg 2003, Janssen and Kunst 2004, Quan et al 2008).  
The most serious concern is the absence of information about lifestyle co-factors possibly related both 
to alcohol consumption and to the cancer outcome. In this study, as in other record linkage cohort 
studies, there was no information on exposure to potential confounders, of which tobacco smoking is 
likely to be the most important. Smoking is etiologically related to many cancers (IARC 2004), and 
there are numerous studies showing a positive association between cigarette smoking and alcohol 
drinking (Bien and Burge 1990, Dawson 2000), across a spectrum of drinking levels from light to 
heavy consumption (Cummins et al 1981, Adami et al 1992, King and Epstein 2005). The lack of 
information on smoking may partly result in the excess cancer risk if the alcohol related hospital 
cohort in this study contained a disproportionate number of smokers compared to the general 
population. Although no direct measure of smoking was available in the present study, the high 
incidence of lung cancer observed in both men and women in the alcohol related hospital cohort 
would suggest a higher prevalence of smoking compared to the Scottish general population. Given 
that cigarette smoking is a strong risk factor for bladder, pancreatic and lung cancer, it is possible that 
the excess risks observed for these cancers in the present study are entirely attributable to the 
confounding effects of smoking. Confounding from smoking may also explain some of the excess risk 
observed in the present study for liver cancer. Hepatitis B and hepatitis C virus infections and obesity 
have also been reported to be independent risk factors for liver cancer in a hospital population, 
interacting synergistically to increase the risk of liver cancer (Donato et al 2002, Marerro et al 2005).  
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Although the risk estimates for the head and neck cancers and cancers of the oesophagus identified in 
this study are also likely to be confounded by smoking, it is unlikely to account for all the excess risk 
of these cancers observed in the alcohol related hospital cohort compared to the Scottish general 
population. A carcinogenic effect of alcohol independently from that of smoking (i.e., an increased 
risk in non-smokers), has been observed as far back as 1961 (Boffetta and Hashibe 2006). Numerous 
studies since have shown a fairly consistent dose response relationship between alcohol consumption 
and risk of cancer in the oral cavity, pharynx and the larynx for non-smokers (Talamini et al 1990, Ng 
et al 1993, Fioretti et al 1999, Bosetti et al 2002) and oesophageal cancer in non-smokers (La Vecchia 
and Negri 1989, Castellsague et al 1999, Zambon et al 2000). 
Alcohol consumption, especially heavy drinking, is also associated with additional risk behaviours 
and hazardous exposures. Since alcohol may account for a substantial proportion of total caloric 
intake, moderate to heavy drinkers are likely to have a different dietary composition and perhaps 
altered energy expenditure compared with abstainers and light drinkers (Boffetta et al 2001). 
Although confounding by diet may differ among cancer sites where diet is a recognised risk factor 
(e.g. colorectal, gastric), the most likely situation is one in which there is low intake of fruits, 
vegetables, fibre, and vitamins, which might increase rather than decrease cancer risk in most 
instances (Herbert and Kabat 1991). A positive association between alcohol intake and consumption 
of foods high in fat might also increase cancer risk among alcoholics (Adami et al 1992). The 
association between heavy alcohol drinking, smoking and diet has been shows to differ by socio-
economic status (La Vecchia
 
1992, Pomerleau et al 1997, Ruidavets et al 2004, Mackenbach et al 
2008). Helicobacter pylori infection also increases the risk of gastric cancer though it has been 
reported that moderate consumption of alcohol may lower the risk of Helicobacter pylori infection 
(Murray et al 2002). It is, therefore, feasible that risk estimates would be lowered if levels of H pylori 
infection were higher in the alcohol related hospital cohort than the general population and it were 
possible to adjust for this. 
The use of comorbidity measures, to control for potential confounders of the alcohol-cancer 
association in the present study, was considered (Schneeweiss and McClure 2003). Comorbidity is the 
presence of a disease unrelated to the disease under study (Paleri and Wright 2002). This is 
particularly relevant in cancer where comorbidity has been found to have a significant impact on both 
survival and treatment selection in several types of cancer (Feinstein et al 1977, Wells et al 1984, 
Feinstein and Wells 1990, Piccirillo et al 1994, Singh et al 1998). A variety of comorbidity scoring 
indexes have been developed with individual characteristics and validity. The most commonly used 





, the Index of Co-Existent Disease, the Alcohol and Tobacco Scale 
Washington University Head and Neck Comorbidity Index and the Charlson Morbidity Index 
(Charlson et al 1987, Hall 2006, Castro et al 2007).  
The Charlson Morbidity Index, unlike other indices which are disease severity indices and cannot be 
implemented with routine data (Stockton 2004), has previously been adapted for use with 
administrative data as the information for the index (originally designed for a chart setting) can be 
extracted from clinically coded (e.g. ICD-9) databases (De Groot et al 2003). The Charlson index 
comprises of a list of 19 diseases (certain of them representing two degrees of severity of the same 
condition) with different weights attached (from 1: least severe to 6: most severe) (Table 7.11). 
Because the Charlson index is weighted and allows for additive scoring, it can take into account both 
the number and the severity of comorbidity to provide a summary of disease burden for each 
individual patient (Khan et al 2010). The index has been validated in several different populations, 
and has been widely used in studies involving cancer patients and survivors (Singh et al 1997, Reid et 
al 2002, Castro et al 2007, Cronin-Fenton et al 2007). 
Table 7.11 Charlson comorbidity index 
Comorbidity Notes Points 
Myocardial infarction alcohol related 1 
Congestive heart failure alcohol related (I42.6 alcoholic 
cardiomypathy) (10+ codes in this category) 
1 
Peripheral vascular disease  1 
Cerebrovascular disease (except hemiplegia) alcohol related 1 
Dementia  1 
Chronic pulmonary disease  1 
Connective tissue (rheumatic) disease  1 
Ulcer disease  1 
Mild liver disease alcohol related 1 
Diabetes (without complications) alcohol related 1 
Diabetes with end organ damage 2 
Hemiplegia  2 
Moderate or severe renal disease  2 
2
nd
 solid tumour (non-metastatic) cancer related 2 
Leukaemia cancer related 2 
Lymphoma, multiple myeloma, etc cancer related 2 
Moderate or severe liver disease alcohol related 3 
2
nd
 Metastatic tumour cancer related 6 
AIDS  6 
 
The Charlson Index was, however, developed from the study of outcomes for general medical 
patients, not patients with alcohol related conditions and/or cancer. While various comorbid ailments 
are common to all populations, the frequency distribution and the relative prognostic impact of each 
condition to the primary disease process may vary (Piccirillo et al 2002 Schneeweiss and McClure 
2003). Furthermore, within a cohort of patients with cancer, the relative impact of individual 
comorbidities may vary across different cancer types. For example, head and neck cancer is primarily 
                                                          
48
 Derived from the original Kaplan- Feinstein index (KFI) which was developed for assessing comorbidity in 
diabetes mellitus (Kaplan and Feinstein 1974), and subsequently modified and validated by Piccirillo (2000) to 
include terms relevant to cancer 
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a disease of the elderly, and the pattern of comorbidities in such a patient population may be quite 
different than that of patients with ovarian cancer which occurs at younger ages (Piccirillo et al 2002). 
This issue is amplified in the present study which involves the study of fifteen cancers, and in this 
context, it is unlikely that the Charlson Index would provide an adequate measure of co-morbidity in 
the present study, across all cancers under investigation. A further limitation of the Charlson Index, in 
respect of the present study, is that six and four of the disease items in the index, relate to alcohol 
and/or cancer respectively (Table 7.11) and, for the study of alcohol and cancer patients, these would 
be generally excluded from the score (Stockton et 2004). This leaves nine eligible disease items in the 
index, out of the original nineteen diseases. Excluding alcohol and related cancer conditions reduces 
the scoring power of the index, and neutralises the weights applied in the index by emphasising the 
less serious comorbidities. An alternative approach to the use of a validated tool like the Charlson 
index would be to derive co-morbidity measures from ICD-9 and ICD-10 codes specific to each 
cancer under investigation in the present study, but this would be complex to apply (Paleri and Wright 
2002) and lay beyond the scope of the present study.  For these afore-mentioned reasons, it was, 
therefore, considered inappropriate to use comorbidity measures in the present study to control for 
confounders of the alcohol-cancer association. 
The findings of the present study are broadly consistent with previous studies of patients with an 
alcohol related hospital discharge or who were ‘alcoholics’. This study found excess risks for all head 
and neck cancers under investigation (oral, pharyngeal, hypopharyngeal and laryngeal cancer) among 
the alcohol related hospital cohort compared to the Scottish general population. This is consistent with 
findings of previous record linkage studies (Adami et al 1992, Sigvardsson et al 1996, Boffetta et al 
2001, Thygesen et al 2009; Figure 7.17) and with the results from high quality meta-analyses (Corrao 
et al 1999, 2004) and systematic reviews (IARC 1988, WCRF/AICR 2007) establishing alcohol as 
major risk for oral, pharyngeal and laryngeal cancer.  
Figure 7.17 Comparison of standardised incidence ratios from previous record linkage studies, by 





























This study was also able to examine the association between patients with an alcohol related 
diagnoses and cancer of the hypopharynx compared to the Scottish general population. 
Hypopharyngeal cancer is a rare disease representing about 0.5% of all human malignancies with an 
annual incidence of less than 1 per 100 000 population and constituting only 3-5% of all head and 
neck cancers (Krstevska et al 2010). However, rising trends in hypopharyngeal cancer incidence rates 
in Scotland have been attributed to alcohol consumption (MacFarlane et al 1993). In this study, the 
SIRs for hypopharyngeal cancer observed in men and women were among the highest of the head and 
neck cancers in the alcohol related hospital cohort. The SIRs reported for head and neck cancers in the 
present study were two to three times higher than SIRs reported for other alcohol related cancers. 
These results offer further evidence consistent with the hypothesis of a carcinogenic effect of alcohol 
involving direct contact with oral and pharyngeal mucosa, which is also supported by epidemiological 
studies of moderate alcohol consumption (Tuyns et al 1988, Boffetta et al 1992, Franceschi et al 1994, 
Kjaerheim et al 1998).  
 
The statistically significant excess SIRS for cancer of the oesophagus observed among both men and 
women in the alcohol related hospital cohort compared to the general population are consistent with 
those reported in other studies of ‘alcoholics’ (Adami et al 1992, Sigvardsson et al 1996, Boffetta et al 
2001, Thygesen et al 2009; see Figure 7.18). Further analysis by histological sub-type revealed 
significantly raised risk for oesophageal squamous cell carcinoma, but no association with 
oesophageal adenocarcinoma. Boffetta et al (2001) reported similar findings in a cohort of Swedish 
patients admitted for ‘alcoholism’ compared to the general population in Sweden. There is a well-
established dose response relationship between cancer of the oesophageal SCC and alcohol 
consumption (Chapter 2.12, WCRF/AICR 2007). Although associations between alcohol 
consumption and oesophageal adenocarcinoma have been inconsistent in past studies, the present 
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study adds further strength to the evidence that alcohol is not associated with an increased risk of 
oesophageal adenocarcinoma (Chapter 2.12, WCRN/AICR 2007, Freedman et al 2011). 
Figure 7.18 Comparison of standardised incidence ratios from previous record linkage studies, by 
gender and cancer type; oesophageal cancer 
 
 
In the present study, a three to four fold statistically significant increased risk of liver cancer was 
observed in both men and women with an alcohol related hospital discharge, compared to the Scottish 
general population. This is consistent with the results of the majority of previous studies (Adami et al 
1992, Sigvardsson et al 1996, Thygesen et al 2009). Kuper et al (2001), however, reported excess 
risks of liver cancer approximately three times lower than those reported in the present study (Figure 
7.19). In this study, ‘alcoholic patients”, with a diagnosis of chronic viral hepatitis or cirrhosis, were 
excluded from the main cohort and their data were analysed separately. Patients with alcoholism in 
the absence of chronic hepatitis and without evidence of cirrhosis had an excess risk of liver cancer 
compared to the general population, but the increase was moderate (SIR 2.4, 95% CI 2.0-2.8) and 
could be explained by the presence of preclinical cirrhosis. Alcohol induced cirrhosis (SIR 40.7, 95% 
CI 33.9-48.9) and chronic hepatitis (SIR 34.4, 95% CI 18.3-58.9) on the other hand were strongly 
associated with liver cancer (Kuper et al 2001). Adami et al (1992) also observed a marked decrease 
in the SIR for liver cancer (from 6.0 to 3.1) when patients in their cohort with liver cirrhosis were 
excluded from the analysis. These results suggest that cirrhosis might be an important, or perhaps 
necessary, intermediary step in a causal pathway from alcohol to liver cancer. As the Scottish 
Morbidity Record (described in Chapter 5.1.1) does not record complete information on liver disease, 
it was not possible to examine the relationship between an alcohol related hospital admission, 
cirrhosis and subsequent liver cancer. Nevertheless, since Scotland has one of the highest mortality 
and morbidity rates for chronic liver disease including cirrhosis in Europe (Leon and Cambridge 
2001, Scottish Public Health Observatory 2010b), it is highly likely that there will a high prevalence 




Figure 7.19 Comparison of standardised incidence ratios from previous record linkage studies, by 
gender and cancer type; liver cancer 
 
The present study found a small, statistically significant, increase in gastric cancer risk in men and a 
non-significant elevated risk in women, after controlling for the effects of age among peoples with an 
alcohol-related hospital discharge compared to the general population. This is consistent with the 
results of similar studies (Adami et al 1992, Thygesen et al 2009, see Figure 7.20). Further controlling 
for the effects of deprivation in the present study resulted in similar incidence ratios of gastric cancer 
in the alcohol related hospital cohort compared to the Scottish general population. This is consistent 
with the findings of the systematic review here and of those published in the literature (IARC 1988, 
Bagnardi et al 2001, WCRF/ACIR 2007) that alcohol has no causal role in the aetiology of stomach 
cancer. 
Figure 7.20 Comparison of standardised incidence ratios from previous record linkage studies, by 














In the present study, the SIRs for colon and rectal cancer were not significantly elevated in men and 
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women with an alcohol related discharge, compared to the general Scottish population. These findings 
are broadly consistent with previous record linkage studies which have shown no difference in 
incidence rates for colon and rectal cancer in their study population, compared to those expected in 
the general population (Adami et al 1992, Sigvardsson et al 1996, Ye et al 2003, Thygesen et al 2009; 
see Figure 7.21). Controlling further for the effects of deprivation did not alter that association in the 
present study between colon and rectal cancer in men, but in women, however, a small and borderline 
statistically significant excess risk for both colon and rectal cancer, compared to the Scottish general 
population, was observed. In women with an alcohol related hospital discharge, however, SIRs were 
only significantly elevated in the most deprived Carstairs quintile. Although alcohol consumption has 
been considered a risk factor for colorectal cancer, the findings of the systematic review (Chapter 2.7) 
would suggest that this increased risk is only apparent for those drinking more than 30 grams per day 
(approximately 4 UK standard ‘units’), but not at lower levels. A recent systematic review and meta-
analysis also concluded that consumption of more than 30-40 grams of alcohol per day is a cause of 
colorectal cancer in men is convincing and probably also in women’ (Cho et al 2004, WCRF/AIRC 
2007). The lack of information on alcohol exposure levels in the present cohort precludes an 
investigation of a risk at certain alcohol intake levels. 
Figure 7.21 Comparison of standardised incidence ratios from previous record linkage studies, by 
















The findings of an excess risk of lung and pancreatic cancer in men and women with an alcohol 
related discharge, compared to that expected in the general population is consistent with the findings 
reported in other studies of lung (Figure 7.22) and pancreatic (Figure 7.23) cancer risk in patients with 
an alcohol related hospital discharge. The small increase in risk of lung and pancreatic cancer in the 
present study among cohort members with an alcohol related diagnosis, which still remains after 
controlling for the effects of deprivation, is most likely to be attributable to smoking. A study of 

















but no excess was found when compared with a population with similar smoking habits (Schmidt and 
Popham 1981). Bagnardi et al (2001) analysed the modifying effect of tobacco on the alcohol and 
lung cancer risk by comparing pooled estimates on unadjusted and adjusted RRs in their meta-
analysis of alcohol and cancer risk. They observed that low (25 grams per day (g/d); unadjusted RR 
1.58 (95% CI 1.12-2.24), adjusted RR 1.01 [95% CI 0.99-1.04)) moderate (50 g/d; unadjusted RR 
2.50 (95% CI 1.25-5.01), adjusted RR 1.03 (95% CI 0.99-1.08)) and high (100 g/d; unadjusted RR 
6.30 (95% CI 1.57-25.18), adjusted RR 1.07 (95% CI 0.98-1.17)) levels of alcohol consumption did 
not show significant effects on the risk of lung cancer when adjusted for smoking.  
Figure 7.22 Comparison of standardised incidence ratios from previous record linkage studies, by 
gender and cancer type; lung cancer 
 
Heavy alcohol consumption is also known to be a major cause of chronic pancreatitis which is linked 
to pancreatic cancer (Go et al 2005, Lowenfels and Maisonneuve 2006). Ye et al (2002) reported SIRs 
for pancreatic cancer considerably lower among alcoholic chronic pancreatitis patients (2.2, 95% CI 
0.9-4.5) than that among non-alcoholic chronic pancreatitis patients (SIR 8.7, 95% CI 6.8-10.9), 
compared to the general population. As information on chronic pancreatitis diagnosis was not 




Figure 7.23 Comparison of standardised incidence ratios from previous record linkage studies, by 
gender and cancer type; pancreatic cancer 
 
The finding of a significantly elevated risk for bladder cancer in men and women in the alcohol 
related hospital cohort compared to the Scottish general population is not in agreement with previous 
Swedish studies, similar in design to the present study (Adami et al 1992, Sigvardsson et al 1996, 
Thygesen et al 2009). These studies have observed comparable incidence rates of bladder cancer in 
their cohorts, compared to those in the Swedish general population (See Figure 7.24). Smoking, a 
major risk factor for bladder cancer, is, however, considerably more prevalent among men and women 
in Scotland than in Sweden (Taulbut et al 2008) and the difference in study results is likely to be 
attributable to a greater proportion of smokers in the present cohort, compared to those found in 
Swedish cohorts. Confounding from smoking will in turn account for the modest excess risk observed 
for bladder cancer in men and women in the alcohol related hospital cohort, compared to the Scottish 
general population. To date, the evidence of an association between levels of alcohol intake and risk 
of bladder cancer remains inconclusive as a result of too few studies, small sample sizes and the 
impact of residual confounding from smoking.  
Figure 7.24 Comparison of standardised incidence ratios from previous record linkage studies, by 





Previous studies have reported statistically significant increased risks of kidney cancer in cohorts of 
‘alcoholics” compared to the general population (Adami et al 1992, Sigvardsson et al 1996, Thygesen 
et al 2009). In the present study, however, women with an alcohol related discharge were not at 
increased risk of kidney cancer and the incidence ratio of kidney cancer in men was significantly 
lower in the alcohol hospital cohort, than would be expected in the Scottish general population (see 
Figure 7.25). These differences in study findings may be partly explained by the greater precision in 
the present study’s estimates as a result of having approximately four to five times as many observed 
kidney cancer cases than previous studies. Two major systematic reviews have also concluded that 
there is insufficient evidence to attribute a causal role of alcohol in the development of kidney cancer 
(IARC 1988, WCRF/AICR 2007). This is also consistent with findings from a meta-analysis, albeit 
based on only two studies (Bagnardi et al 2001). It does not entirely rule out an effect of alcohol on 
kidney cancer risk since much of the evidence is based on a small number of studies, diverse 
population groups, small sample sizes and heterogeneous measures of alcohol consumption. Recent 
studies of reasonable methodological quality would seem to suggest that alcohol consumption may 
even offer some protection against the development of kidney cancer (Lee et al 2007), though the 
mechanism by which alcohol consumption might affect kidney cancer risk is unclear and it is unlikely 
that alcohol has a substantial effect on the risk of kidney cancer (WCRF/AIRC 2007). 
Figure 7.25 Comparison of standardised incidence ratios from previous record linkage studies, by 
gender and cancer type; kidney cancer 
 
 
In the present study, cases of prostate cancer were significantly less frequent, after adjustment for age 
and deprivation, in the men with an alcohol related hospital discharge, compared to the expected 
numbers in the general Scottish population (see Figure 7.26). Previous studies of ‘alcoholics’ have 
reported mixed results from no association with prostate cancer in a cohort of patients admitted to 
hospital with alcoholism (Adami et al 1992) to a modest, but statistically significant excess risk of 
prostate cancer in men attending an alcohol treatment service (Thygesen et al 2009), compared to the 
general population. Neither of the afore-mentioned studies adjusted their estimates for the effects of 
deprivation and this is likely to explain the differences in results. 
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Figure 7.26 Comparison of standardised incidence ratios from previous record linkage studies, by 








The finding of a slightly higher incidence ratio of ovarian cancer in women with an alcohol related 
hospital discharge, compared to the Scottish general population, is consistent with that reported by 
other studies of ‘alcoholics’ (Sigvardsson et al 1996, Thygesen et al 2009). Confounding by 
differences in smoking, parity, dietary pattern, use of oral contraceptives and hormone replacement 
therapy, reproductive history, prevalence of obesity, or diabetes mellitus, all of them associated with 
ovarian cancer risk are likely explanations of this excess. There is no available individual level 
information about these factors in this study.  
Figure 7.27 Comparison of standardised incidence ratios from previous record linkage studies, by 
gender and cancer type; prostate cancer 
 
 
In the present study, the age standardised incidence rates for breast cancer in women with an alcohol 
related hospital discharge were similar to those expected among women in the general Scottish 
population. Further controlling for the effects of deprivation strengthened the lack of association with 
breast cancer, but did not significantly alter the estimate. Modest excess risks of breast cancer of 
between 15% and 40% (without controlling for the effects of deprivation) have been reported in 
previous studies of women with an alcohol related hospital episode (Adami et al 1992, Kuper et al 
2000) or in studies of ‘alcoholic’ women (Sigvardsson et al 1996, Thygesen et al 2009) though 
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incidence ratios were only statistically significantly higher, compared to those expected in the general 
population, in the study by Sigvardsson et al 1996). SIRS for the afore-mentioned studies are 
presented in Figure 7.27. 
As with other hospital based record linkage cohort studies, the absence of information on confounders 
in the present study limits the interpretation of the findings of no excess risk of breast cancer. It is 
possible that women with an alcohol related diagnosis in the present study, compared to the 
background population, have an earlier age at first full-term pregnancy, more pregnancies, and - as a 
consequence of their higher smoking prevalence - an earlier menopause, as well as being generally of 
lower socioeconomic status, which may lower risk of breast cancer. Concerns about confounding by 
body mass index (BMI) cannot be ruled out since there is conflicting evidence for an association 
between alcohol intake and relative weight (Møller al 1994, Sayon-Orea et al 2011). Furthermore, a 
confounding effect of BMI in this present study may be likely given the high prevalence of obesity 
(i.e. BMI≥ 30km/g
2
) among women aged 16yrs and over in Scotland (Corbett et al 2010) though it 
would only act as a confounder if the prevalence of obesity was differentially associated in the 
exposed and unexposed groups. Another factor to consider in interpreting the present study’s findings 
is the young age at which women entered the cohort. Women were considerably younger at entry into 
the present study’s cohort (mean 42.6 years) compared to the age-ranges (50-74 years, mean, range 
from 57-63 years, see Table 2.6.1) covered by the majority of epidemiological studies on alcohol 
intake levels and risk of breast cancer. Evidence from the literature review discussed in Chapter 2.4 
would suggest that the effects of alcohol consumption are more consistent and somewhat greater in 
post-menopausal women, than in pre-menopausal women. 
In conclusion, the present study provides evidence that people who require in-hospital care for an 
alcohol related condition are at substantial subsequent relative risk of head and neck and upper 
gastrointestinal cancers and that the relative risk increases with increasing levels of deprivation. There 
were no significant differences in relative risk of these cancers between men and women. More 
modest increases in relative risk were observed for cancers of the liver, bladder and lung than for the 
previously named cancers. Deprivation may modify the effects of alcohol on risk of many of the 
cancers investigated, but does not explain fully the increased risk in head and neck and upper 
gastrointestinal cancers. Tobacco smoking is likely to contribute to some, but not all of the excess risk 
that appears to be associated with alcohol. There was no excess risk of breast cancer in women 
admitted to hospital with an alcohol diagnosis compared to the general population. Relative risks are 
greatest for cancers originating from mucous membranes that are in direct contact with alcohol. The 
inability to disentangle the effects of smoking and other major risk factors from those of alcohol 




Chapter 8 Conclusions 
 
8.1 Introduction 
In the first chapter of this thesis, historical and policy perspectives on alcohol, health and the alcohol-
cancer association were discussed, and the aims and objectives were presented. In chapter two, a 
systematic review, including a detailed search protocol following guidelines developed by the 
Cochrane Collaboration, assessed the strength of evidence from epidemiological studies, published 
between 1999 and 2009, on the association between alcohol consumption and fourteen cancers. A 
detailed assessment of the strengths and limitations of the systematic review was provided in section 
2.17.2. The epidemiology of alcohol consumption in Scotland was presented in chapter three and the 
strengths and weaknesses of individual and population level measures of alcohol consumption were 
discussed. Chapter 4 describes the recent trends in Scotland in the age-adjusted incidence rates for the 
alcohol-related cancers included in the systematic review. In the following three chapters the results 
from two separate Scottish prospective record linkage cohort studies are presented. Chapter 5 
provides the background and a description of the data sources used in the analyses. The results of the 
first study, which comprised a sample of the general population in Scotland, are presented in chapter 
6, and the results of the second study, comprising people admitted to hospitals in Scotland with an 
alcohol-related condition are presented in chapter 7, with a detailed discussion of the strengths and 
limitations of each study provided at the end of each chapter (sections 6.3.6-6.3.7 and 7.3.2-7.3.3 
respectively). 
The main conclusions that are drawn from this thesis as well as suggestions for future research and the 
implications for policy are presented in the following sections. 
 
8.2 Conclusions 
In the present study, a systematic review of the epidemiological literature supports the well-
established association between alcohol consumption and an increased risk of cancers of the oral 
cavity, pharynx, larynx, and oesophagus. Strong evidence exists that alcohol consumption increases 
the risk of oesophageal squamous cell carcinoma, but not oesophageal adenocarcinoma. For these 
cancer sites, there is a dose-response relationship with alcohol consumption that persists after 
adjustment for potential confounders such as age, tobacco smoking and diet. These results appear to 
hold for both men and women, though many studies suffered from limited numbers of women 
drinkers, compared to men, especially those drinking heavily, to totally rule out an effect of gender. 
The effect of alcohol on head and neck cancers would appear to be stronger where alcohol comes in 
direct contact with the tissues (e.g. oral vs. laryngeal cancer). There is sufficient evidence that 
drinking ≥30g/d is associated with an increased risk of colorectal cancer. For liver cancer, there is 
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evidence of a threshold effect, whereby drinking ≥40 g/d increases the risk of liver cancer, compared 
to non-drinkers. Positive associations between alcohol consumption and an increased risk of breast 
cancer were in general only associated with alcohol consumption of approximately >15 g/d (i.e. 
approximately >1 ‘standard drink’ or >2 UK ‘units’ per day). The risk estimates for breast and 
colorectal cancer were, however modest (the majority of relative risks in cohort studies being less 
than 1.5). Bias and confounding from unknown risk factors or residual confounding from existing risk 
factors could not be ruled out as an explanation for the small associations observed for breast and 
colorectal cancer. The weight of evidence would also suggest that low to moderate alcohol 
consumption is unlikely to be a risk factor for prostate and gastric cancer, though an increased risk 
from heavy alcohol consumption cannot be ruled out. Evidence of an effect on other cancers under 
investigation was inconclusive because of the small number and size of studies, and inconsistent 
findings. 
The review suggests an effect by drink type in some cancers (e.g. oral, bladder, lung) though in the 
majority of studies positive associations between beverage type and cancer outcome generally 
reflected that fact that the beverage type identified as being associated with cancer was the most 
commonly consumed beverage in the population under study. Very few studies explored the impact of 
drinking frequency and/or drinking pattern, mostly because to do so would require a very large 
sample size (which few studies had) and some understanding of the complexity of people’s individual 
drinking behaviour. This has only recently received attention among alcohol epidemiology and is 
lacking in medical epidemiology. Even within categories of low, moderate and heavy drinkers, there 
are patterns and frequency of drinking that may have different effects on the health outcome 
(Wetterling et al 1999, Poikolainen et al 2007). 
The literature review in the present study also concluded that there were major weaknesses in the 
measurement of alcohol consumption in epidemiological studies. This precluded the use of meta-
analysis in the present study because there was considerable heterogeneity of alcohol measures e.g. in 
use of reference periods, the definition of drinkers, non-drinkers, ethanol content and definition of 
standard drinks and questions used to elicit details of alcohol consumption. It is, therefore, the 
contention of this thesis that these shortcomings in measures of alcohol consumption represent a 
significant methodological limitation and restrict any collective assessment of the totality of evidence 
for the alcohol-cancer association, especially where there are weak or small associations. The 
implication of this is discussed below in relation to the current evidence and recommendations, from 
recent international reviews, on the association between alcohol and breast and colorectal cancer. 
Investigation of these associations within the general Scottish population and within a population of 
people attending hospital with an alcohol related condition in the primary data analysis components of 
this thesis confirmed the positive associations between alcohol and an increased risk of UADT (oral 
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cavity, pharynx, larynx and oesophagus) cancers reported in other studies. These analyses, however, 
did not find that alcohol intake was associated with statistically significantly increased risk of breast 
and colorectal cancer at low levels of alcohol consumption. An association cannot be ruled out, 
however, for these cancers, for several reasons; in the general population cohort, very few of the study 
population were drinking at alcohol consumption levels associated with an increased risk of breast 
and colorectal cancer (approximately >15 g/d and >30g/d, respectively), and no adjustment was 
possible for other lifestyle risk factors (e.g. folate and fibre intake), associated with breast and 
colorectal cancer, which may or may not have masked a true association. Findings from the present 
study’s hospital record linkage cohort study would seem to indicate that the risk of colorectal and 
breast cancer varies by level of deprivation, with the risk increasing with increasing levels of 
deprivation. It was not possible to investigate a possible modifying effect of deprivation on risk of 
cancer associated with alcohol, by cancer type, within the general population cohort sample because 
of small numbers of outcomes. This is an area requiring more attention in epidemiological studies as 
the effects of area measures of deprivation are generally not addressed, with the majority of studies 
relying on individual measures of socio-economic status e.g. by length or type of education, income 
or not considering the potential confounding effects of socio-economic status at all. 
Overall, the findings of the thesis on the association between alcohol consumption and the fourteen 
cancers under investigation, both in terms of the conclusions of the review and the findings of the two 
cohort studies are supported by the findings of international systematic reviews, and meta- and pooled 
analyses. During the course of this thesis both IARC and WCRF/AICR updated their earlier reviews 
on alcohol and cancer, using an evidence base covering approximately forty years of published 
research (Baan et al 2007, WCRF/AICR 2007). Significantly, both these reviews concluded that the 
existing evidence was sufficient to consider alcohol a cause of both breast and colorectal cancer. 
These conclusions have important implications for both government policy and prevention strategies 
in the alcohol and cancer policy areas in Scotland and firmly place alcohol consumption as a 
significant risk factor for two cancers which are among the most common cancers in Scotland and 
which are projected to increase over the next twenty years (Stockton 2004).  
 
8.2.1 Research and policy implications 
On one level the assessment of alcohol as risk factor for breast and colorectal cancer is 
understandable, as even a small increase (relative risk of <1.5 for approximately 20 grams per day or 
10-12% increase per 10 grams of alcohol) in risk of these very common cancers represents a very 
significant public health risk; in Scotland, for example, this would equate to alcohol consumption 
contributing to an additional 1000 incident cases of breast cancer and 500 incident cases of colorectal 
cancer in 2003 (Grant et al 2009). Yet on another level, the fact that the associations are small raises 
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the question of whether the observed increases in risk of breast and colorectal cancer could not be 
explained by bias and incomplete control of confounding factors (and a lack of control for unknown 
confounders) of the alcohol-cancer association. Evidence reviewed in the present study would suggest 
that these issues remain unresolved. Although many individual, and meta- and pooled studies, are 
rigorous in their attempts to control for confounders and interactions with other risk factors, the 
complexity of the ‘web’ of confounders (for example, weight, folate intake, other aspects of diet and 
nutrition, genes) of the alcohol and breast, and colorectal cancer associations makes this almost 
impossible to achieve in individual studies. This is even more difficult in combined studies because of 
differences in exposure measurement which may multiply the measurement bias inherent in individual 
studies. The presence of confounding in epidemiological studies still presents problems in interpreting 
the results of these studies. Fewell et al (2007), using simulation studies and logistic regression 
analyses to investigate the size of the apparent exposure-outcome association that can occur if the 
exposure has no causal effect on the outcome, concluded that the small effect sizes of the magnitude 
frequently reported in observational epidemiological studies of alcohol and breast, and colorectal 
cancer for example, can be generated by residual and/or unmeasured confounding alone.  
The full spectrum of drinking behaviour has also not been extensively researched in the literature and 
it is possible further investigation of the full range of drinking behaviour may advance our 
understanding of the association between alcohol consumption and breast, and colorectal cancer. For 
example studies by Dal Maso et al (2008) and Kesse (2005) suggest that the effect of alcohol drunk 
with meals only, compared to drinking only between meals can modify the association between 
cancer and alcohol consumption; Thygesen et al (2008; 2009) has shown that the latency of cancer 
may modify the effect of alcohol consumption on breast and colorectal cancer.  
Of perhaps more significance than the issue of confounding, in explaining the small associations 
reported for breast and colorectal cancer, is the potential impact of misclassification. This arises from 
the heterogeneity of alcohol consumption measures utilised in epidemiological studies; in particular, 
methods used to estimate typical beverage strength and beverage specific serving size, which not only 
makes comparisons across studies problematic, but also raise questions about the precision of risk 
estimates from meta-analyses which are derived from individual epidemiological studies. Greenfield 
and Kerr (2008) argue that the variation contributed by the ‘ethanol [alcohol]’ content of drinks 
however defined in a survey, may be of equal importance to all the other influences such as 
questionnaire type, reference periods, definition of reference groups and definitions of ‘current’ and 
lifetime drinking from the perspective of accuracy of consumption and drinking pattern measurement. 
Most surveys of alcohol consumption are phrased in terms of “drinks”, meaning standard drinks of the 
respective country or area surveyed, yet the use of the ‘standard drink’ concept is complicated by 
different standards across countries and even within countries. In turn these differences will affect the 
precision and the statistical significance of risk estimates derived from meta-analyses of international 
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studies potentially producing positive associations where there are none or vice-versa. The issue of 
alcohol content/standard drinks not only presents a methodological challenge for epidemiological 
studies, but also presents some specific challenges for researchers and policy makers in Scotland (and 
the UK).  
Against a background of rising levels of alcohol consumption up to end of the last century, alongside 
a rise in the incidence in Scotland of many cancers strongly linked to alcohol consumption, it is of no 
surprise that the findings of epidemiological studies are of great interest to researchers, policy makers 
and the media. Summary relative risks derived from individual and pooled epidemiological studies are 
now increasingly used to estimate the cancer burden attributable to alcohol consumption in Scotland 
(Grant et al 2009) and England and Wales (Jones et al 2008), with some moves towards routine 
monitoring of alcohol caused cancer burden underway in England and at a European wide level 
(Rehm and Scafato 2011). Nevertheless, as described above, these risk estimates are based on 
‘standard drinks’ consumed, often converted to grams per day/week, but with different drink-gram 
equivalencies depending on a study’s country of origin.  
What makes this challenging and confusing for UK researchers and policy makers is that in the UK 
there is no ‘standard drink’ measure since the alcohol unit, which varies by drink type and serving 
size, is the mainstay measure used in population surveys, the majority of research and for public 
health messages on safe and excessive drinking levels. In addition, the UK standard unit measure is 
seen as being equivalent to 8 grams, lower than the gram equivalencies (range 12-26 g) of standard 
drinks in epidemiological studies, yet methods used to calculate the cancer burden in the UK assume 
the ‘unit’ and the ‘standard drink’ are comparable when they are not. In international studies, 
calculating the cancer burden attributable to alcohol consumption, the categorisation of alcohol is 
based on gram intake per day so, for example, men drinking between 0.25 and 39.99 grams per day 
are considered low level drinkers. However, if this category is converted into units using the 8 gram 
equivalency, the range would be 0.1 to 4.99 units per day. This exceeds the recommended safe daily 
drinking levels for men in the UK, of no more than 3 units per day, and which in no way could be 
considered as ‘low levels of drinking’. The likely effect of this is that the current estimates of the 
cancer burden attributable to alcohol consumption in Scotland probably underestimate the true 
burden.  
The uncertainty concerning the interpretation of ‘standard drinks’ in the epidemiological literature, on 
the association between alcohol consumption and cancer, may also explain the confusion and 
ambiguity in current government advice on alcohol consumption and cancer. In the current Scottish 
Government cancer strategy, ‘Better Cancer Care, An Action Plan’, drinking more than three units a 
day is highlighted as increasing the risk of cancer of the ‘oral cavity, pharynx, larynx, oesophagus, 
breast and large bowel’ (Scottish Government 2008). The threshold of ‘three units’ (e.g. equivalent to 
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24 grams in Scotland/UK or 2 medium sized (175ml) glasses of wine) is, however, misleading, and 
for a number of the cancers mentioned, not supported by the published literature or by the findings of 
the present thesis and may overestimate the levels of alcohol consumption at which the risk of cancer 
is increased. For example, it is well established in the international literature, that drinking one or 
more ‘standard drinks’ (equivalent to approximately 12-14 grams) increases the risk of oral, 
pharyngeal and laryngeal cancer. In the present study (Chapter 6), an increased risk of cancers of the 
upper aero digestive tract was also found in the Scottish general population, for those drinking 
approximately >2 units per day (equivalent to 16 grams per day, or 1 medium sized (175ml) glasses of 
wine). Equally the suggestion that drinking more than three units (24g) increases the risk of breast 
cancer, is also not consistent with the international evidence which shows an increased risk of breast 
cancer associated with drinking >15 g/d (approximately >2 ‘UK’ units).  
It is now over a hundred years since a link between alcohol and cancer was first postulated and 
despite the library of research that has built up over that time, it is still sobering to think that alcohol’s 
role in cancer aetiology is still, for many cancers, clouded with uncertainty. That said there is still 
sufficient knowledge, and evidence, to enable a more precise message to be delivered, in Scotland, 
about the dangers of alcohol consumption in relation to the risk of certain cancers. With the incidence 
of many of the cancers associated with alcohol consumption increasing in Scotland (and which are 
expected to continue to do so, well into the next decade), combined with high levels of excessive 
drinking in the Scottish population, the link between alcohol consumption and cancer needs to be an 
integral component of public health policy making. Past and future policy developments offer some 
encouragement; McKee et al (2009) reported that one year after the implementation, in 2006, of 
smoke free policy in indoor public venues in Scotland, the heaviest drinking smokers (i.e. those most 
at risk of head and neck cancers) had reduced their alcohol consumption in pubs by about six drinks. 
Drinking behavior overall, and particularly among low to moderate drinkers, however, did not change 
significantly in Scotland compared with the rest of the United Kingdom. Although Mckee et al (2009) 
reported that overall drinking behaviour was not displaced from pubs to the home, no evidence was 
presented on possible displacement occurring for the heaviest drinking smokers. Purshouse et al 
(2010) also reported a small reduction in the prevalence of the cancer cases 10 years after the 
implementation of an alcohol minimum price per unit of £0.50 though as the authors acknowledged 
themselves an analysis of the supply-side response to pricing policies should be undertaken, because it 
is plausible that policies that have a large effect on beverage prices might lead to market restructuring, 





1. To establish a consensus on a minimum standard for the assessment and measurement of alcohol 
consumption in epidemiological studies. In particular, this should include a move towards an 
internationally agreed definition of alcohol measures what constitutes a standard drink. The recent 
launch of the European Commission’s Alcohol Measures for Public Health Research Alliance 
(AMPHORA) offers some hope that a common set of standard definitions of alcohol measurement 
can be achieved.  
2. Given that the magnitude of the association between alcohol consumption and breast  and 
colorectal cancer risk appears to be relatively modest, resolution of the nature of the dose-response 
relationship may require further pooling of data particularly from prospective studies (though only if 
consensus can be reached regarding the definition of exposure categories). This would also assist with 
clarification of whether the association between alcohol consumption and breast and colorectal cancer 
risk is modified by other factors by increasing a study’s power to adjust for measured confounders. 
Furthermore, to better understand the biological mechanisms involved, more studies on alcohol intake 
and studies on interactions between alcohol intake and other lifestyle factors, nutritional factors and 
genetic factors (e.g. alcohol dehydrogenase gene) with adjustment for potential confounding factors 
are needed. 
3. To increase the evidence base in Scotland and the UK. There is currently only a small pool of 
epidemiological evidence of the alcohol–cancer association in Scotland and across the UK despite 
both high levels of alcohol consumption and incidence of many cancers linked to alcohol 
consumption. Further studies in Scotland and the UK are therefore required, with a large sample and a 
long follow-up to further explore associations between alcohol and related cancers particularly the 
effect of heavy drinking and variation by gender, ideally with repeated measures of alcohol intake and 
complete recording of confounding factors 
4. Epidemiological studies of alcohol and cancer (and all disease) outcomes should consider the 
relationship between exposure and outcome more than simply in terms of volume of alcohol drunk. 
Analytical strategies should attempt where possible; to incorporate attempts to combine patterns 
and/or frequency of drinking with average volume consumed; and to stratify by gender where possible 
as opposed to simply adjusting results for gender differences - overall women drink far less than men 
and estimates of risk should be presented separately. 
5. Researchers and policy makers in the UK need to consider the long term validity of the alcohol unit 
as a measure of alcohol consumption. At a minimum, consideration should be given to upgrading the 
unit equivalency in the UK to 10 or 12g. A precedent has already been established to facilitate this 
when conversion factors for converting amount consumed into units were updated by ONS to take 
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into account the increased strength of alcohol drinks over the last 20 years and the different drink 
sizes now available.  
This would be a step towards providing some homogeneity of a standard measure at least in North 
American and European studies as well allowing researchers to estimate more accurately the cancer 
burden due to alcohol. 
6. Government strategies and health promotion campaigns on ‘alcohol’ and ‘cancer’ need to deliver a 
more coherent and accurate message about the threshold at which alcohol consumption may increase 
the risk of cancer. 
7. Develop specific health promotional material, for dissemination through the local framework of 
alcohol and drug partnerships (consisting of regional health boards, local authorities and alcohol and 
drug treatment services), in Scotland, which provide rapid access to holistic care from health and 
social care professionals for individuals who have alcohol problems and who are at high risk of 
developing severe health problems including many alcohol associated cancers.  
8. Policy estimates of the cancer burden attributable to alcohol consumption need to be updated to 
take into account the current evidence and should take into account the variation in risk by tumour 
type (oesophageal squamous cell carcinoma and adenocarcinoma) and the threshold effect of alcohol 
consumption on an increased risk of liver and colorectal cancer.  
 
8.4 Dissemination of study results 
The results of the present thesis will be disseminated through conference presentations, workshops 
and journal papers. This will involve the following outputs: 
1. Conference paper, ‘Risk of cancer in an alcohol-related hospital admission cohort – a Scottish 
record linkage study’ presented at the ‘Health, Culture and Scotland: new challenges, new 
opportunities, Annual Public Health Conference, 11 & 12 November 2010, Faculty of Public Health.  
2. Journal papers to be written on; 
a) The association between alcohol consumption and risk of UADT, colorectal, lung and 
prostate cancer in a representative sample of the Scottish population. 
b) Cancer incidence in a cohort of people hospitalised for alcohol related problems in Scotland. 
c) Alcohol and cancer – the effect of deprivation on the association between alcohol and cancer. 




3. Findings from present study will be discussed in ‘alcohol and cancer’ seminar in December 2011, 
organised by Scottish Health Action on Alcohol Problems, for general practitioners, consultants and 
public health policy makers and researchers.  
4. Oral and poster abstracts to be submitted to relevant conferences and seminars 
 
8.5. Developing PhD research aims 
 
Chapter 2 Literature review 
 Review and appraise the units of alcohol measurement and the ethanol content of drinks and 
corresponding gram equivalencies used in papers included in systematic review 
 Carry out meta-analysis of the association between alcohol and selected cancers where 
number and quality of papers allow 
 
Chapter 6 Self-reported alcohol consumption and subsequent cancer risk in a sample of the Scottish 
population 
 To analyse whether the association between alcohol and breast and colorectal cancer varies by 
drink type i.e. wine, beer and spirits 
 To explore whether demographic differences between the 1995 and 1998 surveys and the 
2003 survey will have an effect on the risk estimates reported  
 As a result of the numerous tests for statistical significance undertaken consideration be given 
for correction for multiple testing by using the Bonferroni method 
 
Chapter 7 Cancer risk in a Scottish alcohol related hospital cohort 
 Patients with multiple alcohol related hospital admissions – do they have an even higher risk 
of alcohol-related cancers? 
 Does the risk of an alcohol related cancer vary by type of alcohol admission i.e. alcohol 
abuse, alcohol dependence and alcohol psychoses? 
 Investigate the development of an alcohol –cancer co-morbidity index to control for potential 





Appendix A: Search strategy terms 
 
Full details of the search strategy, applied to each of the bibliographic databases, are listed below: 
 
MEDLINE 
1.  exp alcohol drinking/ or exp drinking behaviour/ or exp alcoholism/ or exp alcoholic 
beverages/ 
2.  alcohol consumption.tw. 
3.  1 or 2 
4.  exp Pharyngeal Neoplasms/ or exp Laryngeal Neoplasms/ or exp Colonic Neoplasms/ or exp 
Stomach Neoplasms/ or exp Rectal Neoplasms/ or exp Colorectal Neoplasms/ or exp 
Esophageal (and oesophageal) Neoplasms/ or exp Liver Neoplasms/ or exp Mouth 
Neoplasms/ or exp Breast Neoplasms/ or exp Pancreatic Neoplasms/ or exp Bladder 
Neoplasms/ or exp Kidney Neoplasms/ or exp Prostrate Neoplasms/ or exp Ovarian 
Neoplasms/ or exp Endometrial Neoplasms/ 
5.  (carcinoma or cancer or tumour or tumor or malignan$).tw. 
6.  (laryn$ or pharyn$ or colorec$ or colon$ or stomach or liver or mouth or oesophag$ or 
esophag$ or rectal or breast or pancreas or hepatic or oral or gastric or hepatic or ovary or 
ovarian or kidney or bladder or prostrate or endrometrial or endometrium).tw. 
7.  4 or (5 and 6) 
8.  3 and 7 
9.  limit 8 to humans 
10.  limit 9 to yr="1999-2009" 
 
EMBASE 
1.  exp Drinking Behavior/ or exp ALCOHOLISM/ or exp Alcohol Abuse/ or exp Alcohol 
Consumption/ or exp alcoholic beverages/ 
2.  alcohol consumption.tw. 
3.  1 or 2 
4.  exp PANCREAS CANCER/ or exp BREAST CANCER/ or exp MOUTH CANCER/ or exp 
LIVER CANCER/ or exp ESOPHAGUS (and oesophageal)CANCER/ or exp 
COLORECTAL CANCER/ or exp RECTUM CANCER/ or exp STOMACH CANCER/ or 
exp COLON CANCER/ or exp PHARYNX CANCER/ or exp LARYNX CANCER/ or exp 
OVARY CANCER/ or exp BLADDER CANCER/ or exp KIDNEY CANCER/ or exp 
ENDOMETRIUM CANCER/ or exp PROSTATE CANCER/ 
5.  (carcinoma or cancer or tumour or tumor or malignan$).tw. 
6.  (laryn$ or pharyn$ or colorec$ or colon$ or stomach or liver or mouth or oesophag$ or 
esophag$ or rectal or breast or pancreas or hepatic or oral or gastric or ovary or ovarian or 
bladder or kidney or edometrium or endometrial or prostate).tw. 
7.  4 or (5 and 6) 
8.  3 and 7 
9.  limit 8 to humans 
10.  limit 9 to yr="1999 - 2009" 
 
CINAHL 
1.  exp Alcohol Drinking/ or exp Drinking Behavior/ or exp ALCOHOLISM/ or exp Alcohol 
Abuse/ or exp alcoholic beverages/ 
2.  alcohol consumption.tw. 
3.  1 or 2 
4.  exp Pharyngeal Neoplasms/ or exp Laryngeal Neoplasms/ or exp Colonic Neoplasms/ or exp 
Stomach Neoplasms/ or exp Rectal Neoplasms/ or exp Colorectal Neoplasms/ or exp 
Esophageal (and oesophageal) Neoplasms/ or exp Liver Neoplasms/ or exp Mouth 
Neoplasms/ or exp Breast Neoplasms/ or exp Pancreatic Neoplasms/ or exp Bladder 
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Neoplasms/ or exp Kidney Neoplasms/ or exp Prostrate Neoplasms/ or exp Ovarian 
Neoplasms/ or exp Endometrial Neoplasms/ 
5.  (carcinoma or cancer or tumour or tumor or malignan$).tw. 
6.  (laryn$ or pharyn$ or colorec$ or colon$ or stomach or liver or mouth or oesophag$ or 
esophag$ or rectal or breast or pancreas or hepatic or oral or gastric or hepatic).tw. 
7.  4 or (5 and 6) 
8.  3 and 7 
9.  alcohol.tw. 
10.  1 or 9 
11.  10 and 7 
12.  limit 11 to yr="1999 - 2009" 
 
PsycINFO 
1.  exp alcohol abuse/ or exp alcohol drinking attitudes/ or exp alcohol drinking patterns/ or exp 
alcohol intoxication/ or exp alcoholic beverages/ 
2.  alcohol consumption.tw. 
3.  1 or 2 
4.  exp NEOPLASMS/ 
5.  (carcinoma or cancer or tumour or tumor or malignan$).tw. 
6.  (laryn$ or pharyn$ or colorec$ or colon$ or stomach or liver or mouth or oesophag$ or 
esophag$ or rectal or breast or pancreas or hepatic or oral or gastric or ovary or ovarian or 
prostate or bladder or kidney or endometrial or endometrium).tw. 
7.  4 or (5 and 6) 
8.  3 and 7 
9.  alcohol.tw. 
10.  1 or 9 
11.  10 and 7 
12.  limit 12 to yr="1999 - 2009" 
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Appendix B: Newcastle - Ottawa quality assessment scale 
 
Cohort and cross-sectional studies 
Note: A study can be awarded a maximum of one star for each numbered item within the Selection 




1) Representativeness of the exposed cohort 
a)  
b)  
c) selected group of users e.g. nurses, doctors, teachers 
d) no description of the derivation of the cohort 
 
2) Selection of the non exposed cohort 
a) drawn from the same community as the ex  
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
 




d) no description 
 






1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor) e.g. smoking, body mass 
index, vegetable and fruit consumption  




1) Assessment of outcome  
a)  
b)  
c) self report 
d) no description 
 




3) Adequacy of follow up of cohorts 
a) complete follow up -  
b) subjects lost to follow up unlikely to introduce bias - small number lost - > 80 % follow up, or 
 
c) follow up rate < 80% and no description of those lost 
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d) no statement 
 
 
Case Control Studies 
Note: A study can be awarded a maximum of one star for each numbered item within the Selection 




1) Is the case definition adequate? 
a)  
b) yes, e.g. record linkage or based on self reports 
c) no description 
 
2) Representativeness of the cases 
a)  
b) potential for selection biases or not stated 
 
3) Selection of Controls 
a)  
b) hospital or clinic controls 
c) no description 
 
4) Definition of Controls 
a)  




1) Comparability of cases and controls on the basis of the design or analysis 
a) study controls for _______________ (Select the most important factor.) ) e.g. smoking, body 
mass index, vegetable and fruit consumption  




1) Ascertainment of exposure 
a)  
b)  
c) interview not blinded to case/control status 
d) written self report or medical record only 
e) no description 
 




3) Non-Response rate 
a)  
b) non respondents described 









Please score the appropriate Newcastle-Ottawa form, referring to the manual, and enter the 
number of stars for each section in the box below:- 








Crude (and stratified) effect sizes with CIs/SEs (use a table if possible and continue in Notes if you 
need more space) 
List factors adjusted for in the design and/or analysis and state method used for adjustment e.g. 
stratification, statistical modelling. 
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Appendix D, Descriptive tables 
Descriptive tables for bladder cancer: cohort studies 
 





Study aims: to describe the 
relationship of low to moderate 
levels of alcohol intake, with 
subsequent risk of cancer, overall 
and at particular sites, in a large 
cohort of women   
 
Source of funding: 
Cancer Research UK, UK Medical 
Research Council,  
Population: 
Source: middle-aged women who attended 
breast cancer screening clinics in the United Kingdom 
completed between 1996 and 2001 
 
Exclusion criteria:none specified 
 
Study pop: 1 280 296 women, average age  of 55 yrs 
 
Observation time: 
From 1996-2001 to 31 December 2006, followed up for 
cancer incidence over 9.2 millionperson-years, for an 
average of 7.2 years per woman 
928 incident cases of bladder cancer 
Exposure:  
Questionnaire: no details provided 
Repeated during follow-up: Yes, three years after baseline interview 
Reference period: n/s 
Drink type: wine (red and white specified), beer, and spirits 
 
Measure: drinks per week; Reference group: drinking less than 2 drinks per week 
(n=258) 
Results:               ca 
Non-drinkers 271 1.06   (0.94 - 1.21) 
3-6  206 1.05   (0.92- 1.21) 
7-14  151 0.91   (0.77 - 1.07) 









Study aims: to evaluate whether 
total and beverage specific alcohol 
consumption are associated with 
an increased risk of bladder 
cancer in the Framingham Heart 
Study (FHS) 
 
Source of funding: n/s 
 
Population: 
Source: Cohort started in 1948 in Framingham, 
Massachusetts. Original cohort included 5209 participants. In 
1971, children of original cohort and their spouses formed 
the Offspring study (n=5124) 
Exclusion criteria:missing alcohol consumption data and 
prevalent cases of bladder cancer 
 
Study pop: =9821 
 
Observation time: From baselines (1948 and 1971), mean 
follow up 27.3 +/-10.1yrs. Loss to follow up: n/s; 126 incident 
cases 
Exposure:  
Questionnaire: no details provided 
Repeated during follow-up: every 4 years from both cohorts 
Reference period:usual consumption in previous month 
Drink type: beer, wine spirits and cocktails 
 
Measure:grams per day, Reference group: Non drinkers (0 g/day), n=14 
Results:      ca                     
0.1-6.0         43         0.9  (0.5-1.8) 
6.1-12          21         0.9  (0.4-1.9) 
12.1-24.0     14         0.6  (0.3-1.3) 
24.1-48.0     22         0.9  (0.5-1.9) 
>48                8         0.5  (0.2-1.2)         ptrend=0.3   
                  Beer                   Wine                   Spirits 
<1d/w    0.6   (0.3-1.2)      0.9   (0.5-1.6)    1.0  (0.5-2.0) 
1-4d/w   0.7   (0.4-1.3)      0.6   (0.3-1.2)    1.4  (0.7-2.9) 
>4d/w    0.5   (0.2-0.8)      0.8   (0.3-1.7)    1.6  (0.9-3.1)  









Study aims:  to explore the 
influence of quantity and types of 
alcohol beverages consumed on 
risk of bladder cancer’ 
 
 
Source of funding: 
Dutch Cancer Society 
 
Population: 
Source: from 204 municipal population registries throughout 
Netherlands, cohort includes 58,279 men and 62,573 women 
who were aged 55-69 yrs at baseline (1986) 
 
Exclusion criteria:prevalent bladder cancer cases 
 
Study pop: A sub cohort of 3,500 subjects was randomly 
sampled from the cohort after baseline exposure 
measurement and used in analysis 
 
Observation time: 
from baseline (1986), analysis was restricted to 6.3 years of 
follow-up 
Loss to follow up: <5% 
594 incident cases (517 men and 77 women) 
Exposure:  
Questionnaire: Self-administered questionnaire with food-frequency section 
Repeated during follow-up: baseline only 
Reference period: during the year before the study. 
Drink type: beer, wine spirits 
 
Measure:grams per day; Reference group:  non drinkers (less than once a month), n=62 
(men), 25 (women) 
Results: ca          Males                  ca         Females 
<5         108     1.49 (1.00-2.21)       29       0.97  (0.56-1.69) 
5--<15   136     1.52 (1.04-2.21)       33       0.75  (0.41-1.37) 
15->30  109     1.16  (0.78-1.71) 
≥30       102     1.63 (1.08-2.47) ptrend = 0.13 
alcohol increment for 10g/day - 1.04-0.98,1.10 (men), 0.85 0.60, 1.20 (women) 
                      Beer                        Wine                       Spirits 
<5          1.35   (0.94-1.95)      1.54   (1.06-2.23)    1.44   (0.98-2.11) 
5--<15    1.44   (0.95-2.18)     1.23   (0.80-1.90)     1.38   (0.92-2.08) 
15->30   1.70   (0.90-3.23)     1.14   (0.65-2.00)     1.25   (0.81-21.91) 
 ≥30        1.09   (0.46-2.57)     1.73   (0.74-4.05)     1.94   (1.17-3.22)  
 
Descriptive tables for bladder cancer: case control studies 
 





Study aims: ‘to investigate the 
association between lifetime 
consumption of alcoholic 
beverages and cancer risk’ 
 
Source of funding: 
n/s 
Population: 
Cases: were males living in Montreal area with histologically 
confirmed cancer at 20 different sites newly diagnosed at any 
Montreal-area hospital  
N= 425 bladder cancer cases, aged 35-70yrs 
 
Controls: randomly selected from electoral lists 
N= 507 controls, aged 35-70yrs 
 
Exclusion criteria: patients with any other cancers 
 
Observation time: 
between January 2001 and January 2006 
Response rate: n/s 
Exposure:  
Questionnaire: food frequency questionnaire, (no other details provided) 
Interviewers blinded: n/s 
Reference period: any period when alcohol drunk at least once a week or nearly every 
day 
Drink type: beer, wine and spirits 
 
Measure: drinks per week; Reference group: never weekly drinkers (Total alcohol n=78 
cases) 
Results: 
                        ca            Total alcohol       ca             Beer 
1-6 weekly     138     1.14   (0.78-1.66)     129     0.91   (0.66-1.49) 
7+ weekly      209     1.10   (0.77-1.56)     40       0.98   (0.70-1.37) 
                      ca            Wine                                   Spirits 
1-6 weekly     149     1.38   (1.02-1.86)     163     1.09   (0.82-1.46) 









Study aims: ‘To analyse the 
effect of Turkish coffee and black 
tea consumption, alcohol intake 
and smoking on bladder cancer’ 
 




Cases: were patients treated in the Second Urology Clinic of 
Ankara Diskapi Training Hospital  
N= 164 cases (median age 63),  
Controls: selected sequentially from patients without bladder 
tumours and hematuria of unknown aetiology attending the 
same hospital. 
N= 324 controls, aged 25 to 79 years (median age 60) 
 
Exclusion criteria: patients with any other cancers 
 
Observation time: 
between January 2001 and January 2006 
Response rate: n/s 
Exposure:  
Questionnaire: face-to-face interviews, (no other details provided) 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: Turkish raki 
 
Measure: drinking status (yes/no); Reference group: never drinker (n=124/176) 
Results: 
              ca/co 
yes         40/48     1.85   (1.15-2.96) 
 
 





Study aims: To investigate the 
relationship between alcohol 
consumption and bladder cancer, 
and the potential interaction 
between alcohol consumption and 
other exposures. 
 
Source of funding: 
National Cancer Institute & 






Cases: identified through the Los Angeles County Cancer 
Surveillance Program (SEER registry) and diagnosed 
between January 1, 1987 and April 30, 1996 
N= 1,586 






between January 1, 1987 and 1999 







Questionnaire: In-person, structured interviews 
Interviewers blinded: n/s 
Reference period: within the previous two years.  
Drink type: beer, wine, and hard liquor 
 
Measure:drinks/day, duration and age at first use; Reference group: 0 drinks per day 
and never drinkers for age at first use (n=432) 
Results: 
d/d         ca/co      Total alcohol                        Duration (yrs) 
<1.       364/385   0.85 (0.68-1.06)       1-20     311/303    0.83 (0.65-1.05) 
1–4      512/505   0.77 (0.62-0.96)       21-30   275/292    0.72 (0.56-0.92) 
>4        265/234   0.68 (0.52-0.90)       31-40   376/338    0.87 (0.68-1.10) 
ptrend0.003                                          41+    188/199     0.66 (0.48-0.89)   ptrend 0.017 
                     Beer                         Wine                     Spirits 
<1 d/d     0.81 (0.61-1.07)      0.84 (0.64-1.09)       1.18    (0.90-1.55) 
1–4         0.68 (0.49-0.95)      0.65   (0.44-0.95)     1.01    (0.72-1.41) 















Study aims: ‘investigating any 
potential relation between alcohol 
drinking and bladder cancer risk’ 
 
Source of funding: 




Cases: recruited from the National Cancer Institute and 
major general hospitals and university clinics in Northern Italy 
N= 727 cases (617 males, 110 females), (median age 63),  
 
Controls: as per cases 
1,067 controls (769 males, 298 females), aged 25 to 79 
years (median age 60) 
 
Exclusion criteria:admitted to hospital for chronic 




between 1985 and 1992 
Response rate: >98% for cases and controls. 
Exposure:  
Questionnaire: Structured questionnaire administered by trained interviewer 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: wine, beer, and spirits 
 
Measure: drinks/day, drinking duration’ Reference group: non-drinkers, all and drinking 
duration(n=117/152), non-drinkers, wine (n=126/172) 
Results: 
d/d         ca/co          Total alcohol                     years    Duration of alcohol drinking 
<3          207/329   0.80   (0.57-1.11)               1–24     65/157    0.68 (0.45-1.05) 
3 to <6   175/261   0.90   (0.54-1.10)              25–39   199/400   0.73 (0.51-1.02) 
≥6          217/304   0.77   (0.58-1.22)                ≥40      342/351  1.00 (0.71-1.41)  
ptrend=0.52                                                                        ptrend =0.67 
d/d             Wine 
<3             0.90   (0.66-1.25) 
3 to 5        0.78   (0.55-1.11)              
>5             0.86   (0.60-1.23) ptrend=0.37                 
 





Study aims: ‘to analyse the 
relation between occupation, 
lifestyle and risk of bladder cancer 
in Germany 
 
Source of funding: 
Bundesanstalt fur Abreitschutzn 
Population: 
Cases: drawn from four hospitals in Hessen (State of the 
Federal Republic of Germany) 
N=300 cases  
Controls: as per cases 
N=209 controls 
 




Response rate: 93% for cases and 98% for controls 
Exposure:  
Questionnaire: Standardised questionnaire by trained interviewer 
Interviewers blinded: n/s 
Reference period:10 to 15 years prior to survey baseline 
Drink type: beer wine and other beverages(n/s) 
 
Measure: grams per day; Reference group: no daily alcohol intake (n=102/117) 
Results:  ca/co 
1-20         74/67           1.10   (0.70-1.73) 
21-40       35/40           0.83   (0.46-1.47)  






Descriptive tables for breast cancer: cohort studies 
 





Study aims: to evaluate the effect 
of dietary folate intake on the 
relation between alcohol 
consumption and breast cancer 
risk 
 
Source of funding: 
None specified 
Population: 
Source: Melbourne collaborative cohort study of 41 528 
people (24 479 women) aged between 40-69yrs at baseline. 
Participants recruited through electoral rolls, advertisements, 
and community announcements 
 
Exclusion criteria: 
diagnosis before baseline of invasive breast cancer, angina, 
heart attack, or diabetes, missing data on alcohol intake and 
dietary factors 
 
Study pop: 17 447 women born in Australia, New Zealand, or 
the UK Kingdom 
 
Observation time: 
1990-1994, to 31 December 2003, average of 10.1 follow up 
years, LFU 6%, 537 cases of invasive breast cancer  
Exposure:  
Questionnaire: structured interview  
Repeated during follow-up: baseline 
Reference period: in the previous week 
Drink type: n/s 
Quest validated: n/s 
 
Measure: grams per day, Reference group: Abstainers 
Results: 
                  cases 
Ex-drinkers  16       1.03  (0.62 to 1.73) 
1-19 g/day    286    1.12  (0.93 to 1.36) 
20-39 g/day  43      0.87  (0.62 to 1.22) 
≥40 g/day     21      1.41   (0.90 to 2.23) 
 
 





Study aims: to evaluate 
performance of Breast Cancer 
Risk Assessment Tool for 
estimating invasive breast cancer 
risk by receptor status in 
postmenopausal women. 
 
Source of funding: 
National Heart,Lung and Blood 
Institute, NIH  
Population: 
Source: women recruited at 40 clinical centres in US through 
direct mailings Postmenopausal women, 50-79 yrs, unlikely 
to move or die within 3 yrs, were eligible.. 
 
Exclusion criteria:women with previous invasive breast 
cancer, previous non-invasive breast cancer, previous 
mastectomy, or less than 5 years follow-up 
 
Study pop: 147, 916 
 
Observation time: 




Repeated during follow-up: n/s 
Reference period: n/s 
Drink type: n/s 
Quest validated: n/s 
 
Measure: drinks per day, Reference group: <1 drink per day (cases = 127,608) 
Results: 
ER-positive 
>1    359     1.17 (1.02-1.33)    
ER-negative 













Study aims: To examine the 
relation between concurrent use of 
alcohol and postmenopausal 
hormones and invasive breast 
cancer. 
 
Source of funding: 
National Institutes of Health 
Population: 
Source: from Nurses' Health Study cohort (established in 
1976, when 121 700 female registered nurses 30 to 55 years 
of age completed a baseline questionnaire) 
 
Exclusion criteria:Women who left 10 or more food items 
blank (4%), implausibly high or low scores for total food 
intake (2.7%), diagnosis of cancer (except non-melanoma 
skin cancer) before 1980 
 




1980-1986 , 557 984 person-years of follow-up, 1722 cases 
of invasive breast cancer identified; LFU = 5% 
Exposure:  
Questionnaire:semi-quantitative FFQ 
Repeated during follow-up Baseline questionnaire 1980, then updated with responses 
from 1984, 1986, and 1990 questionnaires 
Reference period: within last 12 months prior to survey.  
Drink type: yes 
Quest validated: n/s 
 
Measure: grams per day, Reference group: none (0 g/d) 
Results:  
g/d             ca 
0.1-4.9      538     1 07  (0.95-1.20) 
5.0-9.9      166     0 99  (0.83-1 18) 
10-19.9     257     1 22  (1.06-1.42) 
≥20.0        167     1.33  (1.12-1 58) 
 





Study aims: To examine how oral 
contraceptive use or oestrogen 
dose from oral contraceptives 
interact with alcohol on breast 
cancer risk 
 




Source: Between January 1991 and January 1997, 179,388 
women from general population of Norway, 30-70 yrs, 
sampled according to birth year from the national population 
register102,443 included in study (response rate 57.1%) 
 
Exclusion criteria:prevalent cancer; women recruited in 1997 
(n = 5,933) because questionnaire did not ask for alcohol 
intake; ever users of oral contraceptives for whom duration 
of use was not stated  
 
Study pop: After exclusions, cohort = 86,948  
 
Observation time: 
between 1991 and 2001; 618,638 person-years of follow-up, 
LFU, n/s; 1,130 cases of breast cancer  
Exposure:  
Questionnaire: Self–completed questionnaire (91-92) 
Repeated during follow-up: baseline only, 
Reference period: over the preceding year. 
Drink type: beer, wine, and spirits 
Quest validated: 
 
Measure: grams per day, Reference group: none (0g/d) 
Results: ca 
0.1-4.9   554    1.24        (1.06-1.44) 
5.0-9.9   188    1.35        (1.11-1.64) 

















Study aims: To investigate the 
hypothesis that alcohol 
consumption increases the risk of 
breast cancer mortality. 
 




Source: selected from the 676,306 female participants of 
CPS-II, a prospective mortality study in all 50 States, the 
District of Columbia, and Puerto Rico 
Study pop: includes 242,010 women 
 
Exclusion criteria: missing or poorly quantified alcohol 
consumption data (n=369,326); women reporting a history 
of cancer (other than non-melanoma skin cancer) 
(n=57,107); women reporting a history of cirrhosis (n=314); 
former drinkers (n=7,549). 
 
Observation time:  
1982 through 31 December 1996 
After 14 years of follow-up, 1,442 eligible breast cancer 
deaths were observed 
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: baseline 
Reference period:in the past 10 years 
Drink type:Beer, wine, and liquor 
 
Measure: drinks per day, Reference group: none (0 d/d) 
Results:  
                  Ca          All                     ca    Premenopausal    ca    Postmenopausal 
<0.25       132   1.1  (0.88-1.3)  40   0.94 (0.66-1.3)      92     1.1  (0.89-1.4) 
0.26-<1    273   1.2  (1.0 -1.4)  70   0.99 (0.74 -1.3)     203   1.3  (1.1 -1.6) 
1-<2         177   1.3  (1.1-1.6)  42   1.1   (0.75-1.5)      135   1.4  (1.2-1.7) 
2-<3         162   1.4  (1.2-1.7)  37   1.2   (0.82-1.7)      125   1.5  (1.2-1.9 
3+            130   1.2  (1.0-1.5)  34   1.1   (0.74-1.6)       96    1.3  (1.0-1.6)   
ptrend                    0.08                                  0.37                              0.16      
 





Study aims: to evaluate a possible 
interaction between folate and 
alcohol on incident breast cancer 
 
 




Source: selected from 97,787 female participants in the 
CPS-II Nutrition Cohort, a prospective study of cancer 
incidence and mortality among United States men and 
women established in 1992, 
 
Exclusion criteria: women with prevalent cancer (except 
non-melanoma skin cancer) at baseline (n=11,601); women 
with cirrhosis (n=36); women with unknown menopausal 
status (n=604) or who were not postmenopausal (n 
=4,247); daily energy intake outside range of 550-3500 
kcal/day or missing ≥15% of dietary questions; missing 
alcohol data. 
 
Study pop: After exclusions cohort = 66,561 
 
Observation time:  
1992 to 31 August 1997, lost to follow-up (n=7,592), 1,303 
incident breast cancer cases 
Exposure:  
Questionnaire: Mailed questionnaire. A follow-up questionnaire mailed between 
September 1997 and August 1998 (response rate >90%). a semi-quantitative 68-item 
FFQ, 
Repeated during follow-up: baseline 
Reference period: in the past 10 years 
Drink type: Beer, wine, and liquor 
 
Measure: grams per day, Reference group: none (0d/d n=598) 
Results:     ca 
0.1 to <5    353    1.00  (0.88–1.15) 
5 to <10     109    0.94  (0.77–1.16) 
10 to <15   109    1.18  (0.96–1.46) 












Study aims: To examine alcohol 
consumption in various time periods 
in relation to breast cancer risk in a 
large cohort of mostly 
premenopausal women. 
 
Source of funding: 
National Institutes of Health 
 
 
Design: prospective cohort 
 
Population:  
Source: Female registered nurses (Nurses’ Health Study II) 
who were 25-42 years old and living in one of 14 states in 
the United States when they responded to a baseline 
questionnaire in 1989. 
 
Exclusion criteria: Women who reported cancer at 
enrolment (with the exception of non-melanoma skin 
cancer, hydatidiform mole, or cervical cancer/dysplasia) 
 
Study pop: After exclusions cohort of 116,671 women 
 
Observation time:  
619,691 person-years of follow-up between 1989 and 
1995, LFU n/s; 445 cases of invasive breast  
 
Exposure:  
Questionnaire: baseline questionnaire, participants asked about  alcohol consumption 
during 5 different periods: from 15 to 17 yrs of age, from 18 to 22 yrs of age, from 23 to 30 
yrs of age, from 31 to 40 yrs of age, and during the previous year. 
Repeated during follow-up: baseline and three follow-up questionnaires (1991, 1993, and 
1995), response rate among participants was >90%. 
Reference period:over the previous year 
Drink type: beer, wine, and liquor 
Quest validated: n/s 
 
Measure: grams per day (in last year) and drinks per week (average lifetime), Reference 
group: none (0g/d)  
Results:  
 In the last year                           Average lifetime alcohol consumption 
>0–1.5    68   0.99 (0.74–1.31)    <1             125      0.82 (0.61–1.10) 
>1.5–5    79   0.81 (0.62–1.06)     1–<1.5       46       1.01 (0.69–1.47) 
>5–10     45   1.08 (0.77–1.50)    1.5–<4.5   136      1.02 (0.76–1.38) 
>10–20   34   1.20 (0.83–1.74)     4.5–<6.5   28       1.03 (0.66–1.60) 
>20         12   1.30 (0.73–2.34)     6.5–<10.0 18       1.01 (0.60–1.71) 
                      ptrend =0.85                ≥10            15      1.20 (0.68–2.11) ptrend =0.18                                                                           
 





Study aims: to evaluate the effects 
of patterns of alcohol use (including 
age at drinking and ‘‘sporadic’’ 
versus ‘‘daily’’ drinking) on invasive 
breast cancer risk 
 
 
Source of funding: 
National Cancer Institute 
 
Population: 
Source: California Teachers Study cohort, established in 
1995-1996 when 133,479 active and retired female 
teachers and administrators participating in the California 
State Teachers Retirement System returned questionnaire 
 
Exclusion criteria:not residing in California at baseline 
(n=8,866); having been diagnosed (incl. past history) with 
breast cancer before baseline questionnaire, (n=6,267); 
aged 85 or older at baseline (n=1,994);missing or 
unreliable alcohol consumption data (n=12 892) 
 




1995–1996 to December 31, 2000; LFU, n/s; 1,742 
diagnosed with invasive breast cancer 
 
Exposure:  
Questionnaire: mailed questionnaire 
Repeated during follow-up: baseline only 
Reference period: assessed for three time periods: age 18-22 yrs, 30-35 yrs, and 
previous year 
Drink type: beer wine, champagne wine cooler cocktail 
Quest validated: n/s 
 
Measure: grams per day, Reference group: non-drinkers 
Results: Previous year 
             pre/perimenopausal                   Age 30– 35                          Age 18– 22 
<5        53   0.93  0.66-1.30  47  0.98  0.67-1.43 54   0.97  0.70-1.34 
5-9       55   1.05  0.75-1.47 67  1.27  0.90-1.79 59   1.12  0.81-1.53 
10-14   42   1.09  0.75-1.57  43  1.23  0.84-1.82 39   1.10  0.76-1.60 
15-19   27   1.28  0.83-1.97 21  1.15  0.70-1.89   9   0.72  0.37-1.43 
≥20      23   1.21  0.76-1.92  17  0.91  0.53-1.57 12   0.62  0.34–1.13 
Lifetime 
pre/perimenopausal                                Age 30– 35                          Age 18– 22 
g/d       ca  
<5        181   1.03  0.86-1.24 196    1.22  1.01-1.47 171    1.03  0.86-1.23 
364 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
5-9       150   1.04  0.86-1.27 177    1.04  0.84-1.26 104    0.85  0.68-1.05 
10-14   126   1.08  0.88-1.33 130    1.28  1.03-1.59 82      1.17  0.92–1.48 
15-19   82     0.91  0.71-1.16 75      1.17  0.90-1.51 25      1.01  0.68-1.52 
≥20      123   1.32  1.06-1.63 79      1.20  0.93-1.55 27      1.07  0.72-1.58 
Patterns  (referent group: non-drinkers ) 
‘‘Sporadic’’               282   0.99   0.84-1.17 
‘‘Daily’’ <20 g/day    116   1.07   0.86-1.32 
‘‘Daily’’ ≥20 g/day    110   1.34   1.07-1.67 
 





Study aims: To evaluate the impact 
of alcohol on mortality from breast 
cancer 
 
Source of funding: 




Source: Eligible population were women participating in 
controlled trial of (primarily) mammographic screening for 
breast cancer in women 40-59yrs in Canada between 1980 
and 1985 (n= 89,835) 
 
Exclusion criteria:dietary questionnaires not available; 
extreme values for energy intake 
 
Study pop: 58,926 women returned lifestyle 
 
Observation time: 
Between 1980 and 1985 to 31 December, 1993, LFU n/s. 
241 deaths from breast cancer identified. 
Exposure:  
Questionnaire: self-administered quantitative FFQ 
Repeated during follow-up: baseline only 
Reference period:in one month period prior to completion of questionnaire 
Drink type:beer, wine, and spirits 
 
Measure: grams per day, Reference group: 0g/day 
Results: 
                    ca 
>0-≤10         113       1.008  (0.986-1.032) 
>10-≤20       35         1.039  (1.009-1.071) 
>20              26         1.063  (1.029-1.098)   ptrend <0.0001   
 
per10g/unit; 223,       1.012  (1.005-1.019) 
 





Study aims: To investigate the risk 
of breast cancer among female 
patients with a discharge diagnosis 
of alcoholism,  
 
Source of funding: 




All in-patients (n=196,803) with a discharge diagnosis of 
alcoholism admitted to all Swedish hospitals between 1965 
and 1994. After exclusions final cohort size = 182,667 
patients and of these 36,856 were women, mean age at 
index hospitalisation was 42.7 years, 
 
Exclusion criteria:  
 (1) erroneous or incomplete national registration numbers; 
(2) inconsistencies uncovered during record linkage; (3) 
patients who died during the index hospitalisation; (4) of 
patients with prevalent cancers at entry. 
 
Observation time: mean  follow up 9.6 yrs, 353,596 years 
at risk’; no loss to follow up; 514 incident cases  
Exposure:  
consumption defined by specified ICD-7,8,9 codes (ICD-7=307, 322; ICD-8=291, 303; 
ICD-9=291, 303, 305A),  into category ‘alcoholism’ 
 
Measure: Standardised Incidence, Reference group: 0g/day 
Results:  Years of follow-up    
1–30           514    1.15   1.05-1.25 
< 1              40      1.09   0.78-1.49 
1–9             331    1.21   1.08-1.35 
 ≥10            183    1.06   0.91-1.22 
Age at follow-up (years) 
<50            143     1.11    0.93-1.30 
50–59        153     1.16    0.98-1.36 
60–69        129     1.14    0.95-1.35 









Study aims: To examine among 
postmenopausal women whether 
alcohol was associated with the risk 
of breast cancer defined by tumour 
characteristics and whether the 
association of alcohol with breast 
cancer was modified by folate 
intake, body mass index, and MHT 
use. 
 
Source of funding: 
National Institutes of Health 
Population: 
Source: 50-71 yrs and residing in 1 of 6 states (California, 
Florida, Louisiana, New Jersey, North Carolina, 
Pennsylvania) or 2 metropolitan areas (Atlanta, or Detroit). 
617,119 returned baseline questionnaire 
 
Exclusion criteria:did not answer substantial portions of the 
questionnaire, had more than 10 recording errors or 
reported consuming less than 10 foods; cancer, other than 
non-melanoma skin cancer, at baseline; were 
premenopausal or of uncertain menopausal status  
 
Study pop: 184,418 post-menopausal women  
 
Observation time: 
1995–2003; LFU: n/s; 5,461 breast cancer cases (3,531 
ductal, 550 lobular, 424ductal-lobular, 956 other tumours) 
Exposure:  
Questionnaire: self-administered 124-item FFQ 
Repeated during follow-up:  
Reference period:over the past year 
Drink type: beer, liquor  or mixed drinks wine or wine coolers 
 
Measure: grams per day, Reference group: 0 grams per day (n=1493) 
Results: 
                               All                               ER+/PR+                              ER+/Pr- 
>0-5      531    1.04 (0.97, 1.10)  759   1.07 (0.95, 1.21)  15      1.08 (0.83, 1.42) 
>5-10    395    1.04 (0.93, 1.16)  131   1.13 (0.93, 1.38)  27      1.15 (0.74, 1.78) 
>10-20  550    1.13 (1.02, 1.25) 65     1.07 (0.89, 1.29)  45      1.39 (0.96, 2.02) 
>20-35  265    1.23 (1.08, 1.41)  89     1.34 (1.06, 1.69)  28      1.13 (0.73, 1.77) 
>35        227    1.35 (1.17, 1.56)  67     1.46 (1.12, 1.91) 
ptrend             <0.001                              0.003                                              0.51 
 
 





Study aims: To evaluate the 
association between alcohol 
consumption and breast cancer risk 
 
Source of funding: 
Ministry of Education, Culture, 




Source: Original cohort included 110,792 people (46,465 
men, 64,327 women) aged 40-79 years, enrolled from 45 
areas throughout Japan, analysis included 38,600 women 
whose incident data were available from 24 areas where 
cancer registry systems existed 
 
Exclusion criteria:previous diagnosis of breast cancer 
(165); women who gave no information on drinking status 
(2,591) 
 
Study pop: = 35,844 
 
Observation time: 
Average follow-up of 7.6 years, 271,412 person-years of 
follow-up, LFU = <3%; 151 cases of breast cancer 
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: baseline only 
Reference period:drinking in last week 
Drink type:Japanese sake, Japanese spirits, beer, whiskey and wine] 
 
Measure: grams per day, frequency, age started, Reference group: non-drinkers 
(n=103) 
Results:                ca 
Ex-drinkers              3      0.82      (0.20-3.33) 
Current drinkers     45     1.27      (0.87-1.84) 
0.1– 4.9 (g/day)      13     1.07      (0.57-2.00) 
5.0–14.9                  5      0.83      (0.34-2.04) 
≥15.0                      11     2.93      (1.55-5.54) ptrend = 0.01 
Current drinkers only 
Years         ca   Age started drinking  Frequency of consumption (times/week) 
<25              3       1.02   (0.32-3.24)  <1                    13         1.46    (0.81-2.61) 
25–35          5       0.93   (0.34-2.25)  1–2                  11         1.08    (0.54-2.14) 
>35              7       1.33   (0.78-2.28)  3–4                   7          1.17    (0.54-2.53) 









Study aims: To examine (i) if 
breast cancer risk in post-
menopausal women is associated 
with intakes of total alcohol, specific 
alcoholic beverages (ii) genuine 
effects of total alcohol and fat 
intakes when adjusted for each 
other. 
 
Source of funding: 
Swedish Cancer Society 
Population: 
Source: source population included all men and women (n= 
74,138) born in city of Malmo, between 1923-50, 28,098 
participants had completed questionnaire by October 1996.  
Exclusion criteria:Inadequate Swedish language skills; 
mental incapacity; all prevalent cancer cases, except 
cervical cancer in situ and non-malignant melanoma skin 
cancer 
Study pop: Eligible participants were women 50 years or 
older at baseline examination, 11,726 post-menopausal 
women were included 
 
Observation time: end of follow up (31December 2001), 
average follow-up time, 7.6 years, 89,602 person-years 
LFU <1%; 342 incident (312 invasive and 30 in situ) cases,  
Exposure:  
Questionnaire: interview-based, modified diet history method combines (i) a 7-day menu 
book for registration of lunch and dinner meals, including cold drinks and alcohol, and (ii) 
a questionnaire for assessment of meal patterns, consumption frequencies and portion 
sizes  
Repeated during follow-up: baseline only 
Reference period: during the previous year 
Drink type: n/s 
 
Measure:grams per day, Reference group: group 0-15 g/day (n=257) 
Results:        ca 
Abstainers      22    0.89  (0.57–1.39) 
>15 to ≤30      39    0.88  (0.62–1.24) 
>30                 11    1.68  (0.91–3.12) 
 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: to determine whether 
alcohol interactswith hormone use 
on risk of breast cancer 
 
Source of funding: 
Danish Ministry of Interior and 
Health 
Population: 
Source: Copenhagen City Heart Study (see Petri below) 
 
Exclusion criteria: none specified 
 
Study pop: 5,035 
 
Observation time: 
Baseline year n/s, end of period 31 December 1996, mean 
follow up 6.1 yrs, LFU <1 
Exposure: SEE PETRI BELOW  
 
Measure: drinks per week, Reference group: <1 drink/wk (n=107) 
Results: 
1–7       101  1.19   (0.90–1.57) 
8–14 5   36   1.28   (0.87–1.89) 
15–21     14  1.61   (0.92–2.84) 




















Study aims: To examine the 
influence of alcohol intake and type 
of beverage on breast cancer risk in 
relation to menopausal status. 
 
Source of funding: 
Danish Ministry of Interior and 
Health, The Health Insurance 
Foundation. 
Population: 
Source: Copenhagen Centre for Prospective Population 
Studies (comprising data from various Danish cohort 
studies: the Copenhagen City Heart Study and the 
Research Centre for Prevention and Health 
 
Exclusion criteria:none specified 
 
Study pop: included 13,074 age-stratified women ≥20yrs 
who completed questionnaires 
 
Observation time: 
Baseline year n/s, end of period 31 December 1996, mean 
follow up 6.1 yrs, LFU <1%; 76 incident cases in pre-
menopausal, women  
Exposure:  
Questionnaire: Self-administered questionnaires 
Repeated during follow-up:  
Reference period: in preceding year. 
Drink type: beer, wine, and spirits 
Quest validated:n/s 
 
Measure: drinks per week, Reference group: 1-6 d/w 
Results: 
<1        1.17   (0.66-2.07) 
7–13    1.22   (0.66-2.25) 
14–27  0.86   (0.33-2.21) 
>27      3.49   (1.36-8.99) 
 





Study aims: To study the 
association between alcohol 
consumption and breast cancer risk 
 
 
Source of funding: 
National Cancer Institute of Canada 
Population: 
Source: Conducted as a case-cohort study within a cohort 
of 56,837 women participating in controlled trial of 
mammographic screening for breast cancer in women 40-
59yrs in Canada between 1980 and 1985 
 
Exclusion criteria:dietary questionnaires not available; 
extreme values for energy intake 
 
Study pop: Sub-cohort of 5681 women selected by random 
sampling from cohort of 56,837 women 
 
Observation time: 
1980-1985 to 31 December 1993, median follow-up time 
for cohort-approx. 10 years; 1,469 cases of invasive breast 
cancer, 144 in sub-cohort 
Exposure:  
Questionnaire: self-administered quantitative FFQ  
Repeated during follow-up: baseline only 
Reference period: n/s 
Drink type:beer, wine, and spirits 
 
Measure: grams per day, Reference group: 0 g/d 
Results: 
>0-≤10      1.01    (0.84-1.22) 
>10-≤20    1.16    (0.91-1.47) 
>20-≤30    1.27    (0.91-1.78) 
>30-≤40    0.77    (0.51-1.16) 
>40-≤50    1.00    (0.57-1.75) 
















Study aims: To examine 
interactions of alcohol and low 
folate intake on the risk 
ofpostmenopausal breast cancer 
stratified by tumour receptor status 
for oestrogen (ER) and 
progesterone (PR) 
 




Source: Iowa Women’s Health Study, cohort represents 
41,836 licensed drivers ages 55-69 yrs who responded to a 
mailed survey 
 
Exclusion criteria:not postmenopausal (n=569) or total or 
partial mastectomy (n=1,870); dad any cancer other than 
skin cancer (n=2,293);if >30 items on FFQ left blank; 
extreme energy intake values (<600 or ≥5,000 kcal/day; 
n=2,712). 
 
Study pop: Final cohort size =  34,393 
 
Observation time: 
1986-1999, 14 yrs of follow-up, LFU n/s; identified 1875 
breast cancer cases (1,633 invasive and 242 in situ) 
Exposure:  
Questionnaire: Food frequency questionnaire 
Repeated during follow-up: baseline only 
Reference period: over the previous year 
Drink type: yes 
 
Measure: grams per day, Reference group 0g/d 
Results:   
g/d                 ER+                    ER-                   PR+                      PR- 
≤4     1.06 (0.91–1.22)   1.40 (1.00–1.96)  1.04 (0.89–1.23)   1.24 (0.95–1.62) 









Study aims: to better understand 
the association between folate 
intake (food folate, the natural 
polyglutamate forms in foods, 
synthetic folic acid supplements, 
and total folate), alcohol 
consumption, the interaction of 
these factors, and postmenopausal 
breast cancer 
 
Source of funding: 




Source: Women 55-74yrs recruited between 1993 and 
2001 in 10 US centres to the intervention arm (randomly 
assigned) of the Prostate, Lung, Colorectal, and Ovarian 
Cancer Screening Trial. Of 77,376 women in screening 
trial, only those in intervention arm given dietary 
questionnaire at baseline (n=38,660 women); of that group, 
31,411 (81%) completed the questionnaire 
 
Exclusion criteria: 
history of any cancer other than non-melanoma skin cancer 
(n=2,338); >8 items missing from FFQ (n=319); extreme 
values for energy intake (lowest or highest, n=544); missing 
data on multivitamin use (n=2,810) 
 
Study pop: = 25,400  
 
Observation time: 
follow-up to June 2003 (median 4.94 y; 127,261 person-
years; LFU n/s;500 cases  
Exposure:  
Questionnaire: self-administered FFQ 
Repeated during follow-up: baseline only 
Reference period: within past year 
Drink type: beer, wine, and spirits, 
Quest validated: n/s 
 
Measure: grams per day, Reference group: ≤0.01g/d 
Results:  
>0.01-≤0.43      138   1.21 (0.94, 1.57)  
>0.43- ≤1.39     158   1.18 (0.92, 1.51) 
>1.39-≤7.62      118   0.94 (0.72, 1.22)  
>7.62                173   1.30 (1.02, 1.67) 













Study aims: To investigate whether 
association of alcohol with 
increased risk of postmenopausal 
breast cancer differs across ER+/− 
and PR+/− tumour subtypes, and 
whether there are interactions 
between alcohol intake and other 
known risk factors, on the risk of 
ER- and PR-defined 
postmenopausal breast cancer 
 
Source of funding: 
Swedish Cancer Society 
Population: 
Source: All women born between 1917 and 1948 in 
Västmanland County and between 1914 and 1948 in 
Uppsala County, Sweden, invited to a mammography 
screening between 1987-1990 (response rate 74%, n= 66 
651). 
 
Exclusion criteria:missing or incorrect national identification 
numbers (n=1,122); born before 1914 or after 1948 
(n=165); incomplete questionnaires (n=2,994); pre- and 
peri-menopausal women at the start of follow-up 
(n=27,722), but subsequently re-entered women who 
become postmenopausal during follow-up if cancer-free 
and living in the study area ( n = 23 888);>70 years old at 
baseline (n=2,364) 
 
Study pop: 51,847 post-menopausal women 
 
Observation time: 
November 1997,to June 30, 2004, average 8.3-year follow-
up, 43,0583, person-years, LFU < 1%; 1284 invasive cases  
Exposure:  
Questionnaire: FFQ 
Repeated during follow-up: at baseline, follow-up FFQ in 1997 (response rate 70%) 
Reference period:during the past 6 months 
Drink type: light beer, medium beer, strong beer, wine, and hard liquor 
Quest validated: Spearman rank correlation coefficient, r = .9 for alcohol intake 
estimated by the FFQ-87 and alcohol intake calculated from four 1-week diet records 
obtained 3–4 months apart  
 
Measure: grams per day, Reference group: non-drinkers (n=138) 
Results: 
                     All invasive tumors                   ER+PR+ 
<3.4           476  1.08 (0.94-1.25) 269   1.07 (0.89-1.30) 
3.4 -9.9      343  1.10 (0.94-1.29) 186   1.09 (0.88-1.35) 
≥10            151  1.43 (1.16-1.76) 77     1.35 (1.02-1.80), 
                             ptrend.0012                   ptrend .049 
ER+PR −        ER+PR    ER − PR − 
<3.4           90  1.10 (0.78-1.55) 21  1.27 (0.63 to 2.57) 56  1.11 (0.72 to 1.71) 
3.4 -9.9      81  1.30 (0.91-1.87) 14  1.30 (0.58 to 2.89) 42  1.09 (0.68 to 1.75) 
≥10            54  2.36 (1.56-3.56) 2     0.62 (0.13 to 2.90)  10  0.80 (0.38 to 1.67) 
                         ptrend <.001                          ptrend .57 
 





Study aims: To examine the 
relationship between 
postmenopausal breast cancer 
incidence rate and alcohol 
consumption in different life periods 
 
Source of funding: 
Danish Cancer Society 
 
Population: 
Source: Between December 1993 and May 1997, all 
79,729 women aged 50-64 yrs living in specific 
municipality-defined areas in Denmark invited to participate 
in study.Total of 29,875 women enrolled in study, i.e. 37% 
of the women invited 
 
Exclusion criteria:previous history of cancer (326); 
Incomplete lifestyle information (8); women reporting at 
least one natural menstruation >12 months before entry 
and no use of HRT (4,798); lifetime history of no 
menstruation (9);missing information about present or 
previous alcohol consumption (177); no information on 
reproductive events or length of schooling, (837) 
 




Questionnaire: Mailed questionnaire  
Repeated during follow-up: no 
Reference period: mean alcohol consumption during four different periods of life, i.e., 
their twenties, thirties, forties and from age 50 until 1 y before study entry 
Drink type: wine, fortified wine, beer and spirits. 
 
Measure: per each additional 10 g/d of alcohol intake, Reference group: non-drinkers 
Results:  
Twenties               0.94   (0.79–1.11)  
Thirties                  0.95   (0.84–1.06)  
Forties                   0.99   (0.90–1.08)  
Fifties—baseline   1.01   (0.91–1.13)  
Cumulative intake  0.99  (0.96–1.03)  
Baseline                1.10   (1.03–1.16) 
 
Early maximum drinking period before age 50 with the highest maximum intake  of 
alcohol (ref group forties) 
370 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Follow-up until 31 December 2000; 423 cases of breast 
cancer identified during a median of 4.7 y of follow-up, LFU 
0% 
Twenties     17    1.03   (0.63–1.69) 
Thirties       32     0.92   (0.64–1.33) 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Tjønneland 2007 
 
Country: Norway, Sweden, 
Denmark, United Kingdom, 
Germany, The Netherlands, 
France, Spain, Italy, and Greece, 
 
Study aims: to describe the 
associations between alcohol 
intake and breast cancer risk in the 
European Prospective Investigation 
into Cancer and Nutrition (EPIC) 
 
Source of funding: 
Europe Against Cancer programme 
of the European Commission 
Population: 
Source: consists of sub cohorts recruited in 23 centers in 
ten European countries. Participants recruited from the 
general population residing in a specific geographical area. 
Exceptions were most of the Oxford cohort, UK (based on 
vegetarian volunteers and healthy eaters), the Utrecht 
cohort, the Netherlands and the Florence cohort, Italy 
(based on women attending breast cancer screening), the 
French cohort (based on female members of the health 
insurance for state school employees living throughout 
France), the Ragusa cohort, Italy, and most of the Spanish 
cohort (based on blood donors and their spouses), 
n=368,010 
 
Exclusion criteria: Women with a prevalent cancer 
diagnosis (19,953) and with missing data for variables 
considered in the analysis (67,055 subjects) as well as 
6,314 who were in the lowest and highest 1% of the 
distribution of the ratio of reported total energy intake to 
energy requirement 
 
Study pop: 274,688 female participants aged 35-70 yrs. 
were excluded, 
 
Observation time: 1,695,876 person years (PY) of follow 
up, during which time 5,054 cases (1,114 pre-, 969 peri-, 
and 2,962 postmenopausal) were diagnosed.  
Exposure:  
Questionnaire: food frequency questionnaire 
Repeated during follow-up: no 
Reference period: 12 monthly 24-h recalls 
Drink type: beer and/or cider, wine, liquor, spirits, or fortified wine 
Quest validated: dietary questionnaires used in the different cohorts were all validated 
or are currently being validated 
 
Measure: grams per day, Reference group: >0–1.5 g/day  (n=50,979 incl. 701 cases) 
Results: 
                           Cases/ cohort         incidence rate ratio 
Abstainers          612/46,939                1.01 (0.91–1.13) 
>1.5–4.7             723/51,087                0.98 (0.89–1.09) 
>4.7–10              731/48,585                0.97 (0.88–1.08) 
>10–19               759/40,931                1.07 (0.96–1.19) 
>19–23.6            211/10,724                1.08 (0.92–1.26) 
23.6–29.9             154/8,156                1.03 (0.86–1.23) 
29.9–37.1             194/7,795                1.36 (1.15–1.60) 


















Study aims: to determine the 
influence of both baseline and 
updated alcohol intake on the risk 
for breast cancer and also the 
modifying influence of latency. 
 
Source of funding: 
National Institute of Public Health 
Population: 
Source: Copenhagen City Heart Study initiated in 1976in 
which 19,698 individuals from central Copenhagen invited 
to a health examination and to fill in a questionnaire 
concerning health behaviour sample was randomly selected 
by age strata from a population of 90,000 inhabitants At the 
first examination, 14,223 persons participated (72%)  
 
Exclusion criteria:- no diagnosed malignant disease 
 
Study pop: 9,318 women 
 
Observation time: 
until December 31, 2002, 476 primary breast cancers 
Exposure:  
Questionnaire: questionnaire concerning health behaviour 
Repeated during follow-up: baseline and 1981-83, 1991-94 and 2001-04 
Reference period: n/s, Drink type: beer wine liquor 
 
Measure: grams per day, Reference group:<1.71 grams per day 
Results:          ca      Baseline alcohol intake   ca   Updated alcohol intake 
1.71–12          236   1.00   (0.80–1.24) 164    0.98   (0.78–1.21) 
13–24              79    1.36   (1.01–1.81) 84      1.19   (0.91–1.56) 
25–48                8    1.71   (0.82–3.57) 29      1.12   (0.75–1.68) 
>48                    4    4.64   (1.67–12.9)     7        1.05   (0.46–2.40) 
Intake and length of latency time 
                         0 years                 4 years                   8 years               
1.71–12    0.98 (0.79-1.21)       1.14 (0.91-1.44)      1.05 0.81-1.37) 
13–24       1.19 (0.91-1.56)       1.30 (0.97-1.75)      1.59 1.16-2.18) 
25–48       1.12 (0.75-1.68)       1.28 (0.83-2.00)      1.38 0.83-2.28) 
>48           1.05 (0.46-2.40)       1.17 (0.48-2.89)      1.35 0.49-3.70) 
        -           12 years                     16 years                20 years  
1.71–12    1.29 (0.96-1.74)       1.33 (0.93-1.91)       1.74  (1.00-3.05) 
13–24       1.49 (1.01-2.19)       1.67 (1.06-2.64)       2.48  (1.28-4.81) 
25–48       1.65 (0.91-3.01)       1.31 (0.55-3.09)       6.25  (2.36-16.5) 
>48           2.39 (0.86-6.63)       2.19 (0.52-9.13)       0.50  (1.34-82.6) 
 





Study aims: To examine relation of 
average alcohol consumption and 
of different beverages to the risk of 
breast cancer 
 
Source of funding: 
Institute on Lifestyle & Health, 
Boston University School of 
Medicine 
Population: Source: Cohort started in 1948 in 
Framingham, Massachusetts. Original cohort included 
2,873 women, aged 28-62 years;. In 1971, female children 
of original cohort and their spouses formed the Offspring 
study (n=2,641, aged 12-60 years) 
 
Exclusion criteria: missing alcohol consumption data and 
history of prevalent cases of breast cancer 
 
Study pop: Final cohort for analysis = 5,048 
 
Observation time: Cohort I follow up median, 34.3 years; 
Cohort II follow up median 19.3 years; Loss to follow up n/s; 
287 incident cases (221 cohort I, 66 cohort II) 
Exposure:  
Questionnaire: n/s 
Repeated during follow-up: every 4 years from both cohorts 
Reference period: n/s 
Drink type: beer, wine and cocktails 
 
Measure: grams per day, Reference group: Non-drinker(0g/d) 
Results:   
g/d             ca 
0.1-<5.0     110    0.8   (0.6-1.1) 
5.0-<15       55     0.7   (0.5-1.1) 













Study aims: To examine relation of 
average alcohol consumption and 
of different beverages to the risk of 
breast cancer 
 
Source of funding: 
Institute on Lifestyle & Health, 
Boston University School of 
Medicine 
Population: Source: Cohort started in 1948 in 
Framingham, Massachusetts. Original cohort included 
2,873 women, aged 28-62 years;. In 1971, female children 
of original cohort and their spouses formed the Offspring 
study (n=2,641, aged 12-60 years) 
 
Exclusion criteria: missing alcohol consumption data and 
history of prevalent cases of breast cancer 
 
Study pop: Final cohort for analysis = 5,048 
 
Observation time: Cohort I follow up median, 34.3 years; 
Cohort II follow up median 19.3 years; Loss to follow up n/s; 
287 incident cases (221 cohort I, 66 cohort II) 
Exposure:  
Questionnaire: n/s 
Repeated during follow-up: every 4 years from both cohorts 
Reference period: n/s 
Drink type: beer, wine and cocktails 
 
Measure: grams per day, Reference group: Non-drinker(0g/d) 
Results:   
g/d             ca 
0.1-<5.0     110    0.8   (0.6-1.1) 
5.0-<15       55     0.7   (0.5-1.1) 
>15.0          53     0.7   (0.5-1.1) 
 
 





Study aims: To assess the 
association between moderate 
alcohol consumption and breast 
cancer risk 
 
Source of funding: 
None specified 
Population: 
Source: Women’s Health Study, a randomized trial 
evaluating the benefits and risks of low-dose aspirin and 
vitamin E in the primary prevention of cardiovascular 
disease and cancer among 39,876 US female health 
professionals 
 
Exclusion criteria:- none specified 
 
Study pop: 39,345 (98.7 percent) of the randomized 




end of the trial, March 31, 2004, average duration of follow-
up was 10 years 
1,484 cases of total breast cancer 
Exposure:  
Questionnaire: 131-item food FFQ 
Repeated during follow-up: baseline only 
Reference period: preceding 12 months 
Drink type: beer, wine, and liquor 
 
Measure: grams per day, Reference group: 0 g/day (n=516) 
Results:            Total alcohol intake 
0.1_4.9        549  1.02  (0.90-1.15) 
5.0_9.9        181  1.13  (0.95-1.34) 
10.0_14.9    109  1.14  (0.92-1.40) 
15.0_29.9     88   1.16  (0.92-1.45) 
≥30.0             41  1.32  (0.96-1.82)   10 g/day increment  1.09 (1.03-1.15) 
                     ca      ER+/PR+            ca          ER+/PR-               ca          ER-PR- 
0.1_4.9        295  1.00   (0.84-1.18)  49    1.13   (0.74, 1.72) 69    1.17  (0.82, 1.67) 
5.0_9.9        84    0.96   (0.75-1.24)  16    1.21   (0.67, 2.18) 18    1.04  (0.60, 1.78) 
10.0_14.9    66    1.29   (0.98-1.70)  8      1.01   (0.47, 2.17) 10    1.02  (0.52, 2.01) 
15.0_29.9    50    1.23   (0.91-1.68)  9      1.39   (0.67, 2.90) 10    1.25  (0.63, 2.47) 








Descriptive tables for breast cancer: case control studies 





Study aims: To assess risk factors 
for breast cancer among very young 
compared to older premenopausal 
women 
 
Source of funding: 
US government 
Population: 
Cases:women newly diagnosed with  breast cancer aged 
20-54yrs and living in New Jersey, Seattle and Atlanta  
N=1,750,  




Exclusion criteria: did not have a residential telephone; 




1990-1992; response rate: cases (86%) controls (78%) 
Exposure:  
Questionnaire: interviewed in person 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: n/s 
 
Measure:drinks per week, Reference groupnon-drinker 
Results: 
d/w           ca/co                  <35 yrs                     35-44yrs                      45-54yrs 
<3             74/78      1.33  (0.8-2.2)  414/344  1.04  (0.8-1.3)  80/106   1.98  (1.2-3.2) 
3-6.9        50/64      0.99  (0.6-1.7)  229/186  1.00  (0.8-1.3)  92/66     1.95  (1.1-3.4) 
7-13.9      27/22      1.29  (0.6-2.7)  101/80    1.04  (0.7-1.5)   53/39     1.84  (1.0-3.5) 
14+          20/13      1.71  (0.7-4.0)  59/26      1.95  (1.2-3.30)   34/28     4.24  (1.2-14.6) 
 





Study aims: To examine the 
association between total intake 
and intake of different types of 
alcoholic beverages at different 
time periods and breast cancer risk 
in a case-control study of women 
younger than 50 years 
 
Source of funding: 
None specified 
Population: 
Cases: US-born English-speaking, white (including 
Hispanic) or African-American, female residents of Los 
Angeles County, and 20-49 years old 
N=1,794 
Controls:identified using a neighbourhood walk algorithm, in 
which that field staff conducted walks according to 
predefined pattern in neighbourhoods where case patients 
lived at time of their diagnoses 
N=444 
 
Exclusion criteria: never diagnosed with invasive or in situ 
breast cancer or any other cancer 
 
Observation time: 
between 1998 and 2003 
Response rate: cases (62%) controls (74%) 
Exposure:  
Questionnaire: structured questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime histories: calendar of life events was used to assist the recall. 
Drink type: beer, wine, liquor 
 
Measure: drinks per week, Reference group: never drinker (561/141) 
Results: Lifetime intake (from age 15 years           Early intake (15–20 years age) 
 <3          740/192   1.09 (0.84-1.41)  <3         407/113   0.99 (0.73-1.34) 
3–<7     248/67       0.97 (0.68-1.39  3–<7     100/31     0.78 (0.48-1.25) 
7+           177/34     1.26 (0.81-1.96)  7+          61/14      0.95 (0.50–1.82) 
Recent intake (average intake in the 5 years before the alcohol reference date) 
<3             482/129    1.06 (0.80–1.42) 
3 – <7       217/56      1.05 (0.73–1.53) 
7 – <14     126/24      1.36 (0.82–2.24) 












Study aims: to examine the 
association between drinking 
pattern of alcoholic 
beverages,particularly wine, and 
breast cancer using different 
statistical approaches 
 
Source of funding: 
National Cancer Institute of 
France, 
Population: 
Cases: Eligible case subjects were French-speaking 
women, residing in Southern France (Hérault only), 
identified from both surgical ward and medical information 
department records 
N= 437 
Controls: were randomized from the list of residents 
supplied by the electoral roll 
N= 922 
 
Exclusion criteria:- no former history of breast cancer  
 
Observation time: 
2002–2004; response rate: n/s 
Exposure:  
Questionnaire: structured questionnaire administered by two trained interviewers 
Interviewers blinded: n/s 
Reference period: ‘‘usual drinking’’ habits 
Drink type: wine, aperitifs, beer, spirits 
 
Measure: drinking status, grams per day, Reference group: never, 0 g/day (41/73) 
Results: 
Sporadic 239/499  1.03 (0.62-1.71) 
Frequent 155/350  0.75 (0.40-1.41) 
 
0- ≤5        211/421   0.75 (0.20-2.88) 
5-≤10       57/141     0.36 (0.10-1.53) 
10- ≤15    43/130     0.21 (0.10-0.91) 
>15           83/157    0.97 (0.23-4.10),          Total intake (10 g/d) 0.94 (0.75–1.17) 
 






the association of alcohol and risk 
of breast cancer according to joint 
oestrogen receptor and 
progesterone receptor status 
 
Source of funding: 
National Institutes of Health 
Population: 
Cases: all patients aged ≤40 yrs and aged 55-64yrs, 
living in Los Angeles County and first diagnosed 
between 1 July 1983 and 1 January 1989, with breast 
cancer 
N=744 ≤40yrs, 1,579 55-64yrs 
Controls: selected from housing units in a pre-defined 
walk pattern in neighbourhood where cases lived at the 
time of breast cancer diagnosis 
N=744 ≤40yrs, 1,579 55-64yrs 
 
Exclusion criteria: women no longer menstruating; did 
not know family history of breast cancer because they 




Response rate: cases (72%), controls (73%) 
Exposure:  
Questionnaire: face-to-face interview 
Interviewers blinded: n/s, Quest validated: n/s 
Reference period:at ages 18, 25 and the reference age (women aged 40 years or younger) 
and at ages 25, 40 and the reference age (women aged 55-64) 
Drink type: beer, wine and liquor 
 
Measure: grams per day, Reference group: 0g/d 
Results: Pre-menopausal 
            con/ca         ER+/PR+                       ER+/PR–                                 ER–/PR–       
1–5     135/30   0.73 (0.46-1.15) 135/6    0.45 (0.18-1.10)  20    0.68 (0.40-1.16)     
6–13   118/37   1.07 (0.69-1.65) 118/2    0.16 (0.04-0.69) 23    0.90 (0.53-1.51)   
14+      88/28    1.10 (0.67-1.80)  88/7    0.71 (0.30-1.68) 21    1.04 (0.60-1.81)    
 ptrend 0.56                                                      ptrend  0.21                       ptrend 0.84 
Post-menopausal 
             con/ca           ER+/PR+                     ER+/PR–                             ER–/PR–         
1–13     329/122    0.97 (0.74-1.27)     329/38  0.75 (0.49-1.14)     33    0.81 (0.52-1.26)    
14–26   109/46      1.18 (0.80-1.75)     109/21  1.36 (0.80-2.33)     12    0.91 (0.47-1.75)    
 27+        63/43      1.76 (1.14-2.71)       63/10  1.10 (0.53-2.26)     11    1.37 (0.68-2.76)     












Study aims: investigated the role 
of alcohol according to ER and 
progesterone receptor (PR) status 
in a case-control study on breast 
cancer 
 
Source of funding: 
Italian Association for Cancer 
Research, the Italian League 
Against Cancer, 
Population: 
Cases: from hospitals in six Italian areas:  
N= 989 
Controls: admitted to hospitals in the same catchment 
areas for acute, non-neoplastic, non-gynaecologic 
diseases: non–alcohol related trauma; orthopaedic 
disorders; eye diseases; acute surgical disorders; and 
other miscellaneous diseases related to ear, nose and 
throat, skin, and teeth. 
N=1,350 
 
Exclusion criteria:none specified 
 
Observation time: 
from 1991 to 1994; response rate: >95% in cases and 
controls 
Exposure:  
Questionnaire: Information was collected in the hospital by trained Interviewers using a 
validated FFQ questionnaire 
Interviewers blinded: n/s 
Reference period:lifetime 
Drink type: wine, beer, herb liquors, grappa, whisky/brandy, and other spirits 
 
Measure:grams per day, Reference group: Never drinkers (491 cases/244 controls) 
Results 
                          All                                          ER-                                    ER+ 
< 13.8   429/337   1.55 (1.24-1.93) 429/90   1.57 (1.09-2.26)  429/247   1.51 (1.18-1.93) 
≥ 13.8   430/408   1.96 (1.57-2.47)  430/72   1.36 (0.93-2.01)  430/336   2.16 (1.68-2.76) 
 
per 10 g  1.11 (1.05-1.17)                  per 10 g 1.13 (1.07-1.20) 
 
 





Study aims: to investigate the 
effects of alcohol consumption on 
breast cancer risk in black and 
white women. 
 
Source of funding: 
n/s 
Population: 
Cases: were women 20-74yrs residing in North 
Carolina. Predetermined sampling probabilities based 
on race and age used to randomly recruit approx. equal 
numbers of black and white women, as well as equal 
numbers of women <50yrs and women ≥50 yrs 
N=890 
Controls:randomly selected from computerized 
databases: For women <65yrs from list of licensed 
drivers in North Carolina , women age ≥65 yrs from 
those eligible for Medicare 
N=841 
 
Exclusion criteria:previous history of breast cancer 
 
Observation time: 
between May 1993 and May 1996 
Response rate: Cases (77%) Controls (68%) 
Exposure:  
Questionnaire: Nurse-interviewer administered questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime (during three age periods up to time of the interview: < 25yrs, 25-
49yrs, and ≥50 yrs) 
Drink type:beer, wine and liquor 
Quest validated: n/s 
 
Measure: grams per week (g/w), Reference group: lifetime non drinker 
Results: 
   g/w             All women        Black women         White women 
<13           0.9   (0.7-1.2) 0.6    (0.4-1.0) 1.0    (0.7-1.5) 
13-90.9     0.9   (0.7-1.3) 0.8    (0.5-1.4) 1.0    (0.7-1.5) 
91-181.9   1.4   (0.9-2.1) 2.2    (0.9-5.2) 1.1    (0.6-1.9) 
≥182         1.0   (0.6-1.6) 0.8    (0.3-1.8) 1.2    (0.6-2.3) 













Study aims: to evaluate theeffect of 
low-to-moderate doses on breast 
cancer risk among premenopausal 
women 
 
Source of funding: 
n/s 
Population: 
Cases: German-speaking women who resided in one of 
two geographic areas in southern Germany and who 
were <51 yrs at time of diagnosis of breast cancer. all 
incident breast cancer diagnoses in 38 hospitals in the 
two regions 
N=706 
Controls: selected from random lists of residents 








between January 1, 1992, and December 31, 1995 
Response rate: cases (70.2%) controls (61.2 %)  
Exposure:  
Questionnaire: self-administered questionnaire 
Interviewers blinded: n/s 
Reference period: three time periods: ages 15–20 years, ages 20–30 years, and ages 30–
50 years 
Drink type: beer, wine, aperitifs, liqueur, and spirits 
 
Measure:Lifetime average ethanol intake grams per day, Reference group: non-drinkers 
(0.g/d) 
Results:  
                ca/co 
1–5       257/577   0.71     (0.54-0.91) 
6–11     124/295   0.67     (0.50-0.91) 
12–18    69/150    0.73     (0.51-1.05) 
19–30    59/84      1.10     (0.73-1.65) 
≥31        44/36     1.94      (1.18-3.20) 
 
 





Study aims: To determine the 
association between 
postmenopausal breast cancer and 
prior consumption of alcoholic 
beverages 
 
Source of funding: 
Canadian Breast Cancer Initiative 
 
Population: 
Cases:women 50-75yrs at time of breast cancer 
diagnosis, residents of Montreal area, identified from 
records of pathology departments and cancer registries 
from all 18 major hospitals in area, N=556 




certain sites of cancer excluded because of association 
with particular chemical or physical exposures (i.e. liver, 
pancreas, lung, bronchus and trachea, brain and central 
nervous system, and leukemia); women with non-
melanoma skin cancer, and with cancers of the oral 
cavity, esophagus, and larynx  
 
Observation time: between 1996 and 1997,  
Response rate: Cases (81.1%) Controls (75.7%) 
Exposure:  
Questionnaire: interviewer administered structured questionnaire, 
Interviewers blinded: unaware of cancer site of subject 
Reference period:ever drank in lifetime 
Drink type:beer, wine, cider or liquor 
 
Measure: drinking frequency, Reference group: never drinkers 
Results:  
Ever                                           1.2  (0.9-1.7) 
    Infrequent drinker                  1.2  (0.8-1.8) 
    Ever regular drinker               1.3  (0.9-1.8) 
    Current regular drinker          1.5  (1.0-2.2) 













Study aims: to assess the 
relationship between alcohol use 
and risk of invasive breast cancer 
by histology and hormone receptor 
status 
 
Source of funding: 
National Cancer Institute, 
Population: 
Cases: women, 65-79yrs living in three counties in 
Washington state, with a diagnosis of invasive breast 
cancer and who had a Health Care Financing 
Administration record 
N=975 
Controls: identified from Health Care Financing 
Administration records and frequency matched on age 
to cases to serve as controls 
N=1,007 
 
Exclusion criteria:- prior history of in situ or invasive 
breast cancer 
 
Observation time: between April 1, 1997, and May 31, 
1999, 
Response rate: Cases (80.6%) Controls (73.8%). 
Exposure:  
Questionnaire: interviewed in-person 
Interviewers blinded: n/s 
Reference period: 20 years before diagnosis/reference date. life events calendar was used 
to enhance recall of times when patterns of alcohol use changed 
Drink type: beer, wine, and spirits 
 
Measure: grams per day, Reference group: women who drank <12 alcohol beverages 
during past 20 years, or who did not consume at least one beverage containing alcohol a 
month for 6 months during the past 20 years 
Results:          All                     ER+                    ER-PR+                     PR- 
Current       1.3 (1.1-1.6) 1.1 (0.7-1.8) 1.4 (1.1-1.7) 1.1 (0.8-1.5) 
<1.5            1.3 (0.9-1.8) 1.5 (0.7-3.2) 1.3 (0.9-1.9) 1.3 (0.8-2.2) 
1.5–4.9       1.3 (0.9-1.8) 1.0 (0.4-2.1) 1.4 (1.0-2.1) 0.8 (0.5-1.4) 
5.0–14.9     1.2 (0.9-1.7) 0.8 (0.4-1.6)  1.3 (0.9-1.8) 0.9 (0.5-1.4) 
15.0–29.9   1.2 (0.8-1.7) 1.5 (0.7-3.0)  1.2 (0.8-1.8) 1.2 (0.7-2.1) 
≥30.            1.9 (1.2-3.1) 1.5 (0.5-4.0)  2.0 (1.2-3.2) 1.7 (0.9-3.3) 
ptrend0.386                  0.902                 0.508                    0.462 
 





Study aims: To evaluate the 
relationships between established 
breast cancer risk factors and other 
histologic types 
 
Source of funding: 
National Institute of Child Health 
and Human Development and 
NationalCancer Institute 
Design: population case-control 
 
Population: 
Cases: aged 35-64yrs identified with breast cancer in 5 
metropolitan sites in the United States (Atlanta, Detroit, 
Los Angeles, Philadelphia, and Seattle) 
N= ductal (n=3,463), lobular (n=274), ductal-lobular, 
(n=261), medullary (n=91), tubular (n=77), comedo 
(n=70), and mucinous (n=61) 
Controls: selected using random digit dialling 
techniques from among eligible women enumerated 
during telephone screening, N=4,682 
 
Exclusion criteria: without a history of breast cancer 
 
Observation time: between July 1994 and April 1998, 
Response rate:76.5% cases and 78.6% controls 
Exposure:  
Questionnaire: in-person interviews 
Interviewers blinded: interviewers not blinded but unaware of study hypothesis 
Reference period: consumed ≥12 alcoholic drinks in lifetime and ≥1 drink per month for ≥6 
months. 
Drink type: n/s 
Quest validated: n/s 
 
Measure: drinks per week, Reference group: never drank 
Results: 














Study aims: to examine the 
relationships of cigarette smoking, 
alcohol consumption, 
environmental tobacco smoke 
exposure, and medical treatment 
with ionizing radiation during 
adolescence with subsequent 
breast cancer risk. 
 
Source of funding: 
None specified 
Population: 
Cases:women 20-74yrs residing in 24-county area of 
North Carolina and diagnosed with invasive breast 
cancer 
N=864 
Controls:randomly selected from computerized 
databases: For women <65yrs from list of licensed 
drivers in North Carolina, women age ≥65 yrs from 
those eligible for Medicare 
N=790 
 
Exclusion criteria:previous history of breast cancer 
 
Observation time: between May 1993 and May 1996 
Response rate: cases (77%) controls (68%)  
Exposure:  
Questionnaire: Nurse-interviewer administered questionnaire 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: n/s 
 
Measure: Age at first alcoholic beverage, Reference group: non-drinkers 
Results: 
Age at first alcoholic beverage 
10-15   44/29         1.1 (0.6-1.8) 
16-19   244/211     1.0 (0.7-1.3) 









Study aims: To explore associated 
biological outcomes and clarify the 
role of timing of exposure in the 
alcohol breast cancer relationship 
 
Source of funding: 
National Institute of Child Health 
and Human Development, 
Population: 
Cases: all those aged 35-64yrs identified with breast 
cancer in five metropolitan sites in the United States 
(Atlanta, Detroit, Los Angeles, Philadelphia, and 
Seattle). 
N=4,575 
Controls: Using random digit dialling techniques, 
selected from among eligible women enumerated 
during telephone screening  
N=4,682 
 
Exclusion criteria: without a history of breast cancer 
 
Observation time: between July 1994 and April 1998, 
Response rate: cases (76.5%) controls (64.7%)  
Exposure:  
Questionnaire: in-person interviews 
Interviewers blinded: not blinded but unaware of study hypothesis 
Reference period: consumed ≥12 alcoholic drinks in lifetime and ≥1 drink per month for ≥6 
months 
Drink type: n/s 
Quest validated: n/s 
 
Measure: drinks per week, Reference group: 0 d/w 
Results: 
Overall 2 y before reference age  1-10 y before reference age    
<7      1490/1511    1.0 (0.9-1.1)  1811/852  1.0 (0.9-1.1)    
≥7          34/470      1.2 (1.0-1.3) 550/506    1.1 (1.0-1.3) 
7-<14    322/285     1.2 (1.0-1.4) 345/312    1.1 (1.0-1.3) 
≥14         212/185   1.2 (1.0-1.5) 205 194    1.1 (0.9-1.4)     
Ages 35-49, 2 y before reference ageAges 50-64, 2 y before reference age 
<7          824/852   1.0 (0.9-1.1) 666/659    1.0 (0.9-1.1) 
≥7          249/248   1.0 (0.9-1.3) 285/222    1.3 (1.1-1.6) 
7 to <14 154/146   1.1 (0.8-1.4)  168/139    1.2 (1.0-1.6) 












Study aims: evaluated overall 
alcohol aswell as red and white 
wine consumption to 
examinebeverage-specific effects 
on breast cancer 
 
Source of funding: 
National Cancer Institute 
Population: 
Cases: enrolled breast cancer cases identified from 
population-based registries in Wisconsin, 
Massachusetts (excluding metropolitan Boston), and 
New Hampshire, age 20 to 69 yrs. 
N=6,327 
Controls: frequency matched to cases by 5-yr age 
groups, selected from lists of licensed drivers (<65 






between 1995 and 2000 
Response rate: cases (80%) controls (76%) 
Exposure:  
Questionnaire: Telephone interviews 
Interviewers blinded: n/s 
Reference period: during the year previous to the reference date 
Drink type: beer, red wine, white wine, or liquor (distilled spirits) 
 
Measure:drinks per week, Reference group: Non-drinkers (1,122 /1,379) 
Results: 
                       All women                     Postmenopausal women        Premenopausal women  
<1         2129/2712  0.94 (0.85-1.04)  1106/1480  0.90 (0.79-1.02)   894/1045  1.02 (0.86-1.22) 
1-3.4     1450/1731  0.99 (0.88-1.10)   745/863     1.03 (0.89-1.19)   592/767    0.90 (0.75-1.08) 
3.5-6.9   702/793     1.02 (0.90-1.17)   345/384     1.05 (0.88-1.26)   306/363    0.96 (0.78-1.19) 
7-13.9     619/658    1.11 (0.97-1.28)   355/395     1.07 (0.89-1.28)   221/223    1.17 (0.92-1.48) 
≥14        305/285     1.24 (1.03-1.49)   189/164     1.37 (1.08-1.73)   98/103      1.10 (0.80-1.52) 
1-drink increase p/d 1.01 (1.00-1.02)             1.02 (1.01-1.03)                      1.00 (0.99-1.01) 
 





Study aims: to investigate whether 
association between alcohol and 
breast cancer risk is affected by 
timing of alcohol exposure, 
modified by other risk factors such 
as BMI menopausal status, and 
HRT 
 
Source of funding: 
NationalCancer Institute 
Population: 
Cases: English-speaking women (20-98yrs) living in 
Long Island, New York with  newly diagnosed breast 
cancer 
N=1,508 
Controls: randomly selected through random digit 
dialling methods (for subjects under 65 years) and 




Exclusion criteria: none specified 
 
Observation time: August 1, 1996 to July 31, 1997 
Response rate:cases 82.1%controls62.8% 
Exposure:  
Questionnaire: In-person interview 
Interviewers blinded: n/s 
Reference period: for time periods: <20 yrs, 20 to 29 yrs, 30 to 39 yrs, 40 to 49 yrs, 50 to 59 
yrs, and ≥60yrs 
Drink type: beer, wine, and liquor 
 
Measure: grams per day, Reference group: non-drinkers 
Results: 
g/d          ca/co        Current                              g/d          ca/co    Lifetime 
<0.5       137/184   0.67   (0.50-0.91) <15       691/735   1.12   (0.88-1.42) 
0.5–5    192/217    0.83   (0.63-1.11)  15–30   147/119   1.35   (0.96-1.91) 
5–15     215/206    0.99   (0.75-1.31)  > 30       72/94      0.81   (0.55-1.19) 

















Study aims: examines generally 
recognized breast cancer risk 
factors and years of residence in 
Marin County, California, an area 
with high breast cancer incidence 
and mortality rates  
 
Source of funding: 
California BreastCancer Research 
Program 
Population: 
Cases: any female resident of Marin County 
California with a diagnosis of primary breast cancer 
between July 1997 and June 1999 if under 50 years 
of age, and between July 1997 and March 1999 if 50 
years old or older at diagnosis 
N=285 
Controls: ascertained through random digit dialling 
conducted by two survey research companies 
N=286 
 
Exclusion criteria: without breast cancer 
 
Observation time: Cases from December 1999 to 
September 2001 and controls from April 2000 to 
September 2001 
Response rate: cases (98%) controls (88%) 
Exposure:  
Questionnaire: in-person interviews 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: n/s 
 
Measure:drinks per week and day, Reference group: <1 d/week 
Results: 
Average drinks after age 21 
All Women           ca/co                            aged 50 years and over    under 50 years of age 
≥1 d/w-<2 d/d   137/149   1.1 (0.7-1.8)    90/106   0.63 (0.36-1.1)     47/43   3.5 (1.2-10.1) 
2d/d                    52/27     2.3 (1.2-4.4)    42/22     1.50 (0.70-3.3)    10/5      3.6 (0.79-16.5) 
≥3d/d                  15/6       3.6 (1.2-11.5)  13/5       2.90 (0.80-10.9)   2/1          n/s 





Descriptive Tables for colorectal cancer: cohort studies  
 





Study aims: to further address the 
hypothesis that alcohol drinking is 
associated with an increased risk of 
colon and rectal cancer by 
separating anatomical sub-sites 
 
Source of funding: 
Ministry of Health, Labour and 
Welfare of Japan 
Population: 
Source: 51,921 subjects (25,279 men and 26,642 
women) aged 40 to 64 yrs living in14 municipalities of 
Miyagi Prefecture in rural northern Japan. 47,605 
subjects responded (22,836 men and 24,769 women 
= response rate of 91.7% 
 
Exclusion criteria: already had cancer at the baseline; 
did not fully answer the questions on the frequency or 
amount of alcohol consumed and on alcohol drinking 
status 
 
Study pop: 21,199 men (Since the number of current 
drinkers was small among women (n = 4,995),  
analysis limited to men) 
 
Observation time: June 1, 1990, to March 31, 2001, 
216,494pys, 179 colon, 131 rectum cases, LFU <5%;  
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: baseline only 
Reference period: n/s 
Drink type: sake, shochu, beer, whisky, wine, or others 
 
Measure:grams per day, Reference group: never drinkers (36) 
Results: 
                             ca          Colon                    ca         Rectum 
< 22.8  29   1.15   0.65–2.03 29   1.40     0.76–2.59 
22.8–45.5 36   1.61   0.93–2.80 18   0.996   0.51–1.96 
≥45.6  79   2.03   1.23–3.33 61   1.84     1.05–3.21 
ptrend                              0.0008                                  0.02 
                             ca      Proximal colon          ca        Distal colon 
< 22.8  13    0.82   0.37–1.80 10   1.68    0.57-4.92 
22.8–45.5 12    0.89   0.40–1.99 18   3.30    1.22-8.91 
≥45.6  33    1.40   0.72–2.75 40   4.17    1.63-10.66 
ptrend                               0.16                                   0.0002 
 





Study aims:‘ associations 
betweentotal alcohol consumption, 
specific alcoholic beverage 
consumptionand the risk of CRC 
according to anatomical sub-site 
and sex’ 
 
Source of funding: 
European Research Advisory 
Board 
Population:Netherlands Cohort Study on diet and 
cancer 
Source: cohort includes 58,279 men and 62,573 
women, aged 55–69 at baseline and originating from 
204 municipal population registries throughout The 
Netherlands 
 
Exclusion criteria: Prevalentcancer cases other than 
non-melanoma skin cancer 
 
Study pop: sub-cohort, consisting of 5,000 randomly 
sampled men and women 
 
Observation time: 13.3 yrs follow-up; 2,323 cases, 
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: no 
Reference period:during the year preceding the startof the study, 
Drink type: beer; red wine; white wine; sherry and other fortified wines; liquor types, containing 
on average 16% alcohol and (Dutch) gin, brandyand whiskey. 
 
Measure: grams per day,Reference group: Abstainers 
Results:           Colorectal                     Colon                               Rectal 
0–<5.0         652 1.06 (0.91-1.23)  455 1.03 (0.87-1.22)  141 1.10 (0.83-1.45) 
5.0–<15.0    507 0.97 (0.82-1.14)  341 0.93 (0.78-1.13)  117 1.00 (0.74-1.34) 
15.0–<30.0  383 1.00 (0.83-1.20)  242 0.93 (0.75-1.14)    92 1.04 (0.75-1.44) 














Study aims: To assess association 
between alcohol consumption and 
the risk of colorectal cancer in 
Chinese population 
 
Source of funding: 
National Natural 
ScienceFoundation of China 
Population: 
Source: all residents aged ≥30 yrs in 10 small towns 
invited to participate in CRC screening in, Zhejiang 
Province, China. 84.84% of 75,842 eligible 
individuals, responded 
 
Exclusion criteria: None specified 
 
Study pop: 64,343 (31,087 men, 33,256 women),  
 
Observation time: 
10.6 years of follow-up from  May 1990 to January 
2001; 242 cases of CRC, (colon 107) (rectal 135) 
Exposure:  
Questionnaire: face-to-face questionnaire 
Repeated during follow-up: n/s 
Reference period: n/s 
Drink type:n/s 
 
Measure: drink status, Reference group: non drinker 
Results:    
                                   Daily (RR) 
Colorectal       1.11    0.74-1.67 
Colon              0.97    0.52-1.78 
Rectal             1.24    0.71-2.14 
 





Study aims: ‘…to better elucidate 
the role of alcohol drinking 
oncolorectal carcinogenesis…’  
 
Source of funding: 
‘‘Europe Against Cancer’’ 
Programme of the European 
Commission 
Population:EPIC for further details of study sample 
and characteristics see Section 2.2, Box 2.1 
 
Observation time: 
between 1992and 2000 were followed up for an 
average of 6.2 years, during 
which 1,833 CRC cases 
Exposure:  
Questionnaire: various 
Repeated during follow-up: baseline only 
Reference period:over the 12 months before enrolment 
Drink type:beer, cider, wine, sweet liquor,distilled spirits or fortified wines 
 
Measure: grams per day, Reference group: 0.1-4.9 g/d (colorectal n=433), colon (n=299), 
rectal (n=134) 
Results:                    Colorectal                      Colon                           Rectal 
non-drinkers 110  0.98 (0.72-1.33)     83   1.03 (0.72-1.48)      27   0.85 (0.48-1.52) 
4.9-14.9        444  1.05 (0.90-1.21)     298 1.06 (0.88-1.26)     146  1.02 (0.78-1.32) 
15-29.9         246  1.07 (0.89-1.29)    156  1.07 (0.85-1.34)      90   1.09 (0.79-1.49) 
30-59.9          40   1.23 (0.98-1.55)     82   1.17 (0.87-1.56)      58   1.33 (0.91-1.94) 
>60                74   1.98 (1.46-2.70)     38   1.62 (1.07-2.46)      36    2.59 (1.62-4.13)     




















Study aims: investigated the 
associations of folate, methionine, 
and alcohol intake, as well as 
combinations of these factors, with 
risk of colorectal cancer 
 




Source: 64,182 women selected for entry into study 
cohort from a breast cancer screening programme 
(1973-1980) in US. 96% of women completed 
baseline questionnaire (1979-1981) and were eligible 
for further participation in study 
 
Exclusion criteria: prior colorectal cancer; missing 
(>30) items on the FFQ; implausible or unusually high 
intakes of folate 
 
Study pop: = 45,264 
 
Observation time: 
1987-1989 through to 1995-1998, LFU 10%,  
490 Incident cases of colorectal cancer 
Exposure:  
Questionnaire: 62-item Block/NCI FFQ 
Repeated during follow-up: baseline only 
Reference period:over the previous year 
Drink type: 
 
Measure: drinks per day, Reference group: 0 drinks per day 
Results:  
    d/d                      Colorectal 
0.01-0.50         0.92   0.73-1.16  
0.51-1.00         1.00   0.74-1.35   
1.01-2.00         0.94   0.62-1.42 
<2.00               1.16   0.63-2.14  ptrend 0.84 
 
 





Study aims: investigated the 
association of alcohol consumption, 
smoking, and their joint effect with 
colorectal cancer and estimated the 
population-attributable fraction 
(PAF) to clarify their public health 
impact, based on a study 
 
Source of funding: 
Ministry of Health, Labor and 
Welfare of Japan 
Population: 
Source: subjects (n= 57,591men and 59,103 women) 
identified by population registries in Osaka and 
Tokyo, maintained by local municipalities to form the 
Japan Public Health Centre-based prospective study 
on cancer and cardiovascular disease. 45,452 men 
(79%) and 49,924 women (84%) returned baseline 
questionnaire 
 
Exclusion criteria: Self reported medical history of 
cancer; Previous diagnosis of colorectal cancer;  
incomplete alcohol and/or smoking items 
 
Study pop: 42,540 men and 47,464 women 
 
Observation time: 
From baseline (1990-1993) until December 31, 1999. 
Loss to follow up 5%, 772 incident cases  
Exposure:  
Questionnaire: self-administered validated questionnaire 
Repeated during follow-up: n/s 
Reference period:n/s 
Drink type: yes 
 
Measure: grams per week, Reference group: never drinkers 
Results:   
                  Colon              Rectal  
1-149         1.0  (0.7-1.4)     1.6  (0.9-2.6) 
150-299     1.3  (0.9-1.8)     1.7  (1.0-2.8) 
300+          1.9  (1.4-2.7)     2.4  (1.5-4.0) 
















Study aims: To investigate the 
relationship between amount and 
type of alcohol and the risk of colon 
and rectal cancer. 
 
Source of funding: 
Danish National Board of Health 
and Danish Ministry of Health 
 
Population: 
Source: male participants from 3 longitudinal studies 
in Copenhagen, Denmark between 1976 and 1986, 
two random samples of general population, the other 
collected from 14 large workplaces 
 
Exclusion criteria:subjects with a history of cancer at 
baseline, except for non-melanoma skin cancer or 
carcinoma in situ 
 
Study pop:= 24, 496  
 
Observation time: During a total of 426 934 person 
years (LFU <1%), 411 colon cancers (159 proximal 
colon, distal colon) and 202 rectal cancers. Mean 
follow up 14.7 years (range 2–23 
Exposure:  
Questionnaire: self administered questionnaire 
Repeated during follow-up: yes 
Reference period: n/s 
Drink type: yes 
 
Measure: drinks per week, Reference group: <1 drink per week 
Results:  
             Colon                  Rectum 
1-6       1.0   0.8-1.3       1.5    0.9-2.3 
7-13      0.9  0.7-1.2       1.5    0.9-2.5 
14-27    0.9  0.6-1.2       1.7    1.0-2.8 
28-40    1.1  0.7-1.7       2.1    1.1-4.0 
≥41       0.8  0.5-1.5       2.2    1.0-4.6 
ptrend =0.58                    ptrend=0.03 
 
 





Study aims: ‘We have therefore 
conducted a prospective study, 
among Japanese people, of 
colorectal cancer in relation to 
height, BMI, alcohol consumption, 
and smoking habit’ 
. 
Source of funding: 
Ministry of Education, Culture, 
Science, and Technology, Japan 
 
Population: 
Source:  cohort established in September 1992 with 
residents in Takayama, Japan, who were 35 years 
old or older 
 
Exclusion criteria:Participants who did not report their 
height; those who reported cancer other than non-
melanoma skin cancer or colorectal adenoma at 
baseline; subjects who left four out of nine two page 
spreads of questionnaire or more all blank, and those 
who inadequately reported to the questionnaire  
 
Study pop: 29,051 
 
Observation time: 
1 January 1993 to 31 December 2000 
198 (105 men, 93 women) with colon and 97 (56 
men, 41 women) with rectal cancer. 
Exposure:  
Questionnaire: semi quantitative FFQ 
Repeated during follow-up:  
Reference period: 
Drink type: sake, beer, light beer, shochu (distilled from sweet potatoes, rice, or buckwheat), 
wine, and hard liquor 
 
Measure:grams per day, Reference group:non-drinkers 
Results:  
Men               Colon                     Rectal 
≤36.7    1.79    0.71-4.55,    0.59   0.25-1.42 
>36.7    2.67    1.06-6.76     1.17   0.50-2.73 
ptrend0.01       ptrend0.06  
Women          Colon                     Rectal 
≤36.7    1.07    0.58-1.96,     1.20  0.44-3.26 
>36.7    1.78    1.00-3.18      1.80  0.70-4.62 














Study aims: to examine effects of 
alcohol consumption on the risk of 
colon cancer and the individual role 
of different types of alcoholic 
beverages and their effects on 
colon cancer and to assess 
changes in drinking patterns on 
colon cancer risk. 
 
Source of funding: 
None specified 
Population: 
Source: Study population derived from representative 
national survey  (National Health Epidemiologic 
Follow-up Study) 14,407 participants eligible for 
follow-up, 13,291 (92.2%) were successfully traced 
through 1992 
 
Exclusion criteria:previous history of cancer; subjects 
who were pregnant during the interview period were 
also excluded because drinking behaviours very likely 
were changed as a result of health recommendations 
 




10-yr follow-up (1982–84 to 1993), 111 colon cases 
Exposure:  
Questionnaire: quantity frequency measure of drinking 
Repeated during follow-up: baseline only 
Reference period:over past 12 months 
Drink type: yes 
 
Measure:drinks per day, Reference group: non drinker 
Results:  
<1             1.08  0.65-1.79 
≥1             1.69  1.03-2.79  ptrend        0.04 
                                        Beer                          Wine                                  Spirits 
1 drink/day 27   1.04   0.65-1.66    31   1.04   0.67-1.61     33  1.48   0.95-2.31 
≥1 drink/day 8     1.09   0.51-2.34     3    0.78   0.24-2.49     15  2.48   1.66-4.53 
 





Study aims: to investigate the 
effect of long-term alcohol intake on 
risk of breast cancer 
 
Source of funding: 
National Institutes of Health 
Population:HEALTH PROFESSIONALS FOLLOW-
UP STUDY 
FOR FURTHER DETAILS OF STUDY SAMPLE AND 
CHARACTERISTICS SEE SECTION 2.2, BOX 2.1 
 
Observation time: 
868 colorectal cancer cases were identified between 
1986 and 31 January 2002; 583 were classified as 
colon cancer and 175 as rectal cancer. 
Exposure:  
Questionnaire: FFQ 
Repeated during follow-up: Baseline alcohol intake used as first approach, (1986 FFQ). 
Updated information on alcohol intake was included (most recent intake at any time point), for 
which each 4-year interval between FFQs was treated as a mini-follow-up study and only the 
most recent alcohol intake was included 
Reference period:within the previous year, Drink type:beer, wine and spirits 
 
Measure: grams per day, Reference group: Non-drinkers =67 
Results:                  Baseline                    Updated                  Cumulative average 
0.1-5 g           167  1.05 (0.79-1.40)   124  1.14 (0.83–1.56)   202  1.02 (0.75-1.37) 
5.1-10 g         120  1.30 (0.96-1.76)     98  1.15 (0.83–1.60)   130  1.16 (0.85-1.59) 
10.1-20 g       192  1.38 (1.04-1.83)   186  1.34 (0.99–1.81)   188  1.31 (0.97-1.78) 
20.1-30 g         52  1.43 (0.99-2.07)     46  1.21 (0.81–1.79)     58  1.08 (0.74-1.57) 
30.1-45 g         86  1.44 (1.04-2.00)     77  1.36 (0.95–1.93)     88  1.56 (1.10-2.20) 
≥45 g               59  1.75 (1.21-2.52)     24  1.62 (1.08–2.41)     46  1.59 (1.06-2.38) 
Past drinkers 125  1.31 (0.97-1.77)   232  1.05 (0.78–1.40)     99  1.15 (0.83-1.60) 
P for trend                     0.0006                      0.020                                0.0006 












Study aims: To investigate the 
possible roles of tobacco and 
alcohol in colorectal cancer in non-
white populations 
 
Source of funding: 
National Cancer Institute 
Population:Singapore Chinese Health Study 
Source: permanent residents of Singapore who lived 
in government-built housing estates (86% of 
population lived in such facilities during enrolment 
period. Between April 1993 & December 1998, 
63,257 subjects ( 85% of eligible subjects 
approached) recruited 
 
Exclusion criteria:baseline history of invasive cancer 
(except non-melanoma skin cancer) or superficial, 
papillary bladder cancer from the 
 
Study pop: 61,321 
 
Observation time: 1993-1998 to 31 December 2004;  
average 8.9 yrs of follow-up; LFU: 0.7%; 852 
colorectal cancer cases 
Exposure:  
Questionnaire: in-person interview, 165-item food frequency questionnaire 
Repeated during follow-up: baseline only 
Reference period: n/s 
Drink type: (beer, wine, western hard liquor and Chinese hard liquor 
 
Measure:drinks per week, Reference group: nondrinker (colorectal=658, colon -416, rectal = 
242) 
Results:             Colorectal                   Colon                        Rectal 
<7   117   0.96   (0.72–1.25)    60   0.96   (0.72–1.25)     57   1.22   (1.07–2.35)  
7+     70   1.84   (1.31–2.58)    40   1.84   (1.31–2.35)     30   1.59   (1.07–2.35)  
p trend               0.0004                          0.01                                0.01 
 





Study aims: To examine 
established risk factors to 
determine whether they were 
differentially associated with colon 
and rectal cancer 
 
Source of funding: 
National Institutes of Health 
Population: NURSES’ HEALTH STUDY (NHS)AND  
HEALTH PROFESSIONALS FOLLOW UP STUDY 
(HPFS). See Chapter 2.2 Box 2.1 
-  
Study pop: 134,365 
 
Observation time: 
2,302,712 person years, 1,139 cases of colon cancer 
and 339 cases of rectal cancer 
Exposure: NURSES’ HEALTH STUDY (NHS) AND HEALTH PROFESSIONALS FOLLOW 
UP STUDY (HPFS). See Chapter 2.2 Box 2.1 
 
Measure: grams per day, Reference group: 0 grams per day 
Results:  
                    Colon                 Rectal 
<10         0.97   0.82-1.14     1.04   0.77-1.40 
10-19      1.04   0.85-1.26     1.07   0.75-1.55 
≥20         1.27   1.03-1.56     1.26   0.85-1.87  
past        1.02   0.79-1.32     0.93   0.56-1.54 




















to quantify the risk of colorectal 
cancer among patients hospitalised 
at least once with a diagnosis of 
alcoholism. 
 
Source of funding: 
Swedish Cancer Society. 
 
Population: record-linkage study based on the 
Swedish Inpatient Register created by the National 
Board of Health and Welfare. identified 193040 
discharge records in the Inpatient Register with a 
diagnosis of alcoholism (ICD-8=291, 303; ICD-9=291, 
303, 305A) during 1970–1994 
 
Exclusion criteria:prevalent cancers; erroneous or 
incompletenational registration number, patients who 
died during the hospitalisation for alcoholism  
 
Study pop: 179398 patients, 36568 women and 
142830 men 
 
Observation time:average follow up of 9 yrs, 
1627902 person-years at risk; 929 incident cancers of 
the colon or rectum 
Exposure: consumption defined by specified ICD-7,8,9 codes (ICD-7=307, 322; ICD-8=291, 
303; ICD-9=291, 303, 305A),  into category ‘alcoholism’ 
 
 
Method: drinking status (alcoholism), Standardised incidence ratio 
Results:  
                  Colorectal 
All        1.0     0.93-1.06            
Male     1.02  0.95-1.09            
Female 1.6    0.74-1.06 
 
 
Descriptive Tables for colorectal cancer: case control studies 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Ho 2004 
 
Country: Hong Kong 
 
Study aims: To investigate any 
association of colorectal cancer 
with smoking cigarettes and 
drinking. 
 
Source of funding: 
Health Services Research 
Committee of Hong Kong 
 
Population: 
Cases: ethnic Chinese recruited from the surgical 
departments of 3 public hospitals, representing 
approx. 30% of population in Hong Kong. 
N=822 consecutive new patients, 452 colon cancer 
and 357 rectal cancer 
Controls: from same hospitals as cases  
N=926 
 
Exclusion criteria: too ill for interview or had past 
history of malignancy; controls who required a special 
diet due to underlying medical conditions 
 
Observation time: April 1998 to March 2000 
Response rate: Cases (82.2%) Controls (95.5%) 
Exposure:  
Questionnaire: Structured interviews trained interviewers 
Interviewers blinded: n/s 
Reference period: Drinking habits’ immediately prior to cancer diagnosis 
Drink type: n/s 
 
Measure: units per day, Reference group: never drinkers 
Results:  
                       Current        > 4 units    
CRC   1.42  1.09-1.85    1.29  0.81-2.06    
Colon  1.49  1.08-2.04    1.18  0.67-2.08      








Study and Aims Study and sample characteristics Exposure measurement and main results 
Hong 2005 
 
Country: South Korea 
 
Study aims: To evaluate 
contribution of polymorphisms of 
the XRCC1 gene to the risk of 
colorectal cancer 
 
Source of funding: 
Inha University 
Population: 
Cases: all newly diagnosed at outpatient clinics of 
general surgery at the Inha University Hospital, 
Incheon, South Korea, N=209 (rectal 145, colon 64) 
Controls: selected by random sampling of subjects 
who voluntarily visited the health-screening clinic at 
same hospital, N=209 
 
Exclusion criteria: None specified 
 
Observation time: 2001–2003; Response rate n/s 
Exposure:  
Questionnaire: Self administered questionnaire 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: yes 
 
Measure: grams per week, Reference group: <80 g/wk 
Results:   ca/co 
≥80g/w      64/52   2.60    1.46 -4.62 
 
 





Study aims: To examine the 
association between colorectal 
cancer risk and alcohol and 
tobacco 
 




Cases: permanent Shanghai residents newly 
diagnosed with cancers of the colon  or rectum  at 
ages 30–74 year 
N=931 with colon 874 with rectal cancer 
Controls: randomly selected from the general 




Exclusion criteria: None specified 
 
Observation time: 
Between October 1990 and July 1992 
Response rate n/s 
Exposure:  
Questionnaire: standardized questionnaire 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: n/s 
 
Measure: grams per week, Reference group:non drinker 
Results:   
     g/w                 Colon                                       Rectal 
Ex drinker 2.3   1.4-3.7  1.1   0.9-1.4 
Current  1.0   0.8-1.3  0.6   0.4-1.0 
≤159  0.8   0.5-1.2  0.6   0.4-0.9 
>159-≤329 0.8   0.5-1.2  0.9   0.6-1.3 
>329-<560 0.9   0.6-1.4  1.0   0.6-1.5 
≥560  1.5   1.1-2.2ptrend 0.16 1.2   0.8-1.7 ptrend 0.60 
Years of drinking 
<15  0.7 (0.5–1.1)  0.7 (0.4–1.0)  
15–30  0.8 (0.5–1.2)  0.8 (0.5–1.2)  
30–44  1.3 (0.9-1.8)  1.0 (0.7–1.5)  

















Study aims: to assess the effects 
of alcohol consumption on the risk 
of colorectal cancer according to 
anatomical sub-site by examining 
separately the proximal colon, the 





Cases: All cases of colorectal cancer at 21 sites 
occurring in men aged 35-70 years diagnosed at all 
the large hospitals in Montreal area 
N=585 (176 proximal and 179 distal colon cancers, 
and 230 rectal cancers). 
Controls: selected using as sampling frames either 
electoral lists or random-digit dialling. 
N=533 
 




Between 1979 and 1985 
Response rates: Cases (85.8%) Controls (72.0%) 
Exposure:  
Questionnaire: face-to face interview 
Interviewers blinded:  
Reference period:lifetime consumption 
Drink type: yes 
 
Measure: grams per week, Reference group:non drinker 
Results:   for non weekly drinkers 
                   proximal           distal              rectum 
1-2g/w    0.8 0.4-1.4      1.8  1.0-3.2     1.3   0.7-2.3 
3-4g/w    0.8 0.4-1.7      2.3  1.2-4.4     1.7   1.0-3.1 
≥5g/w    1.6 0.9-2.9      3.0  1.6-5.6     2.0   1.1-3.6 
 
 





Study aims: To explore a possible 
etiologic role of alcohol-drinking 
habit in the incidence of colorectal 
cancer with special reference to the 
ALDH2 genotypes. 
 
Source of funding: 
Ministry of Education, Science, 
Sports and Culture of Japan 
Population: 
Cases: cancer patients who underwent surgery in 
Chiba Cancer Centre Hospital 
N=265 colon 164 rectum 




Exclusion criteria:history of cancer 
 
Observation time: from 1989 through 1997. 
Response rate n/s 
Exposure:  
Questionnaire: Self-administered questionnaire. 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: Japanese sake, shochu, beer, whisky or wine 
 
Measure: cups of sake, Reference group:non drinker 
Results:  men only 
                   Colon                   Rectal 
<1.0       0.53  0.29-0.99     0.48   0.22-1.02 
1.0-1.9   0.81  0.48-1.4       0.84   0.45-1.6 
2.0-2.9   1.66  0.88-3.1       2.04   0.97-4.3 



















Study aims: To investigate how 
fluid intake from beverages and 
sources of fluid intake influence risk 
of rectal cancer. 
 
Source of funding: 
National Institute of Health 
 
Population: from Kaiser Permanente Medical Care 
Program of Northern California and the state of Utah 
Cases:all eligible incident rectal cancer cases within 
these populations between 30-79 yr identified using a 
rapid-reporting system 
N=952  
Controls: randomly selected from membership lists, 
and, in Utah, controls ≥65 yr randomly selected from 
social security lists and controls <65 yr, randomly 
selected from driver’s license lists 
N=1,205 
 
Exclusion criteria:previous colorectal tumour known 
familial adenomatous polyposis, ulcerative colitis, or 
Crohn’s disease 
 
Observation time: May 1997 to May 2001 
Response rates; 65.2% cases, 65.3% controls 
Exposure:  
Questionnaire: trained and certified interviewers using laptop computers 
Interviewers blinded: n/s 
Reference period: per week 10 and 20 yr ago. 
Drink type: n/s 
 
Measure: grams per week, Reference group:non drinker 
Results:  
Rectal           Men                Women 
≤114    1.0   0.75-1.32      1.03  0.73-1.47 
>114    1.0   0.78-1.38      1.07  0.76-1.50 
 
 





Study aims: to assess the effects 
of alcohol consumption on the risk 
of colorectal cancer according to 
anatomical sub-site by examining 
separately the proximal colon, the 





Cases: All cases of colorectal cancer at 21 sites 
occurring in men aged 35-70 years diagnosed at all 
the large hospitals in Montreal area 
N=585 (176 proximal and 179 distal colon cancers, 
and 230 rectal cancers). 
Controls: selected using as sampling frames either 
electoral lists or random-digit dialling. 
N=533 
 
Exclusion criteria: inadequate histories of alcohol 
consumption 
 
Observation time: 1979 to 1985 
Response rates: Cases (85.8%) Controls (72.0%) 
Exposure:  
Questionnaire: face-to face interview 
Interviewers blinded:  
Reference period:lifetime consumption 
Drink type: yes 
 
Measure: grams per week, Reference group:non drinker 
Results:  non weekly drinkers 
                 proximal           distal             rectum 
1-2p/w   0.8 0.4-1.4    1.8  1.0-3.2     1.3 0.7-2.3 
3-4p/w   0.8 0.4-1.7    2.3  1.2-4.4     1.7 1.0-3.1 






Descriptive tables for endometrial cancer: cohort studies 
 





Study aims: to examine the 
association between alcohol and 
endometrial cancer incidence 
 
Source of funding: 
WCRF, Swedish Cancer 
Foundation, The Swedish Research 
Council for Infrastructure. 
Population: 
Source: population-based Swedish Mammography 
Cohort includes women from central Sweden who 
were 40 to 76 years of age at enrolment between 




Study pop: 61,226 after exclusions 
 
Observation time: From December 31, 2005 to 
December 31, 2007; mean follow-up of 17.6 yrs loss 
to follow up: n/s, 687 incident endometrial 
(adenocarcinoma) cancer cases. 
Exposure:  
Questionnaire: self-administered FFQ 
Repeated during follow-up: baseline and in 1997, used updated information on alcohol from 
2nd quest, and by using average alcohol consumption for Jan. 1, 1998 to Dec. 31, 2007 from 
two questionnaires. 
Reference period: n/s 
Drink type: n/s 
 
Measure: grams per day, Reference group: Non-drinkers (n=268) 
Results: 
                 ca              Baseline             ca             Long-term 
<3.4         273      1.01    (0.85-1.20)     300       1.01    (0.84-1.22) 
3.4-9.9    122       0.95    (0.75-1.19)     141       1.01   (0.80-1.27) 
≥10.0        24       1.12    (0.73-1.71)       25       1.09    (0.71-1.67) 
 





Study aims: To examine the 
association between alcohol 
consumption, cigarette smoking, 
and endometrial cancer. 
 
Source of funding: 
n/a 
Population: 
Source: Netherlands Cohort Study (NLCS) started in 
September 1986 when 62,573 women aged 55-69 
years were enrolled in cohort. Sub-cohort of 2,589 
women sampled after the baseline exposure 
measurement. 
 
Exclusion criteria: diagnosed with non-epithelial 
tumours; information on either alcohol consumption 
or cigarette smoking was incomplete; undergone 
hysterectomy. 
 
Study pop: 1,901 (after exclusions) 
 
Observation time: 11.3-year follow-up period from 
September 1986 to December 1997 and no loss to 
follow-up; 280 cases 
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: baseline only 
Reference period: during year preceding baseline interview 
Drink type: beer, red wine, white wine, sherry, other fortified wine, liqueur, and liquor 
 
Measure: grams per day, Reference group: less than once per month (n= 82) 
Results: 
0.1–4  105     1.09   (0.78–1.52) 
5–14 39       0.95    (0.62–1.45) 
15–29 17       0.94    (0.52–1.69) 
















Study aims: To examine the 
impact of alcohol intake on 
endometrial cancer risk among 
postmenopausal African-American, 
Japanese-American, Latina, Native-
Hawaiian and White women 
 
Source of funding: 
National Cancer Institute. 
Population: 
Source: Multiethnic Cohort Study: participants 
identified via US state driver's license files, voter 
registration lists and Health Care Financing 
Administration data files. Cohort consisted of 
>215,000 men and women (45-75 yrs at baseline) 
and comprised mainly 5 self-reported racial/ethnic 
populations: African Americans, Japanese 
Americans, Latinos, Native Hawaiians and Whites 
living in Hawaii and California. 
 
Exclusion criteria:had cancer other than 
nonmelanoma skin cancer; reported a hysterectomy 
or a bilateral oophorectomy; missing data on any of 
the key lifestyle variables 
 
Study pop: 41,574 postmenopausal women (15.7% 
African Americans, 31.5% Japanese Americans, 
21.5% Latinas, 6.7% Native Hawaiians, 24.5% whites 
 
Observation time: 1993-1996 to December 31, 
2002, average follow-up 8.3 yrs, 324 incident cases  
Exposure:  
Questionnaire: self-administered FFQ, nine intake categories ranged from “never” to “4 or 
more times per day” and information on usual serving size also requested 
Repeated during follow-up: baseline only 
Reference period: during the year preceding the baseline questionnaire 
Drink type: regular beer, light beer, red wine, white/pink wine (including champagne and sake) 
and hard liquor 
 
Measure:grams per day (12grams =1 ‘standard’ drink), Reference group: non-drinkers [0 g/d 
or <1 drink/day] (n=196) 
Results: 
g/d              ca      Total alcohol         ca              Beer 
>0 to <12   85  1.01  (0.77-1.33)        42   1.04  (0.73-1.49) 
12 to <24  14   1.09  (0.62-1.93)         5    1.68  (0.67-4.21) 
≥ 24          29    2.01  (1.30-3.11)        4    1.46  (0.52-4.12)  
p trend 0.1910.327 
 
g/d              ca                Wine               ca              Spirits 
>0 to <12   81     1.14 (0.85-1.52)         44   1.18 (0.82-1.69) 
12 to <24   9       1.37 (0.68-2.78)          8    2.25 (1.06-4.77) 
≥ 24           11     3.15 (1.63-6.09)        10    1.96 (0.98-3.90) 
p trend 0.0070.015 
 





Study aims: examine associations 
of physical activity, weight, fruit, 
vegetable, and alcohol 
consumption, SES, parity and 
presence of diabetes mellitus with 
risk of endometrial cancer  
 
Source of funding: 
Swedish Cancer Society 
Population: 
Source: Swedish Twin Registry cohort, of male and 
female same sexed twin pairs, born 1886–1925 and 
living in Sweden in 1961, In 1961, 12,186 women, 
approx. 85% of females in Registry, replied to initial 
questionnaires. 
 
Exclusion criteria:incomplete lifestyle information 
Study pop: 11,659 women  
 
Observation time: 1961 to December 31, 1992. 
Mean follow-up period of 20.4 years, No loss to follow 
up, 133 incident cases,  
Exposure:   
Questionnaire: Mailed self completed questionnaire 




Measure: drinks per week, Reference group: non-drinkers 
Results: 
< 2             22     1.7  (1.0-2.8) 
≥2-< 4        10     1.2  (0.6-2.4) 














Study aims: To investigate 
whether alcohol intake in general 
and alcohol abuse in particular 
increases risk for endometrial 
cancer 
 
Source of funding: 
Swedish Cancer Society 
Population: 
Source: women who were hospitalized at least once 
with a diagnosis of alcoholism between 1965 and 
1994, identified from National Inpatient Registrar 
 
Exclusion criteria:records with erroneous national 
registration numbers; patients with prevalent cancer 
inconsistencies uncovered during record linkage 
 
Study pop: n= 36856 
 
Observation time: 
between 1964 and 1994, followed for an average of 
9.6 years, LFU: n/s 
69 primary endometrial cancer cases 
Exposure: Diagnosis of alcoholism (undefined) 
Questionnaire: n/a 
Repeated during follow-up: n/a 
Reference period :n/a 
Drink type: n/a 
 
Measure: standardised incidence ratio, Reference group: n/a 
Results: 
Total intake               69      0.76   (0.59–0.96) 
Age at follow-up (yr)                                                      Duration of follow-up (yr) 
<50                           17       1.7      1.0–2.7              1–9                 42        0.8       0.6–1.0 
50–59                       21       0.6      0.4–1.0              ≥10                 27        0.8       0.5–1.1 
≥60                           31       0.6      0.4–0.9 
Calendar year at entry 
1965–1974              19         0.9      0.5–1.4 
1975–1984              38         0.7      0.5–1.0 
1985–1994              12         0.8       0.4–1.4 
 
Descriptive tables for endometrial cancer: case control studies 
 





Study aims: To examine the 
association between alcohol 
consumption and endometrial 
cancer risk 
 
Source of funding: 
the Ministry of Education, Science, 
Sports, Culture, and Technology of 
Japan, Ministry of Health, Labour, 
and Welfare of Japan 
Population: 
Cases: all incident cases from Hospital-based 
Epidemiologic Research Program at Aichi Cancer 
Centre 
N= 148 
Controls: randomly selected from the Hospital-based 
Epidemiologic Research Program at Aichi Cancer 
Centre 




Observation time: January 2001 to June 2005 
Response rate: 90% for cases and controls 
Exposure:  
Questionnaire: self-administered questionnaire 
Interviewers blinded: n/a 
Reference period: during the 1-year period before 
onset of the present disease or before being interviewed 
Drink type: Japanese sake, beer, shochu, whiskey and wine 
 
Measure: frequency and amount (grams per week), Reference group: non drinking in last 
week (108/929) 
Results:        Frequency                                       Amount 
<1/week 14/166      0.71  (0.39–1.29)     <25 g/w           23/246   0.79 (0.49–1.28) 
1–2/week 11/119    0.77  (0.40–1.50)      25–175 g/w    12/232    0.42 (0.23–0.79) 
3–4/week 8/99        0.67  (0.31–1.43)      >175 g/w          3/47      0.47 (0.14–1.58) ptrend 0.005 













Study aims: to investigate the 
effect of diet on risk of endometrial 
cancer accounting for known risk 
factors. 
 




Cases: from series of case-control studies of diet and 
cancer of the breast, endometrium, ovary, and 
prostate in western New York 
N= 523 
Controls: randomly selected from driver's license lists 
for women <65 years of age and from Health Care 




Exclusion criteria: None specified 
 
Observation time: 
Between November 1986 and April 1991 
Response rate: 51% for cases and controls 
Exposure:  
Questionnaire: trained nurse interviewers with interview schedule 
Interviewers blinded: n/s 
Reference period: up to 2 years prior to the interview, 10 years, and 20 years before the 
interview and at age 16. 
Drink type:n/s 
 
Measure: grams per month, Reference group: 0.5 grams per month 
Results: 
 
0.6-2.1    62/168     1.0 (0.6-1.6) 
2.2-9.0    42/173     0.8 (0.5-1.3) 
>9.0        39/159     1.0 (0.5-1.8)  ptrend=0.58 
. 
 
Study and Aims Study and sample characteristics Exposure measurement and Main results 




Study aims: To assess effects of 
cigarette smoking and alcohol 
consumption on risk of endometrial 
cancer among postmenopausal 
women. 
 
Source of funding: 
American Cancer Society, Swedish 
Cancer Society, US National 
Institutes of Health 
Population: 
Cases: identified from six regional cancer registries in 
Sweden 
N=1055 
Controls: randomly selected from continuously 
updated population register, 
N=4216 
 
Exclusion criteria: premenopausal women; previous 
diagnosis of breast cancer 
 
Observation time: 
1 January 1994 and 31 December 1995 
Response rate: cases 75% and controls 79.9%  
Exposure:  
Questionnaire: mailed questionnaires supplemented by telephone interviews for 14% of 
controls 
Interviewers blinded: n/a 
Reference period: one year before interview 
Drink type:beer (light, strong), wine, fortified wine, spirits 
 
Measure: grams per day, Reference group: non drinkers 
Results: 
g/d              ca/co 
>0-<1.59    132/491        1.16  (0.90-1.49) 
1.6-3.99     104/506        0.92  (0.70-1.92) 






Descriptive Tables for gastric cancer: cohort studies 
 





Study aims: to assess the effects 
of types of alcoholic beverage on 
the risk of developing gastric 
cancer 
 




Source: Copenhagen Centre for Prospective 
Population Studies, consisting of 3 longitudinal 
population studies in Copenhagen area randomly 
selected from age-stratified population, and from 14 
large workplaces in Copenhagen 
 
Exclusion criteria: previously diagnosed gastric 
cancer. 
 
Study pop: 15 236 men and 13 227 women 
Mean participation rate was 80% 
 
Observation time:   389 051 person-years , LFU: 
<1%; 122 incident cases of gastric cancer 
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: baseline only 
Reference period: n/s 
Drink type: beer, wine and spirits 
 
Measure:drink  per week, Reference group: <1 drink per week 
Results:  
1-6         1.47  (0.93-2.02)      
7-13       0.95  (0.32-1.58)     
14-27     1.04  (0.40-1.68)      
28-         1.13  (0.41-1.86)      
trend test in drinks per day  
Beer     1.02 (0.88-1.17)  ptrend0.81              Wine    0.60 (0.39-0.93) ptrend0.02  
Spirits   1.22 (0.95-1.56)  ptrend0.12 
 





Study aims: To investigate 
associations between alcohol and 
tobacco with oesophageal 
adenocarcinoma and gastric cardia 
adenocarcinoma risk and compared 
them with those for ESCC and 
gastric noncardia adenocarcinoma 
 
Source of funding: 
Intramural Research Program of 
the National Cancer Institute, NIH 
Population: 
Source: risk factor questionnaire mailed to 3.5m 
members of American Association of Retired 
Persons- open to those >50 yrs, residing in 6 US 
states and two metropolitan areas, Of 617,119 
persons who returned questionnaire (17.6%), 
566,407 completed survey  
Exclusion criteria: cancer at baseline; energy intake 
>two interquartile ranges from median; died or 
diagnosed with cancer on 1st day of follow-up; no 
information on  alcohol use 
Study pop: =474,606, 282,856 men and 191,750 
women. 
Observation time: 1995/1996 to 2000 (2,121,797 
pys follow-up), LFU: n/s, 188 with gastric cardia, and 
187 gastric noncardia adenocarcinoma cases 
Exposure:  
Questionnaire: Self administered questionnaire 
Repeated during follow-up: baseline only 
Reference period: over the past 12 months 
Drink type: wine beer liquor 
 
Measure: drinks/day, Reference group: >0–1 drinks per day 
Results: 
            ca       Gastric cardia                                   ca    Gastric noncardia  
0          46    1.19    0.83-1.70                                  59   1.30  0.93-1.82 
>1–3    29    0.99    0.65-1.52                                  31   1.17  0.77-1.77 
















Study aims: to evaluate whether 
lifestyle before diagnosis is related 
to survival of gastric cancer patients 
 
Source of funding: 
the Ministry of Health and Welfare 
Design: retrospective cohort 
 
Population: 
Source: Patients who underwent operations in the 
Department of Gastrointestinal Surgery of a major 
cancer hospital in Aichi, Japan 
 
Exclusion criteria:none specified 
 
Study pop: 877 study subjects (578 men and 299 
women) between 40 and 79 years 
 
Observation time: 
From January 1988 to December1994, LFU: n/s 
636 gastric cancer cases 
Exposure:  
Questionnaire: Self completed questionnaire 
Repeated during follow-up: n/s 
Reference period: n/s 
Drink type: sake 
 
Measure: Drinking Status&‘go’ per day, Reference group: Never(0 go/day, 1 go = 180 ml 
Japanese wine) 
Results:  
Drinking status                                    go per day          Quantity 
Ever         1.40 (0.95-2.06) 0.1-1.0     1.53 (0.98-2.39)          
Current    1.36 (0.91-2.02) 1.1-1.9     1.08 (0.70-1.66)          
Former    1.66(0.89-3.08)         ≥2         1.08 (0.70-1.66)       
 
 





Study aims: to study whether, 
whole-grain intake is related to 
reduced risk of upper aerodigestive 
tract cancers 
 
Source of funding: 
N/s 
Population: 
Source: Random sample of women aged 55–69 
years from state of Iowa driver’s license list.  
 
Exclusion criteria:if left 30 or more items blank on the 
FFQ or reported implausibly high or low energy 
intake; premenopausal women; women at baseline 
reporting cancer of any site other than skin  
 
Study pop: A total of 41,836 women responded to 
mail survey (42.7% response rate). After exclusions, 
cohort = 34,651 
 
Observation time: 
1986–1999, approx 400 ,000 person years, LFU 
<1%; 56 women with gastric cancer 
Exposure:  
Questionnaire: Self-administered 127-item FFQ 
Repeated during follow-up: baseline 
Reference period: n/s 
Drink type: n/s 
 
Measure:drinks per day, Reference group: 0 drinks per day 
Results:   
 d/d         ca       HR 
>0-1.9      8      0.63 
≥2            16    1.15 


















Study aims: Investigated the 
association between total alcohol 
(ethanol) intake as well as specific 
alcoholic beverages and risk of 
gastric cancer in  
 
Source of funding: 
n/s 
Population: Swedish Mammography Cohort 
Source: women from central Sweden 40 to 76 yrs at 
enrolment between 1987 and 1990. 66,651 women, 
(74%) returned questionnaire 
Study pop: After exclusions, 61,433 women. 
 
Exclusion criteria:implausible values for total energy 
intake; incorrect or missing national registration 
number; previous diagnosis of cancer other than non-
melanoma skin cancer 
 
Observation time: 
1987–1990 to June 30, 2005, (966,807pys follow-up), 
LFU: n/s; 160 incident cases of gastric cancer 
Exposure:  
Questionnaire: 96-item FFQ 
Repeated during follow-up: baseline only 
Reference period: over the past year 
Drink type: light beer, medium-strong beer, strong beer, wine, and hard liquor. 
 
Measure: grams per week, Reference group: Non-drinkers (n=61) 
Results: 
g/w              ca 
0.1–19.9     50     0.85     (0.58-1.25) 
20.0–39.9   27     1.18     (0.73-1.91) 
≥40.0          22     1.33     (0.79-2.25)    p-trend0.14 
 





Study aims: evaluated the role of 
smoking or alcohol use as a risk 
factor in gastric cancer, but few 
have considered anatomic and 
histo-pathologic subdivisions 
 
Source of funding: 
Ministry of Health and Welfare of 
Japan; Grant sponsor: Foundation 
for the Promotion of Cancer 
Research in Japan. 
Population: 
Source: men living in 14 catchment areas 
administered by 4 Public Health Centres in Japan 
who returned baseline questionnaire, n=20,665 men 
(76%), aged 40-59yrs 
 
Exclusion criteria:self-reported serious illness 
(cancer, ischemic heart disease; cerebrovascular 
disease, chronic liver disease) at baseline; subjects 
who were not Japanese 
 
Study pop: After exclusions, cohort =19,657 men. 
 
Observation time: 
1 January 1990 to 31 December 1999,  
LFU: n/s; identified 253 gastric cancer cases 
Exposure:  
Questionnaire: Mailed lifestyle questionnaire 
Repeated during follow-up: baseline 
Reference period: consumption at least once per week  
Drink type: sake, shochu/awamori, beer and whiskey  
 
Measure: grams per week, Reference group: 0–3 days/month 
Results:   
All sites              
0-161.0          0.8   (0.6-1.2) 
162.0-322.0   1.1   (0.8-1.5) 
325.5+           1.1   (0.8-1.6)              ptrend=0.66               
Histologic type  
                         Cardia                       Distal Diff                      Distal Undiff 
0-161.0           8   2.5 (0.7-9.5)        27   0.9   (0.5–1.5)       11     0.7 (0.3–1.4) 
162.0-322.0  13   3.3 (0.9-11.6)      38   1.1   (0.7–1.8)       15     0.9 (0.5–1.9) 
325.5+          11   3.0 (0-8-11.1)      27   0.9   (0.5-1.5)        20     1.3 (0.7-2.6) 
















Study aims: to provide valid 
evidence for the role of smoking 
and alcohol drinking in relation to 
gastric adenocarcinoma 
 
Source of funding: 
Swedish Cancer Society, Swedish 
Research Council 
Population: 
Source: health survey in the county of Nord-
Trondelag in Norway between the years 1984 and 
2002. Written invitations to participate in the survey 
were mailed to 85,100 adults living in the county 
75,043 (88.2%) who attended the survey were 
eligible for subsequent follow-up 
 
Exclusion criteria:  attending persons whose follow-up 
time after participation in the health survey was 3 
years or less to avoid selection bias 
 
Study pop: 69,962 
 
Observation time: 
(between 1984 and 1986) through December 31, 
2002, (1,117,648 pys) , LFU: n/s  
251 cases of gastric cancer, of which 224 (89%) were 




Repeated during follow-up: baseline only 
Reference period: during the last 14 days 
Drink type: n/s 
 
Measure: Frequency of alcohol drinking, Reference group: Never drinking alcohol (n=27 
gastric & n=226 non cardia gastric cancer 
Results: 
Gastric cancer (including cardia)                            Non cardia gastric cancer 
Drinking occasionally        109   1.24 (0.80-1.91)         1.16 (0.74–1.82) 
1–4 times                            58   1.30 (0.78-2.16)         1.29 (0.76–2.18) 
≥5 times                              17   1.49 (0.78-2.83)         1.66 (0.87–3.20) 
Feeling of intoxication when drinking 
No                                       70    1.10 (0.67-1.77)         1.12 (0.69–1.82) 
Yes                                     26     1.47 (0.81-2.69)        1.50 (0.80–2.83) 
Drinking excessively, or at least a bit to much 
No                                     113   1.15 (0.73-1.80)        1.13 (0.71–1.79)  
Possibly or maybe             31    1.56 (0.88-2.76)         1.49 (0.82–2.72) 
Yes                                     15    1.13 (0.57-2.24)         1.30 (0.65–2.60) 
 





Study aims: investigated the 
effects of smoking and alcohol 
consumption on the risk of gastric 
cancer by sub-site in the National 
Health Insurance Corporation Study  
 
Source of funding: 
Korean National Cancer Center 
Population: 
Source: government employees, teachers and their 
dependents who were insured by the Korea National 
Health Insurance Program in 1996, had at least one 
medical examination, n= 692 108 men aged ≥30yrs 
 
Exclusion criteria:- cancer at enrolment; missing 
information on questionnaire 
 
Study pop: n=669 634  
 
Observation time: 1996 to 2002, (4,353,317 pys); 
LFU: n/s; 3452 cases of gastric cancer, (127 (4%) 
cardia and upper-third cancers, 2409 (70%) distal 
gastric cancer and 1007 (26% unclassified) 
Exposure:  
Questionnaire: no details  
Repeated during follow-up: baseline only 
Reference period: n/s 
Drink type: Soju 
 
Measure:grams per day, Reference group: 0 grams per day (Gastric n=946, Distal 633, 
Cardia and upper third 36 
Results: 
ca     Gastric cancer       ca       Distal                     ca   Cardia and upper third 
1 –14.9         946   1.0 (0.9-1.1) 633   1.0 (0.9-1.2) 36   1.3 (0.8-2.1) 
15.0-24.9     644    1.1 (1.0-1.3) 430   1.2 (1.0-1.3) 31   1.7 (1.0-2.8) 
≥25               863   1.2 (1.1-1.4) 594   1.3 (1.2-1.5) 31   1.3 (0.8-2.2) 









Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: 'We examined risk 
factors for oesophageal squamous 
cell carcinoma, gastric cardia 
cancer, and gastric non-cardia 
cancer’ 
 
Source of funding: 
n/s 
Population: 
Source: General Population Trial from the general 
population of Linxian. 
 
Exclusion criteria: no history of cancer or debilitating 
disease 
 
Study pop: 29,584 individuals,40–69 yrs 
 
Observation time: 
March 1986 until May 2001, 15 years of follow-up, 
LFU<1%; 1,089 gastric cardia cancer and 363 gastric 
non-cardia cancer  
Exposure:  
Questionnaire: Interview and self-complete questionnaire 
Repeated during follow-up: baseline 
Reference period: in the past 12 months 
Drink type: n/s 
 
Measure: frequency, Reference group not drank in last 12 months 
Results:  
cardia               
use in last 12 months  0.84 (0.72-0.97)    
non cardia 
 use in last 12 months  0.79 (0.61-1.02) 
 
Descriptive tables for gastric cancer: case control studies 
 





Study aims: To evaluate risk 
factors for stomach cancer in 
Poland 
 
Source of funding: 
U.S. National Cancer Institute 
 
Population: 
Cases: identified by collaborating physicians in each 
of 22 hospitals serving the Warsaw area 
N=324 
Controls: randomly selected among Warsaw 
residents from a computerized registry of all legal 
residents in Poland 
N=480 
 
Exclusion criteria: None specified 
 
Observation time: 
between March 1, 1994, and April 30, 1996 
Response rate: Cases (82.1%) Controls (87.4%) 
Exposure:  
Questionnaire: interviewed by trained interviewers  
Interviewers blinded: n/s 
Reference period: prior to 2 years before 
Drink type: beer, wine, liquor 
 
Measure: drinks/week, Reference group: no alcohol on a monthly basis for at least 6 months 
Results:  
                             Current          Former     
<1      41/52   0.7 (0.4-1.2)      0.6  (0.3-1.1) 
1-<3   42/76   0.5 (0.3-0.9)     1.2  (0.5-2.6) 
 3-<7  32/66   0.4  (0.2-0.7)     1.0  (0.4-2.3) 

















Study aims: to evaluate 
relationship between smoking or 
drinking doses and risk for stomach 
cancer, and to clarify whether the 
relationship is dose-dependent or 
U-shaped. 
 
Source of funding: 
Japanese Ministry of Education, 
Culture, Sports, Science and 
Technology 
Population: 
Cases: stomach cancer patients newly hospitalized in 
one of nine hospitals in Tokyo 
N=787 
Controls: recruited from several health check 
programs in a hospital in same area 
N=1007 
 
Exclusion criteria: aged over 70 years; prior therapy 
for stomach cancer; information incomplete on 
smoking or drinking habits   
 
Observation time: 
Between June 1993 and July 1995.  
Response rate: n/s 
Exposure:  
Questionnaire: self completed questionnaire 
Interviewers blinded: n/s 
Reference period:’ lifetime’ 
Drink type: n/s 
 
Measure:lifetime alcohol years, Reference group:never drinker 
Results:   
alcohol years        Males                        Females           
0.1-134.9          0.57  (0.33-1.00)      0.54 (0.35-0.82)                             
135.0-1349.9   1.23  (0.73-2.06)       0.75 (0.43-1.30)                          
1350.0+            1.40  (0.85-2.31)       
                         ptrend<0.001                  ptrend<0.001                   
 
 





Study aims: to test the  association 
between tobacco, snuff and alcohol 
use and the risk of oesophageal 
and cardia cancer 
 
Source of funding: 
Swedish Cancer Society 
 
Population: 
Cases: patients with new diagnosis of 
adenocarcinoma of the gastric cardia in Swedish 
population 
N=262 
Controls:  randomly selected from age and sex strata 
in study base to resemble age and sex distributions 
among the oesophageal adenocarcinoma cases  
N=820 
 
Exclusion criteria: persons aged 80 years or older 
and individuals born abroad 
 
Observation time: 1995 through 1997 
Response rate: Cases (83%) Controls (73%) 
Exposure:  
Questionnaire: face-to-face interviews 
Interviewers blinded: not blinded to case/control status of the interviewees, but  unaware of 
study hypotheses 
Reference period: 20 years before the interview 
Drink type: beer, wine and liquor 
 
Measure: units per week, Reference group:never drank 
Results:, gastric cardia 
u/w               Any alcohol 
1-15             0.9 (0.5-1.5) 
16-70           0.6   (0.4-1.1) 














Study and Aims Study and sample characteristics Exposure measurement and main results 
Lindblad 2005 
 
Country: United Kingdom 
 
Study aims: Toprospectively 
assess influence of BMI, tobacco, 
and alcohol on the occurrence of 
oesophageal, gastric cardia, and 
non-cardia gastric adenocarcinoma, 
and to detect any sex differences 
that could explain the male 
predominance of these tumours 
 
Source of funding: 
AstraZeneca R&D and Swedish 
Cancer Society 
Population: 
Cases: For details see Lindblad et al in Descriptive 
tables for Oesophageal cancer 
N=1023 gastric cancers (195 gastric cardia, 327 
distal, 501 unknown) 
Controls: For details see Lindblad et al in Descriptive 
tables for Oesophageal cancer 
N= 10,000 
 
Exclusion criteria:patients with any cancer recorded 
in database before start of study period  
 
Observation time: 
January 1, 1994 to December 31, 2001 
Response rate: n/s 
Exposure:  
For details see Lindblad et al in descriptive tables for oesophageal cancer 
 
Measure: units per day, Reference group: 0-2 units per day 
Results:  
u/d  ca/co    Total gastric adenocarcinoma 
3-15  166/1662    0.92   0.75-1.12 
16-34  58/563        0.91   0.67-1.22 
>34  16/183        0.75   0.44-1.27 
Unknown 432/4219    0.99   0.80-1.24 
                                     Cardia                      Non-cardia                        Unknown subsite 
3-15    1662/33   1.08   0.70-1.69    1662/61   0.99   0.72-1.36     1662/72   0.82   0.61-1.09 
16-34   563/14      1.22   0.67-2.24    563/19     0.91   0.55-1.51     563/25     0.79   0.51-1.22 
>34   183/4        1.04   0.37-2.93     83/2        0.29   0.07-1.18     183/10     0.96   0.49-1.87 
Unknown   89/4219  1.38   0.84-2.26    89/121    0.57   0.38-0.87 
 





Study aims: To investigate 
behavioural and environmental risk 
factors for gastric cancer  
 




Cases: identified in the general hospital at San 
Cristobal, capital of Tachira State, Venezuela  
N= 302 
Controls: drawn from neighbourhoods around 




Exclusion criteria:previous gastric surgery; non-
epithelial tumours of the stomach 
 
Observation time: 
Between January 1991 and January 1997 
Response rate: n/s 
Exposure:  
Questionnaire: Social workers, who were specially trained for the study, interviewed with a 
structured questionnaire that had been  
Interviewers blinded: n/s 
Reference period: during the year preceding the interview 
Drink type:n/s 
 
Measure:Drinking Status, grams per week, years since quitting, Reference group: never and 
1-150g/w 
Results:  
Drinking Status       Current         2.9   (1.9-4.3)              
                                    Ex            3.5   (2.0-6.0)          
 Years since quitting ( referent group 6–10yrs)                         Quantity 
11–15    9/8       0.8 (0.2, 2.8)                                         151+   32/27      1.0 (0.5-2.1)          
16–20    9/5       1.3 (0.3, 5.3) 
















Study aims: to identify association 
of tobacco use, alcohol drinking, 
non-vegetarian dietary items, 
consumption of tea and coffee and 
living environment  with stomach 
cancer in India 
 
Source of funding: n/s 
Population: 
Cases: were patients attending cancer centre for 
diagnosis and treatment in Mumbai, N=170 
Controls: were cancer free patients attending same 
hospital as cases, N=2,184 
 
Exclusion criteria:infectious disease or benign lesion 
 
Observation time: 
1988–1992, Response rate: n/s 
Exposure:  
Questionnaire: Interviewed by trained social workers 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type:n/s 
 
Measure: habitual drinking, Reference group:non drinkers 
Results:  
alcohol drinkers 0.8 (0.4-1.3) p =0.2 
 
 





Study aims: To investigate various 
aspects of dietary factors, smoking, 
and alcohol drinking in determining 
risk of stomach cancer  
 
Source of funding: n/s 
Population: 
Cases: recruited from Srinagarind Hospital and 
KhonKaen Regional Hospital in KhonKaen Province, 
Thailand, N= 101 
Controls: from same hospitals as cases, N= 202 
 
Exclusion criteria: none specified 
 
Observation time: 2002-2006, Response rate: n/s 
Exposure:  
Questionnaire: interviewed by trained interviewer using a structured questionnaire 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: n/s 
 
Measure: drinking status, Reference group: non-drinkers 
Results:  Ever drinker 35/62  1.4 0.68-2.66 
 
 





Study aims: ‘ to determine role of 
smoking, alcohol use, and body 
size in the etiology of esophageal, 
gastric cardia, and distal gastric 
adenocarcinomas’ 
 
Source of funding: National 
Cancer Institute  
Population: 
Cases: men and women aged 30-74 years identified 
by Cancer Registry, Los Angeles,  
N = 500 gastric cardia/787 distal gastric cancers  
Controls: selected from same cancer registry 
N=1289 
 
Exclusion criteria: none specified 
 
Observation time: 1992-1997 
Response rate: n/s 
Exposure:  
Questionnaire: structured questionnaire administered by interviewer 
Interviewers blinded: not blind to case or control status, but were not aware of study 
hypotheses  
Reference period: lifetime use 
Drink type:beer, wine, hard liquor  
 
Measure: drinks per week, Reference group:never drinkers 
Results:          Cardia                                            Distal 
Former       0.91 (0.6-1.4)                                0.85 (0.6-1.2)    
Current      0.98 (0.7-1.5)                                0.96 (0.7-1.3)   
1-7              1.00  (0.7-1.5)                              0.83 (0.6-1.2) 
8-21            0.70  (0.4-1.1)                              0.68 (0.5-1.0) 
22-35          1.09 (0.7-1.8)                               1.10 (0.7-1.7  









Study aims: To analyse the effects 
of smoking, use of smokeless 
tobacco, alcohol intake and the risk 
of gastric cancer by sub-site and 
histology 
 
Source of funding: 
Swedish Cancer Society 
 
Population: 
Cases: individuals with newly confirmed gastric 
cancer, identified by all departments of surgery and 
pathology, supplemented by linkages to regional and 
national cancer registries, born in Sweden, and living 
in one of 5 counties in northern and central Sweden 
N=567 
Controls randomly sampled from general population 
N=1165 
 
Exclusion criteria: none specified 
 
Observation time: February 1989 through January 
1995. Response rate: cases 62%, controls 76% 
Exposure:  
Questionnaire: Face-to-face interviews were carried out by specially trained professionals 
Interviewers blinded: not blinded to  case/control status, but unaware of  study hypotheses 
Reference period: 20 years before interview 
Drink type: light beer, medium-strong beer, strong beer, wine and hard-liquor c 
 
Measure: lifetimes (ml), Reference group: non drinkers 
Results: 
                  Cardia             Distal diffuse         Distal Intestinal 
1-35 0.9   (0.4-1.9) 1.3   (0.8-2.1) 1.2   (0.8-1.9)          
36-160 0.8   (0.4-1.7) 1.0   (0.6-1.7) 1.2   (0.8-1.9)        
>160 0.7   (0.3-1.5) 1.0   (0.5-1.8) 1.2   (0.7-1.9 )                         
ptrend=        0.30                        0.73                      0.56 
 





Study aims: To examine the risk of 
gastric cancer associated with 
alcohol consumption and smoking 
in men and women in Moscow, 
Russia. 
 
Source of funding: 




Cases: patients, who lived in Moscow, with newly 
diagnosed stomach cancer in two main cancer-
treatment hospitals in Moscow. 
N= 248 men & 200 women 
Controls: selected among patients of the same  
hospitals as cases and living in Moscow 
N=292 men & 318 women 
 
Exclusion criteria: patients who had cancer and/or 
gastrointestinal diseases 
 
Observation time: February 1996-March 1997 
Response rate: cases 98.3% controls 96.5% 
Exposure:  
Questionnaire: self-administered structured questionnaire 
Interviewers blinded: n/s 
Reference period: preceding year 
Drink type: vodka sweet wine 
 
Measure: litres per year, Reference group:never drinkers 
Results:     
                        ca/co          Males          ca/co      Females 






Descriptive Tables for kidney cancer: cohort studies 
 
Study and Aims Study and sample characteristics Exposure measurement and Main results 
Lee 2006 
 
Country: USA  
 
Study aims: examined total fluid 
intake and intakes of specific 
beverages in relation to risk of renal 
cell cancer in two large cohorts, the 
Nurses’ Health Study (NHS) and 
the Health Professionals Follow-up 
Study (HPFS) 
 
Source of funding: 
NIH 
Population: 
Source: see box 2 section 2.4 (p28) 
Study pop: 88,759 women in the NHS and 47,828 
men in the HPFS (after exclusions) 
 
Exclusion criteria: previously diagnosed with cancer 
(except non-melanoma skin cancer); left extensive 
items blank on the baseline FFQ for each analysis 
 
Observation time: 
1986 to May 31, 2000, for women; January 31, 2000, 
for men, Loss to follow up: <10% 
132 incident cases of renal cell cancer during 
1,708,260 person-years of follow-up in the NHS and 
116 cases during 608,265 person-years of follow-up 
in the HPFS 
Exposure:  
Questionnaire: semi quantitative FFQ 
Repeated during follow-up: every four years 
Reference period: during past year 
Drink type: beer wine spirits 
 
Measure: grams per day, Reference group: 0 g/drams per day (n=58) 
Results: 
0.1-4.9         88  0.96  (0.68-1.34) 
 5.0-14.9      61  0.87  (0.46-1.64) 
≥15.0           41  0.66  (0.43-1.00), p trend 0.07 
 
Wine (servings per week, month)                     Spirits (servings per week, month) 
1/mo to <2/wk      96   1.16 (0.86-1.55)                 58       0.90 (0.65-1.23) 
>2/wk                   59   1.12 (0.70-1.79)                 60      0.87 (0.62-1.21) 
Beer drinkers              0.68 (0.38-1.23) 
 





Study aims: To examine the 
relationship between alcohol 
consumption and risk of RCC in a 
large prospective cohort of middle-
aged Finnish male smokers with 
detailed information on body mass 
index (BMI), diet, and lifestyle 
factors 
 
Source of funding: 
National Cancer Institute 
Population: 
Source: randomized, double-blind, placebo-
controlled, two-by-two factorial design, primary 
prevention trial, n= 29,133 males, 50- 69 yrs, who 
smoked five or more cigarettes p/day 
 
Exclusion criteria: diagnosed with prior cancer or 
serious disease limiting long term participation; those 
taking supplements or vitamins E, A, or h-carotene in 
excess of defined amounts 
 
Study pop: = 27,111 (93%)  
 
Observation time: 1985 to 1999, median 12.2yrs 
follow-up , LFU n/s, 195 incident cases of RCC 
Exposure:  
Questionnaire: self-administered food frequency questionnaire 
Repeated during follow-up: baseline only 
Reference period: over previous 12 months 
Drink type: beer, wine spirits 
 
Measure: grams per day, Reference group: 0-2.5 grams per day (n=56) 
Results: 
g/d                     Total alcohol                    Beer                     Spirits 
2.6-11.0       52   0.91 (0.62-1.33)     1.22 (0.85-1.76)     0.93 (0.63-1.39) 
11.1-24.0     53   0.94 (0.64-1.38)     0.83 (0.57-1.22)     0.84 (0.58-1.20) 
24.1-278.5   34   0.53 (0.34-0.83)     0.55 (0.36-0.85)     0.55 (0.36-0.85) 
















To investigate risk factors for renal 
cancer 
 
Source of funding: 
National Cancer Institute 
Population: 
Source: Women aged 55 to 69 randomly chosen from 
Iowa Department of Transportation’s driver’s license 
list. Of the 99,826 women mailed a questionnaire, 
41,836 women (42%) responded 
 
Exclusion criteria: implausible energy intakes (> 
5,000 calories or < 500 calories per day); prevalent 
cancer at the time of the baseline questionnaire; - 
pre- or peri-menopausal status. 
 
Study pop: n= 34,637 after exclusions 
 
Observation time: 1986 to 31 December 1999 
466,398 person-years of follow-up,, loss to follow up 
<1%,  124 incident kidney cancer cases 
Exposure:  
Questionnaire: self administered postal FFQ 
Repeated during follow-up: baseline only 
Reference period: within last year 
Drink type: beer wine spirits 
 
Measure: grams per week, Reference group: 0 g/w (n=79) 
Results: 
0.1–2.9     31  1.02   (0.67–1.55) 
≥3.0         14   0.43   (0.24–0.76) 
 
                                      Red wine                                      Beer 
Current drinker            0.47  (0.27-0.83)                        0.61 (0.35–1.07 
                                       White wine                                   Spirits 
Current drinker            0.63  (0.38-1.04)                        0.67 (0.43–1.06) 
 





Study aims: to examine the 
relation between major dietary 
patterns and RCC in a large 
prospective population-based 
cohort study of Swedish women. 
 
Source of funding: 
World Cancer Research Fund 
International, SwedishCancer 
Foundation, Swedish Research 
Council 
Population: 
Source: Swedish women, aged 40-76 yrs (n=66,651) 
who responded to baseline questionnaire in national 
survey 
 
Exclusion criteria:those with extreme energy intake 
estimates; previous diagnosis of cancer other than 
non-melanoma skin cancer; missing information on 
alcoholic beverages  
 
Study pop: 59, 237 women after exclusions 
 
Observation time: 
(1987–1990) to June 30, 2004, 665,981 person-yrs, 
LFU 0%; 93 incident cases of RCC 
Exposure:  
Questionnaire: self-administered food frequency questionnaire 
Repeated during follow-up: baseline only 
Reference period:how often, on average, per week or per day during the last 6 months 
Drink type:wine, liquor, beer 
 
Measure: grams per day, Reference group: <2.5 g/day (n=94) 
Results: 
Total Alcohol>55yrs 
g/d          caca 
2-5-4.3 19 0.66    0.40-1.09   10    0.78    0.40-1.53 
>4.3 19 0.71    0.42-1.19    3     0.33    0.10-1.05 










Descriptive tables for kidney cancer: case control studies 
 





Study aims: To investigate the 
association of different types of 
alcoholic beverages and of total 
alcohol (ethanol) consumption with 
the risk of renal cell cancer 
 
Source of funding: 
Swedish Cancer Foundation 
Population: 
Cases: through regional cancer registers, identified 
all incident cases of renal cell cancer in five of 
Sweden’s six hospital regions 
N= 877/1,275 




Exclusion criteria:- n/s 
 
Observation time: 
between 1 January 1996 and 30 June 1998 
Response rate: cases 69%, controls 74% 
Exposure:  
Questionnaire: self-administered questionnaire 
Interviewers blinded: n/a 
Reference period:5 years before study, disregarding recent changes 
Drink type: beer (medium, strong) wine, spirits 
Quest validated: n/s 
 
Measure: grams per month, Reference group: Non-users alcohol (136 cases, 179 controls 
Results: 
<54.8              202/258    1.0   (0.7 –1.4) 
54.9-148.9     171/255     0.9    (0.7 –1.3) 
149.0-313.6   185/256     0.9    (0.7 –1.2) 
313.6-620       115/163    0.9   (0.6 –1.3) 
>620 g                46/93    0.6    (0.4 –0.9)ptrend 0.03 
 
Study and Aims Study and sample characteristics Exposure measurement and Main results 
Hsu 2007 
 
Country: Russia, Romania, Poland 
and Czech Republic 
 
Study aims: To examine the role of 
total dairy, meat, vegetable, and 
alcohol consumption, as well as 
specific dietary components, in 
relation to risk of kidney cancer. 
 
Source of funding: 




Cases: no details provided 
N=1,065 
Controls: patients admitted to the same hospital as 
cases for conditions unrelated to smoking or 




Exclusion criteria:- information missing on diet or 
alcohol consumption; those with missing covariates 
(age, sex, tobacco use, hypertension medication use, 
body mass index, or education) 
 
Observation time: 
between August 1999 and January 2003, 
Response rate ranged from 90 to 98.6% for cases 
and from 90.3% to 96.1% for controls 
Exposure:  
Questionnaire: standardized questionnaire 
Interviewers blinded: n/s 
Reference period:usual weekly consumption during different periods of adult life (i.e., ages 
≤25, 26–40, 41–50, 51–60, and >60 years) 
Drink type: beer wine spirits 
 
Measure: grams per week, Reference group: no weekly consumption 
Results: 
g/w                         Total alcohol                                       Spirits 
<36.5             310/378    1.18   (0.93-1.49)         <30.0             1.20   (0.71-2.02) 
36.5–137.5    290/378    1.15   (0.88-1.48)          30.0–157.0   1.08   (0.69-1.72) 
>137.5           191/391    0.83   (0.61-1.12)          ≥157.0          0.51   (0.27-0.97) 
                                                    Beer                                 Wine 
<15.0                              1.20   (0.73-1.97)          <9.5               1.50    (0.93-2.44) 
15.0–49.0                       1.03   (0.58-1.83)           9.5–23.0        0.73    (0.40-1.30) 











Study aims: to address the 
potential for a gender-specific 
association of alcohol consumption 
and RCC development after 
adjustment for accepted and newly 
identified confounding factors 
 
Source of funding: 
National Cancer Institute 
Population: 
Cases: residents of Iowa who were aged 40-85 years 
and with newly diagnosed RCC 
N =406 (261 men and 145 women)  
Controls: Controls aged <65yrs, randomly selected 
from computerized state driver’s license records. 
Controls aged ≥65 yrs selected randomly from listings 
provided by US Health Care Financing Administration 
N = 2,429 (1,598 men and 831 women) 
 
Exclusion criteria: previous diagnosis of malignant 
neoplasm, except basal and squamous cell 
carcinomas of the skin 
 
Observation time: 
1985-1987, Response rate: cases 88%, controls 80% 
Exposure:  
Questionnaire: mailed FFQ supplemented by a telephone interview 
Interviewers blinded: yes (see above) 
Reference period: over all adult years. Participants specifically instructed to ignore recent 
changes in alcohol consumption. 
Drink type: beer, wine and spirits. 
 
Measure:grams per week, Reference group: never drinkers (n=98/376) 
Results:   Total Alcohol  
g/w          ca/co          Men            ca/co        Women 
≤35        77/362     1.3 (0.9-1.9) 41/217   1.0 (0.6-1.5) 
>35        86/500     0.9 (0.6-1.3) 11/101   0.4 (0.2-0.9 
ptrend = 0.5  = 0.04       
can p/w             Beer               shot p/w         Spirits 
≤1             1.4 (0.9-2.0)                1          1.4 (1.0-2.1)   
>1             1.0 (0.7-1.4)               >1         1.1 (0.7-1.6) 
 





Study aims: analysed the 
association of alcohol with RCC in 
Italy, using data from two case–
control studies of RCC conducted 
from 1985 to 2004 
 
Source of funding: 
Italian Association for Cancer 
Research; the Italian League 
against Cancer; the Italian Ministry 
of Education Italian Foundation for 
Cancer Research 
Population: 
Cases: first study, data collected from major teaching 
and general hospitals in the greater Milan area and 
the province of Pordenone, in northern Italy, and in 
second study from 4 Italian areas, including greater 
Milan area and provinces of Udine and Pordenone in 
northern Italy, province of Latina in central Italy and 
urban area of Naples in southern Italy, N=1,115  
Controls: Controls were admitted to the same 
hospitals as cases for a wide spectrum of acute, non-
neoplastic conditions, unrelated to known risk factors 
for RCC, N=2,582 
 
Exclusion criteria: n/s 
 
Observation time: 
Between 1985 and 1992 and 1992 to 2004 
Response rate: >95% for cases and controls 
Exposure:  
Questionnaire: structured questionnaire administered by trained interviewer 
Interviewers blinded: n/s 
Reference period: up to 1 year before diagnosis for cases or hospital admission for control 
Drink type: wine, beer and spirits 
 
Measure: drinks p/day, drinking duration, age started, Reference group: Non-drinkers 
(258/495) 
Results:      Drinks per day 
≤4              617/1371      0.87 (0.73–1.04) 
>4 to ≤8    170/477         0.76 (0.59–0.99) 
>8                70/238        0.70 (0.50–0.97)    ptrend 0.01     Continuous OR 0.97 (0.95–1.00) 
 
Duration of drinking, years                                    Age at starting, years 
≤34 288/797    0.73 (0.58–0.91) 17–19     92/198     0.94 (0.67–1.32) 
35–44 288/655    0.91 (0.73–1.14) 20–22    162/331    0.99 (0.74–1.33) 
≥45 233/532    0.97 (0.76–1.24) ≥23         145/292   1.02 (0.75–1.39) 






Descriptive tables for laryngeal cancer: case control studies 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Bosetti 2002 
 
Country: Italy and Switzerland 
 
Study aims: to study the separate 
effect of alcohol and tobacco on 
laryngeal cancer risk’ 
 
Source of funding: 
Italian Association for Cancer 
Research and Swiss Foundation for 
Research against Cancer 
 
Population: 
Cases: Pooled from two hospital case control studies 
conducted in Italy (cases = 162) and in Switzerland 
(cases = 527), N=40 non-smoking cases 
Controls: non smoking controls selected from the 
same network of hospitals 
N=160 
 
Exclusion criteria:patients admitted with acute non-




1986-1992 (Italy) & 1992-2000 (Switzerland) 
Response rate: n/s 
Exposure:  
Questionnaire: structured questionnaire by trained interviewer 
Interviewers blinded: n/s 
Reference period: within last year 
Drink type: no 
 
Measure:drinks per day, Reference group: 3 TO <5 drinks per day 
Results: 
OR for alcohol drinking non smokers 
5->8  no odds ratio presented 
≥8     2.46    0.98-6.20 
 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: to compare the risks 
for  smoking and drinking by tumour 
site in the high-risk population of 
Uruguay 
 
Source of funding: 
International Agency for 
Research on Cancer 
 
Population: 
Cases: All cases of carcinomas of the hypopharynx 
and larynx which occurred in men from four major 
hospitals in Montevideo 
N=300 
Controls: selected from the same hospitals 
N=640 
 
Exclusion criteria: diseases related with tobacco 





Response rate: case-97.5% control 97.2 % 
Exposure:  
Questionnaire: Interviewed in the hospitals by two trained social workers with questionnaire a 
complete history of alcohol drinking (age at star, age ofquit, number of glasses drunk per day 
Interviewers blinded: n/s 
Reference period:lifetime 
Drink type: beer wine spirits 
 
Measure: status, lifetime intake (milligrams per day) and drinking years, Reference group: 
Never drinkers’ (occasional or less than monthly) 
Results:   Status      co/ca     Hypopharynxca         ca     Larynx 
                  Former    88/15     5.8 1.7-19.3            44    1.8   1.0-3.3 
                  Current   361/66   6.0 2.0-18.0           159  1.6   0.9-2.5 
                  Ever       449/81   6.0 2.0-17.7            203  1.6   1.0-2.6 
Lifetime total alcohol  
(mg )         co/ca  Hypopharynx          ptrend         ca     Larynx                ptrend 
1-60    175/10      2.3   0.7-8.1          31   0.8    0.4-1.5   
61-120    116/23      7.6   2.3-24.4          45   1.5    0.8-2.8   
121-240      88/17      5.6   1.7-18.6          68   2.4    1.4-4.2   
241+      70/31    12.8  4.0-41.2 <0.001         59   2.5    1.4-4.5 <0.0001  
Years of drinking  
yrs         co/caHypopharynx                      caLarynx        
1-29 107/17 5.1     1.5-17.4  36   1.5 0.8-2.9 
409 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
30-39 131/19 3.9     1.2-12.9  51   1.4 0.8-2.5 
40-49 127/27 8.2     2.5-26.5  66   1.9 1.1-3.4 
50+ 84/18 7.9     2.3-27.8 0.0005 50   1.6 0.9-3.0 0.06 
 (mg)Wine                             Spirits                                  Beer 
1-60         0.9    0.5-1.6    0.9    0.5-1.4            1-60      0.6    0.3-1.2 
61-120     2.8    1.7-4.7    1.5    0.8-2.8             61+       0.8    0.4-1.6 
121+        2.3    1.4-3.       9.5   10.8-2.6 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Gallus 2003 
 
Country: Italy and Switzerland 
 
Study aims: To obtain additional 
information about laryngeal cancer 
risk in women 
 
Source of funding: 
Italian Association for Cancer 
Research, Italian Ministry of Health, 
Leagues against Cancer of Italy 
and Vaud, and Swiss Foundation 
for Research against Cancer 
Population: 
Cases: All female cases from hospitals in (1) in the 
provinces of Milan and Pordenone and (2) in the 
provinces of Pordenone and Padua, the greater Milan 
area, northern Italy, and the Swiss Canton of Vaud 
N= 68 women 
Controls: randomly selected from same network of 
hospitals as cases 
N=340 women 
 
Exclusion criteria:patients admitted with acute non-




1986 and 1992 and 1992 and 2000 
Response rate: 95% for cases and controls 
Exposure:  
Questionnaire: Trained interviewers using structured questionnaires 
Interviewers blinded: n/s 
Reference period:No information provided on alcohol questions 
Drink type: no 
 
Measure: drinks per day, Reference group: < 3 drinks per day 
Results:Total intake 
d/d           ca/co                              
3-4 16/28 1.9 0.6-5.8  

























Study aims: To investigate 
whether the risk of laryngeal cancer 
depends on the types of alcoholic 
beverage consumed, 
 
Source of funding: 
Italian Association for Cancer 
Research, Italian League against 
Cancer, Italian Ministry of 
Education and European Research 
Advisory Board 
Population: 
Cases: All cases admitted to major teaching and 
general hospitals in Milan and in province of 
Pordenone, in northern Italy 
N=672 
Controls: selected from those residing in the same 
geographical areas and admitted to the same 
network of hospitals 
N=3,454 
 
Exclusion criteria: patients admitted with acute non-





Response rate: 95% for cases and controls 
Exposure:  
Questionnaire: structured questionnaire, by trained interviewer 
Interviewers blinded: n/s 
Reference period:within last year 
Drink type: wine, beer and spirits, including amari, grappa, whisky, cognac, brandy 
 
Measure:drinks per day and duration, Reference group: For beer and spirits, non-drinkers 
were chosen as the reference category; for total alcohol and wine, non-drinkers and drinkers 
of up to two drinks per day were taken as reference category 
Results: 
d/d             ca/co  Total Alcohol                           Wine 
3-4 111/809  1.12 0.83-1.50           1.12   0.83-1.50 
5-7 149/510  2.43 1.79-3.28           2.45   1.79-3.28 
8-11 180/389  3.65 2.68-4.98           3.29    2.68-4.98 
≥12 84/174    4.83 3.18-7.33           5.91    3.18-7.33 
                          Beer               Spirits 
1-2          1.65   1.31-2.10       0.88  0.70-1.11 
≥3           1.36   0.86-2.15       1.15  0.67-1.96 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Hashibe 2007 
 
Country: Central and Eastern 
Europe 
 
Study aims: to assess whether 
differences exist in risk factors for 
supraglottic and glottic tumours 
 
Source of funding: 
European Commission 
Population: 
Cases: from five hospital or cancer clinic in Central 
and Eastern Europe: Bucharest (Romania), Budapest 
(Hungary), Lodz (Poland), Moscow (Russia), and 
BanksaBystrika (Slovakia). 
N=384 
Controls: inpatients or outpatients in the same 




- histologic type was missing, was not squamous cell 
carcinoma, or was an in situ carcinoma 
diseases related to tobacco and alcohol (no details) 
 
Observation time: 
from 2000 to 2002, Response rate: n/s 
Exposure:  
Questionnaire: structured questionnaire by the same team of interviewers in each centre. 
Interviewers blinded:  n/s 
Reference period:in last year 
Drink type: beer wine spirits 
 
Measure: grams per week, years of drinking, Cumulative consumption, Reference group: 
light drinkers (1–139 grams per week, 431 controls, 106 cases), (1-19yrs 127 controls, 21 
cases 
Results:          Grams per week   Years of drinking 
No drinking   58/ 6     0.60    0.22-1.65  No drinking    58/6    0.85     0.28-2.59 
140–279      144/94    1.57    1.05-2.33 20–39           463/23   1.56   0.94-2.59 
280–419       71/29     1.13    0.64-1.99 ≥40               203/97   1.85    0.88-3.91 
≥420             147/80   1.45    0.92-2.26  
 













Study aims: to study the effects of 
alcohol and tobacco consumption 
on laryngeal and hypopharyngeal 
cancer and to compare these 




Source of funding: 
Foundation de France 
 
Population: 
Cases: all male cases of cancer of the larynx or 
hypopharynx. in 15 French hospitals in 6 cities 
N=528 
Controls: same hospitals as the cases, 
N=242 
 
Exclusion criteria: non-respiratory cancers; patients 
with bladder, liver and pancreatic cancer. 
 
Observation time: 
Response rate: cases 80%, controls 86% 
Exposure:  
Questionnaire: Personal interviews conducted by trained interviewers, 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: wine, beer, cider, aniseed spirit or pastis, whisky, calvados, fortified wines 
 
Measure: grams per day, Reference group: occasional drinkers (less than 1 g/d) 
Results: ca/co          Larynx 
1-2  56/62 1.4 1.2-1.6 
3-4  80/49 2.0 1.5-2.7 
5-8  156/64 2.9 1.9-4.4 
9-12  109/17 4.1 2.4-7.2 
>13  81/13 5.9 2.9-11.8 
By tumour type 
g/d  Glottis               Supraglottis        Hypopharynx. 
1-2 1.2 1.0-1.5  1.3 1.1-1.6  1.6 1.4-1.9 
3-4 1.5 1.1-2.2  1.7 1.1-2.7  2.7 1.9-3.7 
5-8 1.9 1.1-3.2  1.3 1.2-4.3  4.4 2.6-7.2 
9-12 2.3 1.1-4.8  3.1 1.3-7.0  7.2 3.7-14.0 
>13 2.9 1.1-7.1  4.1 1.4-11.5  11.7 5.1-27.2 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Pacella-Norman 2002 
 
Country: South Africa 
 
Study aims: to estimate the 
importance of tobacco and alcohol 
consumption and other suspected 
risk factors with respect to cancer 
of the oesophagus, lung, oral cavity 
and larynx 
 
Source of funding: South African 
Medical Research Council, Cancer 
Association of South Africa, & 
Cancer Research UK. 
Population: 
Cases: recruited from three main public referral 
hospitals of greater Johannesburg, N=51 
Controls: selected from the same network of hospitals 
N=1,370 female patients and 804 male 
 
Exclusion criteria: patients, who had cancers 
associated with effects of tobacco and/or alcohol, 
were excluded i.e. cancers of the stomach, bladder, 
liver, pancreas, naso-pharynx, and uterine cervix plus 
cancer of the larynx in women 
 
Observation time: 1995-1999, Response rate:n/s 
Exposure:  
Questionnaire: questionnaire by trained nurse interview was conducted in the preferred 
language of the patient (usually Zulu or Sesotho), 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: maize, from sorghum, and, commercial beer, wine, commercial and home-distilled 
spirits, 
 
Measure: drinks per week/day, Reference group: Non drinkers’ (not defined) 
Results: 
< 1 drink per week          3/84      1.1    0.2-4.8 
1-3 drinks per week        8/121    1.0    0.3-3.3 














Study aims: To assess the joint 
effect of smoking and alcohol 
consumption on laryngeal risk on 
tumour sub-sites. 
 
Source of funding: 
Federal Ministry for, Education, 
Science, Research and Technology 
 
Population: 
Cases: recruited from laryngeal treatment clinics in 
the Rhein-Neckar-Odenwald region of South-West 
Germany 
N=257 
Controls: selected randomly from the population 
registries of the study areas, 
N=769  
 
Exclusion criteria: restricted to Germans aged up to 




1998-2000; response rate: cases89%, controls 62.4% 
Exposure:  
Questionnaire: interviews conducted by trained interviewers, under standardized conditions 
Interviewers blinded: n/s 
Reference period:10 years before interview 
Drink type: yes but no details provided 
 
Measure: grams per day, Reference group: ≤25g/day 
Results: 
Grams/d    Combined           Glottis & Sub glottis     Supraglottis 
>25-50  1.3 0.8-2.1 1.4   0.8-2.5 1.3     0.4-3.8 
>50-75  1.6 1.2-2.7 1.3   0.7-2.5 1.6     0.5-5.3 
>75-100  1.6 0.9-2.9 2.0   1.0-3.9 1.6     0.4-6.2 
>100-150 2.2 1.1-4.3 1.8   0.7-4.2 2.0     0.5-7.6 
>150  3.0 1.6-5.9  1.9   0.8-4.4 4.3     1.4-13.2 
 





Study aims: To investigate risks of 
hypopharyngeal and laryngeal 
cancers associated with smoking, 
snuffing and chewing different 
tobacco products used in India. 
 
Source of funding: 
International Agency for Research 
on Cancer 
Population: 
Cases: all cases from four participating cancer 
treatment centres 
N=1,024 
Controls: 19% of the controls were hospital-based 
and 81% were visitors to patients at the hospital. 
N=718 
 
Exclusion criteria: patients with disease not related 
to alcohol or tobacco consumption 
 
Observation time: between 2001 and 2004. 
Response rate: n/s 
Exposure:  
Questionnaire: standardized questionnaire was administered to all study participants by 
trained staffmembers 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: no 
 
Results: 
                            co/ca     Hypopharynx          ca          Glottis              ca            Supraglottis 
<Once a week  60/23   0.47 (0.26–0.87)  18   1.02 (0.53–1.95)      7      0.91 (0.33–2.54) 
<Daily   51/49   0.97 (0.59–1.59)  13   0.66 (0.32–1.35)      12    1.63 (0.71–3.74) 





















Study aims: To investigate the 
effects of alcohol consumption on 
the risk of cancers of the upper 
aero-digestive tract 
 
Source of funding: 
Ludwig Institute for Cancer 
Research, and Cancer Research 
Society of Canada 
 
Population: 
Cases: selected from hospitals in three metropolitan 
areas of Brazil, 
N=194 
Controls: recruited from the same or nearby hospitals 
N=388 
 
Exclusion criteria:patients with mental disorders 




Response rate: <1% in cases and controls 
Exposure:  
Questionnaire: Standardised questionnaire by trained nurses 
Interviewers blinded: Subjects and interviewers blinded to study aims 
Reference period:Lifetime consumption(volume X frequency) 
Drink type: beer, wine, hard liquor, cachaҫa. 
 
Measure:kilograms of alcohol, Reference group: non-drinkers (not defined) 
Results: 
kg Cachaca                 Wine              Beer             Liquor 
1-10  1.3    0.1-13.1 1.5  0.7-3.3     1.1  0.5-2.4    4.2  0.9-20.4    
11-100  0.95  0.4-2.5 3.7  1.3-10.7   2.1  0.9-4.9    2.1  0.9-5.1      
100-500  4.0    1.7-9.3 1.5  0.6-4.0     1.8  0.6-5.7    1.8   0.6-5.4     
501-1000 4.4   1.8-10.4  
1001-2000 4.3   1.9-10.0  
>2000  9.9   3.0-33.0  
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Talamini 2002 
 
Country: Italy andSwitzerland 
 
Study aims: 
To provide information on the 
effects of alcohol and tobacco on 
laryngeal cancer and its subsites 
 
Source of funding: 
Italian Association for Cancer 
Research, Italian Ministry of Health, 
and Swiss Foundation for Research 
against Cancer 
Population: 
Cases: identified from major teaching and general 
hospitals in Milan, and in the province of Pordenone, 
in northern Italy and in the Swiss Canton of Vaud 
N=527=  (478 men and 49 women) 
Controls: selected from those residing in the same 
geographical areas and admitted to the same 
network of hospitals 
N=1,297 (1027 men and 245 women) 
 
Exclusion criteria: patients admitted with acute non-





Response rate: cases 97% controls 95% 
Exposure:  
Questionnaire: interviewed by nurses, using validated food frequency questionnaire 
Interviewers blinded: n/s 
Reference period: up to 1 year prior to cancer diagnosis or hospital admission 
Drink type: wine, beer, herb liquors, grappa and whisky/brandy) 
 
Measure: drinks per day, Reference group: abstainers (i.e. never drunk in lifetime) 
Results: 
Ex-drinkers             2.8   1.4-2.5      Current drinkers    1.8   1.0-3.3 
Total Alcohol Intake                            Duration of drinking 
>0-13        0.9   0.5-1.8            <35 years        2.3      1.2-4.3 
14-27        1.2   0.6-2.2            35-44 years     1.8      0.9-3.3 
28-55        2.6   1.4-4.7            ≥45                  1.6      0.8-3.0 
≥56           5.9   3.1-11.3 
x
2
















to identify possible aetiological 
agents of laryngeal cancer 
. 
Source of funding: 
n/s 
Population: 
Cases:All laryngeal cancer patients diagnosed and 
treated at the Clinic for Otorhinolaryngology and 
Maxillofacial Surgery, Montenegro in Podgorica 
N=108 
Controls: patients admitted to different centre clinics 
N=108 
 
Exclusion criteria:acute, non-malignant conditions, 
related to smoking and alcohol consumption 
 
Observation time: 
January 2001 and June 2003. 
Response rate: 94% for cases and controls 
Exposure:  
Questionnaire: structured questionnaire administered by one study doctor 
Interviewers blinded: no 
Reference period: n/s 
Drink type: wine, beer, spirits 
 










Descriptive tables for liver cancer: cohort studies 
 





Study aims: To examine the effect of 
viral infections and lifestyle habits, after 
adjustment for potential confounding 
variables, on the risk of HCC 
 
Source of funding: 
n/s 
Population: 
Source: study group consisted all inhabitants 
(4,904) aged ≥30 yrs resident in K. Town, Japan, 
invited to a national health insurance screening 
programme for liver disorders 
 
Exclusion criteria:those on in screening programs 
supported financially by different health insurance 
agencies; liver disorders 
 
Study pop: 3,059 (62.4%) 
 
Observation time: 
June 1992 until March 1997, median 4.65yrs, 
13,983 person-years, LFU = 2.6%; 51 incident 
cases of HCC 
Exposure:  
Questionnaire: structured questionnaire 
Repeated during follow-up: baseline only 
Reference period: lifetime 
Drink type: sake, beer, whiskey, wine, and sochu converted into equivalent of glasses of 
Japanese sake 
 
Measure: drink-years, Reference group: non-habitual drinkers (n=10) 
Results: 
drinks years    ca 
1-19                 3        2.05   0.48-8.79 
≥20                  9        1.14   0.40-3.26  
ptrend = 0.873 
 
 
Descriptive tables for liver cancer: case control studies 
 
Study and Aims Study and sample characteristics Exposure measurement and Main results 
Donato 2002 
 
Country: Italy  
 
Study aims: To investigate the 
relation between alcohol habits and 
HCC in men and women taking 
account of hepatitis B and hepatitis 
C virus infections 
 
Source of funding: 
Italian Ministero della Ricerca 
Scientifica e Universitaria (MURST) 
and the Ente Universitario 
Lombardia Orientale (EULO) 
Population: 
Cases: first diagnosis of HCC admitted to the two 
main hospitals in province of Brescia, N=464 
Controls: admitted to departments of ophthalmology, 
dermatology, urology, surgery, cardiology, and 
internal medicine of same hospitals as cases, N=824 
 
Exclusion criteria: hospitalized for liver disease or 
malignant neoplasms; hospitalized for injuries 
 
Observation time: between January 1995 and April 
2000 
Response rate: cases (93.5%), controls (96.1%) 
Exposure:  
Questionnaire: standardized questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type:wine, beer, spirits 
 
Measure:grams per day, Reference group: 0 grams per day 
Results:  “peak” exposure 
                          Men                               Women 
1-20    24/56      2.3   0.7-7.2 22/49  0.6     0.2-1.7 
21-40    27/101    0.9   0.3-2.7 15/19  1.4     0.4-5.4 
41-60    44/130    1.6   0.5-4.6 11/10  1.9     0.4-8.1 
61-80    33/89      2.4   0.8-7.1   4/3    3.1     0.3-29.7 
81-100    62/112    4.2   1.5-11.0   8/3    16.5   3.0-90.1 
101-120    47/50      7.7    2.7-22.7 
121-140    48/38      9.8    3.3-29.1 









Study aims: to evaluate the 
independent effects of different 
types of smoking exposure along 
with multiple risk factors for HCC 
and determined whether the 
magnitude of smoking was modified 
by other risk factors in men and 
women. 
Source of funding: National 
Institutes of Health/ Texas Tobacco 
Settlement 
Population: 
Cases: recruited from population of patients with 
newly diagnosed HCC at cancer centre in Texas, 
N=319 
Controls: were healthy nonblood relatives, particularly 
spouses, of patients with cancers other than liver, 
gastrointestinal, lung or head and neck (smoking-
related cancers) who were undergoing treatment at 
same cancer centre, N=1,061 
 
Exclusion criteria: not have ever had cancer; non 
U.S. residency, inability to communicate in English 
 
Observation time: January 2000 through December 
2006, Response rate: cases and controls 82% 
Exposure:  
Questionnaire: personally interviewed by well-trained interviewers, using a structured 
questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime (consumed at least 4 alcoholic drinks of beer, wine or hard liquor 
each month for 6 months during their lifetimes 
Drink type: wine, beer, spirits 
 
Measure: lifetime intake, mL/day, Reference group: not defined , n= cases114/ controls463 
Results: 
                          All                                 Men                                     Women 
<60    134/530   1.1 (0.7–1.5)    106/405    0.7 (0.4–1.2)     28/125   1.5 (0.8–2.9) 
≥60      69/65      2.7 (1.5–4.7)     59/57      1.8 (1.1–3.4)      10/8      7.7 (2.3–25.1) 
  
 






Study aims: To examine tobacco 
smoking, alcohol consumption and 
their interaction in the causation of 
hepatocellular carcinoma 
 
Source of funding: 
Europe Against Cancer Program of 
the European Union. 
Population: 
Cases: admitted to 3 teaching hospitals in Athens 
N=333 
Controls: patients hospitalized for injuries or for eye, 
ear, nose or throat conditions, admitted to same 
hospitals as cases 
N=360 
 
Exclusion criteria:conditions related to smoking, 
alcohol intake or coffee consumption 
 
Observation time: 
Between January 1995 and December 1998 
Response rate: cases (89%) controls (94%) who 
Exposure:  
Questionnaire: Interviewed in hospital 
Interviewers blinded: n/s 
Reference period: within last year 
Drink type:n/s 
 
Measure: glasses per week, Reference group: Non-drinkers 
Results: 
<20        0.8 (0.4–1.4)       
20–39    0.7 (0.3–1.5)       
≥40        1.9 (0.9–3.9)      p for trend 0.13                    
with HBsAgand/or anti-HCV              without both  HBsAg and anti-HCV 
<20        1.0 (0.2–4.1)                                      0.7 (0.3–1.3) 
20–39    1.4 (0.3–7.9)                                      0.6 (0.2–1.4) 


















Study aims: To test the hypothesis 
that tobacco, alcohol, and obesity 
independently increase the risk of 
HCC among Americans with 
cirrhosis 
 
Source of funding: 
National Institute of Health 
Population: 
Cases: subjects enrolled from the Liver or General 
Medicine Clinics at in one hospital in Michigan 
N=210 
Controls: For each case enrolled, 2 controls matched 
for age and gender were recruited (1 matched control 
with cirrhosis and 1 matched control with no liver 
disease) randomly selected for each case from 
patients admitted to same hospital.  
N=420 
 
Exclusion criteria: None specified  
 
Observation time: 
between June 2002 and August 2003 
Response rate: n/s 
Exposure:  
Questionnaire: Skinner Alcohol Use Inventory by a single trained interviewer 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type: beer, wine or hard liquor 
 
Measure:gram-years (average daily consumption (grams) times total duration of alcohol 
exposure (years), Reference group: none (not defined) 
Results: 
                 HCC versus           HCC versus no 
                    cirrhotics              liver disease 
<1500         0.5 (0.1-0.7)         1.4  (0.8-1.9) 
≥1500         5.7 (2.4-13.7)       23.8 (7.3-79) 
 





Study aims: To test hypothesis 
that alcohol abuse and/or tobacco 
smoking is a risk factor for the 
development of HCC, and to 
examine effects of the GSTs, 
CYP2E1 and ALDH2 polymorphism 
on the susceptibility of HCC in 
relation to alcohol-drinking  
 
Source of funding: 
Ministry of Education, Science & 
Culture of Japan  
Population: 
Cases: patients seen in the University of 
Occupational and Environmental Health (UOEH) 
Hospital in Japan 
N=78 
Controls: selected from same hospital 
N=138 
 




from June 1997 to April 1998 
Response rate: n/s 
Exposure:  
Questionnaire: questionnaire administrated by a trained interviewer 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type: n/s 
 
Measure: Lifetime ml, Reference group: non drinker 
Results: 
1–<200,000                      0.31 (0.15–0.62) 
≥200,000–<600,000 ml     0.79 (0.40–1.57) 


















To determine whether HBV or HCV 
infections, alcohol consumption, 
smoking, coffee drinking, BMI, and 
diabetes mellitus are independent 
risk factors for hepatocellular 
carcinoma, and how the effects of 
these factors might change after 
adjusting for severity of liver fibrosis 
 
Source of funding: 
Japanese Ministry of Health, Labor 
and Welfare  
Population: Adult Health Study established in 1958, 
20,000, age, gender, and city-matched proximal and 
distal atomic bomb survivors not present in the cities 
at the time of bombings examined biennially in 
outpatient clinics in Hiroshima and Nagasaki. 
Cases: identified through Hiroshima Tumour and 
Tissue Registry and Nagasaki Cancer Registry, 
supplemented by additional cases detected via 
pathologic review of related diseases, N= 224 
Controls: Nested control selection was random 
among those who matched the case on gender, age, 
city, time of serum storage, and method of serum 
storage, and counter-matched on radiation exposure 
N= 644 
 
Exclusion criteria:- inadequate stored serum 
 
Observation time: between 1970 and 2002; 
Response rate: n/s 
Exposure:  
Questionnaire: Self-administered questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type: n/s 
 
Measure: gram per day. Reference group: Never drinker 
Results: 
 
>0 and <20          1.27 (0.56-2.87)  
>20 and <40        1.02 (0.34-3.05)  
≥40                       4.36 (1.48-13.0)  
Continuous (per 20-g ethanol per day) 1.73 (1.19-2.52) 
 





Study aims: (i) toevaluate the 
dose-response pattern between 
alcohol intake and HCC risk, and 
(ii) to examine whether ALDH2 and 
ADH2 polymorphisms modify the 
HCC risk, depending on the amount 
of alcohol intake 
 
Source of funding: 
n/s 
Population: 
Cases: identified among those who were admitted or 
outpatients of two hospitals in Saga province, Japan 
N=209 
Controls: First control group recruited from among 
first time visitors at the general outpatient clinic to one 
of the above hospitals 
Second control group were patients with CLD but 
without HCC who were out- or inpatients of the above 
2 hospitals  N=275 & 381 
 
Exclusion criteria:<40 yrs old; non-Japanese 
residents; Patients with special types of CLD (primary 
and secondary biliary cirrhosis, autoimmune hepatitis 
and liver disease because of parasitosis, congestive 
heart failure or metabolic disorders)  
 
Observation time: between January 2001 and 
March 2004 
Response rate: Cases (92%) Controls (73%) & (96%) 
Exposure:  
Questionnaire: Questionnaire from research nurses  
Interviewers blinded:  
Reference period: during last 1-2 years and at 10 years prior to interview 
Drink type: n/s 
 
Measure: go’s/day, Reference group: Results: during last 1-2 years 
                  HCC cases vs. hospital controls           HCC cases  vs. CLD  patients 
>0-0.9                   33/33  3.4   1.1-10.1                    33/56  1.2 0.7-2.2 
1.0-1.9                  20/33  0.8   0.2-2.9                      20/30  1.0 0.5-2.1 
2.0-2.9                  15/25  0.6   0.2-2.4                      15/19  1.8 0.8-4.4 
3.0-3.9                    8/7   10.2  1.7-60.5                     8/5 5 0 1.3-19.2 
>4.0                        9/4  18.0   3.0-107.9 p < 0.01     9/7   9.4 2.5-35.4 p < 0.01 
During 10 years before 
                    HCC cases vs. hospital controls         HCC cases vs. CLD  patients 
>0-0.9                   22/24   4.1   1.1–15.2                 22/43   1.2 0.6-2.3 
1.0-1.9                  25/26   1.6   0.5–5.8                   25/42   1.3 0.7-2.6 
2.0-2.9                  20/33   0.8   0.2–2.8                   20/33   1.1 0.5-2.3 
3.0-3.9                  19/13   8.7   2.2–34.4                 19/13   2.8 1.1-6.8 









Study aims: to examine 
associations between ADH2 and 
ALDH2 polymorphisms, alcohol 
drinking and HCC  
 
Source of funding: 
Ministry of Health and Welfare of 
Japan 
Population: 
Cases: recruited from 20 major hospitals in Hyogo 
prefecture in Japan ,N=102 
Controls: enrolled from outpatients or inpatients in the 
same hospitals so that age, sex, and living areas 
were the same or similar to the cases, N=125 
 
Exclusion criteria: patients with liver diseases with 
HBs antigen positives and with HCV antibody 
positives 
 
Observation time: 1995-1996 
Response rate: 100% cases and controls 
Exposure:  
Questionnaire: self-administered questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type: beer, whisky, `Sake', spirits 
 
Measure: drink-years:cumulative amounts of alcohol intake during last 30 years, Reference 
group: 0-20 drink years 
Results: 
20-40      23/23  1.7 (0.8-3.5) 
≥40         32/21  2.7 (1.3-5.5) 






Descriptive tables for lung cancer: cohort studies  
 





Study aims: describe the 
relationship of low to moderate 
levels of alcohol intake, with 
subsequent risk of cancer, overall 
and at particular sites, in a large 
cohort of women in the  
 
Source of funding: Cancer 
Research UK, UK MRC, UK 
National Health Service breast 
screening program 
Population: 
Source: middle-aged women who attended 
breast cancer screening clinics in the United Kingdom 
completed between 1996 and 2001 
 
Exclusion criteria:none specified 
 
Study pop: 1,280,296 women, average age of 55 yrs 
 
Observation time: 
From 1996-2001 to 31 December 2006, followed up for 
cancer incidence over 9.2 millionperson-years, for an 
average of 7.2 years per woman; 5023 incident cases 
of lung cancer 
Exposure:  
Questionnaire: no details provided 
Repeated during follow-up: Yes, three years after baseline interview 
Reference period: n/s 
Drink type: wine, beer, and spirits 
 
Measure: drinks per week Reference group: <2 drinks per week 
Results: 
Non-drinkers 1735  1.17   (1.12 - 1.23) 
≤ 2  1210 1.00   (0.94 - 1.06) 
3-6  886 0.91   (0.85 - 0.97) 
7-14  1040 1.06   (1.00 - 1.13) 
≥15  332  1.01   (0.90 - 1.12) 
ptrend =0.2 
 





Study aims: To investigate the 
effect of alcoholic beverage 
consumption on the risk of lung 
cancer 
 
Source of funding: 
None specified 
Population: (California Men’s Health Study) 
Source: all males from, a managed care organization, in 
California, 45 to 69 yrs in January 2000, and members 
of the health plan for at least 1 year at recruitment,  
 
Exclusion criteria: Any previous cancer diagnosis 
(except non-melanoma skin) and lung cancer cases 
diagnosed within 6 months after study baseline 
 
Study pop: 84,170 men (40% response rate to 
questionnaire). Between study baseline and December 
2006, 11,144 men in the cohort terminated their health 
plan leaving 78,168 men for analysis 
 
Observation time: 2002 to 2006, 300,516 person-
years, LFU 13%. 210 incident cases of lung cancer 
Exposure:  
Questionnaire: semi-quantitative food frequency questionnaire adapted from the Women’s 
Health Initiative and other studies and modified for men’s health 
Repeated during follow-up: NO 
Reference period: n/s 
Drink type: beer, red wine, white or rose´ wine, and liquor 
 
Measure: drinks per day or per week, Reference group: non-drinker (n=94) 
Results: 
    Beer                  Liquor 
<1 d/w   64  1.48 (1.00-2.19)      43   0.92 (0.60-1.42) 
≥1 d/w, <1 d/d 34   1.04 (0.65-1.65)      26   1.05 (0.64-1.71) 
≥1 d/d   18  0.78 (0.45-1.35)      18   0.93 (0.54-1.58) 
Linear for 1 d/m increase 1.00 (0.99-1.00)       1.00 (1.00-1.01) 
p for trend                                 0.42                           0.75 
 
    Red wine                   White wine 
<1 d/w   55   1.15 (0.73-1.81)       49   0.86 (0.54-1.37) 
≥1 d/w, <1 d/d 21   0.65 (0.37-1.15)       20   1.09 (0.62-1.92) 
≥1 d/d   7   0.55 (0.23-1.29)         4    0.87 (0.31-2.40) 
Linear for 1 d/m increase    0.98 (0.97-1.00)            1.00 (0.98-1.01)  









Study aims: To evaluate 
association between total alcohol 
consumption and the risk of lung 
cancer among men and women 
participating in the Framingham 
Study 
 
Source of funding: 
National Heart, Lung, and Blood 
Institute’s Framingham Heart 
Study, National Institutes of Health 
Population: 
Source: Cohort started in 1948 in Framingham, 
Massachusetts. Original cohort included 5209 
participants. In 1971, children of original cohort and 
their spouses formed the Offspring study (n=5,124) 
 
Exclusion criteria: incomplete smoking and alcohol data  
 
Study pop: 4,265 participants from the original cohort 
and 4,973 subjects from the offspring cohort. 
 
Observation time: original cohort: mean follow-up of 
32.8 yrs,194 lung cancer cases, LFU: n/s 
offspring cohort: mean follow-up of 16.2 yrs, 75 lung 
cancer cases, LFU: n/s 
Exposure:  
Questionnaire: standardized questionnaires administered by the examining physician. 
Repeated during follow-up: every four years 
Reference period: in previous month 
Drink type: cocktails, beer, wine 
 
Measure: grams per day, Reference group: 0 grams per day (n=44) 
Results: 
g/d          ca      Both cohorts  ca  Original cohort  ca   Offspring cohort 
0.1–12  100   1.2 (0.7-2.1)   77   1.0 (0.5-2.1)      23   1.4 (0.5-3.6) 
12.1–24    39   1.1 (0.6-2.1)   24   1.0 (0.5-2.3)      15   1.1 (0.3-3.6) 









Study aims: whether alcohol intake 
is an independent risk factor for the 
development of lung cancer and 
whether any such effect depends 
on the type of alcoholic beverage 
consumed 
 
Source of funding: 
Italian Association for Cancer 
Research, the Italian League 
against Cancer, the Italian Ministry 
of Education and the European 
Research Advisory Board 
Population: 
Source: Copenhagen City Heart Study, the Centre of 
Preventive Medicine (formerly the Glostrup Population 
Studies), and the Copenhagen Male Study conducted in 
1964-1992 in Copenhagen, Denmark (see section 2.4) 
 
Exclusion criteria: n/s  
 
Study pop: 15,107 men and 13,053 women 
 
Observation time: 
sample was followed until January 1, 1994, 382,612 
person-years, 
674 cases of lung cancer (480 men and 194 women) 
Exposure:  
Questionnaire: self-administered questionnaires 
Repeated during follow-up: NO 
Reference period: n/s 
Drink type: wine, beers, spirits 
 
Measure:drinks per week, Reference group: <1 drink per week (men= 52, women=63) 
Results: ca                men                              ca              women 
1-6 85 0.85 0.60-1.22 82 0.89 0.64-1.25 
7-13 106 1.01 0.72-1.42 30 1.00 0.64-1.56 
14-20  65 0.86 0.59-1.26 11 0.97 0.50-1.85 
21-41 114 1.23 0.88-1.74 7 0.99 0.45-2.18 
>41 58 1.57 1.06-2.33 1 0.80 0.11-5.79 
Beer                men                                              women 
1-13 1.09 0.83-1.43  0.91 0.62-1.32 
>13 1.36 1.02-1.82  1.49 0.70-3.13 
Spirits 
1-13 1.21 0.97-1.50  0.83 0.58-1.19 
>13 1.46 0.99-2.14  0.67 0.21-2.18 
Wine 
1-13 0.78 0.63-0.97  0.89 0.59-1.33 




Study and Aims Study and sample characteristics Exposure measurement and Main results 
Rohrmann 2006 
 
Country: 10 European countries 
 
Study aims: to separately 
determine effects of past and 
current ethanol intake on lung 
cancer and to examine whether 
lung cancer risk differs between 
never drinkers and former drinkers 
 
Source of funding: 
Europe Against Cancer Program of 
the European Commission  
Population: 
Source: European Prospective Investigation into 
Cancer and Nutrition; conducted in 23 centers in 10 
European countries. The majority of the 521,457 
participants were recruited from the general population 
(see box 2 Section 2.4 for further details). 
 
Exclusion criteria: prevalent cancer cases; subjects with 
incomplete follow-up information; or with a ratio of 
energy intake to energy expenditure in the top ort 
bottom one per cent 
 
Study pop: =478,590 
 
Observation time: 
Start date n/s, end point varied from 1999-2003, 
2,980,381 person-years of observation ; median follow-
up 6.4 yrs, LFU: n/s 
1,119 lung cancer cases (606 in men, 513 in women) 
Exposure:  
Questionnaire: assessed using dietary assessment instruments (FFQs) that had been 
specifically developed for each participating country 
Repeated during follow-up: no 
Reference period: previous 12 months (lifelong intake determined as a weighted average of 
intakes at different ages, with weights equal to total subject-specific time under investigation 
Drink type: beer and/or cider, wine, sweet liquor, distilled spirits, and fortified wine 
 
Measure: grams per day for both current intake and mean lifelong intake 
Reference group: 0-1-4.9 grams per day ( current, n=310) 
Results: 
g/d                         ca     Intake at recruitment               ca         Mean lifelong intake 
non-drinker 146 1.22 0.99-1.50 30 1.01 0.67-1.50 
5–14.9  232 0.76 0.63-0.90 229 0.80 0.66-0.97 
15–29.9  169 0.83 0.68-1.01 201 0.99 0.80-1.22 
30–59.9  184 0.95 0.78-1.16 117 0.87 0.67-1.13 
≥60  78 0.86 0.66-1.14 82 1.29 0.93-1.74 
p-trend                                    0.31                                                    0.12 
Baseline intake – tumour type          
g/d                      Adenocarcinoma             Squamous-cell carcinoma     Small-cell carcinoma 
Non-drinker 40     1.14     0.77-1.67 40     1.85     1.20-2.87  18   0.90  0.51-1.57  
5–14.9  82     0.90     0.67-1.22 49      0.83    0.56-1.24 42   0.81  0.53-1.22  
15–29.9  58     1.06     0.75-1.50 31     0.78     0.49-1.25 26   0.69  0.42-1.12  
30–59.9  62     1.27     0.89-1.80 40     0.96     0.61-1.50 33   0.87  0.54-1.40  
≥60   24     1.22     0.74-2.01 21     0.93     0.53-1.63 16   0.92  0.50-1.71  
ptrend                                0.19                                      0.30                                     0.85   
 
Mean lifelong intake – tumour type           
Non-drinker 9      1.03    0.50-2.15 6      1.15    0.47-2.83 2    0.60   0.14-2.56  
5–14.9  72    0.86    0.61-1.21 43    0.59    0.38-0.91 43  0.99   0.62-1.59  
15–29.9  69    1.30    0.89-1.89 42    0.73    0.46-1.17 32  0.94   0.55-1.61  
30–59.9   35    1.09    0.68-1.75 29    0.70    0.41-1.20 23  1.00   0.54-1.85  
≥60   19    1.41    0.76-2.63 19    0.94    0.49-1.82 16  1.38   0.66-2.83  










Study and Aims Study and sample characteristics Exposure measurement and Main results 
Shimazu 2008 
 
Country: Japan  
 
Study aims: to investigate the 
association between alcohol 
drinking and lung cancer among the 
Japanese population  
 
Source of funding: 
Ministry of Health, Labour and 
Welfare of Japan  
Population: 
Source: all registered Japanese inhabitants (n= 
133,323) in 10 public health centre areas, aged 40–59 
years in cohort I, launched in 1990, and 40–69 years in 
cohort II, launched in 1993, at the start of the respective 
baseline survey 
 
Exclusion criteria:non-Japanese nationality, late report 
of emigration before the start of the follow-up period 
and history of previous cancer 
 
Study pop: 106,206 (80% response rate to 
questionnaire). Analysis limited men, n= 46,347 since 
prevalence of regular drinkers among women in study 
cohort was low 
 
Observation time: 
until 31 December 2004,  LFU 9.1% 
651 incident cases of lung cancer 
Exposure:  
Questionnaire: self-administered, covering frequency and amount of alcohol consumption 
Repeated during follow-up: NO 
Reference period: N/S 
Drink type: sake (rice wine), shochu or awamori (white spirits), beer, whiskey, wine 
 
Measure:grams per week, Reference group: Occasional drinkers (1–3 days/month) 
Results: 
                                All lung cases           Adenocarcinoma 
Non-drinkers   211   1.47 (1.04-2.09)     76   1.96 (1.04–3.72) 
1-149              105   1.10 (0.76-1.61)     35   1.30 (0.66–2.57) 
150-299          117   1.07 (0.74-1.55)     44   1.49 (0.76–2.90) 
300-449           99    1.34 (0.92-1.95)     38   1.87 (0.95–3.68) 
≥450                81    1.31 (0.89-1.94)     21   1.23 (0.59–2.57)  
p for trend                    0.07                                 0.31 
                    Squamous cell carcinomas     Small cell carcinoma 
Non-drinkers   57   1.51 (0.76–2.98)     26    1.06 (0.43–2.61)  
1-149              30   1.25 (0.61–2.58)     12    0.78 (0.29–2.10)  
150-299          31   1.07 (0.52–2.20)     13    0.68 (0.26–1.81)  
300-449          20   1.03 (0.48–2.22)     13    1.00 (0.38–2.66)  
≥450               26   1.56 (0.74–3.26)     13    1.20 (0.45–3.21)  
p for trend                    0.38                                 0.38 
 






to examine the association between 
binge drinking and lung cancer  
 
Source of funding: 
Academy of Finland  
 
Population: 
Source: part of the Findrink study, population based 
sample of middle-aged men from Eastern Finland, 
originally participants part of a prospective cohort 
originally designed to investigate risk factors for 
cardiovascular diseases, and other health related 
outcomes. Of 3235 men, 2682 (83%) participation 
 
Exclusion criteria: death or serious disease and history 
of previous cancer 
Study pop: 2267 men aged 42, 48, 54, and 60 years at 
the time of baseline examination 
 
Observation time: (March 1984 to December 1989) 
and December 2005, average follow-up 16.7 years, 
LFU: n/s, 65 incident cases of lung cancer 
Exposure:  
Questionnaire: assessed with a structured quantity and frequency method using the Nordic 
alcohol consumption inventory 
Repeated during follow-up: NO 
Reference period: N/S 
Drink type: beer, wine, strong wine, spirits 
 
Measure: binge drinkers (classified as the consumption of more than 70 g of ethanol at one 
drinking session), Reference group: non binge drinkers 
Results: 
In whole cohort 
Model 1     1.89 1.10–3.20 P-value 0.02 
 
Among smokers alone 










Study aims: studied the 
independent role of alcohol 
consump-tion in lung 
carcinogenesis among participants 
in the Alpha-Tocopherol, Beta-
Carotene Cancer Prevention 
(ATBC) Study 
 
Source of funding: National 




Source: 29 133 white male smokers aged 50-69 yrs 
participating in the ATBC Study in Finland, a 
randomized, placebo-controlled trial designed to 
determine whether α -tocopherol (50 mg/day), β-
carotene (20 mg/day), or both substances would reduce 
incidence of lung and other cancers.  
 
Exclusion criteria:men who were alcoholics, who had 
liver cirrhosis, severe angina with exertion, diagnosed 
with chronic renal insufficiency, previously diagnosed 
with cancer, or taking vitamin A or E or β-carotene 
beyond specified doses 
 
Study pop: 26,052menaged 50-69 yrs 
 
Observation time: 1985 to 1988, followed during active 
trial period until death or 30/4/1993 (median follow-up, 
7.7 yrs), LFU: n/s; 1059 incident cases of lung cancer 
Exposure:  
Questionnaire: self-administered food-use questionnaire 
Repeated during follow-up: no 
Reference period: over the previous year 
Drink type: beer, wine and spirits 
 
Measure: grams per day, Reference group: 0.04-5,2 grams per day (n=233) 
Results:             ca 
Non-drinkers      154   1.2 (0.9-1.4) 
5.3-13.3             234   1.0 (0.8-1.2) 
3.4-27.6             208   0.9 (0.8-1.1) 








Descriptive tables for lung cancer: case control studies  
 
Study and Aims Study and sample characteristics Exposure measurement and Main results 
Benedetti 2006 
 
Country: Canada  
 
Study aims: to investigate role that 
different types of alcohol might 
play, to assess the effect of alcohol 
on the different histological types of 
lung cancer and to identify possible 
interactions between gender, 
smoking, selected dietary factors, 
and alcohol  
 
Source of funding: 
Health Canada, National Cancer 
Institute of Canada, Canadian 
Institutes of Health Research.  
Population: Two large population-based case-control 
studies The first, in early 1980s, designed to explore 
associations between occupational substances and 
multiple cancer sites in men. The second, in mid-1990s, 
focussed on same occupational exposures and lung 
cancer in men and women. 
Cases: all newly diagnosed lung cancer cases at any 
Montreal-area hospital, and living in the Montreal area.  
N= Study I 699 (64.6% response rate) 
N= Study II 699 (76.4% response rate) 
Controls: population controls were randomly selected 
from the electoral lists 
N= Study I 1,094 (68.5% response rate) 
N= Study II 1,468 (66.5% response rate) 
 
Exclusion criteria: non-completion of interview and 
incomplete alcohol information 
 
Observation time: Study I: n/s; Study II: n/s 
Exposure:  
Questionnaire: subjects asked, separately for beer, wine and spirits, if there had ever been 
a period when they had consumed the alcoholic beverage the equivalent of at least once a 
week, or nearly every day. 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: beer, wine and spirits 
 
Measure: drinks per week (d/w), Reference group: never drank weekly 
Results:  Study I Men 
d/w                Total Alcohol              Beer                    Wine                          Spirits 
1-6  172   1.2 (0.8-1.8)   182   1.2 (0.9-1.7)   208 1.4 (1.0-1.9)   276 1.4 (1.0-1.9) 
≥7  413   1.3 (0.9-1.9)   339   1.5 (1.1-2.1)   82   0.7 (0.4-1.1)   138 1.2 (0.8-1.7) 
Study II Men 
1–6  162   1.0 (0.7-1.4)   197 1.0 (0.7-1.4)   142 0.6 (0.4-0.8)   150 0.9 (0.7-1.2) 
≥7 363   1.2 (0.9-1.8)   259 1.0 (0.7-1.4)     98 0.8 (0.5-1.1)     90 0.9 (0.7-1.3) 
Study II Women 
1–6 105   0.4 (0.2–0.5)   63 0.3 (0.2–0.5)   75 0.3 (0.2–0.4)   55 0.4 (0.3–0.6) 
≥7 116   0.7 (0.5–1.1)   58 0.9 (0.5–1.6)   55 0.7 (0.4–1.2)   39 1.7 (0.8–3.5) 
 
Study and Aims Study and sample characteristics Exposure measurement and Main results 




Study aims: to examine 
relationship between alcohol 
drinking and risk of 
adenocarcinoma of the lung 
 
Source of funding: 
Comisión Honoraria de Lucha 
contra el Cáncer, IARC 
Population: 
Cases: all cases of incident adenocarcinoma of the lung 
admitted to the four major hospitals in Montevideo 
N= 160 (response rate 96.9%) 
Controls: identified through the log book of admissions 
at the same hospital. N= 160 (response rate 93.3%) 
 
Exclusion criteria:  permanent residents in Uruguay of 
<15 yrs; condition related with tobacco smoking and 
alcohol drinking and with recent changes in the diet 
 
Observation time: January 1998 to July 2000 
Exposure:  
Questionnaire: FFQ was administered two social workers 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type: beer, wine hard liquor 
Measure: millilitres per day (lifetime consumption). Reference group: non-drinkers 
including those who drank less than 1 day per week regularly (n25/123) 
Results:    All                                Wine                            Beer                        Hard liquor 
1-60 36/171 0.8   0.4-1.5  50/205  0.6   0.3-1.2   10/29  1.1   0.5-2.5   32/83  1.5   0.8-2.6 
61-120 34/95   1.1   0.6-2.1  37/89    0.6   0.3-1.2   9/32    0.6   0.3-1.6   22/28  2.9   1.4-6.2 
≥121 65/131 1.2   0.6-2.1  29/66    0.4   0.2-1.1                 n/a              22/47  1.4   0.7-3.0 














to investigate association between 
lung cancer and lifetime alcohol 
consumption and interactions with 
ADH3 genotype 
 
Source of funding: 
National Institute on Alcohol Abuse 
and Alcoholism (partial) 
Population: 
Cases: all individuals with newly diagnosed lung cancer 
identified at all the major hospitals in Erie and Niagara 
Counties who were between 35 and 79 y old  
N=111 
Controls between 35 and 65 y were randomly selected 
from a list of those holding a New York State driver’s 
license and residing in Erie and Niagara Counties; 
those _65 y were randomly selected from the rolls of 
the Health Care Finance Administration 
N=1546 
 
Exclusion criteria: previous cancer diagnosis (other 
than non-melanoma skin cancer),  
 
Observation time: 
February 1996 to November 1998 
Response rate: cases 48% and controls 65% 
Exposure:  
Questionnaire: structured questionnaire and computer assisted interviews. Used the 
Cognitive Lifetime Drinking History to obtain  information on lifetime alcohol intake; 
participants reported how old they were when they started drinking alcohol at least once a 
month for 6 mo and at what ages their drinking patterns changed. 
Interviewers blinded:  n/s 
Reference period: within 12 months for cases, and 12-24 months for controls 
Drink type: beer wine spirits 
 
Measure: recent (drinks per week) and lifetime consumption, Reference group: non-
drinkers (n=7 cases/314controls) 
Results: Total alcohol intake 
          ca/co       Lifetime                  ptrend  d/w  ca/co  Over last 12-24 months  ptrend 
≤82 4/1517      1.10 (0.46-2.63)   ≤2.5 30/988  0.96 (0.38-2.44) 
>82 113/1520  1.13 (0.47-2.72)  0.44 >2.5  66/998  1.35 (0.54-3.41)           0.41 
Beer(ref group = 37/1265)  
≤62 41/1041    1.17 (0.70-1.94)   ≤1.6 18/576 0.75 (0.39-1.44) 
>62 90/1045    1.36 (0.82-2.27 0.30 >1.6  50/597 1.67 (0.96-2.92)           0.05 
Wine (ref group = 111/1624)  
≤19 23/863      0.87 (0.53-1.44)   ≤1.0 14/569  0.67 (0.36-1.28) 
>19 34/864      0.80 (0.51-1.25) 0.06 >1.0 18/573 0.72 (0.40-1.29)           0.10 
Hard liquor (ref group = 60/1355)  
≤28 41/998     1.21 (0.77-1.91)  ≤1.0 14/431 0.63 (0.33-1.22) 
>28 67/998     0.79 (0.52-1.20) 0.44 >1.0 27/434 0.87 (0.51-1.48)            0.47 
 
Study and Aims Study and sample characteristics Exposure measurement and Main results 
Kubik 2004 
 
Country: Czech Republic 
 
Study aims:  to examine the 
relationship between dietary factors 
and the risk of lung carcinoma in 
non-smoking and smoking women 
 
Source of funding: Ministry of 
Health of the Czech Republic 
Population: 
Cases: all women with microscopically confirmed 
diagnosis of primary lung cancer identified at Prague 
University hospital 
N= 435 (90% response rate) 
Controls: were all women and were spouses, relatives 
or friends of other patients in the same hospital 
N= 1,710 (79% response rate) 
 
Exclusion criteria: conditions unrelated to smoking;  
Observation time: April 1998 and November 2002 
Exposure:  
Questionnaire: structured questionnaire administered by trained interviewer,  
Interviewers blinded: n/s 
Reference period: usual consumption in most years within the past 10-year period 
Drink type: beer, wine and spirits 
 
Measure:drinking frequency, Reference group: never 
Results: Beer ref 271/1033                              Wine               ref 318/1059  
Monthly  47/224  1.81   0.55-1.18             Monthly            72/408 0.66   0.48-0.91 
Weekly  59/257  0.98   0.69-1.39            Weekly or daily  45/243 0.62   0.42-0.92 













Study aims: to ascertain the effect 
of wine-both overall and by type 
(red and white)-on the 
development of lung cancer 
 
Source of funding: 
Spanish Ministry of Education and 
Culture  
Population: 
Cases: all, recruited from one hospital in north west 
Spain serving population of approx. 500 000 
N=132 
Controls: selected from those attending the Santiago 
University Teaching Hospital Preoperative Unit for non-
tobacco related minor surgery 
N=187 
 
Exclusion criteria: Prevalent cases, those aged less 
than 30 years, those with a clinical history of any type of 




Response rate: cases and controls 99% 
Exposure:  
Questionnaire: Personal interviews conducted by trained interviewers, 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: wine (white, red, rose), beer, and spirits (whisky, rum, gin, brandy, and 
aguardiente (a clear schnapps-like drink distilled from fermented fruit juice). 
 
Measure:drinking status i.e. current drinkers, Reference group: non-drinkers 
Results: Type of wine (ref group = 33/41) 
                    ca/co 
White            26/9  1.47    (0.49 to 4.38) 
Red             47/101  0.43    (0.19 to 0.96) 
Rose´        7/11  0.35    (0.09 to 1.38) 
All types       18/25              0.48    (0.16 to 1.40) 
Beer (ref group =  76/111)                     Spirits (ref group = 85/147) 





Descriptive Tables for oesophageal cancer: cohort studies 
 





Study aims: to identify risk factors 
for oesophageal cancer in a high-
risk population 
 
Source of funding: 
National Institutes of Health 
Population: Shanghai Cohort Study 
Source: all eligible male residents of four small, 
geographically defined communities from a wide area 
of Shanghai City 
 
Exclusion criteria:previous history of cancer; <45 and 
>64 years  of age 
 
Study pop: 18,244 men (80% of eligible subjects) 
 
Observation time: 
1986–1989,to 2006, 100 cases, LFU: n/s 
Exposure:  
Questionnaire: face-to-face interview by a trained nurse. A structured questionnaire used to 
collect information 
Repeated during follow-up: no 
Reference period: ever drunk alcoholic beverages at least once a week continuously for six 
months or longer 
Drink type: beer, rice wine, spirit. 
 
Measure: grams per day, Reference group: non-drinkers 
Results:             Current                                                Lifetime 
<20               19    1.42 (0.81, 2.52)               <300        32 1.69 (1.03, 2.77) 
20 - <40       14     1.67 (0.88, 3.18)             300-<800   20  2.00 (1.11, 3.59) 
40 - <80       24     2.88 (1.64, 5.06)                800+       17 4.26 (2.26, 8.01) 
80+              12     4.65 (2.31, 9.36)                          p for trend <0.0001 
p for trend <0.0001 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Freedman 2008 
 





SEE GASTRIC DESCRIPTIVE TABLES 
 
Study pop: =  
 
Observation time: 
302 cases (97 SCC, 305 adenocarcinoma) 
Exposure: SEE GASTRIC DESCRIPTIVE TABLES 
 
Measure: drinks per day, Reference group: >0–1  drinks per day (n=24-SCC, 101=adeno) 
Results:    squamous cell                            adenocarcinoma 
023          2.06  1.16-3.68                              42  0.96  0.66-1.38 
>1–3 20   2.33  1.28-4.24                              35  0.95  0.64-1.40 
> 30         4.93   2.69-9.03                             27  1.10  0.69-1.74               P trend <0.0001  0.68 
 





Study aims: To study whether, 
whole-grain intake is related to 
reduced risk of upper aero-
digestive tract cancers 
 
Source of funding: 
N/s 
Population: 
Source: random sample of women aged 55-69 yrs 
from Iowa state driver’s license list. A total of 41,836 
women responded to a mail survey in Jan. 1986 
(42.7% response rate) 
Exclusion criteria:if left ≥30 items blank on the FFQ or 
reported implausibly high or low energy intake  
pre-menopausal women; women who at baseline 
reported cancer of any site other than skin  
Study pop: = 34,651 
 
Observation time: 1986-1999, approx 400,000 
person years, LFU <1%, 51 oesophageal, cancers, 
Exposure:  
Questionnaire: Self-administered 127-item FFQ  
Repeated during follow-up: baseline only 
Reference period: n/s 
Drink type: no 
 
Measure:drinks per day, Reference group: 0 drinks per day 
Results: 
d/d           HR 
>0-1.9      0.80        
≥2            1.90 











to elucidate which characteristics of 
smoking and alcohol intake 
contribute to oesophageal cancer 
mortality 
 
Source of funding: 
Ministry of Education, Culture, 
Sports and Technology of Japan 
Population: 
Source: Baseline survey carried out in 45 areas of 
Japan from 1988 to 1990 
 
Exclusion criteria:history of cancer; did not give 
information about their smoking or drinking status 
 
Study pop: 42 578 men 
 
Observation time: 
1988-1990 through to end of 1999, LFU n/s 
100 deaths identified, 
Exposure:  
Questionnaire: self administered 
Repeated during follow-up: baseline only 
Reference period: usual yearly intake 
Drink type: sake (rice wine), shochu (spirit), beer, whisky and wine 
 
Measure:units per day, years of drinking, Reference group: never drinkers 
Results: 
d/w               current                             years of alcohol drinking 
<1    1.47  0.28-7.68  <25.0          1.71  0.64-4.60 
1.0-1.9    1.58  0.65-3.86  25.1-35.0    3.23  1.32-7.92 
2.0-2.9    3.74  1.62-8.66  35.1-45.0    3.74  1.33-7.81 
3.0+    6.39  2.54-16.12 45.1+          6.39  0.85-9.03, 
ptrend =               0.028                                    0.100 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: 'We examined risk 
factors for oesophageal squamous 
cell carcinoma, gastric cardia 
cancer, and gastric non-cardia 
cancer…” 
 
Source of funding: n/s 
Population: 
Source: General Population Trial from the general 
population of Linxian 
 
Exclusion criteria:no history of cancer or debilitating 
disease 
 
Study pop: 29,584 individuals, 40–69 yrs at baseline 
 
Observation time: 
March 1986 until May 2001, 15 years follow-up, LFU 
<1%; 1,958 ESCC, incident cancer cases 
Exposure:  
Questionnaire: interviewed to complete baseline questionnaire 
Repeated during follow-up: baseline only 
Reference period:past 12 months 
Drink type: no 
 
Measure:drink status, Reference group: not drank in last 12 months 
Results:‘drank in the previous 12 months’ 
                 ca 
















Descriptive Tables for oesophageal cancer: case-control studies 
 





Study aims: to determine the risk 
factors of oesophageal cancer in 
the Thai population 
 
Source of funding: 
Prince of Songkla University 
Population: 
Cases: patients at university hospital in south 
Thailand 
N=202 
Controls: selected from same hospital 
N=261 
 




August 1997 to May 2000; Response rate: n/s 
Exposure:  
Questionnaire: face to face interview using structured questionnaire 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: no 
 
Measure:grams per day, Reference group: non drinkers 
Results: 
g/d 
≤60  50/78  2.13  (1.15-3.93) 
>60  99/50   5.84  (3.15-10.83) 
 





Study aims: To investigate the 
separate and combined effect of 
wine-drinking and other alcoholic 
beverages on oesophageal cancer, 
in a high wine-consuming 
population 
 
Source of funding: Italian 
Association for Cancer Research 
Population: 
Cases: selected from hospitals in greater Milan area 
and Pordenone 
N=714 (618 males, 96 females) 
Controls: selected from those admitted to same 
network of hospitals 
N=3,137 (2,400 males, 737 females), 
 
Exclusion criteria: non-neoplastic conditions related 
to alcohol or tobacco consumption. 
 
Observation time:  
Between 1984 and 1998, Response rate:n/s 
Exposure:  
Questionnaire: Trained interviewer structured questionnaires 
Interviewers blinded:  n/s 
Reference period:n/s 
Drink type: wine, beer and spirits 
 
Measure: drinks per day, Reference group: <3 drinks p/d 
Results: 
ca/co     All alcohol                    
3-4 114/701    1.98  (1.46-2.67)          
5-7 149/480   4.22   (3.10-5.75)          
8-11 190/346   7.60   (5.51-10.48)       


















Study aims: To evaluate relation 
between social class factors and 
squamous cell oesophageal cancer 
and the extent to which alcohol, 
tobacco, diet, and low income 
contribute to higher incidence 
among Black men than White men 
in USA 
 
Source of funding: 
National Cancer Institute 
Population: 
Cases: male residents of Atlanta, Georgia, Detroit, 
Michigan, and the state of New Jersey aged 30–79 
years 
N=347 (119 White, 228 Black)  
Controls: aged 30-64 yrs were selected using a 
random digit dialling technique whereas controls 
aged 65-79 yrs randomly chosen from computerized 
listings of Medicare registrants  
N=1,354(743 White, 611 Black) 
 
Exclusion criteria:not having a telephone  
 
Observation time: 
between August 1, 1986 and April 30, 1989 
Response rate: 68% (cases) 74% (controls) 
Exposure:  
Questionnaire: In-person interviews by trained interviewers 




Measure:drinks per week, Reference group: <8 drinks p/w 
Results: 
White and Black men combined 
8-14     3.2     1.8-5.8 
15-35   6.2     3.7-10.3 
≥36      16.9   10.1-28.1 
 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Castellsague 1999 
 
Country: South America 
 
Study aims: To explore the 
effectiveness of alcohol drinking 
and tobacco smoking cessation in 
reducing oesophageal cancer risk, 
taking into account the key 
characteristics of each habit and 
the simultaneous exposure to both 
habits 
 
Source of funding: 
IARC  
Design: pooled analysis of five case control studies 
 
Population: 
Cases: selected from hospitals included in the five 
studies 
N=830 








from 1986 through 1992 
Response rate: >98% in cases and controls 
Exposure:  
Questionnaire: interviewed at the hospitals according to pre-tested standardized questionnaire 
Interviewers blinded:  
Reference period: throughout life. 
Drink type: beer, wine, spirits 
 
Measure: grams per day, Reference group: never drinker 
Results: 
Males               Females 
Ex-drinker                  3.4    (2.3-5.0)      1.9    (0.9-3.8) 
Current (< 1year)       4.4    (3.1-6.2)      2.2    (1.3-3.9) 
1-24                           1.8    (1.2-2.6) 
25-49                         3.0    (2.1-4.4) 
50-149                       4.1    (3.0-5.8) 
150-249                     6.9    (4.5-10.6) 















Study aims: To investigate the 
incidence of adenocarcinoma of the 
oesophagus in British women 
 
Source of funding: 
Scottish Office; the LORS in East 
Anglia; Special Trustees to the 
Nottingham University Hospitals; 
and Medical Research Council 
Population: 
Cases: all women aged <75yrs in study areas of East 
Anglia and Oxford, part of Trent RHA and Eastern 
Scotland covering Health Boards of Highland, 
Grampian, Tayside, Fife, Lothian and Forth Valley 
diagnosed with oesophageal cancer. 
N=74 
Controls: randomly selected using Family Health 




Exclusion criteria: none specified 
 
Observation time: 
Between 1993 and 1996; Response rate: 65% 
Exposure:  
Questionnaire: Trained interviewers used a standard form to conduct interviews, either in 
hospital or at home 




Measure:units per week  and total lifetime consumption, Reference group: non-drinker 
(n=14/22) 
Results: 
u/w                                over lifetime                units                       total lifetime (units 
<2   25/26     0.44   (0.15-1.29) ≤2850               20/18    0.42   (0.14-1.24) 
2-13.99     2/22     0.28   (0.09-0.90) 2881-8312.4    21/17     0.32   (0.09-1.11) 
≥14     2/3       0.66   (0.08-4.96) ≥8212.5            18/16    0.37   (0.11-1.25) 
p trend                           0.074                                                                        0.154 
 
 





Study aims: to comprehensively 
examine PARs separately for 
adenocarcinoma and squamous 
cell carcinoma of the oesophagus, 
as well as for cardia and non-cardia 
sub-sites of gastric 
adenocarcinoma. 
 
Source of funding: 
National Cancer Institute, 
 
Population: 
Cases: newly diagnosed with oesophageal 
adenocarcinoma, gastric cardia adenocarcinoma, 
oesophageal squamous cell carcinoma, or non-cardia 
gastric adenocarcinoma, identified via rapid reporting 
systems. 
N= esophageal adenocarcinoma(293), gastric cardia 
adenocarcinoma(261), oesophageal squamous cell 
carcinoma(221), gastric adenocarcinoma(368), 
Controls: selected via random-digit dialling (for ages 
30–64 yrs) or via Health Care Administration records 
(for ages 65–79 years). N=695 
 
Exclusion criteria: - None specified 
 
Observation time: from 1993 through 1995 
Response rate: 77% cases and 80% controls 
Exposure:  
Questionnaire: Trained interviewers administered structured, in-person interviews 
Interviewers blinded: n/s 
Reference period: 1 year before the interview 
Drink type: beer, wine, and liquor 
 
Measure:drinks per week, Reference group: never drinker  (includes < 1 drink per month) 
Results: 
<5       1.3   0.6-3.0 
5-11    2.5   1.1-5.6 
12-30  4.7   2.2-9.7  










Study and Aims Study and sample characteristics Exposure measurement and main results 
Gallus 2001 
 
Country: Italy and Switzerland 
 
Study aims: to investigate risk of 
squamous cell oesophageal cancer 
in women 







Exposure: SEE BOSETTI 2000 ABOVE 
 
Measure:drink per day, Reference group: <1 drink per day 
Results: 
1-2   50/181.  1.99    1.15-3.44 
≥3    35/40     5.40    2.70-10.80  
 p<0.001 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Hashibe 2007 
 
Country: Central and Eastern 
Europe: Bucharest 
(Romania), Lodz (Poland), Moscow 
(Russia), Olomouc and 
Prague (Czech Republic) 
 
Study aims: To evaluate the role of 
risk factors for oesophageal 
cancer  
 
Source of funding: 
World Cancer Research 
Fund;EuropeanCommission 
Population: 
Cases: hospitals and cancer centres from 
participating countries, no further details provided 
N=227 
Controls: selected from same hospitals etc. as cases 
no further details provided 
N=1,114 
 
Exclusion criteria: none specified 
 
Observation time: 
August 2000 to 2002,  
Response rate: 96% for cases and 97%, for controls. 
Exposure:  
Questionnaire: face to face interview using structured questionnaire 
Interviewers blinded: n/s 
Reference period: drinking of beer, wine and spirits in atypical week during specific age 
periods (at age 25, 40, 50 and60). 
Drink type: as above 
 
Measure: grams per week, Reference group: No drinking (SCC cases = 5, Adeno =3) 
Results: 
                    co/ca     SCC                    ca           Adenocarcinoma 
1–139       540/69   3.08   1.11-8.60       13    1.06   0.25-458 
140–279   159/34   4.51   1.46-13.9       46    2.22   0.40-12.39 
280–419    71/20    8.14   2.45-27.04      4     5.39   0.73-39.93. 
420           142/55   9.78   3.08-31.04      6     2.31   0.30-17.58 
p for trend <0.01 0.20 
Years of drinking 
1–19         129/12    2.25   0.63-8.04       1    0.38  0.02-6.09 
20–39       554/131  4.80   1.68-13.72    17   1.08  0.24-4.94 
40+           229/35    2.39   0.83-6.90      11   1.44  0.31-6.66 



















Study aims: to measure the 
association between carbonated 
beverage intake and risk of 
adenocarcinomas and squamous 
cell carcinoma (SCC) of the 
esophagus 
 
Source of funding: 
not specified 
Population: 
Cases: patients at university hospital in south 
Thailand 
N=202 
Controls: selected from same hospital 
N=1,484 
 




August 1997 to May 2000 
Response rate: not specified 
Exposure:  
Questionnaire: FFQ 
Interviewers blinded: n/s 
Reference period:within the last year 
Drink type: beer only 
 
Measure: grams per day, Reference group: non drinkers 
Results: 
g/d   ca/co 
≤60  50/78   2.13   (1.15-3.93) 
>60  99/50   5.84   (3.15-10.83) 
 





Study aims: to test the  association 
between tobacco, snuff and alcohol 
use and the risk of oesophageal 
and cardia cancer 
 
Source of funding: 
Swedish Cancer Society 
 
Population: 
Cases: all patients in Sweden with a new diagnosis of 
adenocarcinoma of the oesophagus or gastric cardia 
and half of the patients with oesophageal squamous-
cell carcinoma: N= adenocarcinoma (189), 
Squamous-cell carcinoma cases (167), gastric cardia 
adenocarcinoma (262) 
Controls: selected from age and sex strata in study 
base to resemble age and sex distributions among 
the oesophageal cases, N=820 
 
Exclusion criteria: persons aged 80 years or older 
and individuals born abroad 
 
Observation time: 
1995 through 1997 
Response rate: cases 73 to 87%, controls 73% 
Exposure:  
Questionnaire: face-to-face interviews 
Interviewers blinded: not blinded to case/control status of interviewees, but unaware of  study 
hypotheses 
Reference period: 20 years before interview 
Drink type: beer, wine and liquor 
 
Measure:units per week, Reference group: never drank 
Results: Any alcohol 
 u/w               adenoscc 
1-15        0.6  0.4-1.1           0.9  0.4-1.8 
16-70      0.4  0.2-0.7           0.8  0.4-1.8 


















Study aims: To investigate the 
independent and combined effects 
of alcohol intake, tobacco smoking 
and betel quid chewing on the 
development of oesophageal 
cancer  
 
Source of funding: 
Taiwan National Science Council, 
Taiwan National Health Research 
Institute 
Population: 
Cases:all incident oesophagus cancers occurring in 3 
hospitals intropical southern Taiwan 
N=513 
Controls:derived from same geographic areas as 
cases and chosen from healthy community residents 
who attended same network of hospitals  
N=818 
 
Exclusion criteria:patients who were not mentally 




July, 1996 to December, 2003 
Response rate: Cases (64.5%), Controls (95%) 
Exposure:  
Questionnaire: face to face interviews using pre-designed and pre-tested questionnaire 
developed specifically for study 
Interviewers blinded:  
Reference period:a minimum of 6 months prior to study 
Drink type:beer, wine or distilled spirits 
 
Measure: grams per day, years of alcohol drinking, Reference group: never drinkerincluding  
former and current drinkers 
Results: 
g/d      Average over lifetime                 Years of alcohol drinking 
1-20    3.6   2.4-5.4  1–15        45/43      5.5   3.1-9.9 
21-40    6.1   3.6-10.3  16–35    203/131    6.1   4.1-9.2 
>40  19.5   12.1-31.2                >35        155/60     8.6   5.5-13.5  
Ptrend          <0.0001                                           =0.0001 




Study and Aims Study and sample characteristics Exposure measurement and main results 
Lindblad 2005 
 
Country: United Kingdom 
 
Study aims: Toprospectively 
assess the influence of BMI, 
tobacco, and alcohol on the 
occurrence of oesophageal, gastric 
cardia, and non-cardia gastric 
adenocarcinoma 
 
Source of funding: 
AstraZeneca R&D and Swedish 
CancerSociety 
Population: 
Cases:All patients aged between 40-84yrs during 
study period became members of study cohort when 
enrolled in a General practitioners research database 
for at least two years. During follow-up of the study 
cohort 2128 patients with a diagnosis code indicating 
oesophageal or gastric cancer were found 
N=1950 (1315 males and 635 females) 
Controls:randomly selected from same GP database 
N=10,000 
 
Exclusion criteria:any cancer recorded in the 
database before start of the study period were not 
eligible for the study cohort 
 
Observation time: 
January 1, 1994 through December 31, 2001 
Response rate: n/s 
Exposure:  
Questionnaire: Computerised records from General practitioners research database 
Interviewers blinded: n/a 
Reference period: n/s 
Drink type: no 
 
Measure:units per day, Reference group: 0-2: units per day 
Results: 
u/d  co/ca      Squamousco/caAdenoco/caunknown histology 
3-15 1662/20   1.01  0.59-1.72 1662/59 1.06  0.76-1.49   1662/77  1.05 0.78–1.39 
16-34 563/13     2.44  1.26-4.71 563/15 0.69  0.39-1.20   563/26  1.02 0.66–1.58 







Study and Aims Study and sample characteristics Exposure measurement and main results 
Pacella-Norman 2002 
 
Country: South Africa 
 
Study aims: to estimate the 
importance of tobacco and alcohol 
consumption and other suspected 
risk factors with respect to cancer 
of the oesophagus, lung, oral cavity 
and larynx 
 
Source of funding: 
University of Witwatersrand, the 
South African Medical Research 
Council, Cancer Association of 
South Africa, and Cancer Research 
UK. 
Population: 
Cases: recruited from three main public referral 
hospitals of greater Johannesburg 
N=51 
Controls: selected from same network of hospitals,  
N=1,370 female patients and 804 male 
 
Exclusion criteria: cancers  associated with the 
effects of tobacco and/or alcohol, i.e. cancers of the 
stomach, bladder, liver, pancreas, nasopharynx, and 




Response rate: n/s 
Exposure:  
Questionnaire: questionnaire by trained nurse, interview conducted in preferred language of 
patient (usually Zulu or Sesotho), 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: maize, sorghum, and, commercial beer, wine, commercial and home-distilled 
spirits 
 
Measure: drinking frequency, Reference group: ‘Non drinkers’ 
Results: 
                       co/ca    Men                 ca                 Women 
Occasional      84/13       0.7 0.3-1.       5 234/13      0.7 0.4-1.4 
Weekly           121/29      0.7 0.4-1.       3 102/27      2.2 1.3-4.0 
Frequent        333/187   1.8 1.2-2.        8 189/38      1.7 1.0-2.9 
 
 





Study aims: To investigate the 
incidence of squamous cell 
carcinoma of the oesophagus in 
British women 
 
Source of funding: 
Chief Scientist Office, Scottish 
Office; the LORS in East Anglia; 
and the Medical Research Council 
in Oxford 
Population: 
Cases: all women aged <75 years in study areas of 
East Anglia and Oxford, and Eastern Scotland 
covering six Health Boards. 
N=159 
Controls: randomly selected using Family Health 




Exclusion criteria:none specified 
 
Observation time: 
between 1993 and 1996. 
Response rate:n/s 
Exposure:  
Questionnaire: Trained interviewers used a standard form 




Measure:Average weekly alcohol consumption over lifetime;units p/w, Reference group: non 
drinker 
Results: 
                ca/co 
<2            47/52       0.81  0.42-1.56 
2-13.99   41/47       0.72   0.34-1.53 

















Study aims: To clarify the sub-
sitespecific risk factors for 
hypopharyngeal cancer (HC) and 
oesophageal cancer by anatomical 
subsite, 
 
Source of funding: 
Ministry of Health and Welfare, 
Japan 
Population: 
Cases: recruited from male first visit outpatients who 
visited a Cancer Centre hospital in Nagoya, Japan. 
N=284 oesophageal, 62 hypopharnygeal 
Controls: selected from all first-visit male outpatients 






between 1988 and 1997 
Response rate: 100% 
Exposure:  
Questionnaire: self administered questionnaire 
Interviewers blinded:none specified 
Reference period:at least 1 year previously 
Drink type: Japanese sake, beer, shochu and whiskey 
 
Measure: drinks per day, Reference group: 'almost never' 
Results: 
<1-5   1.8   1.1-2.9 
≥5      8.5   5.6-13.1 
 
 





Study aims: To estimate the 
independent effect of different 
alcoholic beverages and type of 
tobacco smoking on the risk of EC 
and its main histological cell type 
(squamous cell carcinoma) 
 
Source of funding: 
Spanish Ministry of Health 
Population: 
Cases: Spanish-speaking men and women 30-80 yrs, 
and hospitalized in any of 9 participant hospitals in 
provinces of Alicante and Valencia, N=202 
Controls: selected from same hospital and matched 
on sex, age and province, N=457 
 
Exclusion criteria: diseases not related a priori to 




August January 1995 and March 1999 
Response rate: >99.5% in cases and controls 
Exposure:  
Questionnaire: face to face interview using structured questionnaire 
Interviewers blinded: not blinded to case/control status, but unaware of main study hypothesis 
and trained to administer structured questionnaires in equal manner to cases and controls 
Reference period:n/s 
Drink type: beer wine and spirits 
 
Measure: grams per day, Reference group: never-drinkers (n=171) 
Results:            ca/co       Average intake                      ca/co     Years of drinking 
Former drinker 49/38     5.40 (2.43 –12.00)        1–19    88/50       1.94  (0.88 – 4.27) 
1–24                 147/27  1.16 (0.54 – 2.49)           20–39 59/34       1.04  (0.53 – 2.02) 
25–74                62/45   2.89 (1.29 – 6.48)           ≥ 40    72/52       1.71  (0.86 – 3.40)  
≥ 75                   26/75   7.65 (3.16 – 18.49) 




















Study aims: to investigate the risk 
of oesophageal squamous cell 
carcinoma in relation to exogenous 
factors in a rural area of China with 
a high incidence of oesophageal 
squamous cell carcinoma.  
 
Source of funding: 
National NatureScience Foundation 
of China 
Population: 
Cases: recruited from Yangzhong Cancer Research 
Institute and Yangzhong People’s Hospital 
N=355 
Controls: randomly selected from the local community 
population living in the same county 
N=408 
 
Exclusion criteria:≤ 30 years old 
 
Observation time: 
1 January 2004 and 28 February 2006  
Response rate: n/s 
Exposure:  
Questionnaire: face to face interview using structured questionnaire 
Interviewers blinded: n/s 
Reference period: drinking alcoholat least once aweek and lasting for more than 6 months. 
Drink type:n/s 
 
Measure: drink frequency and years of drinking, Reference group: never drinkers (n=79/137) 
Results: drink frequency 
                     ca/co                men                pvalue       ca/co          women                 pvalue 
Some           144/115  2.197    1.510–3.195 < 0.001     4/6    0.826   0.221–3.087     0.776 
Occasional   50/45     1.990    1.212–3.267  0.007        3/3    1.476   0.279–7.798     0.647 
Everyday      94/70     2.325    1.529–3.533  < 0.00      1/13   0.326   0.033–3.261     0.340 
Alcohol-drinking duration (years) 
< 30              47/47    1.802   1.082–3.001   0.024         2/4    0.663  0.114–3.843    0.647 
≥30               97/68    2.436   1.605–3.697   < 0.001      2/2    1.107  0.152–8.083    0.920 
 





Study aims: to determine the role 
of smoking, alcohol use, and body 
size characteristics in the aetiology 
of oesophageal, gastric cardia, and 
distal gastric adenocarcinoma.  
 
Source of funding: 
National Cancer Institute 
Population: 
Cases: men and women  aged 30-74 years identified 
by Cancer Registry, Los Angeles 
N=222 
Controls: selected from same cancer registry, 
N=1289 
 




Response rate: Cases 77%, Controls >50% 
Exposure:  
Questionnaire: structured questionnaire administered by interviewer 
Interviewers blinded: interviewers not blind to case or control status, but were not aware of 
study hypotheses 
Reference period:n/s 
Drink type: beer, wine, hard liquor 
 
Measure: Drinks/week, Reference group:never drinkers 
Results: 
1-7      0.72  (0.5-1.2) 
8-21    0.57  (0.3-0.9) 
22-35  0.77  (0.4-1.4) 




















Study aims: the role of alcohol 
drinking and tobacco smoking in 
cancer of the oesophagus in men 
from 3 areas of northern Italy, 
 








Exposure: SEE BOSETTI 2000 ABOVE 
 
Measure:drinks/week, years of drinking, age started drinking 
Reference group: drinks/week 1-20 drinks per week; Years of drinking (<45 yrs); Age started 
drinking (≥21 years) 
Results: 
Abstainers    1/22     0.63  0.08–5.19 
21–34         47/163   4.13  (2.11–8.08) 
35–55         57/120   6.21  (3.16–12.20) 
56–83         84/70   14.48  (7.29–28.77) 
≥ 84             72/36   24.47  (11.74–51.01) (p < 0.001) 
Years of drinking                                                       Age started drinking  
45–54   51/131    0.99 (0.51–1.92)  17–20   137/247    1.12 (0.75–1.67) 
55–64   86/191    0.93 (0.47–1.84)  <17       70/194      0.68 (0.44–1.05)   ptrend0.06 
≥ 65      74/154    1.86 (0.72–4.78)       (ptrend0.31) 
 





Study aims: To investigate 
patterns of tobacco smoking, 
chewing and alcohol drinking in the 
development of oral, pharyngeal 
and oesophageal cancers in 
Southern India  
 
Source of funding: 
not stated 
Population: 
Cases: male patients at a Cancer Institute  and 
Regional Cancer Centre, Kerala, India 
N=566 
Controls: male patients from the same centres. 
N=3,638 
 
Exclusion criteria: - tobacco-related cancers  
 
Observation time: 
during 1993 and 1999 
Response rate: n/s 
Exposure:  
Questionnaire: Interviewed by trained social investigators 
Interviewers blinded: n/s 
Reference period:No details 
Drink type:No details 
 
Measure: ml/day, Reference group: never drinkers 
Results: 
Average daily amount  
<20  70 / 371     1.13  0.83–1.55 
20–50 80/ 178      1.83  1.31–2.55 





Descriptive Tables for oral cancer: case control studies 
 





Study aims: In order to clarify and 
better quantify the separate and 
combined effect of wine and other 
alcoholic beverages on oral cancer,  
 
Source of funding: 
Italian Association for Cancer 
Research, Italian and Swiss 
Leagues against Cancer, Swiss 
Foundation for Research Against 
Cancer 
Population: 
Cases: admitted to major teaching and general 
hospitals in two areas of Italy (Pordenone and Rome) 
and in Swiss Canton of Vaud 
N=749 
Controls: admitted to same network of hospitals 
N=1,772 
 
Exclusion criteria: non-neoplastic conditions 
associated with smoking or alcohol consumption. 
 
Observation time: 
between January 1992 and November 1997 
Response rate: 95% in cases or controls 
Exposure:  
Questionnaire: trained interviewer using structured questionnaire 
Interviewers blinded: n/s 
Reference period: in year before onset of symptoms which led to hospital admission  
Drink type: wine, beer and spirits 
 
Measure: drinks per day (d/d), Reference group: non-drinkers and 1-2 d/d 
Results:  
d/d         Total alcohol  
3–4        95/365     2.1       1.5–2.9 
5–7     132/208     5.0       3.5–7.1 
8–11   199/118     12.2      8.4–17.6 










to evaluate the relative importance 
of smoking, alcohol drinking and 
paan chewing, with or without 
tobacco, on cancer of the oral 
cavity in men and women and the 
modifying effect, if any, of various 
indicators of oral hygiene 
 
Source of funding: 
n/s 
Population: 
Cases: identified by interview and oral examination 
from hospitals in Bangalore, Madras and Trivandrum, 
in Southern India. 
N=309 
Controls: identified from same hospitals where cases 
were found either from relatives and friends who were 
attending patients admitted for cancer other than oral 
cancer in Bangalore and Madras. In Trivandrum, 
controls chosen among outpatients  
N=292 
 
Exclusion criteria:none specified 
 
Observation time: 
Between July 1996 and May 1999 
Response rate: >90% for cases and controls 
Exposure:  
Questionnaire: interviewed by social workers 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: arrack, toddy, beer and wine 
 
Measure: drinks per week, Reference group: Abstainers 
Results:  analyses restricted to men only 
Former drinkers     65/34     1.78 (0.97–3.28) 
Current drinkers 
<3                           29/18     2.17 (1.00–4.69) 
3–13                       22/13     2.14 (0.89–5.19) 
 ≥14/                       29/12     1.97 (0.85–4.57),  ptrend 0.01 
 
Age at start drinking (yr) (ref group ≥31 yrs)           Years since quit drinking 
23-30   29/12  2.11 (0.69–6.48)                               <10  49/27  0.94 (0.43–2.09) 









Study and Aims Study and sample characteristics Exposure measurement and main results 





to better quantify the role of 
smoking and alcohol in oral and 
pharyngeal cancer among women 
 
Source of funding: 
See Altieri (2004) 
Population:SEE ALTIERI 2OO4 ABOVE 
Cases: N=195 cases, women 






Exposure: SEE ALTIERI 2OO4 ABOVE 
 
Measure: drinks per day, Reference group: non-drinkers 
Results:Referent group,  
d/d      ca/co    
<2      42/339        1.45 (0.86–2.43)    









Study aims: To explore the role 
and impact of tobacco type and 
beverage type in oral 
carcinogenesis, 
 
Source of funding: 
n/s 
Population: 
Cases: histologically diagnosed cases recruited from 
4 hospitals: in Granada, Sevilla and Barcelona 
N=375 
Controls: from same hospitals as cases 
N=395  
 




between November 1996 and July 1999  
Response rate: cases (76.5%), controls (91%) 
Exposure:  
Questionnaire: pretested standardized questionnaire administered by trained interviewers 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type: beer, wine and spirits 
 
Measure:drinks per day, Years of alcohol drinking, Reference group: never drinkers 
Results:  Total alcohol intake                         Years of alcohol drinking 
1          59/114       2.00   (1.06–3.77)               1–20    27/42         1.37 (0.65–2.91) 
2          27/41         3.74    (1.62–8.63)            21–30    69/67         2.49 (1.22–5.09) 
3–4      49/44         6.22    (2.82–13.71)          31–40    96/84         3.18 (1.61–6.29) 
5–6      55/28         10.58   (4.57–24.46)         41–50    88/69         4.00 (1.99–8.02) 
7–10    68/37         10.29   (4.57–23.17)             ≥51    60/37         5.13 (2.45–10.72)   
≥11      82/35         13.66   (6.02–30.96)                              ptrend <0.0001  
ptrend < 0.0001 
 





Study aims: we considered risk 
factors for oral and pharyngeal 
cancer in lifelong non-smokers 




Exclusion criteria: SEE ALTIERI 2OO4 ABOVE 
 
Observation time: SEE ALTIERI 2OO4 ABOVE 
Exposure: SEE ALTIERI 2OO4 ABOVE 
 
Measure:drinks/day, Reference group: non drinkers 
Results: 
Total alcohol intake                                           Duration of alcohol intake (years) 
>0-<3      25 327       3.4 (1.1-10.1)           <35   16/382     2.9 (0.9-9.2) 








Study and Aims Study and sample characteristics Exposure measurement and main results 
Franceschi 1999 
 
Country: Italy/ Switzerland 
 
Study aims: to compare the 
separate and combined effect of 
alcohol and tobacco between oral 
cancer and pharyngeal cancer. 
Population:SEE ALTIERI 2OO4 ABOVE 
Cases: N=274 oral cancer cases, 364 pharyngeal 
cancer cases 





Exposure: SEE ALTIERI 2OO4 ABOVE 
 
Measure: 
Reference group:  
Results: 
See main text, Chapter 2.13  
 





Study aims:  examine contribution 
of oral hygiene, dentition, sexual 
habits, sexually transmitted 
diseases, smoking, alcohol 
drinking, and dietary habits to 
cancer of the oral cavity and oro-
pharynx in Cuba 
 
Source of funding: 
Pan American Health Organization 
Population: 
Cases: identified in oncology hospital in Havana 
(Cuba) 
N=200 (153 mouth, 19 oropharynx, 28 both sites) 
Controls: admitted to oncology and 3 other major 




- diseases related to smoking or drinking habits 
 
Observation time: 
Between April 1996 and July 1999 
Response rate: n/s 
Exposure:  
Questionnaire: interviewed during their hospital stay by one trained dentist 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: n/s 
 
Measure:drinks/wk, duration of drinking, Reference group: never drinkers, <33yrs 
Results: 
Drinking habit                                         Duration of drinking (years) 
<7          15/21    1.09 (0.46–2.57)          33–44   31/21   1.98 (0.93–4.22) 
7–20      25/19    1.60 (0.70–3.67)             ≥45    30/17   1.81 (0.85–3.87) ptrend. 0.46 
21–69    21/ 14   2.20 (0.89–5.45) 
≥70        20/ 6     5.73 (1.77–18.52)  ptrend.< 0.01 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Hayes 1999 
 
Country: Puerto Rico 
 
Study aims: To evaluate the role of 
tobacco and alcohol in the aetiology 
of nonsalivary gland cancers of the 
mouth and pharynx and cancers of 
the major and minor salivary 
 
Source of funding: n/s 
Population: 
Cases: all men 21-79 yrs newly diagnosed, with 
cancer of oral cavity or pharynx identified through l 
cancer registry and histologically confirmed, N=519 
Controls: selected from among all male Puerto 
Ricans by probability sampling of households. N=629 
 
Exclusion criteria:none specified 
 
Observation time: December 1992 and February 
1995, Response rate: cases (73%), controls (83%). 
Exposure:  
Questionnaire: interviewed using  structured pre-tested questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type: wine, beer, spirits 
Measure:Lifetime consumption, drinks per week, Reference group: non-drinker 
Results: 
1-7       19/117  0.8  (0.3-2.1) 
8-21       28/87  1.4  (0.6-3.4) 
22-42     49/55   3.3  (1.4-8.0) 








Study and Aims Study and sample characteristics Exposure measurement and main results 
Huang 2003 
 
Country: Puerto Rico 
 
Study aims: to evaluate the effects 
of alcohol concentration and the 
intake of homemade rum as 
potential explanations for the high 
rates of oral cancer reported in 
Puerto Rico 








Exposure: SEE HAYES 1999 ABOVE 
 
Measure:Drinks per week 










Study aims: The effect of smoking, 
drinking, diet, dental care and 
sexual habits on the risk of oral and 
pharyngeal cancer was investigated 
 
Source of funding: 
The Polish State Committee for 
Scientific Research and IARC 
Population: 
Cases: aged 23-80yrs, with cancer of the oral cavity 
and pharynx in large maxillofacial surgery clinics in 
the province of Warsaw, histologically confirmed 
N=122 
Controls: admitted for acute illnesses to major 
hospitals serving the same areas where cases lived 
were eligible control 
N=124 
 
Exclusion criteria: Tobacco and alcohol-related 
diseases (e.g. chronic bronchitis, cardiovascular 
diseases, liver cirrhosis and pancreatitis). 
 
Observation time: 
between March 1997 and June 2000 
Response rate: cases (96%) controls (93%) 
Exposure:  
Questionnaire: interviewed by trained interviewers  
Interviewers blinded: n/s 
Reference period: n/s 
Drink type:n/s 
 
Measure:drinks per week/Age start drinking, Reference group: abstainers/<20 yrs 
Results: 
Total alcohol intake                                                    
Former drinker 10/8    1.47 (0.40–5.34)                      Age start drinking 
Current drinker                                              20–24   22/25    0.55 (0.22–1.41) 
<5                     20/28  1.57 (0.57–4.31)           ≥24     19/13    1.49 (0.50–4.43)  
5–21                 28/26  1.74 (0.58–5.24) 


















Study and Aims Study and sample characteristics Exposure measurement and main results 
Llewellyn 2004 
 
Country: United Kingdom 
 
Study aims: to evaluate the major 
risk factors for oral cancer in young 
adults in the United Kingdom. 
 
Source of funding: 
NHS Executive London Research & 
Development, Responsive Funding 
Programme 
Population: 
Cases: age 45 years or younger in south east of 
England, identified through Thames Cancer Registry 
database, pathologically confirmed, N=116 
Controls: conducted by contacting cases’ general 
medical practitioner and identifying from Practice 
Register two controls who had never had cancer. 
N=207  
 
Exclusion criteria:- None specified 
 
Observation time: 
between 1990 and 1997 
Response rate: cases controls (59% response rate) 
Exposure:  
Questionnaire: Mailed structured questionnaire 
Interviewers blinded: not applicable, postal questionnaire 
Reference period:in last year 
Drink type: wine, beer, spirits 
 
Measure:units per week/Age started drinking, Reference group: ≤14 units per week for 
females and ≤21 units per week for males/ ≥18yrs 
Results:   Total alcohol intake                                           Age started drinking 
Men         ≥ 21          1.6 (0.8-3.1)                             ≤18yrs      67/107      1.1 (0.5-2.0) 




Study and Aims Study and sample characteristics Exposure measurement and main results 
Llewllyn 2004 
 
Country: United Kingdom 
 
Study aims: 
to evaluate the major risk factors for 
oral cancer in young adults in the 
United Kingdom. 
 
Source of funding: 
NHS Executive London Research & 
Development, Responsive Funding 
Programme 
Population: 
Cases: age 45 years or younger in south east of 
England, identified through Thames Cancer Registry 
database, pathologically confirmed 
N=116 
Controls: conducted by contacting cases’ general 
medical practitioner and identifying from Practice 
Register two controls who had never had cancer. 
N=207  
 
Exclusion criteria:- None specified 
 
Observation time: 
between 1990 and 1997 
Response rate: cases controls (59% response rate) 
Exposure:  
Questionnaire: Mailed structured questionnaire 




Measure: units per week/Age started drinking,  
Reference group: ≤14 units per week for females and ≤21 units per week for males/ ≥18yrs 
Results:   Total alcohol intake                                           Age started drinking 
Men         ≥ 21    37/46       1.6 (0.8-3.1)                   ≤18yrs      67/107      1.1 (0.5-2.0) 
















Study and Aims Study and sample characteristics Exposure measurement and main results 
Maso 2002 
 
Country: Italy and Switzerland 
 
Population:SEE ALTIERI 2OO4 ABOVE 




Exclusion criteria: SEE ALTIERI 2OO4 ABOVE 
 
Observation time: SEE ALTIERI 2OO4 ABOVE 
 
Exposure: SEE ALTIERI 2OO4 ABOVE 
 
Measure:drinks per week, Reference group: 1-20 drinks per week 
Results: 
Oral Cavity 
d/w        ca/co     Only at meals         ca/co          outside meals 
21–34    34/95     2.5  (1.5-4.2)              9/70        4.0 (0.9–17.1)) 
35–55   19/129    3.7  (1.9-7.2)            42/79       13.2 (3.4–50.8)) 
≥56       30/64    10.3 (5.3–20.1)        141/113      27.6 (7.3–103.7) 
Pharynx 
d/w                    Only at meals         ca/co      outside meals 
21-34    37/295   2.0 (1.1-3.4)              15/70    2.2 (0.8–6.2)  
35–55   20/129   2.2 (1.1-4.4)              51/79     4.9 (1.9–12.6) 
≥56       32/64     7.1 (3.7-13.8)   )      195/113  11.3 (4.5–28.4) 
 





Study aims: to discover the role of 
tobacco and alcohol consumption 
and of the level of oral hygiene in 
the appearance of oral cancer 
 
Source of funding: 
N/s 
Population: 
Cases: all those with oral cavity cancer diagnosed in 
three hospitals in Madrid, histologically confirmed 
N=75 
Controls: healthy subjects in health care centres that 
corresponded to these hospitals, N=150 
 
Exclusion criteria: cancer in any location or any 
medical oral disease  
 
Observation time: n/s, Response rate: n/s 
Exposure:  
Questionnaire: standardized questionnaire administered by interviewer 
Interviewers blinded: n/s 
Reference period:n/s 
Drink type: wine, beer, spirits 
 
Measure:grams per day, Reference group: non drinker 
Results: 
1-50      28/77       1.55    0.72-3.32   (P<0.05) 
>50        35/22      6.76    2.96-15.42 (P<0.05), ptrend.<0.05 
 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Rodriguez 2004 
 
Country: Italy, Switzerland 
 
Study aims: risk factors for oral 
cancer in the young  
 
 




Exclusion criteria: SEE ALTIERI 2OO4 ABOVE 
 
Observation time: SEE ALTIERI 2OO4 ABOVE 
 
Exposure: SEE ALTIERI 2OO4 ABOVE 
 
Measure: drinks per day, Reference group: non drinkers 
Results:   ca/co 
<3            20/102      0.70   (0.27-1.78) 
3-<6         19/76        0.99   (0.35-2.81) 
6-<10       37/40        3.69   (1.23-11.08) 












Study aims: To examine further 
the relationship between alcohol 
use, ADH3 genotypes, and oral 
squamous cell carcinoma risk  
 
Source of funding: 
National Institute of Dental and 
Craniofacial Research, National 
Cancer Institute 
Population: 
Cases: residents in Washington state, identified 
through population-based state Cancer Surveillance 
System All participating cases and controls asked to 
provide a sample of exfoliated oral tissue 
N=407 
Controls: identified through random-digit telephone 
dialling of state households 
N=615 
 
Exclusion criteria: cases of lip cancer 
 
Observation time: 
Between January 1990 and June 1995 
Response rate: cases (54%) controls (63.3%)  
Exposure:  
Questionnaire: interviewed in-person by trained personnel using a FFQ 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: n/s 
 
Measure:drinks per week, Reference group: <1 drink per week 
Results: 
1–7            1.0   (0.6, 1.5) 
8–14          1.7   (1.0, 2.9) 
15–42        2.8   (1.7, 4.8) 
≥43            4.7   (2.4, 9.4) 
 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 
Vjajiinac 2006 
 
Country: Serbia and Montenegro 
 
Study aims: To test some 
hypotheses of risk factors for 
oropharyngeal malignant tumours 
(neoplasm of base of tongue, 
palate and tonsils). 
 
Source of funding: 
Ministry of Science, Technology 
and Development of Serbia 
Population: 
Cases: consecutive patients diagnosed for the first 
time as oropharyngeal neoplasm cases at 
Otorynolaryngology and maxillofacial surgery, Clinical 
Centre in Belgrade, histologically confirmed 
N=100 
Controls: patients treated during same period for 
some non-malignant diseases of head and neck 
N=100 
 




Response rate: n/s 
Exposure:  
Questionnaire: interviewed by physician with structural questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime 
Drink type:yes 
 
Measure:average weekly consumption and duration, Reference group:  non-drinkers/<19yrs 
Results:  
Average weekly intake (dl)                            Duration of drinking (years) 
≤1.75   39/37    1.55 (0.72–3.35)                20–39     50/40     1.26 (0.87–1.82) 





















Study aims: to understand the 
specific risk factors and protective 
mechanisms potentially involved in 
the aetiology of OC in this atypical 
population. 
 
Source of funding: 
National Institute of Dental and 
Craniofacial Research 
Population: 
Cases: male and female residents of South Greece 
identified at one of three major university hospitals in 
Athens, histologically confirmed, N=110 
Controls: patients of the same institutions, 
hospitalized for conditions unrelated to cancer 
N=115 
 
Exclusion criteria:trauma patients 
 
Observation time: 
Between November 1995 and January 1998 
Response rate: 98% 
Exposure:  
Questionnaire: Trained interviewers used a structured questionnaire specifically designed for 
study 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: wine, beer, ouzo/tsipouro, dark liquors 
 
Measure: drinks per week, Reference group:0 drinks per week 
Results: 
d/w       ca/co       Men                                            Women 
1-28       34/36  1.8 (0.6-4.8)                          15/9   1.4 (0.5-4.1)  
>28-42  10/9     1.6 (0.4-6.2) 
>42        15/4    5.3 (1.2-24.1)  ptrend.0.08                        
 
Descriptive tables for ovarian cancer: cohort studies  





Study aims: To examine the 
association between alcohol 
consumption and risk of ovarian 
cancer in a prospective cohort in 
which baseline alcohol 
consumption was associated with 
increased breast cancer risk 
 
Source of funding: 
National Cancer Institute, and from 
the California Breast Cancer 
Research fund 
Population: California Teachers Study cohort 
Source includes 133,479 active and retired female 
public school teachers and administrators who were 
members of  State Teachers Retirement System and 
returned a mailed questionnaire in 1995–1996 
 
Exclusion criteria: lived outside California at baseline; 
prior diagnosis of ovarian cancer or bilateral 
oophorectomy, aged 85 ≥yrs at baseline; reported 
never having had a 1stmenstrual period; 
providedmultiple invalid, inconsistent, or blank 
responses to questionnaire or reported food 
consumption judged to be implausibly low/high; 
invalid, or missing alcohol intake during previous year 
 
Study pop: 90,371 
 
Observation time: 1995-1996 to 31 December 2003, 
median follow-up 8.1 years; Loss to follow-up: <1% 
253 diagnosed with epithelial ovarian cancer 
Exposure:  
Questionnaire: mailed questionnaire  
Repeated during follow-up:  no 
Reference period: preceding year and at ages 18-22 and 30-35 years 
Drink type: beer, wine/champagne, cocktails/liquor 
 
Measure: grams per day, Reference group: none (n=77) 
Results: 
                         Year before baseline               Ages 30–35 yrs                      Ages 18–22 yrs 
<10.0  81    1.04  (0.76-1.42) 101  1.14 (0.83-1.56) 62   0.76 (0.55-1.03) 
10.0 < 20.0 72    1.47  (1.06-2.03) 47    1.08 (0.74-1.59) 36   1.26 (0.86-1.84) 
≥20.0  23    1.15  (0.71-1.84) 16    0.99 (0.56-1.71) 9    1.00 (0.50-1.99) 








Study and Aims Study and sample characteristics Exposure measurement and main results 
Kelemen 2004 
 
Country: USA  
 
Study aims: To determine if there 
was an association between 
alcohol consumption and ovarian 
cancer, and to test the hypothesis 
that there could be an interaction 
between folate and alcohol for risk 
of ovarian cancer as has been 
reported for breast cancer. 
 
Source of funding: 
National Cancer Institute. 
Population: 
Source: 99,826 eligible women between ages of 55-
69 yrs randomly selected from Iowa driver’s license 
registry. 41,836 (41.9%) responded to questionnaire. 
 
Exclusion criteria: history of cancer other than skin 
cancer; a bilateral oophorectomy at baseline or 
during follow-up; ovarian tumour of borderline 
malignancy 
 
Study pop:27,205  
 
Observation time: 
1986 through December 31, 2000, 367,114 person-
years Loss to follow-up: 35%; 147 cases  
Exposure:  
Questionnaire: semi quantitative FFQ 
Reference period: over last 12 months 
Drink type – no 
Repeated during follow-up: no 
 
Measure: grams per day, Reference group:<0.01g/d 
Results: 
g/d               ca                                     
0.01-3.9      75     0.78 (0.54-1.13) 
4.0-9.9        12     0.75 (0.39-1.42) 
≥10             12     0.58 (0.30-1.11) ptrend 0.08 
 
 





Study aims: To study alcohol 
consumption in relation to ovarian 
cancer risk in a prospective cohort 
study. 
 




Source: Netherlands Cohort Study on diet and cancer 
initiated in 1986 (n=62.573) postmenopausal women.  
 
Exclusion criteria: cancer cases (other than skin 
cancer); undergone an oophorectomy 
 
Study pop: Case cohort approach for design & 
analysis, 2,412 women randomly sampled from 
cohort 
 
Observation time:  
1986-1995, mean 9.3 years of follow-up,  
Loss to follow-up: n/s; 214 incident cases 
Exposure:  
Questionnaire:self-administered FFQ 
Reference period:- preceding year 
Drink type:beer, red wine, white wine, sherry, other fortified wines, liqueur, and liquor 
Repeated during follow-up: no 
 
Measure: grams per day, Reference group:non drinkers (less than once a month) 
Results: 
g/d     ca             all                                                  Wine 
0.1-4  74    1.13 (0.79-1.63)  1.08 (0.76-1.54)                      
5-14   28    0.85 (0.53-1.37)  0.97 (0.60-1.58)                            



















Study aims: to examine the 
association between caffeine, 
alcohol intake, cigarette smoking, 
and ovarian cancer risk, overall and 
by histologic subtype, in the 
Nurses’ Health Study (NHS). 
 
Source of funding: 
National Institutes of Health Grants 
Population: 
Source: Nurses Health Study established in 1976 
when 121,701 U.S. female registered nurses ages 30 
to 55 years completed and returned a questionnaire 
 
Exclusion criteria:those reporting any diagnosis of 
cancer besides non-melanoma skin cancer; with a 
history of bilateral oophorectomy; with a history of 
pelvic irradiation; missing year of birth; implausible 
dietary intakes 
 
Study pop:  = 80,253  
 
Observation time: 
1980 to June 1 2004, Loss to follow-up: 4.7% 
507 cases (443 invasive and 64 borderline) 
Exposure:  
Questionnaire: self-administered FFQ 
Repeated during follow-up:  yes, every two years 
Reference period: preceding year 
Drink type: beer, wine, spirits 
 
Measure: grams per day (g/d) and drinks per week (d/w), Reference group: <0.1g/d (n=110) 
for g/d and never (n=49) for d/w 
Results: 
g/d               cad/w  ca 
0.1–4.9     217    1.05 (0.83–1.33) >0–4         249     0.99 (0.72–1.35) 
5.0–14.9   114    0.99 (0.75–1.30) 5–6             80     0.93 (0.65–1.34) 
15+             66    0.99 (0.72–1.36)  1+ d/d      129     0.97 (0.69–1.35) 
ptrend 0.910 99 
 
Descriptive tables for ovarian cancer: case control studies  
 






To examine the hypothesis that 
alcohol consumption 
is associated with the risk of 
ovarian cancer 
 
Source of funding: 
National Institutes of Health 
 
Population:   
Cases: from two population-based cancer registries, 
in Hawaii and Los Angeles  
N=558 (127 borderline tumours, 431 invasive 
carcinomas) 
Controls: representative sample of all households in 
Hawaii state based on lists of female residents 
interviewed by Health Surveillance Program 
N =607  
 
Exclusion criteria:prior history of ovarian cancer; 
more than one intact ovary 
 
Observation time: 1993 to 1999  
Response rate: cases 60%, controls67% 
Exposure:  
Questionnaire: structured in person interview 
Reference period: lifetime history, drinker defined as woman who drank any type of alcoholic 
beverage at least once a week for 6 months or more. 
Drink type: – beer, wine, spirits 
 
Measure:drinks per week, Reference group: never drinkers 
Results:  
Ever 0.88 (0.67-1.16), Former 1.16 (0.82-1.64), Current  0.69 (0.50-0.96)      
 
d/w        ca/co Total                                           yr         ca/co No. of years drinking 
<3.5 41/64   0.72  (0.46-1.12)                      <10       60/98   0.67   (0.46-0.98) 
3.5-6.9 39/50   0.86  (0.54-1.38)                  10–20      58/68    0.94   (0.62-1.42) 
7.0-13.9 67/61  1.14   (0.76-1.72)                      ≥20       85/72   1.15   (0.78-1.68) ptrend   0 37 













Study aims: To examine alcohol 
consumption as a risk factor for 
epithelial ovarian cancer according 
to tumor histology. 
 
Source of funding: 
National Cancer Institute 
 
Population: 
Cases:women aged 20–69 years diagnosed with 
EOC identified at 39 hospitals around the Delaware 
Valley 
N =767 




Exclusion criteria:none specified  
 
Observation time: 
May 1994 to July 1998,  
Response rate: cases 88%,  controls72% 
Exposure:  
Questionnaire: standardized, 1.5-hour, in-person Interviewers blinded: n/s 
Reference period: n/s 
Drink type - no 
 
Measure:grams per day, Reference group:never drinker 
Results:  
                         Current drinkers                                               Former drinkers       
               Non-Mucinous      Mucinous                     Non-Mucinous                Mucinous 
24           0.98 (0.75-1.30)    0.61 (0.32-1.15)          1.06(0.78-1.43)           0.97 (0.54-1.74) 









Study aims: To investigate alcohol 
consumption as a risk factor for 
ovarian cancer 
 
Source of funding: 
National Institutes of Health; 
 
 
Design: population case control 
 
Population: 
Cases: all women aged 40–79 (1993-1995) or aged 
20-75 (1998-2001) with new diagnosis of ovarian 
cancer reported to state cancer registries  
N =762  
Controls: randomly selected from lists of licensed 
drivers if < 65yrs, and from rosters of Medicare 
beneficiaries if ≥ 65yrs. 
N =6,271  
 
Exclusion criteria: bilateral oophorectomy 
 
Observation time: 
1993-1995 to 1998-2001 
Response rate: cases 66%,  controls 80.6% 
Exposure:  
Questionnaire: structured telephone interview  
Interviewers blinded: yes  
Reference period: information on average alcohol consumption in early adulthood (20–30 
years of age) and at 1 or 5 years before a reference date, depending on era of data collection.  
Drink type: beer, wine, spirits 
 
Measure:drinks per week and day, Reference group: non drinker  
Results:     Recent past                                   At 20-30yrs 
<1d/w      1.05  (0.75-1.30)                              1.12 (0.88–1.42) 
1-6d/w    1.15   (0.75-1.30)                              1.13 (0.90–1.43) 
≥1d/d       0.89  (0.70-1.20) ptrend=0.77          1.27 (0.96–1.68) ptrend=0.11 
Recent past and drink type 
                  Beer                       Wine                           Spirits 
<1d/w   1.17  (0.90-1.51)    1.14  (0.90-1.44)    0.99  (0.78-1.26) 
1-6d/w  1.05  (0.78-1.41)    1.10  (0.84-1.43)    1.27  (0.97-1.66) 
≥1d/d    0.94  (0.58-1.51)    1.34  (0.88-2.05)    1.19  (0.79-1.79) 











Study and Aims Study and sample characteristics Exposure measurement and main results 
Riman 2004 
 
Country: Sweden  
 
Study aims: to examine body 
mass index (BMI), alcohol use, 
coffee consumption, cigarette 
smoking, and leisure-time physical 
activity in relation to epithelial 
ovarian cancer (EOC) risk 
 
Source of funding: not specified 
Population: 
Cases: subjects were 655 newly diagnosed EOC 
cases and, all 50-74 years  
Controls: 3899 population controls 
655 cases 3899 controls 
 
Exclusion criteria: previous bilateral oophorectomy 
 
Observation time: 
1993 to 1995 
Response rate:  
Exposure:  
Questionnaire: postal questionnaire (plus phone interviews for 11% non respondents) 




Measure:grams per day, Reference group: not specified 
Results: 
<5   0.94 (0.77-1.14)         
≥5   0.99 (0.75-1.29)        p for trend 0.80 
 
 





Study aims: To investigate the 
relationship between coffee and 
alcohol intake and ovarian cancer 
risk 
 
Source of funding: 




Cases: selected from major teaching hospitals in four 
Italian areas: Greater Milan, North-eastern Italy, 
Central Italy and Southern Italy. 
N =1031cases (median age 56) 
Controls: women from same geographical areas and 
admitted to same network of hospitals as cases  
N =2411controls (median age 57) 
 
Exclusion criteria: admitted to the hospital for 
hormonal and gynaecological diseases and if they 
had undergone bilateral ovariectomy; admitted to the 
hospital for chronic conditions or digestive tract 
diseases, related to coffee or alcohol intake 
 
Observation time: 
between 1992 and 1999 
Response rate: cases 96%, controls 96% 
Exposure:  
Questionnaire: self administeredstructured questionnaire  
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: wine, beer, grappa, amari and digestives, and spirits 
 
Measure:grams per day, Reference group: never drinkers (life-long alcohol non-drinkers) 
Results: 
g/d              All alcohol                 g/d               Wine 
<12          1.02 (0.80-1.30          ≤13        1.06(0.83-1.35 
12-<24    1.29 (1.00-1.67)          >13-26  1.37(1.06-1.77) 
24-<36    1.04 (0.80-1.36)         >26-39   1.07 (0.82-1.39)  
 ≥36         1.09 (0.76-1.57)          >39       1.03 (0.70-1.50)    
ptrend=           0.409                                         0.386 
 


















Study aims: to evaluate the 
association between alcohol intake 




Source of funding: 
Australian National Health and 
Medical Research Council 
andQueensland Cancer Fund. 
 
Population: 
Cases: ascertained through major treatment centres 
in the three Australian states (New South Wales, 
Victoria, & Queensland). 
N= 696 
Controls: selected at random from the electoral roll  
N= 768 
 
Exclusion criteria: history of ovarian cancer or 
bilateral oophorectomy  
 
Observation time: 
between August 1990 and December 1993 
Response rate: cases 89% controls 73% 
Exposure:  
Questionnaire: self completed FFQ  
Interviewers blinded:  n/s 
Reference period:  n/s 
Drink type: red wine, white wine and champagne, beer and spirits. 
 
Measure: drinks per week, Reference group:  non-drinkers 
Results: 
<1      0.79  (0.59-1.05)      
1-6     0.66  (0.48-0.90)      
1-1.9  0.78  (0.50-1.23)     
 ≥2     0.49  (0.30-0.81)    ptrend 0.003 
 
                         Beer                    Wine                      Spirits 
<1/wk 1.21   (0.51-1.91)     0.68  (0.77-1.91)    1.16   (0.75-1.80) 
1-6 1.28   (0.64-2.10)     0.77  (0.51-1.61)    1.08   (0.64-1.82) 
≥1/day 0.94   (0.55-1.61)     0.56  (0.33-0.93)    1.07   (0.59-1.95) 





Descriptive tables for pancreatic cancer: cohort studies 
 





Study aims: To learn more about 
epidemiology of pancreatic cancer 
by examining associations with a 
variety of possible risk factors for 
death from pancreatic cancer 
 
Source of funding: 
n/s 
Population: 
Source:Cancer Prevention Study II - a prospective 
mortality study of men and women enrolled by 
American Cancer Society volunteers from  all 50 US 
states 
 
Exclusion criteria:Persons <30 years old; Individuals 
with a self reported history of cancer other than non-
melanoma skin cancer 
 
Study pop: 1.2 million men and women 
 
Observation time: 
1982-1996, Loss to follow up 1.4% 
3,751 deaths (1967 men, 1784 women) 
Exposure: 
Questionnaire: Self administered questionnaire   
Repeated during follow-up: Baseline exposure only 
Reference period:within year before survey 
Drink type: n/s 
 
Measure:drinks per day (d/d), Reference group: None’ (not defined) 
Results:  
                       Men                             Women 
Some        0.9 (0.8-1.1)  0.9 (0.8-1.1) 
1d/d          0.9 (0.8-1.1)  0.8 (0.7-1.0) 
>1d/d        0.9 (0.8-1.1)  0.9 (0.8-1.1) 
 
 





Study aims: to investigate the 
association between alcohol 
consumption and the risk of 
pancreatic cancer in a large 
prospective cohort study in the 
Netherlands. 
 
Source of funding: 
No funding 
Population: 
Source: Netherlands Cohort Study began in 
September 1986 and included initially 58,279 men 
and 62,573 women aged 55–69 years from 204 
Dutch municipalities with computerized population 
registries 
 
Exclusion criteria:- incomplete alcohol data 
 
Study pop: 120,852 
 
Observation time: 
1986 to December 1999  LFU: <4% 
447 incident cases of pancreatic cancer, 
Exposure:  
Questionnaire: self-administered 150-item semi-quantitative FFQ 
Repeated during follow-up:  
Reference period:during the year preceding the start of the study 
Drink type: beer; red wine; white wine; sherry and other fortified wines; liqueurs containing,  
(Dutch) gin, brandy, and whiskey 
 
Measure:grams per day, Reference group: Abstainers 73 
Results: 
0.1–<5 93 1.03   (0.74-1.42) 
5–<15 82 1.12   (0.79-1.57) 
15–<30 50 0.86   (0.58-1.28) 

















Study aims: To further elucidate 
the relation between alcohol use 
and pancreatic cancer risk 
 
Source of funding: 
National Institutes of Health 
Population:NIH-AARP Diet and Health Study 
Source: self-administered baseline questionnaire was 
mailed to 3.5 million AARP members 50-71 yrs who 
resided in 6 US states (California, Florida, Louisiana, 
New Jersey, North Carolina, and Pennsylvania) and 2 
metropolitan areas (Atlanta, Georgia, and Detroit, 
Michigan). 617,119 members returned the 
questionnaires, and 567,169 completed the 
questionnaire satisfactorily 
 
Exclusion criteria: moved out of the study areas 
before returning the questionnaire; questionnaire 
completed by proxy respondents;prevalent cancer 
cases identified through cancer registries at baseline, 
those with extreme energy intake 
 
Study pop: 470,681 AARP members, 280,084 men 
and 190,597 women. 
 
Observation time:1995-1996 toDecember 31, 2003, 
LFU = 4%, 1,149 cases 
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: baseline only 
Reference period: over the previous 12 months 
Drink type: beer, wine, and spirits 
 
Measure: grams per day, Reference group: 0-0.9  g/d 
Results: 
0             305     1.14     (0.99-1.32) 
1–1.99   121      0.92     (0.75-1.12) 
2–2.99     41      1.03     (0.75-1.42) 
3–3.99     39      1.31     (0.94-1.82) 
4–4.99     25      1.54     (1.02-2.31) 
5–5.99     10      1.28     (0.68-2.41) 
≥6            52      1.55     (1.13-2.13), P for trend 0.01  
Continuous(per 10-g/dayincrement)1.06 0.98, 1.13 
 
 





Study aims: evaluated the 
associations of such lifestyle factors 
as alcohol drinking, coffee 
consumption and medical history 
with risk of death from pancreatic 
cancer 
 
Source of funding:  
Ministry of Education, Science, 





Source: 127,500 inhabitants who underwent a 
general health check-up enrolled as basic cohort 
population from 45 areas in Japan, response rate:  
>90%, 
 
Exclusion criteria: with a history of any cancer at 
baseline and those with unknown smoking status. 
 
Study pop: 110,792: 46,465 men and 64,327 women 
 
Observation time:  
1988-1990 to 1997, follow-up of 775,697 person-
years, LFU: <5%,  225 pancreatic cancer deaths 
Exposure:  
Questionnaire: Self administered questionnaire 
Repeated during follow-up: Baseline exposure only 
Reference period: amount drunk in last week 
Drink type: n/s 
 
Measure: grams per day, years of drinking grams, cumulative amount, Reference group: non 
drinkers 
Results:              Daily Amount                                        Years of drinking grams  
g/d              men                     women                 yrs           men                    women 
0-29      1.16   (0.66-2.04)   1.01 (0.53–1.91)     0-19   0.93 0.40–2.14)    1.02   0.44-2.36) 
30-59    1.07   (0.56-2.06)                                  20-39 1.09 (0.60–1.99)   0.77  0.24-2.48) 
≥60       0.98   (0.39-2.46)                                  ≥40     0.97 (0.52–1.83)  1.45   0.35-5.96) 
                  ptrend 0.76                    ptrend 0.66                                                
Cumulative amount (grams)  men                                          women 
0–999                                0.8    (0.41–1.57)                    1.04   (0.50–2.19) 
1,000–1,999                      1.55  (0.84–2.86)                    1.81   (0.25–13.27) 









Study aims: We examined the 
relationships of coffee and alcohol 
intakes and pancreatic cancer risk 
in the HPFS3, a prospective cohort 
of men, and in the NHS, a 
prospective cohort of women 
 
Source of funding: 
National Cancer Institute 
 
Population: derived from two cohort studies: Health 
Professionals Follow Up Study (HPFS) and Nurses 
Health Study (NHS) 
 
Exclusion criteria: diagnosed with cancer (other than 
non-melanoma skin cancer) before baseline (1986 
HPFS; 1980 NHS); individuals with very high/ low 
scores for energy. 
 
Study pop: 47 794 men, 88 799 women 
 
Observation time: 
1986 to January 31, 1998 for men 1980 to June 30, 
1996 for women 1,907,222 person years of follow-up, 
LFU <10% 130 cases of pancreatic cancer diagnosed 
in men and 158 pancreatic cancer cases in women 
Exposure:  
Questionnaire: Mailed 131-item semi-quantitative FFQ 
Repeated during follow-up: Information collected at baseline and at four year intervals 
Reference period:over the previous year 
Drink type: n/s 
 
Measure:grams p/d, Reference group: Non drinkers’ (not defined) 
Results:           HPFS                   NHS                  
0.1-4        1.01  0.36-2.83     0.72  0.41-1.30     
1.5-4.9     1.44  0.67-3.12     1.07  0.68-1.67      
5.0-12.9   1.23  0.59-2.53     0.93  0.61-1.42      
≥30          1.34  0.58-3.08     0.78  0.36-1,68       
ptrend 0.55                               ptrend 0.49 
 
Multivariate RRs for every additional drink/day in pooled analyses: 1.08 (95% CI,0.88–1.33) 
for beer, 0.91 (95% CI, 0.70 –1.19) for wine, and 0.96 (95% CI, 0.81–1.15) for hard liquor 
 






o examine the association of 
baseline and 
lifetime ethanol intake with cancer 
of the pancreas 
 
Source of funding: 
European Commission 
Population: European Prospective Investigation into 
Cancer and Nutrition (EPIC) conducted in 23 centres 
in 10 European countries (see Chapter 2.4, Box 2)) 
 
Exclusion criteria:prevalent cancer cases, missing 
follow-up information,6,220 subjects without dietary 
or non-dietary information, 9,674 subjects with 
extreme ranking ratio for energy intake versus energy 
expenditure  
 
Study pop: 478,400 
 
Observation time: 1992 and 2000. Median follow-up 
time of 8.9 years, LFU: n/s; 555 cases 
Exposure:  
Questionnaire: self-administered questionnaire 
Repeated during follow-up: no 
Reference period:over the previous 12 months and (for lifetime) consumed per week at ages 
20, 30, 40, and 50 yrs 
Drink type:beer wine spirits 
 
Measure: grams per day, Reference group: 0.1–4.9 g/d 
Results: 
0             78      1.06   (0.79–1.41)            24   0.78   (0.50–1.24) 
5–14.9    140    0.98   (0.78–1.24)          113   0.86   (0.66–1.12) 
15–29.9  91      1.06   (0.81–1.39)            68   0.87   (0.63–1.20) 
30            80      0.98   (0.72–1.32)                    58     0.94 (0.64–1.37) 


















Study aims: to examinethe 
separate and joint associations of 
demographic and lifestylefactors 
with pancreatic cancer 
 
Source of funding: 
Cancer Research UK, Medical 
Research Council, UK, NHS Breast 
Screening Programme. 
Population: million women study. 
Source: 1.3 million middle-aged women who had 
been invited for screening for breast cancer at breast 
cancer screening centres throughout England and 
Scotland 
 
Exclusion criteria: diagnosed before recruitment with 
any cancer other than non-melanoma skin cancer 
 
Study pop: 1.29 million 
 
Observation time: 1996–2001 to 2006/07, 9.2 
million person-years 1,338 incident pancreatic cancer 
cases and 1,710deaths from the disease 
Exposure:  
Questionnaire: self-administered questionnaire 




Measure: units per week, Reference group:  
Results:                  incidence        mortality 
None     378/492    1.07 (0.06)      1.10 (0.05) 
1-2        382/483    1.00 (0.05)       1.00 (0.05) 
3-6         255/334   0.88 (0.06        0.99 (0.06) 
14+          91/114   1.08 (0.11)      1.07  (0.10) 
 






To investigate the risk of pancreatic 
cancer among patients with a 
discharge diagnosis of alcoholism, 
alcoholic chronic pancreatitis, or 
alcoholic liver cirrhosis. 
 
Source of funding: 




in-patients with discharge diagnosis of alcoholism 
(ICD-7 307, 322; ICD-8 291, 303; ICD-9 291, 303, 
305A),  
Cohort = 178 688 men and women ,  
 
Exclusion criteria: Records: (1) erroneous or 
incomplete national registration numbers; (2) 
inconsistencies uncovered during record linkage; (3) 
patients who died during the index hospitalisation; 
and (4) of patients with prevalent cancers at entry. 
 
Observation time: 
1965-1995, mean duration of follow up 10 years, 1 
789 693 person years at risk, no loss to follow up 
305 incident cases 254 men, 51 women 
Exposure: consumption defined by specified ICD-7,8,9 codes into category ‘alcoholism’ 
 
Results: Alcoholism                        
All                1.4   (1.2-1.5)            
Male            1.3   (1.2-1.5)            
Female        1.6   (1.2-2.1)              
 
Age at index discharge             Follow up duration (yr) 
<50              1.7   (1.4-2.1)            1–4      1.3   (1.0–1.6)  
50-59           1.2   (1.0-1.5)            5–9      1.4   (1.1–1.7)  
60-69           1.3   (1.1-1.6)        10–14      1.5   (1.2–1.9) 
≥70              1.1   (0.7-1.6)         15–30     1.4    (1.1–1.8) 









Descriptive tables for pancreatic cancer: case control studies 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: To investigate and 
potentially corroborate a possible 
association between H. pylori 
infection and subsequent 
development of pancreatic cancer 
 
Source of funding: 
N/s 
Population: 128,992 subscribers to Kaiser 
Permanente Medical Care Program enrolled in a 
multiphase health check-up from 1964 to 1969 
 
Cases: consisted of randomly selected subjects 
among 507 who developed pancreatic cancer in the 
cohort. N=104 
Controls: consisted of pancreatic cancer–free 
subjects from a pool of 730 controls previously tested 
for studies conducted on this cohort. N=262 
 
Exclusion criteria: none specified 
 
Observation time: From enrolment until the year 
2000, Response rate: none specified 
Exposure: NO DETAILS PROVIDED  
Questionnaire:  





Measure:drinks per day, Reference group: never drinkers 
Results: 
Former           0.88  (0.22-3.56) 
≤2 drinks/d    1.93   (0.99-3.75)  
>2 drinks/d    0.62   (0.21-1.85)  
 
 






To evaluate the independent effects 
of multiple risk factors for 
pancreatic cancer and determined 
whether the magnitude of cigarette 
smoking was modified by other risk 
factors in men and women. 
 
Source of funding: 
National Institutes of Health/ Texas 
Tobacco Settlement 
Population: 
Cases: recruited from population of patients with 
newly diagnosed pancreaticcancer at cancer centre 
in Texas N=808 
Controls: were healthy nonblood relatives, particularly 
spouses, of patients with cancers other than liver, 
gastrointestinal, lung or head and neck (smoking-
related cancers) who were undergoing treatment at 
same cancer centre N=808 
 
Exclusion criteria: not have ever had cancer; Non 




January 2000 through December 2006, 
Response rate: cases and controls 84% 
Exposure:  
Questionnaire: personally interviewed by well-trained interviewers, using a structured 
questionnaire 
Interviewers blinded: n/s 
Reference period: lifetime (consumed at least 4 alcoholic drinks of beer, wine or hard liquor 
each month for 6 months during their lifetimes 
Drink type: 
 
Measure:lifetime intake, mL/day, Reference group: No (not defined), n= cases114/ controls 
463 
Results: 
≤60   355/386            0.9  (0.7–1.2) 






Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: to compare alcohol 
and smoking as risk factors in the 
development of chronicpancreatitis 
and pancreatic cancer 
 
Source of funding: 
Italian Cancer Registry and 
University of Rome 
 
Population: 
Cases:All consecutive cases in medical surgical 
departments in Verona 
N=630 




Exclusion criteria:-any patients in whom a 
pancreatic cancer was diagnosed within two years of 
diagnosis of chronicpancreatitis 
 
Observation time: 
Cases 1971-1995, Controls 1985-1987 
Response rate:  n/s 
Exposure:  
Questionnaire: direct interviews at point of diagnosis 
Interviewers blinded: n/s 
Reference period: alcohol intake over the previous 5 years 
Drink type: n/s 
 
Measure:grams per day, Reference group: 0-40g/d 
Results:  Pancreatic Cancer without history of Chronic Pancreatitis versus controls 
g/d 
41-80    0.5  (0.2-1.0),  
>80       0.4  (0.2-1.0)   
 
 





Study aims: To assess the 
relationship between tobacco, 
alcohol and coffee in the aetiology 
of pancreatic cancer 
 
Source of funding: 
Canadian National Enhanced 
Cancer Surveillance System 
project. 
Population:  
Cases: identified from provincial cancer registries in 
eight of the ten Canadian provinces 
N=583 
Controls: random sample from health insurance plans 
or random digit telephone sample 
N=4813 
 
Exclusion criteria: cases known to be deceased 
 
Observation time:  
1994-1997 
Response rates: cases (56%) controls (68%) 
Exposure:  
Questionnaire: mailed FFQ with telephone follow up,  
Interviewers blinded: n/s 
Reference period: two years before interview 
Drink type: wine, beer and spirits. 
 
Measure:times per month’, Reference group: ‘0-3 times per month’ 
Results:  
                  Males                         Females 
>0-<-3   0.83   0.56-1.25           0.90   0.65-1.25 
3-<7      0.86    0.57-1.28           0.59   0.34- 1.02 
7-<14    1.20    0.79- 1.80          0.95   0.57-1.56 





Descriptive tables for prostate cancer: cohort studies 
 






to analyse whether  alcohol intake 
is a risk factor in the development 
of prostate cancer  and whether 
any such relationship depends on 
the type of alcoholic beverage 
consumed 
 
Source of funding: 
Danish National Board of Health 
and Danish Ministry of Health 
Population: 
Source: male participants from three longitudinal 
studies conducted in Copenhagen, Denmark between 
1976 and 1986, two random samples of general 
population, the other collected from 14 large 
workplaces 
 
Exclusion criteria: incomplete data on drinking, 
smoking and diet 
 
Study pop: 24, 496, response rate 80% 
 
Observation time: until 31 December 1998, mean 
follow up 12.3yr, 159,623 person years, LFU n/s 
233 incident cases 
Exposure:  
Questionnaire: Self administered questionnaire 
Repeated during follow-up:collected every 4 years 
Reference period: in previous year 
Drink type: Beer, Wine, Spirits 
 
Measure:drinks per week, Reference group: <1 drink per week 
Results: 
1-6        0.90  0.61-1.34        
7-13      0.86  0.57-1.29 
14-20    0.91  0.58-1.44       
21-41    0.93  0.59-1.47 
>41       0.66  0.29-1.49 p for trend, 0.48 
 
 





Study aims: to examine the 
association between usual alcohol 
consumption and prostate cancer 
and to examine the association 
between distant past alcohol 
consumption and prostate cancer 
 




Source: NHANES I, nationally representative, cross- 
sectional survey of the civilian non-institutionalized 
population of the US, conducted between 1971 and 
1975, formed two separate cohorts, one originated in 
1971–75; the other originated in 1982–84 
 
Exclusion criteria:none specified 
 
Study pop: Cohort I (n = 5766) and Cohort II (n = 
3775, was the subset of Cohort I alive and free of 
prostate cancer at their 1982–84 interview who had 
data on alcohol consumption) 
 
Observation time: median follow-up 17.1 years, LFU 
n/s, Cohort I (252 cases), Cohort II (134 cases)  
Exposure:  
Questionnaire: In-person interview  at baseline, then FFQ at follow-up 
Repeated during follow-up: baseline 1971-1975 and then in 1982–84 
Reference period:  at baseline within last 24 hours and at follow up within the last year 
Drink type: Beer, Wine, Spirits 
 
Measure:drinks per week, Reference group: non drinkers, 
Results: Cohort 1                                  Cohort 2 
caca 
>0-1  41   0.97  0.67-1.41      19  0.74   0.44-1.25 
2-7     65   0.88  0.64-1.29     29  1.13   0.71-1.80 
8-14   25   0.96  0.61-1.44      1   1.05   0.60-1.86 
15-21  8    0.85  0.41-1.47      9   1.12   0.55-2.30 
22+     17  1.42  0.84-2.40      2   0.23   0.06-0.95 
 
Distant past drinking      ca 
Not heavy at age 25       71   0.99   0.69-1.43 Heavy at age 25    3    0.20   0.06-0.63 
Not heavy at age 35       81   1.18   0.80-1.73 Heavy at age 35    5    0.30   0.12-0.77 
Not heavy at age 45       79   1.05   0.72-1.54 Heavy at age 45    6    0.39   0.17-0.93 






Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: ‘to assess the relation 
between tea consumption and the 
risk of developing prostate cancer 
among men... In addition, we also 
studied the effects of coffee, cola, 
and alcohol on prostate cancer risk’ 
 
Source of funding: 
n/s 
Population: 
Source: Residents of the ten Canadian provinces 
were randomly sampled using a three-stage stratified 
cluster design total of 12 795 people aged 50-84 
years, responded to the initial invitation to participate 
(47% response rate) 
 
Exclusion criteria:diagnosed with any form of cancer 
prior to baseline; missing information on tea intake  
 
Study pop: 3584  
 
Observation time: 
1970-1972 to 1993, Loss to follow up n/s 
154 cases of incident prostate cancer 
Exposure:  
Questionnaire: one-month food frequency questionnaire, 
Repeated during follow-up: baseline only 
Reference period: 
Drink type: beer, wine and spirit 
 
Measure:ml/day, Reference group:  
Results: 
ml/day  cases 
>0-9.9        38   0.96   0.63-1.47 
10.0-24.9   54   0.85   0.50-1.45 
>>25.0       22   0.93   0.55-1.57 
any            25   0.93    0.63-1.36 
 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: to examine the 
association between several 
lifestyle and socio-economic factors 
and the development of prostate 
cancer in a cohort of Norwegian 
men’. 
 
Source of funding: 
Norwegian Cancer Society 
Population: 
Source: Large health survey in the county of Nord-
Trøndelag, Norway, all residents aged ≥20yrs by 
31/12/1983 eligible. Of 85 100 eligible persons, 77 
310 (90.8%) filled in questionnaire.  
 
Exclusion criteria:no history of any cancer at study 
entry 
 
Study pop: 22 895 men aged ≥40 years 
 
Observation time: 
1984 to 1986 until of 1 January 1996, mean follow-up 
9.3 years; 644 cases of incident prostate cancer 
Exposure:  
Questionnaire: health survey questionnaire 
Repeated during follow-up: baseline only 
Reference period:n/s 
Drink type: beer, wine and spirit 
 
Measure:drinks per week, Reference group: none (not drunk in past 2 weeks but not 
including teetotallers) 
Results: 
p/w           cases 
1-4 times    148      0.15   0.94-1.41   













Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims:  To evaluate the 
association of alcohol intake and 
alcohol drinking patterns with 
prostate cancer in a large cohort 
study. 
 
Source of funding: 
National Cancer Institute, and 
National Institute on Alcohol Abuse 
and Alcoholism and National Heart, 
Lung, and Blood Institute 
Population: 
Participants members of the Health Professionals 
Follow-up Study, an ongoing prospective cohort study 
of 51,529 men aged 40–75 years in the US 
 
 Final cohort size, 47,843 men. 
 
Exclusion criteria: Men who had been diagnosed with 
cancer (except non-melanoma skin cancer) before 




1986 through to 1998.533 047 person years 
Follow-up response was 94%. 
2,479 cases of incident prostate cancer  
 
Exposure:  
Questionnaire: Mailed semi-quantitative FFQ completed  
Repeated during follow-up: at baseline (1986) and in 1990 and 1994. Analysis of alcohol 
intake from baseline consumption only 
Reference period:over past year 
Drink type: beer, red wine, white wine, and spirits; 
Questions on frequency of consumption of number of days of the week on which alcohol 
consumed; whether alcohol intake had changed in past 10 years. 
 
Measure Grams per day, Reference group:0 grams/d (never drinkers incl. former drinkers) 
Results:       Grams per day             drinking days per week 
0-1-4.9         0.99    (0.86-1.09)         1-2   608   1.05    (0.94-1.16) 
5.0-14.9       1.05    (0.94-1.18)         3-4   335   1.05    (0.92-1.20) 
15.0-29.9     1.13    (0.98-1.31)         5-6   358   1.19    (1.04-1.35) 
30.0-49.9     1.13    (0.96-1.33)         7      393   1.05     (0.92-1.20) p-trend 0.10        
≥50              1.00    (0.77-1.31) p-trend 0.20                  
                       Advanced cases           Distant metastatic or fatal cases (ref group: 0–4.9g/d) 
5.0-14.9      175   1.22   (0.96-1.55)                    79   1.32   (0.91-1.92) 
15.0-29.9     80    1.24   (0.92-1.67)                    27   1.01   (0.62-1.63) 
30.0-49.9     81    1.17   (0.85-1.61)                    38   1.35   (0.83-2.21) 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: evaluated role of 
lifestyle (alcohol, smoking, and 
physical activity) … factors known 
to correlate with or modulate 
endogenous steroid hormones as 
prostate cancer risk factors in a 
population-based cohort of Iowa 
men. 
 
Source of funding: 
National Cancer Institute 
Population: 
Population-based control group study of 6 cancer 
sites in Iowa, 1986-1989  
Controls: randomly selected from Iowa population by 
two sampling methods: 1) random sample of all 
persons 40 to 64 yrs identified through Iowa driver’s 
license records and 2) random sample of all persons 
65 yrs and older identified through US Health Care 
Financing Administration 
 
Exclusion criteria: prior history of cancer. 
Study population: 1,601  
 
Observation time: 1989-December 31, 1995; 9,509 
person-years of follow-up, Loss to follow up 1%; 101 
cases of prostate cancer.  
Exposure:  
Questionnaire: miled food frequency questionnaire, supplemented with telephone interview 
Interviewers blinded:n/a 
Reference period:in the previous year 
Drink type: beer wine and liquor 
 
Measure: grams per week, Reference group: non-drinker 
Results:    ca 
<22            14      1.1   (0.6-2.1)   
22-92         25      2.6   (1.4-4.6) 














Study aims: To examine whether 
baseline or average lifetime alcohol 
consumption was associated with 
the subsequent risk for prostate 
cancer. 
 
Source of funding: 
n/s 
Population: 
Source: European Prospective Investigation into 
Cancer and Nutrition: 10 European countries 
[Denmark France, Germany, England, Greece, Italy, 
The Netherlands, Norway, Spain, and Sweden], 
approx. 500,000 participants. At baseline, men were 
between 40-65 yrs. Recruited 1992-2000, usually 
from the general population. 
 
Exclusion criteria:without prevalent cancers other 
than non-melanoma skin cancer; missing information 
on dietary or non-dietary data or if in the top or 
bottom 1% of the distribution of the ratio of reported 
energy intake to energy requirement 
 
Study pop: 142,607  
 
Observation time: 
Period n/s, 1,235,364 person-years of follow-up, loss 
to follow up: n/s; 2,655 prostate cases 
Exposure:  
Questionnaire: dietary assessment instruments that were specifically developed for each 
participating country 
Repeated during follow-up: baseline only 
Reference period:over the previous 12 months 
Drink type: beer and/or cider, wine, sweet liquor, distilled spirits, or fortified wines 
 
Measure: grams per day at baseline, average lifetime consumption, Reference group: 0.1-
4.9 g/d (n=615) 
Results: 
                  ca    Baseline                    ca   Average lifetime consumption 
0.              204   0.95   (0.81-1.12)      20   0.82   (0.51-1.29) 
5-14.9       745   0.99   (0.89-1.11)    482   1.03   (0.88-1.21) 
15-29.9     531   0.95   (0.84-1.08)    421   1.08   (0.91-1.27) 
30-59.9     422   1.03   (0.90-1.18)    283   1.02   (0.85-1.23) 
≥60           138   0.88   (0.72-1.08)    142   1.09   (0.86-1.39) 
 





Study aims: To investigate red 
wine consumption and prostate 
cancer in the Health Professionals 
Follow-up Study (HPFS). 
 
Source of funding: 
National Institutes of Health 
Population: 
Source: HPFS is an ongoing, prospective study of 
51,529 American male health professionals 40-75 yrs 
at enrolment in 1986. 
 
Exclusion criteria: diagnosed with cancer (except 
nonmelanoma skin cancer); invalid or incomplete 
baseline food frequency or alcohol information  
 
Study pop: 45,433  
 
Observation time: 
1986 to January 31, 2002, Loss to follow up: 6% 
348 cases  
Exposure:  
Questionnaire: semi-quantitative food frequency questionnaire 
Repeated during follow-up: baseline and every 4 years 
Reference period:during the past year 
Drink type: beer red wine white wine liquor, e.g., whiskey, gin 
 
Measure: grams per day, Reference group: No alcohol consumption (n=307) 
Results:      ca 
0.01-1.31     158     0.90  (0.74-1.09) 
1.32-2.41     205    1.02   (0.85-1.22) 
2.42-7.03     594    1.12   (0.97-1.29) 
7.04-16.4     840    1.16   (1.01-1.32) 













Study aims: To examine alcohol 
consumption in relation to prostate 




Source of funding: 
Dutch Cancer Society 
 
Population: 
Source: Cohort consists of 58,279 men; study 
population consists of sub-cohort sample, which was 
sampled directly after identification of the total cohort.  
 
Exclusion criteria:prevalent cancer cases other than 
skin cancer 
 
Study pop: Sub-cohort =  1688  
 
Observation time: 
1986-1992, 6.3 yrs, no loss to follow;680 incident 
cases 
Exposure:  
Questionnaire: self-administered 150-item semi quantitative food-frequency questionnaire  
Repeated during follow-up: baseline only 
Reference period:during year preceding study start 
Drink type: 
 
Measure: grams per day, Reference group:abstainers (incl. ex drinkers) 
Results: 
g/d        ca       Prostate          ca      localised                   ca  advanced 
0.1-4    143    1.1   (0.8-1.5)    59    1.7   (1.0-2.6)          44     1.0   (0.6-1.6) 
5-14     161    0.9   (0.7-1.3)    55    1.1    (0.7-1.8)         63     1.1   (0.7-1.6) 
15-29   161    1.1   (0.8-1.4)    61    1.4    (0.9-3.3)         49     0.9   (0.6-1.5) 
≥30      101    1.1   (0.8-1.6)    33    1.3    (0.8-2.2)         35     1.1   (0.7-1.8) 
p-trend                0.74                                0.6                              0.67       
Total alcohol intake: continuous 10g increment = 1.0   (1.0-1.1)  
 





Study aims: To examine the 
association of total and beverage-
specificalcohol consumption with 
prostate cancer risk using data 
fromthe Harvard Alumni Study, a 
prospective cohort study of middle-
agedand older men 
 
Source of funding: 
National Cancer Instituteand the 
National Heart, Lung, and Blood 
Institute 
Population: 
Source: Men matriculating as undergraduates at 
Harvard University, USA 1916-1950. First mailed a 
health questionnaire to surviving alumni in either 
1962 or 1966, and then periodically to all surviving 
alumni
. 
For this study, information from 12,805 men 
who returned the 1988 questionnaire 
 
Exclusion criteria: Any historyof physician-diagnosed 
cancer; Incomplete data on alcohol consumption and 
other potential risk factors 
 
Study pop: cohort size = 8,935, mean age 66 years 
 
Observation time: 
From 1988 to end of 1993 median follow-up of 5.0 
years, Loss to follow up 15%; 366 cases  
Exposure:  
Questionnaire: Mailed questionnaire 
Repeated during follow-up: baseline only 
Reference period:n/s 
Drink type: wine, beer, and spirits 
 
Measure: units of alcohol, Reference group: Almost never (not defined) 
Results: Total Alcohol  
1 month-<3 p/week   1.33        (0.88-2.01) 
3 p/week-<1p/day     1.65        (1.12-2.44) 
1p/day-<3p/day         1.85        (1.29-2.64) 











Descriptive tables for prostate cancer: case control Studies 
 






We examined the association 
between lifetime alcohol intake, 
duration of alcohol use, and drinks 
per day with risk of prostate cancer 
in western New York.’ 
 
Source of funding: 
Department of Defence, Prostate 
Cancer Program and the National 
Cancer Institute, and in part by an 
American Italian Cancer 
Foundation Fellowship 
Population: Cases: drawn from hospitals in Western 
New York. N=96 
Controls: selected from a list of individuals holding a 
New York State driver's license. Those aged >65 
selected from rolls of the Health Care Financial 
Administration, N=317 
 
Exclusion criteria: men with previous history of 
cancer (except non-melanoma skin cancer), or on 
hormonal or chemotherapy treatment (current or in 
the 6 months prior to diagnosis); chronic or acute liver 
diseases; cases 35-65 yrs also required to have 
driver's license, because driver's license records 
used to identify age-matched controls. 
 
Observation time: December 1998-April 2001. 
Response rate: cases 70%, controls 60% 
Exposure:  
Questionnaire: Trained interviewers during in-person computer assisted interviews and with 
self-administered questionnaires. Detailed information on alcohol consumption throughout the 
lifetime was collected using the Cognitive Lifetime Drinking History 
Interviewers blinded: n/a 
Reference period: n/s 
Drink type: wine, beer, and spirits 
 
Measure: ounces, Reference group: Lifetime : ≤2647 ounces; total drinking years: >53 yrs; 
drinks per day: ≤2d/d 
Results: 
                                   ca/co  Lifetime ethanol intake 
≤2647.62-11048.28    34/90    1.20   (0.65-2.23) 
>11048.28                  25/92    0.83   (0.43-1.60) 
                     ca/co   Total drinking years                          ca/co     Drinks per day  
42–53           27/94     1.44    (0.66–3.14)                     >2   26/54     1.38   (0.76–2.51) 
≤42               47 92      2.16   (0.98–4.78) 
 





Study aims: …whether the 
association of alcohol consumption 
with prostate cancer risk varies 
between localized and advanced 
cases, or between sporadic and 
familial cases. 
 
Source of funding: 
Swedish Cancer Society 
Population: 
Cases: identified from four of six regional cancer 
registries covering northern, central, Stockholm, and 
southeastern health care regions in Sweden, approx. 
67% of Sweden’s total population, N=1,895 
Controls: identified through Swedish Population 
Registry database, and frequency-matched by age 
(five-year categories) to expected distribution of 
incident cases, N=1,684 
 
Exclusion criteria: none specified 
 
Observation time: 1st July 2001 to 1 March 2002. 
Response rate: cases 79%, controls 67% 
Exposure:  
Questionnaire: Completed self-administered questionnaire 
Interviewers blinded: n/a 
Reference period: drinking in the last year 
Drink type: wine, beer, and spirits 
 
Measure: grams per week, Reference group:Non-drinkers 
Results: 0.1-45.0        1.1    (0.8-1.4)  
               45.1-90.0      1.2    (0.9-1.5)  
               90.1-135.0    1.3    (0.9-1.7) 
               ≥135.1          1.3    (1.0-1.7)  ptrend 0.06     
                Localized (804)  Advanced (593) Sporadic (387)  Familial (634) 
0.1–45.0     1.5 (1.1-2.1)    0.8 (0.6-1.0)        0.9 (0.7-1.3)     1.0 (0.7-1.5) 
45.1–90.0   1.4 (1.0-2.0)    0.9 (0.7-1.2)        1.1 (0.8-1.5)     1.2 (0.8-1.8) 
90.1–135.0 1.4 (1.0-2.1)    1.1 (0.8-1.5)        1.3 (0.9-1.8)     1.2 (0.8-1.9) 









Study aims: To examine the 
association between alcohol and 
the risk of prostate cancer/benign 
prostatic hyperplasia in a 
population with a wide range of 
alcohol consumption, 
 
Source of funding: 
Italian Association for Cancer 
Research, Italian League Against 




Cases: those admitted to major teaching and general 
hospitals in four areas of Italy 
N=1294; 
Controls: selected from patients admitted to  same 
hospitals with conditions, unrelated to known or 
potential risk factors for prostatic disease and long-
term diet modification 
N=1451 
 
Exclusion criteria:patients admitted for diseases 
related to alcohol drinking,  
 
Observation time: 
1991 to 2002 
Response rate: <5% of both cases and controls 
refused to participate 
Exposure:  
Questionnaire: Interviewed during hospital stay, using structured questionnaire 
Interviewers blinded: n/s 
Reference period: up to 1 year before diagnosis 
Drink type: wine, beer, and spirits) 
 
Measure: drinks per week, duration of drinking, age at starting, Reference group:drinks per 
week, duration of drinking, abstainers; age at starting - ≤16 yrs 
Results:               drinks per week  
<3  0.89   (0.61-1.29) 
3-4  0.90   (0.61-1.32) 
5-6  1.13   (0.74-1.74) 
7-8  0.95   (0.60-1.49) 
≥9  0.85   (0.54-1.35)      ptrend=0.819 
yr                 Duration of drinking             yr Age at starting 
<35 254/185   1.14 (0.63-2.08)   17–19   233/230   1.36  (1.05-1.75)  
35-44 488/416   1.11 (0.63-1.97)   20–22   408/366   1.13  (0.91-1.42)  
≥45 618/611   0.95 (0.54-1.68)   ≥23       337/334   1.19  (0.94-1.51)  
ptrend=                        0.224                                              0.314 
 





Study aims: to test several 
hypotheses relating to risk factors 
for prostate cancer, including diet, 
particularly with respect to early 
onset, clinically significant disease 
 
Source of funding: 
National Health and Medical 
Research Council, Tattersall's and 
The Whitten Foundation 
Population: 
Cases: aged <70 yrs at diagnosis and registered to 
vote in Melbourne, Sydney or Perth, Australia, N=858 
Controls: randomly selected from State Electoral 
Rolls, N=905 
 
Exclusion criteria: excluded tumours that were 
described as low-grade or had Gleason scores <5. 
 
Observation time: 
between 1994 and 1997 
Response rate: 65% cases and 50%controls 
Exposure:  
Questionnaire: Face to face interviews were with an administered food frequency 
questionnaire 
Interviewers blinded: n/s 
Reference period: n/s 
Drink type: beer, wine, spirits 
 
Measure: grams per day, Reference group: 0-19 grams per day 
Results: 
20-39     1.0    (0.8-1.3) 
40-59     1.0    (0.7-1.3) 











Study and Aims Study and sample characteristics Exposure measurement and main results 





to gain knowledge about the 
relationship between alcohol 
intake and prostate cancer 
 
Source of funding: 
National Cancer Institute, NIH, 





Cases: were newly diagnosed prostate cancer 
identified from the Seattle cancer registry and from 
eligible cases, a random 75% sample was selected. 
N=753 (82.1%) 
Controls were selected using randomly telephone 
dialling and were  frequency-matched to cases by 5-
year age group 
N= 703 (75%) 
 
Exclusion criteria: did not have a residential 
telephone number; aged >64 years 
 
Observation time: 
Between January 1, 1993 and December 311996 
Exposure:  
Questionnaire: In-person interview conducted by trained male interviewers, including a 
validated self-administered food frequency questionnaire 
Interviewers blinded: n/s 
Reference period: For men who drank >12 alcoholic drinks throughout their lives, lifetime 
information on alcohol consumption was recorded per beverage, for each period of drinking 
pattern and number of drinks recorded for every period 
Drink type: beer, spirits and wine 
 
Measure:drinks per week, lifetime duration, total cumulative consumption, Reference group: 
non-drinker’ 
Results:      ca/co      Lifetime intake   
>0-6000    186/170   1.12    (0.75-1.68)       
6001    122/138   0.89    (0.57-1.37)       
12001    138/139   0.97    (0.63-1.51)       
≥24001    235/170   1.29    (0.84-1.97)    ptrend = 0.33                                            
  years     ca/co       Lifetime duration        d/w   Drinks per week-lifetime average 
<31 149/153    1.11   (0.72-1.70)        1-7      266/264    0.94   (0.68-1.31) 
31–35 132/123    1.06   (0.68-1.66)        8-14    166/145    1.06   (0.73-1.54) 
36–40 166/168    0.95   (0.62-1.45)        ≥15      195163    1.08   (0.84-1.97) 
≥ 41  234/173   1.15  (0.75-1.76)     
Ptrend =                        0.97=                                           0.32   
   d/w                Wine                    Beer                      Spirits 
Ever 0.74   (0.59-0.93)     1.17   (0.93-1.49)     1.16   (0.92-1.47) 
1-7 0.73   (0.48-1.10)     1.14   (0.79-1.67)     1.16   (0.76-1.78) 
8-14 0.56   (0.32-0.98)     1.17   (0.72-1.89)     1.22   (0.71-2.11) 
≥15 0.63   (0.31-1.27)     1.16   (0.71-1.91)     1.42   (0.83-2.43) 














Study and Aims Study and sample characteristics Exposure measurement and main results 





‘to assess occupational 
exposures, but which also 
included information on lifelong 
alcohol consumption’ 
 
Source of funding: 
National Health Research and 
Development Program of 
Canada, National Cancer 
Institute of Canada, and Health 
Canada 
Population:  
Cases: ‘virtually’ all (97%) incident cancer cases 
occurring in men aged 35-70 yrs diagnosed at all large 
hospitals in metropolitan Montreal  
N=449 (80.6% response rate) 
Controls: selected from electoral lists and by random 
digit dialling. A second control group was selected from 
pool of all other cancer cases in overall study that were 
accrued during the same years as prostate cancer 
cases. N= 533, Cancer controls = 674 (72.0% response 
rate) 
 
Exclusion criteria: n/s for population controls. For 
cancer controls, sites considered to be related to 
alcohol use were excluded; i.e., cancers of the 
oesophagus, stomach, liver, sigmoid colon, 
rectosigmoid junction, rectum, but not colon cancer 
 
Observation time: 1979 and 1985 
Exposure:  
Questionnaire: Structured questionnaire, carried out by team of three interviewers 
Interviewers blinded: not blinded to whether  subject was a cancer patient or a population 
control, but were blinded to type of cancer that  participant had 
Reference period: lifetime consumption 
Drink type: beer, wine, and spirits 
 
Measure:drink status, age started drinking, duration of daily drinking 
Reference group: those who never drank weekly 
Results:  
Drank weekly, never daily 1.6   (1.1-2.4) 
Drank daily  1.6   (1.1-2.3) 
Yrs  age at starting daily drinking   Duration of daily drinking 
<15 17/10   3.8   (1.6-9.3)  Drank for < 20 yrs     32/41     1.3   (0.7-2.4) 
15-19 51/68   1.4   (0.8-2.4)  Drank for 20-39 yrs   64/110   1.1   (0.7-1.8) 
20-24 49/51   1.6   (0.9-2.7)  Drank for ≥ 39 yrs     88/65     2.0   (1.2-3.1)   ptrend =0.01 
≥ 25 68/87   1.2   (0.8-2.0) ptrend 0.0009 
 
Study and Aims Study and sample characteristics Exposure measurement and main results 




Study aims: To evaluate the 
relationship between prostate 
cancer and several potential 
lifestyle risk factors. 
 
Source of funding: 
None specified  
 
Population:  Cases: identified from provincial cancer 
registries in eight of ten Canadian provinces. N=1623 
(response rate 69%)  
Controls: drawn from provincial health insurance plans, 
ministry of finance data or random digit telephone 
dialling, depending on province, sample, based on 
expected age distribution of all registry cancer cases, 
and not just prostate cancer, N=1623 (response rate 
69%)  
 
Exclusion criteria: prostate cancer cases diagnosed < 
50yrs; people aged ≥74 years 
 
Observation time:  Between 1994 and 1997. 
Exposure:  
Questionnaire: Mailed questionnaires, with telephone follow-up  
Interviewers blinded: n/s 
Reference period:2 years before interview 
Drink type: wine, beer and liquor 
 
Measure:drinks per day  status, age started drinking, duration of daily drinking, Reference 
group:non-drinkers 
Results:   
Up to 1     1.1     (0.9-1.3) 
1-<4         1.1     (0.9-1.4)       
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Appendix F: Previous and revised factors for 














Revised unit  
conversion 
factor 
Normal strength beer, 
lager, stout, cider, 
shandy (less than 6% 
ABV) 
Half pint 1.0 284 4.0% 1.0 
 Can or bottle Amount in 
pints multiplied 
by 2 
330 4.5% Amount in pints 
multiplied by 
2.5 
 Small can (size 
unknown) 
1.0  4.5% 1.5 
 Large can/bottle 
(size unknown) 
2.0  4.5% 2.0 
Strong beer, lager, 
stout, cider, shandy 
(6% ABV or more) 
Half pint 1.5 284 6.5% 2 
 Can or bottle Amount in 
pints multiplied 
by 3 
330 6.5% Amount in pints 
multiplied by 4 
 Small can (size 
unknown) 
1.5  6.5% 2 
 Large can/bottle 
(size unknown) 
3.0 a  6.5% 3.0 
Wine Glass (size 
unspecified) b 
1.0  12.5% 2.0 
 glass - 125ml  125 12.5% 1.5 
 glass - 175ml  175 12.5% 2.0 
 glass - 
250ml/small can 
 250 12.5% 3.0 
 bottle 6.0 750 12.5% 9.4 
Sherry, vermouth and 
other fortified wines 
Glass 1.0 50 17.0% 1.0 
Spirits Glass (single 
measure) 
1.0 25 40.0% 1.0 
 bottle     
Alcopops Small can or 
bottle 
1.0 50 5.0% 1.5 
*Source: adapted from Table 1 in Goddard (2007) and Corbett et al (2009)  
1
The predominant measure of alcoholic strength in use in the UK is alcohol by volume (ABV) 
which is the percentage of the drink by volume that is pure ethyl alcohol. 
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Appendix G Scottish Health Survey sample sizes, 
2003, 2008, 2009 
 
Table G.1 SHeS sample sizes, weighted and un-weighted, 2003, 2008, 2009, men and by 
age-group 
Bases (weighted): 
 16-24 25-34 35-44 45-54 55-64 65-74 ≥75 Total 
Men 2003 536 596 755 665 566 404 258 3780 
Men 2008 405 475 559 549 478 326 218 3011 
Men 2009 514 564 631 648 563 386 257 3563 
Bases (unweighted): 
Men 2003 309 446 726 610 630 507 323 3551 
Men 2008 220 312 456 530 523 451 304 2796 
Men 2009 261 404 548 601 575 516 361 3266 
 
 
Table G.2 SHeS sample sizes, weighted and un-weighted, 2003, 2008, 2009, women and by 
age-group 
Bases (weighted): 
 16-24 25-34 35-44 45-54 55-64 65-74 ≥75 Total 
Women 2003 505 655 805 685 599 491 467 4209 
Women 2008 402 487 614 585 502 382 348 3319 
Women 2009 501 571 694 700 590 450 408 3913 
Bases (unweighted): 
Women 2003 366 598 879 788 774 579 492 4476 
Women 2008 305 450 646 627 630 513 408 3579 





Appendix H: Alcohol related cancer trends in 
Scotland, European Age Standardised Rates by 
gender, 1985-2008 
 
Table G.1 European age-standardised incidence rates (EASRs)
1
 for cancers of the UADT by 
gender, 1985-2008. (Source ISD 2010b) 
 Men Women 
 Oral 
Cavity 
Pharynx Larynx Oesophagus Oral 
Cavity 
Pharynx Larynx Oesophagus 
1985 6.1 1.1 8.2 12.90 2.2 0.4 1.5 6.10 
1986 5.2 1.1 8.5 11.90 2.3 0.3 1.6 5.90 
1987 5.9 1.1 7.1 13.50 3 0.3 1.6 6.90 
1988 6.3 1.1 8.4 13.00 2.8 0.4 1.6 7.10 
1989 6.3 1.8 8.1 13.40 2.8 0.5 1.8 7.40 
1990 6.9 1.8 8.6 15.00 2.7 0.4 2.4 7.50 
1991 7.1 1.3 9.5 13.70 3.2 0.6 1.5 7.50 
1992 7.1 1.5 10.2 14.80 3 0.5 1.8 8.10 
1993 7.5 1.6 9.8 16.90 2.9 0.4 1.6 9.20 
1994 7.5 1.4 9.3 17.10 3.4 0.5 1.9 8.40 
1995 7.9 1.8 8.2 17.10 3.7 0.9 1.8 8.40 
1996 8.2 2.1 10.5 18.50 3.9 0.9 2.9 8.70 
1997 8.1 2.7 8.5 16.60 3.1 0.8 1.8 7.90 
1998 8.9 1.7 9.3 17.60 4.2 0.3 1.8 7.10 
1999 9 2.5 10.2 16.80 3.5 0.9 2 8.20 
2000 8.4 2.7 9.3 16.50 3.7 0.8 2 7.00 
2001 8.1 2.3 9.6 17.40 4.4 0.8 1.9 6.90 
2002 9 2.4 8.5 18.40 3.6 1 1.7 7.40 
2003 9.2 2 8.2 17.80 4 0.9 1.9 7.00 
2004 9.2 2.6 8.4 18.30 4.2 0.9 2 7.90 
2005 8.8 2.5 7.7 17.40 4 0.8 1.7 7.20 
2006 9.2 3 8.3 17.60 3.8 0.7 2.2 7.00 
2007 9.2 3 8.4 17.5 4.3 0.9 1.5 6.7 
2008 8.7  7.3 17.5 4  1.7 6.4 
1
EASR: age-standardised incidence rate per 100,000 person-years at risk (European 
standard population) 





Table G.2 European age-standardised incidence rates (EASRs)
 1
 for alcohol related 
gastrointestinal cancers of the UADT by gender, 1985-2008. (Source ISD 2010b) 
 
 Men Women 
 Liver Pancreas Gastric Colon Rectal Liver Pancreas Gastric Colon Rectal 
1985 3.8 11.5 31 33.4 19.5 1.5 8.8 14.8 28.8 11.1 
1986 3.9 12.1 28.8 34.5 19.9 1.7 9.1 13.4 28.8 11.8 
1987 4.7 12.3 28.6 33.4 19.6 1.5 7.8 13.1 28.6 12.4 
1988 3.9 12.3 28.6 32.9 18.7 1.8 8.2 12.5 28.1 11.8 
1989 4.3 12.0 28 36.8 19.1 1.8 8.2 11.6 30.5 10.9 
1990 4.4 12.8 25.8 36.8 20.6 1.8 8.7 11.2 31 12 
1991 4.6 11.1 25.3 38 22.4 1.9 7.6 11.4 28.5 11.2 
1992 5 12.5 26.4 38 23.1 2.3 8.4 10.9 27.8 11.3 
1993 4.5 10.8 22.1 41.2 22.1 2.3 8.3 9.9 31.4 11.5 
1994 4.6 10.5 23.8 40.2 22.7 1.8 8.3 10.6 30.7 12.4 
1995 4.8 10.1 22.9 40 22 1.8 7.4 10.7 31.3 11.3 
1996 6.1 12.3 22 43.6 26 2.7 8.6 10.1 31.9 13.4 
1997 6.1 11.3 21.9 41.2 26.2 2.4 8.2 10.6 27.9 12.5 
1998 6.1 10.5 19.8 39.8 26.3 2.4 8.8 8.9 26.7 13 
1999 5.6 9.8 19.5 40.1 26.2 2.5 8.3 9.5 28.9 12.2 
2000 5.4 11.6 20.9 42.5 25.4 3 7.8 9 30.1 12.6 
2001 5.8 9.6 19.4 41 24.8 2.6 7.8 8.9 30.2 12.6 
2002 5.8 10.1 18.7 38.1 25.4 2.3 7.6 8.2 28.2 12.3 
2003 6.4 10.6 17.1 41.9 23.8 2.9 9.0 7.6 26.4 12.3 
2004 7 9.8 17.4 40 24.8 3 7.6 7.6 27.3 12.1 
2005 7.1 9.7 15.3 37.8 24.8 2.8 8.5 7.6 26.8 12 
2006 7.9 9.9 15.8 38.8 22.7 3 7.7 6.7 27.6 12.2 
2007 8.7 10.3 14.2 40.1 23.8 2.9 8 6.8 29.2 12.3 
2008 7.3 10.9 16 41.5 24.6 2.8 7.8 6.4 29.8 12.8 
1
EASR: age-standardised incidence rate per 100,000 person-years at risk (European 
standard population) 





Table G3 European age-standardised incidence rates (EASRs)
1 
for prostate, bladder, kidney, 
breast, lung and ovarian cancer, by gender, 1985-2008. (Source ISD 2010b) 
 
 Men Women 
 Lung Bladder Kidney Prostate Lung Bladder Kidney Ovarian Breast 
1985 133 32.2 9.90 46.0 44.8 9.7 5.1 16.5 84.6 
1986 126.2 34.5 9.40 47.8 43.4 10.5 4.3 17.9 87.2 
1987 127.8 35.6 9.80 48.6 45.8 10.4 5.2 17.6 89.3 
1988 122.5 34.6 9.50 49.1 45.8 10.3 5.7 18.3 91.1 
1989 119.5 32.9 9.60 49.8 45.7 10.9 5.6 17.4 93.1 
1990 116.6 35.5 10.10 52.5 49.1 10.4 6.3 18.5 100.8 
1991 118.1 32.2 12.10 52 48.7 11.2 5.4 19.3 108.6 
1992 119.8 36.4 10.90 55.8 52.1 10.7 6 18.8 110.7 
1993 117 35.6 10.70 67.8 50 11.4 5.6 17.9 106.5 
1994 112.7 37.7 12.00 70.3 50.6 10.9 6.9 19.1 104.7 
1995 107.7 35.4 12.50 74 51.5 11.8 6.2 17.9 110.5 
1996 107.6 34.9 13.10 81.4 56.2 11.5 7.4 20.8 109.8 
1997 101.7 30.4 12.70 71.6 53.5 9.9 6.8 21.3 112.6 
1998 99 22.9 13.70 71.4 53.3 7.7 6.8 18.4 115.3 
1999 94.1 21.2 14.00 73.3 51 6 6.5 18.2 118.4 
2000 90.9 18.2 12.60 73.9 53.8 5.7 7.2 19.6 119.4 
2001 89.5 18.2 13.20 77.8 49.1 6.6 6.6 18 113.2 
2002 91.6 18.6 12.70 85.4 53.6 5.9 7.1 18.7 116.1 
2003 85.7 17.7 12.90 86.2 52.7 5.8 7 18.9 120 
2004 85.7 18.3 14.00 91.2 56.2 6.4 7 18.2 120.9 
2005 83.9 15.9 14.00 83.9 54.7 5.8 7.2 18.1 120.8 
2006 83.5 15.6 14.90 87.3 56.7 5.5 7.3 16.2 122.6 
2007 82 15.6 15.3 85.6 58.2 5.5 8.8 17.8 121.9 
2008 77.2 14.8 15 84.3 57.5 5.7 8.7 17.2 122.8 
1
EASR: age-standardised incidence rate per 100,000 person-years at risk (European 
standard population) 




Appendix I: Age standardised incidence ratios, by 
cancer type, gender and Carstairs (2001) deprivation 
quintiles 
 
Table H1 Male age standardised incidence ratios (with 95% confidence intervals), by cancer 
type, and Carstairs (2001) deprivation quintiles. 
Cancer type Carstairs Quintile Obs. Exp. SIR 95% CI 
P-value 
Bladder 1 (least deprived 54 75.1 0.72 0.54-0.94 
0.013 
 2 78 87.0 0.90 0.71-1.12 
0.366 
 3 114 96.0 1.19 0.98-1.43 
0.081 
 4 114 103.2 1.10 0.91-1.33 
0.312 
 5 (most deprived) 229 113.5 2.02 1.77-2.30 
0.000 
      
 
Colon 1 (least deprived 87 155.7 0.56 0.45-0.69 
0.000 
 2 105 159.0 0.66 0.54-0.80 
0.000 
 3 146 161.5 0.90 0.76-1.06 
0.235 
 4 166 157.3 1.06 0.90-1.23 
0.506 
 5 (most deprived) 271 175.5 1.54 1.37-1.74 
0.000 
      
 
Gastric 1 (least deprived 40 56.9 0.70 0.50-0.96 
0.023 
 2 57 70.8 0.81 0.61-1.04 
0.107 
 3 71 81.5 0.87 0.68-1.10 
0.267 
 4 119 95.2 1.25 1.04-1.50 
0.020 
 5 (most deprived) 178 112.4 1.58 1.36-1.83 
0.000 
      
 
Hypopharynx 1 (least deprived 11 1.8 5.98 2.97-10.74 
0.000 
 2 14 2.3 6.15 3.35-10.35 
0.000 
 3 21 2.7 7.87 4.86-12.05 
0.000 
 4 16 3.2 5.04 2.87-8.2 
0.000 
 5 (most deprived) 48 4.2 11.36 8.38-15.08 
0.000 
      
 
Kidney 1 (least deprived 17 58.4 0.29 0.17-0.47 
0.000 
 2 36 55.7 0.65 0.45-0.90 
0.007 
 3 46 54.5 0.84 0.62-1.13 
0.277 
 4 49 54.0 0.91 0.67-1.20 
0.549 
 5 (most deprived) 84 54.5 1.54 1.23-1.91 
0.000 
      
 
Larynx 1 (least deprived 47 18.3 2.57 1.89-3.42 
0.000 
 2 67 29.0 2.31 1.79-2.94 
0.000 
 3 102 36.5 2.80 2.28-3.39 
0.000 
 4 139 44.5 3.12 2.62-3.69 
0.000 
 5 (most deprived) 247 63.6 3.89 3.42-4.40 
0.000 
      
 
Liver 1 (least deprived 52 19.0 2.74 2.05-3.59 
0.000 
 2 61 22.0 2.77 2.12-3.56 
0.000 
 3 83 23.2 3.58 2.85-4.44 
0.000 
 4 83 30.9 2.68 2.14-3.33 
0.000 
 5 (most deprived) 159 36.1 4.40 3.74-5.14 
0.000 
      
 




Cancer type Carstairs Quintile Obs. Exp. SIR 95% CI 
P-value 
 2 409 326.1 1.25 1.14-1.38 
0.000 
 3 581 388.9 1.49 1.37-1.62 
0.000 
 4 711 465.9 1.53 1.42-1.64 
0.000 
 5 (most deprived) 1493 630.6 2.37 2.25-2.49 
0.000 
      
 
Oesophagus 1 (least deprived 61 50.6 1.21 0.92-1.55 
0.170 
 2 89 65.3 1.36 1.09-1.68 
0.006 
 3 122 69.9 1.75 1.45-2.09 
0.000 
 4 149 76.5 1.95 1.65-2.29 
0.000 
 5 (most deprived) 248 90.4 2.74 2.41-3.11 
0.000 
      
 
Oral 1 (least deprived 69 22.9 3.01 2.34-3.81 
0.000 
 2 117 29.1 4.03 3.33-4.83 
0.000 
 3 155 33.9 4.57 3.88-5.35 
0.000 
 4 185 38.5 4.81 4.14-5.56 
0.000 
 5 (most deprived) 323 59.5 5.43 4.85-6.06 
0.000 
      
 
Pancreas 1 (least deprived 34 43.5 0.78 0.54-1.09 
0.164 
 2 45 40.0 1.13 0.82-1.51 
0.465 
 3 52 43.1 1.21 0.90-1.58 
0.206 
 4 71 46.9 1.51 1.18-1.91 
0.001 
 5 (most deprived) 125 53.2 2.35 1.96-2.80 
0.000 
      
 
Pharynx 1 (least deprived 10 5.6 1.77 0.84-3.27 
0.123 
 2 29 7.2 4.02 2.69-5.79 
0.000 
 3 42 10.1 4.17 3.01-5.64 
0.000 
 4 52 11.2 4.66 3.48-6.12 
0.000 
 5 (most deprived) 86 14.6 5.88 4.70-7.27 
0.000 
      
 
Prostate 1 (least deprived 126 355.3 0.35 0.3-0.42 
0.000 
 2 201 322.2 0.62 0.54-0.72 
0.000 
 3 227 307.6 0.74 0.65-0.84 
0.000 
 4 249 294.2 0.85 0.74-0.96 
0.008 
 5 (most deprived) 393 276.3 1.42 1.29-1.57 
0.000 
      
 
Rectal 1 (least deprived 53 96.7 0.55 0.41-0.72 
0.000 
 2 89 98.9 0.90 0.72-1.11 
0.346 
 3 101 102.3 0.99 0.80-1.20 
0.946 
 4 111 100.1 1.11 0.91-1.34 
0.300 
 5 (most deprived) 184 111.5 1.65 1.42-1.91 
0.000 




Table H2 Female age standardised incidence ratios (with 95% confidence intervals), by 
cancer type, and Carstairs (2001) deprivation quintiles. 
 
Cancer type Carstairs Quintile Obs. Exp. SIR 95% CI 
P-value
 
Bladder 1 (least deprived 10 8.0 1.26 0.60-2.32 
0.555 
 2 15 9.2 1.63 0.901-2.7 
0.096 
 3 15 10.1 1.49 0.83-2.46 
0.177 
 4 27 12.1 2.24 1.47-3.26 
0.000 
 5 (most deprived) 48 13.1 3.66 2.69-4.85 
0.000 
      
 
Breast 1 (least deprived 100 193.9 0.52 0.42-0.63 
0.000 
 2 135 195.9 0.69 0.58-0.82 
0.000 
 3 155 189.1 0.82 0.70-0.96 
0.012 
 4 224 184.7 1.21 1.06-1.38 
0.006 
 5 (most deprived) 293 178.7 1.64 1.46-1.84 
0.000 
      
 
Colon 1 (least deprived 32 40.6 0.79 0.54-1.11 
0.196 
 2 41 41.8 0.98 0.70-1.33 
0.984 
 3 51 39.9 1.28 0.95-1.68 
0.101 
 4 53 37.1 1.43 1.07-1.87 
0.016 
 5 (most deprived) 67 38.5 1.74 1.35-2.21 
0.000 
      
 
Gastric 1 (least deprived 7 10.7 0.65 0.26-1.35 
0.319 
 2 8 10.6 0.76 0.32-1.50 
0.542 
 3 13 12.4 1.05 0.55-1.79 
0.945 
 4 13 13.8 0.94 0.50-1.62 
0.979 
 5 (most deprived) 42 16.3 2.57 1.85-3.48 
0.000 
      
 
Hypopharynx 1 (least deprived 3 0.3 11.54 2.18-34.16 
0.007 
 2 4 0.4 11.38 2.96-29.42 
0.002 
 3 2 0.3 6.17 0.58-22.67 
0.090 
 4 4 0.5 8.50 2.21-21.97 
0.004 
 5 (most deprived) 14 0.6 23.16 12.62-38.97 
0.000 
      
 
Kidney 1 (least deprived 4 8.8 0.46 0.12-1.18 
0.125 
 2 6 8.9 0.67 0.24-1.48 
0.430 
 3 9 9.1 0.99 0.45-1.9 
0.838 
 4 14 10.2 1.38 0.75-2.31 
0.297 
 5 (most deprived) 22 9.9 2.23 1.39-3.37 
0.001 
      
 
Larynx 1 (least deprived 5 1.2 4.09 1.29-9.63 
0.018 
 2 12 1.9 6.46 3.32-11.33 
0.000 
 3 13 2.2 5.91 3.13-10.13 
0.000 
 4 19 3.0 6.35 3.82-9.93 
0.000 
 5 (most deprived) 53 5.1 10.32 7.73-13.50 
0.000 
      
 
Liver 1 (least deprived 8 2.7 3.01 1.28-5.95 
0.013 
 2 10 3.0 3.30 1.57-6.09 
0.003 
 3 13 3.4 3.84 2.04-6.59 
0.000 
 4 17 3.7 4.64 2.70-7.45 
0.000 
 5 (most deprived) 22 4.2 5.18 3.24-7.85 
0.000 




Cancer type Carstairs Quintile Obs. Exp. SIR 95% CI 
P-value
 
Lung 1 (least deprived 91 53.5 1.70 1.37-2.09 
0.000 
 2 157 57.2 2.74 2.33-3.21 
0.000 
 3 189 67.8 2.79 2.40-3.22 
0.000 
 4 248 80.8 3.07 2.70-3.48 
0.000 
 5 (most deprived) 423 110.9 3.81 3.46-4.20 
0.000 
      
 
Oesophagus 1 (least deprived 21 8.9 2.36 1.46-3.61 
0.001 
 2 33 10.1 3.28 2.25-4.60 
0.000 
 3 23 9.6 2.39 1.51-3.59 
0.000 
 4 37 11.0 3.36 2.36-4.63 
0.000 
 5 (most deprived) 64 12.4 5.15 3.96-6.58 
0.000 
      
 
Oral 1 (least deprived 18 4.3 4.24 2.50-6.71 
0.000 
 2 29 4.6 6.33 4.23-9.09 
0.000 
 3 42 4.9 8.65 6.23-11.71 
0.000 
 4 60 5.8 10.38 7.92-13.36 
0.000 
 5 (most deprived) 71 7.2 9.87 7.71-12.45 
0.000 
      
 
Ovarian 1 (least deprived 20 27.1 0.74 0.45-1.14 
0.199 
 2 21 27.0 0.78 0.48-1.19 
0.283 
 3 39 27.0 1.44 1.03-1.97 
0.035 
 4 29 26.6 1.09 0.73-1.56 
0.699 
 5 (most deprived) 56 26.0 2.15 1.63-2.80 
0.000 
      
 
Pancreas 1 (least deprived 10 9.6 1.05 0.50-1.93 
0.971 
 2 15 10.3 1.45 0.81-2.40 
0.202 
 3 21 11.7 1.80 1.11-2.75 
0.018 
 4 26 11.7 2.22 1.45-3.25 
0.000 
 5 (most deprived) 45 12.9 3.49 2.54-4.67 
0.000 
      
 
Pharynx 1 (least deprived 5 1.0 4.82 1.52-11.35 
0.010 
 2 16 0.9 17.56 10.01-28.58 
0.000 
 3 14 1.0 13.45 7.33-22.63 
0.000 
 4 19 1.2 16.00 9.61-25.03 
0.000 
 5 (most deprived) 26 1.5 16.92 11.04-24.83 
0.000 
      
 
Rectal 1 (least deprived 12 17.2 0.70 0.36-1.22 
0.249 
 2 23 17.2 1.34 0.85-2.01 
0.205 
 3 26 16.6 1.57 1.02-2.30 
0.040 
 4 19 16.9 1.13 0.68-1.76 
0.664 
 5 (most deprived) 34 16.5 2.06 1.43-2.89 
0.000 
Abbreviations: Obs= observed cases, Exp= expected cases, SIR= standardised incidence ratio
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